Please wait...
| ID | PMID | YEAR | Sequence | MAP | Name | C-ter MOD | N-ter MOD | Linear/Cyclic | Stereo-Chemistry | Modified | Length | Fuction | Activity | RBCs Source | Origin | Experimental structure | Non-Hemolytic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10660589 | 2000 | ALWMTLLKKVLKAAAKAALNAVLVGANA | S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =1.4±0.2μM | Human | Dermaseptin S4 (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWMTLLKKVLKAAAKAALDAVLVGANA | D20-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =1.2±0.1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWDTLLKKVLKAAAKAALNAVLVGANA | D4-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =2.3±0.3μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWDTLLKKVLKAAAKAALDAVLVGANA | D4D20-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =5±1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWMTLLKKVLKAAAKAALKAVLVGANA | K20-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =1.2±0.4μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAAKAALNAVLVGANA | K4-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =2±0.1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAAKAALKAVLVGANA | K4K20-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =0.5±0.1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAAKAALN | S4-(1-20) | Free | Free | Linear | L | None | 20 | Antimicrobial | LC50 =5±1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWMTLLKKVLKAAAK | S4-(1-16) | Free | Free | Linear | L | None | 16 | Antimicrobial | LC50 =23±1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWMTLLKKVLK | S4-(1-12) | Free | Free | Linear | L | None | 12 | Antimicrobial | LC50 =100μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | TLLKKVLKAAAK | S4-(5-16) | Free | Free | Linear | L | None | 12 | Antimicrobial | LC50 >80μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | TLLKKVLKAAAKAALNAVLVGANA | S4-(5-28) | Free | Free | Linear | L | None | 24 | Antimicrobial | LC50 =16.5±0.5μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | KVLKAAAKAALNAVLVGANA | S4-(9-28) | Free | Free | Linear | L | None | 20 | Antimicrobial | LC50 =24±1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | AAAKAALNAVLVGANA | S4-(13-28) | Free | Free | Linear | L | None | 16 | Antimicrobial | LC50 =40μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAAK | K4-S4-(1-16) | Free | Free | Linear | L | None | 16 | Antimicrobial | LC50 =57±3μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAAK{ct:Amid} | K4-S4-(1-16)a | Amidation | Free | Linear | L | None | 16 | Antimicrobial | LC50 =10±0.5μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAA{ct:Amid} | K4-S4-(1-15)a | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 =20±1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKA{ct:Amid} | K4-S4-(1-13)a | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LC50 =57±3μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKV{ct:Amid} | K4-S4-(1-10)a | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 >100μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10978343 | 2000 | G{nnr:W*}L{nnr:R**}{nnr:K**}AA{nnr:K**}SVG{nnr:K**}F{nnr:Y*}{nnr:Y*}{nnr:K**}H{nnr:K*}{nnr:Y*}{nnr:Y*}I{nnr:K*}AAWQIGKHAL{ct:Amid} | Styelin D | Amidation | Free | Linear | L | W* = 6-bromotryptophan, R** = dihydroxyarginine, Y* = 3,4-dihydroxyphenylalanine, K* = 5-hydroxylysine, K** = dihydroxylysine | 32 | Antimicrobial | EC50 =10 μg/ml | Human | Stylein D (blood cells of solitary ascidian Styela clava) | α-helix | NA | ||
| 10978343 | 2000 | G{nnr:W*}L{nnr:R**}{nnr:K**}AA{nnr:K**}SVG{nnr:K**}F{nnr:Y*}{nnr:Y*}{nnr:K**}H{nnr:K*}{nnr:Y*}{nnr:Y*}I{nnr:K*}AAWQIGKHAL{ct:Amid} | Styelin D | Amidation | Free | Linear | L | W* = 6-bromotryptophan, R** = dihydroxyarginine, Y* = 3,4-dihydroxyphenylalanine, K* = 5-hydroxylysine, K** = dihydroxylysine | 32 | Antimicrobial | EC50 =40 μg/ml | Sheep | Stylein D (blood cells of solitary ascidian Styela clava) | α-helix | NA | ||
| 15149180 | 2004 | {conj:lauric acid}YGAAKKAAKAAKKAAKAA | AKK | Free | Conjugated with lauric acid | Linear | L | None | 18 | Antimicrobial | <15% hemolysis at 500μM | Human | Synthetic peptide | α-helix | NA | ||
| 15149180 | 2004 | {conj:lauric acid}YGAKAKAAKAAKAKAAKA | KAK | Free | Conjugated with lauric acid | Linear | L | None | 18 | Antimicrobial | <15% hemolysis at 500μM | Human | Synthetic peptide | α-helix | NA | ||
| 15149180 | 2004 | {conj:lauric acid}KLFKRHLKWKII{ct:Amid} | SC4 | Amidation | Conjugated with lauric acid | Linear | L | None | 12 | Antimicrobial | <15% hemolysis at 500μM | Human | Synthetic peptide | α-helix | NA | ||
| 18243710 | 2008 | DAACAAHCLWR{ct:Amid} | DHWR | Amidation | Free | Linear | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | NA | NA | ||
| 18243710 | 2008 | DAACAAHCLWR{cyc:N-C}{ct:Amid} | DHWRox | Amidation | Free | Cyclic | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | DAACAAKCLWR{ct:Amid} | DKWR | Amidation | Free | Linear | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | DAACAAKCLWR{cyc:N-C}{ct:Amid} | DKWRox | Amidation | Free | Cyclic | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | KAACAAHCLWR{ct:Amid} | KHWR | Amidation | Free | Linear | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | KAACAAHCLWR{cyc:N-C}{ct:Amid} | KHWRox | Amidation | Free | Cyclic | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | KAACAAKCLWR{ct:Amid} | KKWR | Amidation | Free | Linear | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | KAACAAKCLWR{cyc:N-C}{ct:Amid} | KKWRox | Amidation | Free | Cyclic | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 11087404 | 2000 | RRWCFRVCYRGFCYRKCR{ct:Amid} | PM1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 21.3μg/ml | Human | Polyphemusin variants (horseshoe crab Limulus Polyphemus) | NA | NA | ||
| 11087404 | 2000 | RRWCFRVCYRGRFCYRKCR{ct:Amid} | PV5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 42.6μg/ml | Human | Polyphemusin variants (horseshoe crab Limulus Polyphemus) | NA | NA | ||
| 11087404 | 2000 | RRWCFRVCYKGFCRYKCR{ct:Amid} | PV7 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 85μg/ml | Human | Polyphemusin variants (horseshoe crab Limulus Polyphemus) | NA | NA | ||
| 11087404 | 2000 | FRWCFRVCYKGRCRYKCR{ct:Amid} | PV8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 85μg/ml | Human | Polyphemusin variants (horseshoe crab Limulus Polyphemus) | NA | NA | ||
| 11467858 | 2001 | RGLRRLGRKIAHGVKKYGPTVLRIIRIA{ct:Amid} | SMAP-29 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 60.8% hemolysis at 100μM | Human | Cathelecidin derivative SMAP-29 (sheep myeloid mRNA) | NA | NA | ||
| 11467858 | 2001 | RGLRRLGRKIAHGVKKYGPTVKRIKRKA{ct:Amid} | [K22,25,27]-SMAP-29 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | Cathelecidin derivative SMAP-29 derivative (sheep myeloid mRNA) | NA | Non-hemolytic | ||
| 11467858 | 2001 | RGLRRLGRKIAHGVKKYGATVLRIIRIA{ct:Amid} | [A19]-SMAP-29 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50.40% hemolysis at 100μM | Human | Cathelecidin derivative SMAP-29 derivative (sheep myeloid mRNA) | NA | NA | ||
| 11467858 | 2001 | RGLRRLGRKIAHGVKKY{ct:Amid} | SMAP-29(1–17) | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | Cathelecidin derivative SMAP-29 derivative (sheep myeloid mRNA) | NA | Non-hemolytic | ||
| 11467858 | 2001 | RKLRRLKRKIAHKVKKY{ct:Amid} | [K2,7,13]-SMAP-29(1–17) | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | Cathelecidin derivative SMAP-29 derivative (sheep myeloid mRNA) | NA | Non-hemolytic | ||
| 11689009 | 2001 | GLNALKKVFQGIHEAIKLINNHVQ | Pseudin-2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50% hemolysis at >300μM | Human | Pseudin-2 (extract of the skin of the paradoxical frog Pseudis paradoxa (Pseudidae)) | NA | NA | ||
| 15544856 | 2005 | GVVDILKGAAKDIAGHLASKVMNKL{ct:Amid} | Fallaxin | Amidation | Free | Linear | L | None | 25 | Antimicrobial | HC50 >200μM | Human | Fallaxin (skin secretions of the mountain chicken frog Leptodactylus fallax) | NA | NA | ||
| 16236555 | 2005 | GLLDTLKGAAKNVVGSLASKVMEKL{ct:Amid} | Pentadactylin | Amidation | Free | Linear | L | None | 25 | Antimicrobial | LD50 >400μM | Human | Pentadactylin (skin secetion of south American bullfrog Leptodactylus pentadactylus) | NA | NA | ||
| 16413829 | 2006 | GIMSLFKGVLKTAGKHVAGSLVDQLKCKITGGC | Brevinin-2TSa | Free | Free | Linear | L | None | 33 | Antimicrobial | LD50 =100μM | Human | Brevinin (skin of the Tsushima brown frog Rana tsushimensis) | NA | NA | ||
| 16413829 | 2006 | FLGSIVGALASALPSLISKIRN{ct:Amid} | Brevinin-1TSa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | LD50 =12μM | Human | Brevinin (skin of the Tsushima brown frog Rana tsushimensis) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLPKVMAHMK{ct:Amid} | MEP | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 >100μM | Rat | Melectin isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLKKVMAHMK{ct:Amid} | MEP-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 =27.3μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLKVMAHMK{ct:Amid} | MEP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | LC50 =22.9μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLAKVMAHMK{ct:Amid} | MEP-3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 =29.7μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLGKVMAHMK{ct:Amid} | MEP-4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 =41.1μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | KVMAHMK{ct:Amid} | MEP-5 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | LC50 >100μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | PKVMAHMK{ct:Amid} | MEP-6 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | LC50 >100μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | LPKVMAHMK{ct:Amid} | MEP-7 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | LC50 >100μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | VLPKVMAHMK{ct:Amid} | MEP-8 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 >100μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLP{ct:Amid} | MEP-9 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | LC50 >100μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVL{ct:Amid} | MEP-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 >100μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 19799950 | 2010 | SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK | SK84 | Free | Free | Linear | L | None | 84 | Antimicrobial and Anticancer | 0.01% hemolysis at 100μM | Mouse | SK84 (larvae of Drosophila virilis) | NA | NA | ||
| 19799950 | 2010 | SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK | SK84 | Free | Free | Linear | L | None | 84 | Antimicrobial and Anticancer | 0.01% hemolysis at 100μM | Human | SK84 (larvae of Drosophila virilis) | NA | NA | ||
| 20044030 | 2010 | GLMDTVKNAAKNLAGQMLDKLKCKITGSC | Ranatuerin-2ONa | Free | Free | Linear | L | None | 29 | Antimicrobial | LD50 =90μM | Human | Ranatuerin-2ONa (leopard frog Lithobates onca) | NA | NA | ||
| 20044030 | 2010 | FLPVIAGAANFLPKLFCAISKKC | Brevinin-1Ya | Free | Free | Linear | L | None | 23 | Antimicrobial | LD50 =14μM | Human | Brevinin analog (leopard frog Lithobates onca) | NA | NA | ||
| 20044030 | 2010 | FLPIIAGAAAKVVQKIFCAISKKC | Brevinin-1Yb | Free | Free | Linear | L | None | 24 | Antimicrobial | LD50 =10μM | Human | Brevinin analog (leopard frog Lithobates onca) | NA | NA | ||
| 20153801 | 2010 | FLLFPLMCKIQGKC | Japonicin-1Npa | Free | Free | Linear | L | None | 14 | Antimicrobial | 1.92% hemolysis at 80μg/ml | Human | Japonicin-1 (skin of Xizang plateau frog Nanorana parkeri) | NA | NA | ||
| 20153801 | 2010 | FVLPLVMCKILRKC | Japonicin-1Npb | Free | Free | Linear | L | None | 14 | Antimicrobial | 3.40% hemolysis at 80μg/ml | Human | Japonicin-1 (skin of Xizang plateau frog Nanorana parkeri) | NA | NA | ||
| 20153801 | 2010 | GWANTLKNVAGGLCKITGAA | Parkerin | Free | Free | Linear | L | None | 20 | Antimicrobial | 2.36% hemolysis at 80μg/ml | Human | Parkerin (skin of Xizang plateau frog Nanorana parkeri) | NA | NA | ||
| 17145799 | 2007 | RW{ct:Amid} | RW | Amidation | Free | Linear | L | None | 2 | Antimicrobial | HD50 =8.9x103μM | Sheep | Synthetic peptide (Phage display libraries) | NA | NA | ||
| 17145799 | 2007 | RWRW{ct:Amid} | (RW)2 | Amidation | Free | Linear | L | None | 4 | Antimicrobial | HD50 =3.7x103μM | Sheep | Synthetic peptide (Phage display libraries) | NA | NA | ||
| 17145799 | 2007 | RWRWRW{ct:Amid} | (RW)3 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | HD50 =2.1x102μM | Sheep | Synthetic peptide (Phage display libraries) | NA | NA | ||
| 17145799 | 2007 | RWRWRWRW{ct:Amid} | (RW)4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | HD50 =1.0x102μM | Sheep | Synthetic peptide (Phage display libraries) | NA | NA | ||
| 17145799 | 2007 | RWRWRWRWRW{ct:Amid} | (RW)5 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | HD50 =76μM | Sheep | Synthetic peptide (Phage display libraries) | NA | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSAKKTVLHTALKAISS{nt:Acet}{ct:Amid} | V13KL | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =250μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFAKTFKSAKKTVLHTAAKAISS{nt:Acet}{ct:Amid} | L6A/L21A | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =1000 μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFAKTFKSAKKTVLHTALKAISS{nt:Acet}{ct:Amid} | L6A | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =1000μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSAKKTVLHTALKLISS{nt:Acet}{ct:Amid} | A23L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =62.5μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSLKKTVLHTALKAISS{nt:Acet}{ct:Amid} | A12L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =31.3μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSAKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | A20L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =31.3μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSLKKTVLHTALKLISS{nt:Acet}{ct:Amid} | A12L/A23L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =15.6μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | A12L/A20L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =8μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSLKKTVLHTLLKLISS{nt:Acet}{ct:Amid} | A12L/A20L/A23L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =4μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17389605 | 2007 | KILRGVCKKIMRTFLRRISKDILTGKK{ct:Amid} | NK-2 | Amidation | Free | Linear | L | None | 27 | Antimicrobial and Cytotoxic | ~50% hemolysis at 100μg/ml | Human | Synthetic peptide variants based on the NK-2 lysin | α-helix | NA | ||
| 17389605 | 2007 | KILRGVSKKIMRTFLRRISKDILTGKK{ct:Amid} | NK27 | Amidation | Free | Linear | L | None | 27 | Antimicrobial and Cytotoxic | >20% hemolysis at 100μg/ml | Human | Synthetic peptide variants based on the NK-2 lysin | α-helix | NA | ||
| 17389605 | 2007 | KILRGVSKKIMRTFLRRILTGKK{ct:Amid} | NK23c | Amidation | Free | Linear | L | None | 23 | Antimicrobial and Cytotoxic | ~20% hemolysis at 100μg/ml | Human | Synthetic peptide variants based on the NK-2 lysin | α-helix | NA | ||
| 17389605 | 2007 | KISKKIMRTFLRRILTGKK{ct:Amid} | NK19a | Amidation | Free | Linear | L | None | 19 | Antimicrobial and Cytotoxic | ~9% hemolysis at 100μg/ml | Human | Synthetic peptide variants based on the NK-2 lysin | α-helix | NA | ||
| 17389605 | 2007 | RILRGVSRRIMRRILTGRR{ct:Amid} | NK19b-KR | Amidation | Free | Linear | L | None | 19 | Antimicrobial and Cytotoxic | ~8% hemolysis at 100μg/ml | Human | Synthetic peptide variants based on the NK-2 lysin | α-helix | NA | ||
| 17394119 | 2007 | KWKLFKKIGAVLKVL | CAMEL0 | Free | Free | Linear | L | None | 15 | Antimicrobial | ~30% hemolysis at 100μM | Mouse | Cecropin–melittin hybrid (Synthetic peptide) | type I β-turn from Leu4-Lys7,followed by a helix at the C-terminus. | NA | ||
| 17394119 | 2007 | KWKLFKK-{nnr:ΔF}-GAVLKVL | CAMELΔ Phe1 | Free | Free | Linear | L | ΔF = α,β-dehydrophenylalanine (ΔPhe) | 15 | Antimicrobial | ~25% hemolysis at 100μM | Mouse | Cecropin–melittin hybrid (Synthetic peptide) | type I β-turn from Leu4-Lys7,followed by a helix at the C-terminus. | NA | ||
| 17394119 | 2007 | KWKL-{nnr:ΔF}-KKIGAV-{nnr:ΔF}-KVL | CAMELΔ Phe2 | Free | Free | Linear | L | ΔF = α,β-dehydrophenylalanine (ΔPhe) | 15 | Antimicrobial | ~90% hemolysis at 100μM | Mouse | Cecropin–melittin hybrid (Synthetic peptide) | type I β-turn from Leu4-Lys7,followed by a helix at the C-terminus. | NA | ||
| 17394119 | 2007 | KWKL-{nnr:ΔF}-KK-{nnr:ΔF}-GAV-{nnr:ΔF}-KVL | CAMELΔ Phe3 | Free | Free | Linear | L | ΔF = α,β-dehydrophenylalanine (ΔPhe) | 15 | Antimicrobial | >60% hemolysis at 100μM | Mouse | Cecropin–melittin hybrid (Synthetic peptide) | type I β-turn from Leu4-Lys7,followed by a helix at the C-terminus. | NA | ||
| 17451843 | 2007 | GILSSFKGVAKGVAKDLAGKLLETLKCKITGC | Ranatuerin-2CSa | Free | Free | Linear | L | None | 32 | Antimicrobial | LD50 =150μM | Human | Ranatuerin-2 analog (skin secretions of Rana cascadae) | NA | NA | ||
| 17451843 | 2007 | FLPILAGLAAKIVPKLFCLATKKC | Brevinin-1CSa | Free | Free | Linear | L | None | 24 | Antimicrobial | LD50 =5μM | Human | Brevinin-1analog (skin secretions of Rana cascadae) | NA | NA | ||
| 17451843 | 2007 | FLPIVGKLLSGLL{ct:Amid} | Temporin-1Csa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =75μM | Human | Temporin analog (skin secretions of Rana cascadae) | NA | NA | ||
| 17451843 | 2007 | FLPIIGKLLSGLL{ct:Amid} | Temporin-1CSb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =95μM | Human | Temporin analog (skin secretions of Rana cascadae) | NA | NA | ||
| 17451843 | 2007 | FLPLVTGLLSGLL{ct:Amid} | Temporin-1CSc | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 >300μM | Human | Temporin analog (skin secretions of Rana cascadae) | NA | NA | ||
| 17451843 | 2007 | NFLGTLVNLAKKIL{ct:Amid} | Temporin-1CSd | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 =50μM | Human | Temporin analog (skin secretions of Rana cascadae) | NA | NA | ||
| 17462733 | 2007 | RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS | K9CATH | Free | Free | Linear | L | None | 38 | Antimicrobial | 20% hemolysis at 100 μM | Chicken | K9CATH canine cathelicidin present in neutorphil granule content | α-helix | NA | ||
| 17462733 | 2007 | RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS | K9CATH | Free | Free | Linear | L | None | 38 | Antimicrobial | 25% hemolysis at 100 μM | Dog | K9CATH canine cathelicidin present in neutorphil granule content | α-helix | NA | ||
| 17462733 | 2007 | RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS | K9CATH | Free | Free | Linear | L | None | 38 | Antimicrobial | 30% hemolysis at 100 μM | Human | K9CATH canine cathelicidin present in neutorphil granule content | α-helix | NA | ||
| 18098173 | 2007 | EWESFLETFESAKETVLHTALEAISS{nt:Acet}{ct:Amid} | -5 Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC >1000.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | KWKEFLKEFKEAKKEVLHEALKAISE{nt:Acet}{ct:Amid} | 1 Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC >1000.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | KWKEFLKTFKEAKKEVLHTALKAISS{nt:Acet}{ct:Amid} | +4E Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =250.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | SWKSFLKTFSSAKSTVLHTALKAISS{nt:Acet}{ct:Amid} | +4S Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =125.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | KWKSFLKTFKSAKKTVLHTALKAISS{nt:Acet}{ct:Amid} | V13K Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =250.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K | α-helix | NA | ||
| 18098173 | 2007 | KWKSFLKTFKSAKKKVLHTALKAISS{nt:Acet}{ct:Amid} | 8 Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =250.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | KWKSFLKTFKSAKKKVLHKALKAISS{nt:Acet}{ct:Amid} | 9 Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC <7.8μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | KWKSFLKTFKSAKKKVLHKALKAISK{nt:Acet}{ct:Amid} | 10 Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC <7.8μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18186149 | 2008 | KKKKKKAAFAAWAAFDA{cyc:N-C}{ct:Amid} | 7K-F18-1D17 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC =650μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{cyc:N-C}{ct:Amid} | 6k-f17 | Amidation | Free | Cyclic | D | None | 17 | Antimicrobial | MHC =325μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKAAFALWAAFAA{cyc:N-C}{ct:Amid} | 6K-F17-1L11 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC =81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKAAFALWLAFAA{cyc:N-C}{ct:Amid} | 6K-F17-2L11,13 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKAAFLAWALFAA{cyc:N-C}{ct:Amid} | 6K-F17-2L10,14 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}L{d}L{d}{cyc:N-C}{ct:Amid} | 6k-f17-2l16,17 | Amidation | Free | Cyclic | D | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKALFAAWAAFLA{cyc:N-C}{ct:Amid} | 6K-F17-2L8,16 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKLLFAAWAAFAA{cyc:N-C}{ct:Amid} | 6K-F17-2L7,8 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKALFALWLAFAA{cyc:N-C}{ct:Amid} | 6K-F17-3L8,11,13 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <<81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKAAFALWLAFLA{cyc:N-C}{ct:Amid} | 6K-F17-3L11,13,16 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <<81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKALFALWLAFLA{cyc:N-C}{ct:Amid} | 6K-F17-4L8,11,13,16 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <<81μM | Human | Synthetic peptide | random coil | NA | ||
| 18350527 | 2008 | GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK | hBD3 | Free | Free | Linear | L | None | 45 | Antimicrobial | <1% hemolysis at 3-100 μg/ml | Rabbit | Analogue of Human Beta-Defensin 3 | α-helix | NA | ||
| 18350527 | 2008 | GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK | C(Amc)6 | Free | Free | Linear | L | None | 45 | Antimicrobial | 1.5-2.3% hemolysis at 3-100 μg/ml | Rabbit | Analogue of Human Beta-Defensin 3 | α-helix | NA | ||
| 18350527 | 2008 | GIINTLQKYYSRVRGGRSAVLSSLPKEEQIGKSSTRGRKSSRRKK | S6 | Free | Free | Linear | L | None | 45 | Antimicrobial | <1% hemolysis at 3-100 μg/ml | Rabbit | Analogue of Human Beta-Defensin 3 | α-helix | NA | ||
| 18350527 | 2008 | GIINTLQKYYARVRGGRAAVLSALPKEEQIGKASTRGRKAARRKK | A6 | Free | Free | Linear | L | None | 45 | Antimicrobial | 1.5-2.3% hemolysis at 3-100 μg/ml | Rabbit | Analogue of Human Beta-Defensin 3 | α-helix | NA | ||
| 18350527 | 2008 | GIINTLQKYYYRVRGGRYAVLSYLPKEEQIGKYSTRGRKYYRRKK | Y6 | Free | Free | Linear | L | None | 45 | Antimicrobial | <1% hemolysis at 3-100 μg/ml | Rabbit | Analogue of Human Beta-Defensin 3 | α-helix | NA | ||
| 18350527 | 2008 | GIINTLQKYYFRVRGGRFAVLSFLPKEEQIGKFSTRGRKFFRRKK | F6 | Free | Free | Linear | L | None | 45 | Antimicrobial | <1% hemolysis at 3-100 μg/ml | Rabbit | Analogue of Human Beta-Defensin 3 | α-helix | NA | ||
| 18350527 | 2008 | GIINTLQKYYWRVRGGRWAVLSWLPKEEQIGKWSTRGRKWWRRKK | W6 | Free | Free | Linear | L | None | 45 | Antimicrobial | Increased hemolysis at 3-100μg/ml | Rabbit | Analogue of Human Beta-Defensin 3 | α-helix | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCVGR | PC1 | Free | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGGLCYCRRRFCVCVGR | PC3 | Free | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRGWICFCVGR | PC4 | Free | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRPRFCVCVGR | PC5 | Free | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLAYCRRRFCVAVGR | PC9 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0-3% hemolysis upto 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | RGGRLCYARRRFAVCVGR | PC10 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0-3% hemolysis upto 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | LCYCRRRFCVCVGR | PC11 | Free | Free | Linear | L | None | 14 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RCYCRRRFCVCVGR | PC12 | Free | Free | Linear | L | None | 14 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCV | PC13 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCICV | PC14 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCR | PC15 | Free | Free | Linear | L | None | 16 | Antimicrobial | 3-6% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RCYCRRRFCVCR | PC16 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCVCV | PC17 | Free | Free | Linear | L | None | 12 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYARRRFAVCV | PC18 | Free | Free | Linear | L | None | 12 | Antimicrobial | 3-6% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | RCYARRRFAVCR | PC18 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | LAYCRRRFCVAV | PC20 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | RAYCRRRFCVAR | PC21 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | CYCRRRFCVCVGR | PC37 | Free | Free | Linear | L | None | 13 | Antimicrobial | 3-6% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVC | PC45 | Free | Free | Linear | L | None | 15 | Antimicrobial | 3-6% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTRRRFTVCV | PC64 | Free | Free | Linear | L | None | 12 | Antimicrobial | 3-6% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LTYCRRRFCVTV | PC64a | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTRPRFTVCV | PC65 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTFRPRFVCV | PC69 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTFRGRFVCV | PC70 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | CYCRRRFCVCV | PC71 | Free | Free | Linear | L | None | 11 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCVC | PC72 | Free | Free | Linear | L | None | 11 | Antimicrobial | 6-12% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | CYCRRRFCVC | PC73 | Free | Free | Linear | L | None | 10 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | CYCFRRFCVC | PC74 | Free | Free | Linear | L | None | 10 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRRCVCV | PC77 | Free | Free | Linear | L | None | 12 | Antimicrobial | 3-6% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCFRRRCVCV | PC78 | Free | Free | Linear | L | None | 12 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRFRRCVCV | PC79 | Free | Free | Linear | L | None | 12 | Antimicrobial | 3-6% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRFRCVCV | PC80 | Free | Free | Linear | L | None | 12 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | YCYCRRRFCVCVGR | PC91 | Free | Free | Linear | L | None | 14 | Antimicrobial | 25-50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | TCYCRRRFCVCVGR | PC92 | Free | Free | Linear | L | None | 14 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | ACYCRRRFCVCVGR | PC93 | Free | Free | Linear | L | None | 14 | Antimicrobial | 25-50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | VCYCRRRFCVCVGR | PC94 | Free | Free | Linear | L | None | 14 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | ICYCRRRFCVCVGR | PC95 | Free | Free | Linear | L | None | 14 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | FCYCRRRFCVCVGR | PC96 | Free | Free | Linear | L | None | 14 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | WCYCRRRFCVCVGR | PC97 | Free | Free | Linear | L | None | 14 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | ECYCRRRFCVCVGR | PC98 | Free | Free | Linear | L | None | 14 | Antimicrobial | 3-6% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCY | PC100 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCT | PC101 | Free | Free | Linear | L | None | 16 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCA | PC102 | Free | Free | Linear | L | None | 16 | Antimicrobial | 25-50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCL | PC103 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCI | PC104 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCF | PC105 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCW | PC106 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCE | PC107 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RLCYTRGRFTVCV | PC109 | Free | Free | Linear | L | None | 13 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTRGRFTVCVR | PC110 | Free | Free | Linear | L | None | 13 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RLCYTRGRFTVCVR | PC111 | Free | Free | Linear | L | None | 14 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCHHHFCVCV | PC112 | Free | Free | Linear | L | None | 12 | Antimicrobial | 6-12% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTHHHFTVCV | PC113 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCYCV | PC146 | Free | Free | Linear | L | None | 12 | Antimicrobial | 6-12% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCFCV | PC147 | Free | Free | Linear | L | None | 12 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCTCV | PC148 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCGCV | PC149 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCWCV | PC150 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25-50% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18566844 | 2008 | GRRRRSVQWCA | hLF(1–11) | Free | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at ≥200μM | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 18566844 | 2008 | FQWQRNMRKVR | hLF(21–31) | Free | Free | Linear | L | None | 11 | Antimicrobial | >2-3% at ≥16μM | Human | Synthetic peptide | NA | NA | ||
| 18566844 | 2008 | KVAKQEKKKKKTGRAKRR | UBI 18–35 | Free | Free | Linear | L | None | 18 | Antimicrobial | >2-3% at ≥20μM | Human | Synthetic peptide derived from Ubiquicidin | NA | NA | ||
| 18566844 | 2008 | TGRAKRRMQYNRR | UBI 29–41 | Free | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis at ≥200μM | Human | Synthetic peptide derived from Ubiquicidin | NA | Non-hemolytic | ||
| 18566844 | 2008 | LLLFLLKKRKKRKY | dhvar5 | Free | Free | Linear | L | None | 14 | Antimicrobial | >2-3% at ≥16μM | Human | Synthetic peptide | NA | NA | ||
| 18570895 | 2008 | LRQSQFVGSR{ct:Amid} | Urechistachykinins I | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolysis at 3-100 μM (non-hemolytic) | Human | Neuropeptide derived from Urechis unicinctus | NA | Non-hemolytic | ||
| 18570895 | 2008 | AAGMGFFGAR{ct:Amid} | Urechistachykinins II | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolysis at 3-100 μM (non-hemolytic) | Human | Neuropeptide derived from Urechis unicinctus | NA | Non-hemolytic | ||
| 18795096 | 2008 | KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF | Cathelicidin-BF | Free | Free | Linear | L | None | 30 | Antimicrobial | Little hemolysis up to 400 mg/ml (non-hemolytic) | Human | Snake venoms of Bungarus fasciatus | random-coil | Non-hemolytic | ||
| 18852279 | 2008 | KWKLFKKIGAVLKVL{nt:Acet}{ct:Amid} | CM15 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 45% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKKFKKIGAVLKVL{nt:Acet}{ct:Amid} | K4 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 21% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKLFKKIGKVLKVL{nt:Acet}{ct:Amid} | K10 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 67% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKLFKKIGAVLKKL{nt:Acet}{ct:Amid} | K14 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 4% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKKFKKIGKVLKVL{nt:Acet}{ct:Amid} | K410 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 9% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKKFKKIGAVLKKL{nt:Acet}{ct:Amid} | K414 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 3% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKLFKKIGKVLKKL{nt:Acet}{ct:Amid} | K1014 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 8% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18972522 | 2008 | PICTRNGLPVCGETCFGGTCNTPGCTCTW{cyc:N-C} | K1 (B2) | Free | Free | Cyclic | L | None | 29 | Uteroactive and antimicrobial | 100% hemolysis at >0.5 mg/ml | Human | Kalata (Oldenlandia affinis DC) | β-strands | NA | ||
| 18972522 | 2008 | PVCTRNGLPVCGETCVGGTCNTPGCTCSW{cyc:N-C} | K2 (B1) | Free | Free | Cyclic | L | None | 29 | Uteroactive and antimicrobial | 100% hemolysis at >0.5 mg/ml | Human | Kalata (Oldenlandia affinis DC) | β-strands | NA | ||
| 18972522 | 2008 | PICKRNGLPVCGETCTLGTCYTQGCTCSW{cyc:N-C} | K3 (B7) | Free | Free | Cyclic | L | None | 29 | Uteroactive and antimicrobial | 100% hemolysis at >0.5 mg/ml | Human | Kalata (Oldenlandia affinis DC) | β-strands | NA | ||
| 19104020 | 2009 | KLALKLALKALKAALKLA{ct:Amid} | KLAL | Amidation | Free | Linear | L | None | 18 | Antimicrobial | EC50 =13.1μM | Human | Synthetic peptide | α-helix | NA | ||
| 19104020 | 2009 | KLALKLALKALKAALKLA{nt:Acet}{ct:Amid} | Ac-KLAL | Amidation | Acetylation | Linear | L | None | 18 | Antimicrobial | EC50 =9.1μM | Human | Synthetic peptide | α-helix | NA | ||
| 19104020 | 2009 | GIGKFIHAVKKWGKTFIGEIAKS{ct:Amid} | MK5E | Amidation | Free | Linear | L | None | 23 | Antimicrobial | EC50 =33.4μM | Human | Magainin-derived synthetic peptide | α-helix | NA | ||
| 19104020 | 2009 | GIGKFIHAVKKWGKTFIGEIAKS{nt:Acet}{ct:Amid} | Ac-MK5E | Amidation | Acetylation | Linear | L | None | 23 | Antimicrobial | EC50 >400μM | Human | Magainin-derived synthetic peptide | α-helix | NA | ||
| 20033827 | 2011 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | IC50 =3.3μM | Human | Venom of the African scorpion Pandinus imperator | α-helix | NA | ||
| 20033827 | 2011 | FWGALAKGALKLIVSLFSSFSKKD | Pin2 [P14V] | Free | Free | Linear | L | None | 24 | Antimicrobial | IC50 =6.4μM | Human | Venom of the African scorpion Pandinus imperator | α-helix | NA | ||
| 20033827 | 2011 | FWGALAKGALKLIGVSLFSSFSKKD | Pin2 [P14GV] | Free | Free | Linear | L | None | 25 | Antimicrobial | IC50 =9.3μM | Human | Venom of the African scorpion Pandinus imperator | α-helix | NA | ||
| 20033827 | 2011 | FWGALAKGALKLIVGSLFSSFSKKD | Pin2 [P14VG] | Free | Free | Linear | L | None | 25 | Antimicrobial | IC50 =8.8μM | Human | Venom of the African scorpion Pandinus imperator | α-helix | NA | ||
| 20033827 | 2011 | FWGALAKGALKLIGVGSLFSSFSKKD | Pin2 [P14GVG] | Free | Free | Linear | L | None | 26 | Antimicrobial | IC50 =11.5μM | Human | Venom of the African scorpion Pandinus imperator | α-helix | NA | ||
| 19132829 | 2009 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antimicrobial | HC50=21.1(±2.6)μM | Sheep | Gramicidin S (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:hpa}-PV{nnr:O}L-{nnr:hpa}-P{cyc:N-C} | GS1 | Free | Free | Cyclic | Mix | O = L-Ornithine, Hpa = homophenylalanine | 10 | Antimicrobial | HC50=7.0(±0.3)μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:1-nal}-PV{nnr:O}L-{nnr:1-nal}-P{cyc:N-C} | GS2 | Free | Free | Cyclic | Mix | O = L-Ornithine, 1-Nal = 1-naphthylalanine | 10 | Antimicrobial | HC50=5.0(±0.1)μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:2-nal}-PV{nnr:O}L-{nnr:2-nal}-P{cyc:N-C} | GS3 | Free | Free | Cyclic | Mix | O = L-Ornithine, 2-Nal = 2-naphthylalanine | 10 | Antimicrobial | HC50=7.1(±3.5)μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:dip}-PV{nnr:O}L-{nnr:dip}-P{cyc:N-C} | GS4 | Free | Free | Cyclic | Mix | O = L-Ornithine, Dip = β,β-diphenylalanine | 10 | Antimicrobial | HC50=8.6(±1.1)μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:flg}-PV{nnr:O}L-{nnr:flg}-P{cyc:N-C} | GS5 | Free | Free | Cyclic | Mix | O = L-Ornithine, Flg = fluorenylglycine | 10 | Antimicrobial | HC50=6.2(±0.3)μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:tic}-PV{nnr:O}L-{nnr:tic}-P{cyc:N-C} | GS6 | Free | Free | Cyclic | Mix | O = L-Ornithine, Tic = 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | 10 | Antimicrobial | HC50 >50 μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19330556 | 2009 | GIHDILKYGKPS | Myxinidin | Free | Free | Linear | L | None | 12 | Antimicrobial | 0% hemolysis at 1-500μg/ml (non-hemolytic) | Rabbit | Epidermal mucus extract of hagfish (Myxine glutinosa L.) | NA | Non-hemolytic | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.05 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.07 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.09 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.27 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.0 fractions hemolysis at 5.0 μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.05 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.19 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.4 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.02 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.19 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.15 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.28 fractions hemolysis in 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.02 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.08 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fracions Hemoysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.2 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.25 fractions hemolyis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.0 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.03 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.08 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.1 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.14 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.05 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.06 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.05 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.12 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.18 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.0 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.0 fractions hemolysis 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.05 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.18 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.3 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.02 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.07 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.15 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.45 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WALRLYLVY | ARYV | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.0 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WALRLYLVY | ARYV | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.0 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WALRLYLVY | ARYV | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.05 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WALRLYLVY | ARYV | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WALRLYLVY | ARYV | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.07 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WALRLYLVY | ARYV | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.14 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WVLVLRLGY | VVRG | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WVLVLRLGY | VVRG | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.03 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WVLVLRLGY | VVRG | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.1 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WVLVLRLGY | VVRG | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WVLVLRLGY | VVRG | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.1 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WVLVLRLGY | VVRG | Free | Free | Linear | L | None | 9 | Antimicrobial | 0.26 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVL{d}RYGRR | dVAVR | Free | Free | Linear | Mix | None | 15 | Antimicrobial | 5±6 % hemolysis at 15μM | Human | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | RRGWVLALVL{d}RYGRR | dVAVR | Free | Free | Linear | Mix | None | 15 | Antimicrobial | 0 % hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | RRGWVLALYL{d}RYGRR | dVAYR | Free | Free | Linear | Mix | None | 15 | Antimicrobial | 5±3% hemolysis at 15μM | Human | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | RRGWVLALYL{d}RYGRR | dVAYR | Free | Free | Linear | Mix | None | 15 | Antimicrobial | 15±20% hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | RRGWALRLVL{d}AY | dARVA | Free | Free | Linear | Mix | None | 12 | Antimicrobial | 4% hemolysis at 15μM | Human | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | RRGWALRLVL{d}AY | dARVA | Free | Free | Linear | Mix | None | 12 | Antimicrobial | 10±12 % hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | WVLVLRL{d}GY | dVVRG | Free | Free | Linear | Mix | None | 9 | Antimicrobial | 12±13 % hemolysis at 15μM | Human | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | WVLVLRL{d}GY | dVVRG | Free | Free | Linear | Mix | None | 9 | Antimicrobial | 11±9% hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet | NA | ||
| 19479741 | 2009 | VGKTWIKVIRGIGKSKIKWQ | Bactrocerin 1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 1-50μM (non-hemolytic) | Mouse | Immunized dipteran insect, Bactrocera dorsalis | random coil | Non-hemolytic | ||
| 19524300 | 2009 | RFGRFLRKIRRFRPKVTITIQGSARFG | C1-27 | Free | Free | Linear | L | None | 27 | Immunomodulatory and antimicrobial | 50% hemolysis at 40μM | Chicken | Host defense peptide cathelicidin-2 (CATH-2) analog (Chicken ) | Helical | NA | ||
| 19524300 | 2009 | RFGRFLRKIRRFRPKVTITIQGSARF{ct:Amid} | C1-26 | Amidation | Free | Linear | L | None | 26 | Immunomodulatory and antimicrobial | 60% hemolysis at 40μM | Chicken | Host defense peptide cathelicidin-2 (CATH-2) analog (Chicken ) | Helical | NA | ||
| 19524300 | 2009 | RFGRFLRKIRRFRPKVTITIQ | C1-21 | Free | Free | Linear | L | None | 21 | Immunomodulatory and antimicrobial | 40% hemolysis at 40μM | Chicken | Host defense peptide cathelicidin-2 (CATH-2) analog (Chicken ) | Helical | NA | ||
| 19524300 | 2009 | RFGRFLRKIRRFRPK | C1-15 | Free | Free | Linear | L | None | 15 | Immunomodulatory and antimicrobial | 0% hemolysis at 40μM (non-hemolytic) | Chicken | Host defense peptide cathelicidin-2 (CATH-2) analog (Chicken ) | Helical | Non-hemolytic | ||
| 19524300 | 2009 | FRPKVTITIQGSARF{ct:Amid} | C12-26 | Amidation | Free | Linear | L | None | 15 | Immunomodulatory and antimicrobial | 0% hemolysis at 40μM | Chicken | Host defense peptide cathelicidin-2 (CATH-2) analog (Chicken ) | Helical | Non-hemolytic | ||
| 19544481 | 2009 | LKKWLK{ct:Amid} | L2K3W4 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 4.84% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLK{ct:Amid} | L2K3W4 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 4.90% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLK{ct:Amid} | L2K3W4 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 4.73% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLK{ct:Amid} | L2K3W4 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 5.07% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLK{ct:Amid} | L2K3W4 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 5.13%hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLK{ct:Amid} | L2K3W4 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 5.07% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLKK{ct:Amid} | L2K4W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.90% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLKK{ct:Amid} | L2K4W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 5.13% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLKK{ct:Amid} | L2K4W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.90% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLKK{ct:Amid} | L2K4W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 5.19% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLKK{ct:Amid} | L2K4W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 5.01% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKWLKK{ct:Amid} | L2K4W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.90% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKK{ct:Amid} | L3K3W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 5.19% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKK{ct:Amid} | L3K3W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.96% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKK{ct:Amid} | L3K3W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.73% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKK{ct:Amid} | L3K3W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.84% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKK{ct:Amid} | L3K3W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.96% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKK{ct:Amid} | L3K3W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.78% Hmolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLLK{ct:Amid} | L4K2W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.61% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLLK{ct:Amid} | L4K2W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 6.05% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLLK{ct:Amid} | L4K2W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.73% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLLK{ct:Amid} | L4K2W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.44% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLLK{ct:Amid} | L4K2W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.78% hemolysis at12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLLK{ct:Amid} | L4K2W4 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 4.61% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKKL{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 5.01% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKKL{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 4.84% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKKL{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 4.84% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKKL{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 5.01% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKKL{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 4.44% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKWLKKL{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 4.78% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLK{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 5.42% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLK{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 5.99% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLK{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 5.13% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLK{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 5.13% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLK{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 4.73% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLK{ct:Amid} | L4K3W4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 5.47% hemolysis at 63μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLKL{ct:Amid} | L5K3W5 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 7.09% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLKL{ct:Amid} | L5K3W5 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5.36% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLKL{ct:Amid} | L5K3W5 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 4.73% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLKL{ct:Amid} | L5K3W5 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 4.84% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLKL{ct:Amid} | L5K3W5 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5.19% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KLLKWLLKL{ct:Amid} | L5K3W5 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 4.84% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 7.26% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5.76% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4.72% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5.07% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4.78% hemolysis at12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5.30% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 57.58% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 14.92% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 7.38% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5.01% hemolysis at25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4.96% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4.73% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 64.43% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 34.29% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 17.58% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 14.99% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 6.51% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5.13% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 47.72% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 20.86% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 12.80% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10.78% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.31% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.07% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 36.37% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10.90% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 7.61% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.24% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.24% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.44% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19563807 | 2009 | GLFGKLIKKFGRKAISYAVKKARGKH | Ltc2a (native) | Free | Free | Linear | L | None | 26 | Antimicrobial and Cytotoxic | EC50 =6μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GLFGKLQKKFGRKAISYAVKKARGKH | Ltc2a_I7Q | Free | Free | Linear | L | None | 26 | Antimicrobial and Cytotoxic | EC50 >36μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GLFGKLIKKKGRKAISYAVKKARGKH | Ltc2a_F10K | Free | Free | Linear | L | None | 26 | Antimicrobial and Cytotoxic | EC50 >36μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GLFGKLIKKFLRKAISYAVKKARGKH | Ltc2a_G11L | Free | Free | Linear | L | None | 26 | Antimicrobial and Cytotoxic | EC50 =3μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GKLIKKFGRKAISYAVKKARGKH | Ltc2a_N-trim | Free | Free | Linear | L | None | 23 | Antimicrobial and Cytotoxic | EC50 >36μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GFFGKMKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc5 (native) | Amidation | Free | Linear | L | None | 28 | Antimicrobial and Cytotoxic | EC50 =12μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GFFGKRKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc5_M6R | Amidation | Free | Linear | L | None | 28 | Antimicrobial and Cytotoxic | EC50 >36μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GKMKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc5_N-trim | Amidation | Free | Linear | L | None | 25 | Antimicrobial and Cytotoxic | EC50 >36μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19576903 | 2009 | ILPWKWPWWPWRR{ct:Amid} | IL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 64μM | Human | Indolicidin (bovine) | NA | NA | ||
| 19576903 | 2009 | ILPWKWKWWPWRR{ct:Amid} | IL-K7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 41.8% hemolysis at 64μM | Human | Indolicidin analog (bovine) | NA | NA | ||
| 19576903 | 2009 | ILPWKWPFFPWRR{ct:Amid} | IL-F89 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 21.4% hemolysis at 64μM | Human | Indolicidin analog (bovine) | NA | NA | ||
| 19576903 | 2009 | ILPWKWKFFPWRR{ct:Amid} | IL-K7F89 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10% hemolysis at 64μM | Human | Indolicidin analog (bovine) | NA | NA | ||
| 19576903 | 2009 | ILPFKFPFFPFRR{ct:Amid} | IL-F | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.3% hemolysis at 64μM | Human | Indolicidin analog (bovine) | NA | NA | ||
| 19804724 | 2009 | MQFITDLIKKAVDFFKGLFGNK | Warnericin RK | Free | Free | Linear | L | None | 22 | Antimicrobial | 100% hemolysis at 200μM | Human | Warnericin RK (Staphylococcus warneri RK strain) | α-helix | NA | ||
| 19843179 | 2009 | GMWSKIKNAGKAAKAAAKAAGKAALGAVSEAM | DRS-DA4 | Free | Free | Linear | L | None | 32 | Antimicrobial | 0% hemolysis at 1-100μM | Rat | Dermaseptin related protein from skin of the Mexican frog, Pachymedusa dacnicolor | α-helix | Non-hemolytic | ||
| 19635451 | 2010 | GIGAVLKVLALISWIKRKR{ct:Amid} | Mel-H | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 28% hemolysis at 0.4μM | Human | Melittin analog (venom of European honey bee) | α-helix | NA | ||
| 19635451 | 2010 | GIGAVLKVLALISWIKRKR{ct:Amid} | Mel-H | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 42% hemolysis at 23μM | Human | Melittin analog (venom of European honey bee) | α-helix | NA | ||
| 19635451 | 2010 | GIGAV{d}LKV{d}LAL{d}ISWIK{d}RKR{ct:Amid} | Mel-dH | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | 5% hemolysis at 0.4μM | Human | Melittin analog (venom of European honey bee) | α-helix | NA | ||
| 19635451 | 2010 | GIGAV{d}LKV{d}LAL{d}ISWIK{d}RKR{ct:Amid} | Mel-dH | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | 12 % hemolysis at 23μM | Human | Melittin analog (venom of European honey bee) | α-helix | NA | ||
| 20213310 | 2010 | RWKIFKKIEKVGRNVRDGIIKAGPAVAVVGQAATVVKG | Papiliocin | Free | Free | Linear | L | None | 38 | Antimicrobial | 0% hemolysis at 3 - 50μM (non-hemolytic) | Human | Papiliocin (Papilio xuthus) | NA | Non-hemolytic | ||
| 20237682 | 2010 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = 3.0x10-5 g/ml | Human | Indolicidin (bovine neutrophils) | α Helical and β Sheet | NA | ||
| 20237682 | 2010 | ILPWKWPWWPARR{ct:Amid} | Δ5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = 2.8x10-3 g/ml | Human | Indolicidin derivative (bovine neutrophils) | α Helical and β Sheet | NA | ||
| 20237682 | 2010 | ILPWKWPWAPARR{ct:Amid} | Δ45 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = >2.6 x 10-3 g/ml | Human | Indolicidin derivative (bovine neutrophils) | α Helical and β Sheet | NA | ||
| 20237682 | 2010 | ILPWKWPAAPARR{ct:Amid} | Δ345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = >6.7x10-3 g/ml | Human | Indolicidin derivative (bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPWKAPAAPARR{ct:Amid} | Δ2345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = >6.4x10-3 g/ml | Human | Indolicidin derivative (bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPAKAPAAPARR{ct:Amid} | Δ12345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = >6.8x10-3 g/ml | Human | Indolicidin derivative (bovine neutrophils) | NA | NA | ||
| 20308076 | 2010 | FFFLSRIF{ct:Amid} | Temporin-SHf | Amidation | Free | Linear | L | None | 8 | Antimicrobial | LC50 = 200μM | Human | Skin of the frog Pelophylax saharica | α Helical | NA | ||
| 20449481 | 2010 | V{nnr:O}LLF{d}PV{nnr:O}LF{d}P{cyc:N-C} | 2HBr (1) | Free | Free | Cyclic | Mix | O = L-Ornithine | 11 | Antimicrobial | 100% hemolysis at 100μM | Sheep | Gramacidin S (Bacillus brevis ) | antiparallel β-sheet | NA | ||
| 20449481 | 2010 | V{nnr:O}LAF{d}PV{nnr:O}LF{d}P{cyc:N-C} | 2HBr (2) | Free | Free | Cyclic | Mix | O = L-Ornithine | 11 | Antimicrobial | 50% hemolysis at 100μM | Sheep | Gramacidin S (Bacillus brevis ) | antiparallel β-sheet | NA | ||
| 20449481 | 2010 | V{nnr:O}L{nnr:O}F{d}PV{nnr:O}LF{d}P{cyc:N-C} | 3HBr (3) | Free | Free | Cyclic | Mix | O = L-Ornithine | 11 | Antimicrobial | 10% hemolysis at 100μM | Sheep | Gramacidin S (Bacillus brevis ) | antiparallel β-sheet | NA | ||
| 20449481 | 2010 | V{nnr:O}LKF{d}PV{nnr:O}LF{d}P{cyc:N-C} | 3HBr (4) | Free | Free | Cyclic | Mix | O = L-Ornithine | 11 | Antimicrobial | 10% hemolysis at 100μM | Sheep | Gramacidin S (Bacillus brevis ) | antiparallel β-sheet | NA | ||
| 20449481 | 2010 | V{nnr:O}LRF{d}PV{nnr:O}LF{d}P{cyc:N-C} | 3HCl (5) | Free | Free | Cyclic | Mix | O = L-Ornithine | 11 | Antimicrobial | 15% hemolysis at 100μM | Sheep | Gramacidin S (Bacillus brevis ) | antiparallel β-sheet | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKVMAHMK{ct:Amid} | MEP | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 >100μM | Rat | Melectin from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKV-{nnr:Met(O)}-AH-{nnr:Met(O)}-K{ct:Amid} | [Met (O)14,17] MEP | Amidation | Free | Linear | L | Met(O) = methionine sulfoxide | 18 | Antimicrobial | LC50 >200μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKV-{nnr:Met(O2)}-AH-{nnr:Met(O2)}-K{ct:Amid} | [Met (O2)14,17] MEP | Amidation | Free | Linear | L | Met(O2) = methionine sulfone | 18 | Antimicrobial | LC50 >200μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKV-{nnr:Nle}-AH-{nnr:Nle}-K{ct:Amid} | [Nle14,17] MEP | Amidation | Free | Linear | L | Nle = Norleucine | 18 | Antimicrobial | LC50 =50μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSLLKKVLPKV-Met-AH-{nnr:Nle}-K{ct:Amid} | [Nle17] MEP | Amidation | Free | Linear | L | Nle = Norleucine | 18 | Antimicrobial | LC50 =80μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKV-{nnr:Nle}-AH-{nnr:Met(O)}-K{ct:Amid} | [Nle14, Met(O)17] MEP | Amidation | Free | Linear | L | Nle = Norleucine, Met(O) = methionine sulfoxide | 18 | Antimicrobial | LC50 >200μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKV-{nnr:Nle}-AH-Met-K{ct:Amid} | [Nle14] MEP | Amidation | Free | Linear | L | Nle = Norleucine | 18 | Antimicrobial | LC50 =56.3μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSIVKKVLPKV-{nnr:Nle}-AH-{nnr:Met(O)}-K{ct:Amid} | [Val6, Nle14, Met(O)17] MEP | Amidation | Free | Linear | L | Nle = Norleucine, Met(O) = methionine sulfoxide | 18 | Antimicrobial | LC50 >200μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSIVKKVLPKV-{nnr:Nle}-AH-Met(O)-K{ct:Amid} | [Val6, Nle14] MEP | Amidation | Free | Linear | L | Nle = Norleucine | 18 | Antimicrobial | LC50 >200μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | CA(1-7)M(2-9) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =40.2μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K1 (Me3) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =77.2μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K3 (Me3) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =85.6μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K6 (Me3) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =157.6μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K7 (Me3) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =164.0μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K13 (Me3) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =157.4μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K1,3 (Me3)2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =105.0μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K3,6 (Me3)2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =117.3μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K6,7 (Me3)2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =134.0μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K1,13 (Me3)2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =82.6μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K1,3,6,7,13 (Me3)5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 >200μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20690652 | 2010 | KNLRRIIRKGIHIIKKYF | Novicidin | Free | Free | Linear | L | None | 18 | Antimicrobial | IC50 >50μM | Human | Peptide derived from ovispirin, a cationic peptide which originated from the ovine cathelicidin SMAP-29 | Helical | NA | ||
| 20873868 | 2010 | MIRIAMKALNCFKVSGLKCWSFNSPRGQESPCPG | MIRIAM | Free | Free | Linear | L | None | 34 | Antimicrobial | 25% hemolysis at 100μg/ml | Rabbit | Sushi 1 derivative (horseshoe crab) | α Helix | NA | ||
| 20873868 | 2010 | GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS | Sushi 1 | Free | Free | Linear | L | None | 34 | Antimicrobial | 13% hemolysis at 100μg/ml | Rabbit | Factor C protein derivative (horseshoe crab) | α Helix | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 3.6% hemolysis at 3.15μM | Human | Cathelicidin (ring necked pheasant Phasianus colchicus) | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 6.3% hemolysis at 6.30μM | Human | Cathelicidin (ring necked pheasant Phasianus colchicus) | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 9.1% hemolysis at 15.7μM | Human | Cathelicidin (ring necked pheasant Phasianus colchicus) | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 13.2% hemolysis at 31.5μM | Human | Cathelicidin (ring necked pheasant Phasianus colchicus) | NA | NA | ||
| 21110126 | 2011 | FLGWLFKWASK{ct:Amid} | GA-W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =25μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FLGWLFKWAWK{ct:Amid} | GA-W3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =50μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FLWWLFKWAWK{ct:Amid} | GA-W4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =25μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FLGWLFKWAKK{ct:Amid} | GA-K3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =50μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FLKWLFKWAKK{ct:Amid} | GA-K4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =6.3μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FLKWLFKWLKK{ct:Amid} | GA-K4L | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =12.5μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FAKWAFKWAKK{ct:Amid} | GA-K4A | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC ≥200μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FAKWAFKWLKK{ct:Amid} | GA-K4AL | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC ≥200μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 14733952 | 2004 | KWKKLLKKLLKLLKKLLK{ct:Amid} | KLW | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50% hemolysis at 50µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLKLLKKLLK{ct:Amid} | KLW | Amidation | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKPLKLLKKLLK{ct:Amid} | KLW-L9P | Amidation | Free | Linear | L | None | 18 | Antimicrobial | <10% hemolysis at 50µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKPLKLLKKLLK{ct:Amid} | KLW-L9P | Amidation | Free | Linear | L | None | 18 | Antimicrobial | ~10% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKP{d}LKLLKKLLK{ct:Amid} | KLW-L9p | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | <5 % hemolysis at 50µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKP{d}LKLLKKLLK{ct:Amid} | KLW-L9p | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | ~5% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLPLLKKLLK{ct:Amid} | KLW-K11P | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50% hemolysis at 50µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLPLLKKLLK{ct:Amid} | KLW-K11P | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLP{d}LLKKLLK{ct:Amid} | KLW-K11p | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | <20% hemolysis at 50µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLP{d}LLKKLLK{ct:Amid} | KLW-K11p | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | >30% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 15009528 | 2004 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14KD4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =125 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLL{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14LD4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =5 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLF{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14FD4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =2 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLY{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14YD4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =5 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLN{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14ND4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =62 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTTG | HM1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 46% hemolysis at 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTTG | HM1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 30% hemolysis at 50µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 86% hemolysis at 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 69% hemolysis at 50µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 98% hemolysis at 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 83% hemolysis at 50µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15232222 | 2004 | GIFSKLAGKKIKNLLISGLKNIGKEVGMDVVRTGIDIAGCKIKGEC | Esculentin-1c | Free | Free | Linear | L | None | 46 | Antimicrobial | 0.01% hemolysis at 10µg/ml | Human | Esculentin-1 family (skin of the Rana esculenta) | NA | NA | ||
| 15232222 | 2004 | VIPFVASVAAEMMHHVYCAASKRC | Brevinin-1Ed | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.19% hemolysis at 10µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | FLPLLAGLAANFLPKIFCKITRKC | Brevinin-1E | Free | Free | Linear | L | None | 24 | Antimicrobial | 25.8% hemolysis at 10µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | VIPFVASVAAEMMQHVYCAASRKC | Brevinin-1Eb | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.02% hemolysis at 10µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | GIFSKLAGKKIKNLLISGLKNIGKEVGMDVVRTGIDIAGCKIKGEC | Esculentin-1c | Free | Free | Linear | L | None | 46 | Antimicrobial | 0.06% hemolysis at 100µg/ml | Human | Esculentin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | VIPFVASVAAEMMHHVYCAASKRC | Brevinin-1Ed | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.32% hemolysis at 100µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | FLPLLAGLAANFLPKIFCKITRKC | Brevinin-1E | Free | Free | Linear | L | None | 24 | Antimicrobial | 189.2% hemolysis at 100µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | VIPFVASVAAEMMQHVYCAASRKC | Brevinin-1Eb | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.08% hemolysis at 100µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15325526 | 2005 | GILSSFKGVAKGVAKNLAGKLLDELKCKITGC | Ranatuerin-2AUa | Free | Free | Linear | L | None | 32 | Antimicrobial | HC50 =290µM | Human | Ranatuerin-2 from skin secretions of the Northern red-legged frog Rana aurora aurora | NA | NA | ||
| 15325526 | 2005 | FLPILAGLAAKLVPKVFCSITKKC | Brevinin-1AUa | Free | Free | Linear | L | None | 24 | Antimicrobial | HC50 =5µM | Human | Brevinin-1 from skin secretions of the Northern red-legged frog Rana aurora aurora | NA | NA | ||
| 15325526 | 2005 | FLPILAGLAANILPKVFCSITKKC | Brevinin-1AUb | Free | Free | Linear | L | None | 24 | Antimicrobial | HC50 =7µM | Human | Brevinin-1 from skin secretions of the Northern red-legged frog Rana aurora aurora | NA | NA | ||
| 15325526 | 2005 | FLPIIGQLLSGLL{ct:Amid} | Temporin-1AUa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | HC50 >300µM | Human | Temporin-1 from skin secretions of the Northern red-legged frog Rana aurora aurora | NA | NA | ||
| 15639237 | 2005 | GLGSVFGRLARILGRVIPKV{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 20% hemolysis at 10µM | Human | Ant venom toxin pilosulin (Myrmecia pilosula) | α-helical | NA | ||
| 15639237 | 2005 | GLLSKFGRLARKLARVIPKV{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 15% hemolysis at 10µM | Human | Ant venom toxin pilosulin (Myrmecia pilosula) | α-helical | NA | ||
| 15639237 | 2005 | GLGSVFGRLARILGRVIPKV{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 100% hemolysis at 100µM | Human | Ant venom toxin pilosulin (Myrmecia pilosula) | α-helical | NA | ||
| 15639237 | 2005 | GLLSKFGRLARKLARVIPKV{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 40% hemolysis at 100µM | Human | Ant venom toxin pilosulin (Myrmecia pilosula) | α-helical | NA | ||
| 16142907 | 2005 | KWKKLLKKLLKLLKKLLK{ct:Amid} | KLW | Amidation | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 16142907 | 2005 | KWKKLLKK{nnr:a}LKLLKKLLK{ct:Amid} | KLW-L9-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 16142907 | 2005 | KWKKLLKKL{nnr:a}KLLKKLLK{ct:Amid} | KLW-L10-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | 20% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKLL{nnr:a}LLKKLLK{ct:Amid} | KLW-K11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | ~50% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLL{nnr:a}KLL{nnr:a}LLKKLLK{ct:Amid} | KLW-K7,11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | ~30% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKLLKLLKKLLK{ct:Amid} | KLW | Amidation | Free | Linear | L | None | 18 | Antimicrobial | <50% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKK{nnr:a}LKLLKKLLK{ct:Amid} | KLW-L9-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | >5% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKL{nnr:a}KLLKKLLK{ct:Amid} | KLW-L10-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | 10-15% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKLL{nnr:a}LLKKLLK{ct:Amid} | KLW-K11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | ~50% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLL{nnr:a}KLL{nnr:a}LLKKLLK{ct:Amid} | KLW-K7,11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | 10-15% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16226345 | 2006 | DAACAAHCLWR{ct:Amid} | L1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 100% hemolysis at 50μg/ml | Human | Synthetic peptide | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLCYKQRCVTYCRGR{ct:Amid} | Gomesin | Amidation | Free | Linear | L | Z = pyroglutamic acid | 18 | Antimicrobial | At 100µM less than 10% hemolysis | Human | Gomesin(Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}DRRLSYKQRSVTYORGR{cyc:N-C}{ct:Amid} | cyclo(2-15)[Asp2 Ser6,11, Orn15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~10% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}SRRLDYKQROVTYSRGR{cyc:N-C}{ct:Amid} | cyclo(6-11)[Ser2,15, Asp6, Orn11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~10% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLDYKQROVTYCRGR{cyc:N-C}{ct:Amid} | Bicyclo(2-15, 6-11)[Cys2, 15, Asp6, Orn11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | >30% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLDYKQRBVTYCRGR{cyc:N-C}{ct:Amid} | Bicyclo(2-15, 6-11)[Cys2, 15, Asp6, Dap11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | >30% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}DRRLCYKQRCVTYORGR{cyc:N-C}{ct:Amid} | Bicyclo(2-15, 6-11)[Asp2, Cys6, 11, Orn15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~15% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}DRRLCYKQRCVTYBRGR{cyc:N-C}{ct:Amid} | Bicyclo(2-15, 6-11)[Asp2, Cys6, Dap15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~15% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16616888 | 2006 | FQWQRNIRKVR{nt:acylation (CH3-(CH2)10-CO-NH-)}{ct:Amid} | C12LF11 | Amidation | acylation (CH3-(CH2)10-CO-NH-) | Linear | L | None | 11 | Antimicrobial | 0.25% hemolysis at 100µg/ml | Human | N-lauryl-derivative of LF11(human lactoferrin) | NA | NA | ||
| 16621155 | 2006 | GLFGKILGVGKKVLCGLSGMC | Nigrocin-2GRb | Free | Free | Linear | L | None | 21 | Antimicrobial | LC50 = 40µM | Human | Nigrocin isolated from an extract of the skin of the Yunnanfu Kunming frog Rana grahami | NA | NA | ||
| 16621155 | 2006 | GLLSGILGAGKHIVCGLSGLC | Nigrocin-2GRa | Free | Free | Linear | L | None | 21 | Antimicrobial | LC50 = 295µM | Human | Nigrocin isolated from an extract of the skin of the Yunnanfu Kunming frog Rana grahami | NA | NA | ||
| 16621155 | 2006 | GLLSGILGAGKNIVCGLSGLC | Nigrocin-2GRc | Free | Free | Linear | L | None | 21 | Antimicrobial | LC50 = 500µM | Human | Nigrocin isolated from an extract of the skin of the Yunnanfu Kunming frog Rana grahami | NA | NA | ||
| 16621155 | 2006 | GLFSKFAGKGIKNLIFKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC | Esculentin-IGRa | Free | Free | Linear | L | None | 46 | Antimicrobial | LC50 = 210µM | Human | Esculentin isolated from an extract of the skin of the Yunnanfu Kunming frog Rana grahami | NA | NA | ||
| 16621155 | 2006 | GLLDTFKNLALALNAAKSAGVLNSLSCKLSKTC | Brevinin-2GRa | Free | Free | Linear | L | None | 33 | Antimicrobial | LC50 =140µM | Human | Brevinin isolated from an extract of the skin of the Yunnanfu Kunming frog Rana grahami | NA | NA | ||
| 16621155 | 2006 | GVLGTVKNLLIGAGKSAAQSVLKTLSCKLSNDC | Brevinin-2GRb | Free | Free | Linear | L | None | 33 | Antimicrobial | LC50 = 180µM | Human | Brevinin isolated from an extract of the skin of the Yunnanfu Kunming frog Rana grahami | NA | NA | ||
| 16621155 | 2006 | GLFTLIKGAAKLIGKTVAKEAGKTGLELMACKITNQC | Brevinin-2GRc | Free | Free | Linear | L | None | 37 | Antimicrobial | LC50 = 100µM | Human | Brevinin isolated from an extract of the skin of the Yunnanfu Kunming frog Rana grahami | NA | NA | ||
| 16762455 | 2006 | LNLKGIFKKVASLLT | Eumenitin | Free | Free | Linear | L | None | 15 | Antimicrobial | 20% hemolysis at 1mM | Human | Eumenitin isolated from the venom of the solitary eumenine wasp Eumenes rubronotatus | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLLKKLKKLLK{ct:Amid} | M25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | ~80% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLPKKLLKKLKKLLK{ct:Amid} | M25P | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 11% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLLKKLK{ct:Amid} | M21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 65% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLPLLKKLLKKLK{ct:Amid} | M21P | Amidation | Free | Linear | L | None | 21 | Antimicrobial | ~40% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLL{ct:Amid} | M17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ~63% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKPLKLLKKLL{ct:Amid} | M17P | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0-5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLLKKLKKLLK{ct:Amid} | M25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 75% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLPKKLLKKLKKLLK{ct:Amid} | M25P | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 11% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLLKKLK{ct:Amid} | M21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 65% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLPLLKKLLKKLK{ct:Amid} | M21P | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 21% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLL{ct:Amid} | M17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ~63% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKPLKLLKKLL{ct:Amid} | M17P | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16997878 | 2006 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antimicrobial | EC50 = 380µg/ml | Human | Tritrpticin from cathelicidin family of antimicrobial peptides | NA | NA | ||
| 16997878 | 2006 | VRRFPWWWPFLRR{ct:Amid} | Tritrp1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 = 190µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VKKFPWWWPFLKK{ct:Amid} | Tritrp2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 >1000µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRFAWWWAFLRR{ct:Amid} | Tritrp3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 = 60µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRFPYYYPFLRR{ct:Amid} | Tritrp4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 >1000µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRYPWWWPYLRR{ct:Amid} | Tritrp5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 = 220µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRFPFFFPFLRR{ct:Amid} | Tritrp6 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 >1000µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRFAWWWPFLRR{ct:Amid} | Tritrp7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 >1000µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRFPWWWAFLRR{ct:Amid} | Tritrp8 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 =354µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 =310µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 17000029 | 2006 | FLPLAVSLAANFLPKLFCKITKKC | Brevinins-ALb | Free | Free | Linear | L | None | 24 | Antimicrobial | 96% hemolysis at 20 µg/ml | Rabbit | Brevinins derivative (Amolops loloensis) | NA | NA | ||
| 17176094 | 2006 | RGGRLCYCRRRFCVCVGR{ct:Amid} | PG-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | ~100% hemolysis at above 100µg/ml | Human | Protegrins analog (porcine) | NA | NA | ||
| 17176094 | 2006 | RGGRLTYTRP{d}RFTVTVGR{ct:Amid} | TTpTT | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | ~10% hemolysis at above 100µg/ml | Human | Protegrins analog (porcine) | NA | NA | ||
| 17176094 | 2006 | RGGRLVYTR{nnr:p*}RFTVIVGR{ct:Amid} | TTp*TT | Amidation | Free | Linear | Mix | p* = amino-functionalized D-proline | 18 | Antimicrobial | ~20% hemolysis at above 100µg/ml | Human | Protegrins analog (porcine) | NA | NA | ||
| 17176094 | 2006 | RGGRLCYTRP{d}RFTVCVGR{ct:Amid} | CTpTC | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | ~60% hemolysis at above 100µg/ml | Human | Protegrins analog (porcine) | NA | NA | ||
| 17560323 | 2007 | HFLGTLVNLAKKIL{ct:Amid} | Temporin-1DRa | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 65µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | KFLGTLVNLAKKIL{ct:Amid} | Lys-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | LKLGTLVNLAKKIL{ct:Amid} | Lys-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFKGTLVNLAKKIL{ct:Amid} | Lys-3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLKTLVNLAKKIL{ct:Amid} | Lys-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 42µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLKLVNLAKKIL{ct:Amid} | Lys-5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 100µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTKVNLAKKIL{ct:Amid} | Lys-6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLKNLAKKIL{ct:Amid} | Lys-7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 330µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVKLAKKIL{ct:Amid} | Lys-8 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 38µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNKAKKIL{ct:Amid} | Lys-9 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLKKKIL{ct:Amid} | Lys-10 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKKKL{ct:Amid} | Lys-13 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKKIK{ct:Amid} | Lys-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLK{d}TLVNLAKKIL{ct:Amid} | D-Lys-4 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 110µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLK{d}LVNLAKKIL{ct:Amid} | D-Lys-5 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLK{d}NLAKKIL{ct:Amid} | D-Lys-7 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVKLAKKIL{ct:Amid} | D-Lys-8 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 385µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAK{d}KIL{ct:Amid} | D-Lys-11 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 210µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKK{d}IL{ct:Amid} | D-Lys-12 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKKIL{ct:Amid} | Chg-9 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 12µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKKIL{ct:Amid} | Chg-13 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 16µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKKIL{ct:Amid} | Chg-9, Chg-13 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 100µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17658606 | 2007 | DHYICAKKGGTCNFSPCPLFNRIEGTCYSGKAKCCIR | pBD-2 | Free | Free | Linear | L | None | 37 | Antimicrobial | 50% hemolysis at 128µg/ml | Porcine | Porcine defensin | NA | NA | ||
| 17658606 | 2007 | DHYICAKKGGTCNFSPCPLFNRIEGTCYSGKAKCCIR | pBD-2 | Free | Free | Linear | L | None | 37 | Antimicrobial | 10% hemolysis at 64µg/ml | Porcine | Porcine defensin | NA | NA | ||
| 17961502 | 2007 | AKKVFKRLRKLFKKI | HPC2A3 | Free | Free | Linear | L | None | 15 | Antimicrobial | 4.5% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | FKRLKKLFKKIWNWK | HPA3NT3 | Free | Free | Linear | L | None | 15 | Antimicrobial | 11.62% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | FKRLEKLFKKIWNWK | HPA3NT2 | Free | Free | Linear | L | None | 15 | Antimicrobial | 14.92% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | FKRLKKLFSKIWNWK | HPA3NT1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 9.65% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | FKRLEKLFSKIWNWK | HPA3NT0 | Free | Free | Linear | L | None | 15 | Antimicrobial | 4.70% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | WKKVFKRLEKLFSKIWNWK | HPA3A1 | Free | Free | Linear | L | None | 19 | Antimicrobial | 94.69% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKIWNWK | HPA3 | Free | Free | Linear | L | None | 19 | Antimicrobial | 23.11% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 18052076 | 2007 | FFGWLIKGAIHAGKAIHGLIHRRRH | Chrysophsin | Free | Free | Linear | L | None | 25 | Antimicrobial | EC50 = 1 µM | Human | Chrysophsin-1 (Chrysophrys major) | NA | NA | ||
| 15003352 | 2004 | RLRLRIGRR{cyc:N-C}{ct:Amid} | 9-Fluorenylmethoxycarbonyl (F-moc) | Amidation | Free | Cyclic | L | None | 9 | Antimicrobial | 0% hemolysis at 100µg/ml (non-hemolytic) | Rabbit | Synthetic peptide | NA | Non-hemolytic | ||
| 15003352 | 2004 | RLRLRIGRR{cyc:N-C}{ct:Amid} | 9-Fluorenylmethoxycarbonyl (F-moc) | Amidation | Free | Cyclic | L | None | 9 | Antimicrobial | 0% hemolysis at 100µg/ml (non-hemolytic) | Rabbit | Synthetic peptide | NA | Non-hemolytic | ||
| 15003352 | 2004 | RLRLRIGRR{cyc:N-C}{ct:Amid} | 9-Fluorenylmethoxycarbonyl (F-moc) | Amidation | Free | Cyclic | L | None | 9 | Antimicrobial | 0% hemolysis at 100µg/ml (non-hemolytic) | Rabbit | Synthetic peptide | NA | Non-hemolytic | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLTTG | HP(2-9)-ME(1-12) | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLTWG | HM2 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Analog of HP(2-9)-ME(1-12) | NA | Non-hemolytic | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLKKG | HM5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Analog of HP(2-9)-ME(1-12) | NA | Non-hemolytic | ||
| 15246874 | 2004 | MKLSCLLLTLTIIFVLTIVHAPNVEAKDLADPESEAVGFADAVGEADPNAGLGS | Pilosulins 3 | Free | Free | Linear | L | None | 54 | Antimicrobial | No hemolysis at 50µM (non-hemolytic) | Human | Pilosulins family (Myrmecia pilosula) | NA | Non-hemolytic | ||
| 15246874 | 2004 | MKLSCLLLTLTIIFVLTIVHAPNVEAKDLADPESEAVGFADAVGEADPGLGS | Pilosulins 4 | Free | Free | Linear | L | None | 52 | Antimicrobial | No hemolysis at 50µM (non-hemolytic) | Human | Pilosulins family (Myrmecia pilosula) | NA | Non-hemolytic | ||
| 15616319 | 2005 | GRDYRTSLTIVQKLKKMVD | G1 | Free | Free | Linear | L | None | 19 | Antimicrobial | No hemolysis at 10µM (non-hemolytic) | Rabbit | Granulysin-Derived Peptides | NA | Non-hemolytic | ||
| 15616319 | 2005 | RDVCRNFMRR | G11 | Free | Free | Linear | L | None | 10 | Antimicrobial | No hemolysis at 10µM (non-hemolytic) | Rabbit | Granulysin-Derived Peptides | NA | Non-hemolytic | ||
| 15616319 | 2005 | QRSVSNAATRVSRTGRSRWRDVSRNFMRR | G9 | Free | Free | Linear | L | None | 29 | Antimicrobial | No hemolysis at 10µM (non-hemolytic) | Rabbit | Granulysin-Derived Peptides | NA | Non-hemolytic | ||
| 15616319 | 2005 | QRSVSNAATRVCRT | G10 | Free | Free | Linear | L | None | 14 | Antimicrobial | No hemolysis at 10µM (non-hemolytic) | Rabbit | Granulysin-Derived Peptides | NA | Non-hemolytic | ||
| 15616319 | 2005 | QSRVIQGLVAGETAQQICED | G21 | Free | Free | Linear | L | None | 20 | Antimicrobial | No hemolysis at 10µM (non-hemolytic) | Rabbit | Granulysin-Derived Peptides | NA | Non-hemolytic | ||
| 15949628 | 2005 | EWGRRCCGWGPGRRYCVRWC{cyc:N-C} | Ib-AMP1 | Free | Free | Cyclic | L | None | 20 | Antimicrobial | no hemolysis upto 100μM (non-hemolytic) | Rabbit | Synthetic peptide (Impatiens balsamina) | NA | Non-hemolytic | ||
| 15949628 | 2005 | EWGRRCCGWGPGRRYCRRWC{cyc:N-C} | Ib-AMP4 | Free | Free | Cyclic | L | None | 20 | Antimicrobial | no hemolysis upto 100μM (non-hemolytic) | Rabbit | Synthetic peptide (Impatiens balsamina) | NA | Non-hemolytic | ||
| 15980334 | 2005 | QAKIRVRLSA | M4 | Free | Free | Linear | L | None | 10 | Antimicrobial | <1% hemolysis at 120μg/ml | Human | Synthetic peptide | NA | NA | ||
| 15980334 | 2005 | KIRVRLSA | M5 | Free | Free | Linear | L | None | 8 | Antimicrobial | <1% hemolysis at 120μg/ml | Human | Synthetic peptide | NA | NA | ||
| 15980334 | 2005 | QKKIRVRLSA | M6 | Free | Free | Linear | L | None | 10 | Antimicrobial | <1% hemolysis at 120μg/ml | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKK{nnr:a}LKL{nnr:a}KKLLK{ct:Amid} | KLW-L9,13-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16226345 | 2006 | DAACAAKCLWR{ct:Amid} | L2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at 200μg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16226345 | 2006 | KAACAAHCLWR{ct:Amid} | L3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at 200μg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16226345 | 2006 | KAACAAKCLWR{ct:Amid} | L4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at 200μg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16344012 | 2006 | KWKLFKKIGIGKFLHSAKKF{ct:Amid} | CA-MA | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | CA-MA (Hyalaphora cecropia and Xenopus laevis) | NA | Non-hemolytic | ||
| 16344012 | 2006 | KWKKLLKKPLLKKLLKKL{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | CA-MA analog | NA | Non-hemolytic | ||
| 16460028 | 2006 | SADVAGAVIDGASLSFKILKTVLEALGNVKRK | EqTII1-32 | Free | Free | Linear | L | None | 32 | Antimicrobial | Non-hemolytic | Human | Actinoporin (Actinia equina L) | NA | Non-hemolytic | ||
| 16460028 | 2006 | GASLSFKILKTVLEALGNVKRK | EqTII11-32 | Free | Free | Linear | L | None | 22 | Antimicrobial | Non-hemolytic | Human | Actinoporin (Actinia equina L) | NA | Non-hemolytic | ||
| 16616888 | 2006 | FQWQRNIRKVR{ct:Amid} | LF11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | Non-hemolytic | Human | N-lauryl-derivative of LF11(human lactoferrin) | NA | Non-hemolytic | ||
| 16963159 | 2006 | GLWSTIKNVGKEAAIAAGKAALGAL{ct:Amid} | DPh-1 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | No hemolysis at 6µM (non-hemolytic) | Human | Dermaseptins (Phyllomedusa hypochondrialis) | NA | Non-hemolytic | ||
| 16963159 | 2006 | FLSLIPHAINAVSAIAKHF{ct:Amid} | PS-7 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | No hemolysis at 6µM (non-hemolytic) | Human | Phylloseptin (Phyllomedusa hypochondrialis) | NA | Non-hemolytic | ||
| 17553680 | 2007 | {nnr:O}{nnr:O}WW{ct:Amid} | MP-1 | Amidation | Free | Linear | L | O = L-Ornithine | 4 | Antimicrobial | No hemolysis at 1000µg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 17553680 | 2007 | {nnr:O}{nnr:O}WW{nt:Hydroxy cinnamic acid (pHCA)}{ct:Amid} | MP-2 | Amidation | Hydroxy cinnamic acid (pHCA) | Linear | L | O = L-Ornithine | 4 | Antimicrobial | No hemolysis at 1000µg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 17553680 | 2007 | {nnr:O}{nnr:O}WW{nt:Acet}{ct:Amid} | MP-3 | Amidation | Acetylation | Linear | L | O = L-Ornithine | 4 | Antimicrobial | No hemolysis at 1000µg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 17553680 | 2007 | {nnr:O}{nnr:O}WW{nt:pHCA= Hydroxy cinnamic acid} | MP-4 | Free | pHCA= Hydroxy cinnamic acid | Linear | L | O = L-Ornithine | 4 | Antimicrobial | No hemolysis at 1000µg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 17553680 | 2007 | {nnr:O}{nnr:O}WW{nt:CIN= Cinnamic acid}{ct:Amid} | MP-5 | Amidation | CIN= Cinnamic acid | Linear | L | O = L-Ornithine | 4 | Antimicrobial | No hemolysis at 1000µg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 17553680 | 2007 | {nnr:O}{nnr:O}WW{nt:HPPA= 3-(4-hydroxyphenyl) propionic acid}{ct:Amid} | MP-6 | Amidation | HPPA= 3-(4-hydroxyphenyl) propionic acid | Linear | L | O = L-Ornithine | 4 | Antimicrobial | No hemolysis at 1000µg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 17553680 | 2007 | {nnr:O}{nnr:O}FF{nt:pHCA= Hydroxy cinnamic acid}{ct:Amid} | MP-7 | Amidation | pHCA= Hydroxy cinnamic acid | Linear | L | O = L-Ornithine | 4 | Antimicrobial | No hemolysis at 1000µg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 17553680 | 2007 | WW{nt:pHCA= Hydroxy cinnamic acid}{ct:Amid} | MP-8 | Amidation | pHCA= Hydroxy cinnamic acid | Linear | L | O = L-Ornithine | 2 | Antimicrobial | No hemolysis at 1000µg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKIQNDK | HP (2–20) | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | KVFKRLEKLFSKIQNDK | HPN1(4–20) | Free | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | FKRLEKLFSKIQNDK | HPN2(6–20) | Free | Free | Linear | L | None | 16 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | RLEKLFSKIQNDK | HPN3(8–20) | Free | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKIQN | HPC1(2–18) | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKI | HPC2(2–16) | Free | Free | Linear | L | None | 15 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFS | HPC3(2–14) | Free | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | KVFKRLEKLFSKI | HPN1C2(4–16) | Free | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | KVFKRLEKLFS | HPN1C3(4–14) | Free | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | FKRLEKLFSKIQNDK | HPN2C4(6–13) | Free | Free | Linear | L | None | 8 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKIQNWK | HPA1 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKIWNDK | HPA2 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKSFSKIQNDK | HPA4 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVSKRLEKLFSKIQNDK | HPA5 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 20015460 | 2010 | GVIKSVLKGVAKTVALGML{ct:Amid} | B2RP | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 = 280 µM | Human | Skin secretions of the South-East Asian frog Hylarana erythraea (Ranidae) | NA | NA | ||
| 17888907 | 2008 | KWCFRVCYRGICYRRC | Tachyplesin-I | Free | Free | Linear | L | None | 16 | Antimicrobial | 10% hemolysis 100µM | Human | Synthetic peptide | NA | NA | ||
| 17888907 | 2008 | VFQFLGKIIHHVGNFVHGFSHVF | Clavanin-A | Free | Free | Linear | L | None | 23 | Antimicrobial | 20% hemolysis 100 µM | Human | Synthetic peptide | NA | NA | ||
| 17888907 | 2008 | GIGKFLKKAKKFGKAFVKMKK{ct:Amid} | MSI-94 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 45-50% hemolysis 100 µM | Human | Synthetic peptide | NA | NA | ||
| 17888907 | 2008 | GCASRCKAKCAGRRCKGWASASFRGRCYCKCFRC | Mytilin-A | Free | Free | Linear | L | None | 34 | Antimicrobial | 10% hemolysis 100 µM | Human | Synthetic peptide | NA | NA | ||
| 17888907 | 2008 | QGWEAVAAAVASKIVGLWRNEKTELLGHECKFTVKPYLKRFQVYYKGRMWCPGWTAIRGEASTRSQSGVAGKTAKDFVRKAFQKGLLSQQEANQWLSS | ALF—isoform ALFPm3 | Free | Free | Linear | L | None | 98 | Antimicrobial | 55% hemolysis 100 µM | Human | Pichia pastoris | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALVKTVLF{ct:Amid} | Ascaphin-8 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 = 55µM | Human | Ascaphin-8 (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKLLLKGAAKALVKTVLF{ct:Amid} | Lys-4 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 = 24µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKKAAKALVKTVLF{ct:Amid} | Lys-8 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 = 11µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAKKALVKTVLF{ct:Amid} | Lys-10 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 >500µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALKKTVLF{ct:Amid} | Lys-14 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 >500µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALVKTVK{d}F{ct:Amid} | Lys-18 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 >500µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKK{d}LLKGAAKALVKTVLF{ct:Amid} | D-Lys-4 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | LD50 = 300µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKK{d}AAKALVKTVLF{ct:Amid} | D-Lys-8 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | LD50 = 150µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAK{d}KALVKTVLF{ct:Amid} | D-Lys-10 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | LD50 >500 µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALVKTVLF{ct:Amid} | D-Lys-14 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | LD50 >500 µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALVKTVK{d}F{ct:Amid} | D-Lys-18 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | LD50 >500 µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALVKAVLF{ct:Amid} | Ala-16 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 = 22µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GLLGPLLKIAAKVGSNLL{ct:Amid} | XT-7 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 140µM | Human | XT-7 (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | KLLGPLLKIAAKVGSNLL{ct:Amid} | Lys-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 400µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLKPLLKIAAKVGSNLL{ct:Amid} | Lys-4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 >500µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGKLLKIAAKVGSNLL{ct:Amid} | Lys-5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 15µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGPLLKIAKKVGSNLL{ct:Amid} | Lys-11 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 350µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGPLLKIAAKVGKNLL{ct:Amid} | Lys-15 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 110µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGPLLKIAAKVGSKLL{ct:Amid} | Lys-16 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 80µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGPLLKIAAKVGKKLL{ct:Amid} | Lys-15, Lys-16 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 60µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGKLLKIAAKVGKKLL{ct:Amid} | Lys-5, Lys-15, Lys-16 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 25µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLKKLLKIAAKVGKKLL{ct:Amid} | Lys-4, Lys-5,Lys-15, Lys-16 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 25µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 15003829 | 2004 | GLMSLFKGVLKTAGKHIFKNVGGSLLDQAKCKITGEC | Brevinin-2PRa | Free | Free | Linear | L | None | 37 | Antimicrobial | HC50 = 55µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 15003829 | 2004 | GLMSLFRGVLKTAGKHIFKNVGGSLLDQAKCKITGEC | Brevinin-2PRb | Free | Free | Linear | L | None | 37 | Antimicrobial | HC50 = 65µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 15003829 | 2004 | GLMSVLKGVLKTAGKHIFKNVGGSLLDQAKCKISGQC | Brevinin-2PRc | Free | Free | Linear | L | None | 37 | Antimicrobial | HC50 = 125µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 15003829 | 2004 | GLMSVLKGVLKTAGKHIFKNVGGSLLDQAKCKITGQC | Brevinin-2PRd | Free | Free | Linear | L | None | 37 | Antimicrobial | HC50 = 100µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 15003829 | 2004 | GLLSVLKGVLKTAGKHIFKNVGGSLLDQAKCKISGEC | Brevinin-2PRe | Free | Free | Linear | L | None | 37 | Antimicrobial | HC50 = 80µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 15003829 | 2004 | GLMDVFKGAAKNLLASALDKIRCKVTKC | Ranatuerin-2PRa | Free | Free | Linear | L | None | 28 | Antimicrobial | HC50 = 150µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 15003829 | 2004 | FLSLALAALPKLFCLIFKKC | Brevinin-1PRa | Free | Free | Linear | L | None | 20 | Antimicrobial | HC50 = 7µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 15003829 | 2004 | ILPILGNLLNGLL{ct:Amid} | Temporin-1PRa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | HC50 >300µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 15003829 | 2004 | ILPILGNLLNSLL{ct:Amid} | Temporin-1PRb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | HC50 >300µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 21871946 | 2012 | FVDLKKIANIINSIF{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 60% hemolysis at 100 µM | Human | Rana chensinensis | NA | NA | ||
| 21871946 | 2012 | FVDLKKIANIINSIF{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 100% hemolysis at 200 µM | Human | Rana chensinensis | NA | NA | ||
| 22115565 | 2012 | FRFGSFLKKVWKSKLAKKLRSKGKQLLKDYANKVLNGPEEEAAAPAE | BmKbpp | Free | Free | Linear | L | None | 47 | Antimicrobial | 22.5% hemolysis at 30 µM | Human | Chinese scorpion Mesobuthus martensii Karsch | NA | NA | ||
| 22115565 | 2012 | FRFGSFLKKVWKSKLAKKLRSKGKQLLKDYANKVLNGPEEEAAAPAE | BmKbpp | Free | Free | Linear | L | None | 47 | Antimicrobial | 39.9% hemolysis at 50 µM | Human | Chinese scorpion Mesobuthus martensii Karsch | NA | NA | ||
| 22123629 | 2012 | GFGSFLGKALKAGLKLGANLLGGAPQQ | CPF-PG1 | Free | Free | Linear | L | None | 27 | Antimicrobial | LC50 = 145 µM | Human | Skin secretions of the tetraploid frogs Xenopus pygmaeus | NA | NA | ||
| 10631295 | 2000 | KLKLKLKLK{nt:Dansylation}{ct:Amid} | (KL)4K | Amidation | Dansylation | Linear | L | None | 9 | Antimicrobial | >20% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10631295 | 2000 | KLKLKLKLKLK{nt:Dansylation}{ct:Amid} | (KL)5K | Amidation | Dansylation | Linear | L | None | 11 | Antimicrobial | 60% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10631295 | 2000 | KLKLKLKLKLKLKLK{nt:Dansylation}{ct:Amid} | (KL)6K | Amidation | Dansylation | Linear | L | None | 13 | Antimicrobial | ~90% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10631295 | 2000 | KLLKLLLKLLLKLLK{nt:Dansylation}{ct:Amid} | (KL)7K | Amidation | Dansylation | Linear | L | None | 15 | Antimicrobial | ~90% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10667861 | 2000 | INLKALAALAKKIL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 68.2% hemolysis at 100µM | Human | Mastoparan B isolated from the venom of the hornet Vespa basalis | NA | NA | ||
| 10667861 | 2000 | INLKALAALAKKIL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 37.9% hemolysis at 50µM | Human | Mastoparan B (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKAKSIVSWAKKVL{ct:Amid} | [Ala3] MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 13.8% hemolysis at 100µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKAKSIVSWAKKVL{ct:Amid} | [Ala3] MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 11.9% hemolysis at 50µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLASIVSWAKKVL{ct:Amid} | [Ala4]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 93.4% hemolysis at 100µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLASIVSWAKKVL{ct:Amid} | [Ala4]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 60.1% hemolysis at 50µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLKSIVSAAKKVL{ct:Amid} | [Ala9]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 6.0% hemolysis at 100µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLKSIVSAAKKVL{ct:Amid} | [Ala9]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 8.5% hemolysis at 50µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLKSIVSWAKAVL{ct:Amid} | [Ala12]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 66.2% hemolysis at 100µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLKSIVSWAKAVL{ct:Amid} | [Ala12]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 59.1% hemolysis at 50µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10675500 | 2000 | KWKLFKKIGIGKFLHSAKKF{ct:Amid} | CA-MA | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Cecropin A(Hyalophora cecropia), Magainin 2(Xenopus laevis) | NA | Non-hemolytic | ||
| 10675500 | 2000 | KWKLFKKIKFLHSAKKF{ct:Amid} | CA-MA1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Cecropin A(Hyalophora cecropia), Magainin 2(Xenopus laevis) | NA | Non-hemolytic | ||
| 10675500 | 2000 | KWKLFKKIPKFLHSAKKF{ct:Amid} | CA-MA2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Cecropin A(Hyalophora cecropia), Magainin 2(Xenopus laevis) | NA | Non-hemolytic | ||
| 10675500 | 2000 | KWKLFKKIGPGKFLHSAKKF{ct:Amid} | CA-MA3 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Cecropin A(Hyalophora cecropia), Magainin 2(Xenopus laevis) | NA | Non-hemolytic | ||
| 20237682 | 2010 | ILPWKWPWWPWRR{ct:Amid} | Δ0 (Indolicidin) | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC 3.0*10-3 g ml-1 | Human | Indolicidin(Bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPWKWPWWPARR{ct:Amid} | Δ5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC 2.8*10-3 g ml-1 | Human | Indolicidin derivatives(Bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPWKWPWAPARR{ct:Amid} | Δ45 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >2.6*10-3 g ml-1 | Human | Indolicidin derivatives(Bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPWKWPAAPARR{ct:Amid} | Δ345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >6.7*10-3 g ml-1 | Human | Indolicidin derivatives(Bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPWKAPAAPARR{ct:Amid} | Δ2345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >6.4*10-3 g ml-1 | Human | Indolicidin derivatives(Bovine neutrophils) | NA | Non-hemolytic | ||
| 20237682 | 2010 | ILPAKAPAAPARR{ct:Amid} | Δ12345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >6.8*10-3 g ml-1 | Human | Indolicidin derivatives(Bovine neutrophils) | NA | Non-hemolytic | ||
| 21168911 | 2011 | FFRRFFRR{ct:Amid} | (FFRR)2 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | LLRRLLRR{ct:Amid} | (LLRR)2 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | LLKKLLKK{ct:Amid} | (LLKK)2 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | FFRRFFRRFFRR{ct:Amid} | (FFRR)3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | AARRAARRAARR{ct:Amid} | (AARR)3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | LLRRLLRRLLRR{ct:Amid} | (LLRR)3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | LLKKLLKKLLKK{ct:Amid} | (LLKK)3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | FFRRFFRRFFRRFFRR{ct:Amid} | (FFRR)4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | HC50 > ~26 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | LLRRLLRRLLRRLLRR{ct:Amid} | (LLRR)4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | HC50 > ~12 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | LLKKLLKKLLKKLLKK{ct:Amid} | (LLKK)4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | HC50 > ~24 | Human | Synthetic peptide | NA | NA | ||
| 21184791 | 2011 | GRILSFIKGLAEHL{ct:Amid} | OdVP1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | ILGIITSLLKSL{ct:Amid} | OdVP2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | EC50 = 31 (23–41)µM | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | NA | ||
| 21184791 | 2011 | KDLHTVVSAILQAL{ct:Amid} | OdVP3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | LDPKVVQSLL{ct:Amid} | OdVP4 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | INLKGLIKKVASLLT | EpVP1 | Free | Free | Linear | L | None | 15 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | FDLLGLVKKVASAL{ct:Amid} | EpVP2a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | FDLLGLVKSVVSAL{ct:Amid} | EpVP2b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | EC50 = 64 (68–70)µM | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | NA | ||
| 21184791 | 2011 | AINPKSVQSLL{ct:Amid} | EpVP3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | INPKSVQSLL{ct:Amid} | EpVP3S | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | LSPAVMASLA{ct:Amid} | EpVP4a | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | LSPAAMASLA{ct:Amid} | EpVP4b | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | VHVPPICSHRECRK | EpVP5 | Free | Free | Linear | L | None | 14 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | FGPVIGLLSGILKSLL | EpVP6 | Free | Free | Linear | L | None | 16 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 23594231 | 2013 | RKCNFLCKLKEKLRTVITSHIDKVLRPQG | Cathelicidin-PY | Free | Free | Linear | L | None | 29 | Antimicrobial | 2.5% hemolysis at 12.5µg/ml | Human | Cathelicidin-PY from the skin secretions of the frog Paa yunnanensis | NA | NA | ||
| 23594231 | 2013 | RKCNFLCKLKEKLRTVITSHIDKVLRPQG | Cathelicidin-PY | Free | Free | Linear | L | None | 29 | Antimicrobial | 3.5% hemolysis at 25µg/ml | Human | Cathelicidin-PY from the skin secretions of the frog Paa yunnanensis | NA | NA | ||
| 23594231 | 2013 | RKCNFLCKLKEKLRTVITSHIDKVLRPQG | Cathelicidin-PY | Free | Free | Linear | L | None | 29 | Antimicrobial | 5.5% hemolysis at 50µg/ml | Human | Cathelicidin-PY from the skin secretions of the frog Paa yunnanensis | NA | NA | ||
| 16730966 | 2006 | QPTRRPRPGTGPGRRPRPRPRP | QPT22 | Free | Free | Linear | L | None | 22 | Antimicrobial | ~4% hemolysis at 60µM | Human | Synthetic peptide | NA | NA | ||
| 16730966 | 2006 | KRFKQDGGWSHWSPWSS | KRF17 | Free | Free | Linear | L | None | 17 | Antimicrobial | ~3% hemolysis at 60µM | Human | Synthetic peptide | NA | NA | ||
| 22426384 | 2012 | MFTSKKSMLLLFFLGMISMSLCQDERGADEDDGGEMTEEEKRGAFGDLLKGVAKEAGMKLLNMAQCKLSGKC | Brevinin-2LTa | Free | Free | Linear | L | None | 72 | Antimicrobial | LD50 = 520µM | Human | Brevinin from skin of Hylarana latouchii | NA | NA | ||
| 22426384 | 2012 | MFTLKKSLLFLFFLGTISLSFCEEERGADEDDEVEMTEEEKRSILDKIKNVALGVARGAGTGILKALLCKLDKSC | Brevinin-2LTb | Free | Free | Linear | L | None | 75 | Antimicrobial | LD50 = 480µM | Human | Brevinin from skin of Hylarana latouchii | NA | NA | ||
| 22426384 | 2012 | MFTMKKSLLFLFFLGTISLSFCEEERGADEDDEVEMTEEEKRGVLDTFKDVAIGVAKGAGTGVLKALLCKLDKSC | Brevinin-2LTc | Free | Free | Linear | L | None | 75 | Antimicrobial | LD50 > 480µM | Human | Brevinin from skin of Hylarana latouchii | NA | NA | ||
| 22426384 | 2012 | MFTMKKSMLLIVLLGIISLSLCEQERNADEDEQSEMKRISFKKGKGSWIKNGLIKGIKGLGKEISLDVIRTGIDIAGCKIKGEC | Esculentin-1LTa | Free | Free | Linear | L | None | 84 | Antimicrobial | LD50 > 480µM | Human | Esculentin from skin of Hylarana latouchii | NA | NA | ||
| 22426384 | 2012 | MFTMKKSLLFLFFFLGTISLSLCEQERGADEDDGGEEVKRGIFSLFKAGAKFFGKHLLKQAGKAGAEHLACKATNQC | Esculentin-2LTa | Free | Free | Linear | L | None | 77 | Antimicrobial | LD50 > 600µM | Human | Esculentin from skin of Hylarana latouchii | NA | NA | ||
| 22426384 | 2012 | MFTMKKSLLLLFFLGIVSLSLCEQERGADEDEGEDVEEVKRSLWENFKNAGKQFILNILDKIRCRVAGGCRT | Palustrin-2LTa | Free | Free | Linear | L | None | 72 | Antimicrobial | LD50 = 220µM | Human | Palustrin from skin of Hylarana latouchii | NA | NA | ||
| 22426384 | 2012 | MFTLKKSLLLLFFLGTINLSLCEEERDAEEERRDGDDEMDVEVKKRFLAGLIGGLAKMLGK | Temporin-LTe | Free | Free | Linear | L | None | 61 | Antimicrobial | LD50 = 40µM | Human | Temporin from skin of Hylarana latouchii | NA | NA | ||
| 22464970 | 2012 | KWFRVYRGIYRRR{ct:Amid} | CDT | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis at 200µg/ml (non-hemolytic) | Human | Tachyplesin-1(Tachypleus tridentatus) | NA | Non-hemolytic | ||
| 22484288 | 2012 | FLFSLIPHAIGGLISAFK | AamAP1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 10µM | Horse | AamAP1 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FLFSLIPHAIGGLISAFK | AamAP1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 100µM | Horse | AamAP1 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FPFSLIPHAIGGLISAIK | AamAP2 | Free | Free | Linear | L | None | 18 | Antimicrobial | 19% hemolysis at 10µM | Horse | AamAP2 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FPFSLIPHAIGGLISAIK | AamAP2 | Free | Free | Linear | L | None | 18 | Antimicrobial | 75% hemolysis at 100µM | Horse | AamAP2 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FLFSLIPKAIGGLISAFK | AamAP-S1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 17.8% hemolysis at 10µM | Horse | AamAP1 analog (Androctonus amoreuxi) | NA | NA | ||
| 22484288 | 2012 | FLFSLIPKAIGGLISAFK | AamAP-S1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 53% hemolysis at 100µM | Horse | AamAP1 analog (Androctonus amoreuxi) | NA | NA | ||
| 22497805 | 2012 | IKLSPETKDNLKKVLKGAIKGAIAVAKMV{ct:Amid} | Hymenochirin-1B | Amidation | Free | Linear | L | None | 29 | Antimicrobial | LC50 = 225µM | Human | Hymenochirins from norepinephrine-stimulated skin secretions Hymenochirus boettgeri | NA | NA | ||
| 22497805 | 2012 | LKIPGFVKDTLKKVAKGIFSAVAGAMTPS | Hymenochirin-2B | Free | Free | Linear | L | None | 29 | Antimicrobial | LC50 > 300µM | Human | Hymenochirins from norepinephrine-stimulated skin secretions Hymenochirus boettgeri | NA | NA | ||
| 22497805 | 2012 | IKIPAVVKDTLKKVAKGVLSAVAGALTQ | Hymenochirin-3B | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 > 300µM | Human | Hymenochirins from norepinephrine-stimulated skin secretions Hymenochirus boettgeri | NA | NA | ||
| 22497805 | 2012 | IKIPAFVKDTLKKVAKGVISAVAGALTQ | Hymenochirin-4B | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 = 160µM | Human | Hymenochirins from norepinephrine-stimulated skin secretions Hymenochirus boettgeri | NA | NA | ||
| 22497805 | 2012 | IKIPPIVKDTLKKVAKGVLSTIAGALST | Hymenochirin-5B | Free | Free | Linear | L | None | 28 | Antimicrobial | Non-hemolytic | Human | Hymenochirins from norepinephrine-stimulated skin secretions Hymenochirus boettgeri | NA | Non-hemolytic | ||
| 11168889 | 2000 | PKLLKTFLSKWIG | SPFK | Free | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 30 µg/mL | Rat | Synthetic peptide | NA | NA | ||
| 11168889 | 2000 | GIWKSLFTKLLKG | Retro SPFK (RSac) | Free | Free | Linear | L | None | 13 | Antimicrobial | 95-100% hemolysis at 60 µg/mL | Rat | Synthetic peptide | NA | NA | ||
| 11168889 | 2000 | GIWKSLFTKLLKG{ct:Amid} | Retro SPFK amide (RSam) | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 95-100% hemolysis at 60 µg/mL | Rat | Synthetic peptide | NA | NA | ||
| 11168889 | 2000 | PKLL{d}KTFL{d}SKWIG | Diastereo SPFK (DSac) | Free | Free | Linear | Mix | None | 13 | Antimicrobial | ~10% hemolsis at 60 µg/mL | Rat | Synthetic peptide | NA | NA | ||
| 11168889 | 2000 | PKLL{d}ETFL{d}SKWIG{ct:Amid} | Diastereo SPFK amide (DSam) | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | ~40 % hemolysis at 60 µg/mL | Rat | Synthetic peptide | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFKKKKQ | Ponericin-W1 | Free | Free | Linear | L | None | 25 | Antimicrobial and Insecticidal | zone of inhibition (2 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFKKKKQ | Ponericin-W1 | Free | Free | Linear | L | None | 25 | Antimicrobial and Insecticidal | zone of inhibition (1 mm) at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GIWGTLAKIGIKAVPRVISMLKKKKQ | Ponericin-W3 | Free | Free | Linear | L | None | 26 | Antimicrobial and Insecticidal | zone of inhibition (1 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GIWGTLAKIGIKAVPRVISMLKKKKQ | Ponericin-W3 | Free | Free | Linear | L | None | 26 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GIWGTALKWGVKLLPKLVGMAQTKKQ | Ponericin-W4 | Free | Free | Linear | L | None | 26 | Antimicrobial and Insecticidal | zone of inhibition (2 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GIWGTALKWGVKLLPKLVGMAQTKKQ | Ponericin-W4 | Free | Free | Linear | L | None | 26 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | FWGALIKGAAKLIPSVVGLFKKKQ | Ponericin-W5 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | zone of inhibition (4 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | FWGALIKGAAKLIPSVVGLFKKKQ | Ponericin-W5 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | zone of inhibition (1.5 mm) at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | FIGTALGIASAIPAIVKLFK{ct:Amid} | Ponericin-W6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Insecticidal | zone of inhibition (3 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | FIGTALGIASAIPAIVKLFK{ct:Amid} | Ponericin-W6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Insecticidal | zone of inhibition (1 mm) at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ | Ponericin-G1 | Free | Free | Linear | L | None | 30 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ | Ponericin-G1 | Free | Free | Linear | L | None | 30 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GWKDWLNKGKEWLKKKGPGIMKAALKAATQ | Ponericin-G3 | Free | Free | Linear | L | None | 30 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GWKDWLNKGKEWLKKKGPGIMKAALKAATQ | Ponericin-G3 | Free | Free | Linear | L | None | 30 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | DFKDWMKTAGEWLKKKGPGILKAAMAAAT | Ponericin-G4 | Free | Free | Linear | L | None | 29 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | DFKDWMKTAGEWLKKKGPGILKAAMAAAT | Ponericin-G4 | Free | Free | Linear | L | None | 29 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GLVDVLGKVGGLIKKLLP{ct:Amid} | Ponericin-G6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GLVDVLGKVGGLIKKLLP{ct:Amid} | Ponericin-G6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | LLKELWTKIKGAGKAVLGKIKGLL{ct:Amid} | Ponericin-L2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | LLKELWTKIKGAGKAVLGKIKGLL{ct:Amid} | Ponericin-L2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P19(9|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 19 | Antimicrobial | 30% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P19(9|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 19 | Antimicrobial | 70% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P17(9|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 17 | Antimicrobial | 15% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P17(9|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 17 | Antimicrobial | 35% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P15(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 15 | Antimicrobial | 5% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P15(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 15 | Antimicrobial | 30% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-GY{ct:Amid} | P14(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 14 | Antimicrobial | 10% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-GY{ct:Amid} | P14(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 14 | Antimicrobial | 30% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P13(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 13 | Antimicrobial | 5% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P13(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 13 | Antimicrobial | 25% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Nle}-GY{ct:Amid} | P13(5|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 13 | Antimicrobial | 12% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Nle}-{nnr:Orn}-GY{ct:Amid} | P14(6|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 14 | Antimicrobial | 70% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRIIRKIIHIIKKYG | Ovispirin-1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 70.2% hemolysis at 80 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRIIRKIIHIIKKYG | Ovispirin-1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 55.0% hemolysis at 40 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRIIRKGIHIIKKYG | Novispirin G-10 | Free | Free | Linear | L | None | 18 | Antimicrobial | 2.5% hemolysis at 80 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRIIRKGIHIIKKYG | Novispirin G-10 | Free | Free | Linear | L | None | 18 | Antimicrobial | 1.8% hemolysis at 40µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRITRKIIHIIKKYG | Novispirin T-7 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10.0% hemolysis at 80 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRITRKIIHIIKKYG | Novispirin T-7 | Free | Free | Linear | L | None | 18 | Antimicrobial | 3.0% hemolysis at 80 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 11976325 | 2002 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxyopinin 1 | Free | Free | Linear | L | None | 48 | Antimicrobial and Insecticidal | ~90% hemolysis at 50μM | Pig | Oxyopinins (Isolated from the crude venom of the wolf spider Oxyopes kitabensis) | NA | NA | ||
| 11976325 | 2002 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxyopinin 1 | Free | Free | Linear | L | None | 48 | Antimicrobial and Insecticidal | ~100% hemolysis at 50μM | Guinea-pig | Oxyopinins (Isolated from the crude venom of the wolf spider Oxyopes kitabensis) | NA | NA | ||
| 11976325 | 2002 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxyopinin 1 | Free | Free | Linear | L | None | 48 | Antimicrobial and Insecticidal | ~40% hemolysis at 50μM | Sheep | Oxyopinins (Isolated from the crude venom of the wolf spider Oxyopes kitabensis) | NA | NA | ||
| 11976325 | 2002 | GKFSVFGKILRSIAKVFKGVGKVRKQFKTASDLDKNQ | Oxyopinin 2 | Free | Free | Linear | L | None | 48 | Antimicrobial and Insecticidal | ~70% hemolysis at 50μM | Pig | Oxyopinins (Isolated from the crude venom of the wolf spider Oxyopes kitabensis) | NA | NA | ||
| 11976325 | 2002 | GKFSVFGKILRSIAKVFKGVGKVRKQFKTASDLDKNQ | Oxyopinin 2 | Free | Free | Linear | L | None | 48 | Antimicrobial and Insecticidal | ~100% hemolysis at 50μM | Guinea-pig | Oxyopinins (Isolated from the crude venom of the wolf spider Oxyopes kitabensis) | NA | NA | ||
| 11976325 | 2002 | GKFSVFGKILRSIAKVFKGVGKVRKQFKTASDLDKNQ | Oxyopinin 2 | Free | Free | Linear | L | None | 48 | Antimicrobial and Insecticidal | ~10% hemolysis at 50μM | Sheep | Oxyopinins (Isolated from the crude venom of the wolf spider Oxyopes kitabensis) | NA | NA | ||
| 11976325 | 2002 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pandinin 1 | Free | Free | Linear | L | None | 44 | Antimicrobial and Insecticidal | ~30% hemolysis at 50μM | Pig | Pandinins (Extracted from the venom of the scorpion Pandinus imperator) | NA | NA | ||
| 11976325 | 2002 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pandinin 1 | Free | Free | Linear | L | None | 44 | Antimicrobial and Insecticidal | ~45% hemolysis at 50μM | Guinea-pig | Pandinins (Extracted from the venom of the scorpion Pandinus imperator) | NA | NA | ||
| 11976325 | 2002 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pandinin 1 | Free | Free | Linear | L | None | 44 | Antimicrobial and Insecticidal | 0% hemolysis at 50μM | Sheep | Pandinins (Extracted from the venom of the scorpion Pandinus imperator) | NA | NA | ||
| 11976325 | 2002 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | ~100% hemolysis at 50μM | Pig | Pandinins (Extracted from the venom of the scorpion Pandinus imperator) | NA | NA | ||
| 11976325 | 2002 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | ~100% hemolysis at 50μM | Guinea-pig | Pandinins (Extracted from the venom of the scorpion Pandinus imperator) | NA | NA | ||
| 11976325 | 2002 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | ~100% hemolysis at 50μM | Sheep | Pandinins (Extracted from the venom of the scorpion Pandinus imperator) | NA | NA | ||
| 12384369 | 2002 | KKAAAFAAAAAFAAWAAFAAAKKKK{ct:Amid} | F25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 4% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAFAAAAAFAAWAAFAAAKKKK{ct:Amid} | F25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAFAAAAAFAAWAAFAAAKKKK{ct:Amid} | F25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 1% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAFAAAAAFAAWAAFAAAKKKK{ct:Amid} | F25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAFAAAAAFAAWAAFAAA{ct:Amid} | F25-6K | Amidation | Free | Linear | L | None | 25 | Antimicrobial | Not detected hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAFAAAAAFAAWAAFAAA{ct:Amid} | F25-6K | Amidation | Free | Linear | L | None | 25 | Antimicrobial | Not detected hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAFAAAAAFAAWAAFAAA{ct:Amid} | F25-6K | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 17% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAFAAAAAFAAWAAFAAA{ct:Amid} | F25-6K | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 11% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAAF{d}AAF{d}AAW{d}F{d}AAF{d}AAAAKKKK{ct:Amid} | 4F | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 34% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAAFAAFAAWFAAFAAAAKKKK{ct:Amid} | 4F | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 14% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAAFAAFAAWFAAFAAAAKKKK{ct:Amid} | 4F | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 42% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAAFAAFAAWFAAFAAAAKKKK{ct:Amid} | 4F | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 17% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAFAAAAAFAAWAAFAKKKK{ct:Amid} | F21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 3% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAFAAAAAFAAWAAFAKKKK{ct:Amid} | F21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 1% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAFAAAAAFAAWAAFAKKKK{ct:Amid} | F21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAFAAAAAFAAWAAFAKKKK{ct:Amid} | F21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKAAAFAAWAAFAKKK{ct:Amid} | F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKAAAFAAWAAFAKKK{ct:Amid} | F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKAAAFAAWAAFAKKK{ct:Amid} | F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKAAAFAAWAAFAKKK{ct:Amid} | F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRAAF{d}AAW{d}AAF{d}AARRR{ct:Amid} | F17-R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRAAFAAWAAFAARRR{ct:Amid} | F17-R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRAAFAAWAAFAARRR{ct:Amid} | F17-R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRAAFAAWAAFAARRR{ct:Amid} | F17-R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAWAAFAA{ct:Amid} | F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 1% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAWAAFAA{ct:Amid} | F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAWAAFAA{ct:Amid} | F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAWAAFAA{ct:Amid} | F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRRRRAAFAAWAAFAA{ct:Amid} | F17-6R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 3% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRRRRAAFAAWAAFAA{ct:Amid} | F17-6R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 1% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRRRRAAFAAWAAFAA{ct:Amid} | F17-6R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 26% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRRRRAAFAAWAAFAA{ct:Amid} | F17-6R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 14% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAAFWAAAAF{ct:Amid} | KAFW | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 1% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAAFWAAAAF{ct:Amid} | KAFW | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAAFWAAAAF{ct:Amid} | KAFW | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAAFWAAAAF{ct:Amid} | KAFW | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAFAAFAA{ct:Amid} | 3F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAFAAFAA{ct:Amid} | 3F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAFAAFAA{ct:Amid} | 3F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAFAAFAA{ct:Amid} | 3F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAWAAWAAWAA{ct:Amid} | W17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAWAAWAAWAA{ct:Amid} | W17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAWAAWAAWAA{ct:Amid} | W17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAWAAWAAWAA{ct:Amid} | W17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12681513 | 2003 | KKFPWWWPFKK | SYM11KK | Free | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at 200 μg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12681513 | 2003 | VKKFPWWWPFLKK | TRK | Free | Free | Linear | L | None | 13 | Antimicrobial | 1% hemolysis at 200 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 12681513 | 2003 | RRFPWWWPFRR | SYM11 | Free | Free | Linear | L | None | 11 | Antimicrobial | ~60% hemolysis at 200 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 14637016 | 2003 | ILGKIWEGIKSLF | IsCT1 | Free | Free | Linear | L | None | 13 | Antimicrobial | ~20% hemolysis at 50μM | Sheep | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | ILGKIWEGIKSLF | IsCT1 | Free | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 50μM | Pig | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | ILGKIWEGIKSLF | IsCT1 | Free | Free | Linear | L | None | 13 | Antimicrobial | ~100% hemolysis at 50μM | Guinea-pig | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | IFGAIWNGIKSLF | IsCT2 | Free | Free | Linear | L | None | 13 | Antimicrobial | <20% hemolysis at 50μM | Sheep | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | IFGAIWNGIKSLF | IsCT2 | Free | Free | Linear | L | None | 13 | Antimicrobial | ~80% hemolysis at 50μM | Pig | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | IFGAIWNGIKSLF | IsCT2 | Free | Free | Linear | L | None | 13 | Antimicrobial | ~80% hemolysis at 50μM | Guinea-pig | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | >80% hemolysis at 50μM | Sheep | Pandinins analog (Pandinus imperator) | NA | NA | ||
| 14637016 | 2003 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 100% hemolysis at 50μM | Pig | Pandinins analog (Pandinus imperator) | NA | NA | ||
| 14637016 | 2003 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 100% hemolysis at 50μM | Guinea-pig | Pandinins analog (Pandinus imperator) | NA | NA | ||
| 14637016 | 2003 | GKFSGFAKILKSIAKFFKGVGKVRKQFKEASDLDKNQ | Oxki2 | Free | Free | Linear | L | None | 37 | Antimicrobial | ~40% hemolysis at 50μM | Sheep | Oxyopinins analog (Oxyopes kitabensis) | NA | NA | ||
| 14637016 | 2003 | GKFSGFAKILKSIAKFFKGVGKVRKQFKEASDLDKNQ | Oxki2 | Free | Free | Linear | L | None | 37 | Antimicrobial | >60% hemolysis at 50μM | Pig | Oxyopinins analog (Oxyopes kitabensis) | NA | NA | ||
| 14637016 | 2003 | GKFSGFAKILKSIAKFFKGVGKVRKQFKEASDLDKNQ | Oxki2 | Free | Free | Linear | L | None | 37 | Antimicrobial | 100% hemolysis at 50μM | Guinea-pig | Oxyopinins analog (Oxyopes kitabensis) | NA | NA | ||
| 14637016 | 2003 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pin1 | Free | Free | Linear | L | None | 44 | Antimicrobial | 0% hemolysis at 50μM | Sheep | Pandinins analog (Pandinus imperator) | NA | NA | ||
| 14637016 | 2003 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pin1 | Free | Free | Linear | L | None | 44 | Antimicrobial | >20% hemolysis at 50μM | Pig | Pandinins analog (Pandinus imperator) | NA | NA | ||
| 14637016 | 2003 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pin1 | Free | Free | Linear | L | None | 44 | Antimicrobial | >40% hemolysis at 50μM | Guinea-pig | Pandinins analog (Pandinus imperator) | NA | NA | ||
| 14637016 | 2003 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxki1 | Free | Free | Linear | L | None | 48 | Antimicrobial | ~60% hemolysis at 50μM | Sheep | Oxyopinins analog (Oxyopes kitabensis) | NA | NA | ||
| 14637016 | 2003 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxki1 | Free | Free | Linear | L | None | 48 | Antimicrobial | 90% hemolysis at 50μM | Pig | Oxyopinins analog (Oxyopes kitabensis) | NA | NA | ||
| 14637016 | 2003 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxki1 | Free | Free | Linear | L | None | 48 | Antimicrobial | ~100% hemolysis at 50μM | Guinea-pig | Oxyopinins analog (Oxyopes kitabensis) | NA | NA | ||
| 12147359 | 2002 | AKKVFKRLEKLFSKIQNDK | HP (2 – 20) | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) (Helicobacter pylori) | NA | Non-hemolytic | ||
| 15345319 | 2004 | TFRRLKWK{cyc:N-C} | LALF-10 | Free | Free | Cyclic | L | None | 8 | Antimicrobial | ~5% hemolysis at 100µg/ml | Human | Limulus analogs (Limulus polyphemus) | NA | NA | ||
| 15345319 | 2004 | TFRRLKWK{cyc:N-C} | LALF-11 | Free | Free | Cyclic | L | None | 8 | Antimicrobial | ~5% hemolysis at 100µg/ml | Human | Limulus analogs (Limulus polyphemus) | NA | NA | ||
| 15345319 | 2004 | KPTFRRLKWKYK{cyc:N-C} | LALF-14 | Free | Free | Cyclic | L | None | 12 | Antimicrobial | ~5% hemolysis at 100µg/ml | Human | Limulus analogs (Limulus polyphemus) | NA | NA | ||
| 15345319 | 2004 | HYRIKPTFRRLKWKYKGKFW{cyc:N-C} | LALf-22 | Free | Free | Cyclic | L | None | 20 | Antimicrobial | ~20% hemolysis at 100µg/ml | Human | Limulus analogs (Limulus polyphemus) | NA | NA | ||
| 11606214 | 2001 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antimicrobial | Strong hemolysis | Human | Gramicidin S | NA | NA | ||
| 11606214 | 2001 | VKLY{d}PVKLY{d}P{cyc:N-C} | GS10 | Free | Free | Cyclic | Mix | None | 10 | Antimicrobial | Strong hemolysis | Human | Gramicidin S analogs | NA | NA | ||
| 11606214 | 2001 | VKLKY{d}PKVKLY{d}P{cyc:N-C} | GS12 | Free | Free | Cyclic | Mix | None | 12 | Antimicrobial | Weak hemolysis | Human | Gramicidin S analogs | NA | NA | ||
| 11606214 | 2001 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | Very strong hemolysis | Human | Gramicidin S analogs | NA | NA | ||
| 11606214 | 2001 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | [D-Lys]4GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | Weak hemolysis | Human | Gramicidin S analogs | NA | NA | ||
| 10795591 | 2000 | CYCRIPACIAGERRYGTCIYQGRLWAFCC | HNP-2 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.9% hemolysis at 80µg/ml | Human | Human neutrophils | NA | NA | ||
| 10795591 | 2000 | VVCACRRALCLPLERRAGFCRIRGRIHPLCCRR | NP-2 | Free | Free | Linear | L | None | 33 | Antimicrobial | 1.9% hemolysis at 80µg/ml | Human | Rabbit neutrophils | NA | NA | ||
| 10795591 | 2000 | KWCFRVCYRGICYRRCR{ct:Amid} | TP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 66.5% hemolysis at 80µg/ml | Human | Limulus hemocytes | NA | NA | ||
| 10795591 | 2000 | RGGRLCYCRRRFCVCVGR{ct:Amid} | PG-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 70.3% hemolysis at 80µg/ml | Human | Porcine neutrophils | NA | NA | ||
| 10795591 | 2000 | R{d}G{d}G{d}R{d}L{d}C{d}Y{d}C{d}R{d}R{d}R{d}F{d}C{d}V{d}C{d}V{d}G{d}R{d}{ct:Amid} | dPG-1 | Amidation | Free | Linear | D | None | 18 | Antimicrobial | 90% hemolysis at 80µg/ml | Human | PG-1 analog | NA | NA | ||
| 10795591 | 2000 | RGGRLCYARRRFAVCVGR{ct:Amid} | PG-1 “bullet” | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 14.7% hemolysis at 80µg/ml | Human | PG-1 analog | NA | NA | ||
| 10795591 | 2000 | RGGRLAYCRRRFCVAVGR{ct:Amid} | PG-1 “kite” | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 80µg/ml | Human | PG-1 analog | NA | NA | ||
| 10795591 | 2000 | RGGRLAYARRRFAVAVGR{ct:Amid} | PG-1 “snake” | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0.8% hemolysis at 80µg/ml | Human | PG-1 analog | NA | NA | ||
| 10795591 | 2000 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 94.6% hemolysis at 80µg/ml | Human | Bee venom | NA | NA | ||
| 10795591 | 2000 | GIGKFLHSAGKFGKAFVGEIMKS | Magainin 1 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 80µg/ml | Human | Frog skin | NA | NA | ||
| 10795591 | 2000 | GIGKFLKKAKKFGKAFVKILKK | MSI-78 | Free | Free | Linear | L | None | 22 | Antimicrobial | 11.4% hemolysis at 80µg/ml | Human | Magainin-1 analog | NA | NA | ||
| 10795591 | 2000 | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | Cecropin P1 | Free | Free | Linear | L | None | 31 | Antimicrobial | 0.3% hemolysis at 80µg/ml | Human | Porcine intestine | NA | NA | ||
| 10795591 | 2000 | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Cecropin A | Free | Free | Linear | L | None | 37 | Antimicrobial | 0.6% hemolysis at 80µg/ml | Human | Insect hemolymph | NA | NA | ||
| 10795591 | 2000 | VFQFLGKIIHHVGNFVHGFSHVF{ct:Amid} | Clavanin A amide | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 3.7% hemolysis at 80µg/ml | Human | Tunicate hemocytes | NA | NA | ||
| 10795591 | 2000 | VFQFLGKIIHHVGNFVHGFSHVF | Clavanin A acid | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 80µg/ml | Human | Clavanin A analog | NA | NA | ||
| 10795591 | 2000 | VFQFLGKIIKKVGNFVKGFSKVF | Clavanin AK acid | Free | Free | Linear | L | None | 23 | Antimicrobial | 30.6% hemolysis at 80µg/ml | Human | Clavanin A analog | NA | NA | ||
| 10795591 | 2000 | ILPWKWPWWPWRR | Indolicidin | Free | Free | Linear | L | None | 13 | Antimicrobial | 38.2% hemolysis at 80µg/ml | Human | Bovine neutrophils | NA | NA | ||
| 10795591 | 2000 | FLPVLAGIAAKVVPALFCKITKKC | Brevinin-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 89% hemolysis at 80µg/ml | Human | Frog skin | NA | NA | ||
| 10795591 | 2000 | FLPVLAGIAAKVVPALFCKITKKC | CAM-brevinin | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.5% hemolysis at 80µg/ml | Human | Brevinin-1analog | NA | NA | ||
| 10795591 | 2000 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | 17.1% hemolysis at 80µg/ml | Human | Human neutrophils | NA | NA | ||
| 10799508 | 2000 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 10µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 100µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 1% hemolysis at 10µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 8% hemolysis at 100µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K3L4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 3% hemolysis at 10µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K3L4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 37% hemolysis at 100µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLM | Mast 21 | Free | Free | Linear | L | None | 21 | Antimicrobial | 5.4% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGENWELM | Mast 21(+2) | Free | Free | Linear | L | None | 21 | Antimicrobial | 5.3% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGENWKLM | Mast 21(+4) | Free | Free | Linear | L | None | 21 | Antimicrobial | 7.1% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKKIAGMAKKLLKKNWKLM | Mast 21(+8) | Free | Free | Linear | L | None | 21 | Antimicrobial | 6.3% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNW | Mast 18 | Free | Free | Linear | L | None | 18 | Antimicrobial | 2.7% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNW | Mast 19 | Free | Free | Linear | L | None | 18 | Antimicrobial | 5.1% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWELMEK | Mast 23(+4) | Free | Free | Linear | L | None | 23 | Antimicrobial | 6.3% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWELMKK | Mast 23(+6) | Free | Free | Linear | L | None | 23 | Antimicrobial | 7.2% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLMKK | Mast 23(+8) | Free | Free | Linear | L | None | 23 | Antimicrobial | 7.2% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLM{ct:Amid} | Mast 21N | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 12.3% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | NWKGIAAMAKKLL | Mastoparan X | Free | Free | Linear | L | None | 13 | Antimicrobial | 24% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | GIGKFLHSAKKFGKAFVGEIMNS | Magainin 2 | Free | Free | Linear | L | None | 23 | Antimicrobial | 4.5% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10785392 | 2000 | GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLAKTC | Gaegurin 4 (GGN4) | Free | Free | Linear | L | None | 37 | Antimicrobial | Non-hemolytic | Human | Skin of a Korean frog, Rana rugosa | NA | Non-hemolytic | ||
| 10799508 | 2000 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 10μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 100μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 1% hemolytic at 10μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 8% hemolytic at 100μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K3L4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 3% hemolytic at 10μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K3L4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 37% hemolytic at 100μg/ml | Human | Synthetic peptide | NA | NA | ||
| 15195974 | 2004 | KWKKLLKKLLKLL{ct:Amid} | K6L6W | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 75% hemolytic at 100μM | Human | Synthetic peptide | NA | NA | ||
| 15195974 | 2004 | KWKKLPKKLLKLL{ct:Amid} | K6L5WP | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14965277 | 2004 | GWGSFFKKAAHVGKHVGKAALTHYL | Ple | Free | Free | Linear | L | None | 25 | Antimicrobial | 2.5% hemolytic at 100μM | Human | Pleurocidin | NA | NA | ||
| 14965277 | 2004 | GWGSFFKKAAHVAKHVGKAALTHYL | Ple-AG | Free | Free | Linear | L | None | 25 | Antimicrobial | 16.6% hemolytic at 100μM | Human | Pleurocidin | NA | NA | ||
| 14965277 | 2004 | GWGSFFKKAAHVGKHVAKAALTHYL | Ple-GA | Free | Free | Linear | L | None | 25 | Antimicrobial | 15.4% hemolytic at 100μM | Human | Pleurocidin | NA | NA | ||
| 14965277 | 2004 | GWGSFFKKAAHVAKHVAKAALTHYL | Ple-AA | Free | Free | Linear | L | None | 25 | Antimicrobial | 37.4% hemolytic at 100μM | Human | Pleurocidin | NA | NA | ||
| 12931994 | 2003 | RGGRLCYCRRRFCVCVGR{cyc:N-C}{ct:Amid} | Protegrin-I (2) | Amidation | Free | Cyclic | L | None | 18 | Antimicrobial | 37% hemolytic at 100μg/ml | Human | Protegrin | NA | NA | ||
| 12931994 | 2003 | LRLKKRRWKYRVP{d}{cyc:N-C} | 5 | Free | Free | Cyclic | Mix | None | 13 | Antimicrobial | 1.4% hemolytic at 100μg/ml | Human | Protegrin | NA | NA | ||
| 12071741 | 2002 | GIGKFLHAAKKFAKAFVAEIMNS{ct:Amid} | Ala8,13,18-magainin II | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 100% hemolytic at 100μg/ml | Human | Magainin analog | NA | NA | ||
| 11738090 | 2001 | GFLGPLLKLAAKGVAKVIPHLIPSRQQ | XT-1 | Free | Free | Linear | L | None | 27 | Antimicrobial | HC50 = 90μM | Human | Isolated from norepinephrine-stimulated skin secretions of the diploid clawed frog, Xenopus tropicalis | NA | NA | ||
| 11738090 | 2001 | GVFLDALKKFAKGGMNAVLNPK | XT-4 | Free | Free | Linear | L | None | 22 | Antimicrobial | HC50 > 150μM | Human | Isolated from norepinephrine-stimulated skin secretions of the diploid clawed frog, Xenopus tropicalis | NA | NA | ||
| 11738090 | 2001 | GMATKAGTALGKVAKAVIGAAL{ct:Amid} | XT-5 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | HC50 > 150μM | Human | Isolated from norepinephrine-stimulated skin secretions of the diploid clawed frog, Xenopus tropicalis | NA | NA | ||
| 11738090 | 2001 | GFLGSLLKTGLKVGSNLL{ct:Amid} | XT-6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HC50 > 150μM | Human | Isolated from norepinephrine-stimulated skin secretions of the diploid clawed frog, Xenopus tropicalis | NA | NA | ||
| 11738090 | 2001 | GLLGPLLKIAAKVGSNLL{ct:Amid} | XT-7 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HC50 = 70μM | Human | Isolated from norepinephrine-stimulated skin secretions of the diploid clawed frog, Xenopus tropicalis | NA | NA | ||
| 10973820 | 2000 | ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE | CRAMP | Free | Free | Linear | L | None | 38 | Antimicrobial and Anticancer | 2.2% hemolytic at 100μM | Human | Derived from CRMAP, a member of cathelicidin-derived antimicrobial peptides | NA | NA | ||
| 10973820 | 2000 | GEKLKKIGQKIKNFFQKL | CRAMP-18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Anticancer | 0% hemolytic at 100μM (non-hemolytic) | Human | CRMAP | NA | Non-hemolytic | ||
| 10973820 | 2000 | GKKLKKIGQKIKNFFQKL | K2-CRAMP-18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Anticancer | 0% hemolytic at 100μM (non-hemolytic) | Human | CRMAP-18 analogs | NA | Non-hemolytic | ||
| 10973820 | 2000 | GEKLKKIGKKIKNFFQKL | K9-CRAMP-18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Anticancer | 0% hemolytic at 100μM (non-hemolytic) | Human | CRMAP-18 analogs | NA | Non-hemolytic | ||
| 10973820 | 2000 | GEKLKKIGQKIKKFFQKL | K13-CRAMP-18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Anticancer | 0% hemolytic at 100μM (non-hemolytic) | Human | CRMAP-18 analogs | NA | Non-hemolytic | ||
| 10973820 | 2000 | GEKLKKIGQKIKNFFKKL | K16-CRAMP-18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Anticancer | 0.2% hemolytic at 100μM | Human | CRMAP-18 analogs | NA | NA | ||
| 10879468 | 2000 | GIGKFLHSAKKFGKAFVGEIMNS | Magainin 2 | Free | Free | Linear | L | None | 23 | Antimicrobial and Hemolytic | 4.5% hemolytic at 10μM | Human | Magainin-2 (Xenopus laevis) | NA | NA | ||
| 10879468 | 2000 | NWKGIAAMAKKLL | Mastroparan X | Free | Free | Linear | L | None | 13 | Antimicrobial and Hemolytic | 24% hemolytic at 10μM | Human | Wasp Venom | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLM | Mast 21 | Free | Free | Linear | L | None | 19 | Antimicrobial and Hemolytic | 5.4% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGENWELM | Mast 21(+2) | Free | Free | Linear | L | None | 21 | Antimicrobial and Hemolytic | 5.3% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGENWKLM | Mast 21(+4) | Free | Free | Linear | L | None | 21 | Antimicrobial and Hemolytic | 7.1% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKKIAGMAKKLLKKNWKLM | Mast 21(+8) | Free | Free | Linear | L | None | 21 | Antimicrobial and Hemolytic | 6.3% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNW | Mast 18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Hemolytic | 2.7% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNW | Mast 19 | Free | Free | Linear | L | None | 18 | Antimicrobial and Hemolytic | 5.1% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWELMEK | Mast 23(+4) | Free | Free | Linear | L | None | 23 | Antimicrobial and Hemolytic | 6.3% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWELMKK | Mast 23(+6) | Free | Free | Linear | L | None | 23 | Antimicrobial and Hemolytic | 7.2% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLMKK | Mast 23(+8) | Free | Free | Linear | L | None | 23 | Antimicrobial and Hemolytic | 7.2% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLM{ct:Amid} | Mast 21N | Amidation | Free | Linear | L | None | 21 | Antimicrobial and Hemolytic | 12.3% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10673369 | 1999 | KWCFRVCYRGICYRRCR-{nnr:X} | TP-1 | Free | Free | Linear | L | None | 17 | Antimicrobial | EC25 = 29μM | Human | Tachyplesin-1 | NA | NA | ||
| 10673369 | 1999 | KWCFCVCYRGICYCRCRG | cc TP | Free | Free | Linear | L | None | 18 | Antimicrobial | EC25 =590μM | Human | Tachyplesin-1 | NA | NA | ||
| 10673369 | 1999 | GFCRCLCRRGVCRCLCTK | RTD | Free | Free | Linear | L | None | 18 | Antimicrobial | EC25 =2350μM | Human | Tachyplesin-1 | NA | NA | ||
| 18325325 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 77% hemolysis at 100μM | Human | Pleurocidin (Winter flounder) | NA | NA | ||
| 18325325 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 29% hemolysis at 50μM | Human | Pleurocidin (Winter flounder) | NA | NA | ||
| 18325325 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 6% hemolysis at 25μM | Human | Pleurocidin (Winter flounder) | NA | NA | ||
| 18325325 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0% hemolytic at 12.5μM | Human | Pleurocidin (Winter flounder) | NA | NA | ||
| 18325325 | 2008 | RWRSFFKKAAHRGKHVGKRARTHYL{ct:Amid} | Anal-R | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Pleurocidin (Winter flounder) | NA | Non-hemolytic | ||
| 18325325 | 2008 | SWSSFFKKAAHSGKHVGKSASTHYL{ct:Amid} | Anal-S | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Pleurocidin (Winter flounder) | NA | Non-hemolytic | ||
| 18068868 | 2007 | GFKDLLKGAAKALVKTVLF{ct:Amid} | Ascaphin-8 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 =55μM | Human | Frog skin | NA | NA | ||
| 18068868 | 2007 | GFKKLLKGAAKALVKTVLF{ct:Amid} | Lys4-Ascaphin-8 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 =24μM | Human | Frog skin | NA | NA | ||
| 18068868 | 2007 | GFKDLLKKAAKALVKTVLF{ct:Amid} | Lys8-Ascaphin-8 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 =11μM | Human | Frog skin | NA | NA | ||
| 10224074 | 1999 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antimicrobial and Hemolytic | 100% hemolytic at 12.5 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 1.5 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKV{d}KLY{d}P{cyc:N-C} | GS14V10 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 6.2 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C} | GS14L3 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 12.5 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C} | GS14P14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 6.2 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}P{d}LKVKLY{d}P{cyc:N-C} | GS14P7 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 12.5 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14V1 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 40 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C} | GS14L12 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 25 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C} | GS14V5 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 150 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLYP{cyc:N-C} | GS14Y13 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 12.5 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C} | GS14L8 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 50 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVYPLKVKLY{d}P{cyc:N-C} | GS14Y6 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 25 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K2 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 50 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C} | GS14K9 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 100 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 200 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C} | GS14K11 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 150 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VK{d}LK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K2K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at >200 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VK{d}LK{d}VY{d}PLK{d}VK{d}LY{d}P{cyc:N-C} | GS14K2K4K9K11 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at >200 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 23624708 | 2013 | KRGFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY | rNZ2114 | Free | Free | Linear | L | None | 42 | Antimicrobial | >0.1% hemolytic upto 128μg/ml | Human | Variant of plectasin | NA | NA | ||
| 23609760 | 2013 | FVDLKKIANIINSIFGK | Temporin-1CEa | Free | Free | Linear | L | None | 17 | Antimicrobial, Anticancer and moderate Hemolytic | LC50 =95.7μM | Human | Temporin-1CEa (Rana chensinensis) | NA | NA | ||
| 23570790 | 2013 | WKSDVRRWRSRY | TSG-6 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.3 ±0.9% hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | WKSYVRRWRSRY | TSG-7 | Free | Free | Linear | L | None | 12 | Antimicrobial | 1.5 ±1.4%hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | WKSYVRRWRSR | TSG-8 | Free | Free | Linear | L | None | 11 | Antimicrobial | -1.2 ± 2.6%hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | WWSYVRRWRSR | TSG-8-1 | Free | Free | Linear | L | None | 11 | Antimicrobial | 3.4 ±1.3% hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | WKSYVRRWRS | TSG-9 | Free | Free | Linear | L | None | 10 | Antimicrobial | -0.4 ± 0.5%hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | KKSYVRRWRS | TSG-9-1 | Free | Free | Linear | L | None | 10 | Antimicrobial | -0.6 ± 1.6% hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | WKSYVRRWR | TSG-10 | Free | Free | Linear | L | None | 9 | Antimicrobial | 1.1 ±1.3% hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | WKSYVRRW | TSG-11 | Free | Free | Linear | L | None | 8 | Antimicrobial | 2.0 ±0.3% hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23500722 | 2013 | RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK | CecropinXJ | Free | Free | Linear | L | None | 38 | Antimicrobial | ~2% hemolytic at 200μM | Human | Isolated from the larvae of Bombyx mori | NA | NA | ||
| 23519707 | 2013 | GLFDIIKKIAESF | AU | Free | Free | Linear | L | None | 13 | Antimicrobial | 50% hemolytic at 128μmol/L | Human | Aurein 1.2 | NA | NA | ||
| 23519707 | 2013 | GLFDIIKKIAESF | AU | Free | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 4 -16μmol/L | Human | Aurein 1.2 | NA | NA | ||
| 23519707 | 2013 | FSEAIKKIIDFLGEGLFDIIKKIAESF | E(AU)2 | Free | Free | Linear | L | None | 27 | Antimicrobial | ~5% hemolytic at 128μmol/L | Human | N-terminal dimer of aurein | NA | NA | ||
| 23519707 | 2013 | FSEAIKKIIDFLGEGLFDIIKKIAESF | E(AU)2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 0% hemolytic at 4 -32μmol/L | Human | N-terminal dimer of aurein | NA | NA | ||
| 23519707 | 2013 | GLFDIIKKIAESFKFSEAIKKIIDFLG | (AU)2K | Free | Free | Linear | L | None | 27 | Antimicrobial | ~30% hemolytic at 32μmol/L | Human | C-terminal dimer of aurein | NA | NA | ||
| 23519707 | 2013 | GLFDIIKKIAESFKFSEAIKKIIDFLG | (AU)2K | Free | Free | Linear | L | None | 27 | Antimicrobial | 10% hemolytic at 4μmol/L | Human | C-terminal dimer of aurein | NA | NA | ||
| 23344198 | 2013 | WLKKLLKKLLK{ct:Amid} | L5K5W 1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 32 μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | KWLKKLLKKLL{ct:Amid} | L5K5W 2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 16μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | LKWLKKLLKKL{ct:Amid} | L5K5W 3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 64μg/mL | Human | Defencin | NA | NA | ||
| 23344198 | 2013 | LLKWLKKLLKK{ct:Amid} | L5K5W 4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 128μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | KLLKWLKKLLK{ct:Amid} | L5K5W 5 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 64μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | KKLLKWLKKLL{ct:Amid} | L5K5W 6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 32μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | LKKLLKWLKKL{ct:Amid} | L5K5W 7 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 128μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | LLKKLLKWLKK{ct:Amid} | L5K5W 8 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 128μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | KLLKKLLKWLK{ct:Amid} | L5K5W 9 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 64μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | KKLLKKLLKWL{ct:Amid} | L5K5W 10 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 32μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | LKKLLKKLLKW{ct:Amid} | L5K5W 11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 128μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 22914980 | 2013 | KWKW{ct:Amid} | (KW)2 | Amidation | Free | Linear | L | None | 4 | Antimicrobial | 0% hemolytic at 200μM | Human | Synthetic KW peptides | NA | Non-hemolytic | ||
| 22914980 | 2013 | KWKWKW{ct:Amid} | (KW)3 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 0% hemolytic at 200μM | Human | Synthetic KW peptides | NA | Non-hemolytic | ||
| 22914980 | 2013 | KWKWKWKW{ct:Amid} | (KW)4 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 8% hemolytic at 200μM | Human | Synthetic KW peptides | NA | NA | ||
| 22914980 | 2013 | KWKWKWKWKW{ct:Amid} | (KW)5 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 71% hemolytic at 200μM | Human | Synthetic KW peptides | NA | NA | ||
| 23226256 | 2013 | FDWDSVLKGVEGFVRGYF | TP1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolytic at 100 µg/ml (non-hemolytic) | Fish | Derivative of Piscidin (Nile tilapia, Oreochromis niloticus) | NA | Non-hemolytic | ||
| 23226256 | 2013 | GECIWDAIFHGAKHFLHRLVNP | TP2 | Free | Free | Linear | L | None | 22 | Antimicrobial | 60% hemolytic at 40µg/ml | Fish | Derivative of Piscidin (Nile tilapia, Oreochromis niloticus) | NA | NA | ||
| 23226256 | 2013 | FIHHIIGGLFSVGKHIHSLIHGH | TP3 | Free | Free | Linear | L | None | 23 | Antimicrobial | 42% hemolytic at 100 µg/ml | Fish | Derivative of Piscidin (Nile tilapia, Oreochromis niloticus) | NA | NA | ||
| 23226256 | 2013 | FIHHIIGGLFSAGKAIHRLIRRRRR | TP4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 100% hemolytic at 100 µg/ml | Fish | Derivative of Piscidin (Nile tilapia, Oreochromis niloticus) | NA | NA | ||
| 23226256 | 2013 | QLQGKQVSGEVVQKVLQELIQSVAKP | TP5 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0% hemolytic at 100μg/ml (non-hemolytic) | Fish | Derivative of Piscidin (Nile tilapia, Oreochromis niloticus) | NA | Non-hemolytic | ||
| 23220638 | 2013 | KNIGNSVSCLRNKGVCMPGKCAPKMKQIGTCGMPQVKCCKRK | pBD142 | Free | Free | Linear | L | None | 42 | Antimicrobial | <11% hemolytic from 0–100μg/mL | Porcine | Porcine beta defensin 1 (Pigs) | NA | NA | ||
| 23124812 | 2013 | FSGGNCRGFRRRCFCTK{ct:Amid} | SolyC | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <5% hemolytic at 50mg/ml | Mouse | Tomato defensins (Tomato) | NA | NA | ||
| 23093034 | 2013 | SWKSMAKKLKEYMEKLKQRA | La5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 2% hemolytic at 25mM | Human | Analogs of antimicrobial peptides La47 (From venom of Lachesana sp.) | NA | NA | ||
| 23093034 | 2013 | FFGSLLSLGSKLLPSVFKLFQRKKE | Css54 | Free | Free | Linear | L | None | 25 | Antimicrobial | 83% hemolytic at 25mM | Human | Analogs of antimicrobial peptides La47 (From venom of Lachesana sp.) | NA | NA | ||
| 23019445 | 2013 | KWASLWNWFNITNWLWYIK{ct:Amid} | gp41w | Amidation | Free | Linear | L | None | 19 | Antimicrobial | EC50 =550μg/ml | Human | Gp41 derivative (HIV) | NA | NA | ||
| 23019445 | 2013 | KWARLWRWFRITRWLWYIK{ct:Amid} | gp41w-4R | Amidation | Free | Linear | L | None | 19 | Antimicrobial | EC50 = 7-14μg/ml | Human | Gp41 derivative (HIV) | NA | NA | ||
| 23019445 | 2013 | KWAKKWKWFAKAAWKWYKK{ct:Amid} | gp41w-KA | Amidation | Free | Linear | L | None | 19 | Antimicrobial | EC50 = 42μg/ml | Human | Gp41 derivative (HIV) | NA | NA | ||
| 23019445 | 2013 | KFAKKFKWFAKAAFKFFKK{ct:Amid} | gp41w-FKA | Amidation | Free | Linear | L | None | 19 | Antimicrobial | EC50 = 195μg/ml | Human | Gp41 derivative (HIV) | NA | NA | ||
| 22921836 | 2012 | MAFKKLEKVGRNIRDGIIKAGPAVAVIGQATSIARPTGK | Pxcec781 | Free | Free | Linear | L | None | 39 | Antimicrobial | Non-hemolytic | Human | Cecropin 1 derivative (Plutella xylostella) | NA | NA | ||
| 22865764 | 2013 | RGRCYTVCRQLYCLRRCQ | Gomesin (Gm) | Free | Free | Linear | L | None | 18 | Antimicrobial | 40% hemolytic at 100mM | Human | Gomesin (Gm) (Acanthoscurria gomesiana) | NA | NA | ||
| 22865764 | 2013 | RGRCYTVCRQLYCLRRCQ | Cys(Acm)2,15]-Gm | Free | Free | Linear | L | None | 18 | Antimicrobial | 16% hemolytic at 100mM | Human | Gomesin (Gm) (Acanthoscurria gomesiana) | NA | NA | ||
| 22865764 | 2013 | RGRCYTVCRQLYCLRRCQ | [Thr2,6,11,15,D-Pro9]-Gm | Free | Free | Linear | L | None | 18 | Antimicrobial | 17% hemolytic at 100mM | Human | Gomesin (Gm) (Acanthoscurria gomesiana) | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}W{d}L{d}L{d}A{d}L{d}K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid} | D-LAK120 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 4.06±1.30μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid} | D-LAK120-P13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 11.66±0.03μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}W{d}L{d}A{d}L{d}A{d}K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK120-A | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 17.42±2.17μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}W{d}L{d}P{d}L{d}A{d}K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK120-AP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 58.61±10.41μMc | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}H{d}A{d}L{d}K{d}K{d}W{d}L{d}H{d}A{d}L{d}K{d}K{d}L{d}A{d}H{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid} | D-LAK120-H | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 20.29±2.42μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}A{d}L{d}A{d}H{d}A{d}L{d}K{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}K{d}L{d}A{d}H{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK120-HP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 79.61±2.80μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}A{d}L{d}A{d}K{d}A{d}L{d}K{d}H{d}W{d}L{d}P{d}A{d}L{d}H{d}K{d}L{d}A{d}K{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK80-HP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 8.61±0.35μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}A{d}L{d}K{d}H{d}A{d}L{d}A{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}A{d}L{d}A{d}H{d}K{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK160-HP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 185.0±18.65μM | Human | Synthetic peptide | NA | NA | ||
| 22858580 | 2013 | MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLR | cgUbiquitin | Free | Free | Linear | L | None | 74 | Antimicrobial | 0% hemolytic at 100μg/ml (non-hemolytic) | Human | Ubiquitin (Crassostrea gigas) | NA | Non-hemolytic | ||
| 22858580 | 2013 | MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLR | cgUbiquitin | Free | Free | Linear | L | None | 74 | Antimicrobial | 0% hemolytic at 100μg/ml (non-hemolytic) | Hagfish | Ubiquitin (Crassostrea gigas) | NA | Non-hemolytic | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND | YFGAP-OH | Free | Free | Linear | L | None | 32 | Antimicrobial | 0% hemolytic at 3.13μg/ml | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND | YFGAP-OH | Free | Free | Linear | L | None | 32 | Antimicrobial | 0% hemolytic at 6.25μg/ml | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND | YFGAP-OH | Free | Free | Linear | L | None | 32 | Antimicrobial | 0% hemolytic at 12.5μg/ml | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND | YFGAP-OH | Free | Free | Linear | L | None | 32 | Antimicrobial | 0.1% hemolytic at 25.0μg/ml | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND | YFGAP-OH | Free | Free | Linear | L | None | 32 | Antimicrobial | 0.1 hemolytic at 50.0μg/ml | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND | YFGAP-OH | Free | Free | Linear | L | None | 32 | Antimicrobial | 0.4% hemolytic at 100mg/mL | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) (Thunnus albacares) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND{ct:Amid} | YFGAP-NH2 | Amidation | Free | Linear | L | None | 32 | Antimicrobial | 0% hemolytic at 3.13μg/ml | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) (Thunnus albacares) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND{ct:Amid} | YFGAP-NH2 | Amidation | Free | Linear | L | None | 32 | Antimicrobial | 0% hemolytic at 6.25μg/ml | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) (Thunnus albacares) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND{ct:Amid} | YFGAP-NH2 | Amidation | Free | Linear | L | None | 32 | Antimicrobial | 2.3% hemolytic at 12.5μg/ml | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) (Thunnus albacares) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND{ct:Amid} | YFGAP-NH2 | Amidation | Free | Linear | L | None | 32 | Antimicrobial | 2.5% hemolytic at 25μg/ml | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) (Thunnus albacares) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND{ct:Amid} | YFGAP-NH2 | Amidation | Free | Linear | L | None | 32 | Antimicrobial | 2.6% hemolytic at 50μg/ml | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) (Thunnus albacares) | NA | NA | ||
| 22771964 | 2013 | VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND{ct:Amid} | YFGAP-NH2 | Amidation | Free | Linear | L | None | 32 | Antimicrobial | 2.7 % hemolytic at 100mg/mL | Human | Yellowfin tuna GAPDH-related anti-microbial peptide (YFGAP) (Thunnus albacares) | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIFRIF{ct:Amid} | HFU4 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | MHC = 19.6 μM | Human | Synthetic peptide | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIFRIFIRF{ct:Amid} | HFU5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | MHC = 15 μM | Human | Synthetic peptide | NA | NA | ||
| 22670762 | 2013 | GLWDTIKQAGKKFFLNVLDKIRCKVAGGCRT | OG1 | Free | Free | Linear | L | None | 31 | Antimicrobial | 80% hemolytic at 256 μg/mL | Porcine | Palustrin-OG1 ( Odorrana grahami) | NA | NA | ||
| 22670762 | 2013 | GLWDTIKQAGKKFFLNVLDKIRCKVAGGCRT | OG1 | Free | Free | Linear | L | None | 31 | Antimicrobial | 10% hemolytic at 4 μg/mL | Porcine | Palustrin-OG1 ( Odorrana grahami) | NA | NA | ||
| 22670762 | 2013 | KKFFLKVLTKIRCKVAGGCRT | OG2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 10% hemolytic at 256 μg/mL | Porcine | Variant of OG1 | NA | NA | ||
| 22578463 | 2012 | KWLRRVWRWWR{ct:Amid} | MAP-04-03 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 100% hemolytic at 100μM | Human | Peptide amide analogs of Ixosin-B | NA | NA | ||
| 22578463 | 2012 | KRLRRVWRRWR{ct:Amid} | MAP-04-04 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3% hemolytic at 100μM | Human | Peptide amide analogs of Ixosin-B | NA | NA | ||
| 22792229 | 2012 | FIKRIARLLRKIF | Kn2-7 | Free | Free | Linear | L | None | 13 | Antimicrobial | HC50= 90.27 µg/mL | Human | BmKn2 derivative (From venom of Mesobuthus martensii) | NA | NA | ||
| 22792229 | 2012 | FIGAIARLLSKIF | BmKn2 | Free | Free | Linear | L | None | 13 | Antimicrobial | HC50= 17.13 µg/mL | Human | BmKn2 derivative (From venom of Mesobuthus martensii) | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIKIGAKI{ct:Amid} | KIGAKI-wt | Amidation | Free | Linear | L | None | 18 | Antimicrobial | ~14% hemolytic at 7.5μM | Human | Membrane-active model peptide KIGAKI [(KIGAKI)3-NH2] | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIKIGAKI{ct:Amid} | KIGAKI-wt | Amidation | Free | Linear | L | None | 18 | Antimicrobial | ~54% hemolytic at 60μM | Human | Membrane-active model peptide KIGAKI [(KIGAKI)3-NH2] | NA | NA | ||
| 23652359 | 2013 | KIGAK{nnr:L-CF3-Bpg}KIGAKIKIGAKI{ct:Amid} | KIGAKI-6L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~23% hemolytic at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAK{nnr:L-CF3-Bpg}-KIGAKIKIGAKI{ct:Amid} | KIGAKI-6L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~50% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAK-{nnr:D-CF3-Bpg}-KIGAKIKIGAKI{ct:Amid} | KIGAKI-6D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~7% hemolysis at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAK-{nnr:D-CF3-Bpg}-KIGAKIKIGAKI{ct:Amid} | KIGAKI-6D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~10% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIK-{nnr:L-CF3-Bpg}-GAKIKIGAKI{ct:Amid} | KIGAKI-8L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~13% hemolytic at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIK-{nnr:L-CF3-Bpg}-GAKIKIGAKI{ct:Amid} | KIGAKI-8L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~38% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIK-{nnr:D-CF3-Bpg}-GAKIKIGAKI{ct:Amid} | KIGAKI-8D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~5% hemolytic at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIK-{nnr:D-CF3-Bpg}-GAKIKIGAKI{ct:Amid} | KIGAKI-8D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~8% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAK-{nnr:L-CF3-Bpg}-KIGAKI{ct:Amid} | KIGAKI-12L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~17% hemolytic at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAK-{nnr:L-CF3-Bpg}-KIGAKI{ct:Amid} | KIGAKI-12L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~38% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKI-12DKIGAKIKIGAK-{nnr:D-CF3-Bpg}-KIGAKI{ct:Amid} | KIGAKI-12D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~5% hemolysis at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKI-12DKIGAKIKIGAK-{nnr:D-CF3-Bpg}-KIGAKI{ct:Amid} | KIGAKI-12D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~7% hemolysis at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIK-{nnr:L-CF3-Bpg}-GAKI{ct:Amid} | KIGAKI-14L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~13% hemolysis at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIK-{nnr:L-CF3-Bpg}-GAKI{ct:Amid} | KIGAKI-14L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~34% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIK-{nnr:D-CF3-Bpg}-GAKI{ct:Amid} | KIGAKI-14D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~6% hemolysis at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIK-{nnr:D-CF3-Bpg}-GAKI{ct:Amid} | KIGAKI-14D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~7% hemolysis at 60μM | Human | KIGAKI analog | NA | NA | ||
| 22029824 | 2012 | TSRCIFYRRKKCS | Andersonin-C1 | Free | Free | Linear | L | None | 13 | Antimicrobial | 15.2 ± 2.1% hemolytic at 50 μg/mL. | Human | Andersonin (Odorrana andersonii) | NA | NA | ||
| 22249992 | 2012 | NWCKRGRKQCKTHPH | NWC15l | Free | Free | Linear | L | None | 15 | Antimicrobial | ~2% hemolytic at 60μM and 6μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22249992 | 2012 | NWCKRGRKQCKTHPH{cyc:N-C} | NWC15c | Free | Free | Cyclic | L | None | 15 | Antimicrobial | ~2% hemolytic at 6μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22249992 | 2012 | NWCKRGRKQCKTHPH{cyc:N-C} | NWC15c | Free | Free | Cyclic | L | None | 15 | Antimicrobial | ~3% hemolytic at 60μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22249992 | 2012 | NWCKRGRKQCKTHPHFVIPY{cyc:N-C} | NWC20c | Free | Free | Cyclic | L | None | 20 | Antimicrobial | ~4% hemolytic at 6μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22249992 | 2012 | NWCKRGRKQCKTHPHFVIPY{cyc:N-C} | NWC20c | Free | Free | Cyclic | L | None | 20 | Antimicrobial | ~3% hemolytic at 60μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22249992 | 2012 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | ~9% hemolytic at 60μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22371493 | 2012 | MGIIAGIIKVIKSLIEQFTGK | PSMα1 | Free | Free | Linear | L | None | 21 | Immunosuppressive and antimicrobial | 58% hemolytic at 10 μg/mL | Human | Phenol-soluble modulins derivative (Staphylococcus aureus) | NA | NA | ||
| 22371493 | 2012 | GIIKVIKSLIEQFTGK | dPSMα1 | Free | Free | Linear | L | None | 16 | Immunosuppressive and antimicrobial | Non-hemolytic at 10 μg/mL | Human | Phenol-soluble modulins derivative (Staphylococcus aureus) | NA | Non-hemolytic | ||
| 22371493 | 2012 | MAIVGTIIKIIKAIIDIFAK | PSMα4 | Free | Free | Linear | L | None | 20 | Immunosuppressive and antimicrobial | 19% hemolytic at 10 μg/mL | Human | Phenol-soluble modulins derivative (Staphylococcus aureus) | NA | NA | ||
| 22371493 | 2012 | VGTIIKIIKAIIDIFAK | dPSMα4 | Free | Free | Linear | L | None | 17 | Immunosuppressive and antimicrobial | 52% hemolytic at 10 μg/mL | Human | Phenol-soluble modulins derivative (Staphylococcus aureus) | NA | NA | ||
| 22391524 | 2012 | GWLDVAKKIGKAAFNVAKNFL{ct:Amid} | MON | Amidation | Free | Linear | L | None | 21 | Antimicrobial | HC50 = 37.3± 1.4 μmol/L | Human | Ctx-Ha ceratotoxin-like peptide (Hypsiboas albopunctatus) | NA | NA | ||
| 22391524 | 2012 | GWLDVAKKIGKAAFNVAKNFLFNKAVNFAAKGIKKAVDLWG | DSE | Free | Free | Linear | L | None | 42 | Antimicrobial | HC50 = 0.6± 0.1 μmol/L | Human | Dimeric Ctx-Ha without spacer (Hypsiboas albopunctatus) | NA | NA | ||
| 22391524 | 2012 | GWLDVAKKIGKAAFNVAKNFL-{nnr:spacer}-LFNKAVNFAAKGIKKAVDLWG | DEA | Free | Free | Linear | L | spacer = 8-amino-octanoic acid | 42 | Antimicrobial | HC50 = 0.7± 0.1 μmol/L | Human | Dimeric form of Ctx-Ha with a apolar spacer (Hypsiboas albopunctatus) | NA | NA | ||
| 22391524 | 2012 | GWLDVAKKIGKAAFNVAKNFL-{nnr:spacer}-LFNKAVNFAAKGIKKAVDLWG | DEP | Free | Free | Linear | L | spacer = 8-amino-3,6-dioxaoctanoic acid | 42 | Antimicrobial | HC50 = 0.8± 0.1 μmol/L | Human | Dimeric form of Ctx-Ha with a polar spacer (Hypsiboas albopunctatus) | NA | NA | ||
| 22518150 | 2012 | KWKLFKKIPKFLHLAKKF{ct:Amid} | P18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC = 250 μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHLAKKF{ct:Amid} | CP-P | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC = 250 μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHSAKKF{ct:Amid} | S16 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KFKSFIKKLTSKFLHSAKKF{ct:Amid} | F2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC = 250 μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFINKLTSKFLHSAKKF{ct:Amid} | N7 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKSTSKFLHSAKKF{ct:Amid} | S9 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKAKTSFLHSAKKF{ct:Amid} | A9 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLLSKFLHSAKKF{ct:Amid} | L10 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC <125 μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLASKFLHSAKKF{ct:Amid} | A10 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC= 250 μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTDKFLHSAKKF{ct:Amid} | D11 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTKKFLHSAKKF{ct:Amid} | K11 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKALHSAKKF{ct:Amid} | A13 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHSKKKF{ct:Amid} | K17 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHSADKF{ct:Amid} | D18 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHSANKF{ct:Amid} | N18 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHSAKKN{ct:Amid} | N20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22699557 | 2012 | IWRIFR{ct:Amid} | HFU2 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | MHC >256μM | Human | Synthetic peptides | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIF{ct:Amid} | HFU3 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | MHC =101.4μM | Human | Synthetic peptides | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIFRIF{ct:Amid} | HFU4 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | MHC =19.6μM | Human | Synthetic peptides | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIFRIFIRF{ct:Amid} | HFU5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | MHC =15.0μM | Human | Synthetic peptides | NA | NA | ||
| 22038181 | 2012 | GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C} | Lasiocepsin | Free | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C}{ct:Amid} | Lasiocepsin-NH2 | Amidation | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C} | Las[C8-C27, C17-C25] | Free | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C} | Las[C8-C17, C25-C27] | Free | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILCAIAKKKGKAKGPLKLVCKA{cyc:N-C} | Las[C8-C25, Ala17,27] | Free | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILAAIAKKKGKCKGPLKLVAKC{cyc:N-C} | Las[C17-C27, Ala8,25] | Free | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILAAIAKKKGKAKGPLKLVAKA | Las[Ala8,17,25,27] | Free | Free | Linear | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | LCAIAKKKGKCKGPLKLVCKC{cyc:N-C}{ct:Amid} | Las[des1-6]-NH2 | Amidation | Free | Cyclic | L | None | 21 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | AKKKGKCKGPLKLVAKC{cyc:N-C}{ct:Amid} | Las[des1-10, Ala25]-NH2 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILAAIAKKK{ct:Amid} | Las[des15-27, Ala8]-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22526241 | 2012 | GFLSILKKVLPKVMAHMK{ct:Amid} | MEP | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 >100μM | Human | Melectin (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSILKKVLPKVXAHXK{ct:Amid} | MEP-N | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 50μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSILKKVLPKSXAHSK{ct:Amid} | MEP-Ns-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 18.1μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSSLKKSLPKVXAHXK{ct:Amid} | MEP-Ns-2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 14.7μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSSLKKSLPKSXAHSK{ct:Amid} | MEP-Ns-3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 13.9μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFRSILKKVSPKVXAHXK{ct:Amid} | MEP-Ns-4 cis | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 11μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFRSILKKVSPKVXAHXK{ct:Amid} | MEP-Ns-4 trans | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 20μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSSLKKSLGKSXAHSK{ct:Amid} | MEP-Ns-5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 29μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSSLKKSLAKSXAHSK{ct:Amid} | MEP-Ns-6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 39.5μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNWKKILGKIIKVVK{ct:Amid} | LL-III | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 >200μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNWKKSLGKSIKVVK{ct:Amid} | LL-IIIs-1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 = 31.3μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNWKKILGKSIKVSK{ct:Amid} | LL-IIIs-2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 = 69μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VSWKKSLGKIIKVVK{ct:Amid} | LL-IIIs-3 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 = 30μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNSKKISGKSIKVSK{ct:Amid} | LL-IIIs-4 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 >100μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNRKKILGKSIKVVK{ct:Amid} | LL-IIIs-5 cis | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 = 100μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNRKKILGKSIKVVK{ct:Amid} | LL-IIIs-5 trans | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 >100μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNSKKISPKSIKVSK{ct:Amid} | LL-IIIs-6a | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 >100μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNSKKISPKSIKVSK{ct:Amid} | LL-IIIs-6b | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 = 82μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22578463 | 2012 | QLKVDLWGTRSGIQPEQHSSGKSDVRRWRSRY{ct:Amid} | Ixosin-B-amide | Amidation | Free | Linear | L | None | 32 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Ixosin-B-amide | NA | Non-hemolytic | ||
| 22578463 | 2012 | KSLVRRWRSRW{ct:Amid} | MAP-04-01 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Amide analogs of Ixosin-B | NA | Non-hemolytic | ||
| 22578463 | 2012 | KSLRRVWRSWR{ct:Amid} | MAP-04-02 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Amide analogs of Ixosin-B | NA | Non-hemolytic | ||
| 22578463 | 2012 | KWLRRVWRWWR{ct:Amid} | MAP-04-03 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 100% hemolytic at 100μM | Human | Amide analogs of Ixosin-B | NA | NA | ||
| 22578463 | 2012 | KRLRRVWRRWR{ct:Amid} | MAP-04-04 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3% hemolytic at 100μM | Human | Amide analogs of Ixosin-B | NA | NA | ||
| 22581068 | 2012 | SAVGRHGRRFGLRKHRKH | Chensinin-1 | Free | Free | Linear | L | None | 18 | Antimicrobial | LD50 >500 μM | Human | Skin of Rana chensinensis | NA | NA | ||
| 19635451 | 2010 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100% hemolytic at 0.4μM & 23μM | Human | Melittin (Honey bee) | NA | NA | ||
| 19635451 | 2010 | GIGAVLKVLALISWIKRKR{ct:Amid} | Mel-H | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 28% hemolytic at 0.4μM | Human | Melittin analog (Honey bee) | NA | NA | ||
| 19635451 | 2010 | GIGAVLKVLALISWIKRKR{ct:Amid} | Mel-H | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 42% hemolytic at 23μM | Human | Melittin analog (Honey bee) | NA | NA | ||
| 19635451 | 2010 | GIGA{d}VLK{d}VLA{d}LISWI{d}KRKR{ct:Amid} | Mel-dH | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | 5% hemolysis at 0.4μM | Human | Melittin diastereomeric analog (Honey bee) | NA | NA | ||
| 19635451 | 2010 | GIGA{d}VLK{d}VLA{d}LISWI{d}KRKR{ct:Amid} | Mel-dH | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | 12% hemolytic at 23μM | Human | Melittin diastereomeric analog (Honey bee) | NA | NA | ||
| 20015460 | 2010 | GVIKSVLKGVAKTVALGML{ct:Amid} | B2-RP | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 = 280μM | Human | Brevinin-2-related peptides (Hylarana erythraea) | NA | NA | ||
| 20058937 | 2010 | KKL{d}L{d}KLLL{d}KL{d}LK{ct:Amid} | K5L7 | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKL{d}L{d}KLLL{d}KL{d}LK{nt:Acetylation (CH3(CH2)4CO)}{ct:Amid} | C6-K5L7 | Amidation | Acetylation (CH3(CH2)4CO) | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKL{d}L{d}KLLL{d}KL{d}LK{nt:Acetylation (CH3(CH2)6CO)}{ct:Amid} | C8-K5L7 | Amidation | Acetylation (CH3(CH2)6CO) | Linear | Mix | None | 12 | Antimicrobial | 19% hemolytic at 100μM | Human | Synthetic peptides | NA | NA | ||
| 20058937 | 2010 | KKL{d}L{d}KKLK{d}KL{d}LK{ct:Amid} | K7L5 | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKL{d}L{d}KKLK{d}KL{d}LK{nt:Acetylation (CH3(CH2)4CO)}{ct:Amid} | C6-K7L5 | Amidation | Acetylation (CH3(CH2)4CO) | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKL{d}L{d}KKLK{d}KL{d}LK{nt:Acetylation (CH3(CH2)6CO)}{ct:Amid} | C8-K7L5 | Amidation | Acetylation (CH3(CH2)6CO) | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKK{d}L{d}KKLK{d}KK{d}LK{ct:Amid} | K9L3 | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKK{d}L{d}KKLK{d}KK{d}LK{nt:Acetylation (CH3(CH2)4CO)}{ct:Amid} | C6-K9L3 | Amidation | Acetylation (CH3(CH2)4CO) | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKK{d}L{d}KKLK{d}KK{d}LK{nt:Acetylation (CH3(CH2)6CO)}{ct:Amid} | C8-K9L3 | Amidation | Acetylation (CH3(CH2)6CO) | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20798581 | 2010 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 7% hemolytic at 100μM | Human | Pleurocidin (Pleuronectes americanus) | NA | NA | ||
| 20798581 | 2010 | SFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple (4-25) | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolytoc at 100μM (non-hemolytic) | Human | Pleurocidin (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 20798581 | 2010 | KKAAHVGKHVGKAALTHYL{ct:Amid} | Ple (7-25) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Pleurocidin (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 20798581 | 2010 | GWGSFFKKAAHVGKHVGKAALT{ct:Amid} | Ple (1-22) | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | Pleurocidin (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 20798581 | 2010 | GWGSFFKKAAHVGKHVGKA{ct:Amid} | Ple (1-19) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Pleurocidin (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 20848624 | 2010 | F{d}PV{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antimicrobial | HC50=17.5±1.07μM | Human | Gramicidin S | NA | NA | ||
| 20848624 | 2010 | F{d}PV{nnr:O}LF{d}P-{nnr:Ada}-G{nnr:O}L{cyc:N-C} | GS2 | Free | Free | Cyclic | Mix | O = L-Ornithine, Ada = Adamantylglycine | 10 | Antimicrobial | HC50=10.1±1.11μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}PV{nnr:O}LF{d}PV{nnr:O}-{nnr:Ada}-A{cyc:N-C} | GS4 | Free | Free | Cyclic | Mix | O = L-Ornithine, Ada = Adamantylglycine | 10 | Antimicrobial | HC50 =5.20±1.13μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}PV{nnr:O}-{nnr:Ada}-AF{d}PV{nnr:O}-{nnr:Ada}-A{cyc:N-C} | GS5 | Free | Free | Cyclic | Mix | O = L-Ornithine, Ada = Adamantylglycine | 10 | Antimicrobial | HC50 =10.3±1.07μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}P-{nnr:Ada}-G{nnr:O}-{nnr:Ada}-AF{d}P-{nnr:Ada}-G{nnr:O}-{nnr:Ada}-A{cyc:N-C} | GS6 | Free | Free | Cyclic | Mix | O = L-Ornithine, Ada = Adamantylglycine | 10 | Antimicrobial | HC50 =7.55±1.10μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | FP-{nnr:tBuGly}-{nnr:O}-{nnr:tBuAla}-F{d}P-{nnr:tBuGly}-{nnr:O}-{nnr:tBuAla}{cyc:N-C} | GS7 | Free | Free | Cyclic | Mix | O = L-Ornithine, tBuGly = tert-butylglycine, tBuAla = tert-butylalanine | 10 | Antimicrobial | HC50 =9.30±1.07μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}P-{nnr:Chg}-{nnr:O}-{nnr:Cha}-F{d}P-{nnr:Chg}-{nnr:O}-{nnr:Cha}{cyc:N-C} | GS8 | Free | Free | Cyclic | Mix | O = L-Ornithine, Chg = Cyclohexylglycine, Cha = Cyclohexylalanine | 10 | Antimicrobial | HC50 =9.12±1.13μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}P{nnr:O}V{nnr:O}{cyc:N-C} | GS9 | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antimicrobial | Non-hemolytic | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}P{nnr:O}-{nnr:Ada}Gly-{nnr:O}F{d}P{nnr:O}-{nnr:Ada}-Gly-{nnr:O}{cyc:N-C} | GS10 | Free | Free | Cyclic | Mix | O = L-Ornithine, Ada = Adamantylglycine | 10 | Antimicrobial | HC50=107±1.07μM | Human | Gramicidin S analogue | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D1 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 421.5μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D2 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 83μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D3 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 14μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}L{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D4 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 3.5μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}K{d}L{d}H{d}T{d}L{d}L{d}K{d}L{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D5 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 47μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | LLGDEFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid} | L-LL37 | Amidation | Free | Linear | L | None | 37 | Antimicrobial | HC50 = 43.5μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | L{d}L{d}G{d}D{d}E{d}F{d}R{d}K{d}S{d}K{d}E{d}K{d}I{d}G{d}K{d}E{d}F{d}K{d}R{d}I{d}V{d}Q{d}R{d}I{d}K{d}D{d}F{d}L{d}R{d}N{d}L{d}V{d}P{d}R{d}T{d}E{d}S{d} | D-LL37 | Free | Free | Linear | D | None | 37 | Antimicrobial | HC50 = 125μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 13.2% hemolytic at 31.5μM | Human | Novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 9.1% hemolytic at 15.7μM | Human | Novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 6.3% hemolytic at 6.30μM | Human | Novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 3.6% hemolytic at 3.15μM | Human | Novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus | NA | NA | ||
| 21110126 | 2011 | FLGWLFKWASK{ct:Amid} | GA-W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =25μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FLGWLFKWAWK{ct:Amid} | GA-W3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =50 μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FLWWLFKWAWK{ct:Amid} | GA-W4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =25μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FLGWLFKWAKK{ct:Amid} | GA-K3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =50μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FLKWLFKWAKK{ct:Amid} | GA-K4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =6.3μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FLKWLFKWLKK{ct:Amid} | GA-K4L | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =12.5μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FAKWAFKWAKK{ct:Amid} | GA-K4A | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC >200μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FAKWAFKWLKK{ct:Amid} | GA-K4AL | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC >200μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}V{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D1 (V13) | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =1.8μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D1 (K13) | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 140.9μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}V{d}L{d}K{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid} | D11 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 254.1μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid} | D22 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =81.3μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid} | D14 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =351.5μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}L{d}L{d}K{d}T{d}A{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D15 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =169.6μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D16 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =1342.0μM | Human | Synthetic peptides | NA | NA | ||
| 21300831 | 2011 | GKKLLKKLKKLLKKG{nt:Acet}{ct:Amid} | Pep-1 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 0.3% hemolytic at 3.4mg/ml | Human | Synthetic peptides | NA | NA | ||
| 21300831 | 2011 | GKKL{d}L{d}KKL{d}KKL{d}L{d}KKG{nt:Acet}{ct:Amid} | MA-d | Amidation | Acetylation | Linear | Mix | None | 15 | Antimicrobial | 1% hemolytic at 3.4mg/ml | Human | Synthetic peptides | NA | NA | ||
| 21300831 | 2011 | GKKLLKKLKKLLKKW{nt:Acet}{ct:Amid} | MAw-1 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 17% hemolytic at 3.4mg/ml | Human | Synthetic peptides | NA | NA | ||
| 21300831 | 2011 | GKKLLKKLKKLWKKW{nt:Acet}{ct:Amid} | Maw-2 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 18% hemolytic at 3.4mg/ml | Human | Synthetic peptides | NA | NA | ||
| 21300831 | 2011 | GKKLLKKWKKLWKKW{nt:Acet}{ct:Amid} | Maw-3 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 5% hemolytic at 3.4mg/ml | Human | Synthetic peptides | NA | NA | ||
| 21319749 | 2011 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 48% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | LLQWLSKLLGRLL{ct:Amid} | TL-1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 25% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | LLQWLSKLLGRWL{ct:Amid} | TL-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 78% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVQWFSKFLLRIL{ct:Amid} | [Leu10]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 80% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TLb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FLPWFSKFLGRIL{ct:Amid} | [Leu2, Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 19% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVPWFSKFLPRIL{ct:Amid} | [Pro3, Pro10]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.5% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVPWFSKFLP{d}RIL{ct:Amid} | [Pro3, DPro10]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 0.6% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVQWFSKFLGKIL{ct:Amid} | [Lys11]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 14% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVQWFSKFLG{nnr:O}IL{ct:Amid} | [Orn11]TL | Amidation | Free | Linear | L | O = L-Ornithine | 13 | Antimicrobial | 22% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVQWFSRFLGRIL{ct:Amid} | [Arg7]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 29% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVRWFSKFLGRIL{ct:Amid} | [Arg3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 52% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVRWFSRFLGRIL{ct:Amid} | [Arg3, Arg7]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 43% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVPWFSKFLGOIL{ct:Amid} | [Pro3, Orn11]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 2% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | F{d}V{d}Q{d}W{d}F{d}S{d}K{d}F{d}L{d}GR{d}I{d}L{d}{ct:Amid} | D-TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 46% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | L{d}I{d}R{d}GL{d}F{d}K{d}S{d}F{d}W{d}Q{d}V{d}F{d}{ct:Amid} | RI-TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 15% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21335383 | 2011 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 54 ±0.1% hemolytic at 250μM | Human | Synthetic peptide | NA | NA | ||
| 21335383 | 2011 | KKLFKKILKY{d}L{ct:Amid} | BP138 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 7 ±0.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKILKYL{d}{ct:Amid} | BP139 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 23 ±0.9% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKILK{d}YL{ct:Amid} | BP140 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 0± 0% hemolytic at 250μM (non-hemolytic) | Human | Synthetic peptide of BP100 | NA | Non-hemolytic | ||
| 21335383 | 2011 | KKLFKKIL{d}KYL{ct:Amid} | BP141 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 4 ±0.3% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFK{d}KILKYL{ct:Amid} | BP142 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 3± 0.6% hemolysis at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 5± 0.8% hemolysis at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKL{d}FKKILKYL{ct:Amid} | BP144 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 7±0.4% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KK{d}LFKKILKYL{ct:Amid} | BP145 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 51±0.5% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKK{d}ILKYL{ct:Amid} | BP146 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 53 ±1.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}KLFKKILKYL{ct:Amid} | BP147 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 71±0.4% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKI{d}LKYL{ct:Amid} | BP148 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 0±0% hemolytic at 250μM (non-hemolytic) | Human | Synthetic peptide of BP100 | NA | Non-hemolytic | ||
| 21335383 | 2011 | KKL{d}FKKILK{d}YL{ct:Amid} | BP149 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 0±0% hemolytic at 250μM (non-hemolytic) | Human | Synthetic peptide of BP100 | NA | Non-hemolytic | ||
| 21335383 | 2011 | KKLFKKIL{d}K{d}YL{ct:Amid} | BP150 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 1±0.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KK{d}L{d}FKK{d}ILK{d}YL{ct:Amid} | BP151 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 1±0.3% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKI{d}L{d}K{d}YL{ct:Amid} | BP152 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 5±1.6% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}LF{d}KKILKYL{ct:Amid} | BP154 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 41±6.2% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKIL{d}K{d}Y{d}L{d}{ct:Amid} | BP155 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 3±0.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKL{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP156 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 49±1.2% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKK{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP157 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 3±1.0% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFK{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP158 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 28±2.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLF{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP159 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 58±5.7% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KK{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP160 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 65±1.9% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KK{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP161 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 66±2.9% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}KKILKYL{ct:Amid} | BP162 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 17±0.7% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}KILKYL{ct:Amid} | BP163 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 8±5.0% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}ILKYL{ct:Amid} | BP164 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 0±0% hemolytic at 250μM (non-hemolytic) | Human | Synthetic peptide of BP100 | NA | Non-hemolytic | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}LKYL{ct:Amid} | BP165 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 6 ±0.2% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}KYL{ct:Amid} | BP166 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 1±0.2% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}YL{ct:Amid} | BP167 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 21±7.4% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{ct:Amid} | BP168 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 3±2.7% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP153 | Amidation | Free | Linear | D | None | 11 | Antimicrobial | 50±2.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGIL{ct:Amid} | 1Ta | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 27.5% hemolytic at 40μM | Human | Temporin-1Ta (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGIL{ct:Amid} | 1Ta | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.5% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | ALPLIGRVLSGIL{ct:Amid} | Ta A1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 62.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | ALPLIGRVLSGIL{ct:Amid} | Ta A1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 2% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FAPLIGRVLSGIL{ct:Amid} | Ta A2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 15% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FAPLIGRVLSGIL{ct:Amid} | Ta A2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLALIGRVLSGIL{ct:Amid} | Ta A3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLALIGRVLSGIL{ct:Amid} | Ta A3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPAIGRVLSGIL{ct:Amid} | Ta A4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 11.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPAIGRVLSGIL{ct:Amid} | Ta A4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 2% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLAGRVLSGIL{ct:Amid} | Ta A5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLAGRVLSGIL{ct:Amid} | Ta A5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIARVLSGIL{ct:Amid} | Ta A6 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 97% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIARVLSGIL{ct:Amid} | Ta A6 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGAVLSGIL{ct:Amid} | Ta A7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 39% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGAVLSGIL{ct:Amid} | Ta A7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 6% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRALSGIL{ct:Amid} | Ta A8 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRALSGIL{ct:Amid} | Ta A8 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.5% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVASGIL{ct:Amid} | Ta A9 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVASGIL{ct:Amid} | Ta A9 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLAGIL{ct:Amid} | Ta A10 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 70% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLAGIL{ct:Amid} | Ta A10 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSAIL{ct:Amid} | Ta A11 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSAIL{ct:Amid} | Ta A11 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.5% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGAL{ct:Amid} | Ta A12 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGAL{ct:Amid} | Ta A12 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGIA{ct:Amid} | Ta A13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGIA{ct:Amid} | Ta A13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21355570 | 2011 | FFRHLFRGAKAIFRGARQGXRAHKVVSRYRNRDVPETDNNQEEP | Piscidin 4 | Free | Free | Linear | L | None | 44 | Antimicrobial | ~1.4% hemolytic at 100μg/ml | Human | Piscidin 4 derived from mast cells of hybrid striped bass | NA | NA | ||
| 21607695 | 2011 | FKCRRWQWRMKKLGAPSITCVRRAF | LfcinB (C–C) | Free | Free | Linear | L | None | 25 | Antimicrobial | ~7% hemolytic at 256mg/ml | Pig | Synthetic peptide derived from bovine lactoferricin | NA | NA | ||
| 21607695 | 2011 | FKCRRWQWRMKKLGAPSITCVRRAF | LfcinB | Free | Free | Linear | L | None | 25 | Antimicrobial | <10% hemolytic at 256mg/ml | Pig | Synthetic peptide derived from bovine lactoferricin | NA | NA | ||
| 21607695 | 2011 | FKCRRWQWRMKKLGA | LfcinB15 | Free | Free | Linear | L | None | 15 | Antimicrobial | >7% hemolytic at 256mg/ml | Pig | Synthetic peptide derived from bovine lactoferricin | NA | NA | ||
| 21607695 | 2011 | RRWQWRMKKLG | LfcinB11 | Free | Free | Linear | L | None | 11 | Antimicrobial | ~6% hemolytic at 256mg/ml | Pig | Synthetic peptide derived from bovine lactoferricin | NA | NA | ||
| 21607695 | 2011 | RRWQWRMKK | LfcinB9 | Free | Free | Linear | L | None | 9 | Antimicrobial | <5% hemolytic at 256mg/ml | Pig | Synthetic peptide derived from bovine lactoferricin | NA | NA | ||
| 21820306 | 2011 | {nnr:tle}-K-{nnr:tle}-A-{nnr:tle}-A-{nnr:tle}-A{cyc:N-C} | A | Free | Free | Cyclic | Mix | tle = D-Tert-leucine | 8 | Antimicrobial | HC50 =17μM | Human | Synthetic peptides | NA | NA | ||
| 21820306 | 2011 | {nnr:Tle}-K{d}-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}{cyc:N-C} | B | Free | Free | Cyclic | Mix | Tle = Tert-leucine | 8 | Antimicrobial | HC50 =17μM | Human | Synthetic peptides | NA | NA | ||
| 21820306 | 2011 | {nnr:tle}-K{d}-{nnr:tle}-A-{nnr:tle}-A-{nnr:tle}-A{cyc:N-C} | C | Free | Free | Cyclic | Mix | tle = D-Tert-leucine | 8 | Antimicrobial | HC50 =316μM | Human | Synthetic peptides | NA | NA | ||
| 21820306 | 2011 | {nnr:Tle}-K-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}{cyc:N-C} | D | Free | Free | Cyclic | Mix | Tle = Tert-leucine | 8 | Antimicrobial | HC50 =316μM | Human | Synthetic peptides | NA | NA | ||
| 21955251 | 2011 | GIIKKI{ct:Amid} | G(IIKK)I | Amidation | Free | Linear | L | None | 6 | Antimicrobial and Antitumor | Non-hemolytic up to 250 μM | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 21955251 | 2011 | GIIKKIIKKI{ct:Amid} | G(IIKK)2I | Amidation | Free | Linear | L | None | 10 | Antimicrobial and Antitumor | Non-hemolytic up to 250 μM | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 21955251 | 2011 | GIIKKIIKKIIKKI{ct:Amid} | G(IIKK)3I | Amidation | Free | Linear | L | None | 14 | Antimicrobial and Antitumor | EC50 >250μM | Human | Synthetic peptides | NA | NA | ||
| 21955251 | 2011 | GIIKKIIKKIIKKIIKKI{ct:Amid} | G(IIKK)4I | Amidation | Free | Linear | L | None | 18 | Antimicrobial and Antitumor | EC50 = 41±2μM | Human | Synthetic peptides | NA | NA | ||
| 21956793 | 2011 | LLIILRRRIRKQAHAHSK{ct:Amid} | pVEC | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILRRRWRKQARARSK{ct:Amid} | pVEC-a1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILRRRWRKQAKAKSK{ct:Amid} | pVEC-a2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILRRRWRRQARARSR{ct:Amid} | pVEC-a3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 94μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILKKKWKKQAKAKSK{ct:Amid} | pVEC-a4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21968924 | 2011 | GRPNPVNNKPT{nnr:*}PHPRL | formaecin I | Free | Free | Linear | L | * = α-GalNAc | 16 | Antimicrobial | <5% hemolytic at 100 μM | Rat | Synthetic peptides | NA | NA | ||
| 21968924 | 2011 | GRPNPVNNKPTPHPRL | Non-glycosylated formaecin I | Free | Free | Linear | L | None | 16 | Antimicrobial | <5% hemolytic at 100 μM | Rat | non-glycosylated analogs of native formaecin I | NA | NA | ||
| 21968924 | 2011 | GKPRPYSPRPT{nnr:*}SHPRPIRV | M-drosocin | Free | Free | Linear | L | * = α-GalNAc | 19 | Antimicrobial | <5% hemolytic at 100 μM | Rat | Synthetic peptides | NA | NA | ||
| 21968924 | 2011 | GKPRPYSPRPTSHPRPIRV | Non-glycosylated M-drosocin | Free | Free | Linear | L | None | 19 | Antimicrobial | <5% hemolytic at 100 μM | Rat | non-glycosylated analogs of native M-drosocin | NA | NA | ||
| 22040603 | 2011 | GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR | Crp4-wt | Free | Free | Linear | L | None | 32 | Antimicrobial | 4.2% hemolytic at 0μg/ml | Human | Synthetic peptide of Crp4 | NA | NA | ||
| 22040603 | 2011 | GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR | Crp4-wt | Free | Free | Linear | L | None | 32 | Antimicrobial | 4.1% hemolytic at 12.5μg/ml | Human | Synthetic peptide of Crp4 | NA | NA | ||
| 22040603 | 2011 | GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR | Crp4-wt | Free | Free | Linear | L | None | 32 | Antimicrobial | 3.4% hemolytic at 25μg/ml | Human | Synthetic peptide of Crp4 | NA | NA | ||
| 22040603 | 2011 | GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR | Crp4-wt | Free | Free | Linear | L | None | 32 | Antimicrobial | 3.0% hemolytic at 50μg/ml | Human | Synthetic peptide of Crp4 | NA | NA | ||
| 22040603 | 2011 | GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR | Crp4-wt | Free | Free | Linear | L | None | 32 | Antimicrobial | 3.1% hemolytic at 100 μ g/mL | Human | Synthetic peptide of Crp4 | NA | NA | ||
| 22040603 | 2011 | CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL{cyc:N-C} | Crp4-1 | Free | Free | Cyclic | L | None | 32 | Antimicrobial | 4.2% hemolytic at 0μg/ml | Human | Synthetic peptide of Crp4 | NA | NA | ||
| 22040603 | 2011 | CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL{cyc:N-C} | Crp4-1 | Free | Free | Cyclic | L | None | 32 | Antimicrobial | 5.4% hemolytic at 12.5μg/ml | Human | Synthetic peptide of Crp4 | NA | NA | ||
| 22040603 | 2011 | CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL{cyc:N-C} | Crp4-1 | Free | Free | Cyclic | L | None | 32 | Antimicrobial | 5.8% hemolytic at 25μg/ml | Human | Synthetic peptide of Crp4 | NA | NA | ||
| 22040603 | 2011 | CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL{cyc:N-C} | Crp4-1 | Free | Free | Cyclic | L | None | 32 | Antimicrobial | 5.9% hemolytic at 50μg/ml | Human | Synthetic peptide of Crp4 | NA | NA | ||
| 22040603 | 2011 | CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL{cyc:N-C} | Crp4-1 | Free | Free | Cyclic | L | None | 32 | Antimicrobial | 4.9% hemolytic at 100 μ g/mL | Human | Synthetic peptide of Crp4 | NA | NA | ||
| 22082130 | 2011 | KLAKKLAKLAKLAKAL | Modelin-5-COOH | Free | Free | Linear | L | None | 16 | Antimicrobial | ~1% hemolytic at 300μM | Pig | Synthetic peptide of Modelin-5 | NA | NA | ||
| 22082130 | 2011 | KLAKKLAKLAKLAKAL{ct:Amid} | Modelin-5-CONH2 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <2% hemolytic at 300μM | Pig | Synthetic peptide of Modelin-5 | NA | NA | ||
| 22189867 | 2012 | FKCRRWQWRWKKLGAKPVPIIYCNRRTGKCQRM | LFT33 | Free | Free | Linear | L | None | 33 | Antimicrobial | Non-hemolytic upto 256 μg/ml | Human | Novel hybrid peptide of LfcinB & thanatin | NA | Non-hemolytic | ||
| 20927512 | 2011 | MSVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK | Tmp1 | Free | Free | Linear | L | None | 34 | Antimicrobial | Non-hemolytic | Sheep | Holin-like protein Tmp1derived from goat skin surface metagenome | NA | Non-hemolytic | ||
| 20927512 | 2011 | LGFGTFVLMLLGLVVELIK | TMDSP | Free | Free | Linear | L | None | 19 | Antimicrobial | Mild hemolytic at 50 μM | Sheep | Mutants of holin-like protein Tmp1 | NA | NA | ||
| 20927512 | 2011 | MLSVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1RM1 | Free | Free | Linear | L | None | 35 | Antimicrobial | Non-hemolytic | Sheep | Mutants of holin-like protein Tmp1 | NA | Non-hemolytic | ||
| 20927512 | 2011 | MVSVSVAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1RM2 | Free | Free | Linear | L | None | 35 | Antimicrobial | Non-hemolytic | Sheep | Mutants of holin-like protein Tmp1 | NA | Non-hemolytic | ||
| 20927512 | 2011 | MESVSVAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1RM3 | Free | Free | Linear | L | None | 35 | Antimicrobial | Non-hemolytic | Sheep | Mutants of holin-like protein Tmp1 | NA | Non-hemolytic | ||
| 20927512 | 2011 | MLSLSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1RM4 | Free | Free | Linear | L | None | 35 | Antimicrobial | Non-hemolytic | Sheep | Mutants of holin-like protein Tmp1 | NA | Non-hemolytic | ||
| 20927512 | 2011 | MESVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1SDM1 | Free | Free | Linear | L | None | 35 | Antimicrobial | Non-hemolytic | Sheep | Mutants of holin-like protein Tmp1 | NA | Non-hemolytic | ||
| 20927512 | 2011 | MESQSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1SDM2 | Free | Free | Linear | L | None | 35 | Antimicrobial | Non-hemolytic | Sheep | Mutants of holin-like protein Tmp1 | NA | Non-hemolytic | ||
| 20927512 | 2011 | MESQSNAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1SDM3 | Free | Free | Linear | L | None | 35 | Antimicrobial | Non-hemolytic | Sheep | Mutants of holin-like protein Tmp1 | NA | Non-hemolytic | ||
| 21762675 | 2011 | ELLKAVRLIK | Rev–NIS | Free | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolytic upto 100μM (non-hemolytic) | Human | Rev–NIS (HIV) | NA | Non-hemolytic | ||
| 21762675 | 2011 | RLRKAVRLIK | Anal R | Free | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolytic upto 100μM (non-hemolytic) | Human | Rev–NIS analog (HIV) | α helix | Non-hemolytic | ||
| 21762675 | 2011 | ELSKAVRLIK | Anal S | Free | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolytic upto 100μM (non-hemolytic) | Human | Rev–NIS analog (HIV) | α helix | Non-hemolytic | ||
| 21462284 | 2011 | WKWKWK | Normal-(WK)3 | Free | Free | Linear | L | None | 6 | Antimicrobial | 0% hemolytic upto 400μM | Human | Synthetic peptides | NA | NA | ||
| 21462284 | 2011 | WKWKWK | Normal-(WK)3 | Free | Free | Linear | L | None | 6 | Antimicrobial | ~10% hemolytic at 600μM | Human | Synthetic peptides | NA | NA | ||
| 21462284 | 2011 | KWKWKW | Reversed-(KW)3 | Free | Free | Linear | L | None | 6 | Antimicrobial | 0% hemolytic upto 400μM | Human | Synthetic peptides | NA | NA | ||
| 21462284 | 2011 | KWKWKW | Reversed-(KW)3 | Free | Free | Linear | L | None | 6 | Antimicrobial | ~10% hemolytic at 600μM | Human | Synthetic peptides | NA | NA | ||
| 22029824 | 2012 | FIFPKKNIINSLFGR | Andersonin-D1 | Free | Free | Linear | L | None | 15 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 22029824 | 2012 | KEKLKLKCKAPKCYNDKLACT | Andersonin-G1 | Free | Free | Linear | L | None | 21 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 22029824 | 2012 | ENMFNIKSSVESDSFWG | Andersonin-N1 | Free | Free | Linear | L | None | 17 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 22029824 | 2012 | EMLKKKEVKMERKT | Andersonin-Q1 | Free | Free | Linear | L | None | 14 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 22029824 | 2012 | ENAEEDIVLMENLFCSYIVGSADSFWT | Andersonin-R1 | Free | Free | Linear | L | None | 27 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 22029824 | 2012 | DANVENGEDAEDLTDKFIGLMG | Andersonin-S1 | Free | Free | Linear | L | None | 22 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 19038369 | 2009 | ILPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID | Amidation | Free | Cyclic | L | None | 13 | Antimicrobial | 5-10% hemolysis at 25μg/mL | Human | Cytoplasmic granules of bovine neutrophils | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID-I | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 5-10% hemolysis at 25μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-W | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 5-10% hemolysis at 25μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-IW | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 5% hemolysis at 25μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID | Amidation | Free | Cyclic | L | None | 13 | Antimicrobial | 10% hemolysis at 50μg/mL | Human | Cytoplasmic granules of bovine neutrophils | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID-I | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 10% hemolysis at 50μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-W | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 10% hemolysis at 50μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-IW | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 5% hemolysis at 50μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID | Amidation | Free | Cyclic | L | None | 13 | Antimicrobial | 10% hemolysis at 100μg/mL | Human | Cytoplasmic granules of bovine neutrophils | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID-I | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 10-15% hemolysis at 100μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-W | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 10-15% hemolysis at 100μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-IW | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 10% hemolysis at 100μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID | Amidation | Free | Cyclic | L | None | 13 | Antimicrobial | 30% hemolysis at 200μg/mL | Human | Cytoplasmic granules of bovine neutrophils | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID-I | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 30% hemolysis at 200μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-W | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 30% hemolysis at 200μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-IW | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | ~10% hemolysis at 200μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR | Gr-1L(25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 20-30% hemolysis at 50μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR{cyc:N-C} | Gr-1C(25-50) | Free | Free | Cyclic | L | None | 26 | Antimicrobial | 20-30% hemolysis at 50μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVARTGRSRWRDVARNFMR | Gr-2 (25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 20-30% hemolysis at 50μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SRWRDVARNFMRRYQSRVIQGLVA | Gr-3 (39-62) | Free | Free | Linear | L | None | 24 | Antimicrobial | 90% hemolysis at 50μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR | Gr-1L(25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 40-50% hemolysis at 100μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR{cyc:N-C} | Gr-1C(25-50) | Free | Free | Cyclic | L | None | 26 | Antimicrobial | 40-50% hemolysis at 100μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVARTGRSRWRDVARNFMR | Gr-2 (25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 40-50% hemolysis at 100μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SRWRDVARNFMRRYQSRVIQGLVA | Gr-3 (39-62) | Free | Free | Linear | L | None | 24 | Antimicrobial | 100% hemolysis at 100μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR | Gr-1L(25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 80-85% hemolysis at 200μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR{cyc:N-C} | Gr-1C(25-50) | Free | Free | Cyclic | L | None | 26 | Antimicrobial | 70% hemolysis at 200μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVARTGRSRWRDVARNFMR | Gr-2 (25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 90% hemolysis at 200μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SRWRDVARNFMRRYQSRVIQGLVA | Gr-3 (39-62) | Free | Free | Linear | L | None | 24 | Antimicrobial | 100% hemolysis at 200μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 20363271 | 2010 | KLKKLL{d}KKWLKL{d}LKKLLK{d}{ct:Amid} | K9L8W | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HC50 =14μM | Human | Synthetic peptide | α-helical | NA | ||
| 20363271 | 2010 | KLKKLL{d}KKWLKL{d}LKKLLK{d}{ct:Amid} | D3-K9L8W-1 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =150μM | Human | Synthetic peptide | Random coil | NA | ||
| 20363271 | 2010 | KLKKL{d}LKKWL{d}KLLKK{d}LLK{ct:Amid} | D3-K9L8W-2 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =116μM | Human | Synthetic peptide | Random coil | NA | ||
| 20363271 | 2010 | KLKK{d}LLKK{d}WLKL{d}LKKL{d}LK{ct:Amid} | D4-K9L8W | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =800μM | Human | Synthetic peptide | Random coil | NA | ||
| 20363271 | 2010 | KL{d}K{d}KLL{d}KKW{d}LKL{d}LKK{d}LLK{d}{ct:Amid} | D6-K9L8W | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =800μM | Human | Synthetic peptide | Random coil | NA | ||
| 20363271 | 2010 | KL{d}KK{d}LL{d}KK{d}WL{d}KL{d}LK{d}KL{d}LK{d}{ct:Amid} | D9-K9L8W-1 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =800μM | Human | Synthetic peptide | Random coil | NA | ||
| 20363271 | 2010 | KLKKLLKKWL{d}K{d}L{d}L{d}K{d}K{d}L{d}L{d}K{d}{ct:Amid} | D9-K9L8W-2 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =154μM | Human | Synthetic peptide | Random coil | NA | ||
| 20399752 | 2010 | KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF | NA-CATH | Free | Free | Linear | L | None | 34 | Antimicrobial | EC50 =0.37μM | Human | Naja atra (cathelicidin) | α-helical | NA | ||
| 20399752 | 2010 | KRFKKFFKKLK{ct:Amid} | ATRA-1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | EC50 =5.98μM | Human | Naja atra analog | α-helical | NA | ||
| 20399752 | 2010 | KRAKKFFKKPK{ct:Amid} | ATRA-2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | EC50 =107μM | Human | Naja atra analog | α-helical | NA | ||
| 20399752 | 2010 | KRAKKFFKKLK{ct:Amid} | ATRA-1A | Amidation | Free | Linear | L | None | 11 | Antimicrobial | EC50 =7.98μM | Human | Naja atra analog | α-helical | NA | ||
| 20399752 | 2010 | KRFKKFFKKPK{ct:Amid} | ATRA-1P | Amidation | Free | Linear | L | None | 11 | Antimicrobial | EC50 =95.92μM | Human | Naja atra analog | α-helical | NA | ||
| 20399752 | 2010 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | EC50 =0.05μM | Human | cathelicidin | α-helical | NA | ||
| 20457198 | 2010 | DVNDLKNLCAKTHNLLPMCAMFGKK | DK25 | Free | Free | Linear | L | None | 25 | Antimicrobial | no hemolysis upto <400μM | Human | Rana tagoi okiensis | NA | Non-hemolytic | ||
| 20457198 | 2010 | DVNDLKNLCAKTHNLLPMCAMF{ct:Amid} | DF-22-amide | Amidation | Free | Linear | L | None | 22 | Antimicrobial | no hemolysis upto <400μM | Human | Rana tagoi okiensis | NA | Non-hemolytic | ||
| 20466006 | 2010 | YVPPVQKPHPNGPKFPTFP | PP30 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 125μM | Human | Pteromalus puparum cDNA clone (synthetic peptide) | Random coil | NA | ||
| 20466006 | 2010 | YVPPVQKPHPNGPKFPTFP | PP30 | Free | Free | Linear | L | None | 19 | Antimicrobial | 3.8% hemolysis at 250μM | Human | Pteromalus puparum cDNA clone (synthetic peptide) | Random coil | NA | ||
| 20472009 | 2010 | GIGAVLKVLSTGLPALISWIKRKRQQ | melittin-S | Free | Free | Linear | L | None | 26 | Antimicrobial | 35% hemolysis at | Human | Melittin isoform | α-helical | NA | ||
| 20493915 | 2010 | RWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI | ABP-CM4 | Free | Free | Linear | L | None | 35 | Antimicrobial and Cytotoxic | 0% hemolysis at 200μM | Human | Bombyx mori | α-helical | NA | ||
| 20493915 | 2010 | RWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI | ABP-CM4 | Free | Free | Linear | L | None | 35 | Antimicrobial and Cytotoxic | 5% hemolysis at 400μM | Human | Bombyx mori | α-helical | NA | ||
| 20600431 | 2010 | GSKKPVPIIYCNRRSGKCQRM | S-thanatin | Free | Free | Linear | L | None | 21 | Antimicrobial | low hemolytic activity up to 400μg/ml | Human | Thanatin analog | β-sheet | Non-hemolytic | ||
| 20603168 | 2010 | GLKEIFKAGLGSLVKGIAAHVAS | Alyteserin-1c | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 =220μM | Human | Alytes obstetricans (Alyteserin-1c) | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLVKGIAAHVAS | E4K | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLVKGIAAHVAS | E4k | Free | Free | Linear | Mix | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKKIFKKGLGSLVKGIAAHVAS | E4K,A8K | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKKGLGSLVKGIAAHVAS | E4k,A8K | Free | Free | Linear | Mix | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLKKGIAAHVAS | E4K,V14K | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLKKGIAAHVAS | E4k,V14K | Free | Free | Linear | Mix | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLVKGIKAHVAS | E4K,A18K | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLVKGIKAHVAS | E4k,A18K | Free | Free | Linear | Mix | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKEIFKAGLGSLVKGIAAHVAS{nt:palmitate(pal)} | N-Pal,E4K | Free | palmitate(pal) | Linear | L | None | 23 | Antimicrobial | LC50 =10μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKKIFKAGLGSLVKGIK{nnr:*}AHVAS | E4K,Pal-A18K | Free | Free | Linear | L | * = palmitate(PAL) | 23 | Antimicrobial | LC50 =30μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20637182 | 2010 | FSPQMLQDIIEAATAIL | A17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200μg/ml | Mouse | K-17 analog | α-helical | Non-hemolytic | ||
| 20637182 | 2010 | FSPQMLQDIIEKKTKIL | K17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200μg/ml | Mouse | Beta-defensin gene | α-helical | Non-hemolytic | ||
| 20656059 | 2010 | GIGKFLHSAGKFGKAFLGEVMKS | Magainin-B2 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 200μM | Human | Xenopus borealis | NA | Non-hemolytic | ||
| 20656059 | 2010 | GMASKAGSIVGKIAKIALGAL{ct:Amid} | PGLa-B2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 27% hemolysis at 200μM | Human | Xenopus borealis | NA | NA | ||
| 20656059 | 2010 | GLGSLLGKAFKIGLKTVGKMMGGAPREQ | CPF-B1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 18% hemolysis at 200μM | Human | Xenopus borealis | NA | NA | ||
| 20736034 | 2011 | WLKKW{ct:Amid} | LK2W2 | Amidation | Free | Linear | L | None | 5 | Antimicrobial | negligible hemolysis at 320μg/ml | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 20736034 | 2011 | WLLKW{ct:Amid} | L2KW2 | Amidation | Free | Linear | L | None | 5 | Antimicrobial | negligible hemolysis at 320μg/ml | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 20736034 | 2011 | KWLKKWL{ct:Amid} | L2K3W2 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | negligible hemolysis at 320μg/ml | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 20736034 | 2011 | KWLLKWL{ct:Amid} | L3K2W2 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 0-5% hemolysis at 160μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | KKWLKKWLK{ct:Amid} | L2K5W2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | negligible hemolysis at 320μg/ml | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 20736034 | 2011 | LKWLKKWLK{ct:Amid} | L3K4W2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0% hemolysis at 160μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LKWLLKWLK{ct:Amid} | L4K3W2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10% hemolysis at 40μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LKWLLKWLL{ct:Amid} | L5K2W2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 60% hemolysis at 40μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LKKWLKKWLKK{ct:Amid} | L3K6W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | negligible hemolysis at 320μg/ml | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 20736034 | 2011 | LLKWLKKWLKK{ct:Amid} | L4K5W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0-5% hemolysis at 40μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLKK{ct:Amid} | L5K4W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 40-50% hemolysis at 40μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLLK{ct:Amid} | L6K3W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 55-60% hemolysis at 40μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | KWLLKWL{ct:Amid} | L3K2W2 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 10% hemolysis at 320μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LKWLKKWLK{ct:Amid} | L3K4W2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0-5% hemolysis at 320μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LKWLLKWLK{ct:Amid} | L4K3W2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 25% hemolysis at 80μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LKWLLKWLK{ct:Amid} | L4K3W2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 40-50% hemolysis at 160μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LKWLLKWLL{ct:Amid} | L5K2W2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 65% hemolysis at 80μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LKWLLKWLL{ct:Amid} | L5K2W2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 70% hemolysis at 160μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLKKWLKK{ct:Amid} | L4K5W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5% hemolysis at 80μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLKKWLKK{ct:Amid} | L4K5W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 10% hemolysis at 160μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLKK{ct:Amid} | L5K4W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50-60% hemolysis at 80μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLKK{ct:Amid} | L5K4W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 60-65% hemolysis at 160μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLLK{ct:Amid} | L6K3W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 60-70% hemolysis at 80μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLLK{ct:Amid} | L6K3W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 70-75% hemolysis at 160μg/ml | Human | Synthetic peptide | NA | NA | ||
| 21073979 | 2011 | GKLNLFLSRLEILKLFVGAL | Pelteobagrin | Free | Free | Linear | L | None | 20 | Antimicrobial | no hemolysis upto <400μg/ml | Rabbit | Pelteobagrus fulvidraco derived from skin mucus of yellow catfish | α-helical | Non-hemolytic | ||
| 21241661 | 2011 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 12.5μM | Human | Derived from coelomocytes of the marine polychaeta lugworm(Arenicola marina) | β-sheet | NA | ||
| 21241661 | 2011 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 12% hemolysis at 25μM | Human | Derived from coelomocytes of the marine polychaeta lugworm(Arenicola marina) | β-sheet | NA | ||
| 21241661 | 2011 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 35% hemolysis at 50μM | Human | Derived from coelomocytes of the marine polychaeta lugworm(Arenicola marina) | β-sheet | NA | ||
| 21241661 | 2011 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 51% hemolysis at 100μM | Human | Derived from coelomocytes of the marine polychaeta lugworm(Arenicola marina) | β-sheet | NA | ||
| 21241661 | 2011 | CVYAYVRVRGVLVRYRRCW | Arenicin-1(analog-1) | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 50μM | Human | Arenicin-1 analog | NA | NA | ||
| 21241661 | 2011 | CVYAYVRVRGVLVRYRRCW | Arenicin-1(analog-1) | Free | Free | Linear | L | None | 19 | Antimicrobial | 4% hemolysis at 100μM | Human | Arenicin-1 analog | NA | NA | ||
| 21241661 | 2011 | RWCVYAYVRVAGVLVRYRRCW | Arenicin-1(analog-2) | Free | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 12.5μM | Human | Arenicin-1 analog | NA | NA | ||
| 21241661 | 2011 | RWCVYAYVRVAGVLVRYRRCW | Arenicin-1(analog-2) | Free | Free | Linear | L | None | 21 | Antimicrobial | 7% hemolysis at 25μM | Human | Arenicin-1 analog | NA | NA | ||
| 21241661 | 2011 | RWCVYAYVRVAGVLVRYRRCW | Arenicin-1(analog-2) | Free | Free | Linear | L | None | 21 | Antimicrobial | 32% hemolysis at 50μM | Human | Arenicin-1 analog | NA | NA | ||
| 21241661 | 2011 | RWCVYAYVRVAGVLVRYRRCW | Arenicin-1(analog-2) | Free | Free | Linear | L | None | 21 | Antimicrobial | 45% hemolysis at 100μM | Human | Arenicin-1 analog | NA | NA | ||
| 21497177 | 2011 | GRFKRFRKKFKKLFKKLSPVIPLLHL{ct:Amid} | BMAP -27 | Amidation | Free | Linear | L | None | 27 | Antimicrobial | 10% hemolysis at 6.2μM | Human | Bovine myeloid antimicrobial peptide 27 (BMAP 27) | α-helical | NA | ||
| 21497177 | 2011 | GRFKRFRKKFKKLFKKLS{ct:Amid} | BMAP -18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 10% hemolysis at >400μM | Human | BMAP-27 analog | α-helical | NA | ||
| 21497177 | 2011 | GRWKRWRKKWKKLWKKLS{ct:Amid} | BMAP- 18-W | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 10% hemolysis at 38μM | Human | BMAP-27 analog | α-helical | NA | ||
| 21497177 | 2011 | GRLKRLRKKLKKLLKKLS{ct:Amid} | BMAP -18-L | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 10% hemolysis at 300μM | Human | BMAP-27 analog | α-helical | NA | ||
| 21497177 | 2011 | GRIKRIRKKIKKLIKKLS{ct:Amid} | BMAP -18-I | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 10% hemolysis at 265μM | Human | BMAP-27 analog | α-helical | NA | ||
| 21497177 | 2011 | GR{d}F{d}KRF{d}RKKF{d}KKLF{d}KKLS{ct:Amid} | BMAP -18-f | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | 10% hemolysis at >400μM | Human | BMAP-27 analog | α-helical | NA | ||
| 22800690 | 2012 | GKLEVLHSTKKFAKGFITGLTGQ | Magainin-SE1 | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 >160μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GMATKAGTALGKVAKAVIGAAL{ct:Amid} | PGLa-SE1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | LC50 >160μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GMATAAGTTLGKLAKFVIGAV{ct:Amid} | PGLa-SE2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LC50 >160μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GLASTIGSLLGKFAKGGAQAFLQPK | XPF-SE2 | Free | Free | Linear | L | None | 25 | Antimicrobial | LC50 >160μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GFWTTAAEGLKKFAKAGLASILNPK | XPF-SE3 | Free | Free | Linear | L | None | 25 | Antimicrobial | LC50 =105μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GVWTTILGGLKKFAKGGLEALTNPK | XPF-SE4 | Free | Free | Linear | L | None | 25 | Antimicrobial | LC50 =60μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GFLGPLLKLGLKGVAKVIPHLIPSRQQ | CPF-SE1 | Free | Free | Linear | L | None | 27 | Antimicrobial | LC50 =50μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GFLGPLLKLGLKGAAKLLPQLLPSRQQ | CPF-SE2 | Free | Free | Linear | L | None | 27 | Antimicrobial | LC50 =50μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GFLGSLLKTGLKVGSNLL{ct:Amid} | CPF-SE3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 =220μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | FLGALLGPLMNLLQ{ct:Amid} | PFQa | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LC50 =105μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22943778 | 2012 | FLPFLLSALPKVFCFFSKKC{cyc:N-C} | Brevinin-1ZHa | Free | Free | Cyclic | L | None | 20 | Antimicrobial | HC50 =3μM | Human | Derived from skin of Rana zhenhaiensis | NA | NA | ||
| 22943778 | 2012 | FLPLLLASLPSFLCLVFKKC{cyc:N-C} | Brevinin-1ZHb | Free | Free | Cyclic | L | None | 20 | Antimicrobial | HC50 =5μM | Human | Derived from skin of Rana zhenhaiensis | NA | NA | ||
| 22943778 | 2012 | GIMRVFKGVLKTAGKSVAKNVAGSFLDRLKCKISGGC{cyc:N-C} | Brevinin-2ZHa | Free | Free | Cyclic | L | None | 37 | Antimicrobial | HC50 =52μM | Human | Derived from skin of Rana zhenhaiensis | NA | NA | ||
| 22943778 | 2012 | GLADYWRTAFRANFANLGPGIRCKSARC | Ranatuerin-2ZHa | Free | Free | Linear | L | None | 28 | Antimicrobial | HC50 >64μM | Human | Derived from skin of Rana zhenhaiensis | NA | NA | ||
| 22943778 | 2012 | LALKSGGWLRLFGLKDKKH | Chensinin-1ZHa | Free | Free | Linear | L | None | 19 | Antimicrobial | HC50 >92μM | Human | Derived from skin of Rana zhenhaiensis | NA | NA | ||
| 22960382 | 2012 | KIKIPWGKVKDFLVGGMKAV{ct:Amid} | Bicarinalin | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 50% hemolysis at 0.72mg/ml | Human | Derived from venom of Tetramorium bicarinatum | NA | NA | ||
| 22960382 | 2012 | LFKEILEKIKAKL{ct:Amid} | P-17 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | Inactive | Human | Derived from venom of Tetramorium bicarinatum | NA | Non-hemolytic | ||
| 22973850 | 2013 | DHYICAKKGGTCNFSPCPLFNRIEGTCYSGKAKCCIR | pBD2 | Free | Free | Linear | L | None | 37 | Antimicrobial | 12% hemolysis at 80μg/ml | Porcine | Synthetic peptide | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 48μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 94% hemolysis at 24μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 92% hemolysis at 12μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 48% hemolysis at 6μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 13% hemolysis at 3μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3% hemolysis at 1.5μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 92% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 42% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 6% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.5% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 18% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 8% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 5% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 7% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 4% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 2% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 94% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 19% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 19% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 17% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 5% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 4% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 9% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 8% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 7% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 3% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 2% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 2% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 22% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 16% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 8% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 6% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 4% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 2% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 17% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 14% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 10% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 5% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 4% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 2% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 15% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 17% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 17% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 8% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 6% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 3% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 23103587 | 2013 | TDTNVIGECFDEWSRCHRQTRWWTKILFQSCENRCKCKVQLMGNCIKVPFKCFLWKQKRFMCECYGPISGTKPWYCGWEL | mytimacin-AF | Free | Free | Linear | L | None | 80 | Antimicrobial | 1.1% hemolysis at 5μg/ml | Human | Derived from mucus of Achatina fulica | NA | NA | ||
| 23103587 | 2013 | TDTNVIGECFDEWSRCHRQTRWWTKILFQSCENRCKCKVQLMGNCIKVPFKCFLWKQKRFMCECYGPISGTKPWYCGWEL | mytimacin-AF | Free | Free | Linear | L | None | 80 | Antimicrobial | 1.3% hemolysis at 10μg/ml | Human | Derived from mucus of Achatina fulica | NA | NA | ||
| 23103587 | 2013 | TDTNVIGECFDEWSRCHRQTRWWTKILFQSCENRCKCKVQLMGNCIKVPFKCFLWKQKRFMCECYGPISGTKPWYCGWEL | mytimacin-AF | Free | Free | Linear | L | None | 80 | Antimicrobial | 1.7% hemolysis at 20μg/ml | Human | Derived from mucus of Achatina fulica | NA | NA | ||
| 23103587 | 2013 | TDTNVIGECFDEWSRCHRQTRWWTKILFQSCENRCKCKVQLMGNCIKVPFKCFLWKQKRFMCECYGPISGTKPWYCGWEL | mytimacin-AF | Free | Free | Linear | L | None | 80 | Antimicrobial | 2.4% hemolysis at 40μg/ml | Human | Derived from mucus of Achatina fulica | NA | NA | ||
| 23103587 | 2013 | TDTNVIGECFDEWSRCHRQTRWWTKILFQSCENRCKCKVQLMGNCIKVPFKCFLWKQKRFMCECYGPISGTKPWYCGWEL | mytimacin-AF | Free | Free | Linear | L | None | 80 | Antimicrobial | 2.3% hemolysis at 80μg/ml | Human | Derived from mucus of Achatina fulica | NA | NA | ||
| 23103587 | 2013 | TDTNVIGECFDEWSRCHRQTRWWTKILFQSCENRCKCKVQLMGNCIKVPFKCFLWKQKRFMCECYGPISGTKPWYCGWEL | mytimacin-AF | Free | Free | Linear | L | None | 80 | Antimicrobial | 3.2% hemolysis at 160μg/ml | Human | Derived from mucus of Achatina fulica | NA | NA | ||
| 23103587 | 2013 | TDTNVIGECFDEWSRCHRQTRWWTKILFQSCENRCKCKVQLMGNCIKVPFKCFLWKQKRFMCECYGPISGTKPWYCGWEL | mytimacin-AF | Free | Free | Linear | L | None | 80 | Antimicrobial | 3.9% hemolysis at 320μg/ml | Human | Derived from mucus of Achatina fulica | NA | NA | ||
| 23137439 | 2013 | VTCDVLSFEAKGIAVNHSACALHCIALRKKGGSCQNGVCVCRN | Coprisin | Free | Free | Linear | L | None | 43 | Antimicrobial | 0% hemolysis at 100μM | Human | Copris tripartitus | α-helical | Non-hemolytic | ||
| 23270672 | 2013 | RRLMAAKAESRK | CL(14-25) | Free | Free | Linear | L | None | 12 | Antimicrobial | No or little hemolysis upto 800μM | Human | Oryza sativa L. japonica (cyanate lyase) | α-helical | Non-hemolytic | ||
| 23270672 | 2013 | RLMAAKAESRK | CL(15-25) | Free | Free | Linear | L | None | 11 | Antimicrobial | No or little hemolysis upto 800μM | Human | CL-analog | α-helical | Non-hemolytic | ||
| 23270672 | 2013 | LMAAKAESRK | CL(16-25) | Free | Free | Linear | L | None | 10 | Antimicrobial | No or little hemolysis upto 800μM | Human | CL-analog | α-helical | Non-hemolytic | ||
| 23270672 | 2013 | RRLMAAKAESR | CL(14-24) | Free | Free | Linear | L | None | 11 | Antimicrobial | No or little hemolysis upto 800μM | Human | CL-analog | α-helical | Non-hemolytic | ||
| 23270672 | 2013 | RRLMAAKAES | CL(14-23) | Free | Free | Linear | L | None | 10 | Antimicrobial | No or little hemolysis upto 800μM | Human | CL-analog | α-helical | Non-hemolytic | ||
| 23403131 | 2013 | GILKTIKSIASKVANTVQKLKRKAKNAVA | Peptide | Free | Free | Linear | L | None | 29 | Antimicrobial | EC50 =46μM | Human | Derived from venom of hadrurin and vejovine(Synthetic peptide) | α-helical | NA | ||
| 23403131 | 2013 | GILKTIKSIASKVANTVQKLKRKAKNAV | Δ(Α29) | Free | Free | Linear | L | None | 28 | Antimicrobial | EC50 =47μM | Human | Derived from venom of hadrurin and vejovine(Synthetic peptide) | α-helical | NA | ||
| 23403131 | 2013 | GILKTIKSIASKLKRKAK | Δ(K12-Q18;Ν26−Α29) | Free | Free | Linear | L | None | 18 | Antimicrobial | EC50 =80μM | Human | Derived from venom of hadrurin and vejovine(Synthetic peptide) | α-helical | NA | ||
| 23403131 | 2013 | GILNTIKSIASKLKRKAK | K4N Δ(K12-Q18; Ν26−Α29) | Free | Free | Linear | L | None | 18 | Antimicrobial | EC50 =139μM | Human | Derived from venom of hadrurin and vejovine(Synthetic peptide) | α-helical | NA | ||
| 23403136 | 2013 | KKLLPIVANLLKSLL | TB_KKG6A | Free | Free | Linear | L | None | 15 | Antimicrobial | Inactive | Mouse | Temporin-1b analog | α-helical | Non-hemolytic | ||
| 23624072 | 2013 | GILGKLWEGFKSIV{ct:Amid} | Pantinin-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0% hemolysis up to 32μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | IFGAIWNGIKSLF{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis up to 8μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | FLSTIWNGIKSLL{ct:Amid} | Pantinin-3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis upto 8μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | GILGKLWEGFKSIV{ct:Amid} | Pantinin-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 21% hemolysis at 64 μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | IFGAIWNGIKSLF{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 8% hemolysis at 16μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | FLSTIWNGIKSLL{ct:Amid} | Pantinin-3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 70% hemolysis at 16μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | IFGAIWNGIKSLF{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 81% hemolysis at 32μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | FLSTIWNGIKSLL{ct:Amid} | Pantinin-3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 32μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | IFGAIWNGIKSLF{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 64μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 9675125 | 1998 | MASRAAGLAARLARLALRAL | ESF1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.1% hemolysis at 50μg/ml | Human | magainin PGLa analog | α-helical | NA | ||
| 9675125 | 1998 | MASRAARLAARLARLALRAL | GR7 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.4% hemolysis at 50μg/ml | Human | ESF1 analog | β-sheet | NA | ||
| 9675125 | 1998 | MAARAARLAARLARLALRAL | SA3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.4% hemolysis at 50μg/ml | Human | ESF1 analog | β-sheet | NA | ||
| 9675125 | 1998 | MASRAAGLAARLARLALRAL | ESF1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.5% hemolysis at 200μg/ml | Human | magainin PGLa analog | α-helical | NA | ||
| 9675125 | 1998 | MASRAARLAARLARLALRAL | GR7 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.9% hemolysis at 200μg/ml | Human | ESF1 analog | β-sheet | NA | ||
| 9675125 | 1998 | MAARAARLAARLARLALRAL | SA3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.8% hemolysis at 200μg/ml | Human | ESF1 analog | β-sheet | NA | ||
| 9748603 | 1998 | FLPLLAGLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 1E | Amidation | Free | Linear | L | None | 24 | Antimicrobial | HD50=1.1μg/ml | Mouse | Brevinin 1E analogs | α-helical | NA | ||
| 9748603 | 1998 | FLPLLAGLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 1E (red) | Amidation | Free | Linear | L | None | 24 | Antimicrobial | HD50=1.6μg/ml | Mouse | Brevinin 1E analogs | α-helical | NA | ||
| 9748603 | 1998 | LLAGLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 21 (oxi) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | HD50=77μg/ml | Mouse | Brevinin 1E analogs | α-helical | NA | ||
| 9748603 | 1998 | LLAGLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 21 (red) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | HD50=110μg/ml | Mouse | Brevinin 1E analogs | α-helical | NA | ||
| 9748603 | 1998 | GLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 18 (oxi) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HD50=146μg/ml | Mouse | Brevinin 1E analogs | NA | NA | ||
| 9748603 | 1998 | GLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 18 (red) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HD50=230μg/ml | Mouse | Brevinin 1E analogs | NA | NA | ||
| 8163497 | 1994 | FLPLLAGLAANFLPKIFCKITRKC | Brevinin-1E | Free | Free | Linear | L | None | 24 | Antimicrobial | Lethal concentration = 0.5μM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 8163497 | 1994 | GLMDTLKNLAKTAGKGALQSLLNKASCKLSGQC | Brevinin-2E | Free | Free | Linear | L | None | 33 | Antimicrobial | Lethal concentration >100μM | Human | Derived from skin secretion of Rana esculenta(Brevinin analog) | NA | NA | ||
| 8163497 | 1994 | GIFSKLGRKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC | Esculentin-1 | Free | Free | Linear | L | None | 46 | Antimicrobial | Lethal concentration >100μM | Human | Derived from skin secretion of Rana esculenta (Esculentin analog) | NA | NA | ||
| 9022710 | 1996 | FLPLIGRVLSGIL{ct:Amid} | Temporin A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | Lethal concentration >120μM | Human | Temporin analog (Rana esculenta) | NA | NA | ||
| 9022710 | 1996 | LLPIVGNLLKSLL{ct:Amid} | Temporin B | Amidation | Free | Linear | L | None | 13 | Antimicrobial | Lethal concentration >120μM | Human | Temporin analog (Rana esculenta) | NA | NA | ||
| 9022710 | 1996 | FIGSALKVLAGVLPSVISWVKQ{ct:Amid} | MLP | Amidation | Free | Linear | L | None | 22 | Antimicrobial | Lethal concentration =0.5μM | Human | Melittin like peptide | NA | NA | ||
| 9442044 | 1998 | IWLTALKFLGKHAAKHLAKQQLSKL{ct:Amid} | Lycotoxin I | Amidation | Free | Linear | L | None | 25 | Antimicrobial and Neuroactive | 55% hemolysis at 200μM | Rabbit | Lycotoxin (Lycosa carolinensis) | NA | NA | ||
| 9442044 | 1998 | GIGKFLHAAKKFAKAFVAEIMNS | Magainin-B | Free | Free | Linear | L | None | 23 | Antimicrobial | 35% hemolysis at 200μM | Rabbit | Synthetic peptide | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSQRKNQYTGPQFLYPPERIPPQKVIKWNEEGLPIYEIPGEGGHAEPAAA | Lumbricin I | Free | Free | Linear | L | None | 62 | Antimicrobial | 0.02% hemolysis at 5μg/ml | Human | Lumbricin (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSQRKNQYTGPQFLYPPERIPPQKVIKWNEEGLPIYEIPGEGGHAEPAAA | Lumbricin I | Free | Free | Linear | L | None | 62 | Antimicrobial | 0.06% hemolysis at 10μg/ml | Human | Lumbricin (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSQRKNQYTGPQFLYPPERIPPQKVIKWNEEGLPIYEIPGEGGHAEPAAA | Lumbricin I | Free | Free | Linear | L | None | 62 | Antimicrobial | 0.14% hemolysis at 25μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSQRKNQYTGPQFLYPPERIPPQKVIKWNEEGLPIYEIPGEGGHAEPAAA | Lumbricin I | Free | Free | Linear | L | None | 62 | Antimicrobial | 0.19% hemolysis at 50μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSQRKNQYTGPQFLYPPERIPPQKVIKWNEEGLPIYEIPGEGGHAEPAAA | Lumbricin I | Free | Free | Linear | L | None | 62 | Antimicrobial | 0.23% hemolysis at 100μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.03% hemolysis at 5μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.07% hemolysis at 10μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.13% hemolysis at 25μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.17% hemolysis at 50μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.21% hemolysis at 100μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 10430870 | 1999 | CTCSWPVCTRNGLPVCGETCVGGTCNTPG{cyc:N-C} | Kalata B1 | Free | Free | Cyclic | L | None | 29 | Antimicrobial | 50% hemolysis at >400μM | Human | Kalata (Oldenlandia affinis) | NA | NA | ||
| 10430870 | 1999 | CSCKNKVCYRNGIPCGESCVWIPCISAALG{cyc:N-C} | Cir A | Free | Free | Cyclic | L | None | 30 | Antimicrobial | 50% hemolysis at >400μM | Human | Circulin A (Chassalia parvifolia) | NA | NA | ||
| 10430870 | 1999 | CSCKNKVCYRNGVIPCGESCVFIPCISTLLG{cyc:N-C} | Cir B | Free | Free | Cyclic | L | None | 30 | Antimicrobial | 50% hemolysis at >400μM | Human | Circulin B (Chassalia parvifolia) | NA | NA | ||
| 10430870 | 1999 | CSCKSKVCYKNSIPCGESCVFIPCTVTALLG{cyc:N-C} | CPT | Free | Free | Cyclic | L | None | 30 | Antimicrobial | 50% hemolysis at >400μM | Human | Cyclopsychotride (Psychotria longipes) | NA | NA | ||
| 10473569 | 1999 | DYDWSLRGPPKCATYGQKCRTWSPPNCCWNLRCKAFRCRPR | Tachystain C | Free | Free | Linear | L | None | 41 | Antimicrobial | <5% hemolysis at 5μM | Sheep | Tachystatins (Tachypleus tridentatus) | NA | NA | ||
| 10473569 | 1999 | DYDWSLRGPPKCATYGQKCRTWSPPNCCWNLRCKAFRCRPR | Tachystain C | Free | Free | Linear | L | None | 41 | Antimicrobial | <10% hemolysis at 10μM | Sheep | Tachystatins (Tachypleus tridentatus) | NA | NA | ||
| 10473569 | 1999 | DYDWSLRGPPKCATYGQKCRTWSPPNCCWNLRCKAFRCRPR | Tachystain C | Free | Free | Linear | L | None | 41 | Antimicrobial | ~10% hemolysis at 15μM | Sheep | Tachystatins (Tachypleus tridentatus) | NA | NA | ||
| 10473569 | 1999 | DYDWSLRGPPKCATYGQKCRTWSPPNCCWNLRCKAFRCRPR | Tachystain C | Free | Free | Linear | L | None | 41 | Antimicrobial | ~14% hemolysis at 20μM | Sheep | Tachystatins (Tachypleus tridentatus) | NA | NA | ||
| 10942757 | 2000 | ZCRRLCYKQRCVTYCRGR | Gomesin | Free | Free | Linear | L | None | 18 | Antimicrobial | 16% hemolysis at 1μM | Human | Gomesin (Acanthoscurria gomesiana) | NA | NA | ||
| 10942757 | 2000 | ZCRRLCYKQRCVTYCRGR | Gomesin | Free | Free | Linear | L | None | 18 | Antimicrobial | ~23% hemolysis at 100μM | Human | Gomesin (Acanthoscurria gomesiana) | NA | NA | ||
| 10942757 | 2000 | ZCRRLCYKQRCVTYCRGR{ct:Amid} | Gomesin | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 11% hemolysis at 1μM | Human | Gomesin (Acanthoscurria gomesiana) | NA | NA | ||
| 10942757 | 2000 | ZCRRLCYKQRCVTYCRGR{ct:Amid} | Gomesin | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 20% hemolysis at 100μM | Human | Gomesin (Acanthoscurria gomesiana) | NA | NA | ||
| 11085990 | 2001 | GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK | HBD-3 | Free | Free | Linear | L | None | 45 | Antimicrobial | <0.5% hemolysis upto 500μg/ml | Human | Human beta-defensin-3 was isolated from human lesional psoriatic scales and cloned from keratinocytes | NA | NA | ||
| 11713517 | 2001 | FFHHIFRGIVHVGKTIHRLVTG | Piscidin 1 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis at 10μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11713517 | 2001 | FFHHIFRGIVHVGKTIHRLVTG | Piscidin 1 | Free | Free | Linear | L | None | 22 | Antimicrobial | ~90% hemolysis at 100μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11713517 | 2001 | FFHHIFRGIVHVGKTIHKLVTG | Piscidin 2 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis at 10μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11713517 | 2001 | FFHHIFRGIVHVGKTIHKLVTG | Piscidin 2 | Free | Free | Linear | L | None | 22 | Antimicrobial | ~90% hemolysis at 100μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11713517 | 2001 | FIHHIFRGIVHAGRSIGRFLTG | Piscidin 3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis at 10μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11713517 | 2001 | FIHHIFRGIVHAGRSIGRFLTG | Piscidin 3 | Free | Free | Linear | L | None | 22 | Antimicrobial | ~5% hemolysis at 100μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis upto 1.25μM | Human | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 1% hemolysis upto 2.5μM | Human | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis upto 5μM | Sheep | White bass (Morone chrysops) | α-helix | Non-hemolytic | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 19% hemolysis at 5μM | Human | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 11% hemolysis at 10μM | Sheep | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 55% hemolysis at 10μM | Human | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 51% hemolysis at 20μM | Sheep | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100% hemolysis at 80μM | Human | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 80% hemolysis at 40μM | Sheep | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100% hemolysis at 80μM | Sheep | White bass (Morone chrysops) | α-helix | NA | ||
| 11792701 | 2002 | GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME{ct:Amid} | Cupiennin-1a | Amidation | Free | Linear | L | None | 35 | Antimicrobial | EC50 = 24.4μM | Human | Cupiennin analog (Venom of the Spider Cupiennius salei (Ctenidae)) | NA | NA | ||
| 11792701 | 2002 | GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME | Cupiennin-1a | Free | Free | Linear | L | None | 35 | Antimicrobial | EC50 = 20.5μM | Human | Cupiennin analog (Venom of the Spider Cupiennius salei (Ctenidae)) | NA | NA | ||
| 11792701 | 2002 | GFGSLFKFLAKKVAKTVAKQAAKQGAKYVANKHME | Cupiennin-1d | Free | Free | Linear | L | None | 35 | Antimicrobial | EC50 = 14.5μM | Human | Cupiennin analog (Venom of the Spider Cupiennius salei (Ctenidae)) | NA | NA | ||
| 11835991 | 2002 | ILGPVISTIGGVLGGLLKNL{ct:Amid} | Maximin H1 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Cytotoxic and Anti-HIV | 90-100% hemolysis at 50μg/ml | Rabbit | Maximin (skin secretions of Bombina maxima) | NA | NA | ||
| 11835991 | 2002 | ILGPVLSMVGSALGGLIKKI{ct:Amid} | Maximin H2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Cytotoxic and Anti-HIV | 90-100% hemolysis at 50μg/ml | Rabbit | Maximin (skin secretions of Bombina maxima) | NA | NA | ||
| 11835991 | 2002 | ILGPVLGLVGNALGGLIKKI{ct:Amid} | Maximin H3 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Cytotoxic and Anti-HIV | 90-100% hemolysis at 50μg/ml | Rabbit | Maximin (skin secretions of Bombina maxima) | NA | NA | ||
| 11835991 | 2002 | ILGPVISKIGGVLGGLLKNL{ct:Amid} | Maximin H4 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Cytotoxic and Anti-HIV | 90-100% hemolysis at 50μg/ml | Rabbit | Magainin (skin secretions of Bombina maxima) | NA | NA | ||
| 8855958 | 1996 | KKLKKLKKKWKKLKKKLK | Hel 5-13 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 100μM | Human | Synthetic peptide | α-helix | NA | ||
| 8855958 | 1996 | KKLKKLLKKWKKLLKKLK | Hel 7-11 | Free | Free | Linear | L | None | 18 | Antimicrobial | ~5% hemolysis upto 100μM (non hemolytic) | Human | Synthetic peptide | α-helix | Non-hemolytic | ||
| 8855958 | 1996 | KLLKKLLKLWKKLLKKLK | Hel 9-9 | Free | Free | Linear | L | None | 18 | Antimicrobial | ~45% hemolysis at 10μM | Human | Synthetic peptide | α-helix | NA | ||
| 8855958 | 1996 | KLLKKLLKLWKKLLKKLK | Hel 9-9 | Free | Free | Linear | L | None | 18 | Antimicrobial | ~60% hemolysis at 100μM | Human | Synthetic peptide | α-helix | NA | ||
| 8855958 | 1996 | KLLKLLLKLWKKLLKLLK | Hel 11-7 | Free | Free | Linear | L | None | 18 | Antimicrobial | ~45% hemolysis at 1μM | Human | Synthetic peptide | α-helix | NA | ||
| 8855958 | 1996 | KLLKLLLKLWKKLLKLLK | Hel 11-7 | Free | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 10μM | Human | Synthetic peptide | α-helix | NA | ||
| 8855958 | 1996 | KLLKLLLKLWLKLLKLLL | Hel 13-5 | Free | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 1μM | Human | Synthetic peptide | α-helix | NA | ||
| 11738089 | 2001 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial and Mast cell degranulating | Low hemolytic activity | Human | Anoplin (venom of the solitary wasp Anoplius samariensis) | α-helix | NA | ||
| 11738089 | 2001 | FLPLILRKIVTAL{ct:Amid} | Crabrolin | Amidation | Free | Linear | L | None | 13 | Antimicrobial and Mast cell degranulating | No hemolysis (non hemolytic) | Rat | Crabrolin (venom of the Vespa xanthoptera and Vespa crabro) | α-helix | Non-hemolytic | ||
| 11738090 | 2001 | GFLGPLLKLAAKGVAKVIPHLIPSRQQ | XT-1 | Free | Free | Linear | L | None | 27 | Antimicrobial | HC50 =90μM | Human | XT (skin secretions of the diploid frog Xenopus tropicalis) | NA | NA | ||
| 11738090 | 2001 | GVFLDALKKFAKGGMNAVLNPK | XT-4 | Free | Free | Linear | L | None | 22 | Antimicrobial | HC50 >150μM | Human | XT (skin secretions of the diploid frog Xenopus tropicalis) | NA | NA | ||
| 11738090 | 2001 | GMATKAGTALGKVAKAVIGAAL{ct:Amid} | XT-5 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | HC50 >150μM | Human | XT (skin secretions of the diploid frog Xenopus tropicalis) | NA | NA | ||
| 11738090 | 2001 | GFLGSLLKTGLKVGSNLL{ct:Amid} | XT-6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HC50 >150μM | Human | XT (skin secretions of the diploid frog Xenopus tropicalis) | NA | NA | ||
| 11738090 | 2001 | GLLGPLLKIAAKVGSNLL{ct:Amid} | XT-7 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HC50 =70μM | Human | XT (skin secretions of the diploid frog Xenopus tropicalis) | NA | NA | ||
| 14636071 | 2003 | GALRGCWTKSYPPKPCK{ct:Amid} | Ranacyclin T | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 20% hemolysis at 100μM | Human | Ranacyclin (skin secretion of the frog Rana esculenta) | NA | NA | ||
| 14636071 | 2003 | SAPRGCWTKSYPPKPCK{ct:Amid} | Ranacyclin E | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 55% hemolysis at 100μM | Human | Ranacyclin (skin secretion of the frog Rana esculenta) | NA | NA | ||
| 14636071 | 2003 | LVRGCWTKSYPPKPCFVR{ct:Amid} | pLR | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 85% hemolysis at 100μM | Human | pLR (skin of the Northern Leopard frog Rana pipiens) | NA | NA | ||
| 19427345 | 2009 | FLGAIAAALPHVINAVTNAL{ct:Amid} | Kassinatuerin-2Ma | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | FFGAIAAALPHVISAIKNAL{ct:Amid} | Kassinatuerin-2Mb | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | FVGAIAAALPHVISAIKNAL{ct:Amid} | Kassinatuerin-2Mc | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | IIGAIAAALPHVINAIKNTF{ct:Amid} | Kassinatuerin-2Md | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | FIQYLAPLIPHAVKAISDLI{ct:Amid} | Kassinatuerin-2S | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | GFMKYIGPLIPHAVKAISDLI{ct:Amid} | Kassinatuerin-1S | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19539775 | 2009 | FLSLALAALPKLFCLIFKKC | Brevinin-1CDYa | Free | Free | Linear | L | None | 20 | Antimicrobial | HC50 =125μM | Human | Brevinin-1 (skin secretions from the Chinese frog Rana dybowskii) | NA | NA | ||
| 19539775 | 2009 | FFPLALLCKVFKKC | Japonicin-1CDYa | Free | Free | Linear | L | None | 14 | Antimicrobial | HC50 >300μM | Human | Japonicin-1 (skin secretions from the Chinese frog Rana dybowskii) | NA | NA | ||
| 19539775 | 2009 | VLPLVGNLLNDLL{ct:Amid} | Temporin-CDYb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | HC50 =180μM | Human | Temporin (skin secretions from the Chinese frog Rana dybowskii) | NA | NA | ||
| 19539775 | 2009 | IIPLPLGYFAKKT | Dybowskin-1CDYa | Free | Free | Linear | L | None | 13 | Antimicrobial | HC50 >300μM | Human | Dybowskin-1 (skin secretions from the Chinese frog Rana dybowskii) | NA | NA | ||
| 19539775 | 2009 | SAVGRHGRRFGLRKHRKH | Dybowskin-2CDYa | Free | Free | Linear | L | None | 18 | Antimicrobial | HC50 >300μM | Human | Dybowskin-2 (skin secretions from the Chinese frog Rana dybowskii) | NA | NA | ||
| 11689009 | 2001 | GLNALKKVFQGIHEAIKLINNHVQ | Pseudin-2 | Free | Free | Linear | L | None | 24 | Antimicrobial | EC50 >300μM | Human | Pseudin (extract of the skin of the paradoxical frog Pseudis paradoxa) | NA | NA | ||
| 11479030 | 2001 | ILQKAVLDCLKAAGSSLSKAAITAIYNKIT | Dicynthaurin | Free | Free | Linear | L | None | 30 | Antimicrobial | 0% hemolysis at 25μg/ml | Human | Dicynthaurin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 11479030 | 2001 | ILQKAVLDCLKAAGSSLSKAAITAIYNKIT | Dicynthaurin | Free | Free | Linear | L | None | 30 | Antimicrobial | 10% hemolysis at 50μg/ml | Human | Dicynthaurin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 11479030 | 2001 | ILQKAVLDCLKAAGSSLSKAAITAIYNKIT | Dicynthaurin | Free | Free | Linear | L | None | 30 | Antimicrobial | 20% hemolysis at 100μg/ml | Human | Dicynthaurin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 11479030 | 2001 | QKAVLDCLKAAGSSLSKAAITAI | Cynthaurin | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 100μg/ml (non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 3299384 | 1987 | GIGKFLHSAKKFGKAFVGEIMNS | Magainin-2 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 10μg/ml (non hemolytic) | Human | Magainin-2 (skin of the African clawed frog Xenopus laevis) | NA | Non-hemolytic | ||
| 12005415 | 2001 | FLRFIGSVIHGIGHLVHHIGVAL{ct:Amid} | Clavaspirin | Amidation | Free | Linear | L | None | 23 | Antimicrobial | ~70% hemolysis at 20μg/ml | Human | Clavaspirin pharyngeal tissues of the tunicate,Styela clava | NA | NA | ||
| 12005415 | 2001 | FLRFIGSVIHGIGHLVHHIGVAL{ct:Amid} | Clavaspirin | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 75% hemolysis at 80μg/ml | Human | Clavaspirin pharyngeal tissues of the tunicate,Styela clava | NA | NA | ||
| 12067731 | 2002 | WLNALLHHGLNCAKGVLA | 18 monomer halocidin | Free | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 25μg/ml | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 12067731 | 2002 | WLNALLHHGLNCAKGVLA | 18 monomer halocidin | Free | Free | Linear | L | None | 18 | Antimicrobial | <10% hemolysis at 50μg/ml | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 12067731 | 2002 | WLNALLHHGLNCAKGVLA | 18 monomer halocidin | Free | Free | Linear | L | None | 18 | Antimicrobial | ~10% hemolysis at 100μg/ml | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 12067731 | 2002 | WLNALLHHGLNCAKGVLAWLNALLHHGLNCAKGVLA | 18 homodimer halocidin | Free | Free | Linear | L | None | 36 | Antimicrobial | ~1-2% hemolysis at 25μg/ml | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 12067731 | 2002 | WLNALLHHGLNCAKGVLAWLNALLHHGLNCAKGVLA | 18 homodimer halocidin | Free | Free | Linear | L | None | 36 | Antimicrobial | >10% hemolysis at 100μg/ml | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 12067731 | 2002 | ALLHHGLNCAKGVLA | 15 monomer halocidin | Free | Free | Linear | L | None | 15 | Antimicrobial | 0% hemolysis at 100μg/ml (non hemolytic) | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | Non-hemolytic | ||
| 12067731 | 2002 | ALLHHGLNCAKGVLAALLHHGLNCAKGVLA | 15 homodimer halocidin | Free | Free | Linear | L | None | 30 | Antimicrobial | 0% hemolysis at 100μg/ml (non hemolytic) | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | Non-hemolytic | ||
| 11563967 | 2001 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pandinin 1 | Free | Free | Linear | L | None | 44 | Antimicrobial | 1.4±0.3% hemolysis at 44.5μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pandinin 1 | Free | Free | Linear | L | None | 44 | Antimicrobial | 1.1±0.3% hemolysis at 22.2μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pandinin 1 | Free | Free | Linear | L | None | 44 | Antimicrobial | 0.9±0.1% hemolysis at 11.1μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pandinin 1 | Free | Free | Linear | L | None | 44 | Antimicrobial | 0.7±0.3% hemolysis at 5.5μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT | Pandinin 1 | Free | Free | Linear | L | None | 44 | Antimicrobial | 0.2±0.1% hemolysis at 2.7μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 90.5±0.8% hemolysis at 44.5μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 51.4±0.5% hemolysis at 22.2μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 17.5±1.1% hemolysis at 11.1μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 3.7±0.1% hemolysis at 5.5μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 1.4±0.3% hemolysis at 2.7μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 9395500 | 1997 | {nnr:X}ALWKNMLKGIGKLAGKAALGAVKKLVGAES | DS3 | Free | Free | Linear | L | X = H | 31 | Antimicrobial and Cytolytic | No hemolysis at 34μM (non hemolytic) | Human | Dermaseptins (skin of the tree frogs) | NA | Non-hemolytic | ||
| 9395500 | 1997 | {nnr:X}ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 | Free | Free | Linear | L | X = H | 29 | Antimicrobial and Cytolytic | Hemolysis observed at >8.5μM | Human | Dermaseptins (skin of the tree frogs) | NA | NA | ||
| 18519720 | 2008 | AGYLLGKINLKALAALAKKIL{ct:Amid} | TP10 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5% hemolysis at 30μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | KKALL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 =179.2μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | ALALL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LALA{ct:Amid} | HALO-2 | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 <5.6μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | FFKKL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO-F | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 <5.6μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | KKALL{nnr:O}HPLH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO-P8 | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 =89.6μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}A{d}H{d}{nnr:d-o}L{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-HALO-rev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 =716.8μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}P{d}H{d}{nnr:d-o}L{d}K{d}K{d}F{d}F{d}{ct:Amid} | D-HALO-P8Frev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 >65.2μM | Human | Synthetic peptide | NA | NA | ||
| 12969798 | 2004 | KAVAAKKSPKKAKKPAT | Oncorhyncin II | Free | Free | Linear | L | None | 17 | Antimicrobial | No hemolysis at 0.8μM(non hemolytic) | Trout | Oncorhyncin II (acid extract of rainbow trout skin secretion Oncorhynchus mykiss) | NA | Non-hemolytic | ||
| 10387056 | 1999 | KWKSFIKKLTSAAKKVVTTAKPLISS | CP26p | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC=8μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKTFKSAVKTVLHTALKAISS | V681n | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLRTLKSPAKTVFHTALKAISS | V25p | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKKLTSAAKKVLTTALKPISS | V26p | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC=64μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKTLKSPVKTVFYTALKPISS | V1pp | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLRTFKSPVRTVFHTALKPISS | V8pp | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC=32μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKTFKSPVKTVFYTALKPISS | V14pp | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKTFKSPARTVLYTALKPISS | V68pp | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKTFKSPARTVLHTALKPISS | V31pp | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 7479693 | 1995 | IISTIGKLVKWIIDTV | Peptide-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 100% hemolysis at ~25μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGDLVKWIIKTV | Peptide-3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 1-2% hemolysis at 20μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGDLVKWIIKTV | Peptide-3 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 40μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGDLVKWIIKTV | Peptide-3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 80% hemolysis at 60μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGDLVKWIIKTV | Peptide-3 | Free | Free | Linear | L | None | 16 | Antimicrobial | ~90% hemolysis at 80μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGDLVKWIIKTV | Peptide-3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 100% hemolysis at ~90μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGKLVKWIIKTV | Peptide-4 | Free | Free | Linear | L | None | 16 | Antimicrobial | 50% hemolysis at ~15μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGKLVKWIIKTV | Peptide-4 | Free | Free | Linear | L | None | 16 | Antimicrobial | 100% hemolysis at ~20μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 22074926 | 2012 | CGESCVFIPCITSLAGCSCKNKVCYYDGGSVP{cyc:N-C} | Parigidin_br1 | Free | Free | Cyclic | L | None | 32 | Antimicrobial | 41% hemolysis at 40µM | Human | Parigidinbr1 (Palicourea rigida) | NA | NA | ||
| 22074926 | 2012 | CGESCVFIPCITSLAGCSCKNKVCYYDGGSVP{cyc:N-C} | Parigidin_br1 | Free | Free | Cyclic | L | None | 32 | Antimicrobial | 28% hemolysis at 20µM | Human | Parigidinbr1 (Palicourea rigida) | NA | NA | ||
| 21956830 | 2011 | FLKPLFNAALKLLP | Temporin-Ra | Free | Free | Linear | L | None | 14 | Antimicrobial | 1.3% hemolysis at 60µg/ml | Human | Derived from skin secretions of Rana ridibunda | NA | NA | ||
| 21956830 | 2011 | FLPVLAGVLSRA | Temporin-Rb | Free | Free | Linear | L | None | 12 | Antimicrobial | 1.1% hemolysis at 60µg/ml | Human | Derived from skin secretions of Rana ridibunda | NA | NA | ||
| 20027626 | 2009 | DFGCGQGMIFMCQRRCMRLYPGSTGFCRGFRCMCDTHIPLRPPFMVG | Longicornsin | Free | Free | Linear | L | None | 47 | Antimicrobial | 1.2% hemolysis at 200µg/ml | Rabbit | Derived from salivary glands of the Haemaphysalis longicornis | NA | NA | ||
| 7744058 | 1995 | KIAEKFSGTRRG | CGB | Free | Free | Linear | L | None | 12 | Antimicrobial | No hemolysis (Non hemolytic) | Rabbit | Chromogranin-B derivative (Bovine) | NA | Non-hemolytic | ||
| 19088182 | 2009 | IFGAIAGLLKNIF{ct:Amid} | Meucin-13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 37.7% hemolysis at 6.25µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19088182 | 2009 | IFGAIAGLLKNIF{ct:Amid} | Meucin-13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 59.2% hemolysis at 12.5µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19088182 | 2009 | IFGAIAGLLKNIF{ct:Amid} | Meucin-13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | >90% hemolysis at 25µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19088182 | 2009 | FFGHLFKLATKIIPSLFQ | Meucin-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | 74% hemolysis at 6.25µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19088182 | 2009 | FFGHLFKLATKIIPSLFQ | Meucin-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | >90% hemolysis at 12.5µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19088182 | 2009 | FFGHLFKLATKIIPSLFQ | Meucin-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | >95% hemolysis at 25µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19085906 | 2008 | FWGHIWNAVKRVGANALHGAVTGALS | Halocyntin | Free | Free | Linear | L | None | 26 | Antimicrobial | 22% hemolysis at 50µM | Sheep | Halocyntin (Halocynthia papillosa) | NA | NA | ||
| 19085906 | 2008 | GFWKKVGSAAWGGVKAAAKGAAVGGLNALAKHIQ | Papillosin | Free | Free | Linear | L | None | 34 | Antimicrobial | 0% hemolysis upto 50µM (Non hemolytic) | Sheep | Papillosin (Halocynthia papillosa) | NA | Non-hemolytic | ||
| 18942691 | 2008 | GFLSILKKVLPKVMAHMK{ct:Amid} | MEP | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 >100µM | Rat | Derived from venom of Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLKKVMAHMK{ct:Amid} | MEP-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 27.3µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLKVMAHMK{ct:Amid} | MEP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | LC50 = 22.9µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLAKVMAHMK{ct:Amid} | MEP-3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 29.7µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLGKVMAHMK{ct:Amid} | MEP-4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 41.4µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | KVMAHMK{ct:Amid} | MEP-5 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | LC50 >100µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | PKVMAHMK{ct:Amid} | MEP-6 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | LC50 >100µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | LPKVMAHMK{ct:Amid} | MEP-7 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | LC50 >100µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | VLPKVMAHMK{ct:Amid} | MEP-8 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 >100µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLP{ct:Amid} | MEP-9 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | LC50 >100µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVL{ct:Amid} | MEP-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 >100µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18030427 | 2008 | GWMSEKKVQGILDKKLPEGIIRNAAKAIVHKMAKMQFGCFANVDVKGDCKRHCKAEDKEGICHGTKCKCGVPISYL | HgeScplp1 | Free | Free | Linear | L | None | 76 | Antimicrobial | No hemolysis at 200nM | Human | Caraboctonid (Scorpion) | NA | NA | ||
| 18030427 | 2008 | KSTVGQKLKKKLNQAVDKVKEVLNKSEYMCPVVSSFCKQHCARLGKSGQCDLLECIC | HgebKTx | Free | Free | Linear | L | None | 57 | Antimicrobial | No hemolysis at 200nM | Human | Caraboctonid (Scorpion) | NA | NA | ||
| 18000874 | 2007 | GLLNGLALRLGKRALKKIIKRLCR | Cryptonin | Free | Free | Linear | L | None | 24 | Antimicrobial | 5% hemolysis upto 200µg/ml | Rat | Cryptonin (Cryptotympana dubia) | NA | NA | ||
| 17764786 | 2007 | SIITMTKEAKLPQLWKQIACRLYNTC{cyc:N-C} | Pleurain-A1 | Free | Free | Cyclic | L | None | 26 | Antimicrobial | Little hemolysis at 200mg/ml | Human | Derived from skin secretion of Rana pleuraden | NA | NA | ||
| 17764786 | 2007 | SIITMTKEAKLPQSWKQIACRLYNTC{cyc:N-C} | Pleurain-A2 | Free | Free | Cyclic | L | None | 26 | Antimicrobial | Little hemolysis at 200mg/ml | Human | Derived from skin secretion of Rana pleuraden | NA | NA | ||
| 17764786 | 2007 | SIITMTREAKLPQLWKQIACRLYNTC{cyc:N-C} | Pleurain-A3 | Free | Free | Cyclic | L | None | 26 | Antimicrobial | Little hemolysis at 200mg/ml | Human | Derived from skin secretion of Rana pleuraden | NA | NA | ||
| 17764786 | 2007 | SIITTTKEAKLPQLWKQIACRLYNTC{cyc:N-C} | Pleurain-A4 | Free | Free | Cyclic | L | None | 26 | Antimicrobial | Little hemolysis at 200mg/ml | Human | Derived from skin secretion of Rana pleuraden | NA | NA | ||
| 17698252 | 2007 | GLLRASSVWGRKYYVDLAGCAKA | Odorranin-HP | Free | Free | Linear | L | None | 23 | Antimicrobial | Little hemolysis at 100µg/ml | Rabbit | Derived from skin secretion of Odorrana grahami | NA | NA | ||
| 17688900 | 2007 | FLSLALAALPKFLCLVFKKC | Brevinin-1DYa | Free | Free | Linear | L | None | 20 | Antimicrobial | LC50 <5µM | Human | Derived from skin of Rana dybowskii | NA | NA | ||
| 17688900 | 2007 | FLSLALAALPKLFCLIFKKC | Brevinin-1DYb | Free | Free | Linear | L | None | 20 | Antimicrobial | LC50 <5µM | Human | Derived from skin of Rana dybowskii | NA | NA | ||
| 17688900 | 2007 | FLPLLLAGLPKLLCLFFKKC | Brevinin-1DYc | Free | Free | Linear | L | None | 20 | Antimicrobial | LC50 <5µM | Human | Derived from skin of Rana dybowskii | NA | NA | ||
| 17272268 | 2007 | GFMDTAKNVAKNVAVTLLDNLKCKITKAC | Odorranain-F1 | Free | Free | Linear | L | None | 29 | Antimicrobial | 15.4±3.5% hemolysis at 50µg/ml | Human | Odorranain (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLLSGTSVRGSI | Odorranain-V1 | Free | Free | Linear | L | None | 12 | Antimicrobial | 23.9±4.7% hemolysis at 50µg/ml | Human | Odorranain (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLFGKSSVWGRKYYVDLAGCAKA | Odorranain-W1 | Free | Free | Linear | L | None | 23 | Antimicrobial | 17.6±2.2% hemolysis at 50µg/ml | Human | Odorranain (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GIFGKILGVGKKVLCGLSGVC | Odorranain-H1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 21.6±7.3% hemolysis at 50µg/ml | Human | Odorranain (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLLGKILGVEKKVLCGLSGMC | Nigrocin-OG2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 60±7.1% hemolysis at 50µg/ml | Human | Nigrocin (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLLSGILGAGKHIICGLSGLC | Nigrocin-OG4 | Free | Free | Linear | L | None | 21 | Antimicrobial | 65.5±7.7% hemolysis at 50µg/ml | Human | Nigrocin (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLLSGILGAGKQKVCGLSGLC | Nigrocin-OG5 | Free | Free | Linear | L | None | 21 | Antimicrobial | 87.2±2.6% hemolysis at 50µg/ml | Human | Nigrocin (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLLSGVLGVGKKVLCGLSGLC | Nigrocin-OG21 | Free | Free | Linear | L | None | 21 | Antimicrobial | 100% hemolysis at 50µg/ml | Human | Nigrocin (Odorrana grahami) | NA | NA | ||
| 17044815 | 2007 | KDRPKKPGLCPPRPQKPCVKECKNDDSCPGQQKCCNYGCKDECRDPIFVG | Omwaprin | Free | Free | Linear | L | None | 50 | Antimicrobial | 0% hemolysis upto 1 mM | Human | Derived from venom of Oxyuranus microlepidotus | NA | Non-hemolytic | ||
| 8849687 | 1996 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | ~20% hemolysis at 10µM | Rat | Derived from cytoplasmic granules of bovine neutrophils, | NA | NA | ||
| 8508915 | 1993 | FLPLLAGLAANFLPKIFCKITRKC | Brevinin-1 E | Free | Free | Linear | L | None | 24 | Antimicrobial | LC50 =5µM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 8508915 | 1993 | FLPVLAGIAAKVVPALFCKITKKC | Brevinin-2 E | Free | Free | Linear | L | None | 24 | Antimicrobial | LC50 >100µM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 8508915 | 1993 | GIFSKLGRKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC | Esculentin | Free | Free | Linear | L | None | 46 | Antimicrobial | LC50 >100µM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 8508915 | 1993 | FLPAIAGILSQLF{ct:Amid} | A1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LC50 ~20µM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 7989335 | 1994 | ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ | DS s1 | Free | Free | Linear | L | None | 34 | Antimicrobial | 100% hemolysis at >70µM | Human | Dermaseptin analog (Phyllomedusa sauvagii) | NA | NA | ||
| 7989335 | 1994 | ALWKTMLKKLGTMALHAGKAALGAAANTISQGTQ | DS s2 | Free | Free | Linear | L | None | 34 | Antimicrobial | 100% hemolysis at 70µM | Human | Dermaseptin analog (Phyllomedusa sauvagii) | NA | NA | ||
| 7989335 | 1994 | ALWKNMLKGIGKLAGKAALGAVKKLVGAES | DS s3 | Free | Free | Linear | L | None | 30 | Antimicrobial | 100% hemolysis at 80µM | Human | Dermaseptin analog (Phyllomedusa sauvagii) | NA | NA | ||
| 7989335 | 1994 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS s4 | Free | Free | Linear | L | None | 28 | Antimicrobial | 100% hemolysis at 1µM | Human | Dermaseptin analog (Phyllomedusa sauvagii) | NA | NA | ||
| 7989335 | 1994 | GLWSKIKTAGKSVAKAAAKAAVKAVTNAV | DS s5 | Free | Free | Linear | L | None | 29 | Antimicrobial | 100% hemolysis at >90µM | Human | Dermaseptin analog (Phyllomedusa sauvagii) | NA | NA | ||
| 7999137 | 1994 | SLFSLIKAGAKFLGKNLLKQGACYAACKASKQC | Gaegurin 1 | Free | Free | Linear | L | None | 33 | Antimicrobial | 0.59% hemolysis at 100µM | Human | Derived from skin of Rana rugosa | NA | NA | ||
| 7999137 | 1994 | GIMSIVKDVAKNAAKEAAKGALSTLSCKLAKTC | Gaegurin 2 | Free | Free | Linear | L | None | 33 | Antimicrobial | 0.82% hemolysis at 100µM | Human | Derived from skin of Rana rugosa | NA | NA | ||
| 7999137 | 1994 | GIMSIVKDVAKTAAKEAAKGALSTLSCKLAKTC | Gaegurin 3 | Free | Free | Linear | L | None | 33 | Antimicrobial | 1.20% hemolysis at 100µM | Human | Derived from skin of Rana rugosa | NA | NA | ||
| 7999137 | 1994 | GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLALTC | Gaegurin 4 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1.67% hemolysis at 100µM | Human | Derived from skin of Rana rugosa | NA | NA | ||
| 7999137 | 1994 | FLGALFKVASKVLPSVKCAITKKC | Gaegurin 5 | Free | Free | Linear | L | None | 24 | Antimicrobial | 1.01% hemolysis at 100µM | Human | Derived from skin of Rana rugosa | NA | NA | ||
| 7999137 | 1994 | FLPLLAGLAANFLPTIICKISYKC | Gaegurin 6 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.86% hemolysis at 100µM | Human | Derived from skin of Rana rugosa | NA | NA | ||
| 18295522 | 2007 | QLKVDLWGTRSGIQPEQHSSGKSDVRRWRSRY | Ixosin-B | Free | Free | Linear | L | None | 32 | Antimicrobial | Little hemolysis upto 200µg/ml | Rabbit | Derived from the salivary glands of Ixodes sinensis | NA | NA | ||
| 19716842 | 2010 | FLPKMSTKLRVPYRRGTKDYH | Scolopin 1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 25±2% hemolysis at 50µg/ml | Human | Derived from venom of Scolopendra subspinipes mutilans | NA | NA | ||
| 19716842 | 2010 | FLPKMSTKLRVPYRRGTKDYH | Scolopin 1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 21±5% hemolysis at 50µg/ml | Rabbit | Derived from venom of Scolopendra subspinipes mutilans | NA | NA | ||
| 19716842 | 2010 | GILKKFMLHRGTKVYKMRTLSKRSH | Scolopin 2 | Free | Free | Linear | L | None | 25 | Antimicrobial | 32±7% hemolysis at 50µg/ml | Human | Derived from venom of Scolopendra subspinipes mutilans | NA | NA | ||
| 19716842 | 2010 | GILKKFMLHRGTKVYKMRTLSKRSH | Scolopin 2 | Free | Free | Linear | L | None | 25 | Antimicrobial | 37±6% hemolysis at 50µg/ml | Rabbit | Derived from venom of Scolopendra subspinipes mutilans | NA | NA | ||
| 20045493 | 2010 | GFREKHFQRFVKYAVPESTLRTVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF | rMeuTXKβ1 | Free | Free | Linear | L | None | 72 | Antimicrobial | 10.3% hemolysis at 10µM | Mouse | Synthetic peptide (Mesobuthus eupeus) | NA | NA | ||
| 20045493 | 2010 | GFREKHFQRFVKYAVPESTLRTVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF | rMeuTXKβ1 | Free | Free | Linear | L | None | 72 | Antimicrobial | 14.8% hemolysis at 20µM | Mouse | Synthetic peptide (Mesobuthus eupeus) | NA | NA | ||
| 23415652 | 2013 | LLGMIPLAISAISALSKL | Medusin-AC | Free | Free | Linear | L | None | 18 | Antimicrobial | 8.7% hemolysis at 32mg/ml | Horse | Medusin (Phyllomedusine frogs) | NA | NA | ||
| 23415652 | 2013 | LLGMIPVAISAISALSKL | Medusin-PH | Free | Free | Linear | L | None | 18 | Antimicrobial | 1.9% hemolysis at 128mg/ml | Horse | Medusin (Phyllomedusine frogs) | NA | NA | ||
| 23415652 | 2013 | LLGMIPLAISAISSLSKL | Medusin-PD | Free | Free | Linear | L | None | 18 | Antimicrobial | 6.9% hemolysis at 64mg/ml | Horse | Medusin (Phyllomedusine frogs) | NA | NA | ||
| 23483218 | 2013 | LNWGAILKHIIK{ct:Amid} | PNG-1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 =119µM | Human | Derived from venom of Panurgus calcaratus | NA | NA | ||
| 23483218 | 2013 | NLWAGILKHIIK{ct:Amid} | PNG-1/1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | KNWGAILKHIIK{ct:Amid} | PNG-1/2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LKWGAILKHIIK{ct:Amid} | PNG-1/3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNKGAILKHIIK{ct:Amid} | PNG-1/4 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWKAILKHIIK{ct:Amid} | PNG-1/5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 ~110µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGKILKHIIK{ct:Amid} | PNG-1/6 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >140µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAKLKHIIK{ct:Amid} | PNG-1/7 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAIKKHIIK{ct:Amid} | PNG-1/8 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAILKKIIK{ct:Amid} | PNG-1/9 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAILKHKIK{ct:Amid} | PNG-1/10 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAILKHIKK{ct:Amid} | PNG-1/11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | KNWGKILKHIIK{ct:Amid} | PNG-1/12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | KNWKAILKHIIK{ct:Amid} | PNG-1/13 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAVLKHVVK{ct:Amid} | PNG-1/14 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGA-{nnr:Abu}-LKH-{nnr:Abu}-{nnr:Abu}-K{ct:Amid} | PNG-1/15 | Amidation | Free | Linear | L | Abu = 2-aminobutyric acid | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAALKHAAK{ct:Amid} | PNG-1/16 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAFLKHFFK{ct:Amid} | PNG-1/17 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 =81µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAGLKHGGK{ct:Amid} | PNG-1/18 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGALLKHLLK{ct:Amid} | PNG-1/19 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 =63µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGA-{nnr:Nle}-LKH-{nnr:Nle}-{nnr:Nle}-K{ct:Amid} | PNG-1/20 | Amidation | Free | Linear | L | Nle = Norleucine | 12 | Antimicrobial | LC50 =40µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGA-{nnr:Aca}-LKH-{nnr:Aca}-{nnr:Aca}-K{ct:Amid} | PNG-1/21 | Amidation | Free | Linear | L | Aca = 1-aminocyclohexane carboxylic acid | 12 | Antimicrobial | LC50 =43µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAWLKHWWK{ct:Amid} | PNG-1/22 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 =132µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LDVKKIICVACKIKPNPACKKICPK | PNG-K | Free | Free | Linear | L | None | 25 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LDVKKII-{nnr:Abu}-VA-{nnr:Abu}-KIKPNPA-{nnr:Abu}-KKI-{nnr:Abu}-PK | PNG-K/1 | Free | Free | Linear | L | Abu = 2-aminobutyric acid | 25 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LDVKKIICVACKIRPNPACKKICPK | PNG-R | Free | Free | Linear | L | None | 25 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LDVKKII-{nnr:Abu}-VA-{nnr:Abu}-KIRPNPA-{nnr:Abu}-KKI-{nnr:Abu}-PK | PNG-R/1 | Free | Free | Linear | L | Abu = 2-aminobutyric acid | 25 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23562719 | 2013 | KAYSMPRCKGGFRAVMCWL{ct:Amid} | Shuchin 3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.3% hemolysis at 200µg/ml | Rabbit | Derived from skin of Rana shuchinae | NA | NA | ||
| 23562719 | 2013 | KAYSTPRCKGLFRALMCWL{ct:Amid} | Shuchin 4 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.2% hemolysis at 200µg/ml | Rabbit | Derived from skin of Rana shuchinae | NA | NA | ||
| 23562719 | 2013 | KAYSTPRCKYLFRAVLCWL{ct:Amid} | Shuchin 5 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.6% hemolysis at 200µg/ml | Rabbit | Derived from skin of Rana shuchinae | NA | NA | ||
| 23562719 | 2013 | KAYSMPRCKGGFRAVMCWL{ct:Amid} | Shuchin 3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.7% hemolysis at 200µg/ml | Human | Derived from skin of Rana shuchinae | NA | NA | ||
| 23562719 | 2013 | KAYSTPRCKGLFRALMCWL{ct:Amid} | Shuchin 4 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 2.5% hemolysis at 200µg/ml | Human | Derived from skin of Rana shuchinae | NA | NA | ||
| 23562719 | 2013 | KAYSTPRCKYLFRAVLCWL{ct:Amid} | Shuchin 5 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.5% hemolysis at 200µg/ml | Human | Derived from skin of Rana shuchinae | NA | NA | ||
| 10606532 | 1999 | KWL{d}L{d}LLKL{d}LL{d}LK{ct:Amid} | [D]L3,4,8,10-K3L8Wn | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 31% hemolysis at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10606532 | 1999 | KLL{d}L{d}LWKL{d}LL{d}LK{ct:Amid} | [D]L3,4,8,10-K3L8Wm | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 39.4% hemolysis at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10606532 | 1999 | KLL{d}L{d}LLKL{d}LL{d}WK{ct:Amid} | [D]L3,4,8,10-K3L8Wc | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 44.2% hemolysis at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10606532 | 1999 | KWL{d}L{d}KLKL{d}KL{d}LK{ct:Amid} | [D]L3,4,8,10-K5L6Wn | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KLL{d}L{d}KWKL{d}KL{d}LK{ct:Amid} | [D]L3,4,8,10-K5L6Wm | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KLL{d}L{d}KLKL{d}KL{d}WK{ct:Amid} | [D]L3,4,8,10-K5L6Wc | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKWL{d}KLKL{d}KL{d}KK{ct:Amid} | [D]L4,8,10-K7L4Wn | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKL{d}L{d}KWKL{d}KL{d}KK{ct:Amid} | [D]L3,4,8,10-K7L4Wm | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKL{d}L{d}KLKL{d}KW{d}KK{ct:Amid} | [D]L3,4,8-K7L4Wc | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14636071 | 2003 | GALRGCWTKSYPPKPCK{cyc:N-C}{ct:Amid} | Ranacyclin T | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | 20% hemolysis at 100μM | Human | Derived from skin secretion of Rana temporaria | NA | NA | ||
| 14636071 | 2003 | SAPRGCWTKSYPPKPCK{cyc:N-C}{ct:Amid} | Ranacyclin E | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | 55% hemolysis at 100μM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 14636071 | 2003 | LVRGCWTKSYPPKPCFVR{cyc:N-C} | pLR | Free | Free | Cyclic | L | None | 18 | Antimicrobial | 85% hemolysis at 100μM | Human | Derived from skin of Rana pipiens | NA | NA | ||
| 15996769 | 2005 | FLSSIGKILGNLL{ct:Amid} | Temporin-1Va | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =120μM | Human | Derived from skin secretion of Rana virgatipes | NA | NA | ||
| 15996769 | 2005 | FLSIIAKVLGSLF{ct:Amid} | Temporin-1Vb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =30μM | Human | Derived from skin secretion of Rana virgatipes | NA | NA | ||
| 15996769 | 2005 | FLPLVTMLLGKLF{ct:Amid} | Temporin-1Vc | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =30μM | Human | Derived from skin secretion of Rana virgatipes | NA | NA | ||
| 19635516 | 2009 | IPPFIKKVLTTVF{ct:Amid} | Temporin-CPa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =220μM | Human | Derived from skin secretions of Lithobates capito | NA | NA | ||
| 20656059 | 2010 | GMASKAGSIVGKIKIALGAL | PGLa-B2 | Free | Free | Linear | L | None | 20 | Antimicrobial | 27% hemolysis at 200μM | Human | Peptide glycine–leucine-amide (Xenopus borealis) | NA | NA | ||
| 20656059 | 2010 | GLGSLLGKAFKIGLKTVGKMMGGAPREQ | CPF-B1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 18% hemolysis at 200μM | Human | Caerulein-precursor fragments (Xenopus borealis) | NA | NA | ||
| 21073979 | 2010 | GKLNLFLSRLEILKLFVGAL | Pelteobagrin | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis upto 400μM (Non hemolytic) | Rabbit | Derived from skin mucus of Pelteobagrus fulvidraco | NA | Non-hemolytic | ||
| 21396976 | 2011 | SFPFFPPGICKRLKRC | Limnonectin-1Fa | Free | Free | Linear | L | None | 16 | Antimicrobial | 0% hemolysis upto 160μM (Non hemolytic) | Horse | Limnonectin (Limnonectes fujianensis) | NA | Non-hemolytic | ||
| 21396976 | 2011 | SFHVFPPWMCKSLKKC | Limnonectin-1Fb | Free | Free | Linear | L | None | 16 | Antimicrobial | 0% hemolysis upto 160μM (Non hemolytic) | Horse | Limnonectin (Limnonectes fujianensis) | NA | Non-hemolytic | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 5% hemolysis at 30μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 20% hemolysis at 45μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 30% hemolysis at 60μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 50% hemolysis at 75μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 85% hemolysis at 120μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 90% hemolysis at 150μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 100% hemolysis at 180μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9010936 | 1996 | GFFALIPKIISSPLFKTLLSAVGSALSSSGEQE | PX | Free | Free | Linear | L | None | 33 | Antimicrobial | 100% hemolysis at 14μg/ml | Human | Derived from the amino terminal region of the toxin pardaxin | NA | NA | ||
| 9010936 | 1996 | GFFALIPKIISSPLFKTL{ct:Amid} | 18P | Amidation | Free | Linear | L | None | 18 | Antimicrobial | No hemolysis (Non hemolytic) | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 9010936 | 1996 | GFFALIAKIISSPLFKTL{ct:Amid} | 18A | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 33μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 9010936 | 1996 | GFFALIAQIISSPLFQTL{ct:Amid} | 18Q | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 56μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 9204560 | 1997 | F{d}R{d}L{d}K{d}F{d}H{d} | 66-10 | Free | Free | Linear | D | None | 6 | Antimicrobial | 0% hemolysis at 312 to 0μg/ml | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 9204560 | 1997 | F{d}R{d}L{d}K{d}F{d}H{d} | 66-10 | Free | Free | Linear | D | None | 6 | Antimicrobial | 0% hemolysis at 312 to 0μg/ml | Bovine | Synthetic Peptide | NA | Non-hemolytic | ||
| 9204560 | 1997 | F{d}R{d}L{d}K{d}F{d}H{d} | 66-10 | Free | Free | Linear | D | None | 6 | Antimicrobial | 0% hemolysis at 312 to 0μg/ml | Ovine | Synthetic Peptide | NA | Non-hemolytic | ||
| 9271200 | 1997 | RQRVEELSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 5μg/ml | Sheep | Misgurnus anguillicaudatus | NA | NA | ||
| 9271200 | 1997 | RQRVEELSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 10μg/ml | Sheep | Misgurnus anguillicaudatus | NA | NA | ||
| 9271200 | 1997 | RQRVEELSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0.23% hemolysis at 25μg/ml | Sheep | Misgurnus anguillicaudatus | NA | NA | ||
| 9271200 | 1997 | RQRVEELSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0.23% hemolysis at 50μg/ml | Sheep | Misgurnus anguillicaudatus | NA | NA | ||
| 9271200 | 1997 | RQRVEELSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0.46% hemolysis at 100μg/ml | Sheep | Misgurnus anguillicaudatus | NA | NA | ||
| 9639668 | 1998 | GVVKVSRLKGESLRARL | bPaAP | Free | Free | Linear | L | None | 17 | Antimicrobial | 0.42% hemolysis at 200μg/ml | Human | Isolated from the stomach of the bullfrog, Rana catesbeiana | NA | NA | ||
| 9639668 | 1998 | IIKVPLKKFKSMREVMRDHGIKAPVVDPATKY | bPcAP | Free | Free | Linear | L | None | 32 | Antimicrobial | 0.36% hemolysis at 200μg/ml | Human | Isolated from the stomach of the bullfrog, Rana catesbeiana | NA | NA | ||
| 9639668 | 1998 | AVVKVPLKKFKSIRE | mPcAP | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.40% hemolysis at 200μg/ml | Human | Isolated from the stomach of the bullfrog, Rana catesbeiana | NA | NA | ||
| 9639668 | 1998 | AVVKVPLKKFKSIRETMKEKGLLEDF | hPcAP | Free | Free | Linear | L | None | 26 | Antimicrobial | 0.49% hemolysis at 200μg/ml | Human | Isolated from the stomach of the bullfrog, Rana catesbeiana | NA | NA | ||
| 9756752 | 1998 | KKVVFKVKFK{ct:Amid} | KSL | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolysis at 500μg/ml | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 9784609 | 1998 | FSKYERQKDKRPYSERKNQYTG | Lumbricin I | Free | Free | Linear | L | None | 22 | Antimicrobial | 0.02% hemolysis at 5μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSERKNQYTG | Lumbricin I | Free | Free | Linear | L | None | 22 | Antimicrobial | 0.06% hemolysis at 10μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSERKNQYTG | Lumbricin I | Free | Free | Linear | L | None | 22 | Antimicrobial | 0.14% hemolysis at 25μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSERKNQYTG | Lumbricin I | Free | Free | Linear | L | None | 22 | Antimicrobial | 0.19% hemolysis at 50μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSERKNQYTG | Lumbricin I | Free | Free | Linear | L | None | 22 | Antimicrobial | 0.23% hemolysis at 100μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.03% hemolysis at 5μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.07% hemolysis at 10μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.13% hemolysis at 25μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.17% hemolysis at 50μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.21% hemolysis at 100μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9824303 | 1998 | KGRGKQGGKVRAKAKTRSS | Parasin I | Free | Free | Linear | L | None | 19 | Antimicrobial | 0.2% hemolysis at 200μg/ml | Human | Parasilurus asotus | NA | NA | ||
| 9914515 | 1999 | GFFALIPKIISSPLFKTLLSAV{ct:NH(CH2)2NH2} | Par[1-22] | NH(CH2)2NH2 | Free | Linear | L | None | 22 | Antimicrobial | 22% hemolysis at 50μM | Human | Synthetic Peptide | NA | NA | ||
| 9914515 | 1999 | GFFALIP{d}KIISSPLFKTL{d}L{d}SAV{ct:NH(CH2)2NH2} | [D]-P7L18,19-Par[1-22] | NH(CH2)2NH2 | Free | Linear | Mix | None | 22 | Antimicrobial | 1% hemolysis at 50μM | Human | Synthetic Peptide | NA | NA | ||
| 9914515 | 1999 | KGFFALIP{d}KIISSPLFKTL{d}L{d}SAV{ct:NH(CH2)2NH2} | K1[D]-P7L18,19-Par[1-22] | NH(CH2)2NH2 | Free | Linear | Mix | None | 23 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10195441 | 1999 | PKLLKTFLSKWIG | SPFK | Free | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 40μM | Rat | Synthetic Peptide | NA | NA | ||
| 10195441 | 2000 | PKLLKKFLKKWIG | K5 | Free | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 175μM | Rat | Synthetic Peptide | NA | NA | ||
| 10195441 | 2001 | PKLLKTFLSKWKKIG | WKK | Free | Free | Linear | L | None | 15 | Antimicrobial | 100% hemolysis at 85μM | Rat | Synthetic Peptide | NA | NA | ||
| 10195441 | 2002 | PKLLKFLSKWIG | K3S | Free | Free | Linear | L | None | 12 | Antimicrobial | 100% hemolysis at 63μM | Rat | Synthetic Peptide | NA | NA | ||
| 10195441 | 2003 | PKLLKTFLKWIG | K3T | Free | Free | Linear | L | None | 12 | Antimicrobial | 100% hemolysis at >330μM | Rat | Synthetic Peptide | NA | NA | ||
| 10195441 | 2004 | PKLKTFLSKWIG | KTF | Free | Free | Linear | L | None | 12 | Antimicrobial | 0% hemolysis at 300μM | Rat | Synthetic Peptide | NA | Non-hemolytic | ||
| 10195441 | 2005 | PKLLKFLKWIG | K3 | Free | Free | Linear | L | None | 11 | Antimicrobial | 100% hemolysis at 365μM | Rat | Synthetic Peptide | NA | NA | ||
| 10217411 | 1999 | GLPALISWIKRKRQQG{ct:Amid} | MCF | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 100% hemolysis at 100μg/ml | Rat | Synthetic Peptide | NA | NA | ||
| 10217411 | 1999 | GLKKLISWIKRAAQQG{ct:Amid} | MCFA | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 100% hemolysis at 110μg/ml | Rat | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VOLF{d}PVOLF{d}P{cyc:N-C} | GS | Free | Free | Cyclic | Mix | None | 10 | Antimicrobial | 100% hemolysis at 12.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 1.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14V10 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 6.2μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C} | GS14L3 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 12.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C} | GS14P14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 6.2μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}P{d}LKVKLY{d}P{cyc:N-C} | GS14P7 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 12.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | V{d}KLKVYPLKVKLY{d}P{cyc:N-C} | GS14V1 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 40μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C} | GS14L12 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 25μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C} | GS14V5 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 150μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLYP{cyc:N-C} | GS14Y13 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 12.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C} | GS14L8 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 50μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVYPLKVKLY{d}P{cyc:N-C} | GS14Y6 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 25μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K2 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 50μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C} | GS14K9 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C} | GS14K11 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 150μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VK{d}LK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K2K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VK{d}LK{d}VY{d}PLK{d}VK{d}LY{d}P{cyc:N-C} | GS14K2K4K9K11 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10421892 | 1999 | WNPFKELERAGQRIRDSIISAAP | Cecropin D1 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 100μg/ml | Human | Cecropin D (Agrius convolvuli) | NA | Non-hemolytic | ||
| 10421892 | 1999 | WNPFKELERAGQRVRDAIISAAP | Cecropin D2 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 100μg/ml | Human | Cecropin D (Agrius convolvuli) | NA | Non-hemolytic | ||
| 10424354 | 1999 | KWKLFKKIGIGKFLHSAKKF{ct:Amid} | CA(1-8) – MA(1-12) | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 25μM | Human | Cecropia moth | NA | Non-hemolytic | ||
| 10424354 | 1999 | KWKLFKKIGIGKFLHSAKKF{ct:Amid} | CA(1-8) – MA(1-12) | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100μM | Human | Cecropia moth | NA | Non-hemolytic | ||
| 10424354 | 1999 | KWKLFKKIGIGAVLKVLTTG{ct:Amid} | CA(1-8) - ME(1-12) | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 3.1% hemolysis at 25μM | Human | Cecropia moth | NA | NA | ||
| 10424354 | 1999 | KWKLFKKIGIGAVLKVLTTG{ct:Amid} | CA(1-8) - ME(1-12) | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 15.5% hemolysis at 100μM | Human | Cecropia moth | NA | NA | ||
| 15996769 | 2005 | FLSSIGKILGNLL{ct:Amid} | Temporin-1Va | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =120μM | Human | R. catesbeiana, R. clamitans, R. grylio and R. Septentrionalis | NA | NA | ||
| 15996769 | 2005 | FLSIIAKVLGSLF{ct:Amid} | Temporin-IVb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =30μM | Human | R. catesbeiana, R. clamitans, R. grylio and R. Septentrionalis | NA | NA | ||
| 15996769 | 2005 | FLPLVTMLLGKLF{ct:Amid} | Temporin-1Vc | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =30μM | Human | R. catesbeiana, R. clamitans, R. grylio and R. Septentrionalis | NA | NA | ||
| 18375018 | 2000 | INWKKIFEKVKNLV{ct:Amid} | PDD-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIFQKVKNLV{ct:Amid} | PDD-A-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIFEKVKDLV{ct:Amid} | PDD-A-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | IDWKKIFEKVKNLV{ct:Amid} | PDD-A-3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | IDWKKIFEKVKDLV{ct:Amid} | PDD-A-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | IDWSKIFEKVKNLV{ct:Amid} | PDD-A-5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWSSIFEKVKNLV{ct:Amid} | PDD-A-6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWSSIFESVKNLV{ct:Amid} | PDD-A-7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWSSIFESVSNLV{ct:Amid} | PDD-A-8 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIFEKVSNLV{ct:Amid} | PDD-A-9 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIFESVKNLV{ct:Amid} | PDD-A-10 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKSIFEKVKNLV{ct:Amid} | PDD-A-11 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | NIWKKIFEKVKNLV{ct:Amid} | PDD-A-12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKILGAL{ct:Amid} | PDD-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =45μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKILGAI{ct:Amid} | PDD-B-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =75μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLRLGRRILGAL{ct:Amid} | PDD-B-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =25μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INFLKLGKKILGAL{ct:Amid} | PDD-B-3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >140μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKLGKKILGAL{ct:Amid} | PDD-B-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >140μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INSLKLGKKILGAL{ct:Amid} | PDD-B-5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKMMSAL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =100μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKK-{nnr:Nle}-{nnr:Nle}-SAL{ct:Amid} | MP-1 | Amidation | Free | Linear | L | Nle = Nle | 14 | Antimicrobial | IC50 =43μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKLLSAL{ct:Amid} | MP-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =44μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKLLSAL{nt:Fmoc}{ct:Amid} | MP-3 | Amidation | Fmoc | Linear | L | None | 14 | Antimicrobial | IC50 =6μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKLLSAL{nt:Acet}{ct:Amid} | MP-4 | Amidation | Acetylation | Linear | L | None | 14 | Antimicrobial | IC50 =44μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKMMSAI{ct:Amid} | MP-5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | SNWLKLGKKMMSAL{ct:Amid} | MP-6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >>100μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKMMSAL{nt:Fmoc}{ct:Amid} | MP-7 | Amidation | Fmoc | Linear | L | None | 14 | Antimicrobial | IC50 =13μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKMMSAL{nt:Acet}{ct:Amid} | MP-8 | Amidation | Acetylation | Linear | L | None | 14 | Antimicrobial | IC50 >>100μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKMMSAL{ct:OH} | MP-9 | OH | Free | Linear | L | None | 14 | Antimicrobial | IC50 >>100μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIASIGKEVLKAL{ct:Amid} | PMM | Amidation | Free | Linear | L | None | 16 | Antimicrobial | IC50 =80μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIASIGKEVLKAI{ct:Amid} | PMM-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | IC50 >100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | NWKKIASIGKEVLKAL{ct:Amid} | PMM-2 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | IC50 >100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | WKKIASIGKEVLKAL{ct:Amid} | PMM-3 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | KKIASIGKEVLKAL{ct:Amid} | PMM-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | KIASIGKEVLKAL{ct:Amid} | PMM-5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIASIGKEVLKA{ct:Amid} | PMM-6 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIASIGKEVLK{ct:Amid} | PMM-7 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIASIGKEVL{ct:Amid} | PMM-8 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INQKKIASIGKEV{ct:Amid} | PMM-9 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | IWNKIAKSIGKVLEKAL{ct:Amid} | PMM-10 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | IC50 >100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKGKEVLKAL{ct:Amid} | PMM-11 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | NIWKKIASIAKEVLKAL{ct:Amid} | PMM-12 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | IC50 =32μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | KNWKKIASIGKEVLKAL{ct:Amid} | PMM-13 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | SNWKKIASIGKEVLKAL{ct:Amid} | PMM-14 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18568863 | 2008 | FKRLEKLFSKIWNWK{ct:Amid} | A3-NT | Amidation | Free | Linear | L | None | 15 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 (AR-1) | Free | Free | Linear | L | None | 21 | Antimicrobial | MHC >1μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | RWSVYAYVRVRGVLVRYRRSW | AR-1-S | Free | Free | Linear | L | None | 21 | Antimicrobial | MHC >1μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | GKPRPYSPRPTSHPRPIRV | Drosocin | Free | Free | Linear | L | None | 19 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | LNLKGIFKKVASLLT | Euminitin | Free | Free | Linear | L | None | 15 | Antimicrobial | MHC <1000μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | RVKRVWPLVIRTVIAGYNLYRAIKKK | Fowlicidin-1 | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC =1->440μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P | GS | Free | Free | Linear | Mix | O = L-Ornithine | 10 | Antimicrobial | MHC =12.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VKLKVY{d}PLKVKLY{d}P | GS14 | Free | Free | Linear | Mix | None | 14 | Antimicrobial | MHC =1.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VKLK{d}VY{d}PLKVKLY{d}P | GS14K4 | Free | Free | Linear | Mix | None | 14 | Antimicrobial | MHC =200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | AKLK{d}AY{d}PLKAKLY{d}P | GS14K4 V3/A3 | Free | Free | Linear | Mix | None | 14 | Antimicrobial | MHC >800μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC =25μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | IL-({nnr:Nlys})-WKW-({nnr:Nlys})-WW-({nnr:Nlys})-WRR{ct:Amid} | Indolicidin Ink | Amidation | Free | Linear | L | Nlys = Nlys | 13 | Antimicrobial | MHC >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS | K9CATH | Free | Free | Linear | L | None | 38 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | GVVDILKGAAKDLAGHLATKVMNKL | Laticeptin | Free | Free | Linear | L | None | 25 | Antimicrobial | MHC <400μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | LEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSVL | LEK-45 | Free | Free | Linear | L | None | 45 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | MHC ~100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KILRGVSKKIMRTFLRRILTGKK | NK23c | Free | Free | Linear | L | None | 23 | Antimicrobial | MHC <10μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | GLLSGILGAGKHIVCGLTGCAKA | Odorranain-NR | Free | Free | Linear | L | None | 23 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KWKKLLKKPLLKKLLKKL{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KWKKLLKKPLLKK{ct:Amid} | P10 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KWKKPLLKKLLKKL{ct:Amid} | P11 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KKTWWKTWWTKWSQPKKKRKV | Pep-1-K | Free | Free | Linear | L | None | 21 | Antimicrobial | MHC >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | GLGSVFGRLARIGRVIPKV{ct:Amid} | Pilosulin P1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | MHC <10μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | GLLSKFGRLARKLARVIPKV{ct:Amid} | Pilosulin P2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC <10μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | HNKQEGRDHDKSKGHFHRVVIHHKGGKAH | SgI-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | MHC >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | SSLLEKGLDGAKKAVGGLGKLGK | SSL-23 | Free | Free | Linear | L | None | 22 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | SSLLEKGLDGAKKAVGGLGKLGKDA | SSL-25 | Free | Free | Linear | L | None | 25 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | SSLLEKGLDGAKKAVGGLGKLGKDAVEDL | SSL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRFPWWWPFLRR{ct:Amid} | TP | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRFPWWWPFLRR{ct:Amid} | TP | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC =50μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRF-({nnr:Nphe})-WWW-({nnr:Nphe})-FLRR{ct:Amid} | TPf | Amidation | Free | Linear | L | Nphe = Nphe | 13 | Antimicrobial | MHC >1μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRF-({nnr:Nlys})-WWW-({nnr:Nlys})-FLRR{ct:Amid} | TPk | Amidation | Free | Linear | L | Nlys = Nlys | 13 | Antimicrobial | MHC >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRFKWWWKFLRR{ct:Amid} | TPK | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRF-({nnr:Nleu})-WWW-({nnr:Nleu})-FLRR{ct:Amid} | TPl | Amidation | Free | Linear | L | Nleu = Nleu | 13 | Antimicrobial | MHC >1μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KKFPWWWPFKK{ct:Amid} | Tritrpticin STP | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KKF-({nnr:Nlys})-WWW-({nnr:Nlys})-FKK{ct:Amid} | Tritrpticin STPk | Amidation | Free | Linear | L | Nlys = Nlys | 11 | Antimicrobial | MHC >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KWKSFLKTFKSAAKTVLHTALKAISS{nt:Acet}{ct:Amid} | V13AD | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =31.3μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KWKSFLKTFKSAVKTVLHTALKAISS{nt:Acet}{ct:Amid} | V681 | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =7.8μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}V{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | DV681 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | MHC =7.8μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18723059 | 2008 | FMPIIGRLMSGSL | VESP-VB1 | Free | Free | Linear | L | None | 13 | Antimicrobial | 10.2% hemolysis up to 200μg/ml | Rabbit | Synthetic Peptide | NA | NA | ||
| 18723059 | 2008 | FMPIIGRLMSGSL | VESP-VB1 | Free | Free | Linear | L | None | 13 | Antimicrobial | 3.2% hemolysis up to 200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18723059 | 2008 | INMKASAAVAKKLL | MP-VB1 | Free | Free | Linear | L | None | 14 | Antimicrobial | 1.7% hemolysis at 200μg/ml | Rabbit | Synthetic Peptide | NA | NA | ||
| 18723059 | 2008 | INMKASAAVAKKLL | MP-VB1 | Free | Free | Linear | L | None | 14 | Antimicrobial | 2.7% hemolysis at 200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KWKLFKKIPKFLHLAKKF{ct:Amid} | P18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC =50μM | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KKKLFWKIPKFLHLAKKF{ct:Amid} | P18-W6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC <200μM | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KIKLFKKWPKFLHLAKKF{ct:Amid} | P18-W8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC =200μM | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KAKLFKKIPKFLHLWKKF{ct:Amid} | P18-W15 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC =200μM | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KWKLFKKI-{nnr:Nala}-KFLHLAKKF{ct:Amid} | P18-Nala9 | Amidation | Free | Linear | L | Nala = Nala | 18 | Antimicrobial | MHC =200μM | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KWKLFKKIP{d}KFLHLAKKF{ct:Amid} | P18-D-Pro | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC <200μM | Human | Synthetic Peptide | NA | NA | ||
| 8306981 | 1994 | ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ | Dermaseptin I | Free | Free | Linear | L | None | 34 | Antimicrobial | 100% hemolysis at 100μM | Rabbit | Phyllomedusa sauvugii | NA | NA | ||
| 8577744 | 1996 | GSKKPVPIIYCNRRTGKCQRM | Thanatin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 40μM | Porcine | Synthetic Peptide | NA | Non-hemolytic | ||
| 8910461 | 1996 | GRFKRFRKKFKKLFKKLSPVIPLLHLG | BMAP-27 | Free | Free | Linear | L | None | 27 | Antimicrobial | 3% hemolysis at 10μM | Human | Cathelicidins (Zanetti, M., Gennaro, R., and Romeo,D.) | NA | NA | ||
| 8910461 | 1996 | GRFKRFRKKFKKLFKKLSPVIPLLHLG | BMAP-27 | Free | Free | Linear | L | None | 27 | Antimicrobial | 6% hemolysis at 30μM | Human | Cathelicidins (Zanetti, M., Gennaro, R., and Romeo,D.) | NA | NA | ||
| 8910461 | 1996 | GRFKRFRKKFKKLFKKLSPVIPLLHLG | BMAP-27 | Free | Free | Linear | L | None | 27 | Antimicrobial | 22% hemolysis at 100μM | Human | Cathelicidins (Zanetti, M., Gennaro, R., and Romeo,D.) | NA | NA | ||
| 8910461 | 1996 | GGLRSLGRKILRAWKKYGPIIVPIIRIG | BMAP-28 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0% hemolysis at 100μM | Human | Cathelicidins (Zanetti, M., Gennaro, R., and Romeo,D.) | NA | Non-hemolytic | ||
| 9271200 | 1997 | RQRVQQLSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0.46% hemolysis at 100μg/ml | Sheep | Misgurnus anguillicaudatus | NA | Non-hemolytic | ||
| 16441062 | 2005 | CAESCVWIPCTVTALLGCSCSNNVCYNGIP{cyc:N-C} | Cycloviolacin H4 | Free | Free | Cyclic | L | None | 30 | HIV inhibitory, Antimicrobial, Cytotoxic, Neurotensin antagonistic, Trypsin inhibitory, Insecticide | HD50 =5.5μM | Human | Viola hederaceae | NA | NA | ||
| 16488428 | 2006 | SAISCGETCFKFKCYTPRCSCSYPVCK{cyc:N-C} | Violacin A | Free | Free | Cyclic | L | None | 27 | Uterotonic, Insecticidal, Anti-HIV, Antimicrobial, Anti-neurotensive, Cytotoxic and Hemolytic | 30% hemolysis at 1.5μM | Human | Synthetic Peptide | NA | NA | ||
| 17561225 | 2007 | GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS | Dermaseptin-L1 | Free | Free | Linear | L | None | 32 | Antimicrobial | LC50 =200μM | Human | Skin secretions of the lemur leaf frog Hylomantis lemur | NA | NA | ||
| 17561225 | 2007 | LLGMIPLAISAISALSKL{ct:Amid} | Phylloseptin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 =40μM | Human | Skin secretions of the lemur leaf frog Hylomantis lemur | NA | NA | ||
| 19778602 | 2010 | CVISAGWNHKIRCKLTGNC | Nigroain-B1 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | Non-hemolytic | ||
| 19778602 | 2010 | FKTWKRPPFQTSCSGIIKE | Nigroain-C1 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | Non-hemolytic | ||
| 19778602 | 2010 | CVHWQTNPARTSCIGP | Nigroain-D1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | Non-hemolytic | ||
| 19778602 | 2010 | DCTRWIIGINGRICRD | Nigroain-E | Free | Free | Linear | L | None | 16 | Antimicrobial | 7.62±1.60% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | NA | ||
| 19778602 | 2010 | SLWETIKNAGKGFILNILDKIRCKVAGGCKT | Nigroain-K2 | Free | Free | Linear | L | None | 31 | Antimicrobial | 85.52±3.26% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | NA | ||
| 19778602 | 2010 | SIRDKIKTIAIDLAKSAGTGVLKTLICKLDKSC | Rugosin-RN1 | Free | Free | Linear | L | None | 33 | Antimicrobial | 6.69±1.51% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | NA | ||
| 19778602 | 2010 | FLGPIIKIATGILPTAICKILKKC | Gaegurin-RN3 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | Non-hemolytic | ||
| 19778602 | 2010 | FLPLVLGALSGILPKILGK | Temporin-TN1 | Free | Free | Linear | L | None | 19 | Antimicrobial | 95.7±4.12% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.7% hemolysis at 0.0625mg/ml | Human | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.8% hemolysis at 0.125mg/ml | Human | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 5.9% hemolysis at 0.25mg/ml | Human | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 7.6% hemolysis at 0.5mg/ml | Human | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 7.8% hemolysis at 1mg/ml | Human | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 1.5% hemolysis at 0.0625mg/ml | Rabbit | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 7.2% hemolysis at 0.125mg/ml | Rabbit | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 7.8% hemolysis at 0.25mg/ml | Rabbit | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 9.5% hemolysis at 0.5mg/ml | Rabbit | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 57.1% hemolysis at 1mg/ml | Rabbit | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0.6% hemolysis at 0.0625mg/ml | Human | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0.8% hemolysis at 0.125mg/ml | Human | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.2% hemolysis at 0.25mg/ml | Human | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.3% hemolysis at 0.5mg/ml | Human | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 11.3% hemolysis at 1mg/ml | Human | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.2% hemolysis at 0.0625mg/ml | Rabbit | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 4.7% hemolysis at 0.125mg/ml | Rabbit | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.2% hemolysis at 0.25mg/ml | Rabbit | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 12.4% hemolysis at 0.5mg/ml | Rabbit | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 66.3% hemolysis at 1mg/ml | Rabbit | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 16675060 | 2006 | AVDLAKIANKVLSSLF{ct:Amid} | Temporin-1TGb | Amidation | Free | Linear | L | None | 16 | Antimicrobial | LD50 =250μM | Human | Extradermal tissues of Tago’s brown frog Rana tagoi | NA | NA | ||
| 16675060 | 2006 | FLPVILPVIGKLLSGIL{ct:Amid} | Temporin-1TGc | Amidation | Free | Linear | L | None | 17 | Antimicrobial | LD50 =50μM | Human | Extradermal tissues of Tago’s brown frog Rana tagoi | NA | NA | ||
| 16735513 | 2006 | SMWSGMWRRKLKKLRNALKKKLKGE | Ltc1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 20% hemolysis at 80μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | GLFGKLIKKFGRKAISYAVKKARGKH | Ltc2a | Free | Free | Linear | L | None | 26 | Antimicrobial | 20% hemolysis at 6.0μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | SWKSMAKKLKEYMEKLKQRA{ct:Amid} | Ltc3a | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 20% hemolysis at >120μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | SWASMAKKLKEYMEKLKQRA{ct:Amid} | Ltc3b | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 20% hemolysis at >120μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | GLKDKFKSMGEKLKQYIQTWKAKF{ct:Amid} | Ltc4a | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 20% hemolysis at >120μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | SLKDKVKSMGEKLKQYIQTWKAKF{ct:Amid} | Ltc4b | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 20% hemolysis at >120μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | GFFGKMKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc5 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 20% hemolysis at 40μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 12804591 | 2003 | FLPILGKLLSGIL{ct:Amid} | MRP | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 = 8μM | Human | Rana tagoi | NA | NA | ||
| 14531844 | 2003 | FLPILASLAAKFGPKLFCLVTKKC | Brevinin-1BYa | Free | Free | Linear | L | None | 24 | Antimicrobial | HC50 = 4μM | Human | Rana boylii | NA | NA | ||
| 14531844 | 2003 | FLPILASLAAKLGPKLFCLVTKKC | Brevinin-1BYb | Free | Free | Linear | L | None | 24 | Antimicrobial | HC50 = 4μM | Human | Rana boylii | NA | NA | ||
| 14531844 | 2003 | GILSTFKGLAKGVAKDLAGNLLDKFKCKITGC | Ranatuerin-2BYa | Free | Free | Linear | L | None | 32 | Antimicrobial | HC50 = 120μM | Human | Rana boylii | NA | NA | ||
| 14531844 | 2003 | GIMDSVKGLAKNLAGKLLDSLKCKITGC | Ranatuerin-2BYb | Free | Free | Linear | L | None | 28 | Antimicrobial | HC50 >200μM | Human | Rana boylii | NA | NA | ||
| 15328050 | 2004 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 7% hemolysis at 1μM | Guinea-pig | Pandinin 2 from venom of the scorpionid scorpion Pandinus imperator | NA | NA | ||
| 15328050 | 2004 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50% hemolysis at 6μM | Guinea-pig | Pandinin 2 from venom of the scorpionid scorpion Pandinus imperator | NA | NA | ||
| 15328050 | 2004 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 85% hemolysis at 12.5μM | Guinea-pig | Pandinin 2 from venom of the scorpionid scorpion Pandinus imperator | NA | NA | ||
| 15328050 | 2004 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 100% hemolysis at 25μM | Guinea-pig | Pandinin 2 from venom of the scorpionid scorpion Pandinus imperator | NA | NA | ||
| 15328050 | 2004 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxki1 | Free | Free | Linear | L | None | 48 | Antimicrobial | 10% hemolysis at 2.5μM | Guinea-pig | Oxyopinin (Oxyopid spider Oxyopes kitabensis) | NA | NA | ||
| 15328050 | 2004 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxki1 | Free | Free | Linear | L | None | 48 | Antimicrobial | 25% hemolysis at 6μM | Guinea-pig | Oxyopinin (Oxyopid spider Oxyopes kitabensis) | NA | NA | ||
| 15328050 | 2004 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxki1 | Free | Free | Linear | L | None | 48 | Antimicrobial | 50% hemolysis at 12.5μM | Guinea-pig | Oxyopinin (Oxyopid spider Oxyopes kitabensis) | NA | NA | ||
| 15328050 | 2004 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxki1 | Free | Free | Linear | L | None | 48 | Antimicrobial | 60% hemolysis at 25μM | Guinea-pig | Oxyopinin (Oxyopid spider Oxyopes kitabensis) | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHAVKAISDLI{ct:Amid} | Kassinatuerin-1 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LD50 =65μM | Human | Skin of the African frog Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | IPHAVKAISDLI{ct:Amid} | Kassinatuerin-1 (10-21)fragment | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0% hemolysis at 400μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHKVKAISDLI{ct:Amid} | Kassinatuerin-1 (Lys13) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 32% hemolysis at 400μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHAVKAISKLI{ct:Amid} | Kassinatuerin-1 (Lys19) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LD50 =45μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHAVKAIKKLI{ct:Amid} | Kassinatuerin-1 (Lys18, Lys19) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LD50 =25μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIKPLIPHAVKAISKLI{ct:Amid} | Kassinatuerin-1 (Lys7, Lys19) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LD50 =55μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIKPLIPHAVKAIKKLI{ct:Amid} | Kassinatuerin-1 (Lys7, Lys18, Lys19) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LD50 =40μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHAVKAISDLI | Kassinatuerin-1 (COOH) | Free | Free | Linear | L | None | 21 | Antimicrobial | 39% hemolysis at 400μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHAVKAISKLI | Kassinatuerin-1 (Lys19)(COOH) | Free | Free | Linear | L | None | 21 | Antimicrobial | LD50 =120μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIKPLIPHAVKAISKLI | Kassinatuerin-1 (Lys7, Lys19)(COOH) | Free | Free | Linear | L | None | 21 | Antimicrobial | LD50 =135μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIKPLIPHAVKAIKKLI | Kassinatuerin-1 (Lys7, Lys18, Lys19) (COOH) | Free | Free | Linear | L | None | 21 | Antimicrobial | LD50 =200μM | Human | Kassina senegalensis | NA | NA | ||
| 11897590 | 2001 | ALWKTLLKKVLKA{ct:Amid} | P | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFKKKKQ | W1 | Free | Free | Linear | L | None | 25 | Antimicrobial, Insecticidal | Zone of inhibition 2mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFKKKKQ | W1 | Free | Free | Linear | L | None | 25 | Antimicrobial, Insecticidal | Zone of inhibition 1mm at 0.4-0.5mM | Sheep | Ponericin | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFQKKKK | W2 | Free | Free | Linear | L | None | 25 | Antimicrobial, Insecticidal | Zone of inhibition 1mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | GIWGTALKWGVKLLPKLVGMAQTKKQ | W4 | Free | Free | Linear | L | None | 26 | Antimicrobial, Insecticidal | Zone of inhibition 2mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | FWGALIKGAAKLIPSVVGLFKKKQ | W5 | Free | Free | Linear | L | None | 24 | Antimicrobial, Insecticidal | Zone of inhibition 4mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | FWGALIKGAAKLIPSVVGLFKKKQ | W5 | Free | Free | Linear | L | None | 24 | Antimicrobial, Insecticidal | Zone of inhibition 1.5mm at 0.4-0.5mM | Sheep | Ponericin | NA | NA | ||
| 11279030 | 2001 | FIGTALGIASAIPAIVKLFK{ct:Amid} | W6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Insecticidal | Zone of inhibition 3mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | FIGTALGIASAIPAIVKLFK{ct:Amid} | W6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Insecticidal | Zone of inhibition 1mm at 0.4-0.5mM | Sheep | Ponericin | NA | NA | ||
| 10606532 | 1999 | KWL{d}L{d}LLKL{d}LL{d}LK{ct:Amid} | [D]L3,4,8,10-K3 L8W(n) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 31% hemolysis at 50μM | Human | Synthetic Peptide | NA | NA | ||
| 10606532 | 1999 | KLL{d}L{d}LWKL{d}LL{d}LK{ct:Amid} | [D]L3,4,8,10-K3 L8W(m) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 39.4% hemolysis at 50μM | Human | Synthetic Peptide | NA | NA | ||
| 10606532 | 1999 | KLL{d}L{d}LLKL{d}LL{d}WK{ct:Amid} | [D]L3,4,8,10-K3 L8W(c) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 44.2% hemolysis at 50μM | Human | Synthetic Peptide | NA | NA | ||
| 10606532 | 1999 | KWL{d}L{d}KLKL{d}KL{d}LK{ct:Amid} | [D]L3,4,8,10-K5L6W(n) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KLL{d}L{d}KWKL{d}KL{d}LK{ct:Amid} | [D]L3,4,8,10-K5L6W(m) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KLL{d}L{d}KLKL{d}KL{d}WK{ct:Amid} | [D]L3,4,8,10-K5L6W(c) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKW{d}L{d}KLKL{d}KL{d}KK{ct:Amid} | [D]L4,8,10-K7L4W(n) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKL{d}L{d}KWKL{d}KL{d}KK{ct:Amid} | [D]L3,4,8,10-K7L4W(m) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKL{d}L{d}KLKL{d}KW{d}KK{ct:Amid} | [D]L3,4,8-K7L4W(c) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 19635516 | 2009 | IPPFIKKVLTTVF{ct:Amid} | Temporin-CPa | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 =220μM | Human | Lithobates capito | NA | NA | ||
| 19635516 | 2009 | HFLGTLVNLAKKIL{ct:Amid} | Temporin-DRa | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LC50 =65μM | Human | Rana draytonii | NA | NA | ||
| 19635516 | 2009 | FVQWFSKFLGRIL{ct:Amid} | Temporin L | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LC50 =2μM | Human | Rana temporaria | NA | NA | ||
| 16137634 | 2005 | INLKALAALAKALL{ct:Amid} | Mastoparan 7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % hemolysis at 25 µM | Bovine | Mastoparan analogs | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKL{nnr:a}KLLKKLLK{ct:Amid} | KLW-L10-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | >20% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 16142907 | 2005 | KWKKLLKKLL{nnr:a}LLKKLLK{ct:Amid} | KLW-L11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | >50% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 16142907 | 2005 | KWKKLLKK{nnr:a}LKLLKKLLK{ct:Amid} | KLW-L9,13-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | 0% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 16142907 | 2005 | KWKKLL{nnr:a}KLL{nnr:a}LLKKLLK{ct:Amid} | KLW-K7,11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | ~30% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 15009528 | 2004 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14KL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =2 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14LL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =3 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14FL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =3 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLYY{d}YPLKVKLY{d}P{cyc:N-C} | GS14YL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =8 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLNVY{d}PLKVKLY{d}P{cyc:N-C} | GS14NL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =2 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLNVY{d}PLKVKLY{d}P{cyc:N-C} | GS14GL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =3 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLTTG | HP(2-9)-ME(1-12) | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis upto 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | Non-hemolytic | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTTG | HM1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 13% hemolysis at 25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTTG | HM1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 1% hemolysis at 12.5µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTTG | HM1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 6.25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLTWG | HM2 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis upto 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | Non-hemolytic | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 44% hemolysis at 25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 31% hemolysis at 12.5µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 12% hemolysis at 6.25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 4% hemolysis at 3.12µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 1.5µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 44% hemolysis at 25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 43% hemolysis at 12.5µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 30% hemolysis at 6.25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 29% hemolysis at 3.1µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 13% hemolysis at 1.5µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 0.78µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLKKG | HM5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis upto 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | Non-hemolytic | ||
| 22699557 | 2012 | IWRIFR{ct:Amid} | HFU2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | MHC > 256 μM | Human | Synthetic peptide | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIF{ct:Amid} | HFU3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | MHC = 101.4μM | Human | Synthetic peptide | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLCYKQRCVTYCRGR{cyc:N-C}{ct:Amid} | Gomesin | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~ 40% hemolysis at 100µM | Human | Gomesin (Acanthoscurria gomesiana) | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}SRRLSYKQRSVTYSRGR{ct:Amid} | [Ser2,6,11,15]-Gm | Amidation | Free | Linear | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}SRRLCYKQRCVTYSRGR{cyc:N-C}{ct:Amid} | [Ser2,15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLSYKQRSVTYCRGR{cyc:N-C}{ct:Amid} | [Ser6,11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}DRRLSYKQRSVTYORGR{cyc:N-C}{ct:Amid} | Cyclo(2–15)[Asp2, Ser6, 11, Orn15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}SRRLOYKQRDVTYSRGR{cyc:N-C}{ct:Amid} | Cyclo(6-11)[Ser2,15, Orn6, Asp11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLEYKQRKVTYCRGR{cyc:N-C}{ct:Amid} | Bicyclo(2–15, 6–11)[Cys2, 15, Glu6, Lys11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}ERRLCYKQRCVTYKRGR{cyc:N-C}{ct:Amid} | Bicyclo(2–15, 6–11)[Glu2, Cys6, 11, Lys15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~ 32% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 23483218 | 2013 | LNWGAILKHIIK{ct:Amid} | PNG-1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 119 µM | Human | Venom Of Bee Panurgus Calcaratus | α-Helix | NA | ||
| 23483218 | 2013 | NLWAGILKHIIK{ct:Amid} | PNG-1/1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | NLWAGILKHIIK{ct:Amid} | PNG-1/2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LKWGAILKHIIK{ct:Amid} | PNG-1/3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNKGAILKHIIK{ct:Amid} | PNG-1/4 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWKAILKHIIK{ct:Amid} | PNG-1/5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at ~110 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGKILKHIIK{ct:Amid} | PNG-1/6 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >140 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAKLKHIIK{ct:Amid} | PNG-1/7 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAIKKHIIK{ct:Amid} | PNG-1/8 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAILKKIIK{ct:Amid} | PNG-1/9 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAILKHKIK{ct:Amid} | PNG-1/10 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAILKHIKK{ct:Amid} | PNG-1/11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | KNWGKILKHIIK{ct:Amid} | PNG-1/12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | KNWKAILKHIIK{ct:Amid} | PNG-1/13 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAVLKHVVK{ct:Amid} | PNG-1/14 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGA{nnr:Abu}LKH{nnr:Abu}{nnr:Abu}K{ct:Amid} | PNG-1/15 | Amidation | Free | Linear | L | Abu = 2-aminobutyric acid | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAALKHAAK{ct:Amid} | PNG-1/16 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAFLKHFFK{ct:Amid} | PNG-1/17 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 81 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAGLKHGGK{ct:Amid} | PNG-1/18 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGALLKHLLK{ct:Amid} | PNG-1/19 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 63 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGA{nnr:Nle}LKH{nnr:Nle}{nnr:Nle}K{ct:Amid} | PNG-1/20 | Amidation | Free | Linear | L | Nle = Norleucine | 12 | Antimicrobial | 50 % Hemolysis at 40 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGA{nnr:Aca}LKH{nnr:Aca}{nnr:Aca}K{ct:Amid} | PNG-1/21 | Amidation | Free | Linear | L | Aca = 1-aminocyclohexane carboxylic acid | 12 | Antimicrobial | 50 % Hemolysis at 43 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAWLKHWWK{ct:Amid} | PNG-1/22 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 132 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LDVKKIICVACKIKPNPACKKICPK | PNG-K | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LDVKKII{nnr:Abu}VA{nnr:Abu}KIKPNPA{nnr:Abu}KKI{nnr:Abu}PK{ct:Amid} | PNG-K/1 | Free | Free | Linear | L | Abu = 2-aminobutyric acid | 25 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LDVKKIICVACKIRPNPACKKICPK | PNG-R | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LDVKKII{nnr:Abu}VA{nnr:Abu}KIRPNPA{nnr:Abu}KKI{nnr:Abu}PK{ct:Amid} | PNG-R/1 | Free | Free | Linear | L | Abu = 2-aminobutyric acid | 25 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23500722 | 2013 | RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK | CecropinXJ | Free | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 10 µM | Human | Bombyx Mori | α-Helix | Non-hemolytic | ||
| 23500722 | 2013 | RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK | CecropinXJ | Free | Free | Linear or ring-shaped | L | None | 37 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bombyx Mori | α-Helix | Non-hemolytic | ||
| 23500722 | 2013 | RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK | CecropinXJ | Free | Free | Linear or ring-shaped | L | None | 37 | Antimicrobial | <5 % Hemolysis at 100 µM | Human | Bombyx Mori | α-Helix | NA | ||
| 23500722 | 2013 | RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK | CecropinXJ | Free | Free | Linear or ring-shaped | L | None | 37 | Antimicrobial | <5 % Hemolysis at 200 µM | Human | Bombyx Mori | α-Helix | NA | ||
| 23500722 | 2013 | RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK | CecropinXJ | Free | Free | Linear or ring-shaped | L | None | 37 | Antimicrobial | 10 % Hemolysis at 400 µM | Human | Bombyx Mori | α-Helix | NA | ||
| 23500722 | 2013 | RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK | CecropinXJ | Free | Free | Linear or ring-shaped | L | None | 37 | Antimicrobial | 30 % Hemolysis at 800 µM | Human | Bombyx Mori | α-Helix | NA | ||
| 23719232 | 2013 | GLLKRIKTLL{nt:Amid}{ct:Amid} | Anoplin | Amidation | Amidation | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at >500 µg/ml | Human | Anoplius Samariensis | α-Helix | NA | ||
| 23719232 | 2013 | G{nnr:Laa}LIKRKTLL{nt:Amid}{ct:Amid} | Ano-Laa02 | Amidation | Amidation | Linear | L | Laa ((S)-2-aminoundecanoic acid) | 10 | Antimicrobial | 50 % Hemolysis at ~108 µg/ml | Human | Anoplin Analogs | α-Helix | NA | ||
| 23719232 | 2013 | GLLKRK{nnr:Laa}TLL{nt:Amid}{ct:Amid} | Ano-Laa06 | Amidation | Amidation | Linear | L | Laa ((S)-2-aminoundecanoic acid) | 10 | Antimicrobial | 50 % Hemolysis at ~39 µg/ml | Human | Anoplin Analogs | α-Helix | NA | ||
| 23719232 | 2013 | GLLIKRKTL{nnr:Laa}{nt:Amid}{ct:Amid} | Ano-Laa10 | Amidation | Amidation | Linear | L | Laa ((S)-2-aminoundecanoic acid) | 10 | Antimicrobial | 50 % Hemolysis at ~77 µg/ml | Human | Anoplin Analogs | α-Helix | NA | ||
| 23719232 | 2013 | GLLIKRKTLL{ct:Amid} | C9-Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at ~5 µg/ml | Human | Anoplin Analogs | α-Helix | NA | ||
| 23935838 | 2013 | AKKVFKRLEKLFSKIQNDK{ct:Amid} | HP (2–20) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | α-Helix | Non-hemolytic | ||
| 23935838 | 2013 | AKKVFKRLEKLFSKIQNWK{ct:Amid} | Anal 1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | α-Helix | Non-hemolytic | ||
| 23935838 | 2013 | AKKVFKRLEKLFSKIWNDK{ct:Amid} | Anal 2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | α-Helix | Non-hemolytic | ||
| 23935838 | 2013 | AKKVFKRLEKLFSKIWNWK{ct:Amid} | Anal 3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | Random coil/Helical | Non-hemolytic | ||
| 23935838 | 2013 | AKKVFKRLEKSFSKIQNDK{ct:Amid} | Anal 4 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | α-Helix | Non-hemolytic | ||
| 23935838 | 2013 | AKKVSKRLEKLFSKIQNDK{ct:Amid} | Anal 5 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | α-Helix | Non-hemolytic | ||
| 23689723 | 2013 | RQIKIWFQNRRMKWKK{ct:Amid} | Penetratin | Amidation | Free | Linear | L | None | 16 | Antimicrobial | No Hemolysis at 100 µM | Human | Drosophila Transcription Factor Antennapedia | NA | Non-hemolytic | ||
| 23689723 | 2013 | LLIILRRRIRKQAHAHSL{ct:Amid} | pVEC | Amidation | Free | Linear | L | None | 18 | Antimicrobial | No Hemolysis at 100 µM | Human | Murine Vascular Endothelial Cadherin | NA | Non-hemolytic | ||
| 23689723 | 2013 | FILFILFILGGKHKHKHKHKHK{ct:Amid} | R41 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | No Hemolysis at 100 µM | Human | Designed Peptide | NA | Non-hemolytic | ||
| 23689723 | 2013 | GPPRFPPRFPPRFPPRFPPRFP{ct:Amid} | R8 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | No Hemolysis at 100 µM | Human | Design Based On Sequence Of Pr-39 | NA | Non-hemolytic | ||
| 23689723 | 2013 | AGYLLGKINLKALAALAKKIL{ct:Amid} | TP10 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | <2 % Hemolysis at 100 µM | Human | Deletion Analogue Of Transportan, A Chimeric Peptide | NA | NA | ||
| 23689723 | 2013 | MVTVLFRRLRIRRASGPPRVRV{ct:Amid} | M918 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | No Hemolysis at 100 µM | Human | Tumor Suppressor Protein P14Arf | NA | Non-hemolytic | ||
| 23689723 | 2013 | IAWVKAFIRKLRKGPLG{nt:Acet}{ct:Amid} | YTA-4 | Amidation | Acetylation | Linear | L | None | 17 | Antimicrobial | No Hemolysis at 100 µM | Human | Substrate Of Matrix Metalloprotease 2 | NA | Non-hemolytic | ||
| 23689723 | 2013 | KLALKALKALKAALKLA{ct:Amid} | MAP | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 100 µM | Human | Designed Model Amphipathic Peptide | NA | Non-hemolytic | ||
| 23689723 | 2013 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | No Hemolysis at 100 µM | Human | Human Cathelicidin | NA | Non-hemolytic | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <4 % Hemolysis at 10 µg/ml | Human | Human Cathelicidin Family | NA | NA | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <3 % Hemolysis at 20 µg/ml | Human | Human Cathelicidin Family | NA | NA | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 40 µg/ml | Human | Human Cathelicidin Family | NA | Non-hemolytic | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <2 % Hemolysis at 80 µg/ml | Human | Human Cathelicidin Family | NA | NA | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 2 % Hemolysis at 160 µg/ml | Human | Human Cathelicidin Family | NA | NA | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | | Human | Human Cathelicidin Family | NA | NA | | ||
| 23893489 | 2013 | KGCALVKVRGLTLKVCK | AMP72 | Free | Free | Linear | L | None | 17 | Antimicrobial | 12 % Hemolysis at 500 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KGCALVKVRGLTLKVCK | AMP73 | Free | Free | Linear | L | None | 17 | Antimicrobial | 4.2 % Hemolysis at 250 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KGCALVKVRGLTLKVCK | AMP74 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.5 % Hemolysis at 100 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KGCALVKVRGLTLKVCK | AMP75 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 12.5 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KGCALVKVRGLTLKVCK | AMP76 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 1 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KWCRKWQWRGVKFIKCV | AMP126 | Free | Free | Linear | L | None | 17 | Antimicrobial | 12.5 % Hemolysis at 500 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KWCRKWQWRGVKFIKCV | AMP127 | Free | Free | Linear | L | None | 17 | Antimicrobial | 6.9 % Hemolysis at 250 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KWCRKWQWRGVKFIKCV | AMP128 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.3 % Hemolysis at 100 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KWCRKWQWRGVKFIKCV | AMP129 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 12.5 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KWCRKWQWRGVKFIKCV | AMP130 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 1 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | HKCAKIKWRGVHVKYCA | AMP2041 | Free | Free | Linear | L | None | 17 | Antimicrobial | 9.4 % Hemolysis at 500 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | HKCAKIKWRGVHVKYCA | AMP2042 | Free | Free | Linear | L | None | 17 | Antimicrobial | 6.4 % Hemolysis at 250 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | HKCAKIKWRGVHVKYCA | AMP2043 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.73 % Hemolysis at 100 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | HKCAKIKWRGVHVKYCA | AMP2044 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 12.5 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | HKCAKIKWRGVHVKYCA | AMP2045 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 1 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 24004075 | 2013 | RILTMTKRVKMPQLYKQIVCRLFKTC | pleuraina1-thel | Free | Free | Linear | L | None | 26 | Antimicrobial | 2.5 % Hemolysis at 100 µg/ml | Human | Tree Frog Theloderma Kwangsiensis | NA | NA | ||
| 24004075 | 2013 | RILTMTKRVKMPQLYKQIVCRLFKTC | pleuraina1-thel | Free | Free | Linear | L | None | 26 | Antimicrobial | 3.7 % Hemolysis at 200 µg/ml | Human | Tree Frog Theloderma Kwangsiensis | NA | NA | ||
| 24004075 | 2013 | RILTMTKRVKMPQLYKQIVCRLFKTC | pleuraina1-thel | Free | Free | Linear | L | None | 26 | Antimicrobial | 3.2 % Hemolysis at 100 µg/ml | Rabbit | Tree Frog Theloderma Kwangsiensis | NA | NA | ||
| 24004075 | 2013 | RILTMTKRVKMPQLYKQIVCRLFKTC | pleuraina1-thel | Free | Free | Linear | L | None | 26 | Antimicrobial | 3.5 % Hemolysis at 200 µg/ml | Rabbit | Tree Frog Theloderma Kwangsiensis | NA | NA | ||
| 23632907 | 2013 | ILPIRSLIKKLL{ct:Amid} | Temporin-1RNa | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 105.2 ± 10.2 µM | Human | Black-Spotted Frog,Rana Nigromaculata | α-Helix | NA | ||
| 23632907 | 2013 | FLPLKKLRFGLL{ct:Amid} | Temporin-1RNb | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 136.3 ± 5.6 µM | Human | Black-Spotted Frog,Rana Nigromaculata | α-Helix | NA | ||
| 23632907 | 2013 | GLFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC | Brevinin-2RNa | Free | Free | Linear | L | None | 33 | Antimicrobial | 50 % Hemolysis at 65.2 ± 7.6 µM | Human | Black-Spotted Frog,Rana Nigromaculata | α-Helix | NA | ||
| 23713064 | 2013 | QWGRRCCGWGPGRRYCRRWC | Ib-AMP4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 15 % Hemolysis at 200 µg/ml | Sheep | Impatiens Balsamina | complex | NA | ||
| 23713064 | 2013 | QWGRRCCGWGPGRRYCRRWC | Ib-AMP5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at <100 µg/ml | Sheep | Impatiens Balsamina | complex | Non-hemolytic | ||
| 23893605 | 2013 | KILRGVCKKIMRTFLRRISKDILTGKK{ct:Amid} | NK-2 | Amidation | Free | Linear | L | None | 27 | Antimicrobial | <20 % Hemolysis at 10 µM | Human | Porcine Nk-Lysin-Derived Peptide | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVCKKIMRTFLRRISKDILTGKK{ct:Amid} | NK-2 | Amidation | Free | Linear | L | None | 27 | Antimicrobial | <40 % Hemolysis at 100 µM | Human | Porcine Nk-Lysin-Derived Peptide | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRISKDILTGKK{ct:Amid} | C7A | Amidation | Free | Linear | L | None | 27 | Antimicrobial | <40 % Hemolysis at 10 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRISKDILTGKK{ct:Amid} | C7A | Amidation | Free | Linear | L | None | 27 | Antimicrobial | <80 % Hemolysis at 100 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRISKKILTGKK{ct:Amid} | C7A-D21K | Amidation | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 10 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRISKKILTGKK{ct:Amid} | C7A-D21K | Amidation | Free | Linear | L | None | 27 | Antimicrobial | 30 % Hemolysis at 100 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRILTGKK{ct:Amid} | C7A-Δ | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 10 % Hemolysis at 10 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRILTGKK{ct:Amid} | C7A-Δ | Amidation | Free | Linear | L | None | 23 | Antimicrobial | <50 % Hemolysis at 100 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KISKRILTGKK{ct:Amid} | NK11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 10 µM | Human | Variant Of Nk-2 | α-Helix | Non-hemolytic | ||
| 23893605 | 2013 | KISKRILTGKK{ct:Amid} | NK11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Variant Of Nk-2 | α-Helix | Non-hemolytic | ||
| 23893605 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 90 % Hemolysis at 10 µM | Human | Bee Venom | α-Helix | NA | ||
| 23893605 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <100 % Hemolysis at 100 µM | Human | Bee Venom | α-Helix | NA | ||
| 23737519 | 2013 | GRFKRFRKKFKKLFKKLSPVIPLLHLGX | cathelicidin BMAP-27(b27) | Free | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at >>250 µM | Human | Bovine Myeloid Antimicrobial Peptide-27 | α-Helix | NA | ||
| 23737519 | 2013 | GEFAQFEQEAQSLEQELSQLEQQLESL | anti-cathelicidin BMAP-27 (anti-b27) | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis at >>250 µM | Human | Bovine Myeloid Antimicrobial Peptide-28 | α-Helix | NA | ||
| 23737519 | 2013 | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | cecropin B (CB) | Free | Free | Linear | L | None | 35 | Antimicrobial | 50 % Hemolysis at >>250 µM | Human | Cecropia Moth Hyalophora Cecropia | α-Helix | NA | ||
| 23737519 | 2013 | KWKVLKKKIKMLRNRINGLVKAGPALKVKLQALAL | cecropin B template (cBt) | Free | Free | Linear | L | None | 35 | Antimicrobial | 50 % Hemolysis at >>250 µM | Human | Cecropia Moth Hyalophora Cecropia | α-Helix | NA | ||
| 23737519 | 2013 | EAQNLEKEIAALEQAIQGLEKEIPALAQQIQALEL | anti-cecropin B template (anti-cBt) | Free | Free | Linear | L | None | 35 | Antimicrobial | 50 % Hemolysis at >>250 µM | Human | Cecropia Moth Hyalophora Cecropia | α-Helix | NA | ||
| 23609760 | 2013 | FVDLKKIANIINSIFGK{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 99.08 µM | Human | Chinese Brown Frog Rana Chensinensis | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 99 % Hemolysis at 80 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 99.1 % Hemolysis at 40 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 70.2 % Hemolysis at 20 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 54.3 % Hemolysis at 10 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 23.8 % Hemolysis at 5 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 13.3 % Hemolysis at 2.5 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 1.9 % Hemolysis at 1.3 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}YGRKKRRQRRR{ct:Amid} | Tat | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 11 | Antimicrobial | 44/88 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}(KK({nnr:x}(CYGRKKRRQRRRCYGRKKRRQRRR))LAQLAQ){ct:Amid} | Tat-G1L | Amidation | Free | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus,x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 29 | Antimicrobial | 5 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | (C(YGRKKRRQRRRYGRKKRRQRRRYGRKKRRQRRRYGRKKRRQRRR){nnr:x}GGGG)(KGKG)KK{d}K{nnr:*}{nt:Acet}{ct:Amid} | Tat-G2a | Amidation | Acetylation | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 59 | Antimicrobial | <0.3b % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}RQIKIWFQNRRMKWKK{ct:Amid} | Antp | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 16 | Antimicrobial | 45553 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | (C(RQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKK){nnr:x}GG)KK{d}K{nnr:*}{nt:Acet}{ct:Amid} | Antp-G1a | Amidation | Acetylation | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 39 | Antimicrobial | 1 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}(KK({nnr:x}(CRQIKIWFQNRRMKWKKCRQIKIWFQNRRMKWKK))LAQLAQ){ct:Amid} | Antp-G1L | Amidation | Free | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 42 | Antimicrobial | 1 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | (C(RQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKK){nnr:x}GGGG)(KGKG)KK{d}K{nnr:*}{nt:Acet}{ct:Amid} | Antp-G2a | Amidation | Acetylation | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 79 | Antimicrobial | <0.3b % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}LLIILRRRIRKQAHAHSK{ct:Amid} | pVEC | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 18 | Antimicrobial | 45292 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | (C(LLIILRRRIRKQAHAHSKLLIILRRRIRKQAHAHSK){nnr:x}PSPS)KPSK{nnr:*}{nt:Acet}{ct:Amid} | pVEC-G1b | Amidation | Acetylation | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 46 | Antimicrobial | <0.5b % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}AGYLLGKINKLKALAALAKKIL{ct:Amid} | TP10K | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 22 | Antimicrobial | 45324 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | (C(AGYLLGKINKLKALAALAKKILAGYLLGKINKLKALAALAKKIL){nnr:x}PSPS)KPSK{nnr:*}{nt:Acet}{ct:Amid} | TP10K-G1b | Amidation | Acetylation | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 54 | Antimicrobial | <0.5b % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}VRLPPPVRLPPPVRLPPP{ct:Amid} | SAP | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 18 | Antimicrobial | >742/>742c % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | (C([VRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPP]){nnr:x}GG)KK{d}K{nnr:*}{nt:Acet}{ct:Amid} | SAP-G1a | Amidation | Acetylation | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 43 | Antimicrobial | 41 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}(KK({nnr:x}(CVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPP))LAQLAQ){ct:Amid} | SAP-G1L | Amidation | Free | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 46 | Antimicrobial | 79 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | C([VRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPP]){nnr:x}GGGG)(KGKG)KkK{nnr:*}{nt:Acet}{ct:Amid} | SAP-G2a | Amidation | Acetylation | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 87 | Antimicrobial | >173c % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}(KKKK({nnr:x}(CVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPP))LAQLAQLAQLAQ)4{ct:Amid} | SAP-G2L | Amidation | Free | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 92 | Antimicrobial | 41 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}PPPLRVPPPLRVPPPLRV{ct:Amid} | SAPr | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 18 | Antimicrobial | >742/>742c % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | (C(PPPLRVPPPLRVPPPLRV){nnr:x}PSC(PPPLRVPPPLRVPPPLRV){nnr:x}PSKPSK{nnr:*}{nt:Acet}{ct:Amid} | SAPr-G1b | Amidation | Acetylation | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 46 | Antimicrobial | 40 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23624072 | 2013 | MKTQFVILMITVILMOMLVOTEGGILGKLWEGFKSIVGKRGLNDRDQLDDLFDSDLSDADIKLLKEMFK{ct:Amid} | Pantinin-1 | Amidation | Free | Linear | L | None | 69 | Antimicrobial | 0 % Hemolysis at <32 µM | Human | Scorpion Pandinus Imperator | α-Helix | Non-hemolytic | ||
| 23624072 | 2013 | MKTQFVILMITVILMOMLVOTEGGILGKLWEGFKSIVGKRGLNDRDQLDDLFDSDLSDADIKLLKEMFK{ct:Amid} | Pantinin-1 | Amidation | Free | Linear | L | None | 69 | Antimicrobial | 21 % Hemolysis at 64 µM | Human | Scorpion Pandinus Imperator | α-Helix | NA | ||
| 23624072 | 2013 | MKTQFVILMITVILMOMLVOTEGGILGKLWEGFKSIVGKRGLNDRDQLDDLFDSDLSDADIKLLKEMFK{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 68 | Antimicrobial | 0 % Hemolysis at <8 µM | Human | Scorpion Pandinus Imperator | α-Helix | Non-hemolytic | ||
| 23624072 | 2013 | MKAQFAILLITLVLFOMFSOSEAIFGAIWKGISSLLGKRGLNNLNDFDELFDGEITKADLDFMREIMK{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 68 | Antimicrobial | 8 % Hemolysis at 16 µM | Human | Scorpion Pandinus Imperator | α-Helix | NA | ||
| 23624072 | 2013 | MKAQFAILLITLVLFOMFSOSEAIFGAIWKGISSLLGKRGLNNLNDFDELFDGEITKADLDFMREIMK{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 68 | Antimicrobial | 81 % Hemolysis at 32 µM | Human | Scorpion Pandinus Imperator | α-Helix | NA | ||
| 23624072 | 2013 | MKAQFAILLITLVLFOMFSOSEAIFGAIWKGISSLLGKRGLNNLNDFDELFDGEITKADLDFMREIMK{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 68 | Antimicrobial | 100 % Hemolysis at 64 µM | Human | Scorpion Pandinus Imperator | α-Helix | NA | ||
| 23624072 | 2013 | MKTQFAILLIALVLFOLLSOSCAFLSTIWNGIKSLLGRRGLNELDNLDELFDGEISQADIDFLKELMS{ct:Amid} | Pantinin-3 | Amidation | Free | Linear | L | None | 68 | Antimicrobial | 0 % Hemolysis at <8 µM | Human | Scorpion Pandinus Imperator | α-Helix | Non-hemolytic | ||
| 23624072 | 2013 | MKTQFAILLIALVLFOLLSOSCAFLSTIWNGIKSLLGRRGLNELDNLDELFDGEISQADIDFLKELMS{ct:Amid} | Pantinin-3 | Amidation | Free | Linear | L | None | 68 | Antimicrobial | 70 % Hemolysis at 16 µM | Human | Scorpion Pandinus Imperator | α-Helix | NA | ||
| 23624072 | 2013 | MKTQFAILLIALVLFOLLSOSCAFLSTIWNGIKSLLGRRGLNELDNLDELFDGEISQADIDFLKELMS{ct:Amid} | Pantinin-3 | Amidation | Free | Linear | L | None | 68 | Antimicrobial | 100 % Hemolysis at 32 µM | Human | Scorpion Pandinus Imperator | α-Helix | NA | ||
| 23982315 | 2013 | KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF | Cbf-K16 | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 5 µM | Sheep | Snake Venom Of Bungarus Fasciatus | NA | Non-hemolytic | ||
| 23982315 | 2013 | KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF | Cbf-K16 | Free | Free | Linear | L | None | 30 | Antimicrobial | <2 % Hemolysis at 10 µM | Sheep | Snake Venom Of Bungarus Fasciatus | NA | NA | ||
| 23982315 | 2013 | KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF | Cbf-K16 | Free | Free | Linear | L | None | 30 | Antimicrobial | <2 % Hemolysis at 20 µM | Sheep | Snake Venom Of Bungarus Fasciatus | NA | NA | ||
| 23982315 | 2013 | KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF | Cbf-K16 | Free | Free | Linear | L | None | 30 | Antimicrobial | 5.6 % Hemolysis at 40 µM | Sheep | Snake Venom Of Bungarus Fasciatus | NA | NA | ||
| 24012601 | 2013 | INLKAIAALAKKLL | Mastoparan-VT1 | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Human | Venom Gland Of The Wasp Vespa Tropica | NA | Non-hemolytic | ||
| 24012601 | 2013 | NLKAIAALAKKLL | Mastoparan-VT2 | Free | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Human | Venom Gland Of The Wasp Vespa Tropica | NA | Non-hemolytic | ||
| 24012601 | 2013 | INLKAIATLAKKLL | Mastoparan-VT3 | Free | Free | Linear | L | None | 14 | Antimicrobial | 25.04±5.12 % Hemolysis at 100 µg/ml | Human | Venom Gland Of The Wasp Vespa Tropica | NA | Non-hemolytic | ||
| 24012601 | 2013 | FLPIIGKLLSGLL | VCP-VT1 | Free | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Human | Venom Gland Of The Wasp Vespa Tropica | NA | Non-hemolytic | ||
| 24012601 | 2013 | FLPIIGKLLSG | VCP-VT2 | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Human | Venom Gland Of The Wasp Vespa Tropica | NA | Non-hemolytic | ||
| 24105706 | 2013 | KRIVQRIKDFLR{ct:Amid} | KR-12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Ll-37 | α-Helix | NA | ||
| 24105706 | 2013 | KRIVQRIKDWLR{ct:Amid} | KR-12-a1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIVQRIKKWLR{ct:Amid} | KR-12-a2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIVKRIKKWLR{ct:Amid} | KR-12-a3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIVKLIKKWLR{ct:Amid} | KR-12-a4 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at 96 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | LRIVKLILKWLR{ct:Amid} | KR-12-a6 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at 22 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIRKRIKKWLR{ct:Amid} | KR-12-a7 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIRKRIKKWKR{ct:Amid} | KR-12-a8 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | 50 % Hemolysis at 175 µM | Human | Human Leukocytes And Epithelia | α-Helix | NA | ||
| 24307932 | 2013 | ARIVQRIKDFLR{ct:Amid} | KR-12A18 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-37 | Helical | Non-hemolytic | ||
| 24307932 | 2013 | KAIVQRIKDFLR{ct:Amid} | KR-12A19 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-38 | Helical | Non-hemolytic | ||
| 24307932 | 2013 | KRIVQAIKDFLR{ct:Amid} | KR-12A23 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 8.5 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-39 | Helical | NA | ||
| 24307932 | 2013 | KRIVQRIADFLR{ct:Amid} | KR-12A25 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 9.4 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-40 | Helical | NA | ||
| 24307932 | 2013 | KRIVQRIKDFLA{ct:Amid} | KR-12A29 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0.2 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-41 | Helical | Non-hemolytic | ||
| 24307932 | 2013 | AQIVQRIKDFLR{ct:Amid} | KR-12A18Q19 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-42 | Helical | Non-hemolytic | ||
| 24307932 | 2013 | KKIVQKIKDFLK{ct:Amid} | KR-12 K | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 5 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-43 | Helical | NA | ||
| 24307932 | 2013 | RRIVQRIRDFLR{ct:Amid} | KR-12R | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 58 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-44 | Helical | NA | ||
| 23962023 | 2013 | KESRAKKFQRQHMDSDSSPSSSSTYSNQMMRRRNMTQGRSKPVNTFVH | 1 | Free | Free | Linear | L | None | 48 | Antimicrobial | 50 % Hemolysis at 11.6 µM | Sheep | Human Rnases | α-Helix | NA | ||
| 23962023 | 2013 | KPPQFTWAQWFETQHINMTSQQSTNAMQVINNYQRRSKNQNTFLL | 2 | Free | Free | Linear | L | None | 45 | Antimicrobial | 50 % Hemolysis at >100 µM | Sheep | Human Rnases | α-Helix | NA | ||
| 23962023 | 2013 | RPPQFTRAQWFAIQHISLNPPRSTIAMRAINNYRWRSKNQNTFL | 3 | Free | Free | Linear | L | None | 44 | Antimicrobial | 50 % Hemolysis at 9.5 µM | Sheep | Human Rnases | α-Helix | NA | ||
| 23962023 | 2013 | QDGMYQRFLRQHVHPEETGGSDRYSNLMMQRRKMTLYHSKRFNTFIH | 4 | Free | Free | Linear | L | None | 47 | Antimicrobial | 50 % Hemolysis at 15.2 µM | Sheep | Human Rnases | α-Helix | NA | ||
| 23962023 | 2013 | QDNSRYTHFLTQHYDAKPQGRDDRYSESIMRRRGLTSPSKDINTFIH | 5 | Free | Free | Linear | L | None | 47 | Antimicrobial | 50 % Hemolysis at >100 µM | Sheep | Human Rnases | α-Helix | NA | ||
| 23962023 | 2013 | WPKRLTKAHWFEIQHIQPSPLQSNRAMSGINNYTQHSKHQNTFLH | 6 | Free | Free | Linear | L | None | 45 | Antimicrobial | 50 % Hemolysis at 17.4 µM | Sheep | Human Rnases | α-Helix | NA | ||
| 23962023 | 2013 | KPKGMTSSQWFKIQHMQPSPQASNSAMKNINKHTKRSKDLNTFLH | 7 | Free | Free | Linear | L | None | 45 | Antimicrobial | 50 % Hemolysis at 10.4 µM | Sheep | Human Rnases | α-Helix | NA | ||
| 23962023 | 2013 | KPKDMTSSQWFKTQHVQPSPQASNSAMSIINKYTERSKDLNTFLH | 8 | Free | Free | Linear | L | None | 45 | Antimicrobial | 50 % Hemolysis at 15.1 µM | Sheep | Human Rnases | α-Helix | NA | ||
| 23523532 | 2013 | GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME{ct:Amid} | Cu 1a | Amidation | Free | Linear | L | None | 35 | Antimicrobial | 50 % Hemolysis at 7.8 (7.5–8.2) µM | Human | Venom Of The Ctenid Spider Cupiennius Salei | α-Helix | NA | ||
| 23523532 | 2013 | G{nnr:a}GAL{nnr:a}KFLAKKVAKTVAKQAAKQGAKYVVNKQME{ct:Amid} | Cu 2a | Amidation | Free | Linear | L | a = exchanged residues of A-Cu 1a and K-Cu 1a | 35 | Antimicrobial | 50 % Hemolysis at 2.6 (2.4–2.8) µM | Human | Venom Of The Ctenid Spider Cupiennius Salei | α-Helix | NA | ||
| 23523532 | 2013 | G{nnr:k}GAL{nnr:k}KFLAKKVAKTVAKQAAKQGAKYVVNKQME{ct:Amid} | A-Cu 1a | Amidation | Free | Linear | L | k = exchanged residues of A-Cu 1a and K-Cu 1a | 35 | Antimicrobial | 50 % Hemolysis at >40 µM | Human | Venom Of The Ctenid Spider Cupiennius Salei | α-Helix | NA | ||
| 23523532 | 2013 | GFGTILKALAKIAGKVVKKLATKPGATYMLKENLK{ct:Amid} | K-Cu 1a | Amidation | Free | Linear | L | None | 35 | Antimicrobial | 50 % Hemolysis at >40 µM | Human | Venom Of The Ctenid Spider Cupiennius Salei | α-Helix | NA | ||
| 24243598 | 2013 | KWKKLLKKPLLKKLLKKL{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 23925670 | 2013 | FWGALAKGALKLIPSLFSSFSKKD | L-Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 80 % Hemolysis at 10 µM | Human | African Scorpion Pandinus Imperator | α-Helical | NA | ||
| 23925670 | 2013 | F{d}W{d}G{d}A{d}L{d}A{d}K{d}G{d}A{d}L{d}K{d}L{d}I{d}P{d}S{d}L{d}F{d}S{d}S{d}F{d}S{d}K{d}K{d}D{d} | D-Pin2 | Free | Free | Linear | D | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 50 % Hemolysis at 10 µM | Human | African Scorpion Pandinus Imperator | α-Helical | NA | ||
| 23951222 | 2013 | RKKRLKLLKRLV | SP1 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | RKRAARLLKRLV | SP2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | RKRFARFAKRAV | SP3 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | KKKAARALKRAL | SP4 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LLIAAFKKLVKK | SP5 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | ALAHFLKKAIKK | SP6 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | NA | NA | ||
| 23951222 | 2013 | LLIKFLKRFIKH | SP7 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LLIRAAKKFIKK | SP8 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LLKALKKLLKKLL | SP9 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at 50 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LRFLKKILKHLF | SP10 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at 100 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LRALAKALKHKL | SP11 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LKALRKALKHLA | SP12 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | KRRLIARILRLAARALVKKR | SP13 | Free | Free | Linear | L | None | 20 | Antimicrobial | 25 % Hemolysis at 100 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | KRKLTLVFGVMAGVIGTKKR | SP14 | Free | Free | Linear | L | None | 20 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | Strand | NA | ||
| 23951222 | 2013 | KRKLIFLAAFLAALALFKKR | SP15 | Free | Free | Linear | L | None | 20 | Antimicrobial | 25 % Hemolysis at <20 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | KRRLAAFRAFRGALKSVLKK | SP16 | Free | Free | Linear | L | None | 20 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23710779 | 2013 | IKKILSKIKKLLK | L-K6 | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | Frog Skin Peptide Temporin-1Ceb | α-Helical | NA | ||
| 23710779 | 2013 | WKKILSKIKKLLK | I1W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKWLSKIKKLLK | I4W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKIWSKIKKLLK | L5W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKILSKIKKWLK | L11W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKILSKIKKLWK | L12W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKIWSKIKKWLK | L5WL11W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKIWSKIKKLWK | L5WL12W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKILSKIKKWWK | L11WL12W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKIWSKIKKWWK | L5WL11WL12W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 24105706 | 2013 | KRIVQRIKDFLR{ct:Amid} | KR-12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >800 µM | Human | Smallest Region Of Ll-37 | α-Helical | NA | ||
| 24055160 | 2013 | FFPFLLGALGSLLPKIF{ct:Amid} | Temporin-SN1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 82.5 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FITGLIGGLMKAL{ct:Amid} | Temporin-SN2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FISGLIGGLMKAL{ct:Amid} | Temporin-SN3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FITGLISGLLMKAL{ct:Amid} | Temporin-SN4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | AMPWRPATGLLPIKKPTHIKPLCGDD | Spinulosain-A1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | GFLNTAMNTVTNLAGTLMDKAKCKIRGC | Ranatuerin-2SN1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FLPAVLKVAAHILPTAICAISRRC | Brevinin-1SN1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 10.5 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FMGTALKIAANVLPAAFCKIFKKC | Brevinin-1SN2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 51.5 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GLRDKIKNVAIDVAKGAGTGVLKALLCOLDKSC | Brevinin-2SN1 | Free | Free | Linear | L | None | 33 | Antimicrobial | 31.8 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GVLDTLKNVAIGVAKGAGTGVLKALLCQLDKSC | Brevinin-2SN2 | Free | Free | Linear | L | None | 33 | Antimicrobial | 50.1 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGNLLKGVAKKAGLKILSIAQCKLSGTC | Brevinin-2SN3 | Free | Free | Linear | L | None | 30 | Antimicrobial | 12.7 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGDLLKGVAKEAGLKLLNMAQCKLSGNO | Brevinin-2SN4 | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | GIFSLFKAGAKFFGKNLLKEAGKAGAEHLACKAANQC | Esculentin-2SN1 | Free | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FFPFLLGALGSLLPKIF{ct:Amid} | Temporin-SN1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FITGLIGGLMKAL{ct:Amid} | Temporin-SN2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FISGLIGGLMKAL{ct:Amid} | Temporin-SN3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10.5 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FITGLISGLLMKAL{ct:Amid} | Temporin-SN4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 11.1 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | AMPWRPATGLLPIKKPTHIKPLCGDD | Spinulosain-A1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | GFLNTAMNTVTNLAGTLMDKAKCKIRGC | Ranatuerin-2SN1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FLPAVLKVAAHILPTAICAISRRC | Brevinin-1SN1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 30.2 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FMGTALKIAANVLPAAFCKIFKKC | Brevinin-1SN2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 91.4 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GLRDKIKNVAIDVAKGAGTGVLKALLCOLDKSC | Brevinin-2SN1 | Free | Free | Linear | L | None | 33 | Antimicrobial | 54.1 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GVLDTLKNVAIGVAKGAGTGVLKALLCQLDKSC | Brevinin-2SN2 | Free | Free | Linear | L | None | 33 | Antimicrobial | 91.4 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGNLLKGVAKKAGLKILSIAQCKLSGTC | Brevinin-2SN3 | Free | Free | Linear | L | None | 30 | Antimicrobial | 29.8 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGDLLKGVAKEAGLKLLNMAQCKLSGNO | Brevinin-2SN4 | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | GIFSLFKAGAKFFGKNLLKEAGKAGAEHLACKAANQC | Esculentin-2SN1 | Free | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FFPFLLGALGSLLPKIF{ct:Amid} | Temporin-SN1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FITGLIGGLMKAL{ct:Amid} | Temporin-SN2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 11.2 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FISGLIGGLMKAL{ct:Amid} | Temporin-SN3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 53.1 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FITGLISGLLMKAL{ct:Amid} | Temporin-SN4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 51.6 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | AMPWRPATGLLPIKKPTHIKPLCGDD | Spinulosain-A1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | GFLNTAMNTVTNLAGTLMDKAKCKIRGC | Ranatuerin-2SN1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 10.3 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FLPAVLKVAAHILPTAICAISRRC | Brevinin-1SN1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50.2 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FMGTALKIAANVLPAAFCKIFKKC | Brevinin-1SN2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GLRDKIKNVAIDVAKGAGTGVLKALLCOLDKSC | Brevinin-2SN1 | Free | Free | Linear | L | None | 33 | Antimicrobial | 90.2 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GVLDTLKNVAIGVAKGAGTGVLKALLCQLDKSC | Brevinin-2SN2 | Free | Free | Linear | L | None | 33 | Antimicrobial | 100 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGNLLKGVAKKAGLKILSIAQCKLSGTC | Brevinin-2SN3 | Free | Free | Linear | L | None | 30 | Antimicrobial | 53.4 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGDLLKGVAKEAGLKLLNMAQCKLSGNO | Brevinin-2SN4 | Free | Free | Linear | L | None | 30 | Antimicrobial | 11.9 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GIFSLFKAGAKFFGKNLLKEAGKAGAEHLACKAANQC | Esculentin-2SN1 | Free | Free | Linear | L | None | 37 | Antimicrobial | 9.1 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 10 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 20 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 40 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <10 % Hemolysis at 80 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <10 % Hemolysis at 120 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4 % Hemolysis at 160 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 2.5 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 10 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 15 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 18 % Hemolysis at 20 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ~90 % Hemolysis at 40 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 80 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 120 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 160 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 30 % Hemolysis at 5 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <90 % Hemolysis at 10 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 20 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 40 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 80 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 120 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 160 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 30 % Hemolysis at 5 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 80 % Hemolysis at 10 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 20 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 40 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 80 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 120 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 160 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23816372 | 2013 | WRWRWR{ct:Amid} | 1 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 10 % Hemolysis at >256 μg/mL | Human | Synthetic | α-Helical | Non-hemolytic | ||
| 23816372 | 2013 | WRWR{ct:Amid} | 2 | Amidation | Free | Linear | L | None | 4 | Antimicrobial | 10 % Hemolysis at >256 μg/mL | Human | Synthetic | α-Helical | Non-hemolytic | ||
| 23816372 | 2013 | RWR{ct:Amid} | 3 | Amidation | Free | Linear | L | None | 3 | Antimicrobial | 10 % Hemolysis at >256 μg/mL | Human | Synthetic | α-Helical | Non-hemolytic | ||
| 24349477 | 2013 | IWGLIAHGVGHVGRLIHGLIRG | Pc-pis | Free | Free | Linear | L | None | 22 | Antimicrobial | 15.303 % Hemolysis at 24 µM | Human | Pseudosciaena Crocea | α-Helix | NA | ||
| 24349477 | 2013 | IWGLIAHGVGHVGRLIHGLIRGH | Pc-pis-His | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 6 µM | Human | Pc-Pis Analogue | α-Helix | Non-hemolytic | ||
| 24349477 | 2013 | IWGLIAHGVGHVGRLIHGLIRGH | Pc-pis-His | Free | Free | Linear | L | None | 23 | Antimicrobial | 3.573 % Hemolysis at 12 µM | Human | Pc-Pis Analogue | α-Helix | NA | ||
| 24279498 | 2013 | RLARIVVIRVAR{ct:Amid} | WT | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ~40 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RRWRIVVIRVRR{ct:Amid} | sub3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ~55 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RLARIVRIRVRR{ct:Amid} | 7R11R | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ≤10 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RLRRIWVIRVAR{ct:Amid} | 3R6W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ≤10 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RLRRIWVIRVAR{ct:Amid} | 2R6W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ~20 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RWARRVVIRVAR{ct:Amid} | 2W5R | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ≤10 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RWWRIVVIRVAR{ct:Amid} | 2W3W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ~30 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RLWRWVVIRVAR{ct:Amid} | 3W5W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ≤10 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24386139 | 2013 | FAVWGCADYRGYCRAACFAFEYSLGPKGCTEGYVCCVPNTF | CFBD-1 | Free | Free | Linear | L | None | 41 | Antimicrobial | 2.5 % Hemolysis at 400 µg/ml | Human | Salamander Skin Secretions Of C. Fudingensis | NA | NA | ||
| 24386139 | 2013 | FAVWGCADYRGYCRAACFAFEYSLGPKGCTEGYVCCVPNTF | CFBD-1 | Free | Free | Linear | L | None | 41 | Antimicrobial | 3.2 % Hemolysis at 400 µg/ml | Rabbit | Salamander Skin Secretions Of C. Fudingensis | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYL | BP134 | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLAGPA | BP199 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLKDEL | BP214 | Free | Free | Linear | L | None | 15 | Antimicrobial | 2 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYL | BP203 | Free | Free | Linear | L | None | 22 | Antimicrobial | 91 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYL | BP202 | Free | Free | Linear | L | None | 26 | Antimicrobial | 83 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKKLFKKILKYL | BP193 | Free | Free | Linear | L | None | 27 | Antimicrobial | 62 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKKLFKKILKYL | BP195 | Free | Free | Linear | L | None | 27 | Antimicrobial | 71 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPA | BP200 | Free | Free | Linear | L | None | 30 | Antimicrobial | 79 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYLKDEL | BP198 | Free | Free | Linear | L | None | 26 | Antimicrobial | 59 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP192 | Free | Free | Linear | L | None | 30 | Antimicrobial | 51 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPALYKLIKKFLKKKDEL | BP213 | Free | Free | Linear | L | None | 30 | Antimicrobial | 90 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP194 | Free | Free | Linear | L | None | 31 | Antimicrobial | 71 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP196 | Free | Free | Linear | L | None | 31 | Antimicrobial | 61 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPAKDWEHLKDWEHLKDWEHLKDEL | BP236 | Free | Free | Linear | L | None | 52 | Antimicrobial | 49 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYLKKLFKKILKYL | BP204 | Free | Free | Linear | L | None | 33 | Antimicrobial | 97 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPAKKLFKKILKYL | BP201 | Free | Free | Linear | L | None | 41 | Antimicrobial | 74 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP216 | Free | Free | Linear | L | None | 45 | Antimicrobial | 89 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHL | tag54 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHLKDEL | tag54-2 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISW | BP170 | Free | Free | Linear | L | None | 21 | Antimicrobial | 82 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISW | BP171 | Free | Free | Linear | L | None | 25 | Antimicrobial | 5 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPATTGLPALISW | BP207 | Free | Free | Linear | L | None | 26 | Antimicrobial | 5 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPATTGLPALISW | BP208 | Free | Free | Linear | L | None | 26 | Antimicrobial | 15 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISWKDEL | BP172 | Free | Free | Linear | L | None | 25 | Antimicrobial | 14 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISWKDEL | BP173 | Free | Free | Linear | L | None | 29 | Antimicrobial | 8 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGAVLKVLTTGLKDEL | BP189 | Free | Free | Linear | L | None | 28 | Antimicrobial | 41 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISAGPASILAPLGTTLYKLIKKFLKKKDEL | BP217 | Free | Free | Linear | L | None | 48 | Antimicrobial | 91 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAK | BP180 | Free | Free | Linear | L | None | 18 | Antimicrobial | 12 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAK | BP181 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKFLHSAK | BP211 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKFLHSAK | BP212 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAKKDEL | BP182 | Free | Free | Linear | L | None | 22 | Antimicrobial | 1 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAKKDEL | BP183 | Free | Free | Linear | L | None | 26 | Antimicrobial | 1 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAKAGPAKDWEHLKDWEHLKDWEHLKDEL | BP235 | Free | Free | Linear | L | None | 48 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAK | BP176 | Free | Free | Linear | L | None | 21 | Antimicrobial | 3 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAK | BP175 | Free | Free | Linear | L | None | 25 | Antimicrobial | 6 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAGIGKFLHSAK | BP209 | Free | Free | Linear | L | None | 26 | Antimicrobial | 1 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAGIGKFLHSAK | BP210 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAKKDEL | BP179 | Free | Free | Linear | L | None | 25 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAKKDEL | BP178 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLAVAVVGQATQIAKKDEL | BP188 | Free | Free | Linear | L | None | 28 | Antimicrobial | 10 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAVAVVGQATQIAKKDEL | BP215 | Free | Free | Linear | L | None | 31 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | AVAVVGQATQIAKKKLFKKILKYLKDEL | BP190 | Free | Free | Linear | L | None | 28 | Antimicrobial | 11 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYL | BP134 | Free | Free | Linear | L | None | 11 | Antimicrobial | 8 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPA | BP199 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLKDEL | BP214 | Free | Free | Linear | L | None | 15 | Antimicrobial | 6 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYL | BP203 | Free | Free | Linear | L | None | 22 | Antimicrobial | 93 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYL | BP202 | Free | Free | Linear | L | None | 26 | Antimicrobial | 93 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKKLFKKILKYL | BP193 | Free | Free | Linear | L | None | 27 | Antimicrobial | 63 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKKLFKKILKYL | BP195 | Free | Free | Linear | L | None | 27 | Antimicrobial | 73 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPA | BP200 | Free | Free | Linear | L | None | 30 | Antimicrobial | 80 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYLKDEL | BP198 | Free | Free | Linear | L | None | 26 | Antimicrobial | 72 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP192 | Free | Free | Linear | L | None | 30 | Antimicrobial | 69 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPALYKLIKKFLKKKDEL | BP213 | Free | Free | Linear | L | None | 30 | Antimicrobial | 92 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP194 | Free | Free | Linear | L | None | 31 | Antimicrobial | 87 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP196 | Free | Free | Linear | L | None | 31 | Antimicrobial | 66 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPAKDWEHLKDWEHLKDWEHLKDEL | BP236 | Free | Free | Linear | L | None | 52 | Antimicrobial | 84 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYLKKLFKKILKYL | BP204 | Free | Free | Linear | L | None | 33 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPAKKLFKKILKYL | BP201 | Free | Free | Linear | L | None | 41 | Antimicrobial | 81 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP216 | Free | Free | Linear | L | None | 45 | Antimicrobial | 98 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHL | tag54 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHLKDEL | tag54-2 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISW | BP170 | Free | Free | Linear | L | None | 21 | Antimicrobial | 93 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISW | BP171 | Free | Free | Linear | L | None | 25 | Antimicrobial | 16 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPATTGLPALISW | BP207 | Free | Free | Linear | L | None | 26 | Antimicrobial | 36 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPATTGLPALISW | BP208 | Free | Free | Linear | L | None | 26 | Antimicrobial | 47 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISWKDEL | BP172 | Free | Free | Linear | L | None | 25 | Antimicrobial | 49 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISWKDEL | BP173 | Free | Free | Linear | L | None | 29 | Antimicrobial | 16 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGAVLKVLTTGLKDEL | BP189 | Free | Free | Linear | L | None | 28 | Antimicrobial | 60 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISAGPASILAPLGTTLYKLIKKFLKKKDEL | BP217 | Free | Free | Linear | L | None | 48 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAK | BP180 | Free | Free | Linear | L | None | 18 | Antimicrobial | 54 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAK | BP181 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKFLHSAK | BP211 | Free | Free | Linear | L | None | 23 | Antimicrobial | 1 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKFLHSAK | BP212 | Free | Free | Linear | L | None | 23 | Antimicrobial | 5 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAKKDEL | BP182 | Free | Free | Linear | L | None | 22 | Antimicrobial | 38 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAKKDEL | BP183 | Free | Free | Linear | L | None | 26 | Antimicrobial | 4 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAKAGPAKDWEHLKDWEHLKDWEHLKDEL | BP235 | Free | Free | Linear | L | None | 48 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAK | BP176 | Free | Free | Linear | L | None | 21 | Antimicrobial | 44 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAK | BP175 | Free | Free | Linear | L | None | 25 | Antimicrobial | 14 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAGIGKFLHSAK | BP209 | Free | Free | Linear | L | None | 26 | Antimicrobial | 13 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAGIGKFLHSAK | BP210 | Free | Free | Linear | L | None | 26 | Antimicrobial | 17 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAKKDEL | BP179 | Free | Free | Linear | L | None | 25 | Antimicrobial | 12 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAKKDEL | BP178 | Free | Free | Linear | L | None | 29 | Antimicrobial | 3 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAVAVVGQATQIAKKDEL | BP188 | Free | Free | Linear | L | None | 28 | Antimicrobial | 24 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAVAVVGQATQIAKKDEL | BP215 | Free | Free | Linear | L | None | 31 | Antimicrobial | 3 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | AVAVVGQATQIAKKKLFKKILKYLKDEL | BP190 | Free | Free | Linear | L | None | 28 | Antimicrobial | 17 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYL | BP134 | Free | Free | Linear | L | None | 11 | Antimicrobial | 18 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPA | BP199 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLKDEL | BP214 | Free | Free | Linear | L | None | 15 | Antimicrobial | 9 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYL | BP203 | Free | Free | Linear | L | None | 22 | Antimicrobial | 95 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYL | BP202 | Free | Free | Linear | L | None | 26 | Antimicrobial | 98 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKKLFKKILKYL | BP193 | Free | Free | Linear | L | None | 27 | Antimicrobial | 74 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKKLFKKILKYL | BP195 | Free | Free | Linear | L | None | 27 | Antimicrobial | 71 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPA | BP200 | Free | Free | Linear | L | None | 30 | Antimicrobial | 81 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYLKDEL | BP198 | Free | Free | Linear | L | None | 26 | Antimicrobial | 72 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP192 | Free | Free | Linear | L | None | 30 | Antimicrobial | 69 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPALYKLIKKFLKKKDEL | BP213 | Free | Free | Linear | L | None | 30 | Antimicrobial | 98 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP194 | Free | Free | Linear | L | None | 31 | Antimicrobial | 932 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP196 | Free | Free | Linear | L | None | 31 | Antimicrobial | 74 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPAKDWEHLKDWEHLKDWEHLKDEL | BP236 | Free | Free | Linear | L | None | 52 | Antimicrobial | 92 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYLKKLFKKILKYL | BP204 | Free | Free | Linear | L | None | 33 | Antimicrobial | 100 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPAKKLFKKILKYL | BP201 | Free | Free | Linear | L | None | 41 | Antimicrobial | 83 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP216 | Free | Free | Linear | L | None | 45 | Antimicrobial | 100 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHL | tag54 | Free | Free | Linear | L | None | 18 | Antimicrobial | 1 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHLKDEL | tag54-2 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISW | BP170 | Free | Free | Linear | L | None | 21 | Antimicrobial | 98 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISW | BP171 | Free | Free | Linear | L | None | 25 | Antimicrobial | 34 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPATTGLPALISW | BP207 | Free | Free | Linear | L | None | 26 | Antimicrobial | 58 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPATTGLPALISW | BP208 | Free | Free | Linear | L | None | 26 | Antimicrobial | 68 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISWKDEL | BP172 | Free | Free | Linear | L | None | 25 | Antimicrobial | 63 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISWKDEL | BP173 | Free | Free | Linear | L | None | 29 | Antimicrobial | 40 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGAVLKVLTTGLKDEL | BP189 | Free | Free | Linear | L | None | 28 | Antimicrobial | 86 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISAGPASILAPLGTTLYKLIKKFLKKKDEL | BP217 | Free | Free | Linear | L | None | 48 | Antimicrobial | 100 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAK | BP180 | Free | Free | Linear | L | None | 18 | Antimicrobial | 58 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAK | BP181 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKFLHSAK | BP211 | Free | Free | Linear | L | None | 23 | Antimicrobial | 6 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKFLHSAK | BP212 | Free | Free | Linear | L | None | 23 | Antimicrobial | 12 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAKKDEL | BP182 | Free | Free | Linear | L | None | 22 | Antimicrobial | 59 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAKKDEL | BP183 | Free | Free | Linear | L | None | 26 | Antimicrobial | 5 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAKAGPAKDWEHLKDWEHLKDWEHLKDEL | BP235 | Free | Free | Linear | L | None | 48 | Antimicrobial | 0 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAK | BP176 | Free | Free | Linear | L | None | 21 | Antimicrobial | 59 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAK | BP175 | Free | Free | Linear | L | None | 25 | Antimicrobial | 32 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAGIGKFLHSAK | BP209 | Free | Free | Linear | L | None | 26 | Antimicrobial | 24 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAGIGKFLHSAK | BP210 | Free | Free | Linear | L | None | 26 | Antimicrobial | 30 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAKKDEL | BP179 | Free | Free | Linear | L | None | 25 | Antimicrobial | 35 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAKKDEL | BP178 | Free | Free | Linear | L | None | 29 | Antimicrobial | 25 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAVAVVGQATQIAKKDEL | BP188 | Free | Free | Linear | L | None | 28 | Antimicrobial | 42 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAVAVVGQATQIAKKDEL | BP215 | Free | Free | Linear | L | None | 31 | Antimicrobial | 14 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | AVAVVGQATQIAKKKLFKKILKYLKDEL | BP190 | Free | Free | Linear | L | None | 28 | Antimicrobial | 32 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24530880 | 2013 | FFGRLKSVWSAVKHGWKAAKSR | trichoplaxin | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at >800 µM | Rat | Trichoplax Adhaerens | α-Helix | NA | ||
| 23790040 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | ~100 % Hemolysis at 10 µM | Mouse | Bee Venom | α-Helix | NA | ||
| 23790040 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 50 µM | Mouse | Bee Venom | α-Helix | NA | ||
| 23790040 | 2013 | DWFKAFYDKVAEKFKEAF-{nnr:GSG}-GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | α-melittin | Amidation | Free | Linear | L | GSG = GSG linker | 44 | Antimicrobial | ~100 % Hemolysis at 10 µM | Mouse | Synthetic | α-Helix | NA | ||
| 23790040 | 2013 | DWFKAFYDKVAEKFKEAF-{nnr:GSG}-GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | α-melittin | Amidation | Free | Linear | L | GSG = GSG linker | 44 | Antimicrobial | 100 % Hemolysis at 50 µM | Mouse | Synthetic | α-Helix | NA | ||
| 24021230 | 2014 | GRFRRLRKKTRKRLKKIGKV{ct:Amid} | PMAP-36 (1–20) | Amidation | Free | Linear | L | None | 20 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | Porcine Cathelicidin | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | RFRRLRKKTRKRLKKI{ct:Amid} | RI16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | N-Terminal Of Pmap-36 | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | RFRRLRWWTRKRLKKI{ct:Amid} | PRW3 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | RFRRLRWKTRWRLKKI{ct:Amid} | PRW4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | RFRRLRKWTRWRLKKI{ct:Amid} | PRW5 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | RFRRLRWKTRKRLWKI{ct:Amid} | PRW6 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 24102775 | 2014 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 22.0± 2.8 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | NA | ||
| 24102775 | 2014 | KKLFKKILKYLAGPATTGLPALISWKDEL | BP100.m | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.7 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | Non-hemolytic | ||
| 24102775 | 2014 | KKLFKKILKYLAGPAKFLHSAKKDEL | BP100.g | Free | Free | Linear | L | None | 26 | Antimicrobial | 0.2 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | Non-hemolytic | ||
| 24102775 | 2014 | KKLFKKILKYLAGPAKFLHSAKAGPAKDWEHLKDWEHLKDWEHLKDEL | BP100.gtag | Free | Free | Linear | L | None | 48 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | Non-hemolytic | ||
| 24102775 | 2014 | KKLFKKILKYLAGPAGIGKFLHSAKKDEL | BP100.g2 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.2 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | Non-hemolytic | ||
| 24102775 | 2014 | KKLFKKILKYLAGPAVAVVGQATQIAKKDEL | BP100.C | Free | Free | Linear | L | None | 31 | Antimicrobial | 0.1 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | Non-hemolytic | ||
| 24102775 | 2014 | KDWEHLKDWEHLKDWEHLKDEL | Tag54 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | Non-hemolytic | ||
| 24211081 | 2014 | IRIKIRIK{ct:Amid} | IK8-all L | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 10 % Hemolysis at 2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | I{d}R{d}I{d}K{d}I{d}R{d}I{d}K{d}{ct:Amid} | IK8-all D | Amidation | Free | Linear | D | None | 8 | Antimicrobial | 10 % Hemolysis at 1750 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | I{d}R{d}I{d}K{d}I{d}R{d}{ct:Amid} | IK6-all D | Amidation | Free | Linear | D | None | 6 | Antimicrobial | 10 % Hemolysis at >2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | I{d}R{d}I{d}K{d}{ct:Amid} | IK4-all D | Amidation | Free | Linear | D | None | 4 | Antimicrobial | 10 % Hemolysis at >2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | IR{d}IK{d}IR{d}IK{d}{ct:Amid} | IK8-4D | Amidation | Free | Linear | D | None | 8 | Antimicrobial | 10 % Hemolysis at >2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | IRIK{d}IR{d}IK{ct:Amid} | IK8-2D | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 8 | Antimicrobial | 10 % Hemolysis at 1600 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | IRVKIRVKIRVK{ct:Amid} | IK12-all L | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >125 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | I{d}R{d}V{d}K{d}I{d}R{d}V{d}K{d}I{d}R{d}V{d}K{d}{ct:Amid} | IK12-all D | Amidation | Free | Linear | D | None | 12 | Antimicrobial | 10 % Hemolysis at >125 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | IIRKIIRK{ct:Amid} | Control-all L | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 10 % Hemolysis at >2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | I{d}I{d}R{d}K{d}I{d}I{d}R{d}K{d}{ct:Amid} | Control-all D | Amidation | Free | Linear | D | None | 8 | Antimicrobial | 10 % Hemolysis at >2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | II{d}R{d}KII{d}R{d}K{ct:Amid} | Control-4D | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 8 | Antimicrobial | 10 % Hemolysis at >2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24221355 | 2014 | RGLRRLGRKIAHGVKKYGPTVLRIIRIA{ct:Amid} | SMAP-29 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 86 µM | Human | Sheep Myeloid | α-Helix | NA | ||
| 24221355 | 2014 | RGLRRLGRKIAHGVKKYG{ct:Amid} | SMAP-18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at >400 µM | Human | Sheep Myeloid | α-Helix | NA | ||
| 24221355 | 2014 | RGWRRWGRKWAHGWKKYG{ct:Amid} | SMAP-18-W | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at >400 µM | Human | Sheep Myeloid | α-Helix | NA | ||
| 24277042 | 2014 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at 1052.3 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | G{nnr:Cha}LKK({nnr:2-Nal})KTLL{ct:Amid} | Cha2 Lys5 2Nal6 | Amidation | Free | Linear | L | Cha = β-cyclohexylalanine, 2-Nal = 3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 15.3 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKR({nnr:2-Nal})KTLL{ct:Amid} | 2Nal6 Lys8 | Amidation | Free | Linear | L | 2-Nal = 3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 50.1 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKR({nnr:2-Nal})KL{nnr:Cha}{ct:Amid} | Lys5 2Nal6 Cha10 | Amidation | Free | Linear | L | Cha = β-cyclohexylalanine, 2-Nal = 3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 26.6 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKRIKKL{nnr:Cha}{ct:Amid} | Lys8 Cha10 | Amidation | Free | Linear | L | Cha = β-cyclohexylalanine | 10 | Antimicrobial | 50 % Hemolysis at 12.4 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | G{nnr:Cha}LKKIKKL{nnr:Cha}{ct:Amid} | Cha2 Lys5 Lys8 Cha10 | Amidation | Free | Linear | L | Cha = β-cyclohexylalanine | 10 | Antimicrobial | 50 % Hemolysis at 0.5 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKKI{d}KTLL{ct:Amid} | Lys5 D-Ile6 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 10 | Antimicrobial | 50 % Hemolysis at 7209 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKKI{d}KKLL{ct:Amid} | Lys5 D-Ile6 Lys8 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 10 | Antimicrobial | 50 % Hemolysis at 1962.4 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | G{nnr:Cha}LKR({nnr:D-2-Nal})KKLL{ct:Amid} | Cha2 D-2Nal6 Lys8 | Amidation | Free | Linear | Mix | Cha = β-cyclohexylalanine, D-2-Nal = D-3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 27 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKRiKTL{nnr:Cha}{ct:Amid} | Cha2 D-Ile6 Cha10 | Amidation | Free | Linear | Mix | Cha = β-cyclohexylalanine | 10 | Antimicrobial | 50 % Hemolysis at 225.6 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKR({nnr:D-2-Nal})KTL{nnr:Cha}{ct:Amid} | D-2Nal6 Cha10 | Amidation | Free | Linear | Mix | Cha = β-cyclohexylalanine, D-2-Nal = D-3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 74.3 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKKI({nnr:D-2-Nal})KKL{nnr:Cha}{ct:Amid} | Lys5 D-2Nal6 Lys8 Cha10 | Amidation | Free | Linear | Mix | Cha = β-cyclohexylalanine, D-2-Nal = D-3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 23.6 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24419338 | 2014 | LLPIVGNLLKSLLGWKRKRFG | LG21 | Free | Free | Linear | L | None | 21 | Antimicrobial | 8.5 % Hemolysis at 100 µM | mouse | Lipopolysaccharide Trap | α-Helix | NA | ||
| 24419338 | 2014 | FLPLIGRVLSGILGWKRKRFG | FG21 | Free | Free | Linear | L | None | 21 | Antimicrobial | 9.9 % Hemolysis at 100 µM | mouse | Lipopolysaccharide Trap | α-Helix | NA | ||
| 24419338 | 2014 | KLLLKLKLKLLKGWKRKRFG | KG20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 2.4 % Hemolysis at 100 µM | mouse | Lipopolysaccharide Trap | α-Helix | NA | ||
| 24419338 | 2014 | LLPIVGNLLKSLLGWKRKAFG | LG21R19A | Free | Free | Linear | L | None | 21 | Antimicrobial | 25 % Hemolysis at 100 µM | mouse | Analog Of Lg21, Lipopolysaccharide Trap | α-Helix | NA | ||
| 24419338 | 2014 | LLPIVGNLLKSLLGAKRKRAG | LG21W15AF20A | Free | Free | Linear | L | None | 21 | Antimicrobial | 60 % Hemolysis at 100 µM | mouse | Analog Of Lg21, Lipopolysaccharide Trap | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | P | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 5.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLK{d}TFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | K7D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 10.41 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSLKK{d}TVLHTLLKAISS{nt:Acet}{ct:Amid} | K14D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 5.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSLKKTVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLK{d}TFKSLKK{d}TVLHTLLKAISS{nt:Acet}{ct:Amid} | K7D/K14D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLK{d}TFKSLKKTVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K14D/K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLK{d}TFKSLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K7D/K14D/K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 81.31 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K7D/K10D/K14D/K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 325.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWK{d}SFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K3D/K7D/K10D/K14D/K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | >325.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | K{d}WK{d}SFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K1D/K3D/K7D/K10D/K14D/K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | >325.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFL{d}KTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | L6D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 10.41 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSL{d}KKTVLHTLLKAISS{nt:Acet}{ct:Amid} | L12D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSLKKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid} | L20D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFL{d}KTFKSL{d}KKTVLHTLLKAISS{nt:Acet}{ct:Amid} | L6D/L12D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid} | L12D/L20D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 81.31 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFL{d}KTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid} | L6D/L12D/L20D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 162.61 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFL{d}KTFKSL{d}KKTVL{d}HTL{d}LKAISS{nt:Acet}{ct:Amid} | L6D/L12D /L17D/L20D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 81.3 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFL{d}KTFKSL{d}KKTVL{d}HTL{d}L{d}KAISS{nt:Acet}{ct:Amid} | L6D/L12D /L17D/L20 D /L21D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | >325.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 25003126 | 2014 | GIGGALLNVGKVALKGLAKGLAEHFAN{ct:Amid} | Bombinin | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 64 mg/L | Horse | European Yellow-Bellied Toad (Bombina Variegata) | α-Helix | NA | ||
| 25003126 | 2014 | FLGLLGGLL{ct:Amid} | Feleucin-BV1 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 100 % Hemolysis at >512 mg/L | Horse | Skin Secretion-Derived (Bombina Variegata) | α-Helix | NA | ||
| 25003126 | 2014 | FLGLIGSLL{ct:Amid} | Feleucin-BV2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 100 % Hemolysis at >512 mg/L | Horse | Skin Secretion-Derived(Bombina Variegata) | α-Helix | NA | ||
| 25054164 | 2014 | LRPAILVRIK{ct:Amid} | balteatide | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <8 % Hemolysis at 512 mg/L | Horse | Purple-Sided Leaf Frog, Phyllomedusa Baltea | NA | Low hemolytic | ||
| 24321546 | 2014 | LL{nnr:SelenoCys}IALRKK{ct:Amid} | CopSe | Amidation | Free | Linear | L | selenocys = selenocysteine | 9 | Antimicrobial | 1.6 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24321546 | 2014 | LL{nnr:MethylCys}IALRKK{ct:Amid} | CopMe | Amidation | Free | Linear | L | methylcys = methylcysteine | 9 | Antimicrobial | 1 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24321546 | 2014 | LLRIALRKK{ct:Amid} | CopR | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 1 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24321546 | 2014 | LLLIALRKK{ct:Amid} | CopL | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 30 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24321546 | 2014 | LLWIALRKK{ct:Amid} | CopW | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 1.5 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | Non-hemolytic | ||
| 24321546 | 2014 | LLLIVLRKK{ct:Amid} | CopLV | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 13.6 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24321546 | 2014 | LLCIALRKK{ct:Amid} | CopA3 (Mono) | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 2 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24321546 | 2014 | LLCIALRKKLLCIALRKK{ct:Amid} | CopA3 (Dimer) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 20 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24321546 | 2014 | LLCKALRKI{ct:Amid} | CopIK (Mono) | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 2 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24321546 | 2014 | LLCKALRKILLCKALRKI{ct:Amid} | CopIK (Dimer) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 2.6 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 38.5 % Hemolysis at 250 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 29.6 % Hemolysis at 200 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 20.5 % Hemolysis at 150 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 17.7 % Hemolysis at 100 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 14.5 % Hemolysis at 50 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 10.3 % Hemolysis at 25 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 8.6 % Hemolysis at 10 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 5.5 % Hemolysis at 5 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24389272 | 2014 | GVWDWLKKTAKNVWNSDIVKQLKGKAINAAKNYVAEKIGATPS{ct:Amid} | Heterin-1 | Amidation | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at <2.5 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | Non-hemolytic | ||
| 24389272 | 2014 | GVWDWLKKTAKNVWNSDIVKQLKGKAINAAKNYVAEKIGATPS{ct:Amid} | Heterin-1 | Amidation | Free | Linear | L | None | 43 | Antimicrobial | 20.1 % Hemolysis at 5 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | GVWDWLKKTAKNVWNSDIVKQLKGKAINAAKNYVAEKIGATPS{ct:Amid} | Heterin-1 | Amidation | Free | Linear | L | None | 43 | Antimicrobial | 54.2 % Hemolysis at 10 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | GVWDWLKKTAKNVWNSDIVKQLKGKAINAAKNYVAEKIGATPS{ct:Amid} | Heterin-1 | Amidation | Free | Linear | L | None | 43 | Antimicrobial | 74.9 % Hemolysis at 20 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | GVWDWLKKTAKNVWNSDIVKQLKGKAINAAKNYVAEKIGATPS{ct:Amid} | Heterin-1 | Amidation | Free | Linear | L | None | 43 | Antimicrobial | 88.7 % Hemolysis at 40 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFTKKD{ct:Amid} | Heterin-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 2 % Hemolysis at 0.8 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFTKKD{ct:Amid} | Heterin-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 10.6 % Hemolysis at 1.6 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFTKKD{ct:Amid} | Heterin-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 49.3 % Hemolysis at 3.2 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFTKKD{ct:Amid} | Heterin-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 94 % Hemolysis at 6.4 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFT{ct:Amid} | Heterin-2M | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 0.8 µM | Human | Analog Of Heterinscorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFT{ct:Amid} | Heterin-2M | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 1.5 % Hemolysis at 1.6 µM | Human | Analog Of Heterinscorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFT{ct:Amid} | Heterin-2M | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 22.1 % Hemolysis at 3.2 µM | Human | Analog Of Heterinscorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFT{ct:Amid} | Heterin-2M | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 50.1 % Hemolysis at 6.4 µM | Human | Analog Of Heterinscorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | ILGEIWKGIKDIL{ct:Amid} | Spiniferin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at <48 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | Non-hemolytic | ||
| 24389272 | 2014 | ILGKIWKGIKNIL{ct:Amid} | Spiniferin-M | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at <3 µM | Human | Analog Of Spiniferin, Scorpion Heterometrus Spinifer | α-Helix | Non-hemolytic | ||
| 24389272 | 2014 | ILGKIWKGIKNIL{ct:Amid} | Spiniferin-M | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.7 % Hemolysis at 6 µM | Human | Analog Of Spiniferin, Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | ILGKIWKGIKNIL{ct:Amid} | Spiniferin-M | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 19.1 % Hemolysis at 12 µM | Human | Analog Of Spiniferin, Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | ILGKIWKGIKNIL{ct:Amid} | Spiniferin-M | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 31.9 % Hemolysis at 24 µM | Human | Analog Of Spiniferin, Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | ILGKIWKGIKNIL{ct:Amid} | Spiniferin-M | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 56.6 % Hemolysis at 48 µM | Human | Analog Of Spiniferin, Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24595375 | 2014 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 26 µM | Human | Brazilian Wasp Polybia Paulista | α-Helix | NA | ||
| 24652097 | 2014 | KKKHRQFLGIRNYYKEFIPNLSDITSPLHVLLKK | SmAE_P1 | Free | Free | Linear | L | None | 34 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 24652097 | 2014 | YGGGYGYRRPYYGGYHGGYYRRPYYYGGYYGGGYKYKHWGCRFF | SmAE_P5 | Free | Free | Linear | L | None | 44 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 24652097 | 2014 | YGGGYGYRRPYYGGYHGGYYRRPYYYGGYYGGGYKYKHWGCRFF | SmAE_P6 | Free | Free | Linear | L | None | 44 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 24652097 | 2014 | SRGTRFRRGYRRGVGGFRRGGRGGYGGGYGGGYYGGYGAGVPSAGGGY | SmAE_P8 | Free | Free | Linear | L | None | 48 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 24652097 | 2014 | YGIGGGRYGGGYGGGYGGNYGGYRGGYRGGYRGGYRRPGSVGSLGGG | SmAE_P9 | Free | Free | Linear | L | None | 47 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 24652097 | 2014 | CRFAHSVQELRATGVYYKTRFCLFFRRGHCAAGVNCRHAHDINEVR | SmAE_P10 | Free | Free | Linear | L | None | 46 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 24652097 | 2014 | REFVKNMYPDAAHKEQLAREIPGLSPRQVQVWFQNRRAKIKKR | SmAE_P12 | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 24652097 | 2014 | YFCTCNVKGFNAKNKRGIIYPNLPSAMRPVAHGPGIPVP | SmAE_P15 | Free | Free | Linear | L | None | 39 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 24652097 | 2014 | PSGHQREDLINRHLRFECPFQSLIVCHHHHHHHHHHHH | SmAE_P17 | Free | Free | Linear | L | None | 38 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 24652097 | 2014 | ANLATHRRLHKGESSDHCNYCGTSFTRKSHLLRHQRI | SmAE_P18 | Free | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 24652097 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 µg/ml | Mouse | Bee Venom | α-Helix | NA | ||
| 24652097 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 50 µg/ml | Mouse | Bee Venom | α-Helix | NA | ||
| 24652097 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 99 % Hemolysis at 100 µg/ml | Mouse | Bee Venom | α-Helix | NA | ||
| 24675879 | 2014 | KKCKFFCKVKKKIKSIGFQIPIVSIPFK | Cathelicidin-RC1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0.2 % Hemolysis at 100 µg/ml | Human | Bullfrog Rana Catesbeiana | 44.8% Alphα-Helix, 12.2% Betα-Sheet, 14.9% Betα-Turn and 26.3% Random-coil | Low hemolytic | ||
| 24675879 | 2014 | KKCKFFCKVKKKIKSIGFQIPIVSIPFK | Cathelicidin-RC1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 2.6 % Hemolysis at 200 µg/ml | Human | Bullfrog Rana Catesbeiana | 44.8% Alphα-Helix, 12.2% Betα-Sheet, 14.9% Betα-Turn and 26.3% Random-coil | Low hemolytic | ||
| 24127254 | 2014 | KWKSFLKTFKSAKKTVLHTALKA{nnr:I}SS{nt:Acet}{ct:Amid} | V13K | Amidation | Acetylation | Linear | L | I = L-Isoleucine, 2S,3S = 2-amino-3-methyl-valeric acid | 26 | Antimicrobial | 10 % Hemolysis at 250 µg/ml | Human | Model Peptide | α-Helix | NA | ||
| 24127254 | 2014 | KWKSFLKTFKSAKKTVLHTALKA{nnr:alloI}SS{nt:Acet}{ct:Amid} | a-V13K | Amidation | Acetylation | Linear | L | alloI = L-allo-Ile, 2S,3R = 2-amino-3-methyl-valeric acid | 26 | Antimicrobial | 10 % Hemolysis at 500 µg/ml | Human | Model Peptide | α-Helix | Non-hemolytic | ||
| 24378871 | 2014 | GVLSAFKNALPGIMKIIV{ct:Amid} | hylaranin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3 % Hemolysis at 8 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSAFKNALPGIMKIIV{ct:Amid} | hylaranin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 4.2 % Hemolysis at 16 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSAFKNALPGIMKIIV{ct:Amid} | hylaranin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 22.9 % Hemolysis at 64 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSVIKNALPGIMRFIA{ct:Amid} | hylaranin-L2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 5.8 % Hemolysis at 8 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSVIKNALPGIMRFIA{ct:Amid} | hylaranin-L2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 58.6 % Hemolysis at 16 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24449502 | 2014 | GRAMVECWMDGHCRLLCKDGEDSIIRCRNRKRCCVPSRYLTIQPVTIHGILGWTTPQMSTTAPKMKTNITNR | DEFB120 | Free | Free | Linear | L | None | 68 | Antimicrobial | <5 % Hemolysis at 10 µg/ml | Human | Human Beta-Defensins | β-Sheet | Non-hemolytic | ||
| 24449502 | 2014 | GRAMVECWMDGHCRLLCKDGEDSIIRCRNRKRCCVPSRYLTIQPVTIHGILGWTTPQMSTTAPKMKTNITNR | DEFB120 | Free | Free | Linear | L | None | 68 | Antimicrobial | <5 % Hemolysis at 50 µg/ml | Human | Human Beta-Defensins | β-Sheet | Non-hemolytic | ||
| 24449502 | 2014 | GRAMVECWMDGHCRLLCKDGEDSIIRCRNRKRCCVPSRYLTIQPVTIHGILGWTTPQMSTTAPKMKTNITNR | DEFB120 | Free | Free | Linear | L | None | 68 | Antimicrobial | <5 % Hemolysis at 100 µg/ml | Human | Human Beta-Defensins | β-Sheet | Non-hemolytic | ||
| 24449502 | 2014 | GRAMVECWMDGHCRLLCKDGEDSIIRCRNRKRCCVPSRYLTIQPVTIHGILGWTTPQMSTTAPKMKTNITNR | DEFB120 | Free | Free | Linear | L | None | 68 | Antimicrobial | <5 % Hemolysis at 150 µg/ml | Human | Human Beta-Defensins | β-Sheet | Non-hemolytic | ||
| 24449502 | 2014 | GRAMVECWMDGHCRLLCKDGEDSIIRCRNRKRCCVPSRYLTIQPVTIHGILGWTTPQMSTTAPKMKTNITNR | DEFB120 | Free | Free | Linear | L | None | 68 | Antimicrobial | <5 % Hemolysis at 250 µg/ml | Human | Human Beta-Defensins | β-Sheet | Non-hemolytic | ||
| 24756162 | 2014 | YVLWKRKRKFCFI{ct:Amid} | YI13C | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 21.5 % Hemolysis at 50 µM | mouse | Lipopolysaccharide (Lps)-Mediated Inflammations | β-boomerang | NA | ||
| 24756162 | 2014 | {nnr:C4}YVLWKRKRKFCFI{nt:Acet} | C4YI13C | Free | Acetylation | Linear | L | C4= C4 carbon chain | 12 | Antimicrobial | 14.1 % Hemolysis at 50 µM | mouse | Lipopolysaccharide (Lps)-Mediated Inflammations | β-boomerang | NA | ||
| 24756162 | 2014 | {nnr:C8}YVLWKRKRKFCFI{nt:Acet} | C8YI13C | Free | Acetylation | Linear | L | C8 = carbon chain | 12 | Antimicrobial | 21.5 % Hemolysis at 50 µM | mouse | Lipopolysaccharide (Lps)-Mediated Inflammations | β-boomerang | NA | ||
| 24756162 | 2014 | {nnr:C8}YVLAKRKRKACFI{nt:Acet} | C8YI13CAA | Free | Acetylation | Linear | L | C8 = carbon chain | 12 | Antimicrobial | 30.2 % Hemolysis at 50 µM | mouse | Lipopolysaccharide (Lps)-Mediated Inflammations | β-boomerang | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 1 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | Non-hemolytic | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | Non-hemolytic | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 1.38 % Hemolysis at 10 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 7.25 % Hemolysis at 20 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 16.58 % Hemolysis at 40 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 21.29 % Hemolysis at 60 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 29.32 % Hemolysis at 80 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 38.25 % Hemolysis at 100 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24496141 | 2014 | WKKIWSKIKKLLK{ct:Amid} | I1WL5W | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.6 % Hemolysis at 500 µM | Human | Tryptophan (Trp) Residues | α-Helix | Non-hemolytic | ||
| 24496141 | 2014 | IKKWWSKIKKLLK{ct:Amid} | I4WL5W | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 14.6 % Hemolysis at 500 µM | Human | Tryptophan (Trp) Residues | α-Helix | Non-hemolytic | ||
| 24688525 | 2014 | GATAIKQVKKLFKKKGG{nt:Amid} | Pln149(6-22) | Free | Amidation | Linear | L | None | 17 | Antimicrobial | <5 % Hemolysis at 1-500 µM | Human | Analog Of Plantaricin149, Lactobacillus Plantarum | α-Helix | Non-hemolytic | ||
| 24688525 | 2014 | GATAIKQVKKLFKKKGG{nt:Acet} | Ac-Pln149(6-22) | Free | Acetylation | Linear | L | None | 17 | Antimicrobial | <5 % Hemolysis at 1-500 µM | Human | Analog Of Plantaricin149, Lactobacillus Plantarum | α-Helix | Non-hemolytic | ||
| 24688525 | 2014 | NO{d}C{d}T{d}Y{d}L{d}GATAIKQVKKLFKKKGG{nt:Amid} | Noctyl-Pln149(6-22) | Free | Amidation | Linear | L | None | 17 | Antimicrobial | <5 % Hemolysis at 1-500 µM | Human | Analog Of Plantaricin149, Lactobacillus Plantarum | α-Helix | Non-hemolytic | ||
| 24688525 | 2014 | {nnr:Fmoc}GATAIKQVKKLFKKKGG{nt:Amid} | Fmoc-Pln149(6-22) | Free | Amidation | Linear | L | fmoc = 9-fluorenylmethoxycarbonyl | 17 | Antimicrobial | 12 % Hemolysis at 250 µM | Human | Analog Of Plantaricin149, Lactobacillus Plantarum | α-Helix | NA | ||
| 24688525 | 2014 | {nnr:Fmoc}GATAIKQVKKLFKKKGG{nt:Amid} | Fmoc-Pln149(6-22) | Free | Amidation | Linear | L | fmoc = 9-fluorenylmethoxycarbonyl | 17 | Antimicrobial | 24 % Hemolysis at 500 µM | Human | Analog Of Plantaricin149, Lactobacillus Plantarum | α-Helix | NA | ||
| 24412102 | 2014 | RVCSAIPLPICH{ct:Amid} | Tigerinin-1R | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 500 µg/ml | Human | Hoplobatrachus Rugulosus (Dicroglossidae) | α-Helix | Non-hemolytic | ||
| 24412102 | 2014 | RICYAMWIPYPC | tigerinin-1V | Free | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 500 µg/ml | Human | Lithobates Vaillanti (Ranidae) | α-Helix | Non-hemolytic | ||
| 24412102 | 2014 | WCPPMIPLCSRF{ct:Amid} | tigerinin-1M | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 500 µg/ml | Human | Xenopus Muelleri (Pipidae) | α-Helix | Non-hemolytic | ||
| 24616110 | 2014 | GFGMALKLLKKVL{ct:Amid} | MAC-1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 160 µM | Human | Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GF{d}GM{d}A{d}L{d}K{d}L{d}L{d}K{d}K{d}V{d}L{d}{ct:Amid} | MAC-1/1 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 152 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | LVKKLLKLAMGFG{ct:Amid} | MAC-1/7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | L{d}V{d}K{d}K{d}L{d}L{d}K{d}L{d}A{d}M{d}GF{d}G{ct:Amid} | MAC-1/8 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKL{nnr:Aca}KKVL{ct:Amid} | MAC-1/24 | Amidation | Free | Linear | Mix | Aca = 1-aminocyclohexane carboxylic acid | 15 | Antimicrobial | 50 % Hemolysis at 88 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALK{nnr:Aca}LKKVL{ct:Amid} | MAC-1/25 | Amidation | Free | Linear | Mix | Aca = 1-aminocyclohexane carboxylic acid | 15 | Antimicrobial | 50 % Hemolysis at 88 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMA{nnr:Aca}KLLKKVL{ct:Amid} | MAC-1/26 | Amidation | Free | Linear | Mix | Aca = 1-aminocyclohexane carboxylic acid | 15 | Antimicrobial | 50 % Hemolysis at 93 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | AFGMALKLLKKVL{ct:Amid} | MAC-1/2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 241 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | LFGMALKLLKKVL{ct:Amid} | MAC-1/3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 53 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFKMALKLLKKVL{ct:Amid} | MAC-1/9 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 199 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGKALKLLKKVL{ct:Amid} | MAC-1/31 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >800 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMAL{nnr:O}LL{nnr:O}{nnr:O}VL{ct:Amid} | MAC-1/20 | Amidation | Free | Linear | L | O = Ornithine | 13 | Antimicrobial | 50 % Hemolysis at 262 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKLLKKVL{d}{ct:Amid} | MAC-1/14 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKLLKKV{d}L{ct:Amid} | MAC-1/15 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKLLKK{d}VL{ct:Amid} | MAC-1/11 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKLLK{d}KVL{ct:Amid} | MAC-1/12 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKLL{d}KKVL{ct:Amid} | MAC-1/16 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKL{d}LKKVL{ct:Amid} | MAC-1/17 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALK{d}LLKKVL{ct:Amid} | MAC-1/13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMAL{d}KLLKKVL{ct:Amid} | MAC-1/18 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMA{d}LKLLKKVL{ct:Amid} | MAC-1/4 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGM{d}ALKLLKKVL{ct:Amid} | MAC-1/19 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GF{d}GMALKLLKKVL{ct:Amid} | MAC-1/6 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 177 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFK{d}MALKLLKKVL{ct:Amid} | MAC-1/10 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 476 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GF{d}K{d}MALKLLKKVL{ct:Amid} | MAC-1/27 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 391 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | A{d}FGMALKLLKKVL{ct:Amid} | MAC-1/28 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 120 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | A{d}FKMALKLLKKVL{ct:Amid} | MAC-1/29 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 131 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | A{d}FK{d}MALKLLKKVL{ct:Amid} | MAC-1/30 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 476 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24704757 | 2014 | GLVGTLLGHIGKAILG{ct:Amid} | Frenatin 2.1S | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 167 ± 8 µM | Human | Litoria Infrafrenata | α-Helix | NA | ||
| 24704757 | 2014 | GLVGTLLGHIGKAILS{ct:Amid} | Frenatin 2.2S | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 169 ± 7 µM | Human | Litoria Infrafrenata | α-Helix | NA | ||
| 24704757 | 2014 | GLVGTLLGHIGKAILG | frenatin 2.3S | Free | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 404 ± 11 µM | Human | Discoglossus Sardus | coil | Non-hemolytic | ||
| 24723458 | 2014 | SSMKLSFRARAYGFRGPGPQL | Catestatin(SL21) | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 80 μg/ml | Human | Endogenous Neuropeptide | α-Helix | Non-hemolytic | ||
| 24945359 | 2014 | RFRRLRKKTRKRLKKI{ct:Amid} | RI16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 5 % Hemolysis at >256 µM | Human | Truncated From Pamp-36 | α-Helix | Low hemolytic | ||
| 24945359 | 2014 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 5 % Hemolysis at 128 µM | Human | Hybrid Peptide | α-Helix | Low hemolytic | ||
| 24945359 | 2014 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide Embedded Anti-Biofilm Sequence | α-Helix | Low hemolytic | ||
| 24945359 | 2014 | RKKTRKR{ct:Amid} | RR7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 24871991 | 2014 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | L(LL37) | Free | Free | Linear | L | None | 37 | Antimicrobial | 50 % Hemolysis at 32 μg/ml | Sheep | Human Leukocytes And Epithelia | α-Helix | NA | ||
| 24871991 | 2014 | GIGAVLKVLTTGLFKRIVQRIKDFLRN | M-L | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis at >128 μg/ml | Sheep | Hybrid Peptide M (1-13)-L (17-30),Parental Peptides | α-Helix | NA | ||
| 25019413 | 2014 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2(Pin2) | Free | Free | Linear | L | None | 24 | Antimicrobial | 91 % Hemolysis at 25 µM | Human | Scorpion Venom Pandinus Imperator | α-Helix | NA | ||
| 25019413 | 2014 | FWGALAKGALKLIGSLFSSFSKKD | Pin2 [G] | Free | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 25 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | NA | ||
| 25019413 | 2014 | FWGALAKGALKLIGPGSLFSSFSKKD | Pin2 [GPG] | Free | Free | Linear | L | None | 26 | Antimicrobial | 30 % Hemolysis at 25 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | NA | ||
| 25019413 | 2014 | FWGLKGLKKFSKKL | Pin2 [14] | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 25 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | Non-hemolytic | ||
| 25019413 | 2014 | FWGLKGLKKFSKKL | Pin2 [14] | Free | Free | Linear | L | None | 14 | Antimicrobial | 25 % Hemolysis at 100 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | NA | ||
| 25019413 | 2014 | FWGLKGLKGPGKFSKKL | Pin2 [17] | Free | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 25 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | Non-hemolytic | ||
| 25019413 | 2014 | FWGLKGLKGPGKFSKKL | Pin2 [17] | Free | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | Non-hemolytic | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTVLHTALKAISS{nt:Acet}{ct:Amid} | P | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 28.3 % Hemolysis at 1000 μg/ml | Human | Na | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTKLHTALKAISS{nt:Acet}{ct:Amid} | V16LK | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 6.2 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTGLHTALKAISS{nt:Acet}{ct:Amid} | V16LG | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 8.1 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTSLHTALKAISS{nt:Acet}{ct:Amid} | V16LS | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 11.3 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTELHTALKAISS{nt:Acet}{ct:Amid} | V16LE | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 3.9 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTALHTALKAISS{nt:Acet}{ct:Amid} | V16LA | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 14.3 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTLLHTALKAISS{nt:Acet}{ct:Amid} | V16LL | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 53.9 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 24200946 | 2014 | GFWGKLWEGVKNAI{ct:Amid} | UyCT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 22.8 ± 1.6 µM | Human | Venom Of Australian Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 24200946 | 2014 | FWGKLWEGVKNAI{ct:Amid} | UyCT2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >100 µM | Human | Analog Of Uyct1, Venom Of Australian Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 24200946 | 2014 | ILSAIWSGIKSLF{ct:Amid} | UyCT3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 17.3 ± 0.8 µM | Human | Venom Of Australian Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 24200946 | 2014 | IWSAIWSGIKGLL{ct:Amid} | UyCT5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 14.1 ± 0.3 µM | Human | Venom Of Australian Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 24649883 | 2014 | GVVVRVGRVVVRWV{ct:Amid} | VR(+4) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 43 µM | Human | Analog Of Vr(+6) | α-Helix | NA | ||
| 24649883 | 2014 | GVVVRVGRVVVRWVRR{ct:Amid} | VR(+6) | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 94 µM | Human | Val/Arg-Rich Peptides | α-Helix | NA | ||
| 24649883 | 2014 | GVVVRVGRVVVRWVRRRR{ct:Amid} | VR(+8) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 90 µM | Human | Analog Of Vr(+6) | α-Helix | NA | ||
| 24649883 | 2014 | GVVVRVPRVVVRWVRR{ct:Amid} | VR(P) | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >128 µM | Human | Analog Of Vr(+6) | α-Helix | NA | ||
| 24649883 | 2014 | GVVVRVARVVVRWVRR{ct:Amid} | VR(A) | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 80 µM | Human | Analog Of Vr(+6) | α-Helix | NA | ||
| 25332684 | 2014 | FLFSLIPHAISGLISAFK{ct:Amid} | AcrAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 64 µM | Horse | Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 25332684 | 2014 | FLFSLIPNAISGLLSAFK{ct:Amid} | AcrAP2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 64 µM | Horse | Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 25332684 | 2014 | FLFKLIPKAIKGLIKAFK{ct:Amid} | AcrAP1a | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 32 µM | Horse | Analogue Of Acrap1, Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 25332684 | 2014 | FLFKLIPKAIKGLLKAFK{ct:Amid} | AcrAP2a | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 32 µM | Horse | Analogue Of Acrap2, Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 100 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 50 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 12.5 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 74.8 % Hemolysis at 6.3 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 42 % Hemolysis at 3.1 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 12.7 % Hemolysis at 1.6 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 25050859 | 2014 | MKCITLFLVLSMVVLMAEPGEAFFHHIFNGLVGVGKTIHRLI | Rbmoro | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 0.98 µM | Fish | Rock Bream, Oplegnathus Fasciatus | α-Helix | Non-hemolytic | ||
| 25050859 | 2014 | MKCITLFLVLSMVVLMAEPGEAFFHHIFNGLVGVGKTIHRLI | Rbmoro | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 1.95 µM | Fish | Rock Bream, Oplegnathus Fasciatus | α-Helix | Non-hemolytic | ||
| 25050859 | 2014 | MKCITLFLVLSMVVLMAEPGEAFFHHIFNGLVGVGKTIHRLI | Rbmoro | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 7.81 µM | Fish | Rock Bream, Oplegnathus Fasciatus | α-Helix | Non-hemolytic | ||
| 25050859 | 2014 | MKCITLFLVLSMVVLMAEPGEAFFHHIFNGLVGVGKTIHRLI | Rbmoro | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 15.63 µM | Fish | Rock Bream, Oplegnathus Fasciatus | α-Helix | Non-hemolytic | ||
| 25050859 | 2014 | MKCITLFLVLSMVVLMAEPGEAFFHHIFNGLVGVGKTIHRLI | Rbmoro | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 31.25 µM | Fish | Rock Bream, Oplegnathus Fasciatus | α-Helix | Non-hemolytic | ||
| 25050859 | 2014 | MKCITLFLVLSMVVLMAEPGEAFFHHIFNGLVGVGKTIHRLI | Rbmoro | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 62.5 µM | Fish | Rock Bream, Oplegnathus Fasciatus | α-Helix | Non-hemolytic | ||
| 25050859 | 2014 | MKCITLFLVLSMVVLMAEPGEAFFHHIFNGLVGVGKTIHRLI | Rbmoro | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 125 µM | Fish | Rock Bream, Oplegnathus Fasciatus | α-Helix | Non-hemolytic | ||
| 25050859 | 2014 | MKCITLFLVLSMVVLMAEPGEAFFHHIFNGLVGVGKTIHRLI | Rbmoro | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 250 µM | Fish | Rock Bream, Oplegnathus Fasciatus | α-Helix | Non-hemolytic | ||
| 25050859 | 2014 | MKCITLFLVLSMVVLMAEPGEAFFHHIFNGLVGVGKTIHRLI | Rbmoro | Free | Free | Linear | L | None | 43 | Antimicrobial | 61.98 % Hemolysis at 1000 µM | Fish | Rock Bream, Oplegnathus Fasciatus | α-Helix | NA | ||
| 25086320 | 2014 | GIKEFAHSLGKFGKAFVGGILNQ | Magainin-W1 | Free | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GVGKFLHSASKFGKALVGELMKS | Magainin-W2 | Free | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GISKFLHSASKFGKALVGEIMKS | Magainin-W3 | Free | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GMASKAGTIVGKLAKVALNAL{ct:Amid} | PGLa-W1 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GWASKIGQTLGKMAKVGLQELIQPK | XPF-W1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GFGSFLGKALKAGLKLGANLLGGAPQQ | CPF-W1 | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GFGSFLGKALKAGLKLGANLLGGAPQE | CPF-W3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GIGSLLAKAAKLAAGLV{ct:Amid} | CPF-W6 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 190 µM | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GLGTFLGNALKTGLKIGTNLL{ct:Amid} | CPF-W7 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25030320 | 2014 | KLAKKLAKLAKLAKAL{ct:Amid} | Modelin-5-CONH2 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 12 % Hemolysis at 300 µM | Sheep | Synthetic | α-Helical | NA | ||
| 25030320 | 2014 | KLAKKLAKLAKLAKAL{ct:Amid} | Modelin-5-CONH2 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2 % Hemolysis at 300 µM | Human | Synthetic | α-Helical | NA | ||
| 25030320 | 2014 | KLAKKLAKLAKLAKAL{ct:Amid} | Modelin-5-CONH2 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2 % Hemolysis at 300 µM | Pig | Synthetic | α-Helical | NA | ||
| 25473836 | 2014 | FFHHIFRGIVHVGKTIHRLVTG | Pis-1 | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | ~100 % Hemolysis at 100 µM | Human | Mast Cells Of Aquacultured Hybrid Striped Bass | α-Helical | NA | ||
| 25473836 | 2014 | AFHHIFRGIVHVGKTIHRLVTG | PisF1A | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 100 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FAHHIFRGIVHVGKTIHRLVTG | PisF2A | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | >12 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FFHHIARGIVHVGKTIHRLVTG | PisF6A | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 29 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | KFHHIFRGIVHVGKTIHRLVTG | PisF1K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 50 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FKHHIFRGIVHVGKTIHRLVTG | PisF2K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIKRGIVHVGKTIHRLVTG | PisF6K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIFRGIKHVGKTIHRLVTG | PisV10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 50 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIFRGIKHVGKTIHRLVTG | PisV10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 20 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | KFHHIFRGIKHVGKTIHRLVTG | Pis-F1K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FKHHIFRGIKHVGKTIHRLVTG | Pis-F2K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIKRGIKHVGKTIHRLVTG | Pis-F6K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | KFHHIFRGIKHVGKTIHRLVTG | Pis-F1K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | <20 % Hemolysis at 200 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FFHHIKRGIKHVGKTIHRLVTG | Pis-F6K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 19 % Hemolysis at 400 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FFHHIKRGIKHVGKTIHRLVTG | Pis-F2K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 400 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25123582 | 2014 | GMASLLAKVLPHVVKLIK | codesane(COD) | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 105 µM | Human | Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25123582 | 2014 | GMAKLLAKVLPHVVKLIK | COD-1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25123582 | 2014 | GMASKLAKVLPHVVKLIK | COD-2 | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25123582 | 2014 | GMASLLAKVLPKVVKLIK | COD-3 | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25123582 | 2014 | GMASLWAKVLPHVVKLIK | COD-4 | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 162.5 µM | Human | Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25123582 | 2014 | GMASLW{d}AKVLPHVVKLIK | COD-5 | Free | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 18 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25241629 | 2014 | LKLSPKTKDTLKKVLKGAIKGAIAIASMA{ct:Amid} | Hymenochirin-1Pa | Amidation | Free | Linear | L | None | 29 | Antimicrobial, Antitumor | 50 % Hemolysis at 162 ± 13 µM | Human | Skin Secretions Ofthe Frog Pseudhymenochirus Merlini | α-Helix | NA | ||
| 25241629 | 2014 | LKLSPKTKKTLKKVLKGAIKGAIAIASMA{ct:Amid} | [D9K]Hymenochirin-1Pa | Amidation | Free | Linear | L | None | 29 | Antimicrobial, Antitumor | 50 % Hemolysis at 192 ± 21 µM | Human | Analog Of Hymenochirin-1Pa, Skin Secretions Ofthe Frog Pseudhymenochirus Merlini | α-Helix | NA | ||
| 25241629 | 2014 | LKLSPKTKK{d}TLKKVLKGAIKGAIAIASMA{ct:Amid} | [D9k]Hymenochirin-1Pa | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 29 | Antimicrobial, Antitumor | 50 % Hemolysis at >400 µM | Human | Analog Of Hymenochirin-1Pa, Skin Secretions Ofthe Frog Pseudhymenochirus Merlini | α-Helix | NA | ||
| 25447194 | 2014 | IKIPSFFRNILKKVGKEAVSLIAGALKQS | Pseudhymenochirin-1Pb(Ps-1Pb) | Free | Free | Linear | L | None | 29 | Antimicrobial, Antitumor | 50 % Hemolysis at 28 ± 2 µM | Human | Skin Secretions Of The Frog Pseudhymenochirus Merlini | α-Helix | NA | ||
| 25447194 | 2014 | GIFPIFAKLLGKVIKVASSLISKGRTE | (Pseudhymenochirin-2Pa)Ps-2Pa | Free | Free | Linear | L | None | 27 | Antimicrobial, Antitumor | 50 % Hemolysis at 6.2 ± 1.0 µM | Human | Skin Secretions Of The Frog Pseudhymenochirus Merlini | α-Helix | NA | ||
| 25200682 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin(MLT) | Free | Free | Linear | L | None | 26 | Antimicrobial, Antiviral | 50 % Hemolysis at 5 µM | Human | Bee Venom | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 ± 2.3 % Hemolysis at 80 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 ± 3.3 % Hemolysis at 40 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 98.4 ± 2.0 % Hemolysis at 20 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 74.0 ± 7.4 % Hemolysis at 10 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 36.7 ± 9.5 % Hemolysis at 5 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 13.4 ± 7.1 % Hemolysis at 2.5 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 1.3 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25494332 | 2014 | RFRRLRKKTRKRLKKI{ct:Amid} | RI16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 25494332 | 2014 | RFRRLRKKWRKRLKKI{ct:Amid} | T9W | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 50 % Hemolysis at >256 µM | Human | Mutant Peptide | α-Helix | NA | ||
| 25494332 | 2014 | RFRRLRKKIRKRLKKI{ct:Amid} | T9I | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >256 µM | Human | Mutant Peptide | α-Helix | NA | ||
| 25494332 | 2014 | RFRRLRKKKRKRLKKI{ct:Amid} | T9K | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >256 µM | Human | Mutant Peptide | α-Helix | NA | ||
| 25494332 | 2014 | RFRRLRKKFRKRLKKI{ct:Amid} | T9F | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >256 µM | Human | Mutant Peptide | α-Helix | NA | ||
| 24825365 | 2014 | EIAALEQEIAALEYKIAALKGGGKIAALKQKIAALKQEIAALEGGG | SaNet | Free | Free | Linear | L | None | 46 | Antimicrobial | 50 % Hemolysis at >>600 µM | Human | Synthetic Peptide | α-Helical | NA | ||
| 24952727 | 2014 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 1 µM | Human | Synthetic Peptide | α-Helical | NA | ||
| 24952727 | 2014 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | <10 % Hemolysis at 10 µM | Human | Synthetic Peptide | α-Helical | NA | ||
| 24952727 | 2014 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | <20 % Hemolysis at 100 µM | Human | Synthetic Peptide | α-Helical | NA | ||
| 24952727 | 2014 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | <40 % Hemolysis at 200 µM | Human | Synthetic Peptide | α-Helical | NA | ||
| 25016054 | 2014 | GIGAVLVKLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 50 μg/ml | Human | Bee Venom | NA | NA | ||
| 25100358 | 2014 | KRFKKFFKKLKNSVKKRAKKFFKKPRVIGVSIPF | Oh_CRAMP | Free | Free | Linear | L | None | 34 | Antimicrobial | 10 % Hemolysis at 100 µM | Human | Reptilian Cramps From Elapids | α-Helix | NA | ||
| 25100358 | 2014 | KRFKKFFKKVKKSVKKRLKKIFKKPMVIGVTIPF | crotalicidin | Free | Free | Linear | L | None | 34 | Antimicrobial | 10 % Hemolysis at 25 µM | Human | Reptilian Cramps From Pit Vipers | α-Helix | NA | ||
| 25100358 | 2014 | KRFKKFFKKLKNSVKKRVKKFFRKPRVIGVTFPF | batroxicidin | Free | Free | Linear | L | None | 34 | Antimicrobial | 10 % Hemolysis at 12.5 µM | Human | Reptilian Cramps From Pit Vipers | α-Helix | NA | ||
| 25100358 | 2014 | KRFKKFFMKLKKSVKKRVMKFFKKPMVIGVTFPF | Pt_ CRAMP1 | Free | Free | Linear | L | None | 34 | Antimicrobial | 10 % Hemolysis at ~6.25 µM | Human | Reptilian Cramps From Elapids | α-Helix | NA | ||
| 25100358 | 2014 | SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW | Pt_ CRAMP1 | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at 50 µM | Human | Reptilian Cramps From Elapids | α-Helix | NA | ||
| 24706599 | 2014 | {nnr:pGlu}CRRLCYKQRCVTYCRGR | Gomesin (Gm) | Amidation | Free | Linear | L | pGlu = pyroglutamic | 18 | Antimicrobial | 10 % Hemolysis at 0.4 µM | Human | Hemolymph Of The Spider Acanthoscurria Gomesiana | β-Hairpin | NA | ||
| 24706599 | 2014 | {nnr:pGlu}CRRLCYKQRCVTYCRGR | Gomesin (Gm) | Amidation | Free | Linear | L | pGlu = pyroglutamic | 18 | Antimicrobial | 40 % Hemolysis at 100 µM | Human | Hemolymph Of The Spider Acanthoscurria Gomesiana | β-Hairpin | NA | ||
| 24706599 | 2014 | WCRRLCYKQRCVTYCRGR{ct:Amid} | [Trp1 ]-Gm | Amidation | Free | Linear | L | None | 18 | Antimicrobial | <35 % Hemolysis at 100 µM | Human | Gomesin Analogs | β-Hairpin | NA | ||
| 24706599 | 2014 | {nnr:pGlu}CRRLCWKQRCVTYCRGR | [Trp7 ]-Gm | Amidation | Free | Linear | L | pGlu = pyroglutamic | 18 | Antimicrobial | 35 % Hemolysis at 100 µM | Human | Gomesin Analogs | β-Hairpin | NA | ||
| 24706599 | 2014 | {nnr:pGlu}CRRLCYKWRCVTYCRGR | [Trp9 ]- Gm | Amidation | Free | Linear | L | pGlu = pyroglutamic | 18 | Antimicrobial | 40 % Hemolysis at 100 µM | Human | Gomesin Analogs | β-Hairpin | NA | ||
| 24466055 | 2014 | GVFRRLRKVTRKVLKKIGKVLKWI{ct:Amid} | GI24-V3 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 128 µM | Human | Residue-Substituted Derivative Of Cathelicidin Pmap-36 | α-Helix | NA | ||
| 24466055 | 2014 | GVFRVLRKVTRVVLKVIGKVLKWI{ct:Amid} | GI24-V6 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 8 µM | Human | Residue-Substituted Derivative Of Cathelicidin Pmap-36 | α-Helix | NA | ||
| 24466055 | 2014 | GRFRRLRKKTRKRLKKIGKVLKWI{ct:Amid} | GI24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | <30 % Hemolysis at 128 µM | Human | Truncated Derivative Of Cathelicidin Pmap-36 | α-Helix | NA | ||
| 24466055 | 2014 | GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG{ct:Amid} | PMAP-36 | Amidation | Free | Linear | L | None | 36 | Antimicrobial | <40 % Hemolysis at 128 µM | Human | Porcine Myeloid Antimicrobial Peptide-36 | α-Helix | NA | ||
| 24466055 | 2014 | GRFRRLRKKTRK{ct:Amid} | GK12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Truncated Derivative Of Cathelicidin Pmap-36 | α-Helix | Non-hemolytic | ||
| 24466055 | 2014 | RLKKIGKVLKWI{ct:Amid} | RI12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Truncated Derivative Of Cathelicidin Pmap-36 | α-Helix | Non-hemolytic | ||
| 24466055 | 2014 | PPIVGSIPLGCG{ct:Amid} | PG12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Truncated Derivative Of Cathelicidin Pmap-36 | α-Helix | Non-hemolytic | ||
| 24466055 | 2014 | GRFRRLRKKTRKRLKKIGKVLKAI{ct:Amid} | GI24-W23A | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Residue-Substituted Derivative Of Cathelicidin Pmap-36 | α-Helix | Non-hemolytic | ||
| 24466055 | 2014 | GRFRRLRKKTRKRLKKIGKVLKKI{ct:Amid} | GI24-W23K | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Residue-Substituted Derivative Of Cathelicidin Pmap-36 | α-Helix | Non-hemolytic | ||
| 24466055 | 2014 | GRFRRLRKKTRKRLKKIGKVLKLI{ct:Amid} | GI24-W23L | Amidation | Free | Linear | L | None | 24 | Antimicrobial | <40 % Hemolysis at 128 µM | Human | Residue-Substituted Derivative Of Cathelicidin Pmap-36 | α-Helix | NA | ||
| 24466055 | 2014 | GIGAVLVKLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 128 µM | Human | Bee Venom | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}V{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 1.8 µM | Human | Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}V{d}K{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 G13K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 7 µM | Human | Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}K{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 V12K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 35 µM | Human | Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}K{d}V{d}H{d}V{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 I9K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 98 µM | Human | Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | A{d}L{d}W{d}M{d}T{d}L{d}L{d}K{d}K{d}V{d}L{d}K{d}A{d}A{d}A{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid} | D-Dermaseptin S4 | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 27 | Antimicrobial | 50 % Hemolysis at 0.6 µM | Human | South American Frogs Of The Phyllomedusa | α-Helix | NA | ||
| 24670666 | 2014 | A{d}L{d}W{d}M{d}T{d}L{d}K{d}K{d}K{d}V{d}L{d}K{d}A{d}A{d}A{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid} | D-Dermaseptin S4 L7K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 27 | Antimicrobial | 50 % Hemolysis at 8.6 µM | Human | Derivative Of D-Dermaseptin S4 | α-Helix | NA | ||
| 24670666 | 2014 | A{d}L{d}W{d}M{d}T{d}L{d}K{d}K{d}K{d}V{d}L{d}K{d}A{d}K{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid} | D-Dermaseptin S4 L7K,A14K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 27 | Antimicrobial | 50 % Hemolysis at 241 µM | Human | Derivative Of D-Dermaseptin S4 | α-Helix | NA | ||
| 24946217 | 2014 | KWK{nt:C10}{ct:Amid} | AMP-C10-12 | Amidation | C10 | Linear | L | None | 3 | Antimicrobial | <10 % Hemolysis at 250 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 24946217 | 2014 | RKWWK{nt:C10}{ct:Amid} | AMP-C10-3 | Amidation | C10 | Linear | L | None | 5 | Antimicrobial | <10 % Hemolysis at 125 µM | Human | Synthetic | NA | NA | ||
| 24946217 | 2014 | RIKWK{nt:C10}{ct:Amid} | AMP-C10-14 | Amidation | C10 | Linear | L | None | 5 | Antimicrobial | <10 % Hemolysis at 250 µM | Human | Synthetic | NA | NA | ||
| 24946217 | 2014 | KWK{nt:C14}{ct:Amid} | AMP-C14-12 | Amidation | C14 | Linear | L | None | 3 | Antimicrobial | 11 % Hemolysis at 125 µM | Human | Synthetic | NA | NA | ||
| 24946217 | 2014 | KWK{nt:C14}{ct:Amid} | AMP-C14-12 | Amidation | C14 | Linear | L | None | 3 | Antimicrobial | 19 % Hemolysis at 250 µM | Human | Synthetic | NA | NA | ||
| 24946217 | 2014 | KWKW{nt:C14}{ct:Amid} | AMP-C14-16 | Amidation | C14 | Linear | L | None | 4 | Antimicrobial | 17 % Hemolysis at 125 µM | Human | Synthetic | NA | NA | ||
| 24946217 | 2014 | KWKW{nt:C14}{ct:Amid} | AMP-C14-16 | Amidation | C14 | Linear | L | None | 4 | Antimicrobial | <60 % Hemolysis at 250 µM | Human | Synthetic | NA | NA | ||
| 24946217 | 2014 | KWWK{nt:C14}{ct:Amid} | AMP-C14-1 | Amidation | C14 | Linear | L | None | 4 | Antimicrobial | 56 % Hemolysis at 125 µM | Human | Synthetic | NA | NA | ||
| 24946217 | 2014 | RWWR{nt:C14}{ct:Amid} | AMP-C14-5 | Amidation | C14 | Linear | L | None | 4 | Antimicrobial | 90 % Hemolysis at 250 µM | Human | Synthetic | NA | NA | ||
| 24946217 | 2014 | RIKWK{nt:C14}{ct:Amid} | AMP-C14-14 | Amidation | C14 | Linear | L | None | 5 | Antimicrobial | 20 % Hemolysis at 250 µM | Human | Synthetic | NA | NA | ||
| 24946217 | 2014 | RIKWWK{nt:C14}{ct:Amid} | AMP-C14-4 | Amidation | C14 | Linear | L | None | 6 | Antimicrobial | 60 % Hemolysis at 250 µM | Human | Synthetic | NA | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 8.4 ± 1.2 % Hemolysis at 5 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 12.5 ± 1.5 % Hemolysis at 10 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 18.4 ± 2.2 % Hemolysis at 25 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 24.7 ± 1.7 % Hemolysis at 50 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 33.6 ± 2.9 % Hemolysis at 100 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 39.4 ± 2.5 % Hemolysis at 150 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 45.1 ± 2.1 % Hemolysis at 200 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 48.2 ± 1.6 % Hemolysis at 250 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 9.6 ± 0.9 % Hemolysis at 5 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 14.3 ± 1.2 % Hemolysis at 10 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 20.2 ± 1.8 % Hemolysis at 25 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 27.3 ± 2.8 % Hemolysis at 50 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 35.6 ± 1.4 % Hemolysis at 100 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 43.6 ± 2.8 % Hemolysis at 150 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 46.6 ± 3.1 % Hemolysis at 200 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 51.4 ± 2.3 % Hemolysis at 250 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25348533 | 2015 | ACPIFTKIQGTYRGKAKRIGRRIC | hBTD-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 0 µM | Human | Hybrid Peptide Of Human Β-Defensin -1 And Θ-Defensin | α-Helix | Non-hemolytic | ||
| 25348533 | 2015 | ACPIFTKIQGTYRGKAKRIGRRIC | hBTD-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.0012 ± 0.001 % Hemolysis at 5 µM | Human | Hybrid Peptide Of Human Β-Defensin -1 And Θ-Defensin | α-Helix | Non-hemolytic | ||
| 25348533 | 2015 | ACPIFTKIQGTYRGKAKRIGRRIC | hBTD-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.0020 ± 0.001 % Hemolysis at 10 µM | Human | Hybrid Peptide Of Human Β-Defensin -1 And Θ-Defensin | α-Helix | Non-hemolytic | ||
| 25348533 | 2015 | ACPIFTKIQGTYRGKAKRIGRRIC | hBTD-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.0040 ± 0.0040 % Hemolysis at 50 µM | Human | Hybrid Peptide Of Human Β-Defensin -1 And Θ-Defensin | α-Helix | Non-hemolytic | ||
| 25348533 | 2015 | ACPIFTKIQGTYRGKAKRIGRRIC | hBTD-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.0053 ± 0.001 % Hemolysis at 100 µM | Human | Hybrid Peptide Of Human Β-Defensin -1 And Θ-Defensin | α-Helix | Non-hemolytic | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 4.1 ± 1.2 % Hemolysis at 64 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.1 ± 0.1 % Hemolysis at 32 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.0 ± 1.6 % Hemolysis at 16 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.0 ± 1.4 % Hemolysis at 8 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.0 ± 1.1 % Hemolysis at 4 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 0.0 ± 0.0 % Hemolysis at 2 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Hemolysis at 1 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Hemolysis at 0.5 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Hemolysis at 0.25 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 11.1 ± 0.9 % Hemolysis at 64 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 10.9 ± 1.9 % Hemolysis at 32 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 6.4 ± 1.6 % Hemolysis at 16 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5.9 ± 0.2 % Hemolysis at 8 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.4 ± 1.1 % Hemolysis at 4 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.1 ± 0.5 % Hemolysis at 2 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.0 ± 1.2 % Hemolysis at 1 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Hemolysis at 0.5 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Hemolysis at 0.25 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25172690 | 2015 | GLSRLFTALK | ACWWP1 | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibacterial | 0 % Hemolysis at 512 μg/ml | Mouse | Boiled–Dried Anchovies Cooking Wastewater | α-Helix | Non-hemolytic | ||
| 25257597 | 2015 | AYVLDEPKPIKDLEKSLQHNLVYCRRLVLEYFLKSIFEYH | SRTAP-40 | Free | Free | Linear | L | None | 40 | Antimicrobial | 1.5 % Hemolysis at 192 μg/ml | Rabbit | Sheep Reproductive Tract | NA | NA | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.8 % Hemolysis at 1.6 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.3 % Hemolysis at 3.1 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.4 % Hemolysis at 6.3 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.4 % Hemolysis at 12.5 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.5 % Hemolysis at 25 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.3 % Hemolysis at 50 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.2 % Hemolysis at 100 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 4.1 µM | Human | Coelomocytes Of Marine Polychaeta Lugworm Arenicola Marina | β-Hairpin | NA | ||
| 25557880 | 2015 | RGCVYAYVRVRGVLVRYRRCW | W2G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 5.5 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RSCVYAYVRVRGVLVRYRRCW | W2S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 5.5 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RRCVYAYVRVRGVLVRYRRCW | W2R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 9.4 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCGYAYVRVRGVLVRYRRCW | V4G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 36.2 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCSYAYVRVRGVLVRYRRCW | V4S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 23.1 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCRYAYVRVRGVLVRYRRCW | V4R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 48.5 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYGYVRVRGVLVRYRRCW | A6G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 17 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYSYVRVRGVLVRYRRCW | A6S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 13.9 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYRYVRVRGVLVRYRRCW | A6R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 71 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYGRVRGVLVRYRRCW | V8G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 6.7 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYSRVRGVLVRYRRCW | V8S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 26.8 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYRRVRGVLVRYRRCW | V8R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 125 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRGRGVLVRYRRCW | V10G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 4.9 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRSRGVLVRYRRCW | V10S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 4.3 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRRRGVLVRYRRCW | V10R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 9.5 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGGLVRYRRCW | V13G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 5.9 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGSLVRYRRCW | V13S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 9.7 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGRLVRYRRCW | V13R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 13.7 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVGVRYRRCW | L14G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 4.4 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVSVRYRRCW | L14S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 3.1 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVRVRYRRCW | L14R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 3.1 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLGRYRRCW | V15G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 12.8 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLSRYRRCW | V15S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 24.8 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLRRYRRCW | V15R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 28.3 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLVRYRRCG | W21G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 8.4 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLVRYRRCS | W21S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 9.2 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLVRYRRCR | W21R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 10.8 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25680229 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 53 % Hemolysis at 512 μg/ml | Human | Skin Of The African Clawed Frog | α-Helix | NA | ||
| 25680229 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 25 % Hemolysis at 256 μg/ml | Human | Skin Of The African Clawed Frog | α-Helix | NA | ||
| 25680229 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 13 % Hemolysis at 128 μg/ml | Human | Skin Of The African Clawed Frog | α-Helix | NA | ||
| 25680229 | 2015 | GIGKFLKKAKKF{ct:Amid} | CEM1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibacterial | 0 % Hemolysis at 0-512 μg/ml | Human | Pexiganan, Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 25680229 | 2015 | IGKFLKKAKKFG{ct:Amid} | CEM2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibacterial | 0 % Hemolysis at 0-512 μg/ml | Human | Pexiganan, Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 25735802 | 2015 | RFRRLRWKTRWRLKKI{ct:Amid} | PRW4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRCKTRCRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRDKTRDRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRIKTRIRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRPKTRPRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRW{d}KTRW{d}RLKKI{ct:Amid} | PRW4-d | Amidation | Free | Linear | Mix | w = Wd (D-Trp-substituted) | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRWRTRWRLRRI{ct:Amid} | PRW4-R | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at 0.25 µM | Human | Control,Bee Venom | α-Helix | NA | ||
| 25749154 | 2015 | FFGHLYRGITSVVKHVHGLLSG | Cnd | Free | Free | Linear | L | None | 22 | Antimicrobial | ~0.8 % Hemolysis at 50 μg/ml | Human | Gills Of The Chionodraco Hamatus | α-Helix | NA | ||
| 25941221 | 2015 | RIWVIWRR{ct:Amid} | Bac8c | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 10 % Hemolysis at 128 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 25941221 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 64 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 25941221 | 2015 | RWKRWWRWI{ct:Amid} | GN-2 peptide | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 25941221 | 2015 | RWKKWWRWL{ct:Amid} | GN-4 peptide | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 25941221 | 2015 | RKRWWWWFR{ct:Amid} | GN-6 peptide | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 26126210 | 2015 | LKGCWTKSIPPKPCF | ORB-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >500 μg/ml | Human | Synthetic Peptide | β-Hairpin | Low hemolytic | ||
| 26126210 | 2015 | LKGCWTKSIPPKPCF{ct:Amid} | ORB-N | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >500 μg/ml | Human | Orb-1 Analog | β-Hairpin | NA | ||
| 26156126 | 2015 | RWKIFKKIEKVGRNVRDGIIKAGPAVAVVGQAATVVK{ct:Amid} | Papiliocin | Amidation | Free | Linear | L | None | 37 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RAKIFKKIEKVGRNVRDGIIKAGPAVAVVGQAATVVK{ct:Amid} | Papiliocin-2A | Amidation | Free | Linear | L | None | 37 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RWKIAKKIEKVGRNVRDGIIKAGPAVAVVGQAATVVK{ct:Amid} | Papiliocin-5A | Amidation | Free | Linear | L | None | 37 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RAKIAKKIEKVGRNVRDGIIKAGPAVAVVGQAATVVK{ct:Amid} | Papiliocin-2A5A | Amidation | Free | Linear | L | None | 37 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RWKIFKKIEKVGRNVRDGIIKA{ct:Amid} | PapN | Amidation | Free | Linear | L | None | 22 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RAKIFKKIEKVGRNVRDGIIKA{ct:Amid} | PapN-2A | Amidation | Free | Linear | L | None | 22 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RWKIAKKIEKVGRNVRDGIIKA{ct:Amid} | PapN-5A | Amidation | Free | Linear | L | None | 22 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RAKIAKKIEKVGRNVRDGIIKA{ct:Amid} | PapN-2A5A | Amidation | Free | Linear | L | None | 22 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RFKIWKKIEKVGRNVRDGIIKA{ct:Amid} | PapN-2F5W | Amidation | Free | Linear | L | None | 22 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | AVAVVGQAATVVK{ct:Amid} | PapC | Amidation | Free | Linear | L | None | 13 | Antimicrobial and Antiinflammatory Activities | 49 % Hemolysis at 6.25 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | NA | ||
| 26194630 | 2015 | LIQRGRFGRFLGRIRRFRPRINFDIRARGSIRLG | Cl-CATH2 | Free | Free | Linear | L | None | 34 | Antimicrobial | 12.84 % Hemolysis at 200 μg/ml | Human | Columba Livia | α-Helix | NA | ||
| 26107622 | 2015 | GVFDIIKDAGKQLVAHAMGKIAEKV{ct:Amid} | ocellatin-PT1 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 1.98 ± 0.08 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26107622 | 2015 | GVFDIIKDAGKQLVAHATGKIAEKV{ct:Amid} | ocellatin-PT2 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | Non-hemolytic | ||
| 26107622 | 2015 | GVIDIIKGAGKDLIAHAIGKLAEKV{ct:Amid} | ocellatin-PT3 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0.69 ± 0.04 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26107622 | 2015 | GVFDIIKGAGKQLIAHAMGKIAEKV{ct:Amid} | ocellatin-PT4 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 4.29 ± 0.23 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26107622 | 2015 | GVFDIIKDAGRQLVAHAMGKIAEKV{ct:Amid} | ocellatin-PT5 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 4.05 ± 0.19 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26107622 | 2015 | GVFDIIKGAGKQLIAHAMEKIAEKVGLNKDGN | ocellatin-PT6 | Free | Free | Linear | L | None | 32 | Antimicrobial | 0.69 ± 0.04 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26107622 | 2015 | GVFDIIKGAGKQLIAHAMGKIAEKVGLNKDGN | ocellatin-PT7 | Free | Free | Linear | L | None | 32 | Antimicrobial | 13.72 ± 1.29 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26107622 | 2015 | GVFDIIKGAGKQLIARAMGKIAEKVGLNKDGN | ocellatin-PT8 | Free | Free | Linear | L | None | 32 | Antimicrobial | 8.09 ± 0.52 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26096124 | 2015 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at 512 μg/ml | Human | Venom Of The Solitary Wasp | α-Helix | NA | ||
| 26028561 | 2015 | FKRLKKLFKKIWNWK{ct:Amid} | HPA3NT3 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 68.2 % Hemolysis at 250 µM | Rat | Helicobacter Pylori | α-Helix | NA | ||
| 26028561 | 2015 | GIGAVLVKLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 250 µM | Rat | Bee Venom | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 1 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at 215 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LRWLRWG{cyc:N-C} | 2 | Free | Free | Cyclic | L | None | 7 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LK{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 3 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C} | 4 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LK{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C} | 5 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LKWLKWG{cyc:N-C} | 6 | Free | Free | Cyclic | L | None | 7 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LKFLKFG{cyc:N-C} | 7 | Free | Free | Cyclic | L | None | 7 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:Abu}){cyc:N-C} | 8 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Abu = 4-aminobutyric acid | 4 | Antimicrobial | 50 % Hemolysis at 230 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:6-Ahx}{cyc:N-C} | 9 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 6-Ahx = 6-aminohexanoic acid | 4 | Antimicrobial | 50 % Hemolysis at 115 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C} | 10 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid | 4 | Antimicrobial | 50 % Hemolysis at 22 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:10-Adc}{cyc:N-C} | 11 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 10-Adc = 10-aminodecanoic acid | 4 | Antimicrobial | 50 % Hemolysis at 15 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:Dab}){cyc:N-C} | 12 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid | 4 | Antimicrobial | 50 % Hemolysis at 265 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:εK}){cyc:N-C} | 13 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, εK = coupling of 2-Nal6 has occurred on lysine’s ε-amino functionality | 4 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:Dab}{nnr:Dab}){cyc:N-C} | 14 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid | 4 | Antimicrobial | 50 % Hemolysis at >450 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:Abu})({nnr:Dab}){cyc:N-C} | 15 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid | 4 | Antimicrobial | 50 % Hemolysis at 420 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:Dab})({nnr:Abu}){cyc:N-C} | 16 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid | 4 | Antimicrobial | 50 % Hemolysis at 255 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR({nnr:Bip})LR({nnr:Bip})G{cyc:N-C} | 17 | Free | Free | Cyclic | Mix | Bip = 4,4’-biphenyl-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 16 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR({nnr:Dip})LR({nnr:Dip})G{cyc:N-C} | 18 | Free | Free | Cyclic | Mix | Dip = 3,3-diphenyl-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 145 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | {nnr:2-Aoc}R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 19 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid | 4 | Antimicrobial | 50 % Hemolysis at 55 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C} | 20 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid | 4 | Antimicrobial | 50 % Hemolysis at 33 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | ({nnr:Cha})R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 21 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 28 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}({nnr:Cha})R{nnr:2-Nal}G{cyc:N-C} | 22 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 60 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}({nnr:Nle})R{nnr:2-Nal}G{cyc:N-C} | 23 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Nle = norleucine | 4 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | PR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 24 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}PR{nnr:2-Nal}G{cyc:N-C} | 25 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LRYG{cyc:N-C} | 26 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 6 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | TR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 27 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}TR{nnr:2-Nal}G{cyc:N-C} | 28 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | QR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 29 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:D-2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C} | 30 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid | 4 | Antimicrobial | 50 % Hemolysis at 55 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}(D-2-Aoc)R{nnr:2-Nal}G{cyc:N-C} | 31 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid | 4 | Antimicrobial | 50 % Hemolysis at 55 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR(2NalNal)LR{nnr:D-2-Nal}G{cyc:N-C} | 32 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid | 5 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | TR{nnr:2-Nal}IR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C} | 33 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid | 4 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C} | 34 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 3 | Antimicrobial | 50 % Hemolysis at 55 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 1 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 27 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LRWLRWG{cyc:N-C} | 2 | Free | Free | Cyclic | L | None | 7 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LK{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 3 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 14 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR(NalNaI)LK{nnr:2-Nal}G{cyc:N-C} | 4 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 19 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LK{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C} | 5 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 13 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LKWLKWG{cyc:N-C} | 6 | Free | Free | Cyclic | L | None | 7 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LKFLKFG{cyc:N-C} | 7 | Free | Free | Cyclic | L | None | 7 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:Abu}){cyc:N-C} | 8 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Abu = 4-aminobutyric acid | 4 | Antimicrobial | 22 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:6-Ahx}{cyc:N-C} | 9 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 6-Ahx = 6-aminohexanoic acid | 4 | Antimicrobial | 75 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C} | 10 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid | 4 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:10-Adc}{cyc:N-C} | 11 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 10-Adc = 10-aminodecanoic acid | 4 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:Dab}){cyc:N-C} | 12 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid | 4 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:εK}){cyc:N-C} | 13 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, εK = coupling of 2-Nal6 has occurred on lysine’s ε-amino functionality | 4 | Antimicrobial | 51 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C} | 14 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid | 4 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:Abu})({nnr:Dab}){cyc:N-C} | 15 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid | 4 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:2-Nal}({nnr:Dab})({nnr:Abu}){cyc:N-C} | 16 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid | 4 | Antimicrobial | 12 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR({nnr:Bip})LR({nnr:Bip})G{cyc:N-C} | 17 | Free | Free | Cyclic | Mix | Bip = 4,4’-biphenyl-L-alanine | 5 | Antimicrobial | 96 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR({nnr:Dip})LR({nnr:Dip})G{cyc:N-C} | 18 | Free | Free | Cyclic | Mix | Dip = 3,3-diphenyl-L-alanine | 5 | Antimicrobial | 54 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | {nnr:2-Aoc}R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 19 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid | 4 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C} | 20 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid | 4 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | ({nnr:Cha})R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 21 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine | 4 | Antimicrobial | 99 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}({nnr:Cha})R{nnr:2-Nal}G{cyc:N-C} | 22 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine | 4 | Antimicrobial | 96 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}({nnr:Nle})R{nnr:2-Nal}G{cyc:N-C} | 23 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, Nle = norleucine | 4 | Antimicrobial | 35 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | PR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 24 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}PR{nnr:2-Nal}G{cyc:N-C} | 25 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LRYG{cyc:N-C} | 26 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 6 | Antimicrobial | 19 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | TR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 27 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}TR{nnr:2-Nal}G{cyc:N-C} | 28 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | QR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C} | 29 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:D-2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C} | 30 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid | 4 | Antimicrobial | 92 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}(D-2-Aoc)R{nnr:2-Nal}G{cyc:N-C} | 31 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid | 4 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}LR{nnr:D-2-Nal}G{cyc:N-C} | 32 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid | 4 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | TR{nnr:2-Nal}IR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C} | 33 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid | 4 | Antimicrobial | 10 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26318064 | 2015 | LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C} | 34 | Free | Free | Cyclic | Mix | 2-Nal = 3-(2-naphthyl)-L-alanine | 3 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 0.0625 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 0.125 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 0.25 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 0.5 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 1 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 2 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 4 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 8 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26291880 | 2015 | ILPWKWPWWPWRR{ct:Amid} | IL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100 % Hemolysis | Human | Cpp | α-Helix | NA | ||
| 26291880 | 2015 | ILPWKWKWWPWRR{ct:Amid} | IL-K7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 42 % Hemolysis | Human | Indolicidin Modification | α-Helix | NA | ||
| 26291880 | 2015 | ILPWKWPFFPWRR{ct:Amid} | IL-F89 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 22 % Hemolysis | Human | Indolicidin Modification | α-Helix | NA | ||
| 26291880 | 2015 | ILPWRWRFFPWRR{ct:Amid} | IL-R57F89 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 13 % Hemolysis | Human | Indolicidin Modification | α-Helix | NA | ||
| 26291880 | 2015 | ILPWKWKFFPWRR{ct:Amid} | IL-K7F89 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis | Human | Indolicidin Modification | α-Helix | NA | ||
| 26291880 | 2015 | RRWKFFPWRR{ct:Amid} | SAP10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 1 % Hemolysis | Human | Synthetic | α-Helix | NA | ||
| 26291880 | 2015 | RRRRRRRRR{ct:Amid} | R9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | NA | Human | Cpp | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}F{nnr:O}RPVYIPRPRPPHPRL{nt:gu}{ct:OH} | Api723 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.66 ± 0.84 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}FRPVYIPRPRPPHPRL{nt:gu}{ct:OH} | Api724 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.08 ± 0.60 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}WRPVYIPRPRPPHPRL{nt:gu}{ct:OH} | Api732 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.99 ± 0.60 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}W{nnr:O}RPVYIPRPRPPHPRL{nt:gu}{ct:OH} | Api733 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.51 ± 0.36 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}F{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api753 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.28 ± 0.19 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}FRPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api754 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.32 ± 0.38 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api755 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | -0.35 ± 0.89 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}IRPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api756 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | -0.12 ± 0.30 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}Y{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api757 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.31 ± 0.50 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}YRPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api758 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.08 ± 0.17 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}WRPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api759 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.55 ± 0.16 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api760 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.54 ± 0.46 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26091834 | 2015 | SSRRPCRGRSCGPRLRGGYTLIGRPVKNQNRPKYMWV | BG-CATH37 | Free | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 400 μg/ml | Human | Toad Bufo Bufo Gargarizans | Random-coil | NA | ||
| 26091834 | 2015 | PCRGRSCGPRLRGGYTLIGRPVKNQNRPKYMWV | BG-CATH(5- 37) | Free | Free | Linear | L | None | 33 | Antimicrobial | 0 % Hemolysis at 400 μg/ml | Human | Toad Bufo Bufo Gargarizans | Random-coil | NA | ||
| 26088720 | 2015 | WKPGKW{ct:Amid} | WK1 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 5 % Hemolysis at 512 µM | Human | Tryptophan Zipper | β-Hairpin | NA | ||
| 26088720 | 2015 | (WKWK)PG(KWKW){ct:Amid} | WK2 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5 % Hemolysis at 512 µM | Human | Tryptophan Zipper | β-Hairpin | NA | ||
| 26088720 | 2015 | (WKWKWK)PG(KWKWKW){ct:Amid} | WK3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at 512 µM | Human | Tryptophan Zipper | β-Hairpin | NA | ||
| 26088720 | 2015 | (WKWKWKWK)PG(KWKWKWKW){ct:Amid} | WK4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 5 % Hemolysis at 8 µM | Human | Tryptophan Zipper | β-Hairpin | NA | ||
| 26088720 | 2015 | (WKWKWKWKWK)PG(KWKWKWKWKW){ct:Amid} | WK5 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 5 % Hemolysis at 4 µM | Human | Tryptophan Zipper | β-Hairpin | NA | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 25 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 25 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 ± 0.8 % Hemolysis at 100 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 ± 1.8 % Hemolysis at 50 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 98.1 ± 2.1 % Hemolysis at 25 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 87.4 ± 3.3 % Hemolysis at 12.5 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 52.6 ± 3.2 % Hemolysis at 6.3 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 22.5 ± 2.7 % Hemolysis at 3.1 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 8.6 ± 1.4 % Hemolysis at 1.6 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26352292 | 2015 | LPFFLLSLIPSAISAIKKI{ct:Amid} | VpAmp1.0 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 9.2 ± 0.3 µM | Human | Scorpion Vaejovispunctatus | α-Helix | NA | ||
| 26352292 | 2015 | FFLLSLIPSAISAIKKI{ct:Amid} | VpAmp1.1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 33.7 ± 2.4 µM | Human | Scorpion Vaejovispunctatus | α-Helix | NA | ||
| 26352292 | 2015 | FWGFLGKLAMKAVPSLIGGNKSSSK | VpAmp2.0 | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 167 ± 22.5 µM | Human | Scorpion Vaejovispunctatus | α-Helix | NA | ||
| 26352292 | 2015 | FWGFLGKLAMKAVPSLIGGNKK | VpAmp2.1 | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 103.5 ± 1.7 µM | Human | Scorpion Vaejovispunctatus | α-Helix | NA | ||
| 26530005 | 2015 | GKLWLKG{ct:Amid} | GG1 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | GKLWLKGGKLWLKG{ct:Amid} | GG2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | GKLWLKGGKLWLKGGKLWLKG{ct:Amid} | GG3 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | GKLWLKGGKLWLKGGKLWLKGGKLWLKG{ct:Amid} | GG4 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 5 % Hemolysis at 16 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | GKLWGLKGKLWGLKGKLWGLK{ct:Amid} | GG3s1 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | GLWKGKLGLWKGKLGLWKGKL{ct:Amid} | GG3s2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | AKLWLKA{ct:Amid} | AA1 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | AKLWLKAAKLWLKA{ct:Amid} | AA2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at 128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | AKLWLKAAKLWLKAAKLWLKA{ct:Amid} | AA3 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at 8 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | AKLWLKAAKLWLKAAKLWLKAAKLWLKA{ct:Amid} | AA4 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 5 % Hemolysis at 1 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | AKLWALKAKLWALKAKLWALK{ct:Amid} | AA3s1 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at 16 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 5 % Hemolysis at 0.25 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26608073 | 2015 | KRFWQLVPLAIKIYRAWKRR | dCATH | Free | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at 20 µM | Human | Cathelicidin Ortholog From Ducks | α-Helix | NA | ||
| 26608073 | 2015 | KRFWQLVPLAIKIYRAWKRR | dCATH | Free | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at 32 µM | Human | Cathelicidin Ortholog From Ducks | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 0 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0.2 % Hemolysis at 1 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 1.4 % Hemolysis at 2 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 1.3 % Hemolysis at 4 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 5 % Hemolysis at 8 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 9.5 % Hemolysis at 16 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 38.6 % Hemolysis at 32 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 79.6 % Hemolysis at 64 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 107.4 % Hemolysis at 128 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 104.1 % Hemolysis at 512 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 25934283 | 2015 | KLDLKLDLKLDL | KLD | Free | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 50 μg/mL | Human | Self-Assembling | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | KLDLKLDLKLDL | KLD | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.5 % Hemolysis at 100 μg/mL | Human | Self-Assembling | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | KLDLKLDLKLDL | KLD | Free | Free | Linear | L | None | 12 | Antimicrobial | <1 % Hemolysis at 200 μg/mL | Human | Self-Assembling | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | RKLDLKLDLKLDL | KLD-R | Free | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 50 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | RKLDLKLDLKLDL | KLD-R | Free | Free | Linear | L | None | 13 | Antimicrobial | 0.5 % Hemolysis at 100 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | RKLDLKLDLKLDL | KLD-R | Free | Free | Linear | L | None | 13 | Antimicrobial | 1.5 % Hemolysis at 200 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRKLDLKLDLKLDL | KLD-2R | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 50 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | RRKLDLKLDLKLDL | KLD-2R | Free | Free | Linear | L | None | 14 | Antimicrobial | 1 % Hemolysis at 100 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRKLDLKLDLKLDL | KLD-2R | Free | Free | Linear | L | None | 14 | Antimicrobial | <2.5 % Hemolysis at 200 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRRKLDLKLDLKLDL | KLD-3R | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.5 % Hemolysis at 50 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | RRRKLDLKLDLKLDL | KLD-3R | Free | Free | Linear | L | None | 15 | Antimicrobial | <1.5 % Hemolysis at 100 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRRKLDLKLDLKLDL | KLD-3R | Free | Free | Linear | L | None | 15 | Antimicrobial | 2.5 % Hemolysis at 200 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRRRKLDLKLDLKLDL | KLD-4R | Free | Free | Linear | L | None | 16 | Antimicrobial | 1.5 % Hemolysis at 50 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRRRKLDLKLDLKLDL | KLD-4R | Free | Free | Linear | L | None | 16 | Antimicrobial | <3 % Hemolysis at 100 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRRRKLDLKLDLKLDL | KLD-4R | Free | Free | Linear | L | None | 16 | Antimicrobial | 5 % Hemolysis at 200 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-WT | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 7±4 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-WT | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 35±6 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGK{nnr:X}LHSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-F5A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 19±2 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGK{nnr:X}LHSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-F5A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 98±4 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKF{nnr:X}HSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-L6A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 7±6 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKF{nnr:X}HSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-L6A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 25±4 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKK{nnr:X}GKAFVGEIMNS{ct:Amid} | MAG2-F12A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 10±9 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKK{nnr:X}GKAFVGEIMNS{ct:Amid} | MAG2-F12A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 49±12 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKF{nnr:X}KAFVGEIMNS{ct:Amid} | MAG2-G13A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 36±10 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKF{nnr:X}KAFVGEIMNS{ct:Amid} | MAG2-G13A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 100±0 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKA{nnr:X}VGEIMNS{ct:Amid} | MAG2-F16A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 12±3 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKA{nnr:X}VGEIMNS{ct:Amid} | MAG2-F16A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 55±14 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAF{nnr:X}GEIMNS{ct:Amid} | MAG2-V17A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 2±4 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | Non-hemolytic | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAF{nnr:X}GEIMNS{ct:Amid} | MAG2-V17A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 30±7 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFV{nnr:X}EIMNS{ct:Amid} | MAG2-G18A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 29±5 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFV{nnr:X}EIMNS{ct:Amid} | MAG2-G18A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 88±2 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKF{nnr:CF-3Bpg}HSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-L6B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 17±11 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKF{nnr:CF-3Bpg}HSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-L6B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 35±8 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKF{nnr:CF-3Bpg}KAFVGEIMNS{ct:Amid} | MAG2-G13B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 77±15 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKF{nnr:CF-3Bpg}KAFVGEIMNS{ct:Amid} | MAG2-G13B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 100±0 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGK{nnr:CF-3Bpg}FVGEIMNS{ct:Amid} | MAG2-A15B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 14±3 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGK{nnr:CF-3Bpg}FVGEIMNS{ct:Amid} | MAG2-A15B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 72±13 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKA{nnr:CF-3Bpg}VGEIMNS{ct:Amid} | MAG2-F16B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 27±4 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKA{nnr:CF-3Bpg}VGEIMNS{ct:Amid} | MAG2-F16B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 84±20 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAF{nnr:CF-3Bpg}GEIMNS{ct:Amid} | MAG2-V17B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 20±5 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAF{nnr:CF-3Bpg}GEIMNS{ct:Amid} | MAG2-V17B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 95±9 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFV{nnr:CF-3Bpg}EIMNS{ct:Amid} | MAG2-G18B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 12±6 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFV{nnr:CF-3Bpg}EIMNS{ct:Amid} | MAG2-G18B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 24±10 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25664972 | 2015 | GLFDIVKKVVGALC{ct:Amid} | Aurein 2.2∆3-cys | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 15.6 μg/mL | Sheep | Aurein 2.2 Conjugates | α-Helical | NA | ||
| 25664972 | 2015 | GLFDIVKKVVGALC{ct:Amid} | Aurein 2.2∆3-cys | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 31.2 μg/mL | Sheep | Aurein 2.2 Conjugates | α-Helical | NA | ||
| 25664972 | 2015 | GLFDIVKKVVGALC{ct:Amid} | Aurein 2.2∆3-cys | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <10 % Hemolysis at 62.5 μg/mL | Sheep | Aurein 2.2 Conjugates | α-Helical | NA | ||
| 25664972 | 2015 | GLFDIVKKVVGALC{ct:Amid} | Aurein 2.2∆3-cys | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at 125 μg/mL | Sheep | Aurein 2.2 Conjugates | α-Helical | NA | ||
| 25664972 | 2015 | GLFDIVKKVVGALC{ct:Amid} | Aurein 2.2∆3-cys | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 15 % Hemolysis at 250 μg/mL | Sheep | Aurein 2.2 Conjugates | α-Helical | NA | ||
| 25495219 | 2015 | {nnr:dab}-{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L{ct:Amid} | 29 | Amidation | Free | Linear | Mix | Dab = diaminobutyric acid | 3 | Antimicrobial | <2 % Hemolysis at 100 µM | Mouse | Synthetic Analogues Of Battacin | NA | NA | ||
| 25495219 | 2015 | {nnr:F{d}A}-{nnr:dab}-{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L{ct:Amid} | 17 | Amidation | Free | Linear | Mix | FA = fatty acid, Dab = diaminobutyric acid | 3 | Antimicrobial | 1.79 % Hemolysis at 100 µM | Mouse | Synthetic Analogues Of Battacin | Random coil | NA | ||
| 25495219 | 2015 | {nnr:R1}-{nnr:dab}-[{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L] | 13 | Free | Free | Cyclic | Mix | R1 = 4-methylhexanoyl, Dab = diaminobutyric acid | 3 | Antimicrobial | 2.02 % Hemolysis at 100 µM | Mouse | Synthetic Analogues Of Battacin | NA | NA | ||
| 25495219 | 2015 | {nnr:F{d}moc}-{nnr:dab}-[{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L] | 12 | Free | Free | Cyclic | Mix | Dab = diaminobutyric acid, Fmoc = fluorenylmethyloxycarbonyl | 3 | Antimicrobial | 41 % Hemolysis at 100 µM | Mouse | Synthetic Analogues Of Battacin | NA | NA | ||
| 25495219 | 2015 | {nnr:R3}-{nnr:dab}-{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L{ct:Amid} | 19 | Amidation | Free | Linear | Mix | R3 = myristyl, Dab = diaminobutyric acid | 3 | Antimicrobial | 76.9 % Hemolysis at 100 µM | Mouse | Synthetic Analogues Of Battacin | NA | NA | ||
| 25261129 | 2015 | GFGCNGPWSEKDMHCHNHCKSIKGYKGGYCAKGGFICKCY | rMP1106 | Free | Free | Linear | L | None | 43 | Antimicrobial | 1.16 % Hemolysis at 512 μg/mL | Human | Plectasin-Derived | α-Helix/β-Sheets | NA | ||
| 25425644 | 2015 | {nnr:T1}-VAGVVGLALIVAGVVVLNVAS-{nnr:T2} | TM4 | Free | Free | Linear | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH2 | 28 | Antimicrobial | 10 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-GLALIVAGV-{nnr:T2} | TM4(90–98) | Free | Free | Linear | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH3 | 9 | Antimicrobial | 10 % Hemolysis at >200 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VGLALIVAGVV-{nnr:T2} | TM4(89–99) | Free | Free | Linear | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH4 | 11 | Antimicrobial | 10 % Hemolysis at >200 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGLALIVAGVVV-{nnr:T2} | TM4(88–100) | Free | Free | Linear | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH5 | 13 | Antimicrobial | 10 % Hemolysis at >200 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGLALINAGVVV-{nnr:T2} | TM4(88–100)-N95 | Free | Free | Linear | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH6 | 13 | Antimicrobial | 10 % Hemolysis at >200 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVLVGIAGVALVV- {nnr:T2} | TM4(88–100)scr | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH7 | 13 | Antimicrobial | Not specified | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGL{nnr:X}LIV{nnr:X}GVVV-{nnr:T2} | S-TM4(88–100) | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH8 | 13 | Antimicrobial | 10 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGL{nnr:X}LIG{nnr:X}GVVV-{nnr:T2} | S-TM4(88–100)-G95 | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH9 | 13 | Antimicrobial | 10 % Hemolysis at 25 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGL{nnr:X}LIN{nnr:X}GVVV-{nnr:T2} | S-TM4(88–100)-N95 | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH10 | 13 | Antimicrobial | 10 % Hemolysis at >200 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-V{nnr:X'}GLALIN{nnr:X}GVVV-{nnr:T2} | S1-TM4(88–100)-N95 | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH11 | 13 | Antimicrobial | 10 % Hemolysis at 100 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGL{nnr:X'}LINAGV{nnr:X}V-{nnr:T2} | S2-TM4(88–100)-N95 | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH12 | 13 | Antimicrobial | 10 % Hemolysis at 100 µM | Human | Synthetic | α-Helical | NA | ||
| 26407061 | 2016 | VARGWKRKCPLFGKGGVARGWKRKCPLFGKGG | VG16KRKP Dimer | Free | Free | Linear | L | None | 32 | Antimicrobial | <0.25 % Hemolysis at 1 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | VARGWKRKCPLFGKGGVARGWKRKCPLFGKGG | VG16KRKP Dimer | Free | Free | Linear | L | None | 32 | Antimicrobial | 0.25 % Hemolysis at 5 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | VARGWKRKCPLFGKGGVARGWKRKCPLFGKGG | VG16KRKP Dimer | Free | Free | Linear | L | None | 32 | Antimicrobial | <0.25 % Hemolysis at 10 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | VARGWKRKCPLFGKGGVARGWKRKCPLFGKGG | VG16KRKP Dimer | Free | Free | Linear | L | None | 32 | Antimicrobial | 0.3 % Hemolysis at 25 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | VARGWKRKCPLFGKGGVARGWKRKCPLFGKGG | VG16KRKP Dimer | Free | Free | Linear | L | None | 32 | Antimicrobial | <0.35 % Hemolysis at 50 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | VARGWKRKCPLFGKGGVARGWKRKCPLFGKGG | VG16KRKP Dimer | Free | Free | Linear | L | None | 32 | Antimicrobial | <0.45 % Hemolysis at 100 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.25 % Hemolysis at 1 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.35 % Hemolysis at 5 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.35 % Hemolysis at 10 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.35 % Hemolysis at 25 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.35 % Hemolysis at 50 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.45 % Hemolysis at 100 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.69 % Hemolysis at 0.11 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.78 % Hemolysis at 0.22 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.8 % Hemolysis at 0.44 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.94 % Hemolysis at 0.88 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.06 % Hemolysis at 1.75 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.1 % Hemolysis at 3.5 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.15 % Hemolysis at 7 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.37 % Hemolysis at 14.01 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.77 % Hemolysis at 28.01 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 3.22 % Hemolysis at 56.02 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26574005 | 2016 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 33 % Hemolysis at 150 µM | Human | Cecropin-Α-Melittin 29 Hybrid | NA | NA | ||
| 26574005 | 2016 | RRLFRRILRWL{ct:Amid} | RW-BP100 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFKK{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP157 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | 8 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | RKLFKRILKYL{ct:Amid} | BP201 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 45 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KRLFRKILKYL{ct:Amid} | BP202 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 44 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFKKILRYL{ct:Amid} | BP203 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 31 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KRLFRKILRYL{ct:Amid} | BP204 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 69 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFRRILKYL{ct:Amid} | BP205 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 63 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | RRLFKKILKYL{ct:Amid} | BP206 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 68 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFKKI{d}LKYL{ct:Amid} | BP207 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | Not determined | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP208 | Amidation | Free | Linear | L | X = F (NPhe) | 18 | Antimicrobial | Not determined | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFK{nnr:B}{nnr:Z}{nnr:Z}{nnr:B}{nnr:X}{nnr:Z}{ct:Amid} | BP209 | Amidation | Free | Linear | L | X = F (NPhe), Z = L (NLeu), B= K(NLys) | 18 | Antimicrobial | Not determined | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | RRL({nnr:2Nal})RRILRYL{ct:Amid} | BP210 | Amidation | Free | Linear | L | 2Nal = 2-Nal | 18 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLF{d}KKILRYL{ct:Amid} | BP211 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | 43 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKL({nnr:D2-nal})KKILKYL{ct:Amid} | BP212 | Amidation | Free | Linear | Mix | D2-nal = D-2-nal | 18 | Antimicrobial | 85 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFKK{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid} | BP213 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid} | BP214 | Amidation | Free | Linear | D | None | 18 | Antimicrobial | 42 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | W362 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 5 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | 3W62 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 5 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-W362 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 5 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-3W62 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 5 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | W362 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 10 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | 3W62 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 10 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-W362 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 10 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-3W62 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 10 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | W362 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 20 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | 3W62 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <10 % Hemolysis at 20 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-W362 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 20 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-3W62 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 20 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | W362 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | 20 % Hemolysis at 40 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | 3W62 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 40 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-W362 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 40 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-3W62 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 40 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 26700464 | 2016 | RTLAFVRFK | RTL-PA | Free | Free | Linear | L | None | 9 | Antimicrobial | 100 % Hemolysis at 1.4 ± 0.1 µM | Rat | Tissue-Factor Targeted Found In The Heavy Chain Of Factor Vii | α-Helix | NA | ||
| 26700464 | 2016 | RTLAFVRFK | RTL-PA | Free | Free | Linear | L | None | 9 | Antimicrobial | 400 % Hemolysis at 2.0 ± 0.1 µM | Rat | Tissue-Factor Targeted Found In The Heavy Chain Of Factor Vii | α-Helix | NA | ||
| 26814379 | 2016 | RWCVYARVRGVRYRRCW | ALP1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 68 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVYACVRGVCYRRCW | ALP2 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 10 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVRARVRGVRYRRCW | ALP3 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 88 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVYARRRGVRYRRCW | ALP4 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 73 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVYARVRGRRYRRCW | ALP5 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 50 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVYARVRGVRYRRCR | ALP6 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 110 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVYAAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 5 µM | Human | Arenicola Marina | β-Hairpin | NA | ||
| 26873587 | 2016 | GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR | IP | Free | Free | Linear | L | None | 38 | Antimicrobial | <3 % Hemolysis at 0.78 μg/ml | Human | Ixodes Persulcatus | one α Helix and two β Sheets | NA | ||
| 26873587 | 2016 | GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR | IP | Free | Free | Linear | L | None | 38 | Antimicrobial | 3 % Hemolysis at 1.56 μg/ml | Human | Ixodes Persulcatus | one α Helix and two β Sheets | NA | ||
| 26873587 | 2016 | GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR | IP | Free | Free | Linear | L | None | 38 | Antimicrobial | <3 % Hemolysis at 3.13 μg/ml | Human | Ixodes Persulcatus | one α Helix and two β Sheets | NA | ||
| 26873587 | 2016 | GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR | IP | Free | Free | Linear | L | None | 38 | Antimicrobial | <3 % Hemolysis at 6.25 μg/ml | Human | Ixodes Persulcatus | one α Helix and two β Sheets | NA | ||
| 26873587 | 2016 | GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR | IP | Free | Free | Linear | L | None | 38 | Antimicrobial | <3 % Hemolysis at 12.5 μg/ml | Human | Ixodes Persulcatus | one α Helix and two β Sheets | NA | ||
| 26873587 | 2016 | GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR | IP | Free | Free | Linear | L | None | 38 | Antimicrobial | <3 % Hemolysis at 25 μg/ml | Human | Ixodes Persulcatus | one α Helix and two β Sheets | NA | ||
| 26873587 | 2016 | GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR | IP | Free | Free | Linear | L | None | 38 | Antimicrobial | <3 % Hemolysis at 5 μg/ml | Human | Ixodes Persulcatus | one α Helix and two β Sheets | NA | ||
| 26873587 | 2016 | GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR | IP | Free | Free | Linear | L | None | 38 | Antimicrobial | <3 % Hemolysis at 100 μg/ml | Human | Ixodes Persulcatus | one α Helix and two β Sheets | NA | ||
| 26873587 | 2016 | GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR | IP | Free | Free | Linear | L | None | 38 | Antimicrobial | 3 % Hemolysis at 200 μg/ml | Human | Ixodes Persulcatus | one α Helix and two β Sheets | NA | ||
| 27014065 | 2016 | SKKPVPIIYCNRRSGKCQRM | TS | Free | Free | Linear | L | None | 20 | Antimicrobial | <15 % Hemolysis at 1 mmol/L | Human | Tumor-Specific Cell-Surface | β-Sheet | NA | ||
| 27014065 | 2016 | CIRTPKISKPIKFELSG | P1c | Free | Free | Linear | L | None | 17 | Antimicrobial | <15 % Hemolysis at 1 mmol/L | Human | Human Connective Tissue | Random coil | NA | ||
| 27014065 | 2016 | GSKKPVPIIYCNRRSGKCQRMGSIRTPKISKPIKFELSG | PTS | Free | Free | Linear | L | None | 39 | Antimicrobial | <15 % Hemolysis at 1 mmol/L | Human | Hybrid Peptide | Random coil | NA | ||
| 26881456 | 2016 | KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF{ct:Amid} | cathelicidin-BF | Amidation | Free | Linear | L | None | 30 | Antimicrobial | 10 % Hemolysis at >320 μg/ml | Human | Bungarus Fasciatus | α-Helix | NA | ||
| 26881456 | 2016 | VKRFKKFFRKLKKSV{ct:Amid} | cathelicidin-BF15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at >320 μg/ml | Human | Bungarus Fasciatus | α-Helix | NA | ||
| 26881456 | 2016 | VKRFKKFFRKFKKSV{ct:Amid} | FS-15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKWWRKLKKSV{ct:Amid} | WS-15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKFWRKWKKWW{ct:Amid} | ZY8 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 51.7 ± 5.3 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKWRWKWKKWV{ct:Amid} | ZY13 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKWRWKKWRWKWKWKV{ct:Amid} | ZY15 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 178.3 ± 11.5 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKWRWKWKWRWKWKWKV{ct:Amid} | ZY16 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 62.8 ± 5.8 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF{ct:Amid} | cathelicidin-BF | Amidation | Free | Linear | L | None | 30 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Bungarus Fasciatus | α-Helix | NA | ||
| 26881456 | 2016 | VKRFKKFFRKLKKSV{ct:Amid} | cathelicidin-BF15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Bungarus Fasciatus | α-Helix | NA | ||
| 26881456 | 2016 | VKRFKKFFRKFKKSV{ct:Amid} | FS-15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKWWRKLKKSV{ct:Amid} | WS-15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKFWRKWKKWW{ct:Amid} | ZY8 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKWRWKWKKWV{ct:Amid} | ZY13 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKWRWKKWRWKWKWKV{ct:Amid} | ZY15 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKWRWKWKWRWKWKWKV{ct:Amid} | ZY16 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26795535 | 2016 | RGLRRLGRKIAHGVKKYGPTVLRIIRIA{ct:Amid} | SMAP-29 | Amidation | Free | Linear | L | None | 28 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at 6 µM | Human | Sheep Myeloid Cells | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}P{d}T{d}V{d}L{d}R{d}I{d}I{d}R{d}I{d}A{d}{ct:Amid} | SMAP-29-E1 | Amidation | Free | Linear | D | i = D-Isoleucine | 28 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at 5.5 µM | Human | Smap-29 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}P{d}T{d}V{d}L{d}R{d}{nnr:i}{nnr:i}R{d}{nnr:i}A{d}{ct:Amid} | SMAP-29-E2 | Amidation | Free | Linear | D | i = d-allo-isoleucine | 28 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at 16 µM | Human | Smap-29 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | RGLRRLGRKIAHGVKKYGP{d}T{d}V{d}L{d}R{d}I{d}I{d}R{d}I{d}A{d}{ct:Amid} | SMAP-29-D1 | Amidation | Free | Linear | Mix | i = D-Isoleucine | 28 | Antimicrobial, Anti-MRSA, Anti-inflammatory | 10 % Hemolysis at 110 µM | Human | Smap-29 Diastereomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | RGLRRLGRKIAHGVKKYGP{d}T{d}V{d}L{d}R{d}{nnr:i}{nnr:i}R{d}{nnr:i}A{d}{ct:Amid} | SMAP-29-D2 | Amidation | Free | Linear | Mix | i = d-allo-isoleucine | 28 | Antimicrobial, Anti-MRSA, Anti-inflammatory | 10 % Hemolysis at 217.5 µM | Human | Smap-29 Diastereomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | RGLRRLGRKIAHGVKKYG{ct:Amid} | SMAP-18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at <512 µM | Human | Derived From Smap-29 | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}{ct:Amid} | SMAP-18-E1 | Amidation | Free | Linear | D | i = D-Isoleucine | 18 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at <512 µM | Human | Smap-18 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}{nnr:i}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}{ct:Amid} | SMAP-18-E2 | Amidation | Free | Linear | D | i = d-allo-isoleucine | 18 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at <512 µM | Human | Smap-18 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26802742 | 2016 | LLNSGVKLGTKLLSGLLN{ct:Amid} | Reverse Pxt-12 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | Non-hemolytic | ||
| 26883426 | 2016 | QLLGGKVSFFQSVCLLGYCIFPINIEAIVIAFFGSYLPFVVKLIPVFICFAWSAYSSVGFMASLVPPHKKKLAVYPVFLFYLFLSWFSLIV{ct:carboxylic acid} | cPcAMP1 | carboxylic acid | Free | Linear | L | None | 91 | Antimicrobial | Little hemolysis % at 12.5 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 26883426 | 2016 | QLLGGKVSFFQSVCLLGYCIFPINIEAIVIAFFGSYLPFVVKLIPVFICFAWSAYSSVGFMASLVPPHKKKLAVYPVFLFYLFLSWFSLIV{ct:carboxylic acid} | cPcAMP1 | carboxylic acid | Free | Linear | L | None | 91 | Antimicrobial | Little hemolysis % at 25 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 26883426 | 2016 | QLLGGKVSFFQSVCLLGYCIFPINIEAIVIAFFGSYLPFVVKLIPVFICFAWSAYSSVGFMASLVPPHKKKLAVYPVFLFYLFLSWFSLIV{ct:carboxylic acid} | cPcAMP1 | carboxylic acid | Free | Linear | L | None | 91 | Antimicrobial | Little hemolysis % at 50 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 26883426 | 2016 | QLLGGKVSFFQSVCLLGYCIFPINIEAIVIAFFGSYLPFVVKLIPVFICFAWSAYSSVGFMASLVPPHKKKLAVYPVFLFYLFLSWFSLIV{ct:carboxylic acid} | cPcAMP1 | carboxylic acid | Free | Linear | L | None | 91 | Antimicrobial | Little hemolysis % at 100 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 26883426 | 2016 | PPHKKKLAVYPVFLFYLFLSWFSLIV{ct:Amid} | cPcAMP1/26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | Little hemolysis % at 12.5 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 26883426 | 2016 | PPHKKKLAVYPVFLFYLFLSWFSLIV{ct:Amid} | cPcAMP1/26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | Little hemolysis % at 25 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 26883426 | 2016 | PPHKKKLAVYPVFLFYLFLSWFSLIV{ct:Amid} | cPcAMP1/26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | Little hemolysis % at 50 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 26883426 | 2016 | PPHKKKLAVYPVFLFYLFLSWFSLIV{ct:Amid} | cPcAMP1/26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | Little hemolysis % at 100 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | <5 % Hemolysis at 16 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | 11.8 % (±4.0) % Hemolysis at 32 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | <20 % Hemolysis at 64 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | <60 % Hemolysis at 128 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | 80 % Hemolysis at 256 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | 89.6 ±5.6 % Hemolysis at 512 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | GVWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS | Smp43 | Free | Free | Linear | L | None | 43 | Antimicrobial | <5 % Hemolysis at 16 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | Non-hemolytic | ||
| 27019370 | 2016 | GVWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS | Smp43 | Free | Free | Linear | L | None | 43 | Antimicrobial | <5 % Hemolysis at 32 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | Non-hemolytic | ||
| 27019370 | 2016 | GVWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS | Smp43 | Free | Free | Linear | L | None | 43 | Antimicrobial | <5 % Hemolysis at 64 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | Non-hemolytic | ||
| 27019370 | 2016 | GVWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS | Smp43 | Free | Free | Linear | L | None | 43 | Antimicrobial | <5 % Hemolysis at 128 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | Non-hemolytic | ||
| 27019370 | 2016 | GVWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS | Smp43 | Free | Free | Linear | L | None | 43 | Antimicrobial | <5 % Hemolysis at 256 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | Non-hemolytic | ||
| 27019370 | 2016 | GVWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS | Smp43 | Free | Free | Linear | L | None | 43 | Antimicrobial | 1.2 ± 0.5 % Hemolysis at 512 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | Non-hemolytic | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | <5 % Hemolysis at 16 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | 15.9 % (±1.9)) % Hemolysis at 32 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | <30 % Hemolysis at 64 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | <70 % Hemolysis at 128 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | <90 % Hemolysis at 256 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | 90 % Hemolysis at 512 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 16 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 32 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 64 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | <20 % Hemolysis at 128 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | <50 % Hemolysis at 256 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 512 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27351824 | 2016 | LLPIVGNLLKSLL{ct:Amid} | TB | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 20-160 µg/mL | Human | Frog Rana Temporaria Skin | α-Helix | NA | ||
| 27351824 | 2016 | LLPIVGNLLKSLL{ct:Amid} | TB | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 45 % Hemolysis at 320 µg/mL | Human | Frog Rana Temporaria Skin | α-Helix | NA | ||
| 27542832 | 2016 | FSTKTRNWFSEHFKKVKEKLKDTFA | Apo5 APOC1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <1 % Hemolysis at 300 µg/mL | Sheep | American Alligator, Alligator Mississippiensis | α-Helix | Non-hemolytic | ||
| 27542832 | 2016 | KTRNWFSEHFKKVKEKLKDTFA | Apo6 APOC1 | Free | Free | Linear | L | None | 22 | Antimicrobial | <1 % Hemolysis at 300 µg/mL | Sheep | American Alligator, Alligator Mississippiensis | α-Helix | Non-hemolytic | ||
| 27542832 | 2016 | PPPVIKFNRPFLMWIVERDTRSILFMGKIVNPKAP | A1P | Free | Free | Linear | L | None | 35 | Antimicrobial | <1 % Hemolysis at 300 µg/mL | Sheep | American Alligator, Alligator Mississippiensis | α-Helix | Non-hemolytic | ||
| 27542832 | 2016 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | <1 % Hemolysis at 300 µg/mL | Sheep | Human Camp | Random or Disordered | Non-hemolytic | ||
| 27442521 | 2016 | LKKLLKLLKKLLKLAG | LK | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 5 µM | Human | Cell Penetrating Peptides (Cpps) | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLGKKLLKLAG | L8G | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 40 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLSKKLLKLAG | L8S | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 80 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLPKKLLKLAG | L8P | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 1280 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLNKKLLKLAG | L8N | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 640 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLQKKLLKLAG | L7Q | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 640 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLDKKLLKLAG | L8D | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at >1280 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLEKKLLKLAG | L8E | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at >1280 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLKKKLLKLAG | L8K | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 640 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLRKKLLKLAG | L8R | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 640 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLHKKLLKLAG | L8H | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 160 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27336672 | 2016 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 1.6 % Hemolysis at 90 µM pHat6 | Sheep | Belly Toad, Bombina Maxima | α-Helical | NA | ||
| 27336672 | 2016 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 1.2 % Hemolysis at 90 µM pHat8 | Sheep | Belly Toad, Bombina Maxima | α-Helical | NA | ||
| 27423268 | 2016 | INLKALAALAKKIL{ct:Amid} | [I5 , R8 ] mastoparan | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Mp Derived | α-Helix | NA | ||
| 27423268 | 2016 | INLKILARLAKKIL{ct:Amid} | mastoparan L | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 40 % Hemolysis at 10 µM | Human | Wasp Venom | α-Helix | NA | ||
| 27862650 | 2016 | GLLKRIKTLL{ct:Amid} | 1 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Anoplin(Wasp, Anoplius Samariensis) | α-Helix | NA | ||
| 27862650 | 2016 | GLLKRIKTLL{nt:C8-octanoic}{ct:Amid} | 2 | Amidation | C8-octanoic | Linear | L | C8 = Octanoic Acid | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | GLLKRIKTLL{nt:C10- decanoic}{ct:Amid} | 3 | Amidation | C10- decanoic | Linear | L | C10 = decanoic | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | GLLKFIKKLL{ct:Amid} | 4 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | KLLKFIKKLL{ct:Amid} | 5 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | RLLKFIKKLL{ct:Amid} | 6 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | GLLKFIKKLL{nt:C8-octanoic}{ct:Amid} | 7 | Amidation | C8-octanoic | Linear | L | C8 = Octanoic Acid | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | GLLKFIKKLL{nt:C10- decanoic}{ct:Amid} | 8 | Amidation | C10- decanoic | Linear | L | C10 = decanoic | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | GLLKFIKKLL{nt:C12-dodecanoic}{ct:Amid} | 9 | Amidation | C12-dodecanoic | Linear | L | C12 = dodecanoic | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27439393 | 2016 | WMQKVIDRFGG | T-1 | Free | Free | Linear | L | None | 11 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | KKWMQKVIDRFGG | T-2 | Free | Free | Linear | L | None | 13 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | RLKKWMQKVIDRFGG | T-3 | Free | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | VFRLKKWMQKVIDRFGG | T-4 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | THVFRLKKWMQKVIDRFGG | T-5 | Free | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | FYTHVFRLKKWMQKVIDRFGG | T-6 | Free | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | YGFYTHVFRLKKWMQKVIDRFGG | T-7 | Free | Free | Linear | L | None | 23 | Antimicrobial | 5 % Hemolysis at 34.5 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | GKYGFYTHVFRLKKWMQKVIDRFGG | T-8 | Free | Free | Linear | L | None | 25 | Antimicrobial | 5 % Hemolysis at 39.4 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRELIGWLDWLK | AmyI-1-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0.1 % Hemolysis at 100 µM | Sheep | Α-Amylase In Rice (Oryza Sativa L. Japonica) | α-Helix | NA | ||
| 27478151 | 2016 | HLNARVQRELIGWLDWLK | AmyI-1-18(K4A) | Free | Free | Linear | L | None | 18 | Antimicrobial | Hemolysis not determined at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | Non-hemolytic | ||
| 27478151 | 2016 | HLNKAVQRELIGWLDWLK | AmyI-1-18(R5A) | Free | Free | Linear | L | None | 18 | Antimicrobial | Hemolysis not determined at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | Non-hemolytic | ||
| 27478151 | 2016 | HLNKRVQAELIGWLDWLK | AmyI-1-18(R8A) | Free | Free | Linear | L | None | 18 | Antimicrobial | Hemolysis not determined at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | Non-hemolytic | ||
| 27478151 | 2016 | HLNKRVQRELIGWLDWLA | AmyI-1-18(K18A) | Free | Free | Linear | L | None | 18 | Antimicrobial | Hemolysis not determined at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRELRGWLDWLK | AmyI-1-18(I11R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 1 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRELIRWLDWLK | AmyI-1-18(G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 2 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRELIGWLRWLK | AmyI-1-18(D15R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 2 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIGWLDWLK{ct:Amid} | AmyI-1-18(N3L) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIGWLDWLK{ct:Amid} | AmyI-1-18(E9L) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 5 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 9 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 200 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 300 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 400 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 500 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | 14 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | 20 % Hemolysis at 200 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | <40 % Hemolysis at 300 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | <40 % Hemolysis at 400 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | <40 % Hemolysis at 500 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 14 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 31 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 40 % Hemolysis at 200 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <50 % Hemolysis at 300 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 60 % Hemolysis at 400 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 87 % Hemolysis at 500 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | 30 % Hemolysis at 0.78 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | <45 % Hemolysis at 7.8 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | <45 % Hemolysis at 15.6 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | 70 % Hemolysis at 31.2 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | 70 % Hemolysis at 62.5 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | 73 % Hemolysis at 125 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 1 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 512 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 1 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 1 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 1 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <10 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 1 µM in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 1 µM in 2hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 5 µM in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 5 µM in 2hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 10 µM in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 10 µM in 2hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 20 µM in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 20 µM in 2hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 40 µM in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 40 µM in 2hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 4.96 % Hemolysis at 60 µM | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 6.58 % Hemolysis at 60 µM | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 22.31 % Hemolysis at 80 µM | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 22.88 % Hemolysis at 80 µM | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 37.77 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 39.27 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRH | Em-Pis1M | Free | Free | Linear | L | None | 25 | Antimicrobial | 19.7 % Hemolysis at 20 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRH | Em-Pis1M | Free | Free | Linear | L | None | 25 | Antimicrobial | 65.7 % Hemolysis at 5 µmoL/L | Rabbit | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRH | Em-Pis1M | Free | Free | Linear | L | None | 25 | Antimicrobial | 74.1 % Hemolysis at 20 µmoL/L | Rabbit | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FFFHIIKGLFHAGRMIHGLVNRRRHRH | Em-Pis2M | Free | Free | Linear | L | None | 27 | Antimicrobial | 19 % Hemolysis at 20 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FFFHIIKGLFHAGRMIHGLVNRRRHRH | Em-Pis2M | Free | Free | Linear | L | None | 27 | Antimicrobial | 66 % Hemolysis at 5 µmoL/L | Rabbit | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FFFHIIKGLFHAGRMIHGLVNRRRHRH | Em-Pis2M | Free | Free | Linear | L | None | 27 | Antimicrobial | 73.4 % Hemolysis at 20 µmoL/L | Rabbit | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRHGVEELQDLDQRAFEREKAFA | Em-Pis1L | Free | Free | Linear | L | None | 45 | Antimicrobial | 5 % Hemolysis at 5 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRH | Em-Pis1M | Free | Free | Linear | L | None | 25 | Antimicrobial | 5 % Hemolysis at 5 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVT | Em-Pis1S | Free | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at 5 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FFFHIIKGLFHAGRMIHGLVNRRRHRHGMEELDLDQRAFEREKAFA | Em-Pis2L | Free | Free | Linear | L | None | 46 | Antimicrobial | 5 % Hemolysis at 5 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRHGVEELQDLDQRAFEREKAFA | Em-Pis2M | Free | Free | Linear | L | None | 27 | Antimicrobial | 5 % Hemolysis at 5 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27104500 | 2016 | INWKKIKSIIKAAMN{ct:Amid} | mastoparan V1 (MP-V1) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Venom Of Social Wasp Vespula Vulgaris | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | INWKKIKSIIKAAMN{ct:Amid} | mastoparan V1 (MP-V1) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 6.6 % Hemolysis at 50 µM | Human | Venom Of Social Wasp Vespula Vulgaris | α-Helical | NA | ||
| 27104500 | 2016 | INWKKIKSIIKAAMN{ct:Amid} | mastoparan V1 (MP-V1) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | ~20 % Hemolysis at 100 µM | Human | Venom Of Social Wasp Vespula Vulgaris | α-Helical | NA | ||
| 27104500 | 2016 | INLKALAALAKKIL{ct:Amid} | mastoparan L (MP-L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Vespula Lewisii | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | INLKALAALAKKIL{ct:Amid} | mastoparan L (MP-L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Vespula Lewisii | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | INWKGIAAMAKKLL{ct:Amid} | mastoparan X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Vespa Simillina Xanthoptera | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | INWKGIAAMAKKLL{ct:Amid} | mastoparan X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Vespa Simillina Xanthoptera | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | INWKGIAAMAKKLL{ct:Amid} | mastoparan X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 100 µM | Human | Vespa Simillina Xanthoptera | α-Helical | NA | ||
| 27104500 | 2016 | LKLKSIVSWAKKVL{ct:Amid} | mastoparan B (MP-B) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Vespa Basalis | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | LKLKSIVSWAKKVL{ct:Amid} | mastoparan B (MP-B) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Vespa Basalis | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | LKLKSIVSWAKKVL{ct:Amid} | mastoparan B (MP-B) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Vespa Basalis | α-Helical | Non-hemolytic | ||
| 26860588 | 2016 | PFWRIRIRR{ct:Amid} | PFR | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 10 µM | Human | Derivatives Of Lactoferrin | α-Helical | Non-hemolytic | ||
| 26860588 | 2016 | PFWRIRIRR{ct:Amid} | PFR | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 30 µM | Human | Derivatives Of Lactoferrin | α-Helical | Non-hemolytic | ||
| 26860588 | 2016 | PFWRIRIRR{ct:Amid} | PFR | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Derivatives Of Lactoferrin | α-Helical | Non-hemolytic | ||
| 26860588 | 2016 | PFWRIRIRR{ct:Amid} | PFR | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Derivatives Of Lactoferrin | α-Helical | Non-hemolytic | ||
| 26860588 | 2016 | PFWRIRIRR{ct:Amid} | PFR | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Derivatives Of Lactoferrin | α-Helical | Non-hemolytic | ||
| 26860588 | 2016 | PFWRIRIRR{ct:Amid} | PFR | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 225 µM | Human | Derivatives Of Lactoferrin | α-Helical | Non-hemolytic | ||
| 26860588 | 2016 | PFWRIRIRR{ct:Amid} | PFR | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 300 µM | Human | Derivatives Of Lactoferrin | α-Helical | Non-hemolytic | ||
| 27067326 | 2016 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 15 µM | Human | Fish | α-Helical | NA | ||
| 27067326 | 2016 | FFHHAFRGIVHVGKTIHRLVTG{ct:Amid} | I5Apiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 500 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGAVHVGKTIHRLVTG{ct:Amid} | I9Apiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGIVHVGKTAHRLVTG{ct:Amid} | I16Apiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 500 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHVFRGIVHVGKTIHRLVTG{ct:Amid} | I5Vpiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 40 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGVVHVGKTIHRLVTG{ct:Amid} | I9Vpiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 35 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGIVHVGKTVHRLVTG{ct:Amid} | I16Vpiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 40 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHFARGIVHVGKTIHRLVTG{ct:Amid} | I5F,F6Apiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGIVHIGKTIHRLVTG{ct:Amid} | V12Ipiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 7 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 26914652 | 2016 | MRILFFLVAVLFFLFQAAPAYSQEDADTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS | sAvBD-9 | Free | Free | Linear | L | None | 67 | Antimicrobial | 2 % Hemolysis at 12.5 μg/ml | Chicken | Chickens From Saudi Arabia | NA | NA | ||
| 26914652 | 2016 | MRILFFLVAVLFFLFQAAPAYSQEDADTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS | sAvBD-9 | Free | Free | Linear | L | None | 67 | Antimicrobial | 3 % Hemolysis at 25 μg/ml | Chicken | Chickens From Saudi Arabia | NA | NA | ||
| 26914652 | 2016 | MRILFFLVAVLFFLFQAAPAYSQEDADTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS | sAvBD-9 | Free | Free | Linear | L | None | 67 | Antimicrobial | 4 % Hemolysis at 50 μg/ml | Chicken | Chickens From Saudi Arabia | NA | NA | ||
| 26914652 | 2016 | MRILFFLVAVLFFLFQAAPAYSQEDADTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS | sAvBD-9 | Free | Free | Linear | L | None | 67 | Antimicrobial | 5 % Hemolysis at 100 μg/ml | Chicken | Chickens From Saudi Arabia | NA | NA | ||
| 27936728 | 2016 | CKRWWKWIRW{ct:Amid} | CysHHC10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at >1000 μg/ml | Human | Synthetic | NA | NA | ||
| 27698732 | 2016 | LVQRGRFGRFLRKIRRFRPKVTITIQGSARF | fowlicidin-2 | Free | Free | Linear | L | None | 31 | Antimicrobial | 50 % Hemolysis at 128-256 μg/ml | Human | Pichia Pastoris X-33 | α-Helical | NA | ||
| 27900727 | 2016 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MPI | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <0.7 % Hemolysis at 256 µM | Human | Social Wasp Polybia Paulista | α-Helical | Non-hemolytic | ||
| 27900727 | 2016 | IDWKKL{d}L{d}DAAKQIL{d}{ct:Amid} | D-lys-MPI | Amidation | Free | Linear | Mix | l = D-Lys lowercase letters correspond to D-amino acids | 15 | Antimicrobial | 0 % Hemolysis at 256 µM | Human | Polybia-Mpi Analogues | α-Helical | Non-hemolytic | ||
| 27900727 | 2016 | I{d}D{d}W{d}K{d}K{d}L{d}L{d}D{d}A{d}A{d}K{d}Q{d}I{d}L{d}{ct:Amid} | D-MPI | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 15 | Antimicrobial | 0.4 % Hemolysis at 256 µM | Human | Polybia-Mpi Analogues | α-Helical | Non-hemolytic | ||
| 26549611 | 2017 | KWCFRVCYRGICYRRCR | THI | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 12 µM | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRSCYRGICYRRCR | V6S | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 280 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRRCYRGICYRRCR | V6R | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 200 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRVCSRGICYRRCR | Y8S | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 310 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRVCRRGICYRRCR | Y8R | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 195 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRVCYRGSCYRRCR | I11S | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 190 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRVCYRGRCYRRCR | I11R | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 180 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 27487034 | 2017 | RRGRRGP{nnr:O}GP{nnr:O}GP{nnr:O}GP{nnr:O}GP{nnr:O}GPCCY{ct:Amid} | RR4 | Amidation | Free | Linear | L | O = 4-hydroxy-L-proline | 25 | Antimicrobial | 0 % Hemolysis at 0.3-30 µM | Human | R3 Derivatives | Triple-Helical | Non-hemolytic | ||
| 27487034 | 2017 | RRGRRGP{nnr:O}GP{nnr:O}GP{nnr:O}GPCCY{ct:Amid} | RR4SS | Amidation | Free | Linear | L | O = 4-hydroxy-L-proline | 19 | Antimicrobial | 0 % Hemolysis at 0.3-30 µM | Human | R3 Derivatives | Triple-Helical | Non-hemolytic | ||
| 27450123 | 2017 | GFLSILKKVLPKVMAHMK{ct:Amid} | MEP(melectin) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 100 µM | Rat | Cleptoparasitic Bee Melecta Albifrons | α-Helix | NA | ||
| 27450123 | 2017 | GLLSALRKMIPHILSHIKK{ct:Amid} | ANTP(antapin) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 97.8 µM | Human | Wild Bee Anthophora Plumipes | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAI{ct:Amid} | UyCT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at 31.5 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKSLF{ct:Amid} | UyCT3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 15.78 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IWSAIWSGIKGLL{ct:Amid} | UyCT5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 2.39 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKGLL{ct:Amid} | Uy17 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 26.65 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKGLL{ct:Amid} | Uy192 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 35.85 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLLSLIPSAISAIKRL{ct:Amid} | Uy234 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 55.14 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ISQSDAILSAIWSGIKSLF{ct:Amid} | Um2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 10 % Hemolysis at 2.36 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKSAI{ct:Amid} | Um3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at 70.48 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FFSALLSGIKSLF{ct:Amid} | Um4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFKAIWSGIKSLF{ct:Amid} | Um5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 11.944 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFGAIWSGIKSLF{ct:Amid} | D1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 15.5 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKSLF{ct:Amid} | D2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 2.94 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWKPVKKAI{ct:Amid} | D4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLLEGVKKAI{ct:Amid} | D5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at 110.86 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLKLSLKIPKSAIKSAIKRL{ct:Amid} | D10 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 149.75 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAIKKK{ct:Amid} | D11 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 39.76 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAI{ct:Amid} | UyCT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 142.5 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKSLF{ct:Amid} | UyCT3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 58.15 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IWSAIWSGIKGLL{ct:Amid} | UyCT5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 20.59 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKGLL{ct:Amid} | Uy17 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 138.4 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKGLL{ct:Amid} | Uy192 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 155.6 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLLSLIPSAISAIKRL{ct:Amid} | Uy234 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 104.5 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ISQSDAILSAIWSGIKSLF{ct:Amid} | Um2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 129 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKSAI{ct:Amid} | Um3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 126.2 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FFSALLSGIKSLF{ct:Amid} | Um4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFKAIWSGIKSLF{ct:Amid} | Um5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 59.25 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFGAIWSGIKSLF{ct:Amid} | D1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 48 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKSLF{ct:Amid} | D2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 24.48 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWKPVKKAI{ct:Amid} | D4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLLEGVKKAI{ct:Amid} | D5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 1636 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLKLSLKIPKSAIKSAIKRL{ct:Amid} | D10 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 1726 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAIKKK{ct:Amid} | D11 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 1110 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAI{ct:Amid} | UyCT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at 644.46 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKSLF{ct:Amid} | UyCT3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 214.22 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IWSAIWSGIKGLL{ct:Amid} | UyCT5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 177.49 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKGLL{ct:Amid} | Uy17 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 718.55 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKGLL{ct:Amid} | Uy192 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 675.22 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLLSLIPSAISAIKRL{ct:Amid} | Uy234 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 90 % Hemolysis at 198.04 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ISQSDAILSAIWSGIKSLF{ct:Amid} | Um2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 90 % Hemolysis at 7033.22 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKSAI{ct:Amid} | Um3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at 246.84 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FFSALLSGIKSLF{ct:Amid} | Um4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFKAIWSGIKSLF{ct:Amid} | Um5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 293.9 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFGAIWSGIKSLF{ct:Amid} | D1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 148.51 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKSLF{ct:Amid} | D2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 200.83 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWKPVKKAI{ct:Amid} | D4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLLEGVKKAI{ct:Amid} | D5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at 24141.72 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLKLSLKIPKSAIKSAIKRL{ct:Amid} | D10 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 90 % Hemolysis at 19894.17 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAIKKK{ct:Amid} | D11 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 90 % Hemolysis at 30984.53 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 27992168 | 2017 | {nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nt:R1 = 4-methylhexanoyl}{ct:Amid} | GZ3.27 | Amidation | R1 = 4-methylhexanoyl | Linear | Mix | R1 = 4-methylhexanoyl, Dab = 2,4-diaminobutyric acid, dab = D-2,4-diaminobutyric acid | 3 | Antimicrobial | 1.8 ± 0.45 % Hemolysis at 100 µM | Mouse | Lipopeptide | NA | NA | ||
| 27992168 | 2017 | C{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nt:R1 = 4-methylhexanoyl}{ct:Amid} | GZ3.163 | Amidation | R1 = 4-methylhexanoyl | Linear | Mix | R1 = 4-methylhexanoyl, Dab = 2,4-diaminobutyric acid, dab = D-2,4-diaminobutyric acid | 4 | Antimicrobial | 4.3 ± 0.42 % Hemolysis at 100 µM | Mouse | Battacin Lipopeptide Analogue | NA | NA | ||
| 27992168 | 2017 | {nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}LC{nt:R1 = 4-methylhexanoyl}{ct:Amid} | GZ3.160 | Amidation | R1 = 4-methylhexanoyl | Linear | Mix | R1 = 4-methylhexanoyl, Dab = 2,4-diaminobutyric acid, dab = D-2,4-diaminobutyric acid | 4 | Antimicrobial | 2.8 ± 0.30 % Hemolysis at 100 µM | Mouse | Battacin Lipopeptide Analogue | NA | NA | ||
| 27992168 | 2017 | {nnr:dab}{nnr:Dab}(C){nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nt:R1 = 4-methylhexanoyl}{ct:Amid} | GZ3.155 | Amidation | R1 = 4-methylhexanoyl | Linear | Mix | R1 = 4-methylhexanoyl, Dab = 2,4-diaminobutyric acid, dab = D-2,4-diaminobutyric acid | 4 | Antimicrobial | 2.2 ± 0.93 % Hemolysis at 100 µM | Mouse | Battacin Lipopeptide Analogue | NA | NA | ||
| 28115922 | 2017 | GVVDILKGAAKDIAGHLASKVM{ct:Amid} | Ocellatin-LB1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 6 % Hemolysis at 0.46 µM | Rabbit | American Frog Leptodactylus Labyrinthicus | α-Helix | NA | ||
| 28115922 | 2017 | GVVDILKGAAKDIAGHLASKVMN{ct:Amid} | Ocellatin-LB2 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 1 % Hemolysis at 0.5 µM | Rabbit | American Frog Leptodactylus Labyrinthicus | α-Helix | NA | ||
| 28115922 | 2017 | GVVDILKGAAKDIAGHLASKVMNKL{ct:Amid} | Ocellatin-F1 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 13 % Hemolysis at 0.4 µM | Rabbit | American Frog Leptodactylus Labyrinthicus | α-Helix | NA | ||
| 27935673 | 2017 | RIIDLLWRVRRPQKPKFVTVWVR{nt:Dansyl}{ct:Amid} | DNS-PMAP23 | Amidation | Dansyl | Linear | L | Dansyl(DNS) = 5-(dimetylamino)napthalene-1-sulphonyl | 23 | Antimicrobial | 50 % Hemolysis at 29 µM | Human | Analogue Of The Cathelicidin Hdp Pmap-23 | NA | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 25 % Hemolysis at 25 µM | Sheep | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <20 % Hemolysis at 12.5 µM | Sheep | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 6.25 µM | Sheep | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <10 % Hemolysis at 5 µM | Sheep | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 60 % Hemolysis at 25 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 70 % Hemolysis at 50 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 40 % Hemolysis at 6.25 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 20 % Hemolysis at 5 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFWHHIGHALDAAKRVHGMLSG{ct:Amid} | moroNC-NH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | ~10 % Hemolysis at 50 µM | Horse | Notothenia Coriiceps | α-Helix | NA | ||
| 28122029 | 2017 | FFWHHIGHALDAAKRVHGMLSG{ct:Amid} | moroNC-NH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | <1 % Hemolysis at 25 µM | Sheep | Notothenia Coriiceps | α-Helix | NA | ||
| 28122029 | 2017 | FFWHHIGHALDAAKRVHGMLSG{ct:Amid} | moroNC-NH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | <1 % Hemolysis at 25 µM | Horse | Notothenia Coriiceps | α-Helix | NA | ||
| 28122029 | 2017 | FFGHLFRGIINVGKHIHGLLSG{ct:Amid} | moroPC-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 50 µM | Sheep | Parachaenichthys Charcoti | α-Helix | NA | ||
| 28122029 | 2017 | FFGHLFRGIINVGKHIHGLLSG{ct:Amid} | moroPC-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <10 % Hemolysis at 25 µM | Sheep | Parachaenichthys Charcoti | α-Helix | NA | ||
| 28122029 | 2017 | FFGHLFRGIINVGKHIHGLLSG{ct:Amid} | moroPC-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 50 µM | Horse | Parachaenichthys Charcoti | α-Helix | NA | ||
| 28122029 | 2017 | FFGHLFRGIINVGKHIHGLLSG{ct:Amid} | moroPC-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <10 % Hemolysis at 25 µM | Horse | Parachaenichthys Charcoti | α-Helix | NA | ||
| 27912176 | 2017 | FLGALWNVAKSVF{ct:Amid} | VmCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 6.25 µmol/L | Human | Vaejovis Mexicanus Smithi | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLKALWNVAKSVF{ct:Amid} | [K]3 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGALWKVAKSVF{ct:Amid} | [K]7 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGALWNVAKKVF{ct:Amid} | [K]11-VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGELWNVAKSVF{ct:Amid} | [E]4 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 25 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGALWEVAKSVF{ct:Amid} | [E]7 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGALWNVWKSVF{ct:Amid} | [W]9 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGELWNVWKSVF{ct:Amid} | [E]4 [W]9 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | FALALKALKKALKKLKKALKKAL | Hecate | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Horse | Synthetic, Derivate Of Melittin | α-Helix | NA | ||
| 28012857 | 2017 | FALALKALKKALKKLKKALKKAL | Hecate | Free | Free | Linear | L | None | 23 | Antimicrobial | <60 % Hemolysis at 25 µM | Human | Synthetic, Derivate Of Melittin | α-Helix | NA | ||
| 28012857 | 2017 | FALALKALKKALKKLKKALKKAL | Hecate | Free | Free | Linear | L | None | 23 | Antimicrobial | <40 % Hemolysis at 15 µM | Human | Synthetic, Derivate Of Melittin | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 5 µM | Horse | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 75 % Hemolysis at 10 µM | Horse | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 15-25 µM | Horse | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 80 % Hemolysis at 5 µM | Human | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 µM | Human | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | ILGPVLGLVSDTLDDVLGIL | Maximin H5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Human | Bombina Maxima Smap2 9 Rglrrlgrkiahgvkkygptvlriiri Ag 29 3256.0 0 12.3 1 +9 Derivative Of Ovispi | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | ILGPVLGLVSDTLDDVLGIL | Maximin H5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Horse | Bombina Maxima Smap2 9 Rglrrlgrkiahgvkkygptvlriiri Ag 29 3256.0 0 12.3 1 +9 Derivative Of Ovispi | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | RGLRRLGRKIAHGVKKYGPTVLRIIRIAG | SMAP29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Horse | Derivative Of Ovispirin, Ovis Aries | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | RGLRRLGRKIAHGVKKYGPTVLRIIRIAG | SMAP29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 40 % Hemolysis at 20 µM | Human | Derivative Of Ovispirin, Ovis Aries | α-Helix | NA | ||
| 28012857 | 2017 | RGLRRLGRKIAHGVKKYGPTVLRIIRIAG | SMAP29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 50 % Hemolysis at 25 µM | Human | Derivative Of Ovispirin, Ovis Aries | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | 10 % Hemolysis at 1 µM | Human | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 10 µM | Human | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | <80 % Hemolysis at 5 µM | Human | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | 80 % Hemolysis at 5 µM | Horse | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 10 µM | Horse | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | WEAALAEALAEALAEHLAEALAEALEALAA | GALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 10 % Hemolysis at 25 µM | Horse | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | WEAALAEALAEALAEHLAEALAEALEALAA | GALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 60 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | NA | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | <60 % Hemolysis at 25 µM | Horse | Synthetic | α-Helix | NA | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 50 % Hemolysis at 15 µM | Horse | Synthetic | α-Helix | NA | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 40 % Hemolysis at 10 µM | Horse | Synthetic | α-Helix | NA | ||
| 28108242 | 2017 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 48.47 µM | Human | Pseudopolybia Vespiceps Testacea | α-Helix | NA | ||
| 28108242 | 2017 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 24.18 µM | Mouse | Pseudopolybia Vespiceps Testacea | α-Helix | NA | ||
| 28178190 | 2017 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 5 % Hemolysis at 4 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 28178190 | 2017 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial | 15 % Hemolysis at 128 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 28178190 | 2017 | FRIRVRVFKRIVQRIKDFLR{ct:Amid} | FV-LL | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Hybrid | α-Helix | Non-hemolytic | ||
| 28178190 | 2017 | FRRIRVRVFKRIVQRIKDF{ct:Amid} | FV-MA | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 128 µM | Human | Hybrid | α-Helix | NA | ||
| 28178190 | 2017 | FRIRVRVAKKFGKAFVG{ct:Amid} | FV-CE | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Hybrid | α-Helix | Non-hemolytic | ||
| 28275372 | 2017 | IFSAIAGLLSNLL{ct:Amid} | NDBP-5.5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 6.25-400 µM | Human | Hadrurus Gertschi | α-Helix | Non-hemolytic | ||
| 28275372 | 2017 | IFSAIAGLLSNLL{ct:Amid} | NDBP-5.5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 611.8 µM | Human | Hadrurus Gertschi | α-Helix | NA | ||
| 28275372 | 2017 | IFSAIAGLLSNLL{ct:Amid} | NDBP-5.5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 39 % Hemolysis at 1600 µM | Human | Hadrurus Gertschi | α-Helix | NA | ||
| 28230084 | 2017 | MLKKFRGMF{ct:Amid} | MreB1–9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Membrane-Binding Region Of E. Coli Mreb | α-Helix | Non-hemolytic | ||
| 28230084 | 2017 | MLKKFRGMF{nt:Acet}{ct:Amid} | Ac-MreB1–9 | Amidation | Acetylation | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Membrane-Binding Region Of E. Coli Mreb | α-Helix | Non-hemolytic | ||
| 28230084 | 2017 | WMLKKFRGMF{ct:Amid} | W-MreB1–9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Membrane-Binding Region Of E. Coli Mreb | α-Helix | NA | ||
| 28230084 | 2017 | WMLKKFRGMF{nt:Acet}{ct:Amid} | Ac-W-MreB1–9 | Amidation | Acetylation | Linear | L | None | 9 | Antimicrobial | 4.15±0.96 % Hemolysis at 50 µM | Human | Membrane-Binding Region Of E. Coli Mreb | α-Helix | NA | ||
| 28230084 | 2017 | MLKKFRGMF{ct:Amid} | MreB1–9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Membrane-Binding Region Of E. Coli Mreb | α-Helix | Non-hemolytic | ||
| 28230084 | 2017 | MLKKFRGMF{nt:Acet}{ct:Amid} | Ac-MreB1–9 | Amidation | Acetylation | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Membrane-Binding Region Of E. Coli Mreb | α-Helix | Non-hemolytic | ||
| 28230084 | 2017 | WMLKKFRGMF{ct:Amid} | W-MreB1–9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 1.62±0.08 % Hemolysis at 100 µM | Human | Membrane-Binding Region Of E. Coli Mreb | α-Helix | NA | ||
| 28230084 | 2017 | WMLKKFRGMF{nt:Acet}{ct:Amid} | Ac-W-MreB1–9 | Amidation | Acetylation | Linear | L | None | 9 | Antimicrobial | 11.88±2.44 % Hemolysis at 100 µM | Human | Membrane-Binding Region Of E. Coli Mreb | α-Helix | NA | ||
| 27591703 | 2017 | KKWRWWLKALAKK{ct:Amid} | pEM-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Snake Bothrops Asper | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Hornet Vespa Basalis | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | INLKAIAALAKKLL{ct:Amid} | MP-VT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Venom Of Vespa Tropica | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRWWLKALAKKLL{ct:Amid} | PV | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 8 μg/ml | Human | Hybrid | α-Helix | NA | ||
| 27591703 | 2017 | KKWRWWLKALAKKLL{ct:Amid} | PV | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 16 μg/ml | Human | Hybrid | α-Helix | NA | ||
| 27591703 | 2017 | KKWRWWLKALAKKLL{ct:Amid} | PV | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 85 % Hemolysis at 32 μg/ml | Human | Hybrid | α-Helix | NA | ||
| 27591703 | 2017 | KKWRWWLKALAKKLL{ct:Amid} | PV | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 90 % Hemolysis at 64 μg/ml | Human | Hybrid | α-Helix | NA | ||
| 27591703 | 2017 | LKLKAIAALAKKKW{ct:Amid} | BVP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRKLLKWLAKK{ct:Amid} | PVP | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRKLLKKLKKLL{ct:Amid} | PV3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRWWLKALAKK{ct:Amid} | pEM-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Snake Bothrops Asper | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Hornet Vespa Basalis | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | INLKAIAALAKKLL{ct:Amid} | MP-VT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Venom Of Vespa Tropica | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRWWLKALAKKLL{ct:Amid} | PV | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | LKLKAIAALAKKKW{ct:Amid} | BVP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 64 μg/ml | Sheep | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRKLLKWLAKK{ct:Amid} | PVP | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRKLLKKLKKLL{ct:Amid} | PV3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Hybrid | α-Helix | Non-hemolytic | ||
| 27999446 | 2017 | ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD{nt:Amid}{ct:Acet} | WT | Acetylation | Amidation | Linear | L | None | 39 | Antimicrobial | 50 % Hemolysis at >115 µM | Human | Cecropin D-Like From Galleria Mellonella | α-Helix | NA | ||
| 27999446 | 2017 | ENFFKRIRRAGKRIRDAIISAAPAVETLAQAQKIIKGGD{nt:Amid}{ct:Acet} | ΔM1 | Acetylation | Amidation | Linear | L | None | 39 | Antimicrobial | 50 % Hemolysis at 1752.3 µM | Human | Cecropin D-Like From Galleria Mellonella | α-Helix | NA | ||
| 27999446 | 2017 | ENFFKRIRRAGKRIRDAIISAAPAVETLAQAQKIIKGGD{nt:Amid}{ct:Acet} | ΔM1 | Acetylation | Amidation | Linear | L | None | 39 | Antimicrobial | 2.3 % Hemolysis at 115 µM | Human | Cecropin D-Like From Galleria Mellonella | α-Helix | NA | ||
| 27999446 | 2017 | RNFFKRIRRAGKRIRKAIISAAPAVETLAQAQKIIKGGD{nt:Amid}{ct:Acet} | ΔM2 | Acetylation | Amidation | Linear | L | None | 39 | Antimicrobial | 50 % Hemolysis at 735.4 µM | Human | Cecropin D-Like From Galleria Mellonella | α-Helix | NA | ||
| 27999446 | 2017 | RNFFKRIRRAGKRIRKAIISAAPAVETLAQAQKIIKGGD{nt:Amid}{ct:Acet} | ΔM2 | Acetylation | Amidation | Linear | L | None | 39 | Antimicrobial | 6.88 % Hemolysis at 115 µM | Human | Cecropin D-Like From Galleria Mellonella | α-Helix | NA | ||
| 28287172 | 2017 | FKAWRWAWRMKKLAAPS | Lfcin4 | Free | Free | Linear | L | None | 17 | Antimicrobial, Anti-endotoxin | 4.87 % Hemolysis at 512 µM | Mouse | Lfcinb17-31 Derivatives | α-Helix | Non-hemolytic | ||
| 28287172 | 2017 | FKCRRWQWRMKKLGA | Lfcin1 | Free | Free | Linear | L | None | 16 | Antimicrobial, Anti-endotoxin | 7.5 % Hemolysis at 256 µM | Mouse | Lfcinb17-31 Derivatives | α-Helix | Non-hemolytic | ||
| 28287172 | 2017 | FKAFRRWKKLAAPS | Lfcin5 | Free | Free | Linear | L | None | 15 | Antimicrobial, Anti-endotoxin | 2.2 % Hemolysis at 512 µM | Mouse | Lfcinb17-31 Derivatives | α-Helix | Non-hemolytic | ||
| 28248495 | 2017 | RQIKIWFQNRRW | MAAPC01 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 516.5 µM | Human | Homeobox Domain Of The Antp Protein | α-Helix | NA | ||
| 28248495 | 2017 | GWIRNQFRKIWQR | MAAPC02 | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >1000 µM | Human | Homeobox Domain Of The Antp Protein | α-Helix | NA | ||
| 28248495 | 2017 | GWRRNQFWIKIQR | MAAPC03 | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >1000 µM | Human | Homeobox Domain Of The Antp Protein | α-Helix | NA | ||
| 28248495 | 2017 | GWRNQIRKGWQR | MAAPC04 | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >2000 µM | Human | Homeobox Domain Of The Antp Protein | α-Helix | NA | ||
| 28248495 | 2017 | RQIKIWFQNRRW | MAAPC05 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 676.7 µM | Human | Homeobox Domain Of The Antp Protein | α-Helix | NA | ||
| 28453851 | 2017 | R{d}L{d}W{d}V{d}L{d}W{d}R{d}R{d} | D-Bac8c2,5Leu | Free | Free | Linear | D | None | 8 | Antimicrobial | 50 % Hemolysis at 414 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | F{d}A{d}K{d}L{d}L{d}A{d}K{d}L{d}A{d}K{d}K{d}L{d}L{d} | D-HB43 | Free | Free | Linear | D | None | 13 | Antimicrobial | 50 % Hemolysis at 77 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | F{d}L{d}G{d}G{d}L{d}I{d}K{d}I{d}V{d}P{d}A{d}M{d}I{d}C{d}A{d}V{d}T{d}K{d}K{d}C{d} | D-Ranalexin | Free | Free | Linear | D | None | 20 | Antimicrobial | 50 % Hemolysis at 195 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | RRWCFRVCYRGFCYRKCR | L-Polyphemusin | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 1885 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | W{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d} | D-WMR3,6Leu | Free | Free | Linear | D | None | 13 | Antimicrobial | 50 % Hemolysis at >4000 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | K{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d} | DP188Leu | Free | Free | Linear | D | None | 13 | Antimicrobial | 50 % Hemolysis at 873 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | I{d}L{d}R{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d}K{d} | D-Omiganan | Free | Free | Linear | D | None | 12 | Antimicrobial | 50 % Hemolysis at 1775.5 μg/ml | Human | Synthetic | NA | NA | ||
| 28282123 | 2017 | KKAGKIAKKAGKIA{ct:Amid} | KIA(7)14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAK{ct:Amid} | KIA(7)15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAKIA{ct:Amid} | KIA(7)17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 5 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGK{ct:Amid} | KIA19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 12 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIA{ct:Amid} | KIA21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 9 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAK{ct:Amid} | KIA(7)22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 16 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAKIA{ct:Amid} | KIA(7)24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 18 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGK{ct:Amid} | KIA(7)26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 39 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGKIA{ct:Amid} | KIA(7)28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 90 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAKKIAKIAKKIA{ct:Amid} | KIKA14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAK{ct:Amid} | KIKA15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 8 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAKIA{ct:Amid} | KIKA17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 9 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGKIAK{ct:Amid} | KISA22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 7 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIAKIA{ct:Amid} | KISA24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 24 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGK{ct:Amid} | KISA26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 18 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGKIA{ct:Amid} | KISA28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 53 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KKAGKIAKKAGKIA{ct:Amid} | KIA(7)14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAK{ct:Amid} | KIA(7)15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 6 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAKIA{ct:Amid} | KIA(7)17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 5 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGK{ct:Amid} | KIA19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIA{ct:Amid} | KIA21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 17 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAK{ct:Amid} | KIA(7)22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 24 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAKIA{ct:Amid} | KIA(7)24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 62 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGK{ct:Amid} | KIA(7)26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 72 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGKIA{ct:Amid} | KIA(7)28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 100 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAKKIAKIAKKIA{ct:Amid} | KIKA14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAK{ct:Amid} | KIKA15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 4 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAKIA{ct:Amid} | KIKA17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 6 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGKIAK{ct:Amid} | KISA22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 12 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIAKIA{ct:Amid} | KISA24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 44 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGK{ct:Amid} | KISA26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 29 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGKIA{ct:Amid} | KISA28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 82 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KKAGKIAKKAGKIA{ct:Amid} | KIA(7)14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 4 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAK{ct:Amid} | KIA(7)15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAKIA{ct:Amid} | KIA(7)17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGK{ct:Amid} | KIA19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 7 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIA{ct:Amid} | KIA21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 43 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAK{ct:Amid} | KIA(7)22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 44 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAKIA{ct:Amid} | KIA(7)24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 98 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGK{ct:Amid} | KIA(7)26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 98 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGKIA{ct:Amid} | KIA(7)28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 100 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAKKIAKIAKKIA{ct:Amid} | KIKA14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 4 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAK{ct:Amid} | KIKA15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 4 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAKIA{ct:Amid} | KIKA17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 9 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGKIAK{ct:Amid} | KISA22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 19 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIAKIA{ct:Amid} | KISA24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 89 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGK{ct:Amid} | KISA26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 63 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGKIA{ct:Amid} | KISA28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 98 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KKAGKIAKKAGKIA{ct:Amid} | KIA(7)14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 6 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAK{ct:Amid} | KIA(7)15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAKIA{ct:Amid} | KIA(7)17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 5 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGK{ct:Amid} | KIA19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 10 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIA{ct:Amid} | KIA21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 83 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAK{ct:Amid} | KIA(7)22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 76 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAKIA{ct:Amid} | KIA(7)24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGK{ct:Amid} | KIA(7)26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGKIA{ct:Amid} | KIA(7)28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 100 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAKKIAKIAKKIA{ct:Amid} | KIKA14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAK{ct:Amid} | KIKA15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 6 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAKIA{ct:Amid} | KIKA17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 14 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGKIAK{ct:Amid} | KISA22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 39 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIAKIA{ct:Amid} | KISA24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGK{ct:Amid} | KISA26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGKIA{ct:Amid} | KISA28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 99 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKILRAWKKYGPIIVPIIRI{ct:Amid} | BMAP-28 | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antiprotozoal | 38 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKILRAWKKYGPIIVPIIRI{ct:Amid} | BMAP-28 | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antiprotozoal | 81.7 % Hemolysis at 30 µM | Human | Synthetic | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKILRAWKKYG{ct:Amid} | BMAP-28(1-18) | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 3.4 % Hemolysis at 10 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKILRAWKKYG{ct:Amid} | BMAP-28(1-18) | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 9.6 % Hemolysis at 30 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GGFRSFGRKIFRAWKKYG{ct:Amid} | Syn1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 1.9 % Hemolysis at 10 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GGFRSFGRKIFRAWKKYG{ct:Amid} | Syn1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 7.2 % Hemolysis at 30 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKAARAWKKYG{ct:Amid} | Syn2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 0.8 % Hemolysis at 10 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKAARAWKKYG{ct:Amid} | Syn2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 1.9 % Hemolysis at 30 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GRKILRAWKKYG{ct:Amid} | Syn3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antiprotozoal | 0.5 % Hemolysis at 10 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GRKILRAWKKYG{ct:Amid} | Syn3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antiprotozoal | 1.2 % Hemolysis at 30 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28408902 | 2017 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | 4.47 (±0.35) % Hemolysis at 175 μg/ml | Human | Human Cathelicidin | α-Helix | NA | ||
| 28408902 | 2017 | KEFKRIVQRIKDFLRNLV | KE-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | 1.17 (±0.18) % Hemolysis at 175 μg/ml | Human | Truncated Mimetics | α-Helix | NA | ||
| 28408902 | 2017 | KRIVQRIKDFLR | KR-12 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.45 (±0.10) % Hemolysis at 175 μg/ml | Human | Truncated Mimetics | α-Helix | NA | ||
| 28346717 | 2017 | VGVGGGFGR{ct:Amid} | Crinicepsin-1 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 100 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | VGVGGGFGR{ct:Amid} | Crinicepsin-1 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 0 % Hemolysis at 150 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | VGVGGGFGR{ct:Amid} | Crinicepsin-1 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | <5 % Hemolysis at 200 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | VGVGGGFGR{ct:Amid} | Crinicepsin-1 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at 250 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | VGVGGGFGR{ct:Amid} | Crinicepsin-1 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | <10 % Hemolysis at 300 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | VGVGGGFGR{ct:Amid} | Crinicepsin-1 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 18 % Hemolysis at 500 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <5 % Hemolysis at 100 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <5 % Hemolysis at 150 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <5 % Hemolysis at 200 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 250 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <15 % Hemolysis at 300 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 14.5 % Hemolysis at 500 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28429216 | 2017 | KWCFRVCYGICYRRCR{nt:Acet}{ct:Amid} | tachyplesin I | Amidation | Acetylation | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 90 µM | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 28429216 | 2017 | KWCFRVCYGICYRRCR{nt:Acet}{ct:Amid} | tachyplesin I | Amidation | Acetylation | Linear | L | None | 16 | Antimicrobial | 25 % Hemolysis at 50 µM | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 28443279 | 2017 | LLPIVGNLLKSLL{ct:Amid} | TB | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 96 µM | Human | Frog Skin-Derived | α-Helix | Non-hemolytic | ||
| 28443279 | 2017 | FLPIVGLLKSLLK{ct:Amid} | TB_L1FK | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <10 % Hemolysis at 48 µM | Human | Tb Analogs | α-Helix | Non-hemolytic | ||
| 28443279 | 2017 | FLPIVGLLKSLLK{ct:Amid} | TB_L1FK | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 40 % Hemolysis at 96 µM | Human | Tb Analogs | α-Helix | NA | ||
| 28443279 | 2017 | KKLLPIVANLLKSLL{ct:Amid} | TB_KKG6A | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <10 % Hemolysis at 24 µM | Human | Tb Analogs | α-Helix | Non-hemolytic | ||
| 28443279 | 2017 | KKLLPIVANLLKSLL{ct:Amid} | TB_KKG6A | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 48 µM | Human | Tb Analogs | α-Helix | NA | ||
| 28443279 | 2017 | KKLLPIVANLLKSLL{ct:Amid} | TB_KKG6A | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 55 % Hemolysis at 96 µM | Human | Tb Analogs | α-Helix | NA | ||
| 28073163 | 2017 | {nnr:Val}WWVAARAARR{ct:Amid} | LP1 | Amidation | Free | Linear | L | Val = valerylamide, X = (S)-2-(4-pentenyl)-alanine | 10 | Antimicrobial | 50 % Hemolysis at 1810 µM | Human | Synthetic | β-Strand | NA | ||
| 28073163 | 2017 | {nnr:Val}WWV{nnr:X}ARA{nnr:X}RR{ct:Amid} | Val-HSLP | Amidation | Free | Linear | L | Val = valerylamide, X = (S)-2-(4-pentenyl)-alanine, * = Hydrocarbon-stapled using Grubbs 1st Generation Catalyst | 10 | Antimicrobial | 50 % Hemolysis at 14.5 µM | Human | Hslp Analogs | β-Strand | NA | ||
| 28073163 | 2017 | {nnr:Val}WWV{nnr:X}ARA{nnr:X}RR{ct:Amid} | Val-nHSLP | Amidation | Free | Linear | L | Val = valerylamide, X = (S)-2-(4-pentenyl)-alanine | 10 | Antimicrobial | 50 % Hemolysis at 13.4 µM | Human | Hslp Analogs | β-Strand | NA | ||
| 28073163 | 2017 | {nnr:Cap}WWV{nnr:X}AFA{nnr:X}RRR{ct:Amid} | Cap-HSLP | Amidation | Free | Linear | L | Cap = caproylamide, X = (S)-2-(4-pentenyl)-alanine, *= Hydrocarbon-stapled | 11 | Antimicrobial | 50 % Hemolysis at 4.49 µM | Human | Hslp Analogs | β-Strand | NA | ||
| 28073163 | 2017 | {nnr:Cap}WWV{nnr:X}AFA{nnr:X}RRR{ct:Amid} | Cap-nHSLP | Amidation | Free | Linear | L | Cap = caproylamide, X = (S)-2-(4-pentenyl)-alanine | 11 | Antimicrobial | 50 % Hemolysis at 3.59 µM | Human | Hslp Analogs | β-Strand | NA | ||
| 28089718 | 2017 | GLFKKLRRKIKKGFKKIFKRLPPIGVGVSIPLAGKR | AM-CATH36 | Free | Free | Linear | L | None | 36 | Antimicrobial | 0 % Hemolysis at 300 μg/ml | Sheep | A. Mississippiensis | α-Helix | Non-hemolytic | ||
| 28089718 | 2017 | KIKKGFKKIFKRLPPIGVGVSIPLAGKR | AM-CATH28 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at 300 μg/ml | Sheep | A. Mississippiensis | α-Helix | Non-hemolytic | ||
| 28089718 | 2017 | GLFKKLRRKIKKGFKKIFKRL | AM-CATH21 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 300 μg/ml | Sheep | A. Mississippiensis | α-Helix | Non-hemolytic | ||
| 28089718 | 2017 | KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF | AM-CATH | Free | Free | Linear | L | None | 34 | Antimicrobial | 0 % Hemolysis at 300 μg/ml | Sheep | A. Mississippiensis | α-Helix | Non-hemolytic | ||
| 28236791 | 2017 | GLLWKWGWKWKEFLRIVGY{ct:Amid} | Peptido 6 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 51.36 % Hemolysis at 128 μg/ml | Human | Synthetic | α-Helix | NA | ||
| 28236791 | 2017 | GLLRKWGKKWKEFLRRVWK{ct:Amid} | Peptido 6.2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 34.46 % Hemolysis at 128 μg/ml | Human | Synthetic | α-Helix | NA | ||
| 28370835 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 93 at pH-7.4 % Hemolysis at 2.5 µM | Human | Apis Mellifera Honeybees | α-Helix | NA | ||
| 28370835 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 4 at pH-5 % Hemolysis at 2.5 µM | Human | Apis Mellifera Honeybees | α-Helix | NA | ||
| 28370835 | 2017 | GIGAVLEVLTTGLPALISWIEEEEQQ{ct:Amid} | aMel | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 74 at pH-5 % Hemolysis at 10 µM | Human | Mel Analogs | α-Helix | NA | ||
| 28370835 | 2017 | GIGAVLEVLTTGLPALISWIEEEEQQ{ct:Amid} | aMel | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 15 at pH-7.4 % Hemolysis at 10 µM | Human | Mel Analogs | α-Helix | NA | ||
| 28370835 | 2017 | RIGVLLARLPKLFSLFKLMGKKV{ct:Amid} | RV-23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 4 at pH-7.4 % Hemolysis at 2.5 µM | Human | Mel Analogs | α-Helix | NA | ||
| 28370835 | 2017 | RIGVLLAELPELFSLFELMGEEV{ct:Amid} | aRV | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 0 at pH-7.4 % Hemolysis at 160 µM | Human | Mel Analogs | α-Helix | Non-hemolytic | ||
| 28546807 | 2017 | GFVALLKKLPLILKHLH{ct:Amid} | Xac-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 37.5 ± 1.9 % Hemolysis at 100 µM | Rat | Venom Of X. Appendiculata | α-Helix | NA | ||
| 28546807 | 2017 | GFVALLKKLPLILKHLP{ct:Amid} | Xac-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 23.5 ± 1.3 % Hemolysis at 100 µM | Rat | Venom Of X. Appendiculata | α-Helix | NA | ||
| 28546807 | 2017 | INLKALAALAKKIL{ct:Amid} | Mastoparan | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 40.6 ± 2.7 % Hemolysis at 100 µM | Rat | Wasp Venom | α-Helix | NA | ||
| 28546807 | 2017 | GIGAVLEVLTTGLPALISWIEEEEQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 91.8 ± 1.8 % Hemolysis at 10 µM | Rat | Apis Mellifera | α-Helix | NA | ||
| 28258530 | 2017 | MMRVMRRKTKVIWEKKDFIGLYSID | Catesbeianin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 8 % Hemolysis at 100 μg/ml | Human | Lithobates Catesbeianus | α-Helix | NA | ||
| 28258530 | 2017 | MMRVMRRKTKVIWEKKDFIGLYSID | Catesbeianin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 30 % Hemolysis at 200 μg/ml | Human | Lithobates Catesbeianus | α-Helix | NA | ||
| 28258530 | 2017 | MMRVMRRKTKVIWEKKDFIGLYSID | Catesbeianin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 300 μg/ml | Human | Lithobates Catesbeianus | α-Helix | NA | ||
| 28258530 | 2017 | MMRVMRRKTKVIWEKKDFIGLYSID | Catesbeianin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <100 % Hemolysis at 400 μg/ml | Human | Lithobates Catesbeianus | α-Helix | NA | ||
| 28258530 | 2017 | MMRVMRRKTKVIWEKKDFIGLYSID | Catesbeianin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <100 % Hemolysis at 500 μg/ml | Human | Lithobates Catesbeianus | α-Helix | NA | ||
| 28314993 | 2017 | YGRKKRRQRRR{ct:Amid} | Tat(47–57) | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Sequence Of Hiv Transactivator Protein | α-Helix | NA | ||
| 28314993 | 2017 | RQIKIWFQNRRMKWKK{ct:Amid} | Penetratin | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Third Helix Of The Homeodomain Of Drosophila Antennapedia Protein | α-Helix | NA | ||
| 28314993 | 2017 | AGYLLGKINLKALAALAKKIL{ct:Amid} | Transportan | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 50 % Hemolysis at 38.0 ± 3.79 µM | Human | Hybrid Peptide | α-Helix | NA | ||
| 28314993 | 2017 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Amphibians | α-Helix | NA | ||
| 28314993 | 2017 | RAGLQFPVGRVHRLLRK{ct:Amid} | Buforin II (5-21) | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Amphibians | α-Helix | NA | ||
| 28314993 | 2017 | VCRTGRSRWRDVCRNFMRRYQSR{ct:Amid} | GranF2 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Synthetic Derivative | Helix-Loop-Helix | NA | ||
| 28314993 | 2017 | KRLFKKLLFSLRKY{ct:Amid} | Dhvar4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Synthetic Derivatives | α-Helix | NA | ||
| 28314993 | 2017 | YKQCHKKGGKKGSG{ct:Amid} | Crot(1–9,38–42) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Venom Of Rattlesnake | α-Helix | NA | ||
| 28314993 | 2017 | KWKLFKKIGAVLKVL{ct:Amid} | CM15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 18.9 ± 1.71 µM | Human | Hybrid | α-Helix | NA | ||
| 28314993 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 0.339 ± 0.0854 µM | Human | Bee Venom | α-Helix | NA | ||
| 28314993 | 2017 | TKPKGTKPKGTKPKGTKPKG{ct:Amid} | OT20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Synthetic | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | ALA | Amidation | Free | Linear | L | * = cross-linked residues, X = Ala | 7 | Antimicrobial | <1 % Hemolysis at 50 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | LEU | Amidation | Free | Linear | L | * = cross-linked residues, X = Leu | 7 | Antimicrobial | <1 % Hemolysis at 50 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | VAL | Amidation | Free | Linear | L | * = cross-linked residues, X = Leu | 7 | Antimicrobial | 2.5 % Hemolysis at 50 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | ILE | Amidation | Free | Linear | L | * = cross-linked residues, X = Leu | 7 | Antimicrobial | 3 % Hemolysis at 50 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | NLE | Amidation | Free | Linear | L | * = cross-linked residues, X = Nle | 7 | Antimicrobial | 7.9 % Hemolysis at 50 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | PHE | Amidation | Free | Linear | L | * = cross-linked residues, X = Phe | 7 | Antimicrobial | 4.4 % Hemolysis at 50 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | TRP | Amidation | Free | Linear | L | * = cross-linked residues, X = Trp | 7 | Antimicrobial | 5.9 % Hemolysis at 50 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | GLU | Amidation | Free | Linear | L | * = cross-linked residues, X = Glu | 7 | Antimicrobial | <1 % Hemolysis at 50 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | LYS | Amidation | Free | Linear | L | * = cross-linked residues, X = Lys | 7 | Antimicrobial | <1 % Hemolysis at 50 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | ALA | Amidation | Free | Linear | L | * = cross-linked residues, X = Ala | 7 | Antimicrobial | <1 % Hemolysis at 25 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | LEU | Amidation | Free | Linear | L | * = cross-linked residues, X = Leu | 7 | Antimicrobial | <1 % Hemolysis at 25 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | VAL | Amidation | Free | Linear | L | * = cross-linked residues, X = Leu | 7 | Antimicrobial | 1.3 % Hemolysis at 25 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | ILE | Amidation | Free | Linear | L | * = cross-linked residues, X = Leu | 7 | Antimicrobial | 1.5 % Hemolysis at 25 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | NLE | Amidation | Free | Linear | L | * = cross-linked residues, X = Nle | 7 | Antimicrobial | 3.3 % Hemolysis at 25 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | PHE | Amidation | Free | Linear | L | * = cross-linked residues, X = Phe | 7 | Antimicrobial | 1.9 % Hemolysis at 25 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | TRP | Amidation | Free | Linear | L | * = cross-linked residues, X = Trp | 7 | Antimicrobial | 3.2 % Hemolysis at 25 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | GLU | Amidation | Free | Linear | L | * = cross-linked residues, X = Glu | 7 | Antimicrobial | <1 % Hemolysis at 25 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28547390 | 2017 | K{nnr:*}WK{nnr:X}{nnr:*}K{ct:Amid} | LYS | Amidation | Free | Linear | L | * = cross-linked residues, X = Lys | 7 | Antimicrobial | <1 % Hemolysis at 25 µM | Human | Stapled Heptapeptide Helices | α-Helix | NA | ||
| 28611397 | 2017 | FFGWLIKGAIHAGKAIHGLIHRRRH | Chrysophsin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 100 % Hemolysis at 10-50 µM | Human | Chrysophrys Major | α-Helix | NA | ||
| 28611397 | 2017 | FFGWLIKPAIHAGKAIHGLIHRRRH | G8P-Chr-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 20 % Hemolysis at 50 µM | Human | Chrysophsin-1 Analogs | α-Helix | Low hemolytic | ||
| 28611397 | 2017 | FFGWLIKGAIHAPKAIHGLIHRRRH | G13P-Chr-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <20 % Hemolysis at 50 µM | Human | Chrysophsin-1 Analogs | α-Helix | Low hemolytic | ||
| 28611397 | 2017 | FFGWLIKGAIHAGKAIHPLIHRRRH | G18P-Chr-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <10 % Hemolysis at 50 µM | Human | Chrysophsin-1 Analogs | α-Helix | Low hemolytic | ||
| 28611397 | 2017 | FFGWLIKGAIHAPKAIHPLIHRRRH | G13,18P-Chr-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Chrysophsin-1 Analogs | α-Helix | Non-hemolytic | ||
| 28372989 | 2017 | RRWWRHWRR{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at > 86.67 µM | Human | Synthetic | α-Helix | NA | ||
| 28372989 | 2017 | RRWHRWWRR{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at > 86.67 µM | Human | Synthetic | α-Helix | NA | ||
| 28372989 | 2017 | RRHWRWWRR{ct:Amid} | P3 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at > 86.67 µM | Human | Synthetic | α-Helix | NA | ||
| 28372989 | 2017 | RRWHRHWRR{ct:Amid} | P4 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at > 86.67 µM | Human | Synthetic | α-Helix | NA | ||
| 28372989 | 2017 | RRWWRWWRR{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at 33.33 µM | Human | Synthetic | α-Helix | NA | ||
| 28372989 | 2017 | HRWWRWWRR{ct:Amid} | P6 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at 86.67 µM | Human | Synthetic | α-Helix | NA | ||
| 28372989 | 2017 | RRWWHWWRR{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at 86.67 µM | Human | Synthetic | α-Helix | NA | ||
| 28372989 | 2017 | HRWWRWWRH{ct:Amid} | P8 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at 86.67 µM | Human | Synthetic | α-Helix | NA | ||
| 28459130 | 2017 | RKSREWRSKKTQPRRPR | Glycinin-17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0.3 % Hemolysis at 0-500 µM | Sheep | Soybean Proteins | NA | Non-hemolytic | ||
| 28459130 | 2017 | KNQYGRIRVLQRFNQR | BCAS-16 | Free | Free | Linear | L | None | 16 | Antimicrobial | 40 % Hemolysis at 50 µM | Sheep | Soybean Proteins | NA | NA | ||
| 28459130 | 2017 | KNQYGRIRVLQRFNQR | BCAS-16 | Free | Free | Linear | L | None | 16 | Antimicrobial | >40 % Hemolysis at 200 µM | Sheep | Soybean Proteins | NA | NA | ||
| 28459130 | 2017 | KNQYGRIRVLQRFNQR | BCAS-16 | Free | Free | Linear | L | None | 16 | Antimicrobial | >40 % Hemolysis at 300 µM | Sheep | Soybean Proteins | NA | NA | ||
| 28459130 | 2017 | KNQYGRIRVLQRFNQR | BCAS-16 | Free | Free | Linear | L | None | 16 | Antimicrobial | >40 % Hemolysis at 400 µM | Sheep | Soybean Proteins | NA | NA | ||
| 28459130 | 2017 | KNQYGRIRVLQRFNQR | BCAS-16 | Free | Free | Linear | L | None | 16 | Antimicrobial | >40 % Hemolysis at 500 µM | Sheep | Soybean Proteins | NA | NA | ||
| 28459130 | 2017 | RIRLLQRFNKR | BCBS-11 | Free | Free | Linear | L | None | 11 | Antimicrobial | 1.4 % Hemolysis at 0-500 µM | Sheep | Soybean Proteins | NA | Non-hemolytic | ||
| 28461043 | 2017 | AIGHCLGATL | Andricin 01 | Free | Free | Linear | L | None | 10 | Antimicrobial | 0 % Hemolysis at 25 μg/ml | Human | Andrias Davidianus, The Chinese Giant Salamander | NA | NA | ||
| 28461043 | 2017 | AIGHCLGATL | Andricin 01 | Free | Free | Linear | L | None | 10 | Antimicrobial | 0 % Hemolysis at 50 μg/ml | Human | Andrias Davidianus, The Chinese Giant Salamander | NA | NA | ||
| 28461043 | 2017 | AIGHCLGATL | Andricin 01 | Free | Free | Linear | L | None | 10 | Antimicrobial | 4.3 ± 0.16 % Hemolysis at 100 μg/ml | Human | Andrias Davidianus, The Chinese Giant Salamander | NA | NA | ||
| 28461043 | 2017 | AIGHCLGATL | Andricin 01 | Free | Free | Linear | L | None | 10 | Antimicrobial | 16.3 ± 2.16 % Hemolysis at 200 μg/ml | Human | Andrias Davidianus, The Chinese Giant Salamander | NA | NA | ||
| 28522372 | 2017 | RLLRKFFRKLKKSV | Cbf-14 | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Cathelicidin-Bf | α-Helix | Non-hemolytic | ||
| 28522372 | 2017 | R{nnr:Nle}LRKFFRKLKKSV | Cbf-14-N | Free | Free | Linear | L | Nle = Norleucine | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Mutant Of Cbf-14 | α-Helix | Non-hemolytic | ||
| 28522372 | 2017 | RLLR{nnr:O}FFRKLKKSV{ct:Amid} | Cbf-14-1 | Amidation | Free | Linear | L | O = L-Ornithine | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Mutant Of Cbf-14 | α-Helix | Non-hemolytic | ||
| 28522372 | 2017 | RLLR{nnr:O}FFR{nnr:O}LKKSV{ct:Amid} | Cbf-14-2 | Amidation | Free | Linear | L | O = L-Ornithine | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Mutant Of Cbf-14 | α-Helix | Non-hemolytic | ||
| 28522372 | 2017 | RLLR{nnr:O}FFR{nnr:O}LK{nnr:O}SV{ct:Amid} | Cbf-14-3 | Amidation | Free | Linear | L | O = L-Ornithine | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Mutant Of Cbf-14 | α-Helix | Non-hemolytic | ||
| 28522372 | 2017 | RDLDLDRDKDFDFDRDKDLDKDKDSDVD | D-Cbf-14 | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Mutant Of Cbf-14 | α-Helix | Non-hemolytic | ||
| 28675109 | 2017 | FKRIVQRIKDFLRNLV{ct:Amid} | FK-16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at ~35 µM | Human | Ll-37 Peptide | α-Helix | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 99 % Hemolysis at 80 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 91.1 % Hemolysis at 40 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 70.2 % Hemolysis at 20 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 54.3 % Hemolysis at 10 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 23.8 % Hemolysis at 5 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 13.3 % Hemolysis at 2.5 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 1.9 % Hemolysis at 1.3 µM | Human | Bee Venom | NA | NA | ||
| 28850103 | 2017 | FLSLIPKIAGGIAALAKHL{ct:Amid} | Phylloseptin-PTa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 7.79 µM | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 28850103 | 2017 | FLSLIPKIAGGIAALAKHL{ct:Amid} | Phylloseptin-PTa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 22.8 µM | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 28850103 | 2017 | FLSLIPAAISAVSALANHF{ct:Amid} | phylloseptin-PHa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 76.5 µM | Horse | Phyllomedusa Hypochondrialis | α-Helix | NA | ||
| 28850103 | 2017 | FLSLIPAAISAVSALANHF{ct:Amid} | phylloseptin-PHa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 109.5 µM | Horse | Phyllomedusa Hypochondrialis | α-Helix | NA | ||
| 28855917 | 2017 | GFVALLKKLPLILKHLH{ct:Amid} | xylopin | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 30 % Hemolysis at 1 mM | Mouse | Xylocopa Appendiculata Circumvolans | α-Helix | Non-hemolytic | ||
| 28593346 | 2017 | ASENGKCNLLCLVKKKLRAVGNVIKTVVGKIA | Cathelicidin-PP | Free | Free | Linear | L | None | 32 | Antimicrobial | 5.65 % Hemolysis at 200 μg/ml | Rabbit | Tree Frog Polypedates Puerensis | β-Sheet | NA | ||
| 28630199 | 2017 | KRVKRFKKFFRKIKKGFRKIFKKTKIFIGGT | Pb-CATH1 | Free | Free | Linear | L | None | 31 | Antimicrobial | 0 % Hemolysis at 4 μg/ml | Chicken | Python Bivittatus | α-Helix | Non-hemolytic | ||
| 28630199 | 2017 | KRVKRFKKFFRKIKKGFRKIFKKTKIFIGGT | Pb-CATH1 | Free | Free | Linear | L | None | 31 | Antimicrobial | 1.4±0.4 % Hemolysis at 8 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | KRVKRFKKFFRKIKKGFRKIFKKTKIFIGGT | Pb-CATH1 | Free | Free | Linear | L | None | 31 | Antimicrobial | 5.1±0.5 % Hemolysis at 16 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | KRVKRFKKFFRKIKKGFRKIFKKTKIFIGGT | Pb-CATH1 | Free | Free | Linear | L | None | 31 | Antimicrobial | 7.3±0.6 % Hemolysis at 32 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | KRVKRFKKFFRKIKKGFRKIFKKTKIFIGGT | Pb-CATH1 | Free | Free | Linear | L | None | 31 | Antimicrobial | 12.2±0.7 % Hemolysis at 64 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | HRVKRNGFRKFMRRLKKFFAGG | Pb-CATH3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 4 μg/ml | Chicken | Python Bivittatus | α-Helix | Non-hemolytic | ||
| 28630199 | 2017 | HRVKRNGFRKFMRRLKKFFAGG | Pb-CATH3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 8 μg/ml | Chicken | Python Bivittatus | α-Helix | Non-hemolytic | ||
| 28630199 | 2017 | HRVKRNGFRKFMRRLKKFFAGG | Pb-CATH3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 1.7±0.5 % Hemolysis at 16 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | HRVKRNGFRKFMRRLKKFFAGG | Pb-CATH3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 3.1±0.5 % Hemolysis at 32 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | HRVKRNGFRKFMRRLKKFFAGG | Pb-CATH3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 4.0±0.2 % Hemolysis at 64 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | TRSRWRRFIRGAGRFARRYGWRIAL | Pb-CATH4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 0 % Hemolysis at 4 μg/ml | Chicken | Python Bivittatus | α-Helix | Non-hemolytic | ||
| 28630199 | 2017 | TRSRWRRFIRGAGRFARRYGWRIAL | Pb-CATH4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 1.2±0.3 % Hemolysis at 8 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | TRSRWRRFIRGAGRFARRYGWRIAL | Pb-CATH4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 3.2±0.4 % Hemolysis at 16 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | TRSRWRRFIRGAGRFARRYGWRIAL | Pb-CATH4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 6.5±0.4 % Hemolysis at 32 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | TRSRWRRFIRGAGRFARRYGWRIAL | Pb-CATH4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 10.7±0.2 % Hemolysis at 64 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ | melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 13±1.1 % Hemolysis at 4 μg/ml | Chicken | Bee Venom | α-Helix | NA | ||
| 28630199 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ | melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 71.3±5.2 % Hemolysis at 8 μg/ml | Chicken | Bee Venom | α-Helix | NA | ||
| 28630199 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ | melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 110.3±1.5 % Hemolysis at 16 μg/ml | Chicken | Bee Venom | α-Helix | NA | ||
| 28630199 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ | melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 114.7±1.7 % Hemolysis at 32 μg/ml | Chicken | Bee Venom | α-Helix | NA | ||
| 28630199 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ | melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 113.4±0.2 % Hemolysis at 64 μg/ml | Chicken | Bee Venom | α-Helix | NA | ||
| 28754346 | 2017 | INWKAILGKIGK | Communis | Free | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 142.6 µM | Swiss mouse | Chartergellus Communis | α-Helix | Non-hemolytic | ||
| 28754346 | 2017 | INWKAILGKIGKAAAAVL{ct:Amid} | Communis-AAAA | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 142.6 µM | Swiss mouse | Chartergellus Communis | α-Helix | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 1 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 2 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 4 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 8 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 16 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 32 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | ~15 % Hemolysis at 64 µM | Sheep | Synthetic | NA | NA | ||
| 28653651 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 10 % Hemolysis at 25 µM | Human | Bee Venom | α-Helix | NA | ||
| 28894024 | 2017 | GIGGALLSFGKSALKGLAKGLAEHF{ct:Amid} | BHL-bombinin | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 64 mg/l | Horse | Bombina Orientalis | α-Helix | NA | ||
| 28894024 | 2017 | LLGPVLGLVSNVLGGLL{ct:Amid} | Bombinin HL | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >512 mg/l | Horse | Bombina Orientalis | α-Helix | NA | ||
| 28894024 | 2017 | LLGPVLGLVSNVLGGLL{ct:Amid} | Bombinin HD | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >512 mg/l | Horse | Bombina Orientalis | α-Helix | NA | ||
| 28894024 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 1 mg/l | Horse | Bee Venom | α-Helix | NA | ||
| 29185466 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 93 % Hemolysis at 25 µM | Human | Bee Venom | α-Helical | NA | ||
| 29135962 | 2017 | HSDAVFTDNYTRLRKQMAVKKYLNSILN | VIP 1(vasoactive intestinal peptide) | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Host-Defence Peptide | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSKAVFTKNYTRLRKQMAVKKYLNSILN | VIP 2 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSDAVFTDNSTRLRKQMAVKKSLNSILN | VIP 3 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSDAVFTDNYTRLRKQMAVKKYLNSILT | VIP 4 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSKAVFTKNYTRLRKQMAVKKYLNSILT | VIP 5 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSDAVFTDNSTRLRKQMAVKKSLNSILT | VIP 6 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSDAVFTANYTRLRRQLAVRRYLAAILGRR | VIP 7 | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | FTANYTRLRRQLAVRRYLAAILGRR | VIP 8 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | FTANYTRLRRQLAVRRYLAAILGRR | VIP 8 | Free | Free | Linear | L | None | 26 | Antimicrobial | 1.12 % Hemolysis at 76.8 µM | Porcine | Vip Analogues | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 23 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 64 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 128 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 256 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 512 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29163899 | 2017 | C{d}WK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH1 | Amidation | Free | Cyclic | Mix | None | 6 | Antimicrobial | MHC at 1000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}WK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH2 | Amidation | Free | Cyclic | Mix | None | 7 | Antimicrobial | MHC at 125 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | C{d}WW{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH3 | Amidation | Free | Cyclic | Mix | None | 8 | Antimicrobial | MHC at 500 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}WW{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH4 | Amidation | Free | Cyclic | Mix | None | 9 | Antimicrobial | MHC at 125 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}WW{d}KK{d}KK{d}KC{cyc:N-C}{ct:Amid} | RH5 | Amidation | Free | Cyclic | Mix | None | 10 | Antimicrobial | MHC at 1000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}WW{d}WK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH6 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 31 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | C{d}WW{d}WW{d}KK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH7 | Amidation | Free | Cyclic | Mix | None | 12 | Antimicrobial | MHC at 31 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwWwWkKkKkC{cyc:N-C}{ct:Amid} | RH6m | Amidation | Free | Cyclic | Mix | Cyclized with α,α′-dichloro-meta-xylene | 11 | Antimicrobial | MHC at 31 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwWwWkKkKkC{cyc:N-C}{ct:Amid} | RH6o | Amidation | Free | Cyclic | Mix | Cyclized with α,α′-dichloro-ortho-xylene. | 11 | Antimicrobial | MHC at 31 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwWwWkKkKkC{cyc:N-C}{ct:Amid} | RH6ss | Amidation | Free | Cyclic | Mix | Cyclized with disulfide bridge | 11 | Antimicrobial | Minimum Hemolytic Concentration | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CF{d}FF{d}FK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH8 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 500 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CL{d}LL{d}LK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH9 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at >2000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CK{d}KK{d}WW{d}WW{d}KK{d}C{cyc:N-C}{ct:Amid} | RH10 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 250 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}WK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid} | RH11 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 125 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | C{d}WW{d}KK{d}KK{d}KW{d}WC{d}{cyc:N-C}{ct:Amid} | dRH11 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | Minimum Hemolytic Concentration | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwWkKkKkWwC{cyc:N-C}{ct:Amid} | RH11m | Amidation | Free | Cyclic | Mix | Cyclized with α,α′-dichloro-meta-xylene | 11 | Antimicrobial | Minimum Hemolytic Concentration | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwWkKkKkWwC{cyc:N-C}{ct:Amid} | RH11o | Amidation | Free | Cyclic | Mix | Cyclized with α,α′-dichloro-ortho-xylene. | 11 | Antimicrobial | Minimum Hemolytic Concentration | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CK{d}WK{d}WK{d}WK{d}WK{d}C{cyc:N-C}{ct:Amid} | RH12 | Amidation | Free | Cyclic | Mix | None | 10 | Antimicrobial | MHC at 1000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CWW{d}KK{d}KK{d}KW{d}WW{d}C{cyc:N-C}{ct:Amid} | RH13 | Amidation | Free | Cyclic | Mix | None | 12 | Antimicrobial | MHC at 125 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | C{d}W{d}WK{d}KK{d}KK{d}WW{d}WC{d}{cyc:N-C}{ct:Amid} | dRH13 | Amidation | Free | Cyclic | Mix | None | 12 | Antimicrobial | Minimum Hemolytic Concentration | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}WK{d}KK{d}KW{d}WW{d}C{cyc:N-C}{ct:Amid} | RH14 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 8 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}KK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid} | RH15 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 250 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CL{d}LK{d}KK{d}KK{d}LL{d}C{cyc:N-C}{ct:Amid} | RH16 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at >2000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CWWKKKKKWWC{cyc:N-C}{ct:Amid} | RH17 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 250 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | C({nnr:Me})wWkKkKkW({nnr:Me})wC{cyc:N-C}{ct:Amid} | RH18 | Amidation | Free | Cyclic | Mix | Me = N-methylation of the peptide bond. | 11 | Antimicrobial | MHC at 8 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | Cw({nnr:Me})WkKkKkW({nnr:Me})wC{cyc:N-C}{ct:Amid} | RH19 | Amidation | Free | Cyclic | Mix | Me = N-methylation of the peptide bond. | 11 | Antimicrobial | MHC at 1000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwW({nnr:Me})kKkK({nnr:Me})kWwC{cyc:N-C}{ct:Amid} | RH20 | Amidation | Free | Cyclic | Mix | Me = N-methylation of the peptide bond. | 11 | Antimicrobial | MHC at 1000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 28987278 | 2017 | VVRRVIEPRGLL | REP-VVR | Free | Free | Linear | L | None | 12 | LPS-neutralizing, angiogenic activities,Antimicrobial | 3.3 % Hemolysis at 500 µM | Sheep | Peptic Hydrolysates Of Rice Endosperm Protein | NA | Non-hemolytic | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 12.5 µg/mL | Human | Sea Snake, Hydrophis Cyanocinctus | α-Helix | Non-hemolytic | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 25 µg/mL | Human | Sea Snake, Hydrophis Cyanocinctus | α-Helix | Non-hemolytic | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 50 µg/mL | Human | Sea Snake, Hydrophis Cyanocinctus | α-Helix | Non-hemolytic | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 100 µg/mL | Human | Sea Snake, Hydrophis Cyanocinctus | α-Helix | Non-hemolytic | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | L | None | 30 | Antimicrobial | 5.25 % Hemolysis at 200 µg/mL | Human | Sea Snake, Hydrophis Cyanocinctus | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | Hc1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.09 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | Hc1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 2.9 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | Hc1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 3.26 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | Hc1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 4.35 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | Hc1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 8.33 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFR{ct:Amid} | Hc2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 1.45 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFR{ct:Amid} | Hc2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0.36 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFR{ct:Amid} | Hc2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 1.09 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFR{ct:Amid} | Hc2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 2.9 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFR{ct:Amid} | Hc2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3.98 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKF{ct:Amid} | Hc3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.17 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKF{ct:Amid} | Hc3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4.35 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKF{ct:Amid} | Hc3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 5.43 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKF{ct:Amid} | Hc3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 5.8 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKF{ct:Amid} | Hc3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 6.88 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKK{ct:Amid} | Hc4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.9 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKK{ct:Amid} | Hc4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 1.81 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKK{ct:Amid} | Hc4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 1.09 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKK{ct:Amid} | Hc4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.54 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKK{ct:Amid} | Hc4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 4.71 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVK{ct:Amid} | Hc5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 3.62 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVK{ct:Amid} | Hc5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 1.09 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVK{ct:Amid} | Hc5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 2.9 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVK{ct:Amid} | Hc5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5.43 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVK{ct:Amid} | Hc5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5.07 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAV{ct:Amid} | Hc6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 1.45 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAV{ct:Amid} | Hc6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2.9 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAV{ct:Amid} | Hc6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 1.81 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAV{ct:Amid} | Hc6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0.72 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAV{ct:Amid} | Hc6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3.62 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRA{ct:Amid} | Hc7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 2.17 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRA{ct:Amid} | Hc7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.45 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRA{ct:Amid} | Hc7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.72 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRA{ct:Amid} | Hc7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.26 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRA{ct:Amid} | Hc7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.07 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKFRK{ct:Amid} | Hc8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 2.17 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKFRK{ct:Amid} | Hc8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3.62 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKFRK{ct:Amid} | Hc8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0.36 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKFRK{ct:Amid} | Hc8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 2.17 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKFRK{ct:Amid} | Hc8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 1.45 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKFRK{ct:Amid} | Hc9 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 3.99 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKFRK{ct:Amid} | Hc9 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.9 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKFRK{ct:Amid} | Hc9 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.54 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKFRK{ct:Amid} | Hc9 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.54 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKFRK{ct:Amid} | Hc9 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4.17 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KRLLKSVRRAVKKFRK{ct:Amid} | Hc10 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.17 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KRLLKSVRRAVKKFRK{ct:Amid} | Hc10 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.9 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KRLLKSVRRAVKKFRK{ct:Amid} | Hc10 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3.99 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KRLLKSVRRAVKKFRK{ct:Amid} | Hc10 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 1.81 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KRLLKSVRRAVKKFRK{ct:Amid} | Hc10 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.17 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | RLLKSVRRAVKKFRK{ct:Amid} | Hc11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 4.71 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | RLLKSVRRAVKKFRK{ct:Amid} | Hc11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 3.26 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | RLLKSVRRAVKKFRK{ct:Amid} | Hc11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 2.9 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | RLLKSVRRAVKKFRK{ct:Amid} | Hc11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 4.71 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | RLLKSVRRAVKKFRK{ct:Amid} | Hc11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5.8 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LLKSVRRAVKKFRK{ct:Amid} | Hc12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2.17 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LLKSVRRAVKKFRK{ct:Amid} | Hc12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 1.45 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LLKSVRRAVKKFRK{ct:Amid} | Hc12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0.11 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LLKSVRRAVKKFRK{ct:Amid} | Hc12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 4.35 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LLKSVRRAVKKFRK{ct:Amid} | Hc12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3.99 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LKSVRRAVKKFRK{ct:Amid} | Hc13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.45 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LKSVRRAVKKFRK{ct:Amid} | Hc13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.81 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LKSVRRAVKKFRK{ct:Amid} | Hc13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.36 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LKSVRRAVKKFRK{ct:Amid} | Hc13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.45 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LKSVRRAVKKFRK{ct:Amid} | Hc13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.16 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKF{ct:Amid} | Hc14 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3.98 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKF{ct:Amid} | Hc14 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.54 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKF{ct:Amid} | Hc14 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 1.98 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKF{ct:Amid} | Hc14 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 1.36 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKF{ct:Amid} | Hc14 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3.26 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKF{ct:Amid} | Hc15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 3.62 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKF{ct:Amid} | Hc15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 4.35 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKF{ct:Amid} | Hc15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5.07 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKF{ct:Amid} | Hc15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 8.7 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKF{ct:Amid} | Hc15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 9.06 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFCWTKSIPPKPC | H3TI | Free | Free | Linear | L | None | 28 | Antimicrobial | 1.8 % Hemolysis at 12.5 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFCWTKSIPPKPC | H3TI | Free | Free | Linear | L | None | 28 | Antimicrobial | 1.55 % Hemolysis at 25 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFCWTKSIPPKPC | H3TI | Free | Free | Linear | L | None | 28 | Antimicrobial | 2.28 % Hemolysis at 50 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFCWTKSIPPKPC | H3TI | Free | Free | Linear | L | None | 28 | Antimicrobial | 3.5 % Hemolysis at 100 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFCWTKSIPPKPC | H3TI | Free | Free | Linear | L | None | 28 | Antimicrobial | 7.39 % Hemolysis at 200 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRFFKSFRRAFKKFCWTKSIPPKPC | H3TIF | Free | Free | Linear | L | None | 28 | Antimicrobial | 1.6 % Hemolysis at 12.5 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRFFKSFRRAFKKFCWTKSIPPKPC | H3TIF | Free | Free | Linear | L | None | 28 | Antimicrobial | 1.23 % Hemolysis at 25 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRFFKSFRRAFKKFCWTKSIPPKPC | H3TIF | Free | Free | Linear | L | None | 28 | Antimicrobial | 1.96 % Hemolysis at 50 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRFFKSFRRAFKKFCWTKSIPPKPC | H3TIF | Free | Free | Linear | L | None | 28 | Antimicrobial | 2.35 % Hemolysis at 100 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRFFKSFRRAFKKFCWTKSIPPKPC | H3TIF | Free | Free | Linear | L | None | 28 | Antimicrobial | 5.53 % Hemolysis at 200 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRLLKSVRRAVKKF{ct:Amid} | TIH3 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 1.94 % Hemolysis at 12.5 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRLLKSVRRAVKKF{ct:Amid} | TIH3 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 0.94 % Hemolysis at 25 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRLLKSVRRAVKKF{ct:Amid} | TIH3 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 1.76 % Hemolysis at 50 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRLLKSVRRAVKKF{ct:Amid} | TIH3 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 3.17 % Hemolysis at 100 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRLLKSVRRAVKKF{ct:Amid} | TIH3 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 3.08 % Hemolysis at 200 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRFFKSFRRAFKKF{ct:Amid} | TIH3F | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 4.91 % Hemolysis at 12.5 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRFFKSFRRAFKKF{ct:Amid} | TIH3F | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 2.62 % Hemolysis at 25 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRFFKSFRRAFKKF{ct:Amid} | TIH3F | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 5.44 % Hemolysis at 50 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRFFKSFRRAFKKF{ct:Amid} | TIH3F | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 6.41 % Hemolysis at 100 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRFFKSFRRAFKKF{ct:Amid} | TIH3F | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 10 % Hemolysis at 200 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28203232 | 2017 | K{nt:X = C16 = Heksadecanoic fatty acid chain}{ct:Amid} | 1 | Amidation | X = C16 = Heksadecanoic fatty acid chain | Linear | L | C16 = Heksadecanoic fatty acid chain | 1 | Antimicrobial | 10 % Hemolysis at 512 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KK{nt:X = C16 = Heksadecanoic fatty acid chain}{ct:Amid} | 2 | Amidation | X = C16 = Heksadecanoic fatty acid chain | Linear | L | C16 = Heksadecanoic fatty acid chain | 2 | Antimicrobial | 10 % Hemolysis at 16 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KKK{nt:X = C16 = Heksadecanoic fatty acid chain}{ct:Amid} | 3 | Amidation | X = C16 = Heksadecanoic fatty acid chain | Linear | L | C16 = Heksadecanoic fatty acid chain | 3 | Antimicrobial | 10 % Hemolysis at 32 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KKKK{nt:X = C16 = Heksadecanoic fatty acid chain}{ct:Amid} | 4 | Amidation | X = C16 = Heksadecanoic fatty acid chain | Linear | L | C16 = Heksadecanoic fatty acid chain | 4 | Antimicrobial | 10 % Hemolysis at 16 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KG{nt:X = C16 = Heksadecanoic fatty acid chain}{ct:Amid} | 5 | Amidation | X = C16 = Heksadecanoic fatty acid chain | Linear | L | C16 = Heksadecanoic fatty acid chain | 2 | Antimicrobial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KGK{nt:X = C16 = Heksadecanoic fatty acid chain}{ct:Amid} | 6 | Amidation | X = C16 = Heksadecanoic fatty acid chain | Linear | L | C16 = Heksadecanoic fatty acid chain | 3 | Antimicrobial | 10 % Hemolysis at 64 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KGKG{nt:X = C16 = Heksadecanoic fatty acid chain}{ct:Amid} | 7 | Amidation | X = C16 = Heksadecanoic fatty acid chain | Linear | L | C16 = Heksadecanoic fatty acid chain | 4 | Antimicrobial | 10 % Hemolysis at 64 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | K{nt:X = C14 = Tetradecanoic fatty acid chain}{ct:Amid} | 8 | Amidation | X = C14 = Tetradecanoic fatty acid chain | Linear | L | C14 = Tetradecanoic fatty acid chain | 1 | Antimicrobial | 10 % Hemolysis at 512 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KK{nt:X = C14 = Tetradecanoic fatty acid chain}{ct:Amid} | 9 | Amidation | X = C14 = Tetradecanoic fatty acid chain | Linear | L | C14 = Tetradecanoic fatty acid chain | 2 | Antimicrobial | 10 % Hemolysis at 128 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KKK{nt:X = C14 = Tetradecanoic fatty acid chain}{ct:Amid} | 10 | Amidation | X = C14 = Tetradecanoic fatty acid chain | Linear | L | C14 = Tetradecanoic fatty acid chain | 3 | Antimicrobial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KKKK{nt:X = C14 = Tetradecanoic fatty acid chain}{ct:Amid} | 11 | Amidation | X = C14 = Tetradecanoic fatty acid chain | Linear | L | C14 = Tetradecanoic fatty acid chain | 4 | Antimicrobial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KG{nt:X = C14 = Tetradecanoic fatty acid chain}{ct:Amid} | 12 | Amidation | X = C14 = Tetradecanoic fatty acid chain | Linear | L | C14 = Tetradecanoic fatty acid chain | 2 | Antimicrobial | 10 % Hemolysis at >1000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KGK{nt:X = C14 = Tetradecanoic fatty acid chain}{ct:Amid} | 13 | Amidation | X = C14 = Tetradecanoic fatty acid chain | Linear | L | C14 = Tetradecanoic fatty acid chain | 3 | Antimicrobial | 10 % Hemolysis at 128 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KGKG{nt:X = C14 = Tetradecanoic fatty acid chain}{ct:Amid} | 14 | Amidation | X = C14 = Tetradecanoic fatty acid chain | Linear | L | C14 = Tetradecanoic fatty acid chain | 4 | Antimicrobial | 10 % Hemolysis at 512 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | K{nt:X = C12 = Dodecanoic fatty acid chain}{ct:Amid} | 15 | Amidation | X = C12 = Dodecanoic fatty acid chain | Linear | L | C12 = Dodecanoic fatty acid chain | 1 | Antimicrobial | 10 % Hemolysis at 1000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KK{nt:X = C12 = Dodecanoic fatty acid chain}{ct:Amid} | 16 | Amidation | X = C12 = Dodecanoic fatty acid chain | Linear | L | C12 = Dodecanoic fatty acid chain | 2 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KKK{nt:X = C12 = Dodecanoic fatty acid chain}{ct:Amid} | 17 | Amidation | X = C12 = Dodecanoic fatty acid chain | Linear | L | C12 = Dodecanoic fatty acid chain | 3 | Antimicrobial | 10 % Hemolysis at 512 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KKKK{nt:X = C12 = Dodecanoic fatty acid chain}{ct:Amid} | 18 | Amidation | X = C12 = Dodecanoic fatty acid chain | Linear | L | C12 = Dodecanoic fatty acid chain | 4 | Antimicrobial | 10 % Hemolysis at 1000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KG{nt:X = C12 = Dodecanoic fatty acid chain}{ct:Amid} | 19 | Amidation | X = C12 = Dodecanoic fatty acid chain | Linear | L | C12 = Dodecanoic fatty acid chain | 2 | Antimicrobial | 10 % Hemolysis at 1000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KGK{nt:X = C12 = Dodecanoic fatty acid chain}{ct:Amid} | 20 | Amidation | X = C12 = Dodecanoic fatty acid chain | Linear | L | C12 = Dodecanoic fatty acid chain | 3 | Antimicrobial | 10 % Hemolysis at 1000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KGKG{nt:X = C12 = Dodecanoic fatty acid chain}{ct:Amid} | 21 | Amidation | X = C12 = Dodecanoic fatty acid chain | Linear | L | C12 = Dodecanoic fatty acid chain | 4 | Antimicrobial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | K{nt:X = C10 = Decanoic fatty acid chain}{ct:Amid} | 22 | Amidation | X = C10 = Decanoic fatty acid chain | Linear | L | C10 = Decanoic fatty acid chain | 1 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KK{nt:X = C10 = Decanoic fatty acid chain}{ct:Amid} | 23 | Amidation | X = C10 = Decanoic fatty acid chain | Linear | L | C10 = Decanoic fatty acid chain | 2 | Antimicrobial | 10 % Hemolysis at 4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KKK{nt:X = C10 = Decanoic fatty acid chain}{ct:Amid} | 24 | Amidation | X = C10 = Decanoic fatty acid chain | Linear | L | C10 = Decanoic fatty acid chain | 3 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KKKK{nt:X = C10 = Decanoic fatty acid chain}{ct:Amid} | 25 | Amidation | X = C10 = Decanoic fatty acid chain | Linear | L | C10 = Decanoic fatty acid chain | 4 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KG{nt:X = C10 = Decanoic fatty acid chain}{ct:Amid} | 26 | Amidation | X = C10 = Decanoic fatty acid chain | Linear | L | C10 = Decanoic fatty acid chain | 2 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KGK{nt:X = C10 = Decanoic fatty acid chain}{ct:Amid} | 27 | Amidation | X = C10 = Decanoic fatty acid chain | Linear | L | C10 = Decanoic fatty acid chain | 3 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KGKG{nt:X = C10 = Decanoic fatty acid chain}{ct:Amid} | 28 | Amidation | X = C10 = Decanoic fatty acid chain | Linear | L | C10 = Decanoic fatty acid chain | 4 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | K{nt:X = C8 = Octanoic fatty acid chain}{ct:Amid} | 29 | Amidation | X = C8 = Octanoic fatty acid chain | Linear | L | C8 = Octanoic fatty acid chain | 1 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KK{nt:X = C8 = Octanoic fatty acid chain}{ct:Amid} | 30 | Amidation | X = C8 = Octanoic fatty acid chain | Linear | L | C8 = Octanoic fatty acid chain | 2 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KKK{nt:X = C8 = Octanoic fatty acid chain}{ct:Amid} | 31 | Amidation | X = C8 = Octanoic fatty acid chain | Linear | L | C8 = Octanoic fatty acid chain | 3 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KKKK{nt:X = C8 = Octanoic fatty acid chain}{ct:Amid} | 32 | Amidation | X = C8 = Octanoic fatty acid chain | Linear | L | C8 = Octanoic fatty acid chain | 4 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KG{nt:X = C8 = Octanoic fatty acid chain}{ct:Amid} | 33 | Amidation | X = C8 = Octanoic fatty acid chain | Linear | L | C8 = Octanoic fatty acid chain | 2 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KGK{nt:X = C8 = Octanoic fatty acid chain}{ct:Amid} | 34 | Amidation | X = C8 = Octanoic fatty acid chain | Linear | L | C8 = Octanoic fatty acid chain | 3 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28203232 | 2017 | KGKG{nt:X = C8 = Octanoic fatty acid chain}{ct:Amid} | 35 | Amidation | X = C8 = Octanoic fatty acid chain | Linear | L | C8 = Octanoic fatty acid chain | 4 | Antimicrobial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Cationic Lipopeptides | NA | NA | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 14.5 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 11.2 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 7.8 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 100 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 91.5 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 89.3 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 86.9 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 85.2 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 84.9 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 10.8 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 10.3 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 19.5 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 78.1 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 48.8 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 20.2 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 7.3 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 78 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 77.8 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 77.4 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 64.8 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 33.3 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 7.9 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 61.8 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 61.3 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 60.6 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 46 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 38.1 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 10.2 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 40.9 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 23.1 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 11.7 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 8.5 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 6.8 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 100 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 68.4 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 45.4 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 35.2 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 22.8 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 13 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 8.4 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 99.8 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 95.3 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 59 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 13 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 92.4 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 84.8 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 39.9 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 15.9 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | SFLDKFKDVAIGVAKGAVTGVLKALLCKLDNSC{ct:Amid} | Brevinin-2MS1 | Amidation | Free | Linear | L | None | 33 | Antioxidant, Antimicrobial | 58.5 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | SFLDKFKDVAIGVAKGAVTGVLKALLCKLDNSC{ct:Amid} | Brevinin-2MS1 | Amidation | Free | Linear | L | None | 33 | Antioxidant, Antimicrobial | 28.1 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | SFLDKFKDVAIGVAKGAVTGVLKALLCKLDNSC{ct:Amid} | Brevinin-2MS1 | Amidation | Free | Linear | L | None | 33 | Antioxidant, Antimicrobial | 8.4 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | SFLDKFKDVAIGVAKGAVTGVLKALLCKLDNSC{ct:Amid} | Brevinin-2MS1 | Amidation | Free | Linear | L | None | 33 | Antioxidant, Antimicrobial | 4.3 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | SFLDKFKDVAIGVAKGAVTGVLKALLCKLDNSC{ct:Amid} | Brevinin-2MS1 | Amidation | Free | Linear | L | None | 33 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | SFLDKFKDVAIGVAKGAVTGVLKALLCKLDNSC{ct:Amid} | Brevinin-2MS1 | Amidation | Free | Linear | L | None | 33 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | SFLDKFKDVAIGVAKGAVTGVLKALLCKLDNSC{ct:Amid} | Brevinin-2MS1 | Amidation | Free | Linear | L | None | 33 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | SFLDKFKDVAIGVAKGAVTGVLKALLCKLDNSC{ct:Amid} | Brevinin-2MS1 | Amidation | Free | Linear | L | None | 33 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 8.6 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 5.7 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 5 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 16.6 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 16.1 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | SLWETIKNAGKGFILNILDKIRCKVAGGCKT{ct:Amid} | Nigroain-K-SN1 | Amidation | Free | Linear | L | None | 31 | Antioxidant, Antimicrobial | 85.3 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | SLWETIKNAGKGFILNILDKIRCKVAGGCKT{ct:Amid} | Nigroain-K-SN1 | Amidation | Free | Linear | L | None | 31 | Antioxidant, Antimicrobial | 67.1 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | SLWETIKNAGKGFILNILDKIRCKVAGGCKT{ct:Amid} | Nigroain-K-SN1 | Amidation | Free | Linear | L | None | 31 | Antioxidant, Antimicrobial | 40.1 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | SLWETIKNAGKGFILNILDKIRCKVAGGCKT{ct:Amid} | Nigroain-K-SN1 | Amidation | Free | Linear | L | None | 31 | Antioxidant, Antimicrobial | 23 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | SLWETIKNAGKGFILNILDKIRCKVAGGCKT{ct:Amid} | Nigroain-K-SN1 | Amidation | Free | Linear | L | None | 31 | Antioxidant, Antimicrobial | 11.9 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | SLWETIKNAGKGFILNILDKIRCKVAGGCKT{ct:Amid} | Nigroain-K-SN1 | Amidation | Free | Linear | L | None | 31 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | SLWETIKNAGKGFILNILDKIRCKVAGGCKT{ct:Amid} | Nigroain-K-SN1 | Amidation | Free | Linear | L | None | 31 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | SLWETIKNAGKGFILNILDKIRCKVAGGCKT{ct:Amid} | Nigroain-K-SN1 | Amidation | Free | Linear | L | None | 31 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28026016 | 2017 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Antimicrobial | 3 ± 0.6 % Hemolysis at 150 µM | Horse | Synthetic Peptidotriazoles | NA | NA | ||
| 28026016 | 2017 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Antimicrobial | 3 ± 0.6 % Hemolysis at 250 µM | Horse | Synthetic Peptidotriazoles | NA | NA | ||
| 28026016 | 2017 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Antimicrobial | 4 ± 0.7 % Hemolysis at 375 µM | Horse | Synthetic Peptidotriazoles | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Bn}{cyc:N-C} | BPC458 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 2 ± 0.3 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Bn}{cyc:N-C} | BPC458 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 3 ± 0.5 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Bn}{cyc:N-C} | BPC458 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 5 ± 0.2 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Nle}{cyc:N-C} | BPC460 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 0.3 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Nle}{cyc:N-C} | BPC460 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 0.3 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Nle}{cyc:N-C} | BPC460 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 0.1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhNH2}{cyc:N-C} | BPC518 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 1 ± 0.1 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhNH2}{cyc:N-C} | BPC518 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 1 ± 0.1 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhNH2}{cyc:N-C} | BPC518 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 1 ± 0.1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhMe}{cyc:N-C} | BPC540 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 2 ± 0.5 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhMe}{cyc:N-C} | BPC540 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 4 ± 0.4 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhMe}{cyc:N-C} | BPC540 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 6 ± 1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhOMe}{cyc:N-C} | BPC542 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 1 ± 0.6 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhOMe}{cyc:N-C} | BPC542 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 2 ± 0.2 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhOMe}{cyc:N-C} | BPC542 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 4 ± 0.4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPh}{cyc:N-C} | BPC544 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 1 ± 0.4 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPh}{cyc:N-C} | BPC544 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 1 ± 0.3 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPh}{cyc:N-C} | BPC544 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 2 ± 0.4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC516 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 5 ± 0.2 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC516 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 6 ± 0.4 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC516 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 8 ± 0.1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC538 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 1 ± 0.8 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC538 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 1 ± 0.4 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC538 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 2 ± 0.4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C} | BPC548 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 12 ± 0.3 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C} | BPC548 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 24 ± 1 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C} | BPC548 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 26 ± 4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC550 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 7 ± 0.8 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC550 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 10 ± 0.8 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC550 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 19 ± 5 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTr}{cyc:N-C} | BPC692 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 3 | Antimicrobial | 5 ± 0.7 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTr}{cyc:N-C} | BPC692 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 3 | Antimicrobial | 5 ± 0.8 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTr}{cyc:N-C} | BPC692 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 3 | Antimicrobial | 7 ± 0.2 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrBn}{cyc:N-C} | BPC696 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 19 ± 4 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrBn}{cyc:N-C} | BPC696 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 20 ± 5 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrBn}{cyc:N-C} | BPC696 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 30 ± 4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrNle}{cyc:N-C} | BPC700 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 2 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrNle}{cyc:N-C} | BPC700 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 0.4 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrNle}{cyc:N-C} | BPC700 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 0.1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA({nnr:TrBn}{cyc:N-C} | BPC510 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 32 ± 2 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA({nnr:TrBn}{cyc:N-C} | BPC510 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 35 ± 3 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA({nnr:TrBn}{cyc:N-C} | BPC510 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 40 ± 4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:Tr-Nle}{cyc:N-C} | BPC512 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 5 | Antimicrobial | 2 ± 0.1 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:Tr-Nle}{cyc:N-C} | BPC512 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 5 | Antimicrobial | 2 ± 0.2 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:Tr-Nle}{cyc:N-C} | BPC512 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 5 | Antimicrobial | 3 ± 0.4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:TrPhNH2}{cyc:N-C} | BPC514 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 16 ± 0.9 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:TrPhNH2}{cyc:N-C} | BPC514 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 19 ± 0.8 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:TrPhNH2}{cyc:N-C} | BPC514 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 23 ± 2 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC562 | Free | Free | Cyclic | L | Tr-Ph = triazole bearing a phenyl group | 5 | Antimicrobial | 42 ± 5 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC562 | Free | Free | Cyclic | L | Tr-Ph = triazole bearing a phenyl group | 5 | Antimicrobial | 51 ± 3 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC562 | Free | Free | Cyclic | L | Tr-Ph = triazole bearing a phenyl group | 5 | Antimicrobial | 58 ± 1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC572 | Free | Free | Cyclic | L | Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 8 ± 0.2 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC572 | Free | Free | Cyclic | L | Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 13 ± 0.2 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC572 | Free | Free | Cyclic | L | Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 25 ± 5 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC558 | Free | Free | Cyclic | L | Tr-PhOMe = triazole bearing an anisole moiety | 5 | Antimicrobial | 54 ± 4 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC558 | Free | Free | Cyclic | L | Tr-PhOMe = triazole bearing an anisole moiety | 5 | Antimicrobial | 76 ± 8 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC558 | Free | Free | Cyclic | L | Tr-PhOMe = triazole bearing an anisole moiety | 5 | Antimicrobial | 90 ± 8 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTr}){cyc:N-C} | BPC690 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 5 | Antimicrobial | 47 ± 7 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTr}){cyc:N-C} | BPC690 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 5 | Antimicrobial | 67 ± 8 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTr}){cyc:N-C} | BPC690 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 5 | Antimicrobial | 75 ± 7 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrBn}{cyc:N-C} | BPC694 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 57 ± 5 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrBn}{cyc:N-C} | BPC694 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 74 ± 15 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrBn}{cyc:N-C} | BPC694 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 93 ± 15 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrNle}{cyc:N-C} | BPC698 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 3 ± 0.5 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrNle}{cyc:N-C} | BPC698 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 4 ± 1 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrNle}{cyc:N-C} | BPC698 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 5 ± 0.7 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28833783 | 2017 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <10 % Hemolysis at 50 µM | Human | Venom Of The Social Wasp Polybia Paulista | NA | NA | ||
| 28833783 | 2017 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 30 % Hemolysis at 150 µM | Human | Venom Of The Social Wasp Polybia Paulista | NA | NA | ||
| 28833783 | 2017 | IDWKKLLKAAK{nnr:Pra}IL{cyc:N-C}{nt:Acet}{ct:Amid} | C-MPI-1 | Amidation | Acetylation | Cyclic | Mix | Pra = L-propargylglycine | 16 | Antimicrobial | 30 % Hemolysis at 50 µM | Human | Mpi Analogs | α-Helical | NA | ||
| 28833783 | 2017 | IDWKKLLKAAK{nnr:Pra}IL{cyc:N-C}{nt:Acet}{ct:Amid} | C-MPI-1 | Amidation | Acetylation | Cyclic | Mix | Pra = L-propargylglycine | 16 | Antimicrobial | 35 % Hemolysis at 150 µM | Human | Mpi Analogs | α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0.1 % Hemolysis at <20 µM | Human | Social Wasp Polybia Paulista | α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLK{d}SL{ct:Amid} | D-lys-CP | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0 % Hemolysis at <20 µM | Human | D-Lysine Substituted Derivative | α-Helical | Non-hemolytic | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | <0.2 % Hemolysis at <20 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <0.4 % Hemolysis at >30 µM | Human | Social Wasp Polybia Paulista | α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLK{d}SL{ct:Amid} | D-lys-CP | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0 % Hemolysis at >30 µM | Human | D-Lysine Substituted Derivative | α-Helical | Non-hemolytic | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | <0.4 % Hemolysis at >30 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0.6 % Hemolysis at <70 µM | Human | Social Wasp Polybia Paulista | α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLK{d}SL{ct:Amid} | D-lys-CP | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0 % Hemolysis at <70 µM | Human | D-Lysine Substituted Derivative | α-Helical | Non-hemolytic | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | <0.5 % Hemolysis at <70 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0.6 % Hemolysis at 130 µM | Human | Social Wasp Polybia Paulista | α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLK{d}SL{ct:Amid} | D-lys-CP | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0.2 % Hemolysis at 130 µM | Human | D-Lysine Substituted Derivative | α-Helical | NA | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0.5 % Hemolysis at 130 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 1 μg/ml in 1hr | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 5 μg/ml in 1hr | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 50 μg/ml in 1hr | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 100 μg/ml in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 1 μg/ml in 1hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 5 μg/ml in 1hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 50 μg/ml in 1hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 100 μg/ml in 1hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 1 μg/ml in 24hr | Human | Synthetic Peptide | NA | NA | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | <10 % Hemolysis at 5 μg/ml in 24hr | Human | Synthetic Peptide | NA | NA | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | <15 % Hemolysis at 50 μg/ml in 24hr | Human | Synthetic Peptide | NA | NA | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 21.62 % Hemolysis at 100 μg/ml in 24hr | Human | Synthetic Peptide | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at 1 μg/ml in 24hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <10 % Hemolysis at 5 μg/ml in 24hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <10 % Hemolysis at 50 μg/ml in 24hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | 9 % Hemolysis at 100 μg/ml in 24hr | Human | Hbd-1 Motif | NA | NA | ||
| 28756544 | 2017 | GLFDIIKKIAESF{ct:Amid} | aurein 1.2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 1-512 μg/ml | Human | Australian Bell Frogs, Ranoidea Aurea | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | FSEAIKKIIDFLG{ct:Amid} | r-aurein 1.2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Analog Of Aurein 1.2 | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | FSEAIKKIIDFLG{ct:Amid} | r-aurein 1.2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <10 % Hemolysis at 512 μg/ml | Human | Analog Of Aurein 1.2 | α-Helical | NA | ||
| 28756544 | 2017 | KWKLFKKIGAVLKVL{ct:Amid} | CAMEL | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 45299 μg/ml | Human | Hybrid Peptide | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | KWKLFKKIGAVLKVL{ct:Amid} | CAMEL | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <10 % Hemolysis at 64 μg/ml | Human | Hybrid Peptide | α-Helical | NA | ||
| 28756544 | 2017 | KWKLFKKIGAVLKVL{ct:Amid} | CAMEL | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 512 μg/ml | Human | Hybrid Peptide | α-Helical | NA | ||
| 28756544 | 2017 | LVKLVAGIKKFLKWK{ct:Amid} | r-CAMEL | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Analog Of Camel | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | LVKLVAGIKKFLKWK{ct:Amid} | r-CAMEL | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 512 μg/ml | Human | Analog Of Camel | α-Helical | NA | ||
| 28756544 | 2017 | GLFDVIKKVASVIGGL{ct:Amid} | citropin 1.1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Green Tree Frog, Ranoidea Citropa | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | GLFDVIKKVASVIGGL{ct:Amid} | citropin 1.1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <20 % Hemolysis at 512 μg/ml | Human | Green Tree Frog, Ranoidea Citropa | α-Helical | NA | ||
| 28756544 | 2017 | LGGIVSAVKKIVDFLG{ct:Amid} | r-citropin 1.1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 1-512 μg/ml | Human | Analog Of Citropin 1.1 | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | ILRWPWWPWRRK{ct:Amid} | omiganan | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Analog Of Indolicidin, Cytoplasmic Granules Of Bovine Neutrophils | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | ILRWPWWPWRRK{ct:Amid} | omiganan | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <10 % Hemolysis at 512 μg/ml | Human | Analog Of Indolicidin, Cytoplasmic Granules Of Bovine Neutrophils | α-Helical | NA | ||
| 28756544 | 2017 | KRRWPWWPWRLI{ct:Amid} | r-omiganan | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Analog Of Omiganan | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | KRRWPWWPWRLI{ct:Amid} | r-omiganan | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <20 % Hemolysis at 512 μg/ml | Human | Analog Of Omiganan | α-Helical | NA | ||
| 28756544 | 2017 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 1 μg/ml | Human | African Clawed Frog, Xenopus Laevis | distorted α-Helix | Non-hemolytic | ||
| 28756544 | 2017 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <20 % Hemolysis at 512 μg/ml | Human | African Clawed Frog, Xenopus Laevis | distorted α-Helix | NA | ||
| 28756544 | 2017 | KKLIKVFAKGFKKAKKLFKGIG{ct:Amid} | r-pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 1-512 μg/ml | Human | Analog Of Pexiganan | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | FLPLIGRVLSGIL{ct:Amid} | temporin A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | European Red Frog, Rana Temporaria | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | FLPLIGRVLSGIL{ct:Amid} | temporin A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 70 % Hemolysis at 512 μg/ml | Human | European Red Frog, Rana Temporaria | α-Helical | NA | ||
| 28756544 | 2017 | LIGSLVRGILPLF{ct:Amid} | r-temporin A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Analog Of Temporin A | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | LIGSLVRGILPLF{ct:Amid} | r-temporin A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <10 % Hemolysis at 512 μg/ml | Human | Analog Of Temporin A | α-Helical | NA | ||
| 28969703 | 2017 | FNARRCHRHCRSIRRRAGYCAGRLRLLTCTCVR | HlDFS1 | Free | Free | Linear | L | None | 33 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Hard Tick Haemaphysalis Longicornis | NA | Non-hemolytic | ||
| 28969703 | 2017 | FNARRCHRHCRSIRRRAGYCAGRLRLLTCTCVR | HlDFS1 | Free | Free | Linear | L | None | 33 | Antimicrobial | <50 % Hemolysis at 10 µM | Human | Hard Tick Haemaphysalis Longicornis | NA | NA | ||
| 28969703 | 2017 | FNARRCHRHCRSIRRRAGYCAGRLRLLTCTCVR | HlDFS1 | Free | Free | Linear | L | None | 33 | Antimicrobial | <50 % Hemolysis at 20 µM | Human | Hard Tick Haemaphysalis Longicornis | NA | NA | ||
| 28969703 | 2017 | FNARRCHRHCRSIRRRAGYCAGRLRLLTCTCVR | HlDFS1 | Free | Free | Linear | L | None | 33 | Antimicrobial | <100 % Hemolysis at 50 µM | Human | Hard Tick Haemaphysalis Longicornis | NA | NA | ||
| 28969703 | 2017 | LNQGACHRHCRSIRRRGGYCSGIIKQTCTCYRN | HlDFS2 | Free | Free | Linear | L | None | 33 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Hard Tick Haemaphysalis Longicornis | NA | Non-hemolytic | ||
| 28969703 | 2017 | LNQGACHRHCRSIRRRGGYCSGIIKQTCTCYRN | HlDFS2 | Free | Free | Linear | L | None | 33 | Antimicrobial | 0 % Hemolysis at 10 µM | Human | Hard Tick Haemaphysalis Longicornis | NA | Non-hemolytic | ||
| 28969703 | 2017 | LNQGACHRHCRSIRRRGGYCSGIIKQTCTCYRN | HlDFS2 | Free | Free | Linear | L | None | 33 | Antimicrobial | 0 % Hemolysis at 20 µM | Human | Hard Tick Haemaphysalis Longicornis | NA | Non-hemolytic | ||
| 28969703 | 2017 | LNQGACHRHCRSIRRRGGYCSGIIKQTCTCYRN | HlDFS2 | Free | Free | Linear | L | None | 33 | Antimicrobial | <50 % Hemolysis at 50 µM | Human | Hard Tick Haemaphysalis Longicornis | NA | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 60 % Hemolysis at 5 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <100 % Hemolysis at 10 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 15 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <100 % Hemolysis at 20 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <100 % Hemolysis at 25 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 30 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 40 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | PLILLRLLRGQF{ct:Amid} | WWSP(2) | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | AAVLLPVLLAAP{ct:Amid} | KFGF(3) | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | KLALKALKALKAALKLA{ct:Amid} | MAP-1(4) | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <20 % Hemolysis at 5 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <30 % Hemolysis at 10 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 30 % Hemolysis at 15 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 40 % Hemolysis at 20 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <50 % Hemolysis at 25 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <40 % Hemolysis at 30 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 40 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | PLIKLRLDRGQF{ct:Amid} | sWWSP(6) | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | AAKLLPDLLAAP{ct:Amid} | sKFGF(7) | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | KLALKALKKLKADLKLA{ct:Amid} | sMAP-1(8) | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28483966 | 2017 | GGLKKLGKKLEGAGKRVFNAAEKALPVVAGAKALRK | cecropin A2 | Free | Free | Linear | L | None | 36 | Antimicrobial | 0 % Hemolysis at 60 μg/mL | Human | Aedes Aegypti Cecropin A | α-Helical | Non-hemolytic | ||
| 31554187 | 2019 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 50 µM | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 181 µM | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | FDIMGLIKKVAGAL{ct:Amid} | EMP-ER | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 200 µM | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LKLMGIVKKVLGAL{ct:Amid} | EMP-EM1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LKLLGIVKKVLGAI{ct:Amid} | EMP-EM2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGIFKKVKSLLT | Eumenitin | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 353 µM | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGLIKKVASLLN | Eumenitin-R | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 530 µM | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | SLLSLIRKLIT{ct:Amid} | Decoralin | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 50 µM | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 181 µM | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | FDIMGLIKKVAGAL{ct:Amid} | EMP-ER | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 200 µM | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LKLMGIVKKVLGAL{ct:Amid} | EMP-EM1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LKLLGIVKKVLGAI{ct:Amid} | EMP-EM2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGIFKKVKSLLT | Eumenitin | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 353 µM | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGLIKKVASLLN | Eumenitin-R | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 530 µM | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | SLLSLIRKLIT{ct:Amid} | Decoralin | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31311351 | 2019 | KRWWKWIRW{ct:Amid} | HHC-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5 % Hemolysis at 130 µM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | AILFLSLGAIKKG | BRGP-001 | Free | Free | Linear | L | None | 13 | Antimicrobial | 17.48 % Hemolysis at 1.127 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | FLIKSLAGAKGIL | BRGP-002 | Free | Free | Linear | L | None | 13 | Antimicrobial | 2.87 % Hemolysis at 1.879 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | KGGAIKSLFLILA | BRGP-003 | Free | Free | Linear | L | None | 13 | Antimicrobial | 8.8 % Hemolysis at 1.127 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | KGIKGALSILFAL | BRGP-004 | Free | Free | Linear | L | None | 13 | Antimicrobial | 27.9 % Hemolysis at 1.503 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | GIKGALKSILFAL | BRGP-005 | Free | Free | Linear | L | None | 13 | Antimicrobial | 13.81 % Hemolysis at 0.188 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | FALSILGALGIKK | BRGP-006 | Free | Free | Linear | L | None | 13 | Antimicrobial | 16.34 % Hemolysis at 1.503 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | PQQYPEMNTRRNW | BRGP-007 | Free | Free | Linear | L | None | 13 | Antimicrobial | 7.58 % Hemolysis at 1.454 mM | Human | Synthetic | not Helix | NA | ||
| 37760701 | 2023 | FLGSLFSIGSKLLPGVFKLFSRKKQ{ct:α-Amidation} | TtAP-1 | α-Amidation | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 18 ± 2 μg/mL | Mouse | Trinidad Thick-Tailed Scorpion Tityus Trinitatis | α-Helical | NA | ||
| 37760701 | 2023 | IFGMIPGLIGGLISAFK{ct:α-Amidation} | TtAP-2 | α-Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 31 ± 4 μg/mL | Mouse | Trinidad Thick-Tailed Scorpion Tityus Trinitatis | α-Helical | NA | ||
| 37760701 | 2023 | FFSLIPSLIGGLVSAIK{ct:α-Amidation} | TtAP-3 | α-Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 95 ± 3 μg/mL | Mouse | Trinidad Thick-Tailed Scorpion Tityus Trinitatis | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNAGKAALNEINQIVQ{ct:Amid} | SS1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | American Tarsier Leaf Frog, Phyllomedusa Tarsius | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNAGKALNEINQIVQ{ct:Amid} | L14 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNAGKAVLNEINQIVQ{ct:Amid} | 14V | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNAGKAGLNEINQIVQ{ct:Amid} | 14G | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNVGKVLNEINQIVQ{ct:Amid} | L2V | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37764334 | 2023 | ALWKKILKNAGKAVLNEINQIVQ{ct:Amid} | 14V5K | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNAGKAVLNEINQIV{ct:Amid} | 14VL23 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 6.25 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 12.5 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 25 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 50 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 10 % Hemolysis at 100 μg/mL | Murine | Original Octominin | Random coil | NA | ||
| 37892141 | 2023 | GLFGRLRDSLRRGGQKILEKVERIGDRIKDIFRG | MAP34-B | Free | Free | Linear | L | None | 34 | Antimicrobial | <0.5 % Hemolysis at 25 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/Random curls | NA | ||
| 37892141 | 2023 | GLFGRLRDSLRRGGQKILEKVERIGDRIKDIFRG | MAP34-B | Free | Free | Linear | L | None | 34 | Antimicrobial | <0.5 % Hemolysis at 50 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/Random curls | NA | ||
| 37892141 | 2023 | GLFGRLRDSLRRGGQKILEKVERIGDRIKDIFRG | MAP34-B | Free | Free | Linear | L | None | 34 | Antimicrobial | <0.5 % Hemolysis at 100 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/Random curls | NA | ||
| 37892141 | 2023 | GLFGRLRDSLRRGGQKILEKVERIGDRIKDIFRG | MAP34-B | Free | Free | Linear | L | None | 34 | Antimicrobial | 0.68 % Hemolysis at 200 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/Random curls | NA | ||
| 37892141 | 2023 | RITKQPWAPPQAARICQFVLIRVCR | CATH 1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <2 % Hemolysis at 25 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RITKQPWAPPQAARICQFVLIRVCR | CATH 1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <2 % Hemolysis at 50 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RITKQPWAPPQAARICQFVLIRVCR | CATH 1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <2 % Hemolysis at 100 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RITKQPWAPPQAARICQFVLIRVCR | CATH 1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 2.13 % Hemolysis at 200 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RFRLPFRRPPIRIHPPPFYPPFRRFLGRR | CATH 2 | Free | Free | Linear | L | None | 29 | Antimicrobial | <2 % Hemolysis at 25 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RFRLPFRRPPIRIHPPPFYPPFRRFLGRR | CATH 2 | Free | Free | Linear | L | None | 29 | Antimicrobial | <2 % Hemolysis at 50 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RFRLPFRRPPIRIHPPPFYPPFRRFLGRR | CATH 2 | Free | Free | Linear | L | None | 29 | Antimicrobial | <2.5 % Hemolysis at 100 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RFRLPFRRPPIRIHPPPFYPPFRRFLGRR | CATH 2 | Free | Free | Linear | L | None | 29 | Antimicrobial | 2.13 % Hemolysis at 200 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37768945 | 2023 | QRSVSNAATRVCRTGRSRWRDVCRNFMRR{nt:Acet}{ct:Amid} | Human granulysin (hGRNL) | Amidation | acetylation | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 0.39-50 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.8 % Hemolysis at 50 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.8 % Hemolysis at 25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 12.5 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 6.25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 3.12 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.8 % Hemolysis at 1.56 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 0.78 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 0.39 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <1.6 % Hemolysis at 50 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | ~0.4 % Hemolysis at 25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0.4 % Hemolysis at 12.5 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 6.25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 3.12 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 1.56 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 0.78 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 0.39 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37888622 | 2023 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Anterhynchium Flavormarginatum Micado | α-Helical | NA | ||
| 37888622 | 2023 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 110.6 ± 9.8 µM | Human | Anterhynchium Flavormarginatum Micado | α-Helical | NA | ||
| 37888622 | 2023 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Anterhynchium Flavormarginatum Micado | α-Helical | NA | ||
| 37888622 | 2023 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 122.1 ± 13.1 µM | Rat | Anterhynchium Flavormarginatum Micado | α-Helical | NA | ||
| 37888622 | 2023 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Eumenes Fraterculus | α-Helical | NA | ||
| 37888622 | 2023 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 125.2 ± 20.6 µM | Human | Eumenes Fraterculus | α-Helical | NA | ||
| 37888622 | 2023 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 48 % Hemolysis at 320 μg/mL | Rat | Eumenes Fraterculus | α-Helical | NA | ||
| 37888622 | 2023 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 216.8 ± 1.6 µM | Rat | Eumenes Fraterculus | α-Helical | NA | ||
| 37888622 | 2023 | FDIMGLIKKVAGAL{ct:Amid} | EMP-ER | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 25 % Hemolysis at 320 μg/mL | Human | Eumenes Rubrofemoratus | α-Helical | NA | ||
| 37888622 | 2023 | FDIMGLIKKVAGAL{ct:Amid} | EMP-ER | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 46 % Hemolysis at 30 μg/mL | Rat | Eumenes Rubrofemoratus | α-Helical | NA | ||
| 37888622 | 2023 | FDIMGLIKKVAGAL{ct:Amid} | EMP-ER | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 230.6 ± 3.7 µM | Rat | Eumenes Rubrofemoratus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLIKKVASLLN | Eumenitin-R | Free | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at 320 μg/mL | Human | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 67 % Hemolysis at 320 μg/mL | Human | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGIFKKVASLLT | Eumenitin | Free | Free | Linear | L | None | 15 | Antimicrobial | 6 % Hemolysis at 320 μg/mL | Human | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 157.1 ± 2.6 µM | Human | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLIKKVASLLN | Eumenitin-R | Free | Free | Linear | L | None | 15 | Antimicrobial | 7 % Hemolysis at 320 μg/mL | Rat | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 44 % Hemolysis at 320 μg/mL | Rat | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGIFKKVASLLT | Eumenitin | Free | Free | Linear | L | None | 15 | Antimicrobial | 4 % Hemolysis at 320 μg/mL | Rat | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 207.1 ± 2.0 µM | Rat | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | INLKGLIKKVASLLT | EpVP1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 9 % Hemolysis at 320 μg/mL | Human | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKKVASAL{ct:Amid} | EpVP2a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 79 % Hemolysis at 320 μg/mL | Human | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKSVVSAL{ct:Amid} | EpVP2b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKKVASAL{ct:Amid} | EpVP2a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 151.9 ± 6.3 µM | Human | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKSVVSAL{ct:Amid} | EpVP2b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 34.1 ± 3.5 µM | Human | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | INLKGLIKKVASLLT | EpVP1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Eumenes Pomiformis | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | FDLLGLVKKVASAL{ct:Amid} | EpVP2a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 41 % Hemolysis at 320 μg/mL | Rat | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKSVVSAL{ct:Amid} | EpVP2b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKKVASAL{ct:Amid} | EpVP2a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 238.8 ± 7.6 µM | Rat | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKSVVSAL{ct:Amid} | EpVP2b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 50.6 ± 2.6 µM | Rat | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | LKLMGIVKKVLGAL{ct:Amid} | EMP-EM1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 21 % Hemolysis at 320 μg/mL | Human | Eumenes Micado | α-Helical | NA | ||
| 37888622 | 2023 | LKLLGIVKKVLGAI{ct:Amid} | EMP-EM2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 8 % Hemolysis at 320 μg/mL | Human | Eumenes Micado | α-Helical | NA | ||
| 37888622 | 2023 | LKLMGIVKKVLGAL{ct:Amid} | EMP-EM1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 7 % Hemolysis at 320 μg/mL | Rat | Eumenes Micado | α-Helical | NA | ||
| 37888622 | 2023 | LKLLGIVKKVLGAI{ct:Amid} | EMP-EM2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2 % Hemolysis at 320 μg/mL | Rat | Eumenes Micado | α-Helical | NA | ||
| 37888622 | 2023 | GRILSFIKGLAEHL{ct:Amid} | EMP-OD | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2 % Hemolysis at 320 μg/mL | Human | Orancistrocerus Drewseni | α-Helical | NA | ||
| 37888622 | 2023 | KDLHTVVSAILQAL{ct:Amid} | OdVP3a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 24 % Hemolysis at 320 μg/mL | Human | Orancistrocerus Drewseni | α-Helical | NA | ||
| 37888622 | 2023 | GRILSFIKGLAEHL{ct:Amid} | EMP-OD | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 49 % Hemolysis at 320 μg/mL | Rat | Orancistrocerus Drewseni | α-Helical | NA | ||
| 37888622 | 2023 | KDLHTVVSAILQAL{ct:Amid} | OdVP3a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 27 % Hemolysis at 320 μg/mL | Rat | Orancistrocerus Drewseni | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALAKKIL{ct:Amid} | Mastoparan (L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespula Lewisii | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALAKKIL{ct:Amid} | Mastoparan (L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 82.9 ± 3.8 µM | Human | Vespula Lewisii | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALAKKIL{ct:Amid} | Mastoparan (L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 41 % Hemolysis at 320 μg/mL | Rat | Vespula Lewisii | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALAKKIL{ct:Amid} | Mastoparan (L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 242.5 ± 2.6 µM | Rat | Vespula Lewisii | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIKSIIKAAMN{ct:Amid} | Mastoparan-V1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 9 % Hemolysis at 320 μg/mL | Human | Vespula Vulgaris | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIKSLIKAAMS{ct:Amid} | Mastoparan-V2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 15 % Hemolysis at 320 μg/mL | Human | Vespula Vulgaris | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIKSIIKAAMN{ct:Amid} | Mastoparan-V1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 16 % Hemolysis at 320 μg/mL | Rat | Vespula Vulgaris | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIKSLIKAAMS{ct:Amid} | Mastoparan-V2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 52 % Hemolysis at 320 μg/mL | Rat | Vespula Vulgaris | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIKSLIKAAMS{ct:Amid} | Mastoparan-V2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 182.4 ± 3.6 µM | Rat | Vespula Vulgaris | α-Helical | NA | ||
| 37888622 | 2023 | INMKASAAVAKKLL{ct:Amid} | MP-VB1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Vespa Bicolor | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INMKAVAAVAKKPL{ct:Amid} | MP-VB2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Vespa Bicolor | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INMKASAAVAKKLL{ct:Amid} | MP-VB1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 7 % Hemolysis at 320 μg/mL | Rat | Vespa Bicolor | α-Helical | NA | ||
| 37888622 | 2023 | INMKAVAAVAKKPL{ct:Amid} | MP-VB2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Vespa Bicolor | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWKGIAAMAKKLL{ct:Amid} | Mastoparan-X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 29 % Hemolysis at 320 μg/mL | Human | Vespa. Xanthoptera | α-Helical | NA | ||
| 37888622 | 2023 | INWKGIAAMAKKLL{ct:Amid} | Mastoparan-X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 349.4 ± 4.9 µM | Human | Vespa. Xanthoptera | α-Helical | NA | ||
| 37888622 | 2023 | INWKGIAAMAKKLL{ct:Amid} | Mastoparan-X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 70 % Hemolysis at 320 μg/mL | Rat | Vespa. Xanthoptera | α-Helical | NA | ||
| 37888622 | 2023 | INWKGIAAMAKKLL{ct:Amid} | Mastoparan-X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 156.5 ± 2.4 µM | Rat | Vespa. Xanthoptera | α-Helical | NA | ||
| 37888622 | 2023 | IKWKAILDAVKKVL{ct:Amid} | Mastoparan-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 7 % Hemolysis at 320 μg/mL | Human | Vespa Analis | α-Helical | NA | ||
| 37888622 | 2023 | IKWKAILDAVKKVL{ct:Amid} | Mastoparan-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 56 % Hemolysis at 320 μg/mL | Rat | Vespa Analis | α-Helical | NA | ||
| 37888622 | 2023 | IKWKAILDAVKKVL{ct:Amid} | Mastoparan-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 183.0 ± 3.4 µM | Rat | Vespa Analis | α-Helical | NA | ||
| 37888622 | 2023 | LKLKSIVSWAKKVL{ct:Amid} | Mastoparan-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 22 % Hemolysis at 320 μg/mL | Human | Vespa Basalis | α-Helical | NA | ||
| 37888622 | 2023 | LKLKSIVSWAKKVL{ct:Amid} | Mastoparan-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 19 % Hemolysis at 320 μg/mL | Rat | Vespa Basalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKALLAVAKKIL{ct:Amid} | Mastoparan-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespa Crabro | α-Helical | NA | ||
| 37888622 | 2023 | INLKALLAVAKKIL{ct:Amid} | Mastoparan-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 30.2 ± 1.3 µM | Human | Vespa Crabro | α-Helical | NA | ||
| 37888622 | 2023 | INLKALLAVAKKIL{ct:Amid} | Mastoparan-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Vespa Crabro | α-Helical | NA | ||
| 37888622 | 2023 | INLKALLAVAKKIL{ct:Amid} | Mastoparan-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 64.4 ± 10.7 µM | Rat | Vespa Crabro | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALVKKVL{ct:Amid} | Mastoparan-II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 78 % Hemolysis at 320 μg/mL | Human | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALVKKVL{ct:Amid} | HR1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 56 % Hemolysis at 320 μg/mL | Human | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALVKKVL{ct:Amid} | Mastoparan-II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 134.6 ± 1.2 µM | Human | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALVKKVL{ct:Amid} | HR1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 197.7 ± 8.9 µM | Human | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALVKKVL{ct:Amid} | Mastoparan-II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at 320 μg/mL | Rat | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALVKKVL{ct:Amid} | HR1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 39 % Hemolysis at 320 μg/mL | Rat | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALVKKVL{ct:Amid} | Mastoparan-II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 146.8 ± 3.4 µM | Rat | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALVKKVL{ct:Amid} | HR1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 253.4 ± 13.0 µM | Rat | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIFQKVKNLV{ct:Amid} | PDD-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 30 % Hemolysis at 320 μg/mL | Human | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAL{ct:Amid} | PDD-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIFQKVKNLV{ct:Amid} | PDD-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 353.5 ± 44.8 µM | Human | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAL{ct:Amid} | PDD-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 48.5 ± 3.4 µM | Human | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIFQKVKNLV{ct:Amid} | PDD-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 27 % Hemolysis at 320 μg/mL | Rat | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAL{ct:Amid} | PDD-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAL{ct:Amid} | PDD-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 55.6 ± 4.1 µM | Rat | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIAEIGKQVLSAL{ct:Amid} | Dominulin A | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4 % Hemolysis at 320 μg/mL | Human | Polistes Dominulus | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIAEIGKQVLSAL{ct:Amid} | Dominulin B | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 8 % Hemolysis at 320 μg/mL | Rat | Polistes Dominulus | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIAEIGKQVLSAL{ct:Amid} | Dominulin A | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Polistes Dominulus | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWKKIAEIGKQVLSAL{ct:Amid} | Dominulin B | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Polistes Dominulus | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWLKLGKKILGAI{ct:Amid} | Pm-R1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | LNFKALAALAKKIL{ct:Amid} | Pm-R2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 66 % Hemolysis at 320 μg/mL | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKQILGAL{ct:Amid} | Pm-R3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAI{ct:Amid} | Pm-R1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 72.0 ± 8.5 µM | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | LNFKALAALAKKIL{ct:Amid} | Pm-R2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 165.9 ± 8.0 µM | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKQILGAL{ct:Amid} | Pm-R3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 32.3 ± 1.7 µM | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAI{ct:Amid} | Pm-R1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 92 % Hemolysis at 320 μg/mL | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | LNFKALAALAKKIL{ct:Amid} | Pm-R2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 34 % Hemolysis at 320 μg/mL | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKQILGAL{ct:Amid} | Pm-R3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAI{ct:Amid} | Pm-R1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 105.1 ± 2.2 µM | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | LNFKALAALAKKIL{ct:Amid} | Pm-R2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 249.5 ± 9.9 µM | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKQILGAL{ct:Amid} | Pm-R3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 73.5 ± 5.1 µM | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAAFAKKLL{ct:Amid} | Mastoparan-T(D) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 15 % Hemolysis at 320 μg/mL | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAAFAKKLL{ct:Amid} | Mastoparan-T(D) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 19 % Hemolysis at 320 μg/mL | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKFL{ct:Amid} | Mastoparan-T1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKLL{ct:Amid} | Mastoparan-T2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLRGFAALVKKFL{ct:Amid} | Mastoparan-T3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLFGFAALVKKFL{ct:Amid} | Mastoparan-T4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKFL{ct:Amid} | Mastoparan-T1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 30.8 ± 1.6 µM | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKLL{ct:Amid} | Mastoparan-T2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 11.8 ± 3.1 µM | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLRGFAALVKKFL{ct:Amid} | Mastoparan-T3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 112.1 ± 8.0 µM | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLFGFAALVKKFL{ct:Amid} | Mastoparan-T4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 28.5 ± 2.3 µM | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKFL{ct:Amid} | Mastoparan-T1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 87 % Hemolysis at 320 μg/mL | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKLL{ct:Amid} | Mastoparan-T2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLRGFAALVKKFL{ct:Amid} | Mastoparan-T3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLFGFAALVKKFL{ct:Amid} | Mastoparan-T4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKFL{ct:Amid} | Mastoparan-T1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 22.7 ± 7.1 µM | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKLL{ct:Amid} | Mastoparan-T2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 21.1 ± 2.4 µM | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLRGFAALVKKFL{ct:Amid} | Mastoparan-T3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 51.6 ± 2.1 µM | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLFGFAALVKKFL{ct:Amid} | Mastoparan-T4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 17.6 ± 2.4 µM | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INWKGIAAMKKLL{ct:Amid} | Mastoparan-like peptide 12b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Vespa Magnifica | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWKGIAAMKKLL{ct:Amid} | Mastoparan-like peptide 12b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Vespa Magnifica | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INLKAIAALAKKLL{ct:Amid} | Mastoparan-M | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 18 % Hemolysis at 320 μg/mL | Human | Vespa Mandarinia | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALAKKLL{ct:Amid} | Mastoparan-M | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 28 % Hemolysis at 320 μg/mL | Rat | Vespa Mandarinia | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 47 % Hemolysis at 320 μg/mL | Human | Vespa Affinis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 227.0 ± 3.1 µM | Human | Vespa Affinis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 92 % Hemolysis at 320 μg/mL | Rat | Vespa Affinis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 107.3 ± 15.7 µM | Rat | Vespa Affinis | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAIIDAL{ct:Amid} | Agelaia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWKAILQRIKKML{ct:Amid} | Agelaia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAIIDAL{ct:Amid} | Agelaia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 3.7 ± 0.14 µM | Human | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWKAILQRIKKML{ct:Amid} | Agelaia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 44.8 ± 10.4 µM | Human | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAIIDAL{ct:Amid} | Agelaia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 98 % Hemolysis at 320 μg/mL | Rat | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWKAILQRIKKML{ct:Amid} | Agelaia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 97 % Hemolysis at 320 μg/mL | Rat | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAIIDAL{ct:Amid} | Agelaia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 7.0 ± 0.7 µM | Rat | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWKAILQRIKKML{ct:Amid} | Agelaia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 62.1 ± 3.8 µM | Rat | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKMMSAL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 87 % Hemolysis at 320 μg/mL | Human | Mischocyttarus Phthisicus | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKMMSAL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 123.6 ± 15.3 µM | Human | Mischocyttarus Phthisicus | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKMMSAL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at 320 μg/mL | Rat | Mischocyttarus Phthisicus | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVSAIL{ct:Amid} | Protopolybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at 320 μg/mL | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVSAIL{ct:Amid} | Protopolybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at 320 μg/mL | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWKAIIEAAKQAL{ct:Amid} | ProtopolybiaMPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 13 % Hemolysis at 320 μg/mL | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWKAIIEAAKQAL{ct:Amid} | ProtopolybiaMPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 24 % Hemolysis at 320 μg/mL | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDAL{ct:Amid} | ProtopolybiaMPIII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 96 % Hemolysis at 320 μg/mL | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDAL{ct:Amid} | ProtopolybiaMPIII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 93 % Hemolysis at 320 μg/mL | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDAL{ct:Amid} | ProtopolybiaMPIII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 61.9 ± 8.3 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDAL{ct:Amid} | ProtopolybiaMPIII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 34.6 ± 2.8 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWKALLDAAKKVL{ct:Amid} | ProtonectarinaMP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Protonectarina Sylveirae | α-Helical | NA | ||
| 37888622 | 2023 | INWKALLDAAKKVL{ct:Amid} | ProtonectarinaMP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 85.2 ± 5.9 µM | Human | Protonectarina Sylveirae | α-Helical | NA | ||
| 37888622 | 2023 | INWKALLDAAKKVL{ct:Amid} | ProtonectarinaMP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 35 % Hemolysis at 320 μg/mL | Rat | Protonectarina Sylveirae | α-Helical | NA | ||
| 37888622 | 2023 | INWKALLDAAKKVL{ct:Amid} | ProtonectarinaMP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 326.5 ± 26.4 µM | Rat | Protonectarina Sylveirae | α-Helical | NA | ||
| 37888622 | 2023 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 56 % Hemolysis at 320 μg/mL | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MP II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 91 % Hemolysis at 320 μg/mL | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLGKMVMDVL{ct:Amid} | Polybia-MP III | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 79 % Hemolysis at 320 μg/mL | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLRVISVIDL{ct:Amid} | Polybia-MP IV | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Polybia Paulista | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWHDIAIKNIDAL{ct:Amid} | Polybia-MP V | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Polybia Paulista | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 176.6 ± 7.0 µM | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MP II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 23.3 ± 1.4 µM | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLGKMVMDVL{ct:Amid} | Polybia-MP III | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 38.5 ± 5.9 µM | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MP II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLGKMVMDVL{ct:Amid} | Polybia-MP III | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLRVISVIDL{ct:Amid} | Polybia-MP IV | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Polybia Paulista | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWHDIAIKNIDAL{ct:Amid} | Polybia-MP V | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Polybia Paulista | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 51.4 ± 2.2 µM | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MP II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 29.1 ± 1.5 µM | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLGKMVMDVL{ct:Amid} | Polybia-MP III | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 74.8 ± 10.4 µM | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | INWKKMAATALKMI{ct:Amid} | Parapolybia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 32 % Hemolysis at 320 μg/mL | Human | Parapolybia Indica | α-Helical | NA | ||
| 37888622 | 2023 | INWKKMAATALKMI{ct:Amid} | Parapolybia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 306.4 ± 162.6 µM | Human | Parapolybia Indica | α-Helical | NA | ||
| 37888622 | 2023 | INWKKMAATALKMI{ct:Amid} | Parapolybia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 22 % Hemolysis at 320 μg/mL | Rat | Parapolybia Indica | α-Helical | NA | ||
| 37888622 | 2023 | INWAKLGKLALQAL{ct:Amid} | Ropalidia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Ropalidia | α-Helical | NA | ||
| 37888622 | 2023 | INWAKLGKLALQAL{ct:Amid} | Ropalidia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 42.5 ± 1.7 µM | Human | Ropalidia | α-Helical | NA | ||
| 37888622 | 2023 | INWAKLGKLALQAL{ct:Amid} | Ropalidia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 94 % Hemolysis at 320 μg/mL | Rat | Ropalidia | α-Helical | NA | ||
| 37888622 | 2023 | INWAKLGKLALQAL{ct:Amid} | Ropalidia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 122.2 ± 4.3 µM | Rat | Ropalidia | α-Helical | NA | ||
| 37888622 | 2023 | VDWKKIGQHILSVL{ct:Amid} | Mastoparan-J | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Polistes Jadwigae | α-Helical | NA | ||
| 37888622 | 2023 | VDWKKIGQHILSVL{ct:Amid} | Mastoparan-J | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 69.5 ± 3.2 µM | Human | Polistes Jadwigae | α-Helical | NA | ||
| 37888622 | 2023 | VDWKKIGQHILSVL{ct:Amid} | Mastoparan-J | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polistes Jadwigae | α-Helical | NA | ||
| 37888622 | 2023 | VDWKKIGQHILSVL{ct:Amid} | Mastoparan-J | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 60.1 ± 1.3 µM | Rat | Polistes Jadwigae | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIASIGKEVLKAL{ct:Amid} | PMM2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Polistes Major Major | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIASIGKEVLKAL{ct:Amid} | PMM2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 42.6 ± 2.5 µM | Human | Polistes Major Major | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIASIGKEVLKAL{ct:Amid} | PMM2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polistes Major Major | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIASIGKEVLKAL{ct:Amid} | PMM2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 80.9 ± 6.4 µM | Rat | Polistes Major Major | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIDAL{ct:Amid} | Protopolybia-MPIII-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 176.4 ± 1.0 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIDAL{ct:Amid} | Protopolybia-MPIII-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 158.4 ± 2.3 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSDAL{ct:Amid} | Protopolybia-MPIII-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 673.3 ± 189.0 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSDAL{ct:Amid} | Protopolybia-MPIII-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 639.5 ± 1.6 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIAAL{ct:Amid} | Protopolybia-MPIII-3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 16.8 ± 1.0 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIAAL{ct:Amid} | Protopolybia-MPIII-3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 21.5 ± 1.2 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDIL{ct:Amid} | Protopolybia-MPIII-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 11.3 ± 6.2 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDIL{ct:Amid} | Protopolybia-MPIII-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 19.8 ± 1.2 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIAAL{ct:Amid} | Protopolybia-MPIII-6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 110.0 ± 2.5 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIAAL{ct:Amid} | Protopolybia-MPIII-6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 107.6 ± 3.2 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIDIL{ct:Amid} | Protopolybia-MPIII-7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 37.8 ± 3.7 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIDIL{ct:Amid} | Protopolybia-MPIII-7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 57.5 ± 2.7 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSAAL{ct:Amid} | Protopolybia-MPIII-8 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 307.8 ± 6.2 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSAAL{ct:Amid} | Protopolybia-MPIII-8 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 444.0 ± 2.1 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSDIL{ct:Amid} | Protopolybia-MPIII-9 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 167.3 ± 2.7 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSDIL{ct:Amid} | Protopolybia-MPIII-9 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 161.7 ± 1.3 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIAIL{ct:Amid} | Protopolybia-MPIII-10 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 11.3 ± 1.2 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIAIL{ct:Amid} | Protopolybia-MPIII-10 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 11.7 ± 1.0 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSAIL{ct:Amid} | Protopolybia-MPIII-11 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 140.6 ± 2.4 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSAIL{ct:Amid} | Protopolybia-MPIII-11 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 133.6 ± 2.2 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIAIL{ct:Amid} | Protopolybia-MPIII-12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 43.9 ± 3.6 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIAIL{ct:Amid} | Protopolybia-MPIII-12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 55.2 ± 2.2 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 38062792 | 2023 | VDKPPYLPRPRPPRRIYNR | Onc | Free | Free | Linear | L | None | 19 | Antimicrobial | MHC at >1000 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38062792 | 2023 | KKLLKLLKLLL | ln65 | Free | Free | Linear | L | None | 11 | Antimicrobial | MHC at 125 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | K{d}K{d}LLK{d}LLK{d}LLL | ln69 | Free | Free | Linear | Mix | k = D-lysine | 11 | Antimicrobial | MHC at 1000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:NLys}KLLKLLKLL{nnr:NLeu} | EB1 | Free | Free | Linear | L | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at 1000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:Nlys}KLLKLLK{d}LL{nnr:Nleu} | EB2 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | KKLLKLLK{nnr:Nleu}{nnr:Nleu}{nnr:Nleu} | EB3 | Free | Free | Linear | L | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | KKLLK{nnr:Nleu}{nnr:Nleu}{nnr:Nlys}{nnr:Nleu}{nnr:Nleu}{nnr:Nleu} | EB4 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:Nlys}{nnr:Nlys}{nnr:Nleu}{nnr:Nleu}{nnr:Nlys}LLKLLL | EB5 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at 1000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:Nlys}{nnr:Nlys}LL{nnr:Nlys}LLKLLL | EB6 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at 250 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:Nlys}{nnr:Nlys}LL{nnr:Nlys}LL{nnr:Nlys}LLL | EB7 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | KK{nnr:Nleu}{nnr:Nleu}K{nnr:Nleu}{nnr:Nleu}K{nnr:Nleu}{nnr:Nleu}{nnr:Nleu} | EB8 | Free | Free | Linear | L | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | K{nnr:Nlys}L{nnr:Nleu}K{nnr:Nleu}L{nnr:Nlys}L{nnr:Nleu}L | EB9 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:Nlys}K{nnr:Nleu}L{nnr:Nlys}L{nnr:Nleu}K{nnr:Nleu}L{nnr:Nleu} | EB10 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | K{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}L{d} | EB11 | Free | Free | Linear | D | None | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRPPRRIYNR{ct:Amid} | oncocin(1a) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 6.5 % Hemolysis at 800 μg/mL | Human | Resin Bound | NA | NA | ||
| 37797458 | 2023 | ({nnr:gVal})DKPPYLPRPRPPRRIYNR{ct:Amid} | 1b | Amidation | Free | Linear | L | gVal = N-terminal-guanidine valine | 18 | Antimicrobial | 0.7 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | (Me4{nnr:gVal})DKPPYLPRPRPPRRIYNR{ct:Amid} | 1c | Amidation | Free | Linear | L | gVal = N-terminal-guanidine valine | 18 | Antimicrobial | 0.2 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLP({nnr:Har})PRPPRRIYNR{ct:Amid} | 2a | Amidation | Free | Linear | L | Har = homoarginine | 20 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRP({nnr:Har})PPRRIYNR{ct:Amid} | 2b | Amidation | Free | Linear | L | Har = homoarginine | 20 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRPRPP({nnr:Har})RIYNR{ct:Amid} | 2c | Amidation | Free | Linear | L | Har = homoarginine | 20 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRPRPPR({nnr:Har})IYNR{ct:Amid} | 2d | Amidation | Free | Linear | L | Har = homoarginine | 20 | Antimicrobial | 0.2 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRPPRRIYN({nnr:Har}){ct:Amid} | 2e | Amidation | Free | Linear | L | Har = homoarginine | 20 | Antimicrobial | 1.4 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRPPR({nnr:Har})IYN({nnr:Har}){ct:Amid} | 3 | Amidation | Free | Linear | L | Har = homoarginine | 18 | Antimicrobial | 1.4 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLP({nnr:Har})P({nnr:Har})PP({nnr:Har})({nnr:Har})IYN({nnr:Har}){ct:Amid} | 4 | Amidation | Free | Linear | L | Har = homoarginine | 15 | Antimicrobial | 1.3 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | ({nnr:gVal})DKPPYLP({nnr:Har})P({nnr:Har})PP({nnr:Har})({nnr:Har})IYN({nnr:Har}){ct:Amid} | 5 | Amidation | Free | Linear | L | Har = homoarginine, gVal = N-terminal-guanidine valine | 14 | Antimicrobial | 0.5 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDK({nnr:Hyp})PYLPRPRPPRRIYNR{ct:Amid} | 6a | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | 1.4 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKP({nnr:Hyp})YLPRPRPPRRIYNR{ct:Amid} | 6b | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | 1.5 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYL({nnr:Hyp})RPRPPRRIYNR{ct:Amid} | 6c | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPR({nnr:Hyp})RPPRRIYNR{ct:Amid} | 6d | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRPR({nnr:Hyp})PRRIYNR{ct:Amid} | 6e | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | 1.4 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRP({nnr:Hyp})RRIYNR{ct:Amid} | 6f | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDK({nnr:Dfp})PYLPRPRPPRRIYNR{ct:Amid} | 7a | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | 1 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKP({nnr:Dfp})YLPRPRPPRRIYNR{ct:Amid} | 7b | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | 1.5 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYL({nnr:Dfp})PRPRPPRRIYNR{ct:Amid} | 7c | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPR({nnr:Dfp})PRPPRRIYNR{ct:Amid} | 7d | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRPR({nnr:Dfp})PRRIYNR{ct:Amid} | 7e | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | 1 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRP({nnr:Dfp})RRIYNR{ct:Amid} | 7f | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRPPRR{d}IYNR{d}{ct:Amid} | Oncocin112(8) | Amidation | Free | Linear | Mix | None | 21 | Antimicrobial | 3.3 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDK({nnr:Hyp})({nnr:Hyp})YLPRPR({nnr:Hyp})PRR{d}IYNR{d}{ct:Amid} | 9 | Amidation | Free | Linear | Mix | Hyp = trans-4-Hydroxy-l-proline | 17 | Antimicrobial | 1.2 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDK({nnr:Dfp})({nnr:Dfp})YLPRPR({nnr:Dfp})PRR{d}IYNR{d}{ct:Amid} | 10 | Amidation | Free | Linear | Mix | Dfp = 4,4-Difluoro-l-proline | 17 | Antimicrobial | 0.2 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37770629 | 2023 | K{nt:myristic — C14}{ct:Amid} | 1M | Amidation | myristic — C14 | Linear | L | C14 = myristic, Me3 = trimethyl | 1 | Antimicrobial | 50 % Hemolysis at 477.61 ± 28.02 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | KK{nt:myristic — C14}{ct:Amid} | 2M | Amidation | myristic — C14 | Linear | L | C14 = myristic | 2 | Antimicrobial | 50 % Hemolysis at 345.21 ± 12.80 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | KKK{nt:myristic — C14}{ct:Amid} | 3M | Amidation | myristic — C14 | Linear | L | C14 = myristic | 3 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | KKKK{nt:myristic — C14}{ct:Amid} | 4M | Amidation | myristic — C14 | Linear | L | C14 = myristic | 4 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | K{nt:palmitic — C16}{ct:Amid} | 1P | Amidation | palmitic — C16 | Linear | L | C16 = palmitic | 1 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | KK{nt:palmitic — C16}{ct:Amid} | 2P | Amidation | palmitic — C16 | Linear | L | C16 = palmitic | 2 | Antimicrobial | 50 % Hemolysis at 55.21 ± 1.69 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | KKK{nt:palmitic — C16}{ct:Amid} | 3P | Amidation | palmitic — C16 | Linear | L | C16 = palmitic | 3 | Antimicrobial | 50 % Hemolysis at 135.46 ± 8.69 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | KKKK{nt:palmitic — C16}{ct:Amid} | 4P | Amidation | palmitic — C16 | Linear | L | C16 = palmitic | 4 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | K{nt:stearic — C18}{ct:Amid} | 1S | Amidation | stearic — C18 | Linear | L | C18 = stearic | 1 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | KK{nt:stearic — C18}{ct:Amid} | 2S | Amidation | stearic — C18 | Linear | L | C18 = stearic | 2 | Antimicrobial | 50 % Hemolysis at 21.88 ± 0.68 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | KKK{nt:stearic — C18}{ct:Amid} | 3S | Amidation | stearic — C18 | Linear | L | C18 = stearic | 3 | Antimicrobial | 50 % Hemolysis at 32.11 ± 1.54 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | KKKK{nt:stearic — C18}{ct:Amid} | 4S | Amidation | stearic — C18 | Linear | L | C18 = stearic, Me3 = trimethyl | 4 | Antimicrobial | 50 % Hemolysis at 48.44 ± 4.12 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C14}K({nnr:Me3}){nt:myristic — C14}{ct:Amid} | 1Mq | Amidation | myristic — C14 | Linear | L | C14 = myristic, Me3 = trimethyl | 1 | Antimicrobial | 50 % Hemolysis at 88.25 ± 1.57 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C14}K({nnr:Me3})K({nnr:Me3}){nt:myristic — C14}{ct:Amid} | 2Mq | Amidation | myristic — C14 | Linear | L | C14 = myristic, Me3 = trimethyl | 2 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C14}K({nnr:Me3})K({nnr:Me3})K({nnr:Me3}){nt:myristic — C14}{ct:Amid} | 3Mq | Amidation | myristic — C14 | Linear | L | C14 = myristic, Me3 = trimethyl | 3 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C14}K({nnr:Me3})K({nnr:Me3})K({nnr:Me3})K({nnr:Me3}){nt:myristic — C14}{ct:Amid} | 4Mq | Amidation | myristic — C14 | Linear | L | C14 = myristic, Me3 = trimethyl | 4 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C16}K({nnr:Me3}){nt:palmitic — C16}{ct:Amid} | 1Pq | Amidation | palmitic — C16 | Linear | L | C16 = palmitic, Me3 = trimethyl | 1 | Antimicrobial | 50 % Hemolysis at 32.21 ± 1.97 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C16}K({nnr:Me3})K({nnr:Me3}){nt:palmitic — C16}{ct:Amid} | 2Pq | Amidation | palmitic — C16 | Linear | L | C16 = palmitic, Me3 = trimethyl | 2 | Antimicrobial | 50 % Hemolysis at 133.32 ± 6.27 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C16}K({nnr:Me3})K({nnr:Me3})K({nnr:Me3}){nt:palmitic — C16}{ct:Amid} | 3Pq | Amidation | palmitic — C16 | Linear | L | C16 = palmitic, Me3 = trimethyl | 3 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C16}K({nnr:Me3})K({nnr:Me3})K({nnr:Me3})K({nnr:Me3}){nt:palmitic — C16}{ct:Amid} | 4Pq | Amidation | palmitic — C16 | Linear | L | C16 = palmitic, Me3 = trimethyl | 4 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C18}K({nnr:Me3}){nt:stearic — C18}{ct:Amid} | 1Sq | Amidation | stearic — C18 | Linear | L | C18 = stearic, Me3 = trimethyl | 1 | Antimicrobial | 50 % Hemolysis at 16.13 ± 9.88 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C18}K({nnr:Me3})K({nnr:Me3}){nt:stearic — C18}{ct:Amid} | 2Sq | Amidation | stearic — C18 | Linear | L | C18 = stearic, Me3 = trimethyl | 2 | Antimicrobial | 50 % Hemolysis at 22.42 ± 0.98 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C18}K({nnr:Me3})K({nnr:Me3})K({nnr:Me3}){nt:stearic — C18}{ct:Amid} | 3Sq | Amidation | stearic — C18 | Linear | L | C18 = stearic, Me3 = trimethyl | 3 | Antimicrobial | 50 % Hemolysis at 385.50 ± 71.51 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 37770629 | 2023 | {nnr:C18}K({nnr:Me3})K({nnr:Me3})K({nnr:Me3})K({nnr:Me3}){nt:stearic — C18}{ct:Amid} | 4Sq | Amidation | stearic — C18 | Linear | L | C18 = stearic, Me3 = trimethyl | 4 | Antimicrobial | 50 % Hemolysis at >512 μg/mL | Human | Ultrashort Cationic Lipopeptides (Uscls) | NA | NA | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-140 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.355731 ± 0.0395 % Hemolysis at 1 mg/ml | Human | Chicken Cathelicidin-2 | α-Helical | Non-hemolytic | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-141 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.250329 ± 0.0456 % Hemolysis at 0.5 mg/ml | Human | Chicken Cathelicidin-3 | α-Helical | Non-hemolytic | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-142 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.27668 ± 0.0395 % Hemolysis at 0.25 mg/ml | Human | Chicken Cathelicidin-4 | α-Helical | Non-hemolytic | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-143 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.184453 ± 0.114 % Hemolysis at 0.125 mg/ml | Human | Chicken Cathelicidin-5 | α-Helical | Non-hemolytic | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-144 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.184453 ± 0.0604 % Hemolysis at 0.0625 mg/ml | Human | Chicken Cathelicidin-6 | α-Helical | Non-hemolytic | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-145 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.184453 ± 0.0913 % Hemolysis at 0.03125 mg/ml | Human | Chicken Cathelicidin-7 | α-Helical | Non-hemolytic | ||
| 37972089 | 2023 | KKLFKKILRYL{ct:Amid} | BP203 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 31 % Hemolysis at ~300 μg/mL | Sheep | Bp100 Analog | NA | NA | ||
| 37972089 | 2023 | KKLFKKILRYL{ct:Amid} | BP203 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 200 μg/mL | Sheep | Bp100 Analog | NA | Non-hemolytic | ||
| 37972089 | 2023 | KWLRRPWRRWR{ct:Amid} | MAP-0403 J-2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3.4 % Hemolysis at ~678 μg/mL | Sheep | Analog Of Map-0403 | NA | NA | ||
| 37972089 | 2023 | KWLRRPWRRWR{ct:Amid} | MAP-0403 J-2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 200 μg/mL | Sheep | Analog Of Map-0403 | NA | Non-hemolytic | ||
| 38139394 | 2023 | CIANRNGCQPDGSQGNCCSGYCHKEPGWVAGYR | Mak | Free | Free | Linear | L | None | 33 | Antimicrobial | 0 % Hemolysis at 5-100 μg/mL | mouse | Monochamus Alternatus | antiparallel β-Strands | Non-hemolytic | ||
| 38139394 | 2023 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <60 % Hemolysis at 5 μg/mL | mouse | Bee Venom | α-Helical | NA | ||
| 38139394 | 2023 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <100 % Hemolysis at 10 μg/mL | mouse | Bee Venom | α-Helical | NA | ||
| 38139394 | 2023 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 μg/mL | mouse | Bee Venom | α-Helical | NA | ||
| 38139394 | 2023 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 50 μg/mL | mouse | Bee Venom | α-Helical | NA | ||
| 38139394 | 2023 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 100 μg/mL | mouse | Bee Venom | α-Helical | NA | ||
| 38188573 | 2023 | GFGCPWDEMQCHNHCKSIKGYKGGYCAKGGFVCKCY | Ple-AB | Free | Free | Linear | L | None | 36 | Antimicrobial | 1.07 % Hemolysis at 0.5-256 μg/mL | Mouse | Derived From Plectasin | α-Helical | Non-hemolytic | ||
| 38247598 | 2023 | KFRNWFSQHFKKFKQKLKNTFA | GATR-3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 5000 μg/mL | Human | Short Apo6 Peptide | α-Helical | NA | ||
| 38663759 | 2024 | RRRW-{nnr:Dip}-{nnr:Dip}{cyc:N-C} | 1a | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 50 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRR-{nnr:Dip}-W-{nnr:Dip}{cyc:N-C} | 1b | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 75 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRR-{nnr:Dip}-{nnr:Dip}-W{cyc:N-C} | 1c | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 65 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRW-{nnr:Nal}-{nnr:Nal}{cyc:N-C} | 2a | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 60 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRR-{nnr:Nal}-W-{nnr:Nal}{cyc:N-C} | 2b | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 55 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRR-{nnr:Nal}-{nnr:Nal}-W{cyc:N-C} | 2c | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 45 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRRW-{nnr:Dip}-{nnr:Dip}{cyc:N-C} | 3a | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at 85 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRR-{nnr:Dip}-W-{nnr:Dip}{cyc:N-C} | 3b | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at 230 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRR-{nnr:Dip}-{nnr:Dip}-W{cyc:N-C} | 3c | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRRW-{nnr:Nal}-{nnr:Nal}{cyc:N-C} | 4a | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at 150 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRR-{nnr:Nal}-W-{nnr:Nal}{cyc:N-C} | 4b | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at 175 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRR-{nnr:Nal}-{nnr:Nal}-W{cyc:N-C} | 4c | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at 105 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRRW-{nnr:Dip}-W{cyc:N-C} | 5a | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 6 | Antimicrobial | 50 % Hemolysis at 220 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRRW-{nnr:Nal}-W{cyc:N-C} | 5b | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 6 | Antimicrobial | 50 % Hemolysis at 200 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRR-{nnr:Dip}-L-{nnr:Dip}{cyc:N-C} | 6a | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at 155 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRR-{nnr:Nal}-L-{nnr:Nal}{cyc:N-C} | 6b | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 5 | Antimicrobial | 50 % Hemolysis at 170 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | {nnr:Agp}-{nnr:Agp}-{nnr:Agp}-{nnr:Agp}-{nnr:Dip}-W-{nnr:Dip}{cyc:N-C} | 7a | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine, Agp = (S)−2-amino-3-guanidinopropionic acid | 1 | Antimicrobial | 50 % Hemolysis at 240 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | {nnr:Agb}-{nnr:Agb}-{nnr:Agb}-{nnr:Agb}-{nnr:Dip}-W-{nnr:Dip}{cyc:N-C} | 7b | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine, Agb = (S)−2-amino-4-guanidinobutyric acid | 1 | Antimicrobial | 50 % Hemolysis at 190 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | {nnr:hArg}R{nnr:hArg}R{nnr:Dip}W{nnr:Dip}{cyc:N-C} | 7c | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine, hArg = homo-arginine (S)−2-amino-6-guanidino-hexanoic acid | 7 | Antimicrobial | 50 % Hemolysis at 160 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRR-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C} | 8a | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 70 μg/mL | Human | Synthetic | NA | NA | ||
| 38663759 | 2024 | RRRR-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C} | 8b | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 4 | Antimicrobial | 50 % Hemolysis at 80 μg/mL | Human | Synthetic | NA | NA | ||
| 38276499 | 2024 | AGLGKIGALIQKVIAKYKA | LC-AMP-F1 | Free | Free | Linear | L | None | 21 | Antimicrobial and Antibiofilm | 0 % Hemolysis at 5-160 µM | Rabbit | Wolf Spider Lycosa Coelestis | α-Helical | Non-hemolytic | ||
| 38276499 | 2024 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 98 % Hemolysis at 5 µM | Rabbit | Bee Venom | α-Helical | NA | ||
| 38276499 | 2024 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 10-160 µM | Rabbit | Bee Venom | α-Helical | NA | ||
| 38535822 | 2024 | FLWGLIPGAISAVTSLIKK{ct:Amid} | Ctriporin | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 90.6 ± 11.8 % Hemolysis at 256 μg/mL | Human | Scorpion Chaerilus Tricostatus | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPGAISAVTSLIKK{ct:Amid} | CM1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 75.6 ± 10.1 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPKAISAVTSLIKK{ct:Amid} | CM2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 74.3 ± 9.2 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPKAIKAVTSLIKK{ct:Amid} | CM3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 89.1 ± 12.1 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPKAIKKVTSLIKK{ct:Amid} | CM4 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 14.0 ± 4.7 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPKAIKKVKSLIKK{ct:Amid} | CM5 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 9.8 ± 0.6 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPKAIKKVKKLIKK{ct:Amid} | CM6 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 8.1 ± 1.9 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIKKAIKKVKKLIKK{ct:Amid} | CM7 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 57.5 ± 9.8 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38794259 | 2024 | AVNIPFKVHFRCKAAFC | OSTI−1949 | Free | Free | Linear | L | None | 17 | Antimicrobial | 20 % Hemolysis at 287.8 µM | Horse | Kunitz-Type Inhibitor From Odorrana Schmackeri | α-Helical | NA | ||
| 38794259 | 2024 | VIFKVFWRCKAAFC | OSTI−1716 | Free | Free | Linear | L | None | 14 | Antimicrobial | 20 % Hemolysis at 270.4 µM | Horse | Osti−1949 Analogues | α-Helical | NA | ||
| 38794259 | 2024 | IKFKVHFRCKAAFC | OSTI−1696 | Free | Free | Linear | L | None | 14 | Antimicrobial | 20 % Hemolysis at 297.7 µM | Horse | Osti−1949 Analogues | β-Strand | NA | ||
| 38794259 | 2024 | AVKRAVKRFKVHFRCKAAFC | OSTI−2363 | Free | Free | Linear | L | None | 20 | Antimicrobial | 20 % Hemolysis at 555.4 µM | Horse | Osti−1949 Analogues | β-Strand | NA | ||
| 38794259 | 2024 | AVNIPFKVHFKVHFRCKAAFC | OSTI−2461 | Free | Free | Linear | L | None | 20 | Antimicrobial | 20 % Hemolysis at 304.2 µM | Horse | Osti−1949 Analogues | α-Helical | NA | ||
| 38755634 | 2024 | FLVKLIL{ct:Amid} | BiF | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 15.63 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38755634 | 2024 | FLVKLILKILRR{ct:Amid} | BiF2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 1.95 μg/mL | Human | Derivative Of Bif | α-Helical | NA | ||
| 38755634 | 2024 | FLVKLIKKILRR{ct:Amid} | BiF2_7K | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 15.63 μg/mL | Human | Derivative Of Bif | α-Helical | NA | ||
| 38755634 | 2024 | FLVKKIKKILRR{ct:Amid} | BiF2_5K7K | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10 % Hemolysis at >250 μg/mL | Human | Lysine-Substituted Hybrid Peptide | α-Helical | NA | ||
| 38755634 | 2024 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 10 % Hemolysis at <0.98 μg/mL | Human | Bee Venom | α-Helical | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 10 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 10 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 10 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <40 % Hemolysis at 20 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 20 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 20 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <60 % Hemolysis at 30 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 30 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 30 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <70 % Hemolysis at 40 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 40 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 40 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <90 % Hemolysis at 50 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 50 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 50 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <100 % Hemolysis at 100 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 100 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 100 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 10 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | <20 % Hemolysis at 10 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 10 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <50 % Hemolysis at 20 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | <20 % Hemolysis at 20 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | <20 % Hemolysis at 20 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <60 % Hemolysis at 30 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | <20 % Hemolysis at 30 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 30 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <80 % Hemolysis at 40 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 40 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 40 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <80 % Hemolysis at 50 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 50 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 50 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | 100 % Hemolysis at 100 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 100 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 100 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38276646 | 2024 | GFGCPWNRYQCHSHCRSIGRLGGYCAGSLRLTCTCYRS | American oyster defensin (AOD) | Free | Free | Linear | L | None | 38 | Antimicrobial | 1.29 % Hemolysis at 256 μg/mL | Mouse | Crassostrea Virginica | NA | NA | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <20 % Hemolysis at 32 μg/mL | Sheep | As-21 Mutants | α-Helical | NA | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <20 % Hemolysis at 64 μg/mL | Sheep | As-21 Mutants | α-Helical | NA | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <40 % Hemolysis at 128 μg/mL | Sheep | As-21 Mutants | α-Helical | NA | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <80 % Hemolysis at 256 μg/mL | Sheep | As-21 Mutants | α-Helical | NA | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 512 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 512 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <80 % Hemolysis at 512 μg/mL | Sheep | As-21 Mutants | α-Helical | NA | ||
| 38561076 | 2024 | YVPGVIESLL{ct:Amid} | Peptide YL | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at >500 µM | Mouse | Skin Secretions Of The Banana Tree Dwelling Frog Boana Platanera | α-Helical | NA | ||
| 38561076 | 2024 | GLLSTVGGLVGGLLNNLGL{ct:Amid} | Plasticin PL | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 272 ± 13 µM | Mouse | Skin Secretions Of The Banana Tree Dwelling Frog Boana Platanera | α-Helical | NA | ||
| 38561076 | 2024 | FLGLIPALAGAIGNLIK{ct:Amid} | Hylin PL | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 65 ± 5 µM | Mouse | Skin Secretions Of The Banana Tree Dwelling Frog Boana Platanera | α-Helical | NA | ||
| 38561076 | 2024 | GVFDTVKKIGKAVGKFALGVAKNYLNS{ct:Amid} | Raniseptin PL | Amidation | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis at 262 ± 14 µM | Mouse | Skin Secretions Of The Banana Tree Dwelling Frog Boana Platanera | α-Helical | NA | ||
| 38561076 | 2024 | FLGTVLKLGKAIAKTVVPMLTNAMQPKQ{ct:Amid} | Figainin 2PL | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 157 ± 16 µM | Mouse | Skin Secretions Of The Banana Tree Dwelling Frog Boana Platanera | α-Helical | NA | ||
| 36988897 | 2024 | GIGAVLKVLTTGLPALISWIKRKRQQCONH2{ct:Amid} | MLT | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 16 μg/mL | Human | Bee Venom Apis Mellifera | α-Helical | NA | ||
| 36988897 | 2024 | GLPLLISWIKRKRQQ{ct:Amid} | M1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 40 % Hemolysis at 16 μg/mL | Human | Analog Of Mlt | α-Helical | NA | ||
| 36988897 | 2024 | GLPLLRSWIKRKRQQ{ct:Amid} | M2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 14.25 % Hemolysis at 16 μg/mL | Human | Analog Of Mlt | α-Helical | NA | ||
| 38004789 | 2024 | KRFKKFFKKVKKSVKKRLKKIFKKPMVIGVSFPF{ct:Amid} | Aquiluscidin | Amidation | Free | Linear | L | None | 34 | Antimicrobial | <2.3 % Hemolysis at | Rat | Crotalus Aquilus | α-Helical | NA | | ||
| 38004789 | 2024 | FFKKVKKSVKKRLKKIFKKPMVI{ct:Amid} | Vcn-23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | <1.2 % Hemolysis at | Rat | Derivative Peptide | α-Helical | NA | | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µM | Human | Analogue Of Temporin-L | NA | Non-hemolytic | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µM | Human | Analogue Of Temporin-L | NA | Non-hemolytic | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | <50 % Hemolysis at 64 µM | Human | Analogue Of Temporin-L | NA | NA | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | <100 % Hemolysis at 128 µM | Human | Analogue Of Temporin-L | NA | NA | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | <100 % Hemolysis at 256 µM | Human | Analogue Of Temporin-L | NA | NA | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | 100 % Hemolysis at 512 µM | Human | Analogue Of Temporin-L | NA | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVAIVAINA{ct:Amid} | Analog 5 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | 14.1 % Hemolysis at 1024 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVAIVAINA{ct:Amid} | Analog 5 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | 11.8 % Hemolysis at 512 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND{ct:Amid} | Analog 1(SJGAP) | Amidation | Free | Linear | L | None | 33 | Antimicrobial | <4 % Hemolysis at 1024 μg/mL | Horse | Skipjack Tuna Glyceraldehyde-3-Phosphate Dehydrogenase (Gapdh)-Related Peptide (Sjgap) | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVKIVAINK{ct:Amid} | Analog 6 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | 10 % Hemolysis at 1024 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVKIVAINK{ct:Amid} | Analog 6 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | <10 % Hemolysis at 512 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRLLFHGKKVEIVLIND{ct:Amid} | Analog 7 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | <10 % Hemolysis at 1024 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRLLFHGKKVEIVLIND{ct:Amid} | Analog 7 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | <6 % Hemolysis at 512 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND{ct:Amid} | Analog 8 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | <6 % Hemolysis at 1024 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND{ct:Amid} | Analog 8 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | 4 % Hemolysis at 512 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37887806 | 2024 | MNFSRILFFVFACFVLLASVSAAPEPRWKIFKRIEKVGRNVRDGVIKAGPAVAVLGQAKALGK | Peyn-cec | Free | Free | Linear | L | None | 64 | Antimicrobial | 0.07± 0.24 % Hemolysis at 1 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MNFSRILFFVFACFVLLASVSAAPEPRWKIFKRIEKVGRNVRDGVIKAGPAVAVLGQAKALGK | Peyn-cec | Free | Free | Linear | L | None | 64 | Antimicrobial | 2.5 ± 0.78 % Hemolysis at 5 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MNFSRILFFVFACFVLLASVSAAPEPRWKIFKRIEKVGRNVRDGVIKAGPAVAVLGQAKALGK | Peyn-cec | Free | Free | Linear | L | None | 64 | Antimicrobial | 5.78± 0.58 % Hemolysis at 20 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MNFSRILFFVFACFVLLASVSAAPEPRWKIFKRIEKVGRNVRDGVIKAGPAVAVLGQAKALGK | Peyn-cec | Free | Free | Linear | L | None | 64 | Antimicrobial | 6.37± 0.57 % Hemolysis at 50 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MRIFSVLFIAFALLALFATPAESKWKFGKKLERIGQNVFRAAEKVLPVATGYAQLPATLAGAKQG | Pvul-cec | Free | Free | Linear | L | None | 66 | Antimicrobial | 2.01± 0.76 % Hemolysis at 1 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MRIFSVLFIAFALLALFATPAESKWKFGKKLERIGQNVFRAAEKVLPVATGYAQLPATLAGAKQG | Pvul-cec | Free | Free | Linear | L | None | 66 | Antimicrobial | 1.59± 1.18 % Hemolysis at 5 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MRIFSVLFIAFALLALFATPAESKWKFGKKLERIGQNVFRAAEKVLPVATGYAQLPATLAGAKQG | Pvul-cec | Free | Free | Linear | L | None | 66 | Antimicrobial | 1.90 ± 0.72 % Hemolysis at 20 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MRIFSVLFIAFALLALFATPAESKWKFGKKLERIGQNVFRAAEKVLPVATGYAQLPATLAGAKQG | Pvul-cec | Free | Free | Linear | L | None | 66 | Antimicrobial | 2.19 ± 0.92 % Hemolysis at 50 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MKIFGAMFVLFLVFALLANQTEARWKFGKKLERMGKRIFKATEKGLPVATGVAALARG | Tpen-cec | Free | Free | Linear | L | None | 60 | Antimicrobial | 0.05 ± 0.15 % Hemolysis at 1 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MKIFGAMFVLFLVFALLANQTEARWKFGKKLERMGKRIFKATEKGLPVATGVAALARG | Tpen-cec | Free | Free | Linear | L | None | 60 | Antimicrobial | 0.67 ± 0.48 % Hemolysis at 5 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MKIFGAMFVLFLVFALLANQTEARWKFGKKLERMGKRIFKATEKGLPVATGVAALARG | Tpen-cec | Free | Free | Linear | L | None | 60 | Antimicrobial | 1.32 ± 1.24 % Hemolysis at 20 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MKIFGAMFVLFLVFALLANQTEARWKFGKKLERMGKRIFKATEKGLPVATGVAALARG | Tpen-cec | Free | Free | Linear | L | None | 60 | Antimicrobial | 1.72 ± 1.28 % Hemolysis at 50 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MNFSRIFFFVFALVLALSTVSAAPEPKWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG | Hcec-cecB | Free | Free | Linear | L | None | 63 | Antimicrobial | 0.46 ± 0.07 % Hemolysis at 1 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MNFSRIFFFVFALVLALSTVSAAPEPKWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG | Hcec-cecB | Free | Free | Linear | L | None | 63 | Antimicrobial | 0.97 ± 0.77 % Hemolysis at 5 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MNFSRIFFFVFALVLALSTVSAAPEPKWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG | Hcec-cecB | Free | Free | Linear | L | None | 63 | Antimicrobial | 1.25 ± 0.20 % Hemolysis at 20 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37887806 | 2024 | MNFSRIFFFVFALVLALSTVSAAPEPKWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG | Hcec-cecB | Free | Free | Linear | L | None | 63 | Antimicrobial | 1.75 ± 0.57 % Hemolysis at 50 μg/mL | Sheep | Synthetic | α-Helical | Low hemolytic | ||
| 37907616 | 2024 | LIQRGRFGRFLGKIRHFRPRVKFNVHLRGSVGLG{ct:Amid} | Corvus CATH-2 | Amidation | Free | Linear | L | None | 38 | Antimicrobial | 22 % Hemolysis at 62.89 µM | Human | Sythesized | α-Helical | NA | ||
| 28941793 | 2017 | FIG{nnr:M(ox)}IPGLIGGLISAIK{ct:Amid} | Im-4 | Amidation | Free | Linear | L | M(ox) = oxidized Methionine | 17 | Antimicrobial, Insecticidal,neurotoxic | 50 % Hemolysis at >30 µM | Sheep | Modified Isometrus Maculatus Scorpion Venom | α-Helix | NA | ||
| 28941793 | 2017 | FLGSLFSIGSKLLPGVIKLFQRKKQ | Im-5 | Free | Free | Linear | L | None | 25 | Antimicrobial and Insecticidal | 50 % Hemolysis at 28 µM | Sheep | Isometrus Maculatus Scorpion Venom | α-Helix | NA | ||
| 28941793 | 2017 | FFFLPSLIGGLVSAIK{ct:Amid} | Im-6 | Amidation | Free | Linear | L | None | 16 | Antimicrobial and Insecticidal | 50 % Hemolysis at >25 µM | Sheep | Isometrus Maculatus Scorpion Venom | α-Helix | NA | ||
| 29075946 | 2017 | IDWKKLLDAAKQIL{ct:Amid} | MP1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <1 % Hemolysis at 12.5 µM | Human | Venom Of The Social Wasp Polybia Paulista | α-Helix | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LDA{nnr:*}KQIL{ct:Amid} | MP1S | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 6.7 % Hemolysis at 12.5 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LNA{nnr:*}KQIL{ct:Amid} | MP1S-D8N | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 16.3 % Hemolysis at 12.5 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LDA{nnr:*}KKIL{ct:Amid} | MP1S-Q12K | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 9.6 % Hemolysis at 12.5 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29075946 | 2017 | IDWKKLLDAAKQIL{ct:Amid} | MP1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3.2 % Hemolysis at 25 µM | Human | Venom Of The Social Wasp Polybia Paulista | α-Helix | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LDA{nnr:*}KQIL{ct:Amid} | MP1S | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 12.3 % Hemolysis at 25 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LNA{nnr:*}KQIL{ct:Amid} | MP1S-D8N | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 37.8 % Hemolysis at 25 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LDA{nnr:*}KKIL{ct:Amid} | MP1S-Q12K | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 13.9 % Hemolysis at 25 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29077406 | 2017 | F{d}PV{nnr:O}L-F{d}PV{nnr:O}L{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = Ornithine, f = D-Phenylalanine | 10 | Antimicrobial | 90 % Hemolysis at 12 μg/mL | Human | Aneurinibacillus Migulanus | C2-symmetric antiparallel β-Sheet | NA | ||
| 29077406 | 2017 | F{d}({nnr:Dyp})V{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C} | GS mimetic 15 | Free | Free | Cyclic | Mix | O = Ornithine, Dyp = cis-dihydroxyproline, f = D-Phenylalanine | 10 | Antimicrobial | 90 % Hemolysis at 85 μg/mL | Human | Gs Derivative Synthesized | β-Turn | NA | ||
| 29077406 | 2017 | {nnr:D-Hot═Tap}-V-{nnr:O}-L-F{d}-P-V-{nnr:O}-L{cyc:N-C} | dimethylketal modified GS analogue | Free | Free | Cyclic | Mix | O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine | 9 | Antimicrobial | 90 % Hemolysis at >200 μg/mL | Human | Dihydroxylated Dipeptide D-Hot═Tap (D-Hydroxythreonine═Thiaproline With The “═” Representing The Two Covalent Ring Connections) | twisted β-Sheet structure | NA | ||
| 29077406 | 2017 | {nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-decyliden)]═Tap}-V-{nnr:O}-L-F{d}-P-V-{nnr:O}-L{cyc:N-C} | GS mimetic 17 | Free | Free | Cyclic | Mix | O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine | 10 | Antimicrobial | 90 % Hemolysis at 38 μg/mL | Human | Gs Analogue Modified With A C8- Alkyl Chain | twisted β-Sheet structure | NA | ||
| 29077406 | 2017 | {nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-pentadecyliden)]═Tap}-V-{nnr:O}-L- F{d}-P-V-{nnr:O}-L{cyc:N-C} | GS mimetic 18 | Free | Free | Cyclic | Mix | O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine | 10 | Antimicrobial | 90 % Hemolysis at 6 μg/mL | Human | Gs Analogue 18 Modified With A C13-Alkyl Chain | twisted β-Sheet structure | NA | ||
| 29077406 | 2017 | {nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-8-pentadecyliden)]═Tap}-V-{nnr:O}L-F{d}-P-V-{nnr:O}-L{cyc:N-C} | GS mimetic 19 | Free | Free | Cyclic | Mix | O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine | 10 | Antimicrobial | 90 % Hemolysis at 5 μg/mL | Human | Gs Analogue Modified With Two C7-Alkyl Chains | twisted β-Sheet structure | NA | ||
| 29196622 | 2017 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 73 μM | Human | Synthetic Peptide Xenopus Laevis Frog | α-Helical | NA | ||
| 29196622 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 10 % Hemolysis at 1 μM | Human | Bee Venom-Derived | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Anticancer, Antimicrobial | 10 % Hemolysis at 14 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-P-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-Pro6 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 10 % Hemolysis at 83 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-P-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-Pro9 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 10 % Hemolysis at 165 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 11mer | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 11 | Antimicrobial | 10 % Hemolysis at 103 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 17mer | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 17 | Antimicrobial | 10 % Hemolysis at 3 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}{nt:H}{ct:Amid} | peptoid 2 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nssb = N-(S)-(sec-butyl)glycine | 12 | Antimicrobial | 10 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | RVKRVWPLVIRTVIAGYNLYRAIKKK | fowlicidin-1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 10 % Hemolysis at 7 μM | Human | Cathelicidin-1 | α-Helical | NA | ||
| 29196622 | 2017 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial Agents and Chemotherapy | 10 % Hemolysis at >100 μM | Human | Human Neutrophils | α-Helical peptide | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}{nt:H}{ct:Amid} | peptoid 1 achiral | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Npm = N-(phenylmethyl)glycine | 12 | Antimicrobial | 10 % Hemolysis at 180 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:NLys}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:NLys}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-NLys5,11 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 10 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nsna}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nsna}{nt:H}{ct:Amid} | peptoid 1-Nsna6,12 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine, Nsna = (S)-N-(1-naphthylethyl) glycine | 12 | Antimicrobial | 10 % Hemolysis at 7 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:Ntridec}-({nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}){nt:H}{ct:Amid} | peptoid 1-C134mer | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine, Ntridec = N-(tridecyl)glycine | 4 | Antimicrobial | 10 % Hemolysis at 65 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial peptides | 50 % Hemolysis at >200 μM | Human | Synthetic Peptide Xenopus Laevis Frog | α-Helical | NA | ||
| 29196622 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial peptide | 50 % Hemolysis at 6 μM | Human | Bee Venom-Derived | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Anticancer, Antimicrobial | 50 % Hemolysis at 62 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-P-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-Pro6 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-P-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-Pro9 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 11mer | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 11 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 17mer | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 17 | Antimicrobial | 50 % Hemolysis at 15 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}{nt:H}{ct:Amid} | peptoid 2 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nssb = N-(S)-(sec-butyl)glycine | 12 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | RVKRVWPLVIRTVIAGYNLYRAIKKK | fowlicidin-1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at >20 μM | Human | Cathelicidin-1 | α-Helical | NA | ||
| 29196622 | 2017 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial Agents and Chemotherapy | 50 % Hemolysis at >100 μM | Human | Human Neutrophils | α-Helical peptide | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}{nt:H}{ct:Amid} | peptoid 1 achiral | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Npm = N-(phenylmethyl)glycine | 12 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:NLys}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:NLys}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-NLys5,11 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nsna}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nsna}{nt:H}{ct:Amid} | peptoid 1-Nsna6,12 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine, Nsna = (S)-N-(1-naphthylethyl) glycine | 12 | Antimicrobial | 50 % Hemolysis at 27 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:Ntridec}-({nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}){nt:H}{ct:Amid} | peptoid 1-C134mer | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine, Ntridec = N-(tridecyl)glycine | 4 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29219046 | 2017 | FFGSTIGALANFLPSLISKIRN{ct:Amid} | brevinin-1ULf | Amidation | Free | Linear | L | None | 22 | Antimicrobial Peptides | 13.1 % Hemolysis at 32 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | FFGSTIGALANFLPSLISKIRN{ct:Amid} | brevinin-1ULf | Amidation | Free | Linear | L | None | 22 | Antimicrobial Peptides | 54.7 % Hemolysis at 64 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | FFGSTIGALANFLPSLISKIRN{ct:Amid} | brevinin-1ULf | Amidation | Free | Linear | L | None | 22 | Antimicrobial Peptides | 90.1 % Hemolysis at 128 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | LALRTAGWLRLLGFRDKKKN | Ulmin-1ULa | Free | Free | Linear | L | None | 20 | Antimicrobial Peptides | 4 % Hemolysis at 32 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | LALRTAGWLRLLGFRDKKKN | Ulmin-1ULa | Free | Free | Linear | L | None | 20 | Antimicrobial Peptides | 5 % Hemolysis at 64 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | LALRTAGWLRLLGFRDKKKN | Ulmin-1ULa | Free | Free | Linear | L | None | 20 | Antimicrobial Peptides | 8 % Hemolysis at 128 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29210028 | 2017 | RVMFKWA | a | Free | Free | Linear | L | None | 7 | Antimicrobial peptides | 12.63 % Hemolysis at 256 μg/ml | mouse | Yak Milk | NA | NA | ||
| 29210028 | 2017 | KVISMI | b | Free | Free | Linear | L | None | 6 | Antimicrobial peptides | 20.81 % Hemolysis at 256 μg/ml | mouse | Yak Milk | NA | NA | ||
| 28960954 | 2017 | KWCFRVCYRGICYRRCR | TP1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.25 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | Low hemolytic | ||
| 28960954 | 2017 | AWCFRVCYRGICYRRCR | TP1[K1A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 2.1 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KACFRVCYRGICYRRCR | TP1[W2A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 8 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWAFRVCYRGICYRRSR | TP1[C3A,C16S] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 8 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCARVCYRGICYRRCR | TP1[F4A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 40 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 28960954 | 2017 | KWCFAVCYRGICYRRCR | TP1[R5A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRACYRGICYRRCR | TP1[V6A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 1.2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVAYRGISYRRCR | TP1[C7A,C12S] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 1 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCARGICYRRCR | TP1[Y8A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 8 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYAGICYRRCR | TP1[R9A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRAICYRRCR | TP1[G10A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.5 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGACYRRCR | TP1[I11A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 32 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 28960954 | 2017 | KWCFRVSYRGIAYRRCR | TP1[C7S,C12A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.6 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGICARRCR | TP1[Y13A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 1 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGICYARCR | TP1[R14A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.5 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGICYRACR | TP1[R15A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.45 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWSFRVCYRGICYRRAR | TP1[C3S,C16A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 3 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGICYRRCA | TP1[R17A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.45 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWAFRVCYRGICYRRAR | TP1[C3A,C16A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 40 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | β-Sheet | NA | ||
| 28960954 | 2017 | KWCFRVAYRGIAYRRCR | TP1[C7A,C12A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 8 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWAFRVAYRGIAYRRAR | TP1[C3A,C7A,C12A,C16A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.24 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | Low hemolytic | ||
| 28960954 | 2017 | KWCFRRCYAGICYRRCR | TP1[V6R,R9A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 11 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | RWCFRVCYRGICYRRCR | TP1[K1R] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 1 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCGRVCYRGICYRRCR | TP1[F4G] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.47 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCSRVCYRGICYRRCR | TP1[F4S] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.23 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | Low hemolytic | ||
| 28960954 | 2017 | KWCFRVCGRGICYRRCR | TP1[Y8G] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.4 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGGCYRRCR | TP1[I11G] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | Low hemolytic | ||
| 28960954 | 2017 | KWCARVCARGACYRRCR | TP1[F4A,Y8A,I11A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.9 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWC-FVCYRGICYRRCG | TP1[-R5,R17G] | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 0.3 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | AWCARVCYRGICYRRCR | TP1[K1A,F4A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 32 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | AWCFRVCARGICYRRCR | TP1[K1A,Y8A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.4 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | AWCFRVCYRGACYRRCR | TP1[K1A,I11A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | Low hemolytic | ||
| 28960954 | 2017 | KWCFRVCYAGICYRRCA | TP1[R9A,R17A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R5}{ct:Amid} | Benzoyl-Pat | Amidation | R5 = benzoyl | Linear | Mix | R5 = benzoyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.70 ± 0.34 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R6}{ct:Amid} | Cbz-Pat | Amidation | R6 = benzyloxycarbonyl | Linear | Mix | R6 = benzyloxycarbonyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.65 ± 0.29 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R7}{ct:Amid} | Cha-Pat | Amidation | R7 = 3-cyclohexylalanyl | Linear | Mix | R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 1.63 ± 0.40 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R7}{ct:Amid} | ChaPhe2DLeu7Phe8-Pat | Amidation | R7 = 3-cyclohexylalanyl | Linear | Mix | R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 34.6 ± 0.91 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R5 = benzoyl}{ct:Amid} | Benzoyl-Pat | Amidation | R5 = benzoyl | Linear | Mix | R5 = benzoyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 1.14 ± 1.05 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R6 = benzyloxycarbonyl}{ct:Amid} | Cbz-Pat | Amidation | R6 = benzyloxycarbonyl | Linear | Mix | R6 = benzyloxycarbonyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.54 ± 0.70 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid} | Cha-Pat | Amidation | R7 = 3-cyclohexylalanyl | Linear | Mix | R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.65 ± 0.62 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid} | ChaPhe2DLeu7Phe8-Pat | Amidation | R7 = 3-cyclohexylalanyl | Linear | Mix | R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 11.02 ± 0.99 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R5 = benzoyl}{ct:Amid} | Benzoyl-Pat | Amidation | R5 = benzoyl | Linear | Mix | R5 = benzoyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.71 ± 0.82 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R6 = benzyloxycarbonyl}{ct:Amid} | Cbz-Pat | Amidation | R6 = benzyloxycarbonyl | Linear | Mix | R6 = benzyloxycarbonyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.41 ± 0.67 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid} | Cha-Pat | Amidation | R7 = 3-cyclohexylalanyl | Linear | Mix | R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.33 ± 0.83 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid} | ChaPhe2DLeu7Phe8-Pat | Amidation | R7 = 3-cyclohexylalanyl | Linear | Mix | R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 2.46 ± 0.34 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R5 = benzoyl}{ct:Amid} | Benzoyl-Pat | Amidation | R5 = benzoyl | Linear | Mix | R5 = benzoyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.22 ± 0.17 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R6 = benzyloxycarbonyl}{ct:Amid} | Cbz-Pat | Amidation | R6 = benzyloxycarbonyl | Linear | Mix | R6 = benzyloxycarbonyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.77 ± 0.15 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid} | Cha-Pat | Amidation | R7 = 3-cyclohexylalanyl | Linear | Mix | R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.55 ± 0.75 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid} | ChaPhe2DLeu7Phe8-Pat | Amidation | R7 = 3-cyclohexylalanyl | Linear | Mix | R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid | 9 | Antimicrobial | 0.60 ± 0.18 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29140694 | 2017 | F{d}PFF{d}NQYV{nnr:O}L{cyc:N-C} | Tyrocidine A | Free | Free | Cyclic | Mix | BE2 = 2-AMINOBENZOIC ACID, f = D-Phenylalanine, O = L-Ornithine | 10 | Antimicrobial | 100 % Hemolysis at 5 μg/ml | Mouse | Bacillus Brevis | β-Hairpin | NA | ||
| 29280948 | 2017 | KWKSFLKTFKSAKKTVLHTALKAISS{nt:Acet}{ct:Amid} | V13K | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial, Anticancer | <20 % Hemolysis at 250 μM | Human | Magainin (African Clawed Frog) | α-Helical | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKSAKK{d}TVLHTALKAISS{nt:Acet}{ct:Amid} | K14D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 125 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKS{d}AKK{d}TVLHTALKAISS{nt:Acet}{ct:Amid} | S11D/K14D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 125 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKSAKK{d}T{d}VLHTALKAISS{nt:Acet}{ct:Amid} | K14D/T15D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 250 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKS{d}AKK{d}T{d}VLHTALKAISS{nt:Acet}{ct:Amid} | S11D/K14D/T15D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 250 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKSA{d}KKTVLHTALKAISS{nt:Acet}{ct:Amid} | A12D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 125 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKSA{d}KKTVLHTALKAISS{nt:Acet}{ct:Amid} | F9D/A12D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 250 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKSA{d}KKTVLHTALKAISS{nt:Acet}{ct:Amid} | A12D/V16D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 0 % Hemolysis at >500 μM | Human | V13K Analogs | NA | Non-hemolytic | ||
| 29280948 | 2017 | KWKSFLKTF{d}KSA{d}KKTV{d}LHTALKAISS{nt:Acet}{ct:Amid} | F9D/A12D/V16D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 0 % Hemolysis at >500 μM | Human | V13K Analogs | NA | Non-hemolytic | ||
| 28636781 | 2018 | GIGGALLSAGKSALKGLAKGLAEHFAN{ct:Amid} | BLP-7 | Amidation | Free | Linear | L | None | 27 | Antimicrobial and Haemolytic | 0 % Hemolysis at 128 mg/ml | Human | African Clawed Frog (Xenopus Laevis) | α-Helical | NA | ||
| 28636781 | 2018 | GIGGALLSAGKSALKGLAKGLAEHFAN{ct:Amid} | BLP-7 | Amidation | Free | Linear | L | None | 27 | Antimicrobial and Haemolytic | >80 % Hemolysis at 256 mg/ml | Human | African Clawed Frog (Xenopus Laevis) | α-Helical | NA | ||
| 28636781 | 2018 | IIGPV LGLIG KALGG LL{ct:Amid} | Bombinin H-BO | Amidation | Free | Linear | L | None | 17 | Antimicrobial and Haemolytic | 38 % Hemolysis at 128 mg/ml | Human | African Clawed Frog (Xenopus Laevis) | α-Helical | NA | ||
| 28636781 | 2018 | IIGPV LGLIG KALGG LL{ct:Amid} | Bombinin H-BO | Amidation | Free | Linear | L | None | 17 | Antimicrobial and Haemolytic | 85 % Hemolysis at 256 mg/ml | Human | African Clawed Frog (Xenopus Laevis) | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D33 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 89 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}A{d}A{d}K{d}K{d}K{d}K{d}L{d}A{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D34 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 126 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}A{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}A{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D35 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 30 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}A{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}A{d}{nt:Acet}{ct:Amid} | D36 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 61 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}A{d}A{d}A{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D37 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.6 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}A{d}A{d}A{d}K{d}K{d}A{d}L{d}A{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D38 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.8 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}A{d}T{d}L{d}S{d}K{d}A{d}A{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}A{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D39 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.8 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}A{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}A{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}A{d}{nt:Acet}{ct:Amid} | D40 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.8 μM | Human | Synthesized | α-Helical | NA | ||
| 28815904 | 2018 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial peptides | 50 % Hemolysis at 21 μM | Human | Polychaeta Arenicola Marina | β-Hairpin | NA | ||
| 28815904 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | Tachyplesin I | Amidation | Free | Linear | L | None | 17 | Antimicrobial peptides | ~20 % Hemolysis at 50 μM | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 28815904 | 2018 | {nnr:Z}CRRLCYKQRCVTYCRGR{nt:Z- pyroglutamic acid}{ct:Amid} | Gomesin | Amidation | Z- pyroglutamic acid | Linear | L | Z = pyroglutamic acid | 18 | Antimicrobial peptides | 8 % Hemolysis at 100 μM | Human | Spider Acanthoscurria Gomesiana | β-Hairpin | NA | ||
| 28837852 | 2018 | VKLKKRNVNLKTILGVG | MrChit3 - MrVG | Free | Free | Linear | L | None | 17 | Antimicrobial | ≤5 % Hemolysis at 20 μM | Human | Prawn (Macrobrachium Rosenbergii) Chitinase-3 | NA | Low hemolytic | ||
| 28837852 | 2018 | VKLKKRNVNLKTILGVG | MrChit3 - MrVG | Free | Free | Linear | L | None | 17 | Antimicrobial | ≤5 % Hemolysis at 40 μM | Human | Prawn (Macrobrachium Rosenbergii) Chitinase-3 | NA | Low hemolytic | ||
| 28837852 | 2018 | VKLKKRNVNLKTILGVG | MrChit3 - MrVG | Free | Free | Linear | L | None | 17 | Antimicrobial | ≤5 % Hemolysis at 80 μM | Human | Prawn (Macrobrachium Rosenbergii) Chitinase-3 | NA | Low hemolytic | ||
| 28837852 | 2018 | VKLKKRNVNLKTILGVG | MrChit3 - MrVG | Free | Free | Linear | L | None | 17 | Antimicrobial | ≤5 % Hemolysis at 160 μM | Human | Prawn (Macrobrachium Rosenbergii) Chitinase-3 | NA | Low hemolytic | ||
| 28887200 | 2018 | FLFTVA-{nnr:Dhb}{ct:Acet} | ASP-1 | Acetylation | Free | Linear | L | Dhb = dehydrobutyrine | 7 | Antimicrobial, Anti-MRSA | 31.5 % Hemolysis at 256 μg/ml | Human | Bacillus Subtilis Urid 12.1 | β-Sheet | Low hemolytic | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR | pteroicidin-α-COOH or α-Pte | Free | Free | Linear | L | None | 21 | Antimicrobial | 60 % Hemolysis at 200 μM | Human | Lionfish (Pterois Volitans),Piscidin-1 | NA | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR{ct:Amid} | Pteroicidin-α-CONH2 or α-Pte-CONH2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 90 % Hemolysis at 50 μM | Human | Lionfish (Pterois Volitans),Piscidin-1 | α-Helix | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR | α-Pte | Free | Free | Linear | L | None | 21 | Antimicrobial | 50 % Hemolysis at 50 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | NA | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR | α-Pte | Free | Free | Linear | L | None | 21 | Antimicrobial | 97 % Hemolysis at 100 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | NA | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR | α-Pte | Free | Free | Linear | L | None | 21 | Antimicrobial | 97 % Hemolysis at 200 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | NA | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR{ct:Amid} | α-PteCONH2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 90 % Hemolysis at 50 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | α-Helix | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR | α-Pte | Free | Free | Linear | L | None | 21 | Antimicrobial | 60 % Hemolysis at 200 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | NA | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR{ct:Amid} | α-PteCONH2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 90 % Hemolysis at 50 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | α-Helix | NA | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 1 % Hemolysis at 8 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 1 % Hemolysis at 16 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 1 % Hemolysis at 32 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 1 % Hemolysis at 64 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 1 % Hemolysis at 128 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 2.4 % Hemolysis at 256 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | <20 % Hemolysis at 512 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | NA | ||
| 29183811 | 2018 | KCRRRKVHGPMIRIRKK | TO17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 300 μM | Fish | Red Drum (Sciaenops Ocellatus) Tissue Factor Pathway Inhibitor (Tfpi)-1 | NA | Non-hemolytic | ||
| 29198866 | 2018 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | Pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial peptides | 21.5 ± 2.9 % Hemolysis at 200 mM | Rat | Synthetic Peptide Xenopus Laevis Frog | α-Helical | NA | ||
| 29198866 | 2018 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | Pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial peptides | 10 % Hemolysis at 113.4 μM | Rat | Synthetic Peptide Xenopus Laevis Frog | α-Helical | NA | ||
| 29198866 | 2018 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | Pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial peptides | 50 % Hemolysis at >200 μM | Rat | Synthetic Peptide Xenopus Laevis Frog | α-Helical | NA | ||
| 29191658 | 2018 | FLPIVAKLLSGLL{ct:Amid} | Temporin-PE | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 39.64 μM | Horse | Frog(Pelophylax Kl. Esculentus) | α-Helical | NA | ||
| 29191658 | 2018 | FLYIVAKLLSGLL{ct:Amid} | Temporin-PEa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 531.7 μM | Horse | Frog(Pelophylax Kl. Esculentus) | α-Helical | NA | ||
| 29191658 | 2018 | FLPIVAKLLSGLLGRKKRRQRRR{ct:Amid} | Temporin-PEb | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 44.64 μM | Horse | Frog(Pelophylax Kl. Esculentus) | α-Helical | NA | ||
| 29364903 | 2018 | KLIPILSKTIPAGKNLFYKI | NCP-2 | Free | Free | Linear | L | None | 20 | Antimicrobial | 8 % Hemolysis at 100 μg/ml | Sheep | Subsequence Of Naja Cardiotoxin Peptide-0(Naja Atra Subsp. Atra Cardiotoxin 1 (Ctx-1)) Chinese Cobra Snake | α-Helix | NA | ||
| 29364903 | 2018 | KLIWILSKTIPAGKNLFYKI | NCP-3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 9 % Hemolysis at 100 μg/ml | Sheep | Subsequence Of Naja Cardiotoxin Peptide-0(Naja Atra Subsp. Atra Cardiotoxin 1 (Ctx-1)) Chinese Cobra Snake | Beta Sheet | NA | ||
| 29364903 | 2018 | KLIPILSKTIPAGKNLFYKI | NCP-2 | Free | Free | Linear | L | None | 20 | Antimicrobial | 2 % Hemolysis at 12.5 μg/ml | Sheep | Subsequence Of Naja Cardiotoxin Peptide-0(Naja Atra Subsp. Atra Cardiotoxin 1 (Ctx-1)) Chinese Cobra Snake | α-Helix | NA | ||
| 29364903 | 2018 | KLIWILSKTIPAGKNLFYKI | NCP-3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 3 % Hemolysis at 12.5 μg/ml | Sheep | Subsequence Of Naja Cardiotoxin Peptide-0(Naja Atra Subsp. Atra Cardiotoxin 1 (Ctx-1)) Chinese Cobra Snake | Beta Sheet | NA | ||
| 29379033 | 2018 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2 % Hemolysis at 12.5 μM | Mouse | Scorpion Heterometrus Petersii | amphipathic α-Helical | NA | ||
| 29379033 | 2018 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 11 % Hemolysis at 25 μM | Mouse | Scorpion Heterometrus Petersii | amphipathic α-Helical | NA | ||
| 29379033 | 2018 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 55 % Hemolysis at 50 μM | Mouse | Scorpion Heterometrus Petersii | amphipathic α-Helical | NA | ||
| 29379033 | 2018 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 92 % Hemolysis at 100 μM | Mouse | Scorpion Heterometrus Petersii | amphipathic α-Helical | NA | ||
| 29379033 | 2018 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 200 μM | Mouse | Scorpion Heterometrus Petersii | amphipathic α-Helical | NA | ||
| 29379033 | 2018 | ILKKLLKGVKSI{ct:Amid} | Hp1404-T1c | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <2 % Hemolysis at 200 μM | Mouse | Synthetic Peptides From Hp1404 | amphipathic α-Helical | Non-hemolytic | ||
| 29379033 | 2018 | ILKKLLKKVKSI{ct:Amid} | Hp1404-T1d | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <2 % Hemolysis at 200 μM | Mouse | Synthetic Peptides From Hp1404 | amphipathic α-Helical | Non-hemolytic | ||
| 29379033 | 2018 | ILKKLLKKVKKI{ct:Amid} | Hp1404-T1e | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <2 % Hemolysis at 200 μM | Mouse | Synthetic Peptides From Hp1404 | amphipathic α-Helical | Non-hemolytic | ||
| 29098406 | 2018 | GIGSAILSAGKSIIKGLAKGLAEHF{ct:Amid} | Bombinin-BO1 | Amidation | Free | Linear | L | None | 25 | broad-spectrum Antimicrobial | 2.89 % Hemolysis at 26.3 μM | Human | Oriental Fre-Bellied Toad, Bombina Orientalis, | Alphα-Helical amphipathic | NA | ||
| 29098406 | 2018 | GIGSAILSAGKSIIKGLAKGLAEHF{ct:Amid} | Bombinin-BO1 | Amidation | Free | Linear | L | None | 25 | broad-spectrum Antimicrobial | 38.05 % Hemolysis at 52.5 μM | Human | Oriental Fre-Bellied Toad, Bombina Orientalis, | Alphα-Helical amphipathic | NA | ||
| 29098406 | 2018 | IIGPVLGLVGKALGGLL{ct:Amid} | Bombinin H-BO1 | Amidation | Free | Linear | L | None | 17 | broad-spectrum Antimicrobial | 42.03 % Hemolysis at 40.4 μM | Human | Oriental Fre-Bellied Toad, Bombina Orientalis, | Alphα-Helical amphipathic | NA | ||
| 29098406 | 2018 | IIGPVLGLVGKALGGLL{ct:Amid} | Bombinin H-BO1 | Amidation | Free | Linear | L | None | 17 | broad-spectrum Antimicrobial | 100 % Hemolysis at 161.1 μM | Human | Oriental Fre-Bellied Toad, Bombina Orientalis, | Alphα-Helical amphipathic | NA | ||
| 29101485 | 2018 | PFKLSLHL{ct:Amid} | Jelleine-I | Amidation | Free | Linear | L | None | 8 | Antimicrobial and Antifungal activity | <2 % Hemolysis at 100 μM | Mouse | Royal Jelly Of Honeybees (Apis Mellifera) | NA | Low hemolytic | ||
| 29101485 | 2018 | PFKLSLHL{ct:Amid} | Jelleine-I | Amidation | Free | Linear | L | None | 8 | Antimicrobial and Antifungal activity | ≤5 % Hemolysis at 256 μM | Mouse | Royal Jelly Of Honeybees (Apis Mellifera) | NA | Low hemolytic | ||
| 29392557 | 2018 | KRFKKFFRKLKKSVKKRAKEFFKKPRVIGVSIPF | Cath-BF | Free | Free | Linear | L | None | 32 | Antimicrobial | 20 % Hemolysis at 500 μg/ml | Human | Snakes Naja Atra, Bugarus Fasciatus | NA | NA | ||
| 29392557 | 2018 | KRFKKFFRKLKKSVKKRKKEFKKKPRVIKVSIPF | Cath-A | Free | Free | Linear | L | None | 32 | Antimicrobial | 20 % Hemolysis at 500 μg/ml | Human | Snakes Naja Atra, Bugarus Fasciatus | α-Helix | NA | ||
| 29392557 | 2018 | KRFKKFFRKLKKSVKKRKKEFKKKPRVIGVSIPF | Cath-B | Free | Free | Linear | L | None | 32 | Antimicrobial | 5 % Hemolysis at 500 μg/ml | Human | Snakes Naja Atra, Bugarus Fasciatus | α-Helix | Low hemolytic | ||
| 29402952 | 2018 | MTESLVLSPAPAKPKRVKASRRSASHPTYSEMIAAAIRAEKSRGGSSRQSIQKYIKSHYKVGHNADLQIKLSIRRLLAAGVLKQTKGVGASGSFRLAKSDKAKRSPGKKKKAVRRSTSPKKAARPRKARSPAKKPKATARKARKKSRASPKKAKKPKTVKAKSRKASKAKKVKRSKPRAKSGARKSPKKK | histone H5 | Free | Free | Linear | L | None | 190 | Antimicrobial | 2.0 ± 1.4 % Hemolysis at 1 mg/mL | Rat | Chicken Erythrocytes | Random Coil in aq | Non-hemolytic | ||
| 29402952 | 2018 | MTESLVLSPAPAKPKRVKASRRSASHPTYSEMIAAAIRAEKSRGGSSRQSIQKYIKSHYKVGHNADLQIKLSIRRLLAAGVLKQTKGVGASGSFRLAKSDKAKRSPGKKKKAVRRSTSPKKAARPRKARSPAKKPKATARKARKKSRASPKKAKKPKTVKAKSRKASKAKKVKRSKPRAKSGARKSPKKK | histone H5 | Free | Free | Linear | L | None | 190 | Antimicrobial | 2.8 ± 1.3 % Hemolysis at 0.75 mg/mL | Rat | Chicken Erythrocytes | Random Coil in aq | Non-hemolytic | ||
| 29402952 | 2018 | MTESLVLSPAPAKPKRVKASRRSASHPTYSEMIAAAIRAEKSRGGSSRQSIQKYIKSHYKVGHNADLQIKLSIRRLLAAGVLKQTKGVGASGSFRLAKSDKAKRSPGKKKKAVRRSTSPKKAARPRKARSPAKKPKATARKARKKSRASPKKAKKPKTVKAKSRKASKAKKVKRSKPRAKSGARKSPKKK | histone H5 | Free | Free | Linear | L | None | 190 | Antimicrobial | 2.4 ± 1.4 % Hemolysis at 0.5 mg/mL | Rat | Chicken Erythrocytes | Random Coil in aq | Non-hemolytic | ||
| 29402952 | 2018 | MTESLVLSPAPAKPKRVKASRRSASHPTYSEMIAAAIRAEKSRGGSSRQSIQKYIKSHYKVGHNADLQIKLSIRRLLAAGVLKQTKGVGASGSFRLAKSDKAKRSPGKKKKAVRRSTSPKKAARPRKARSPAKKPKATARKARKKSRASPKKAKKPKTVKAKSRKASKAKKVKRSKPRAKSGARKSPKKK | histone H5 | Free | Free | Linear | L | None | 190 | Antimicrobial | 2.6 ± 0.6 % Hemolysis at 0.25 mg/mL | Rat | Chicken Erythrocytes | Random Coil in aq | Non-hemolytic | ||
| 29402952 | 2018 | MTESLVLSPAPAKPKRVKASRRSASHPTYSEMIAAAIRAEKSRGGSSRQSIQKYIKSHYKVGHNADLQIKLSIRRLLAAGVLKQTKGVGASGSFRLAKSDKAKRSPGKKKKAVRRSTSPKKAARPRKARSPAKKPKATARKARKKSRASPKKAKKPKTVKAKSRKASKAKKVKRSKPRAKSGARKSPKKK | histone H5 | Free | Free | Linear | L | None | 190 | Antimicrobial | 3.2 ± 1.1 % Hemolysis at 0.125 mg/mL | Rat | Chicken Erythrocytes | Random Coil in aq | Non-hemolytic | ||
| 29402952 | 2018 | MTESLVLSPAPAKPKRVKASRRSASHPTYSEMIAAAIRAEKSRGGSSRQSIQKYIKSHYKVGHNADLQIKLSIRRLLAAGVLKQTKGVGASGSFRLAKSDKAKRSPGKKKKAVRRSTSPKKAARPRKARSPAKKPKATARKARKKSRASPKKAKKPKTVKAKSRKASKAKKVKRSKPRAKSGARKSPKKK | histone H5 | Free | Free | Linear | L | None | 190 | Antimicrobial | 2.3 ± 0.6 % Hemolysis at 0.05 mg/mL | Rat | Chicken Erythrocytes | Random Coil in aq | Non-hemolytic | ||
| 29402952 | 2018 | MTESLVLSPAPAKPKRVKASRRSASHPTYSEMIAAAIRAEKSRGGSSRQSIQKYIKSHYKVGHNADLQIKLSIRRLLAAGVLKQTKGVGASGSFRLAKSDKAKRSPGKKKKAVRRSTSPKKAARPRKARSPAKKPKATARKARKKSRASPKKAKKPKTVKAKSRKASKAKKVKRSKPRAKSGARKSPKKK | histone H5 | Free | Free | Linear | L | None | 190 | Antimicrobial | 1.8 ± 1.6 % Hemolysis at 0.025 mg/mL | Rat | Chicken Erythrocytes | Random Coil in aq | Non-hemolytic | ||
| 29402952 | 2018 | MTESLVLSPAPAKPKRVKASRRSASHPTYSEMIAAAIRAEKSRGGSSRQSIQKYIKSHYKVGHNADLQIKLSIRRLLAAGVLKQTKGVGASGSFRLAKSDKAKRSPGKKKKAVRRSTSPKKAARPRKARSPAKKPKATARKARKKSRASPKKAKKPKTVKAKSRKASKAKKVKRSKPRAKSGARKSPKKK | histone H5 | Free | Free | Linear | L | None | 190 | Antimicrobial | 0.5 ± 0.5 % Hemolysis at 0.0125 mg/mL | Rat | Chicken Erythrocytes | Random Coil in aq | Non-hemolytic | ||
| 29402952 | 2018 | MTESLVLSPAPAKPKRVKASRRSASHPTYSEMIAAAIRAEKSRGGSSRQSIQKYIKSHYKVGHNADLQIKLSIRRLLAAGVLKQTKGVGASGSFRLAKSDKAKRSPGKKKKAVRRSTSPKKAARPRKARSPAKKPKATARKARKKSRASPKKAKKPKTVKAKSRKASKAKKVKRSKPRAKSGARKSPKKK | histone H5 | Free | Free | Linear | L | None | 190 | Antimicrobial | 0.1 ± 0.4 % Hemolysis at 0.005 mg/mL | Rat | Chicken Erythrocytes | Random Coil in aq | Non-hemolytic | ||
| 29473887 | 2018 | (KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF){nnr:4-arm-PEG-PLGA} | cathelicidin-BF-30loaded 4-arm-PEG-PLGA | Free | Free | NA | L | 4-arm-PEG-PLGA = ethylene glycol-b-dl-lactic acid-co-glycolic acid(microspheres) | 30 | Antimicrobial | ~15 % Hemolysis at 1000 μg/mL | Rabbit | Snake Venoms Of Bungarus Fasciatus | α-Helical | NA | ||
| 29599756 | 2018 | GFREKHFQRFVKYAVPESTLRTVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF | MeuTXKβ1 | Free | Free | Linear | L | None | 72 | Antimicrobial | 25 % Hemolysis at 25 μM | Mouse | Mesobuthus Eupeus Scorpion Species | α-Helical | Low hemolytic | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFKGRRKRDLN{ct:Amid} | Marmelittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSFFRRKNQ | Marcin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSLFQRKKE | Meucin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFK{ct:Amid} | MeuFSPL-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLINAFK{ct:Amid} | MeuFSPL-2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | IFGAIAGLLKNIF{ct:Amid} | Meucin-13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100 % Hemolysis at 12.5 μM | Mouse | Mesobuthus Eupeus Scorpion Species | NA | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSLFQ | Meucin-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Eupeus Scorpion Species | NA | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSLFQRKKE | Meucin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 25 μM | Lizard | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSFFRRKNQ | Marcin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 99 % Hemolysis at 25 μM | Lizard | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFK{ct:Amid} | MeuFSPL-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 99 % Hemolysis at 25 μM | Lizard | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFKGRRKRDLN{ct:Amid} | Marmelittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 99 % Hemolysis at 25 μM | Lizard | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSLFQRKKE | Meucin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 45 % Hemolysis at 25 μM | Pigeons | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSFFRRKNQ | Marcin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 40 % Hemolysis at 25 μM | Pigeons | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFK{ct:Amid} | MeuFSPL-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 40 % Hemolysis at 25 μM | Pigeons | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFKGRRKRDLN{ct:Amid} | Marmelittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 μM | Pigeons | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29275987 | 2018 | KKKKKK-AAFAAWAAFAA{nt:6 Lys}{ct:Amid} | 6K-F17 | Amidation | 6 Lys | Linear | L | None | 17 | Antimicrobial Peptide | 10 % Hemolysis at 320 µM | Human | Cationic Antimicrobial Peptide | Random coil | NA | ||
| 29515090 | 2018 | KFFKKLKNSVKKRAKKFFKKPRVIGVSIPF | OH-CATH30 | Free | Free | Linear | L | None | 30 | Antimicrobial | ~10 % Hemolysis at 125 µg/mL | Human | Cathelicidin-Derived Peptide From The King Cobra | NA | NA | ||
| 29515090 | 2018 | K{d}F{d}F{d}K{d}K{d}L{d}K{d}N{d}S{d}V{d}K{d}K{d}R{d}A{d}K{d}K{d}F{d}F{d}K{d}K{d}P{d}R{d}V{d}I{d}G{d}V{d}S{d}I{d}P{d}F{d} | analog D-OH-CATH30 | Free | Free | Linear | D | None | 30 | Antimicrobial | ~10 % Hemolysis at 125 µg/mL | Human | Cathelicidin-Derived Peptide From The King Cobra | NA | NA | ||
| 29515090 | 2018 | KFFKKLKNSVKKRAKKFFKKPRVIGVSIPF | OH-CATH30 | Free | Free | Linear | L | None | 30 | Antimicrobial | 70 % Hemolysis at 250 µg/mL | Human | Analog D-Oh-Cath30 | NA | NA | ||
| 29515090 | 2018 | K{d}F{d}F{d}K{d}K{d}L{d}K{d}N{d}S{d}V{d}K{d}K{d}R{d}A{d}K{d}K{d}F{d}F{d}K{d}K{d}P{d}R{d}V{d}I{d}G{d}V{d}S{d}I{d}P{d}F{d} | analog D-OH-CATH30 | Free | Free | Linear | D | None | 30 | Antimicrobial | 80 % Hemolysis at 250 µg/mL | Human | Analog D-Oh-Cath30 | NA | NA | ||
| 29282543 | 2018 | GKEFKRIVWLSKTAKKL{ct:Amid} | LC | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0.14 % Hemolysis at 128 μM | Human | Lc From Ll37 And Cp-1 | at aq :unordered conformation, at membrane : α-Helix | Low hemolytic | ||
| 29282543 | 2018 | GKEFKRIVKWPWWPWRR{ct:Amid} | LI | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.42 % Hemolysis at 128 μM | Human | Ll37 Hybrids With Indolicidin And Np-1, | at aq :unordered conformation, at membrane :β-Turn and β-Hairpin structures | Low hemolytic | ||
| 29282543 | 2018 | GKEFKRIVGRIYRLCCR{ct:Amid} | LN | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.08 % Hemolysis at 128 μM | Human | Ll37 Hybrids With Indolicidin And Np-1, | at aq :unordered conformation, at membrane : α-Helix | Low hemolytic | ||
| 29282543 | 2018 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid} | LL37 | Amidation | Free | Linear | L | None | 37 | Antimicrobial | 8.6 % Hemolysis at 128 μM | Human | Homo Sapiens | NA | Low hemolytic | ||
| 29282543 | 2018 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 46.22 % Hemolysis at 128 μM | Human | Bos Taurus | NA | Low hemolytic | ||
| 29282543 | 2018 | SWLSKTAKKLENSAKKRISEGIAIAQGGPR{ct:Amid} | CP-1 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | 0.35 % Hemolysis at 128 μM | Human | Pig (Ascaris Suum) | NA | Low hemolytic | ||
| 29282543 | 2018 | VTCYCRRTRCGFRERLSGACGYRGRIYRLCCR{ct:Amid} | NP-1 | Amidation | Free | Linear | L | None | 32 | Antimicrobial | 0.72 % Hemolysis at 128 μM | Human | Rat (Rattus Norvegicus) | NA | Low hemolytic | ||
| 29282543 | 2018 | GKEFKRIVWLSKTAKKL{ct:Amid} | LC | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at >128 μM | Human | Lc From Ll37 And Cp-1 | at aq :unordered conformation, at membrane : α-Helix | Low hemolytic | ||
| 29282543 | 2018 | GKEFKRIVKWPWWPWRR{ct:Amid} | LI | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at >128 μM | Human | Ll37 Hybrids With Indolicidin And Np-1, | at aq :unordered conformation, at membrane :β-Turn and β-Hairpin structures | Low hemolytic | ||
| 29282543 | 2018 | GKEFKRIVGRIYRLCCR{ct:Amid} | LN | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at >128 μM | Human | Ll37 Hybrids With Indolicidin And Np-1, | at aq :unordered conformation, at membrane : α-Helix | Low hemolytic | ||
| 29282543 | 2018 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid} | LL37 | Amidation | Free | Linear | L | None | 37 | Antimicrobial | ≥5 % Hemolysis at 64 μM | Human | Homo Sapiens | NA | Low hemolytic | ||
| 29282543 | 2018 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | ≥5 % Hemolysis at 32 μM | Human | Bos Taurus | NA | Low hemolytic | ||
| 29282543 | 2018 | SWLSKTAKKLENSAKKRISEGIAIAQGGPR{ct:Amid} | CP-1 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | ≥5 % Hemolysis at >128 μM | Human | Pig (Ascaris Suum) | NA | Low hemolytic | ||
| 29282543 | 2018 | VTCYCRRTRCGFRERLSGACGYRGRIYRLCCR{ct:Amid} | NP-1 | Amidation | Free | Linear | L | None | 32 | Antimicrobial | ≥5 % Hemolysis at >128 μM | Human | Rat (Rattus Norvegicus) | NA | Low hemolytic | ||
| 29553266 | 2018 | KIAKGALKALKIAKVALKAL{ct:Amid} | kiadin-2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at 30 ± 3 µM | Human | Modification Of Kiadin-1 Natural Amp (Pgla-H) | α-Helical | NA | ||
| 29553266 | 2018 | KIGKALGKALKALGKALGKA{ct:Amid} | kiadin-4 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and cytotoxic activity | 50 % Hemolysis at 15± 2 µM | Human | Ab Initio Designed | α-Helical | NA | ||
| 29553266 | 2018 | KIALKALKALKALGKALKAL{ct:Amid} | kiadin-6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at 10 ± 1 µM | Human | Ab Initio Designed | α-Helical | NA | ||
| 29670004 | 2018 | FFSLIPSLVGGLISAFK{ct:Amid} | Stigmurin | Amidation | Free | Linear | L | None | 17 | Antimicrobial,Antiproliferative, Antiparasitic | 3 % Hemolysis at 75 µM | Human | Scorpion Tityus Stigmurus Venom Gland | Random | Low hemolytic | ||
| 29670004 | 2018 | FFSLIPKLVKGLISAFK{ct:Amid} | StigA6 | Amidation | Free | Linear | L | None | 17 | Antiparasitic, Antimicrobial, Anticancer | 30 % Hemolysis at 75 µM | Human | Analogs To Stigmurin | Random coil | NA | ||
| 29670004 | 2018 | FFKLIPKLVKGLISAFK{ct:Amid} | StigA16 | Amidation | Free | Linear | L | None | 17 | Antiparasitic, Antimicrobial, Anticancer | 30 % Hemolysis at 75 µM | Human | Analogs To Stigmurin | Random coil | NA | ||
| 29411917 | 2018 | aza-β3Lys-K-{nnr:aza-β3-1Nal}-K-{nnr:aza-β3-1Nal}-L{cyc:N-C} | ACPP20 | Free | Free | Cyclic | L | aza-β3-Lys = aza-β3-Lysine, aza-β3-1Nal = aza-β3-1-Naphthylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 1.5 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | Low hemolytic | ||
| 29411917 | 2018 | aza-β3Lys-K-{nnr:aza-β3-2Nal}-L-{nnr:aza-β3-2Nal}-L{cyc:N-C} | ACPP21 | Free | Free | Cyclic | L | aza-β3-Lys = aza-β3-Lysine, aza-β3-2Nal = aza-β3-2-Naphthylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 8 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | NA | ||
| 29411917 | 2018 | aza-β3Lys-K-{nnr:aza-β3-1Nal}-L-{nnr:aza-β3-4Fluo-1Nal}-L{cyc:N-C} | ACPP22 | Free | Free | Cyclic | L | aza-β3-Leu = aza-β3-Leucine, aza-β3-1Nal = aza-β3-1-Naphthylalanine, aza-β3-4Fluo-1Nal = aza-β3-4Fluoro-1-Nahphtylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 5 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | Low hemolytic | ||
| 29411917 | 2018 | K-aza-β3Lys-L-{nnr:aza-β3-1Nal}-aza-β3Leu-{nnr:aza-β3-1Nal}{cyc:N-C} | ACPP23 | Free | Free | Cyclic | L | aza-β3-Lys = aza-β3-Lysine, aza-β3-1Nal = aza-β3-1-Naphthylalanine, aza-β3-Leu = aza-β3-Leucine, aza-β3-1Nal = aza-β3-1-Naphthylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 6 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | NA | ||
| 29411917 | 2018 | aza-β3Arg-R-{nnr:aza-β3-1Nal}-L-{nnr:aza-β3-1Nal}-L{cyc:N-C} | ACPP24 | Free | Free | Cyclic | L | aza-β3-Arg = aza-β3-Arginine, aza-β3-1Nal = aza-β3-1-Naphthylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 12 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | NA | ||
| 29411917 | 2018 | aza-β3Lys-R-{nnr:aza-β3-2Nal}-F-{nnr:aza-β3-2Nal}-F{cyc:N-C} | ACPP25 | Free | Free | Cyclic | L | aza-β3-Lys = aza-β3-Lysine, aza-β3-2Nal = aza-β3-2-Naphthylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 50 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | NA | ||
| 29549839 | 2018 | SKVWRHWRRFWHRAHRKL | Chensinin-1b | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at >500 µM | Human | Chinese Brown Frog Rana Cheninensis | NA | Non-hemolytic | ||
| 29549839 | 2018 | {conj:CH3(CH2)6CO}SKVWRHWRRFWHRAHRKL | OA-C1b | Free | CH3(CH2)6CO | Linear | L | octanoic acid (OA),conjugation of aliphatic acid was designed lipo-chensinin-1b | 14 | Antimicrobial | 0 % Hemolysis at >500 µM | Human | Designed Lipo-Chensinin-1B | Random coil at aq, α-Helical at TFE solution | Non-hemolytic | ||
| 29549839 | 2018 | {conj:CH3(CH2)10CO}SKVWRHWRRFWHRAHRKL | LA-C1b | Free | CH3(CH2)10CO | Linear | L | lauric acid (LA) conjugation of aliphatic acid was designed lipo-chensinin-1b | 14 | Antimicrobial | 0 % Hemolysis at >500 µM | Human | Designed Lipo-Chensinin-1B | Random coil at aq | Non-hemolytic | ||
| 29904274 | 2018 | LNLKALLAVAKKIL{ct:Amid} | MP-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 40.11 µM | Horse | European Hornet (Vespa Crabro) | Random-coil at aq, α-Helical at membrane mimic solution | NA | ||
| 29904274 | 2018 | CLNLKALLAVAKKILC{cyc:N-C}{ct:Amid} | cMP-C | Amidation | Free | Cyclic | L | None | 16 | Antimicrobial | 50 % Hemolysis at 9.19 µM | Horse | Modifcation In Mp-C A Skeleton-Based Cyclization By Two Cysteine Residues | α-Helical at aq, α-Helical at membrane mimic solution | NA | ||
| 29266746 | 2018 | WLSKTAKKL{ct:Amid} | WL1 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | >5 % Hemolysis at >128 µM | Human | Tandem Repeat Cecropin P1 | unordered conformations | Non-hemolytic | ||
| 29266746 | 2018 | WLSKTAKKLWLSKTAKKL{ct:Amid} | WL2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | >5 % Hemolysis at >128 µM | Human | Tandem Repeat Cecropin P1 | Random coil at aq, α-Helical at 50% TFE solution | Non-hemolytic | ||
| 29266746 | 2018 | WLSKTAKKLWLSKTAKKLWLSKTAKKL{ct:Amid} | WL3 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | >5 % Hemolysis at >128 µM | Human | Tandem Repeat Cecropin P1 | Random coil at aq, α-Helical at 50% TFE solution | Non-hemolytic | ||
| 29266746 | 2018 | SWLSKTAKKLENSAKKRISEGIAIAQGGPR{ct:Amid} | CP-1 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | >5 % Hemolysis at >128 µM | Human | Pig Nematode Porcine Small Intestine | Helical | Non-hemolytic | ||
| 29307075 | 2018 | KWKLFKKIGAVLKVL ({nnr:AcO−}){ct:Amid} | CAMEL acetate | Amidation | Free | Linear | L | AcO− = Counter-ion acetate | 15 | Antimicrobial | 80 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | GLFDVIKKVASVIGGL ({nnr:AcO−}){ct:Amid} | Citropin 1.1 acetate | Amidation | Free | Linear | L | AcO− = Counter-ion acetate | 16 | Antimicrobial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES ({nnr:AcO−}) | LL-37 acetate | Free | Free | Linear | L | AcO− = Counter-ion acetate | 37 | Antimicrobial | ~4 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 29307075 | 2018 | GIGKFLKKAKKFGKAFVKILKK ({nnr:AcO−}){ct:Amid} | Pexiganan acetate | Amidation | Free | Linear | L | AcO− = Counter-ion acetate | 22 | Antimicrobial | 30.75 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | FLPLIGRVLSGIL ({nnr:AcO−}){ct:Amid} | Temporin A acetate | Amidation | Free | Linear | L | AcO− = Counter-ion acetate | 13 | Antimicrobial | ~4 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 29307075 | 2018 | KWKLFKKIGAVLKVL ({nnr:TFA−}){ct:Amid} | CAMEL trifluoroacetate | Amidation | Free | Linear | L | TFA− = Counter-ion trifluoroacetate | 15 | Antimicrobial | 50 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | GLFDVIKKVASVIGGL ({nnr:TFA−}){ct:Amid} | Citropin 1.1 trifluoroacetate | Amidation | Free | Linear | L | TFA− = Counter-ion trifluoroacetate | 16 | Antimicrobial | 12 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES ({nnr:TFA−}) | LL-37 trifluoroacetate | Free | Free | Linear | L | TFA− = Counter-ion trifluoroacetate | 37 | Antimicrobial | ~4 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 29307075 | 2018 | GIGKFLKKAKKFGKAFVKILKK ({nnr:TFA−}){ct:Amid} | Pexiganan trifluoroacetate | Amidation | Free | Linear | L | TFA− = Counter-ion trifluoroacetate | 22 | Antimicrobial | 8.51 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | FLPLIGRVLSGIL ({nnr:TFA−}){ct:Amid} | Temporin A trifluoroacetate | Amidation | Free | Linear | L | TFA− = Counter-ion trifluoroacetate | 13 | Antimicrobial | 2.5 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 29307075 | 2018 | GLFDVIKKVASVIGGL ({nnr:Cl−}){ct:Amid} | Citropin 1.1 chloride | Amidation | Free | Linear | L | Cl− = Counter-ion chloride | 16 | Antimicrobial | 6 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES ({nnr:Cl−}) | LL-37 chloride | Free | Free | Linear | L | Cl− = Counter-ion chloride | 37 | Antimicrobial | ~4 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 29307075 | 2018 | GIGKFLKKAKKFGKAFVKILKK ({nnr:Cl−}){ct:Amid} | Pexiganan chloride | Amidation | Free | Linear | L | Cl− = Counter-ion chloride | 22 | Antimicrobial | 9 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | FLPLIGRVLSGIL({nnr:Cl−}){ct:Amid} | Temporin A chloride | Amidation | Free | Linear | L | Cl− = Counter-ion chloride | 13 | Antimicrobial | 1 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 29501691 | 2018 | KWKIFKKIEKVGRNVRDGIIKAGPAVQVVGQATSIAK | DAN1 | Free | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 200 µg/mL | Sheep | Danaus Plexippus (Monarch Butterfly) | NA | Non-hemolytic | ||
| 29501691 | 2018 | RWKFLKKIEKVGRKVRDGVIKAGPAVGVVGQATSIYK | DAN2 | Free | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 200 µg/mL | Sheep | Danaus Plexippus (Monarch Butterfly) | NA | Non-hemolytic | ||
| 29501691 | 2018 | VTCDLLSAEAKGVKVNHAACAAHCLLKRKRGGYCNKRRICVCRN | HOLO1 | Free | Free | Linear | L | None | 44 | Antimicrobial | 0 % Hemolysis at 200 µg/mL | Sheep | Tribolium Castaneum (Red Flour Beetle) | NA | Non-hemolytic | ||
| 29501691 | 2018 | ATCDLLSASTPWGSLNHSACAAHCLTKRYKGGRCRNGICRCRR | LOUDEF1 | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 200 µg/mL | Sheep | Pediculus Humanus Humanus (Human Body Louse) | NA | Non-hemolytic | ||
| 29501691 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 35 % Hemolysis at 200 µg/mL | Sheep | Honeybee Venom | NA | NA | ||
| 29765362 | 2018 | KWCFRVCYRGICYRKCR{cyc:3-7}{cyc:12-16} | Tachyplesin III | Free | Free | Linear | L | cysteines with the same type font formed on disulfide | 17 | Antimicrobial | 1 % Hemolysis at 50 mg/L | Mouse | Horseshoe Crab | NA | Non-hemolytic | ||
| 29765362 | 2018 | KWCFRVCYRGICYRKCR{cyc:3-7}{cyc:12-16} | Tachyplesin III | Free | Free | Linear | L | cysteines with the same type font formed on disulfide | 17 | Antimicrobial | 2 % Hemolysis at 100 mg/L | Mouse | Horseshoe Crab | NA | Non-hemolytic | ||
| 29765362 | 2018 | KWCFRVCYRGICYRKCR{cyc:3-7}{cyc:12-16} | Tachyplesin III | Free | Free | Linear | L | cysteines with the same type font formed on disulfide | 17 | Antimicrobial | 4 % Hemolysis at 200 mg/L | Mouse | Horseshoe Crab | NA | NA | ||
| 29765362 | 2018 | KWCFRVCYRGICYRKCR{cyc:3-7}{cyc:12-16} | Tachyplesin III | Free | Free | Linear | L | cysteines with the same type font formed on disulfide | 17 | Antimicrobial | 6 % Hemolysis at 400 mg/L | Mouse | Horseshoe Crab | NA | NA | ||
| 29648811 | 2018 | RLRLLLRLR{ct:Amid} | 1 - L4 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical at membrane-mimetic environments | Low hemolytic | ||
| 29648811 | 2018 | LLRRLRRLL{ct:Amid} | 2 - L4pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 9 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RFRFFFRFR{ct:Amid} | 3 - F4 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | FFRRFRRFF{ct:Amid} | 4 - F4pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 9 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RIRIIIRIR{ct:Amid} | 5 - I4 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | IIRRIRRII{ct:Amid} | 6 - I4pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 9 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RWRWWWRWR{ct:Amid} | 7 - W4 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | WWRRWRRWW{ct:Amid} | 8 - W4pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 9 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RRLRLLLRLRR{ct:Amid} | 9 - L6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RLLRRLRRLLR{ct:Amid} | 10 - L6pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RRFRFFFRFRR{ct:Amid} | 11 - F6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RFFRRFRRFFR{ct:Amid} | 12 - F6pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RIIRRIRRIIR{ct:Amid} | 14 - I6pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RRWRWWWRWRR{ct:Amid} | 15 - W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RWWRRWRRWWR{ct:Amid} | 16 - W6pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RRIRIIIRIRR{nt:Fluorescein isothiocyanate (FITC)-labeled peptide}{ct:Amid} | 17 - FITC-I6 | Amidation | Fluorescein isothiocyanate (FITC)-labeled peptide | Linear | L | FITC = Fluorescein isothiocyanate-labeled peptide | 11 | Antimicrobial | 9.26 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29783753 | 2018 | LRLKKYKVPQL{ct:Amid} | Cp1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 16 µM | Human | Synthesized From Bovine Αs1-Casein | unordered conformation at different environment | Non-hemolytic | ||
| 29783753 | 2018 | LRLKKYKVPQL{ct:Amid} | Cp1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5 % Hemolysis at 32 µM | Human | Synthesized From Bovine Αs1-Casein | unordered conformation at different environment | Low hemolytic | ||
| 29783753 | 2018 | LRLKKYKVPQL{ct:Amid} | Cp1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 23.54 % Hemolysis at 512 µM | Human | Synthesized From Bovine Αs1-Casein | unordered conformation at different environment | NA | ||
| 29783753 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 5 % Hemolysis at 1 µM | Human | Bee Venom | unordered conformation at 10 mM sodium phosphate, α-Helix at TFE and SDS | NA | ||
| 29783753 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 46.8 % Hemolysis at 2 µM | Human | Bee Venom | unordered conformation at 10 mM sodium phosphate, α-Helix at TFE and SDS | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY | Cap18 - pure | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 ± 1 % Hemolysis at 64 μg/ml | Horse | Rabbit Neutrophils | α-Helical | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY | Cap18 - library | Free | Free | Linear | L | None | 37 | Antimicrobial | 2 ± 1 % Hemolysis at 32 μg/ml | Horse | Rabbit Neutrophils | α-Helical | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRPRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 1 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFLNKIKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 2 | Free | Free | Linear | L | None | 37 | Antimicrobial | 6 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKFKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 4 | Free | Free | Linear | L | None | 37 | Antimicrobial | 2 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKHKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 5 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKMKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 6 | Free | Free | Linear | L | None | 37 | Antimicrobial | 2 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKQKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 7 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKSKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 8 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKECLKKIGQKIQGLLPKLAPRTDY | Peptide 9 | Free | Free | Linear | L | None | 37 | Antimicrobial | 4 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEDLKKIGQKIQGLLPKLAPRTDY | Peptide 10 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEFLKKIGQKIQGLLPKLAPRTDY | Peptide 11 | Free | Free | Linear | L | None | 37 | Antimicrobial | 9 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEILKKIGQKIQGLLPKLAPRTDY | Peptide 12 | Free | Free | Linear | L | None | 37 | Antimicrobial | 10 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKELLKKIGQKIQGLLPKLAPRTDY | Peptide 13 | Free | Free | Linear | L | None | 37 | Antimicrobial | 14 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEMLKKIGQKIQGLLPKLAPRTDY | Peptide 14 | Free | Free | Linear | L | None | 37 | Antimicrobial | 8 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEYLKKIGQKIQGLLPKLAPRTDY | Peptide 15 | Free | Free | Linear | L | None | 37 | Antimicrobial | 9 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKKKKIGQKIQGLLPKLAPRTDY | Peptide 17 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLPKIGQKIQGLLPKLAPRTDY | Peptide 19 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKEGQKIQGLLPKLAPRTDY | Peptide 20 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKHGQKIQGLLPKLAPRTDY | Peptide 21 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKNGQKIQGLLPKLAPRTDY | Peptide 22 | Free | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKICQKIQGLLPKLAPRTDY | Peptide 23 | Free | Free | Linear | L | None | 37 | Antimicrobial | 4 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKILQKIQGLLPKLAPRTDY | Peptide 24 | Free | Free | Linear | L | None | 37 | Antimicrobial | 7 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKCQGLLPKLAPRTDY | Peptide 25 | Free | Free | Linear | L | None | 37 | Antimicrobial | 2 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKGQGLLPKLAPRTDY | Peptide 27 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKSQGLLPKLAPRTDY | Peptide 29 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQTLLPKLAPRTDY | Peptide 30 | Free | Free | Linear | L | None | 37 | Antimicrobial | 2 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGPLPKLAPRTDY | Peptide 31 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLAKLAPRTDY | Peptide 32 | Free | Free | Linear | L | None | 37 | Antimicrobial | 4 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLDKLAPRTDY | Peptide 33 | Free | Free | Linear | L | None | 37 | Antimicrobial | 3 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLFKLAPRTDY | Peptide 34 | Free | Free | Linear | L | None | 37 | Antimicrobial | 7 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLHKLAPRTDY | Peptide 35 | Free | Free | Linear | L | None | 37 | Antimicrobial | 3 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLSKLAPRTDY | Peptide 36 | Free | Free | Linear | L | None | 37 | Antimicrobial | 4 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 28659061 | 2018 | NLLNDALGTVNGLLGRS | Dc1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >256 µM | Human | Frog Skin Secretion Of D. Columbianus | water = unordered structures , TFE = α-Helix | Non-hemolytic | ||
| 29614317 | 2018 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 0 % Hemolysis | Human | Solitary Wasp | water = Random coil, TFE/H2O(30%) = α-Helix | Non-hemolytic | ||
| 29614317 | 2018 | GLLKRIKT{nt:palmitoyl group (C16)}{ct:Amid} | Pal-ano-8 | Amidation | palmitoyl group (C16) | Linear | L | C16 = palmitoyl group | 8 | Antimicrobial | 50 % Hemolysis at 33.74 μg/mL | Human | Truncated Analogues Of Pal-Anoplin | water = Random coil, TFE/H2O(30%) = Helical | NA | ||
| 29614317 | 2018 | GLLKRIK{nt:palmitoyl group (C16)}{ct:Amid} | Pal-ano-7 | Amidation | palmitoyl group (C16) | Linear | L | C16 = palmitoyl group | 7 | Antimicrobial | 50 % Hemolysis at 37.7 μg/mL | Human | Truncated Analogues Of Pal-Anoplin | water = Random coil, TFE/H2O(30%) = Helical | NA | ||
| 29614317 | 2018 | GLLKR{nt:palmitoyl group (C16)}{ct:Amid} | Pal-ano-5 | Amidation | palmitoyl group (C16) | Linear | L | C16 = palmitoyl group | 5 | Antimicrobial | 50 % Hemolysis at 66.12 μg/mL | Human | Truncated Analogues Of Pal-Anoplin | water = Random coil, TFE/H2O(30%) = Random coil | NA | ||
| 29626660 | 2018 | INLKAIAALAKKLL{ct:Amid} | Mastoparan-1 (MP-I) | Amidation | Free | Linear | L | None | 14 | Antimicrobial against MRSA | 18.7 % Hemolysis at 128 mg/L | Human | Hornet Venom | Helical | NA | ||
| 29626660 | 2018 | INLKAIAALAKKLL{ct:Amid} | Mastoparan-1 (MP-I) | Amidation | Free | Linear | L | None | 14 | Antimicrobial against MRSA | 0 % Hemolysis at 0.5 mg/L | Human | Hornet Venom | Helical | Non-hemolytic | ||
| 29626660 | 2018 | INLKAIAALAKKLL{ct:Amid} | Mastoparan-1 (MP-I) | Amidation | Free | Linear | L | None | 14 | Antimicrobial against MRSA | 0 % Hemolysis at 64 mg/L | Human | Hornet Venom | Helical | Non-hemolytic | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | Tachyplesin I | Amidation | Free | Linear | L | First Disulfide Bond = CysII─CysIII, Second Disulfide Bond = CysI─CysIV | 17 | Antimicrobial | 9.6 % Hemolysis at 8 μg/mL | Human | Horseshoe Crabs(Limulus Lymphocyte Granulosa Cells) | antiparallel β‐Strand connected by a β‐Turn and stabilized by 2 disulfide bonds | NA | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | 3C7C | Amidation | Free | Linear | L | First Disulfide Bond = CysI─CysIII, Second Disulfide Bond = CysII─CysIV | 17 | Antimicrobial | 14.3 % Hemolysis at 8 μg/mL | Human | Tachyplesin I Isomers | Random coil | NA | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | 3C12C | Amidation | Free | Linear | L | First Disulfide Bond = CysI─CysII, Second Disulfide Bond = CysIII─CysIV | 17 | Antimicrobial | 4.8 % Hemolysis at 8 μg/mL | Human | Tachyplesin I Isomers | Random coil | NA | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | Tachyplesin I | Amidation | Free | Linear | L | First Disulfide Bond = CysII─CysIII, Second Disulfide Bond = CysI─CysIV | 17 | Antimicrobial | 72.8 % Hemolysis at 512 μg/mL | Human | Horseshoe Crabs(Limulus Lymphocyte Granulosa Cells) | antiparallel β‐Strand connected by a β‐Turn and stabilized by 2 disulfide bonds | NA | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | 3C7C | Amidation | Free | Linear | L | First Disulfide Bond = CysI─CysIII, Second Disulfide Bond = CysII─CysIV | 17 | Antimicrobial | 20.5 % Hemolysis at 64 μg/mL | Human | Tachyplesin I Isomers | Random coil | NA | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | 3C12C | Amidation | Free | Linear | L | First Disulfide Bond = CysI─CysII, Second Disulfide Bond = CysIII─CysIV | 17 | Antimicrobial | 14.9 % Hemolysis at 64 μg/mL | Human | Tachyplesin I Isomers | Random coil | NA | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 10 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 25 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 40 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 55 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 70 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 85 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 2.1 % Hemolysis at 100 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | NA | ||
| 30108987 | 2018 | {nnr:KP}FF{nnr:KP}FF{nnr:KP}FFK{nt:H}{ct:Amid} | CAP11 | Amidation | H | Linear | L | KP = phosphonium isostere of (trimethyl)lysine | 10 | Antimicrobial | 1.5 ± 0.1 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Non-hemolytic | ||
| 30108987 | 2018 | {nnr:RP}FF{nnr:RP}FF{nnr:RP}FF{nnr:RP}{nt:H}{ct:Amid} | CAP12 | Amidation | H | Linear | L | RP = phosphonium side chain length comparable o that of arginine | 10 | Antimicrobial | 3.1 ± 0.1 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Low hemolytic | ||
| 30108987 | 2018 | KRWWKWIRW{nt:H}{ct:Amid} | HHC10 | Amidation | H | Linear | L | None | 9 | Antimicrobial | 14.3 ± 3.6 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | NA | ||
| 29966346 | 2018 | GLFDVIKKVASVIGGL | citropin 1.1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 9 % Hemolysis at 128 µg/mL | Human | Frog Litoria Citropa | water = Random coil, TFE or SDS = Alphα-Helical structure | NA | ||
| 29966346 | 2018 | GLFDVIKKVASVIGGL | citropin 1.1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 74 % Hemolysis at 512 µg/mL | Human | Frog Litoria Citropa | water = Random coil, TFE or SDS = Alphα-Helical structure | NA | ||
| 29524591 | 2018 | MGFGCPEDEYECHNHCKNSVGCRGGYCDAGTLRQRCTCYGCNQKGRSIQE | rVpDef | Free | Free | Linear | L | None | 50 | Antimicrobial | 0 % Hemolysis at 115 µg/mL | Rabbit | Pichia Pastoris | NA | Non-hemolytic | ||
| 29524591 | 2018 | MGFGCPEDEYECHNHCKNSVGCRGGYCDAGTLRQRCTCYGCNQKGRSIQE | rVpDef | Free | Free | Linear | L | None | 50 | Antimicrobial | <0.2 % Hemolysis at 145 µg/mL | Rabbit | Pichia Pastoris | NA | Low hemolytic | ||
| 29524591 | 2018 | MGFGCPEDEYECHNHCKNSVGCRGGYCDAGTLRQRCTCYGCNQKGRSIQE | rVpDef | Free | Free | Linear | L | None | 50 | Antimicrobial | <1.5 % Hemolysis at 175 µg/mL | Rabbit | Pichia Pastoris | NA | Low hemolytic | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 0 % Hemolysis at 1 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | Non-hemolytic | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 0 % Hemolysis at 5 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | Non-hemolytic | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 5.1 % Hemolysis at 10 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 16.8 % Hemolysis at 20 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 36.1 % Hemolysis at 40 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 47.9 % Hemolysis at 60 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 49.4 % Hemolysis at 80 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30052685 | 2018 | KKK({nnr:COC5H11})FKKILKYL{nt:Acet}{ct:Amid} | BP370 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 11 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC5H11}){nt:Acet}{ct:Amid} | BP378 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 26 ± 0.4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC3H7})LFKKILKYL{nt:Acet}{ct:Amid} | BP381 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 54 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC3H7})KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 14 ± 0.5 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC3H7})L{nt:Acet}{ct:Amid} | BP389 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 22 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC5H11})FKKILKYL{nt:Acet}{ct:Amid} | BP370 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 14 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC5H11}){nt:Acet}{ct:Amid} | BP378 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 52 ± 6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC3H7})LFKKILKYL{nt:Acet}{ct:Amid} | BP381 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 76 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC3H7})KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 18 ± 1 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC3H7})L{nt:Acet}{ct:Amid} | BP389 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 39 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 28072492 | 2018 | FFPGIIKVASAILPTAICAITKRC | Brevinin1 HYba1 B1/1 COOH | Free | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >40 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 28072492 | 2018 | FFPGIIKVASAILPTAICAITKRC{ct:Amid} | Brevinin1 HYba1 B1/1 CONH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >80 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 28072492 | 2018 | FFPGIIKVAGAILPTAICAITKRC | Brevinin1 HYba2 B1/2 COOH | Free | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >50 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 28072492 | 2018 | FFPGIIKVAGAILPTAICAITKRC{ct:Amid} | Brevinin1 HYba2 B1/2 CONH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >90 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 29682907 | 2018 | SCLPKEEQIGKSTRGRKCRRKK{ct:myristoylated} | MPhd3 | myristoylated | Free | Linear | L | Myr = Myristic acid | 22 | Antimicrobial, Antibacterial | >40 % Hemolysis at 10 μM | Rat | Human-Β-Defensins | buffer = unordered conformation | NA | ||
| 29750913 | 2018 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at >64 μM | Human | Combination Of Melittin And Cecropin A | membrane = α-Helical | NA | ||
| 29750913 | 2018 | KKLFKKILKYLA-hexadecyl-1-amine{ct:n-hexadecyl acyl chain} | BP100-Ala-NH-C16H33 | n-hexadecyl acyl chain | Free | Linear | L + chain | additional alanine and an n-hexadecyl acyl chain at the C-terminus | 12 | Antimicrobial | 50 % Hemolysis at 6.3 μM | Human | Synthesized Analog Of Bp100 | membrane = α-Helical | NA | ||
| 29750913 | 2018 | C{d}ILC-KKLFKKILKYL{cyc:1‑4} | Cyclo (1‑4)‑cILC-BP100 | Free | Free | Cyclic | Mix | disulfide bond between D-Cys1 and Cys4 at N-Terminal | 11 | Antimicrobial | 50 % Hemolysis at 8.7 μM | Human | Synthesized Analog Of Bp100 | membrane =Partly α-Helical and partly β-Turn | NA | ||
| 30087268 | 2018 | ALWKDILKNAGKAALNEINQIVQ{ct:Amid} | DPS3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 138.1 μM | Horse | Frog Phyllomedusa Sauvagii | aqueous = Random coils, membrane-mimicking solution = α-Helical | NA | ||
| 30087268 | 2018 | ALWKKILKNAGKAALNKINQIVQ{ct:Amid} | K5, 17-DPS3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 14.98 μM | Horse | Analogs Of Dermaseptin-Ps3 | aqueous = Random coils, membrane-mimicking solution = α-Helical | NA | ||
| 30087268 | 2018 | ALWKDILKNLLKAALNEINQIVQ{ct:Amid} | L10, 11-DPS3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Anticancer | 50 % Hemolysis at 3.44 μM | Horse | Analogs Of Dermaseptin-Ps3 | aqueous = Random coils, membrane-mimicking solution = α-Helical | NA | ||
| 29890331 | 2018 | DLIWKLLVKAQEKFGRGKPSKRVKKMRRQWQACKSSHHHHHH | cLF36 | Free | Free | Linear | L | None | 42 | Antimicrobial | 4 % Hemolysis at 250 μg/ml | Chicken | Bacterial Escherichia Col | NA | Low hemolytic | ||
| 30192822 | 2018 | IFGAILPLALGALKNLIK | Hylin-a1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 1 % Hemolysis at 25 mM | Human | Hypsiboas Albopunctatus | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antimicrobial | 14 % Hemolysis at 25 mM | Human | Porcine Cathelicidin | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | KLLKFVTKVGKAIFKALIKAI{d} | Ocellatin4-analogue | Free | Free | Linear | Mix | None | 21 | Antimicrobial | 88 % Hemolysis at 25 mM | Human | Leptodatylus Ocellatus Analogue Of Ocellatin 4 | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | IFGAILPLALGALKNLIK | Hylin-a1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 50 mM | Human | Hypsiboas Albopunctatus | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antimicrobial | 53 % Hemolysis at 50 mM | Human | Porcine Cathelicidin | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | KLLKFVTKVGKAIFKALIKAI{d} | Ocellatin4-analogue | Free | Free | Linear | Mix | None | 21 | Antimicrobial | 100 % Hemolysis at 50 mM | Human | Leptodatylus Ocellatus Analogue Of Ocellatin 4 | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | IFGAILPLALGALKNLIK | Hylin-a1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 75 mM | Human | Hypsiboas Albopunctatus | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antimicrobial | 83 % Hemolysis at 75 mM | Human | Porcine Cathelicidin | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | KLLKFVTKVGKAIFKALIKAI{d} | Ocellatin4-analogue | Free | Free | Linear | Mix | None | 21 | Antimicrobial | 100 % Hemolysis at 75 mM | Human | Leptodatylus Ocellatus Analogue Of Ocellatin 4 | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | IFGAILPLALGALKNLIK | Hylin-a1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 1 % Hemolysis at 100 mM | Human | Hypsiboas Albopunctatus | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antimicrobial | 99 % Hemolysis at 100 mM | Human | Porcine Cathelicidin | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | KLLKFVTKVGKAIFKALIKAI{d} | Ocellatin4-analogue | Free | Free | Linear | Mix | None | 21 | Antimicrobial | 100 % Hemolysis at 100 mM | Human | Leptodatylus Ocellatus Analogue Of Ocellatin 4 | amphipathic α-Helix | NA | ||
| 29859288 | 2018 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | 2.9±0.7 % Hemolysis at 500 μg/ml | Human | Human Cathelicidin-Derived Peptide | α-Helical | Low hemolytic | ||
| 30070835 | 2018 | LKWLKKL{nt:Amid}{ct:Amid} | P4 | Amidation | Amidation | Linear | L | None | 7 | Antimicrobial, Antifungal | < 10 % Hemolysis at 200 μM | Human | Salt Tolerant De Novo Designed Leucine-Lysine Based Peptides | water = Random coil | Low hemolytic | ||
| 30070835 | 2018 | LRWLRRL{nt:Amid}{ct:Amid} | P5 | Amidation | Amidation | Linear | L | None | 7 | Antimicrobial, Antifungal | < 10 % Hemolysis at 200 μM | Human | Salt Tolerant De Novo Designed Leucine-Lysine Based Peptides | water = Random coil | Low hemolytic | ||
| 30070835 | 2018 | LKWLKKL{nt:Amid}{ct:Amid} | P4 | Amidation | Amidation | Linear | L | None | 7 | Antimicrobial, Antifungal | >2 % Hemolysis at 1 μM | Human | Salt Tolerant De Novo Designed Leucine-Lysine Based Peptides | water = Random coil | Non-hemolytic | ||
| 30070835 | 2018 | LRWLRRL{nt:Amid}{ct:Amid} | P5 | Amidation | Amidation | Linear | L | None | 7 | Antimicrobial, Antifungal | >2 % Hemolysis at 1 μM | Human | Salt Tolerant De Novo Designed Leucine-Lysine Based Peptides | water = Random coil | Non-hemolytic | ||
| 30258724 | 2018 | ALWKDLLKNVGKAAGKAVLNKVTDMVNQ{ct:Amid} | DRS-CA-1 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 114.7 μM | Horse | Callimedusa Camba(Phyllomedusa) | α-Helical | NA | ||
| 30258724 | 2018 | ALWKSLLKNVGKAAGKAALNAVTDMVNQ{ct:Amid} | DRS-DU-1 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 216.6 μM | Horse | Phyllomedusa Duellmani | α-Helical | NA | ||
| 30258724 | 2018 | ALWKSLLKNVGKA{ct:Amid} | DP-1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >512 μM | Horse | Truncated Analogue | α-Helical | NA | ||
| 30258724 | 2018 | GRKKRRQRRRGALWKSLLKNVGKA{ct:Amid} | DP-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >512 μM | Horse | Tat-Fused Dp-1 | α-Helical | NA | ||
| 30124040 | 2018 | PIMYKVPLIRKKSLRRTLSERGLLKDFLKKHNLNPARKYFPQWKAPTL | (P)PAP-A3 | Free | Free | Linear | L | None | 48 | Antimicrobial | 0 % Hemolysis at 20 μM | Mouse | Human Pepsinogen A3 | NA | Non-hemolytic | ||
| 30124040 | 2018 | PIMYKVPLIRKKSLRRTLSERGLLKDFLKKHNLNPARKYFPQWKAPTL | (P)PAP-A3 | Free | Free | Linear | L | None | 48 | Antimicrobial | 0 % Hemolysis at 40 μM | Mouse | Human Pepsinogen A3 | NA | Non-hemolytic | ||
| 30283025 | 2018 | KKKKKKAAFAAWAAFAA{ct:Amid} | 6K-F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm | 0 % Hemolysis at >500 μg/ml | Human | Synthetic Amps | NA | Non-hemolytic | ||
| 30240951 | 2018 | GLFAVIKKVASVIKGL{ct:Amid} | A4K14-citropin 1.1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | >20 % Hemolysis at 10 µM | Human | Australian Freetail Lizards | α-Helix | NA | ||
| 30240951 | 2018 | GKWLSLLKHILK{ct:Amid} | Halictine-2/11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | >35 % Hemolysis at 10 µM | Human | Derived From Bee Venom | α-Helix | NA | ||
| 30240951 | 2018 | VNWKKILGKIIKVVK{ct:Amid} | Lasioglossin-III | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Anticancer | >35 % Hemolysis at 10 µM | Human | Derived From Bee Venom | α-Helix | NA | ||
| 30240951 | 2018 | GLFAVIKKVASVIKGL{ct:Amid} | A4K14-citropin 1.1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 100 % Hemolysis at 100 µM | Human | Australian Freetail Lizards | α-Helix | NA | ||
| 30240951 | 2018 | GKWLSLLKHILK{ct:Amid} | Halictine-2/11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 100 % Hemolysis at 100 µM | Human | Derived From Bee Venom | α-Helix | NA | ||
| 30240951 | 2018 | VNWKKILGKIIKVVK{ct:Amid} | Lasioglossin-III | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Anticancer | 100 % Hemolysis at 100 µM | Human | Derived From Bee Venom | α-Helix | NA | ||
| 30121851 | 2018 | FIFHIIRFFNFRVFRI | FI16 | Free | Free | Linear | L | None | 16 | Antimicrobial | 2 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | KIFDAEILLNGKRKGLG | KG17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | AKAFKKAFEKLAAVVPFGGT | AT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | Non-hemolytic | ||
| 30121851 | 2018 | GKSNKPALTLIQARILKHKT | GT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 1 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIFHIIRFFNFRVFRI | FI16 | Free | Free | Linear | L | None | 16 | Antimicrobial | 5.39 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | NA | NA | ||
| 30121851 | 2018 | KIFDAEILLNGKRKGLG | KG17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | AKAFKKAFEKLAAVVPFGGT | AT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | Non-hemolytic | ||
| 30121851 | 2018 | GKSNKPALTLIQARILKHKT | GT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIFHIIRFFNFRVFRI | FI16 | Free | Free | Linear | L | None | 16 | Antimicrobial | 9.53 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | NA | NA | ||
| 30121851 | 2018 | KIFDAEILLNGKRKGLG | KG17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.25 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | AKAFKKAFEKLAAVVPFGGT | AT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | Non-hemolytic | ||
| 30121851 | 2018 | GKSNKPALTLIQARILKHKT | GT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIFHIIRFFNFRVFRI | FI16 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10.79 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | NA | NA | ||
| 30121851 | 2018 | KIFDAEILLNGKRKGLG | KG17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.13 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | AKAFKKAFEKLAAVVPFGGT | AT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | Non-hemolytic | ||
| 30121851 | 2018 | GKSNKPALTLIQARILKHKT | GT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30135470 | 2018 | {nnr:R}-{nnr:dab}V{nnr:dab}FL{nnr:dab}VLS{cyc:N-C} | PGP-E | Free | Free | Cyclic | Mix | Dab = Diaminobutyric acid, R = CH2CH2CH3(propyl group) | 9 | Antimicrobial | <50 % Hemolysis at 200 µM | Human | Bacteria Paenibacillus Elgii Bc34-6 | NA | NA | ||
| 30149134 | 2018 | CVKGGKKYKRQGKGHRMRRYRNNH | TO24 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis | Fish | Fish Red Drum (Sciaenops Ocellatus) | NA | Non-hemolytic | ||
| 30325566 | 2018 | ELL{d}VDL{d}L{cyc:N-C}{nt:Amid} | surfactin | Free | Amidation | Cyclic | Mix | l = D-Leucine | 7 | Antimicrobial | high % Hemolysis at 100 µM | Human | Bacteria Bacillus Subtilis | NA | NA | ||
| 30039186 | 2018 | FFRNLWKGAKAAFRAGHAAWRA | Moronecidin-like | Free | Free | Linear | L | None | 22 | Antimicrobial, Anti-bioflim | 50 % Hemolysis at 87.5 μg/mL | Human | Fish Seahorse Hippocampus Comes | α-Helix | NA | ||
| 30039186 | 2018 | FFHHIFRGIVHVGKTIHRLVTG | Moronecidin | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 2.34 μg/mL | Human | Fish Hybrid Striped Bass | α-Helix | Low hemolytic | ||
| 30208331 | 2018 | MKKKIISAILMSTVILSAAAPLSGVYALDISSTCDADLIWKLLVKAQEKFGRGKPSKRVKKMRRQWQACKSSHHHHHH{ct:His-tag} | cLFchimera | His-tag | Free | Linear | L | None | 78 | Antimicrobial | 2.5 % Hemolysis at 250 μg/mL | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 30475621 | 2018 | NLCASLRARHTIPQCRKFGRR{nt:Amid}{ct:Amid} | mBjAMP1-ox | Amidation | Amidation | Linear | L | None | 21 | Antimicrobial | <1 % Hemolysis at 256 µM | Sheep | Lancelet Branchiostoma Japonicum Mbjamp1 Analogs | TFE or SDS = α-Helix | Non-hemolytic | ||
| 30475621 | 2018 | NLSASLRARHTIPQSRKFGRR{nt:Amid}{ct:Amid} | mBjAMP1-sre | Amidation | Amidation | Linear | L | None | 21 | Antimicrobial | <1 % Hemolysis at 256 µM | Sheep | Lancelet Branchiostoma Japonicum Mbjamp1 Analogs | 10 mM sodium phosphate buffer = Random coil, TFE or SDS = α-Helix | Non-hemolytic | ||
| 29959905 | 2019 | KRFIKWYNAWNEKRRVY{ct:Amid} | CXCL14-C17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <10 % Hemolysis at 1024 µM | Human | Human Chemokine Cxcl14 | α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYKAWNKKRRVY{ct:Amid} | CXCL14-C17-a1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <10 % Hemolysis at 1024 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYKAWNKKWRKY{ct:Amid} | CXCL14-C17-a2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | 10 % Hemolysis at 480 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | NA | ||
| 29959905 | 2019 | KRFKKWYKAWRKKWRKY{ct:Amid} | CXCL14-C17-a3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | 10 % Hemolysis at 700 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYNAWNEKRRVY{ct:Amid} | CXCL14-C17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Human Chemokine Cxcl14 | α-Helix | Non-hemolytic | ||
| 29959905 | 2019 | KRFIKWYKAWNKKRRVY{ct:Amid} | CXCL14-C17-a1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | Non-hemolytic | ||
| 29959905 | 2019 | KRFIKWYKAWNKKWRKY{ct:Amid} | CXCL14-C17-a2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | Non-hemolytic | ||
| 29959905 | 2019 | KRFKKWYKAWRKKWRKY{ct:Amid} | CXCL14-C17-a3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | Non-hemolytic | ||
| 30120878 | 2019 | TSVRQRWRWRQRVRTS{ct:Amid} | P38 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 50 μg/ml | Human | Derived From Human Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 30120878 | 2019 | KRSKRKRRIHQRVRIS{ct:Amid} | P22 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 50 μg/ml | Human | Derived From Human Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 30120878 | 2019 | TLSKEKERIVQRVRTS{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 50 μg/ml | Human | Derived From Human Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 30176540 | 2019 | AKRFFGYKRKFF{nt:Acet}{ct:Amid} | Phe-P-113 | Amidation | Acetylation | Linear | L | None | 12 | Antimicrobial, Anti-inflammatory | 0 % Hemolysis at 25 μg/ml | Human | Analoge Of P-113 | NA | Non-hemolytic | ||
| 30176540 | 2019 | AKR{nnr:nal}{nnr:nal}GYKRKF{nnr:nal}{nt:Acet}{ct:Amid} | Nal-P-113 | Amidation | Acetylation | Linear | L | Nal = β-naphthylalanine | 12 | Antimicrobial, Anti-inflammatory | 0 % Hemolysis at 25 μg/ml | Human | Analoge Of P-113 | NA | Non-hemolytic | ||
| 30176540 | 2019 | AKR{nnr:bip}{nnr:bip}GYKRKF{nnr:bip}{nt:Acet}{ct:Amid} | Bip-P-113 | Amidation | Acetylation | Linear | L | Bip = β-(4,4’-biphenyl)alanine | 12 | Antimicrobial, Anti-inflammatory | 4 % Hemolysis at 25 μg/ml | Human | Analoge Of P-113 | NA | NA | ||
| 30176540 | 2019 | AKR{nnr:dip}{nnr:dip}GYKRKF{nnr:dip}{nt:Acet}{ct:Amid} | Dip-P-113 | Amidation | Acetylation | Linear | L | Dip = β-diphenylalanine | 12 | Antimicrobial, Anti-inflammatory,salt resistance, serum proteolytic stability, peptide-induced permeabilization | 0 % Hemolysis at 25 μg/ml | Human | Analoge Of P-113 | NA | Non-hemolytic | ||
| 30658410 | 2019 | GILDWGKKVMDWIKDKM{ct:Amid} | PLP1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 50 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30658410 | 2019 | GWGSIFKTVGKMIAKAAVKAAPEAISAMASQNE | PLP2 | Free | Free | Linear | L | None | 33 | Antimicrobial, histamine-releasing activity | 10.4 % Hemolysis at 50 µM | Human | Ant Odontomachus Monticola | α-Helix | NA | ||
| 30658410 | 2019 | KIKWGKIFKKGGKLIGKTALEAAANAAASEAISAMASQNE | PLP3 | Free | Free | Linear | L | None | 40 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 50 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30658410 | 2019 | GVKELFGKAWGLVKKHLPKACGLLGYVKQ | PLP4 | Free | Free | Linear | L | None | 29 | Antimicrobial, histamine-releasing activity | 10.5 % Hemolysis at 50 µM | Human | Ant Odontomachus Monticola | α-Helix | NA | ||
| 30658410 | 2019 | IKGKKIMKNMGKAMKIAGKVAKAMAPIVVPLIVSAA{ct:Amid} | PLP6 | Amidation | Free | Linear | L | None | 36 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 50 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30658410 | 2019 | GILDWGKKVMDWIKDKM{ct:Amid} | PLP1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 10 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30658410 | 2019 | GWGSIFKTVGKMIAKAAVKAAPEAISAMASQNE | PLP2 | Free | Free | Linear | L | None | 33 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 10 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30658410 | 2019 | KIKWGKIFKKGGKLIGKTALEAAANAAASEAISAMASQNE | PLP3 | Free | Free | Linear | L | None | 40 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 10 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30658410 | 2019 | GVKELFGKAWGLVKKHLPKACGLLGYVKQ | PLP4 | Free | Free | Linear | L | None | 29 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 10 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30658410 | 2019 | IKGKKIMKNMGKAMKIAGKVAKAMAPIVVPLIVSAA{ct:Amid} | PLP6 | Amidation | Free | Linear | L | None | 36 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 10 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30709056 | 2019 | FFSLIPSLVGGLISAFK | Stigmurin | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.8 % Hemolysis at 150 µM | Human | Scorpion Tityus Stigmurus Venom | Water and PBS = Random coil, SDS 20mM = α-Helix, 40% TFE = α-Helix | Low hemolytic | ||
| 30709056 | 2019 | FFSLIPSLVKKLIKAFK | StigA25 | Free | Free | Linear | L | None | 17 | Antimicrobial, Antiparasitic | 18.5 % Hemolysis at 9.4 µM | Human | Analogs Of Stigmurin | Water and PBS = Random coil, SDS 20mM = α-Helix, 60% TFE = α-Helix | NA | ||
| 30709056 | 2019 | FFKLIPKLVKKLIKAFK | StigA31 | Free | Free | Linear | L | None | 17 | Antimicrobial, Antiparasitic | 11.2 % Hemolysis at 9.4 µM | Human | Analogs Of Stigmurin | Water and PBS = Random coil, SDS 20mM = α-Helix, 30% TFE = α-Helix | NA | ||
| 30500360 | 2019 | PFKLSLHL{ct:Amid} | Jelleine-I | Amidation | Free | Linear | L | None | 8 | Antibiofilm, Antimicrobial | ~5 % Hemolysis at 256 µM | Mouse | Royal Jelly Of Honeybees (Apis Mellifera) | NA | Low hemolytic | ||
| 30500360 | 2019 | P{nnr:Fc}KLSLHL{ct:Amid} | fluorine-Jelleine-I (F-J-I) | Amidation | Free | Linear | L | Fc = 4-F-phe-amino acid | 8 | Antibiofilm, Antimicrobial | 3 % Hemolysis at 256 µM | Mouse | Jelleine-I Halogenated Derivatives | NA | Low hemolytic | ||
| 30500360 | 2019 | P{nnr:Fd}KLSLHL{ct:Amid} | chlorine-Jelleine-I (Cl-J-I) | Amidation | Free | Linear | L | Fd = 4-Cl-phe-amino acid | 8 | Antibiofilm, Antimicrobial | 2 % Hemolysis at 256 µM | Mouse | Jelleine-I Halogenated Derivatives | NA | Low hemolytic | ||
| 30500360 | 2019 | P{nnr:Fe}KLSLHL{ct:Amid} | bromine-Jelleine-I (Br-J-I) | Amidation | Free | Linear | L | Fe = 4-Br-phe-amino acid | 8 | Antibiofilm, Antimicrobial | ~4 % Hemolysis at 256 µM | Mouse | Jelleine-I Halogenated Derivatives | NA | Low hemolytic | ||
| 30500360 | 2019 | P{nnr:Ff}KLSLHL{ct:Amid} | iodine-Jelleine-I (I-J-I) | Amidation | Free | Linear | L | Ff = 4-I-phe-amino acid | 8 | Antibiofilm, Antimicrobial | ~10 % Hemolysis at 256 µM | Mouse | Jelleine-I Halogenated Derivatives | NA | Low hemolytic | ||
| 30717183 | 2019 | GMWSKILGHLIR | HAL-1 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 82 µM | Rat | Eusocial Bee Venom Halictus Sexcinctus | 30% TFE = α-Helix | NA | ||
| 30717183 | 2019 | GMWSKILGPLIR | HAL-1/2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Rat | Analogs Of Hal-1 | 30% TFE = α-Helix | NA | ||
| 30717183 | 2019 | GMWSKILGHLIK | HAL-1/6 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 132 µM | Rat | Analogs Of Hal-1 | 30% TFE = α-Helix | NA | ||
| 30717183 | 2019 | GMWKKILGKLIR | HAL-1/10 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Rat | Analogs Of Hal-1 | 30% TFE = α-Helix | NA | ||
| 30717183 | 2019 | GKWSKILGKLIR | HAL-1/20 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Rat | Analogs Of Hal-1 | 30% TFE = α-Helix | NA | ||
| 30612735 | 2019 | FLSLIPHIASGIASLVKNF{ct:Amid} | Phylloseptin-PBa1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anticancer | 50 % Hemolysis at 18.6 µM | Horse | Leaf Forg (Phyllomedusa Burmeisteri) | α-Helix | NA | ||
| 30612735 | 2019 | FLSLLPHIASGIASLVSKF{ct:Amid} | Phylloseptin-PBa2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anticancer | 50 % Hemolysis at 15.82 µM | Horse | Leaf Forg (Phyllomedusa Burmeisteri) | α-Helix | NA | ||
| 30612735 | 2019 | FLSLIPHIVSGVAALANHL{ct:Amid} | Phylloseptin-PBa3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anticancer | 50 % Hemolysis at 52.98 µM | Horse | Leaf Forg (Phyllomedusa Burmeisteri) | α-Helix | NA | ||
| 30481557 | 2019 | HSDGIFTDSYSRYRKQMAVKKYLAAVLGRRYRQRFRNK{ct:Amid} | PACAP | Amidation | Free | Linear | L | None | 38 | Anticancer, Antimicrobial | 0 % Hemolysis at 18.75 µM | Fish | Catfish Clarias Gariepinus | α-Helix | Non-hemolytic | ||
| 30481557 | 2019 | HSDGIFTDSYSRYRKQMAVKKYLAAVLGRRYRQRFRNK{ct:Amid} | PACAP | Amidation | Free | Linear | L | None | 38 | Anticancer, Antimicrobial | <20 % Hemolysis at 150 µM | Fish | Catfish Clarias Gariepinus | α-Helix | NA | ||
| 30481557 | 2019 | HSDGIFTDSYSRYRKQMAVKKYLAAVLGRRYRQRFRNK{ct:Amid} | PACAP | Amidation | Free | Linear | L | None | 38 | Anticancer, Antimicrobial | 39 % Hemolysis at 300 µM | Fish | Catfish Clarias Gariepinus | α-Helix | NA | ||
| 30481557 | 2019 | HSDGIFTDSYSRYRKQMAVKKYLAAVLGRRYRQRFRNK{ct:Amid} | PACAP | Amidation | Free | Linear | L | None | 38 | Anticancer, Antimicrobial | 0 % Hemolysis at 75 µM | Human | Catfish Clarias Gariepinus | α-Helix | Non-hemolytic | ||
| 30481557 | 2019 | HSDGIFTDSYSRYRKQMAVKKYLAAVLGRRYRQRFRNK{ct:Amid} | PACAP | Amidation | Free | Linear | L | None | 38 | Anticancer, Antimicrobial | <3 % Hemolysis at 150 µM | Human | Catfish Clarias Gariepinus | α-Helix | NA | ||
| 30481557 | 2019 | HSDGIFTDSYSRYRKQMAVKKYLAAVLGRRYRQRFRNK{ct:Amid} | PACAP | Amidation | Free | Linear | L | None | 38 | Anticancer, Antimicrobial | 6 % Hemolysis at 300 µM | Human | Catfish Clarias Gariepinus | α-Helix | NA | ||
| 30842436 | 2019 | K-K-{nnr:(NBu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N4-MeBn)Gly}-{nnr:(N1-Nal)Gly} | B1 | Free | Free | Linear | L | (NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (N4-MeBn)Gly = N-(4-methylbenzyl)glycine | 7 | Antimicrobial | 32 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 23 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antimicrobial | 59 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:nle}-(1-Nal)ala-F{d}-(1-Nal)ala | 26 | Free | Free | Linear | Mix | nle = D-Norleucine, (1-Nal)Ala = 1-Naphthylalanine | 7 | Antimicrobial | 56 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-{nnr:(NBu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N4-MeBn)Gly}-{nnr:(N1-Nal)Gly} | B1 | Free | Free | Linear | L | (NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (N4-MeBn)Gly = N-(4-methylbenzyl)glycine | 7 | Antimicrobial | 10 % Hemolysis at 64 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 23 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antimicrobial | 10 % Hemolysis at 14 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-{nnr:(NBu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N4-MeBn)Gly}-{nnr:(N1-Nal)Gly} | B1 | Free | Free | Linear | L | (NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (N4-MeBn)Gly = N-(4-methylbenzyl)glycine | 7 | Antimicrobial | 50 % Hemolysis at 230 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 23 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antimicrobial | 50 % Hemolysis at 104 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:nle}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala} | 26 | Free | Free | Linear | Mix | nle = D-Norleucine, (1-Nal)Ala = 1-Naphthylalanine | 7 | Antimicrobial | 50 % Hemolysis at 63 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30648626 | 2019 | QSHLSLCRWCCNCCHNKGCGFCCKF | Bthepc | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 34.71 µM | Human | Hepcidin Gene Brown Trout (Salmo Trutta) | NA | NA | ||
| 30648626 | 2019 | QSHLSLCRWCCNCCHNKGCGFCCKF | Bthepc | Free | Free | Linear | L | None | 25 | Antimicrobial | 28.2 % Hemolysis at 2.17 µM | Human | Hepcidin Gene Brown Trout (Salmo Trutta) | NA | NA | ||
| 30848594 | 2019 | K{d}L{d}R{d}S{d}L{d}L{d}R{d}T{d}L{d}S{d}R{d}A{d}K{d}A{d}A{d}K{d}L{d}R{d}T{d}L{d}L{d}R{d}A{d}L{d}S{d}R{d}{nt:Acet}{ct:Amid} | D87(Lys'-6 Arg-1) | Amidation | Acetylation | Linear | D | substituted with positive charged Arg | 26 | Antimicrobial | 50 % Hemolysis at 12 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D84(Lys¹-6 Lys-1) | Amidation | Acetylation | Linear | D | substituted with positive charged Lys | 26 | Antimicrobial | 50 % Hemolysis at 155.5 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:o}S{d}L{d}L{d}{nnr:o}T{d}L{d}S{d}{nnr:o}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:o}T{d}L{d}L{d}{nnr:o}A{d}L{d}S{d}{nnr:o} | D85(Lys'-6 Orn-1) | Amidation | Acetylation | Linear | D | o = D-Ornithine | 26 | Antimicrobial | 50 % Hemolysis at 406.5 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}{nnr:Dab} | D86(Lys¹-6 Dab-1) | Amidation | Acetylation | Linear | Mix | Dab = diaminobutyric acid | 26 | Antimicrobial | 50 % Hemolysis at >2000 μg/mL | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 30848594 | 2019 | K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}{nnr:Dap}aK{d}A{d}A{d}K{d}L{d}{nnr:Dap}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap} | D105(Lys¹-6 Dap-1) | Amidation | Acetylation | Linear | Mix | Dap = diaminopropionic acid | 26 | Antimicrobial | 50 % Hemolysis at >3000 μg/mL | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 30848594 | 2019 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}S{d}{nt:Acet}{ct:Amid} | D101(Lys' Ser26-5 Lys-1) | Amidation | Acetylation | Linear | D | substituted with positive charged Lys | 26 | Antimicrobial | 50 % Hemolysis at 279 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{d} | D102(Lys Ser26-5 Dab-1) | Amidation | Acetylation | Linear | Mix | Dab = diaminobutyric acid | 26 | Antimicrobial | 50 % Hemolysis at >2000 μg/mL | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 30848594 | 2019 | K{d}L{d}{nnr:o}S{d}L{d}L{d}{nnr:o}T{d}L{d}S{d}{nnr:o}A{d}A{d}A{d}A{d}A{d}L{d}{nnr:o}T{d}L{d}L{d}{nnr:o}A{d}L{d}S{d}{nnr:o} | D85(K13A/K16A) -(Lys'-6 Orn-1) | Amidation | Acetylation | Linear | D | o = D-Ornithine | 26 | Antimicrobial | 50 % Hemolysis at 2.3 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}A{d}A{d}A{d}A{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}{nnr:Dab} | D86(K13A/K16A) -(Lys¹-6 Dab-1) | Amidation | Acetylation | Linear | Mix | Dab = diaminobutyric acid | 26 | Antimicrobial | 50 % Hemolysis at 20 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}{nnr:Dap}A{d}A{d}A{d}A{d}A{d}L{d}{nnr:Dap}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap} | D105(K13A/K16A) -(Lys'-6 Dap-1) | Amidation | Acetylation | Linear | Mix | Dap = diaminopropionic acid | 26 | Antimicrobial | 50 % Hemolysis at 7.2 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30794440 | 2019 | RQCKAESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC | NoD173 | Free | Free | Linear | L | None | 47 | Antitumor, Antiproliferative, Antimicrobial | ~12 % Hemolysis at 100 µM | Human | Plant Nicotiana Occidentalis Defensin 173 (Nod173) | single α-Helix braced by 3 disulfide bonds to a Triple-Stranded antiparallel b-Sheet | Low hemolytic | ||
| 30802593 | 2019 | MFTLKKPLLLLFFLGTINLSLCEEERNADEEERRDDPEERDVEVEKRFIVPSIFLLKKAFCIALKKC | Japonicin-2LF | Free | Free | Linear | L | None | 67 | Antibiofilm, Antimicrobial | > 80 % Hemolysis at 64 µM | Horse | Limnonectes Fujianensis (Fujian Large-Headed Frog) | aqueous = Random coil, membrane-mimic solutions = α-Helix | NA | ||
| 31016971 | 2019 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | cathelicidin LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | 5 % Hemolysis at 10 µM | Human | Homo Sapiens (Human) Cathelicidin Amp | α-Helix | Low hemolytic | ||
| 31016971 | 2019 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNL | Fragment LL-32 | Free | Free | Linear | L | None | 32 | Antimicrobial | 40 % Hemolysis at 10 µM | Human | Fragment Of Cathelicidin Ll-37 | α-Helix | NA | ||
| 31159194 | 2019 | CGIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis at 0.8 ± 0.2 (n at25) µM (pH 5.5) | Human | Cell-Penetrating Peptide | NA | NA | ||
| 31159194 | 2019 | CYGRKKRRQRR | Tat | Free | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 5.5) | Human | Cell Penetrating Cargo Delivery Peptides | NA | NA | ||
| 31159194 | 2019 | CRQIKIWFQNRRMKWKK | Penetratin | Free | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 5.5) | Human | Cell Penetrating Cargo Delivery Peptides | NA | NA | ||
| 31159194 | 2019 | CGLFEAIAGFIENGWEGMIDGWYG | HA2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 5.5) | Human | Parent Influenza Hemagglutinin Peptide | NA | NA | ||
| 31159194 | 2019 | CGLFEAIEGFIENGWEGMIDGWYG | INF7 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 16 µM (pH 5.5) | Human | Ha2 Analog | NA | NA | ||
| 31159194 | 2019 | CGLFEAIAGFIENGWEGMIDGWYGYGRKKRRQRR | HA2-Tat | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at 2.3 ± 0.5 (n at 10) µM (pH 5.5) | Human | Chimeric Peptide | NA | NA | ||
| 31159194 | 2019 | CGLFEAIEGFIENGWEGMIDGWYGYGRKKRRQRR | INF7-Tat | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at 1.4 ± 0.4 (n at 10) µM (pH 5.5) | Human | Lead Chimeric Peptide By Combining Several Known Ha2 Analogs With Tat | pH 5.5 = α-Helix | NA | ||
| 31159194 | 2019 | CGLFHAIAHFIHGGWHGLIHGWYGYGRKKRRQRR | H5WYG-Tat | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at 5.9 µM (pH 5.5) | Human | Lead Chimeric Peptide By Combining Several Known Ha2 Analogs With Tat | NA | NA | ||
| 31159194 | 2019 | CGLFKAIAKFIKGGWKGLIKGWYGYGRKKRRQRR | K5WYG-Tat | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at 1.9 µM (pH 5.5) | Human | Lead Chimeric Peptide By Combining Several Known Ha2 Analogs With Tat | NA | NA | ||
| 31159194 | 2019 | CGLFEAIAEFIEGGWEGLIEGWYGYGRKKRRQRR | E5WYG-Tat | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 5.5) | Human | Lead Chimeric Peptide By Combining Several Known Ha2 Analogs With Tat | NA | NA | ||
| 31159194 | 2019 | CGLFEAIAGFIENGWEGMIDGWYGRQIKIWFQNRRMKWKKGG | HA2-Penetratin | Free | Free | Linear | L | None | 42 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 5.5) | Human | Chimeric Fusion Peptides Of Ha2 And Inf7 With Penetratin | NA | NA | ||
| 31159194 | 2019 | CGLFEAIEGFIENGWEGMIDGWYGRQIKIWFQNRRMKWKKGG | INF7-Penetratin | Free | Free | Linear | L | None | 42 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 5.5) | Human | Chimeric Fusion Peptides Of Ha2 And Inf7 With Penetratin | NA | NA | ||
| 31159194 | 2019 | CGIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis at 2.6 ± 0.6 (n at 25) µM (pH 7.4) | Human | Cell-Penetrating Peptide | NA | NA | ||
| 31159194 | 2019 | CYGRKKRRQRR | Tat | Free | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Cell Penetrating Cargo Delivery Peptides | NA | NA | ||
| 31159194 | 2019 | CRQIKIWFQNRRMKWKK | Penetratin | Free | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Cell Penetrating Cargo Delivery Peptides | NA | NA | ||
| 31159194 | 2019 | CGLFEAIAGFIENGWEGMIDGWYG | HA2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Parent Influenza Hemagglutinin Peptide | NA | NA | ||
| 31159194 | 2019 | CGLFEAIEGFIENGWEGMIDGWYG | INF7 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Ha2 Analog | NA | NA | ||
| 31159194 | 2019 | CGLFEAIAGFIENGWEGMIDGWYGYGRKKRRQRR | HA2-Tat | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at 5.7 ± 1.1 (n at 10) µM (pH 7.4) | Human | Chimeric Peptide | NA | NA | ||
| 31159194 | 2019 | CGLFEAIEGFIENGWEGMIDGWYGYGRKKRRQRR | INF7-Tat | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at 4.6 ± 1.2 (n at 10) µM (pH 7.4) | Human | Lead Chimeric Peptide By Combining Several Known Ha2 Analogs With Tat | pH 7.4 = Random coil | NA | ||
| 31159194 | 2019 | CGLFHAIAHFIHGGWHGLIHGWYGYGRKKRRQRR | H5WYG-Tat | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at 0.3 µM (pH 7.4) | Human | Lead Chimeric Peptide By Combining Several Known Ha2 Analogs With Tat | NA | NA | ||
| 31159194 | 2019 | CGLFKAIAKFIKGGWKGLIKGWYGYGRKKRRQRR | K5WYG-Tat | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at 0.9 µM (pH 7.4) | Human | Lead Chimeric Peptide By Combining Several Known Ha2 Analogs With Tat | NA | NA | ||
| 31159194 | 2019 | CGLFEAIAEFIEGGWEGLIEGWYGYGRKKRRQRR | E5WYG-Tat | Free | Free | Linear | L | None | 34 | Antimicrobial | 50 % Hemolysis at 2.2 µM (pH 7.4) | Human | Lead Chimeric Peptide By Combining Several Known Ha2 Analogs With Tat | NA | NA | ||
| 31159194 | 2019 | CGLFEAIAGFIENGWEGMIDGWYGRQIKIWFQNRRMKWKKGG | HA2-Penetratin | Free | Free | Linear | L | None | 42 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Chimeric Fusion Peptides Of Ha2 And Inf7 With Penetratin | NA | NA | ||
| 31159194 | 2019 | CGLFEAIEGFIENGWEGMIDGWYGRQIKIWFQNRRMKWKKGG | INF7-Penetratin | Free | Free | Linear | L | None | 42 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Chimeric Fusion Peptides Of Ha2 And Inf7 With Penetratin | NA | NA | ||
| 31303986 | 2019 | IWLTALKFLGKHAAKHLAKQQLSKL{ct:Amid} | M-lycotoxin | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 0.78 μM | Human | Wolf Spider Lycosa Carolinensis | α-Helix | NA | ||
| 31303986 | 2019 | GIGKFLHSAKKFGKAFVGEIMNS{nt:Acet}{ct:Amid} | Magainin 2 derivative | Amidation | Acetylation | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at >100 μM | Human | Xenopus Laevis (The African Clawed Frog | α-Helix | Non-hemolytic | ||
| 31199859 | 2019 | FIGAIARLLSKIF | BmKn-2 | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer, Antibiofilm | 100 % Hemolysis at 800 μM | Sheep | Scorpion Mesobuthus Martensii Karsch | α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT{ct:OH} | Ranatuerin-2Pb | OH | Free | Linear | L | None | 34 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 16.11 μM | Horse | Frog Rana Pipiens | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC{ct:OH} | RPa | OH | Free | Linear | L | None | 32 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 63.9 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAAL{ct:Amid} | RPb | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 178 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT{ct:OH} | Ranatuerin-2Pb | OH | Free | Linear | L | None | 34 | Antimicrobial, Antibiofilm | 20 % Hemolysis at 8 μM | Horse | Frog Rana Pipiens | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC{ct:OH} | RPa | OH | Free | Linear | L | None | 32 | Antimicrobial, Antibiofilm | 20 % Hemolysis at 32 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAAL{ct:Amid} | RPb | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 20 % Hemolysis at 64 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 30927490 | 2019 | ACYCRIPACIAGERRYGTCIYQGRLWAFCC | HNP-1 | Free | Free | Linear | L | None | 30 | Antimicrobial | 9.3 % Hemolysis at 5 μM | Mouse | Α‐Defensin (Human Neutrophil Peptide‐1) | Triple-Stranded β-Sheet structure | NA | ||
| 30927490 | 2019 | YGTCIYQGRLWAFCC | HNP‐R | Free | Free | Linear | L | None | 15 | Antimicrobial | 9.9 % Hemolysis at 5 μM | Mouse | D Posterior‐Half Fragment Of Hnp | NA | NA | ||
| 30927490 | 2019 | ACYCRIPACIAGERRYGTCIYQGRLWAFCC | HNP-1 | Free | Free | Linear | L | None | 30 | Antimicrobial | 8.7 % Hemolysis at 500 μM | Mouse | Α‐Defensin (Human Neutrophil Peptide‐1) | Triple-Stranded β-Sheet structure | Low hemolytic | ||
| 30927490 | 2019 | YGTCIYQGRLWAFCC | HNP‐R | Free | Free | Linear | L | None | 15 | Antimicrobial | 8.4 % Hemolysis at 500 μM | Mouse | D Posterior‐Half Fragment Of Hnp | NA | Low hemolytic | ||
| 30927490 | 2019 | ACYCRIPACIAGERRYGTCIYQGRLWAFCC | HNP-1 | Free | Free | Linear | L | None | 30 | Antimicrobial | 8.8 % Hemolysis at 5000 μM | Mouse | Α‐Defensin (Human Neutrophil Peptide‐1) | Triple-Stranded β-Sheet structure | Low hemolytic | ||
| 30927490 | 2019 | YGTCIYQGRLWAFCC | HNP‐R | Free | Free | Linear | L | None | 15 | Antimicrobial | 9.2 % Hemolysis at 5000 μM | Mouse | D Posterior‐Half Fragment Of Hnp | NA | Low hemolytic | ||
| 31087626 | 2019 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL, 2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | >40 % Hemolysis at 3.12 μM | Sheep | Analogue Temporin L | PB =Random coil, DPC = α-Helix, SDS = α-Helix, DPC/SDS = α-Helix | NA | ||
| 31087626 | 2019 | FV{nnr:cis4-MeS-Pro}WFSKFLGRIL{ct:Amid} | peptide 6 | Amidation | Free | Linear | L | cis-4MeS-Pro = cis-4-Methylthio-L-Proline | 13 | Antimicrobial | >20 % Hemolysis at 3.12 μM | Sheep | Modification Of Proline In [Pro3]Tl | PB =β-Sheet, DPC = α-Helix, SDS = α-Helix, DPC/SDS = α-Helix | NA | ||
| 31087626 | 2019 | FV{nnr:cis4-NH2-Pro}WFSKFLGRIL{ct:Amid} | peptide 7 | Amidation | Free | Linear | L | cis-4NH2-Pro = cis-4-amino-L-Proline | 13 | Antimicrobial | >30 % Hemolysis at 50 μM | Sheep | Modification Of Proline In [Pro3]Tl | PB =Random coil, DPC = α-Helix, SDS = α-Helix, DPC/SDS = α-Helix | NA | ||
| 31087626 | 2019 | FV({nnr:cis-4PhO-Pro})WFSKFLGRIL{ct:Amid} | peptide 11 | Amidation | Free | Linear | L | cis-4PhO-Pro = cis-4-Phenoxy-L-Proline | 13 | Antimicrobial | >40 % Hemolysis at 3.12 μM | Sheep | Modification Of Proline In [Pro3]Tl | PB =Random coil, DPC = α-Helix, SDS = α-Helix, DPC/SDS = α-Helix | NA | ||
| 31409990 | 2019 | ILPWKWPWWPWRR{ct:Amid} | indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antifungal | 20 % Hemolysis at 50 µg/mL | Human | Host Defense Peptides (Hdps) | NA | NA | ||
| 31409990 | 2019 | ILPWKWPWWPWRR{ct:Amid} | indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antifungal | 1 % Hemolysis at 0.78 µg/mL | Human | Host Defense Peptides (Hdps) | NA | NA | ||
| 31360462 | 2019 | MKIFYYLLHFLCYMTFILPAICTLVDPERCSKMYGQCRTRCYKIEKQIDICYSPSKICCIQRAFEEDLS | rPBD114 (Recombinant porcine beta defensin 114) | Free | Free | Linear | L | None | 69 | Antimicrobial | <3.9 % Hemolysis at 256 μg/mL | Pig | Pig Beta-Defensin 114 Precursor [Sus Scrofa] | NA | Low hemolytic | ||
| 31059203 | 2019 | KWLRRVWRWWR{ct:Amid} | MAP-0403 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 70.7 % Hemolysis at 100 μM | Human | Synthetic Amp | α-Helix | NA | ||
| 31059203 | 2019 | KWLRWVRRRWW{ct:Amid} | J-1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 46.2 % Hemolysis at 100 μM | Human | Map-0403 Peptide Analogs | SDS = β-Sheet | NA | ||
| 31059203 | 2019 | KWLRRPWRRWR{ct:Amid} | J-2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3.4 % Hemolysis at 100 μM | Human | Map-0403 Peptide Analogs | SDS = Random coil | Low hemolytic | ||
| 31059203 | 2019 | KWLRRPWRWWR{ct:Amid} | J-3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 55.6 % Hemolysis at 100 μM | Human | Map-0403 Peptide Analogs | SDS = Random coil | NA | ||
| 31426323 | 2019 | ALWKTLLKHVGKAAGKAALNAVTDMVNQ{ct:Amid} | Der-PS4 | Amidation | Free | Linear | L | None | 28 | Antimicrobial, Antibiofilm, Antiproliferative, Anticancer | 50 % Hemolysis at 128 μM | Horse | Waxy Monkey Tree Frog, Phyllomedusa Sauvagii | mimetic environment(DOPE, DOPC and DOPG, TFE) = α-Helix | NA | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.2 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 61 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.1 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.6 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 89.6 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 40.2 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 23.5 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 58.8 % Hemolysis at 256 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 23.2 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 49.3 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 11.9 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 15.4 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 19.2 % Hemolysis at 128 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 6.6 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.7 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 16.1 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 2.9 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 12 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.5 % Hemolysis at 64 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.5 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.4 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.5 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.4 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 6.5 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.5 % Hemolysis at 32 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.2 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.4 % Hemolysis at 16 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.4 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.4 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.5 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.5 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.6 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.6 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.6 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 17.4 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.6 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 2 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.4 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.6 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 18 % Hemolysis at 400 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Low hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 5 % Hemolysis at 200 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Low hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 100 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 50 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 25 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 12.5 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 6.25 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 3.125 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31319057 | 2019 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 170 μM | Human | Human Innate Immune Peptide Ll-37 | α-Helix | NA | ||
| 31319057 | 2019 | GFKRIVQRIKDFLRNLV{ct:Amid} | GF-17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 180 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF-W | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 12.1 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17mF-W | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 7.1 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | Low hemolytic | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17W2 | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 8 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | Low hemolytic | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF2 | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 32.5 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17B-tF | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 30.2 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KD {nnr:X2}L{d}RKLV{ct:Amid} | 17BIPHE2 | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = biphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 61.5 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF-W | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17mF-W | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17W2 | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF2 | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17B-tF | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KD {nnr:X2}L{d}RKLV{ct:Amid} | 17BIPHE2 | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = biphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 180 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31880884 | 2019 | MLSTKQLVILGLLGCLSTLQAGVVLNVNPGKSLEEPAVKHLKVSPVNANEVPVLKELKSVQKTKSGDTLYGFVCTVGQIKTDSLGCVGSDSVAWPSEQNVELTVSCDKSNVGRIITYVEVHFVVSTQNVGCNVSAGSIGTSSIEVKVYAAGTNYLEYSSLFYIQ | AMP17 | Free | Free | Linear | L | None | 164 | Antimicrobial, Antifungal | 1.47 % Hemolysis at 300 μM | Human | Housefly Musca Domestica | Random coil, Extended Strand and ɑ-Helix | Non-hemolytic | ||
| 31489876 | 2019 | GFGGGRGGFGGGRGGFGGGGIGGGGFGGGYGGGKIKG{ct:Amid} | Serrulin | Amidation | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 60 µg/mL | Human | Tityus Serrulatus (Brazilian Scorpion) | NA | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 29.12 % Hemolysis at 1 M | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | NA | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 25.14 % Hemolysis at 500 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | NA | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 250 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 125 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 32 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 16 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 8 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 4 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31448889 | 2019 | KIKKIIKKIIKI{ct:Amid} | A1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 5 % Hemolysis at 4000 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | Low hemolytic | ||
| 31448889 | 2019 | GIVKOIVKOIVKOI{ct:Amid} | A2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 4000 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | Low hemolytic | ||
| 31448889 | 2019 | GIVKKIVKKIVKKI{ct:Amid} | A3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 1500 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | Low hemolytic | ||
| 31448889 | 2019 | GIIKKIIKKIIKKI | A4 | Free | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 2000 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | Low hemolytic | ||
| 31448889 | 2019 | GIIKKIIKKIIKKI{ct:Amid} | A5 (G3) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 900 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | Low hemolytic | ||
| 31448889 | 2019 | GILKKILKKILKKL{ct:Amid} | A6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 80 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | NA | ||
| 31635388 | 2019 | GLWSKIKDAA-KTAGKAALGFVNEMV | DPT9 | Free | Free | Linear | L | None | 25 | Antimicrobial, Antibiofilm, Anticancer | 50 % Hemolysis at 210 μM | Horse | Derived From Frog Phyllomedusa Tarsius Dpt9 | NA | NA | ||
| 31635388 | 2019 | GLWSKIKKAA-KTAGKAALGFVNKMV | K8, 23-DPT9 | Free | Free | Linear | L | None | 25 | Antimicrobial, Antibiofilm, Anticancer | 50 % Hemolysis at 107 μM | Horse | Analogue And Modified Dtp9 | NA | Low hemolytic | ||
| 31653005 | 2019 | ALWKSILKNVGKAAGKAVLNAVTDMVNQ{ct:Amid} | DM-PC | Amidation | Free | Linear | L | None | 28 | Antimicrobial | >80 % Hemolysis at 256 μM | Horse | Frog Phyllomedusa Coelestis | aqueous = Random coil, 50% TFE buffer = Helical | NA | ||
| 31653005 | 2019 | ALWKSILKNVGKAAGKAVL{ct:Amid} | DMPC-19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 256 μM | Horse | Dm-Pc Designed Truncated Derivatives | aqueous = Random coil, 50% TFE buffer = Helical | Low hemolytic | ||
| 31653005 | 2019 | ALWKKLLKKA{ct:Amid} | DMPC-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <5 % Hemolysis at 256 μM | Horse | Dm-Pc Designed Truncated Derivatives | aqueous = Random coil, 50% TFE buffer = Helical | Low hemolytic | ||
| 31653005 | 2019 | ALWKKLLKK-{nnr:Cha}{ct:Amid} | DMPC-10A | Amidation | Free | Linear | L | Cha = cyclohexylalanine | 10 | Antimicrobial | >35 % Hemolysis at 256 μM | Horse | Dm-Pc Designed Truncated Derivatives | aqueous = Random coil, 50% TFE buffer = Helical | NA | ||
| 31671555 | 2019 | FLSLIPHVISAIPHVVNALSNL{ct:Amid} | Phylloseptin-SP1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | >40 % Hemolysis at 64 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | NA | ||
| 31671555 | 2019 | ASWKVFLKNIGKAAGKAVLNSVTDMVNQ{ct:Amid} | Dermaseptin-SP2 | Amidation | Free | Linear | L | None | 31 | Antimicrobial | <4 % Hemolysis at 64 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | Non-hemolytic | ||
| 31671555 | 2019 | SLWSSIKDMAAAAGRAALNAVNGIVNP{ct:Amid} | Dermaseptin-SP3 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | <4 % Hemolysis at 64 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | Non-hemolytic | ||
| 31671555 | 2019 | SLWSSIKDMAAAAGRAALNAVNGILNP{ct:Amid} | Dermaseptin-SP4 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | <4 % Hemolysis at 64 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | Non-hemolytic | ||
| 31671555 | 2019 | SLRSSIKDMAAAAGRAALNAVNGIVNP{ct:Amid} | Dermaseptin-SP5 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | <2 % Hemolysis at 64 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | Non-hemolytic | ||
| 31671555 | 2019 | FLSLIPHVISAIPHVVNALSNL{ct:Amid} | Phylloseptin-SP1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | >85 % Hemolysis at 256 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | NA | ||
| 31671555 | 2019 | ASWKVFLKNIGKAAGKAVLNSVTDMVNQ{ct:Amid} | Dermaseptin-SP2 | Amidation | Free | Linear | L | None | 31 | Antimicrobial | >10 % Hemolysis at 256 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | NA | ||
| 31671555 | 2019 | SLWSSIKDMAAAAGRAALNAVNGIVNP{ct:Amid} | Dermaseptin-SP3 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | >10 % Hemolysis at 256 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | NA | ||
| 31671555 | 2019 | SLWSSIKDMAAAAGRAALNAVNGILNP{ct:Amid} | Dermaseptin-SP4 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | >10 % Hemolysis at 256 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | NA | ||
| 31674183 | 2019 | {nnr:Dhb}-L{nnr:O}I{nnr:V}{nnr:V}K{nnr:V}{nnr:V}KYL{nt:FA = Fatty acid}{ct:Valinol} | brevibacillin V | Valinol | FA = Fatty acid | Linear | L | O = Ornithine, V = Valinol, FA = Fatty acid, Dhb = dehydrobutyrine | 13 | Antimicrobial | <8 % Hemolysis at 512 µg/ml | Sheep | Brevibacillus Laterosporus Fmb70 | NA | Low hemolytic | ||
| 31674183 | 2019 | {nnr:Dhb}-L{nnr:O}II{nnr:V}K{nnr:V}{nnr:V}KYL{nt:FA = Fatty acid}{ct:Valinol} | brevibacillin | Valinol | FA = Fatty acid | Linear | L | O = Ornithine, V = Valinol, FA = Fatty acid, Dhb = dehydrobutyrine | 13 | Antimicrobial | <8 % Hemolysis at 512 µg/ml | Sheep | Brevibacillus Laterosporus Osy-I1 Lipotridecapeptide | NA | Low hemolytic | ||
| 31752079 | 2019 | FLQHIIGALGHLF | GHa | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 20 µM | Human | Frog Hylarana Guentheri | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGKLF | GHaK | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 16 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGHLF | GHa4K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 26 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQHIIGALGKLF | GHa11K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 15 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQHIIGALGHLF | GHa | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 115 µM | Human | Frog Hylarana Guentheri | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGKLF | GHaK | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 66 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGHLF | GHa4K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 69 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQHIIGALGKLF | GHa11K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 40 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31642159 | 2019 | ILGKIWEGIKSLF{ct:Amid} | IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 6.25 mmol/L | Human | Scorpion Venom Opisthacanthus Madagascariensis | α-Helical | NA | ||
| 31642159 | 2019 | ILLKIWEGIKSLF{ct:Amid} | [L]3-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 3.3 mmol/L | Human | Isct1 Analogs | α-Helical | NA | ||
| 31642159 | 2019 | ALGKFWEKIKSLF{ct:Amid} | [A]1[F]5[K]8-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 25 μmol/L | Human | Isct1 Analogs | α-Helical | NA | ||
| 31642159 | 2019 | ILKKIWEGIKSLF{ct:Amid} | [K]3-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 6.25 μmol/L | Human | Isct1 Analogs | α-Helical | NA | ||
| 31642159 | 2019 | ILGKFWEGIKSLF{ct:Amid} | [F]5-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 6.25 mmol/L | Human | Isct1 Analogs | α-Helical | NA | ||
| 31642159 | 2019 | ILGKIWEPIKSLF{ct:Amid} | [P]8-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 100 μmol/L | Human | Isct1 Analogs | α-Helical | Non-hemolytic | ||
| 31642159 | 2019 | WLGKIWEGIKSLF{ct:Amid} | [W]1-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1.56 mmol/L | Human | Isct1 Analogs | α-Helical | NA | ||
| 31668583 | 2019 | {nnr:Dap}-KKK{nt:(C12)2}{ct:Amid} | 1 | Amidation | (C12)2 | Linear | L | Dap = 2,3-diaminopropionic, C12 = lauric acid | 4 | Antimicrobial | 50 % Hemolysis at 128 µg/mL | Human | Lipopeptides With Surfactant | NA | NA | ||
| 31668583 | 2019 | {nnr:Dab}-KKK{nt:(C12)2}{ct:Amid} | 2 | Amidation | (C12)2 | Linear | L | Dab = 2,4-diaminobutyric, C12 = lauric acid | 4 | Antimicrobial | 13 % Hemolysis at 128 µg/mL | Human | Lipopeptides With Surfactant | NA | Low hemolytic | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 23 % Hemolysis at 150 µM | Human | Synthetic All D-Peptide Analogue Peptide | TFE = α-Helical | NA | ||
| 31847173 | 2019 | A{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-1 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 41 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}A{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-2 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 59 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}K{d}A{d}F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-3 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 2 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | Low hemolytic | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})A{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-4 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 22 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}A{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-5 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 47 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}A{d}K{d}({nnr:nle}){ct:Amid} | D2D analog-6 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 10 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})A{d}({nnr:nle}){ct:Amid} | D2D analog-7 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 67 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}A{d}{ct:Amid} | D2D analog-8 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 5 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | Low hemolytic | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}({nnr:1-nal})({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-9 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 20 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}({nnr:dap})({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-10 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, dap = Diaminopropionic acid, D-amino acid | 8 | Antimicrobial | 28 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}({nnr:nle})({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-11 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 33 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}F{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-12 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 74 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}S{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-13 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 29 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}T{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-14 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 28 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}Y{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-15 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 40 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}V{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-16 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 54 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})({nnr:1-nal})({nnr:nle}){ct:Amid} | D2D analog-17 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 89 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})({nnr:dap})({nnr:nle}){ct:Amid} | D2D analog-18 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, dap = Diaminopropionic acid, D-amino acid | 8 | Antimicrobial | 21 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})({nnr:nle})({nnr:nle}){ct:Amid} | D2D analog-19 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 56 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})F{d}({nnr:nle}){ct:Amid} | D2D analog-20 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 91 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})S{d}({nnr:nle}){ct:Amid} | D2D analog-21 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 85 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})T{d}({nnr:nle}){ct:Amid} | D2D analog-22 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 66 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})Y{d}({nnr:nle}){ct:Amid} | D2D analog-23 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 74 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})V{d}({nnr:nle}){ct:Amid} | D2D analog-24 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}K{d}({nnr:1-nal})({nnr:nle}){ct:Amid} | D2D analog-25 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})({nnr:nle})K{d}{ct:Amid} | D2D analog-26 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 18 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-27 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 7 | Antimicrobial | 49 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | ({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-28 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 6 | Antimicrobial | 62 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-29 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 5 | Antimicrobial | 12 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}{ct:Amid} | D2D analog-30 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, D-amino acid | 7 | Antimicrobial | 11 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal}){ct:Amid} | D2D analog-31 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, D-amino acid | 6 | Antimicrobial | 20 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}{ct:Amid} | D2D analog-32 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, D-amino acid | 5 | Antimicrobial | 5 % Hemolysis at 150 µM | Human | D2D Analogues | NA | Low hemolytic | ||
| 31847173 | 2019 | R{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-33 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 60 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}R{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-34 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 35 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}R{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-35 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 49 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})R{d}({nnr:nle}){ct:Amid} | D2D analog-36 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 51 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31324383 | 2019 | LLILMK{d}VGNK{d}L | SBH-LLI | Free | Free | Linear | L | None | 11 | Antimicrobial | 1.8 % Hemolysis at 1000 µM | Sheep | Soybean Auxin Efflux Carrier Component | NA | Non-hemolytic | ||
| 31324383 | 2019 | LPRSF{d}SK{d}SK{d}K{d}K{d} | SBH-LPR | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | F{d}RAPYIASLLR | SBH-FRA | Free | Free | Linear | L | None | 11 | Antimicrobial | 1.3 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | LPLRTRLLK{d}VL | SBH-LPL | Free | Free | Linear | L | None | 11 | Antimicrobial | 0.056 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | K{d}AVK{d}K{d}RK{d}K{d}K{d}LAK{d}AK{d}K{d} | SBH-KAV | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.44 % Hemolysis at 1000 µM | Sheep | Soybean Serine/Threonineprotein Kinase Rio1 | NA | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.13 % Hemolysis at 25 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.23 % Hemolysis at 50 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.38 % Hemolysis at 75 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.75 % Hemolysis at 100 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.83 % Hemolysis at 150 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 1.6 % Hemolysis at 200 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Low hemolytic | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}RR{ct:Amid} | 3 | Amidation | C12 = Dodecanoic acid | Linear | L | None | 2 | Antimicrobial | 50 % Hemolysis at >256 μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}RR{ct:Amid} | 4 | Amidation | C14 = tetradecanoic acid | Linear | L | None | 2 | Antimicrobial | 50 % Hemolysis at 68.43(±1.41) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C16 = hexadecanoic acid}RR{ct:Amid} | 5 | Amidation | C16 = hexadecanoic acid | Linear | L | None | 2 | Antimicrobial | 50 % Hemolysis at 22.91(±1.18) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C18 = octadecanoic acid}RR{ct:Amid} | 6 | Amidation | C18 = octadecanoic acid | Linear | L | None | 2 | Antimicrobial | 50 % Hemolysis at 25.19(±0.67) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:A}RR{ct:Amid} | 10 | Amidation | C14 = tetradecanoic acid | Linear | L | A = non-proteinogenic amino acid A | 3 | Antimicrobial | 50 % Hemolysis at 41.08(±0.62) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:C(Acm)}RR{ct:Amid} | 14 | Amidation | C14 = tetradecanoic acid | Linear | L | C(Acm) = Acm = S-acetamidomethyl group(non-proteinogenic Amino acid) | 3 | Antimicrobial | 50 % Hemolysis at 39.72(±1.25) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:D}RR{ct:Amid} | 18 | Amidation | C14 = tetradecanoic acid | Linear | L | D = non-proteinogenic amino acid D | 3 | Antimicrobial | 50 % Hemolysis at 49.95(±1.00) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:E}RR{ct:Amid} | 22 | Amidation | C14 = tetradecanoic acid | Linear | L | E = non-proteinogenic amino acid E | 3 | Antimicrobial | 50 % Hemolysis at 59.51(±4.00) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C10 = decanoic}{nnr:F}RR{ct:Amid} | 24 | Amidation | C10 = decanoic | Linear | L | F = non-proteinogenic amino acid F | 3 | Antimicrobial | 50 % Hemolysis at >256 μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:F}RR{ct:Amid} | 25 | Amidation | C12 = Dodecanoic acid | Linear | L | F = non-proteinogenic amino acid F | 3 | Antimicrobial | 50 % Hemolysis at 91.21(±16.38) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:F}RR{ct:Amid} | 26 | Amidation | C14 = tetradecanoic acid | Linear | L | F = non-proteinogenic amino acid F | 3 | Antimicrobial | 50 % Hemolysis at 39.09(±1.18) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:G}RR{ct:Amid} | 29 | Amidation | C12 = Dodecanoic acid | Linear | L | G = non-proteinogenic amino acid G | 3 | Antimicrobial | 50 % Hemolysis at >256 μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:G}RR{ct:Amid} | 30 | Amidation | C14 = tetradecanoic acid | Linear | L | G = non-proteinogenic amino acid G | 3 | Antimicrobial | 50 % Hemolysis at 31.94(±1.99) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:H}RR{ct:Amid} | 34 | Amidation | C14 = tetradecanoic acid | Linear | L | H = non-proteinogenic amino acid H | 3 | Antimicrobial | 50 % Hemolysis at 50.31(±0.52) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:I}RR{ct:Amid} | 37 | Amidation | C12 = Dodecanoic acid | Linear | L | I = non-proteinogenic amino acid I | 3 | Antimicrobial | 50 % Hemolysis at 120.40(±1.55) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:I}RR{ct:Amid} | 38 | Amidation | C14 = tetradecanoic acid | Linear | L | I = non-proteinogenic amino acid I | 3 | Antimicrobial | 50 % Hemolysis at 78.92(±4.38) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:K}RR{ct:Amid} | 42 | Amidation | C14 = tetradecanoic acid | Linear | L | K = non-proteinogenic amino acid K | 3 | Antimicrobial | 50 % Hemolysis at 212.08(±6.12) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:L}RR{ct:Amid} | 45 | Amidation | C12 = Dodecanoic acid | Linear | L | L = non-proteinogenic amino acid L | 3 | Antimicrobial | 50 % Hemolysis at 112.81(±1.39) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:L}RR{ct:Amid} | 46 | Amidation | C14 = tetradecanoic acid | Linear | L | L = non-proteinogenic amino acid L | 3 | Antimicrobial | 50 % Hemolysis at 29.50(±1.05) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:M}RR{ct:Amid} | 49 | Amidation | C12 = Dodecanoic acid | Linear | L | M = non-proteinogenic amino acid M | 3 | Antimicrobial | 50 % Hemolysis at 206.50(±9.14) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:M}RR{ct:Amid} | 50 | Amidation | C14 = tetradecanoic acid | Linear | L | M = non-proteinogenic amino acid M | 3 | Antimicrobial | 50 % Hemolysis at 35.11(±0.90) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:M(O)}RR{ct:Amid} | 54 | Amidation | C14 = tetradecanoic acid | Linear | L | Met(O)/M(O) = methionine sulfoxide(non-proteinogenic Amino acid) | 3 | Antimicrobial | 50 % Hemolysis at 116.28(±1.77) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:M(O2)}RR{ct:Amid} | 58 | Amidation | C14 = tetradecanoic acid | Linear | L | Met(O2)/M(O2) = methionine sulfone(non-proteinogenic Amino acid) | 3 | Antimicrobial | 50 % Hemolysis at 70.11(±2.93) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:N}RR{ct:Amid} | 62 | Amidation | C14 = tetradecanoic acid | Linear | L | N = non-proteinogenic amino acid N | 3 | Antimicrobial | 50 % Hemolysis at 64.37(±2.23) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C10 = decanoic}{nnr:Nle}RR{ct:Amid} | 64 | Amidation | C10 = decanoic | Linear | L | Nle = Norleucine(non-proteinogenic Amino acid) | 3 | Antimicrobial | 50 % Hemolysis at >256 μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:Nle}RR{ct:Amid} | 65 | Amidation | C12 = Dodecanoic acid | Linear | L | Nle = Norleucine(non-proteinogenic Amino acid) | 3 | Antimicrobial | 50 % Hemolysis at >256 μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:Nle}RR{ct:Amid} | 66 | Amidation | C14 = tetradecanoic acid | Linear | L | Nle = Norleucine(non-proteinogenic Amino acid) | 3 | Antimicrobial | 50 % Hemolysis at 37.54(±1.39) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:Nva}RR{ct:Amid} | 69 | Amidation | C12 = Dodecanoic acid | Linear | L | Nva = Norvaline(non-proteinogenic Amino acid) | 3 | Antimicrobial | 50 % Hemolysis at 207.62(±5.27) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:Nva}RR{ct:Amid} | 70 | Amidation | C14 = tetradecanoic acid | Linear | L | Nva = Norvaline(non-proteinogenic Amino acid) | 3 | Antimicrobial | 50 % Hemolysis at 42.04(±1.38) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:P}RR{ct:Amid} | 73 | Amidation | C12 = Dodecanoic acid | Linear | L | P = non-proteinogenic amino acid P | 3 | Antimicrobial | 50 % Hemolysis at >256 μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:P}RR{ct:Amid} | 74 | Amidation | C14 = tetradecanoic acid | Linear | L | P = non-proteinogenic amino acid P | 3 | Antimicrobial | 50 % Hemolysis at 53.41(±1.84) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:Q}RR{ct:Amid} | 78 | Amidation | C14 = tetradecanoic acid | Linear | L | Q = non-proteinogenic amino acid Q | 3 | Antimicrobial | 50 % Hemolysis at 72.31(±3.00) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:R}{nnr:R}{nnr:R}{ct:Amid} | 81 | Amidation | C12 = Dodecanoic acid | Linear | L | R = non-proteinogenic amino acid R | 3 | Antimicrobial | 50 % Hemolysis at >256 μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:R}{nnr:R}{nnr:R}{ct:Amid} | 82 | Amidation | C14 = tetradecanoic acid | Linear | L | R = non-proteinogenic amino acid R | 3 | Antimicrobial | 50 % Hemolysis at 211.32(±9.57) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:S}RR{ct:Amid} | 86 | Amidation | C14 = tetradecanoic acid | Linear | L | S = non-proteinogenic amino acid S | 3 | Antimicrobial | 50 % Hemolysis at 41.54(±1.29) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:T}RR{ct:Amid} | 89 | Amidation | C12 = Dodecanoic acid | Linear | L | T = non-proteinogenic amino acid T | 3 | Antimicrobial | 50 % Hemolysis at >256 μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:T}RR{ct:Amid} | 90 | Amidation | C14 = tetradecanoic acid | Linear | L | T = non-proteinogenic amino acid T | 3 | Antimicrobial | 50 % Hemolysis at 43.43(±0.90) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:V}RR{ct:Amid} | 93 | Amidation | C12 = Dodecanoic acid | Linear | L | V = non-proteinogenic amino acid V | 3 | Antimicrobial | 50 % Hemolysis at 246.30(±14.12) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:V}RR{ct:Amid} | 94 | Amidation | C14 = tetradecanoic acid | Linear | L | V = non-proteinogenic amino acid V | 3 | Antimicrobial | 50 % Hemolysis at 30.73(±0.41) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C10 = decanoic}{nnr:W}RR{ct:Amid} | 96 | Amidation | C10 = decanoic | Linear | L | W = non-proteinogenic amino acid W | 3 | Antimicrobial | 50 % Hemolysis at >256 μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:W}RR{ct:Amid} | 97 | Amidation | C12 = Dodecanoic acid | Linear | L | W = non-proteinogenic amino acid W | 3 | Antimicrobial | 50 % Hemolysis at 42.42(±0.57) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:W}RR{ct:Amid} | 98 | Amidation | C14 = tetradecanoic acid | Linear | L | W = non-proteinogenic amino acid W | 3 | Antimicrobial | 50 % Hemolysis at 36.91 (±0.89) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C12 = Dodecanoic acid}{nnr:Y}RR{ct:Amid} | 101 | Amidation | C12 = Dodecanoic acid | Linear | L | Y = non-proteinogenic amino acid Y | 3 | Antimicrobial | 50 % Hemolysis at 123.08 (±1.12) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C14 = tetradecanoic acid}{nnr:Y}RR{ct:Amid} | 102 | Amidation | C14 = tetradecanoic acid | Linear | L | Y = non-proteinogenic amino acid Y | 3 | Antimicrobial | 50 % Hemolysis at 46.52 (±5.24) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | NA | ||
| 31936341 | 2020 | {conj:C10(6) = 2‐hexyldecanoic}RR{ct:Amid} | 105 | Amidation | C10(6) = 2‐hexyldecanoic | Linear | L | C10(6) = 2‐hexyldecanoic | 2 | Antimicrobial | 50 % Hemolysis at 200.25 (±16.07) μg/ml | Human | Synthetic Ultrashort Cationic Lipopeptides | NA | Low hemolytic | ||
| 31802582 | 2020 | GWWRRTVDKVRNAGRKVAGFASKACGALGH{ct:-OH} | P1-HC1 (EeCentrocin 1) | -OH | Free | Linear | L | None | 30 | Antimicrobial | 74.6 % Hemolysis at 200 μM | Human | Sea Urchin Echinus Esculentus | α‐Helix | NA | ||
| 31802582 | 2020 | GWWRRTVDKVRNAGRKVAGFASKACGALGH{ct:-OH} | P1-HC1 (EeCentrocin 1) | -OH | Free | Linear | L | None | 30 | Antimicrobial | 13.5 % Hemolysis at 25 μM | Human | Sea Urchin Echinus Esculentus | α‐Helix | NA | ||
| 32041161 | 2020 | FFGHLLRGIVSVGKHIHGLITG | Trematocine | Free | Free | Linear | L | None | 22 | Antimicrobial | 1 % Hemolysis at 5 μM | Rabbit | Teleost Fish Trematomus Bernacchii | PE/PG 70:30(large unilamellar vesicles (LUVs) = α-Helix, buffer = Random coil | Low hemolytic | ||
| 32041161 | 2020 | FFGHLLRGIVSVGKHIHGLITG | Trematocine | Free | Free | Linear | L | None | 22 | Antimicrobial | 7 % Hemolysis at 10 μM | Rabbit | Teleost Fish Trematomus Bernacchii | PE/PG 70:30(large unilamellar vesicles (LUVs) = α-Helix, buffer = Random coil | NA | ||
| 32041161 | 2020 | FFGHLLRGIVSVGKHIHGLITG | Trematocine | Free | Free | Linear | L | None | 22 | Antimicrobial | 55 % Hemolysis at 50 μM | Rabbit | Teleost Fish Trematomus Bernacchii | PE/PG 70:30(large unilamellar vesicles (LUVs) = α-Helix, buffer = Random coil | NA | ||
| 32153522 | 2020 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial | 50 % Hemolysis at >80 μM | Human | Human Host Defense Peptide | SDS = α-Helical, Tris-buffer = Random coil | NA | ||
| 32153522 | 2020 | KRIVQRIKDFLR | KR-12 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >80 μM | Human | Fragment Of Ll-37 | SDS = α-Helical, Tris-buffer = Random coil | NA | ||
| 32153522 | 2020 | AGGKRIVQRIKDFLRGAGGKRIVQRIKDFLRG{cyc:N-C} | cd4 | Free | Free | Cyclic | L | None | 32 | Antimicrobial | 50 % Hemolysis at >40 μM | Human | Cyclized Kr-12 Dimer | SDS = α-Helical, Tris-buffer = Random coil | NA | ||
| 32153522 | 2020 | AGGKRIVKRIKKFLRGAGGKRIVKRIKKFLRG{cyc:N-C} | cd4(Q5K,D9K) | Free | Free | Cyclic | L | None | 32 | Antimicrobial | 50 % Hemolysis at 10 μM | Human | Cyclized Kr-12 Dimer | SDS = α-Helical, Tris-buffer = Random coil | NA | ||
| 31585860 | 2020 | AAIGSSKPK | LPR-AAI | Free | Free | Linear | L | None | 9 | Antimicrobial, LPS-neutralizing, angiogenic | 1.37 % Hemolysis at 500 μM | Sheep | Rice Protein Uncharacterized Protein | NA | Low hemolytic | ||
| 31585860 | 2020 | LVPRPRR | LPR-LVP | Free | Free | Linear | L | None | 7 | Antimicrobial, LPS-neutralizing, angiogenic | 2.46 % Hemolysis at 500 μM | Sheep | Rice Protein Uncharacterized Protein | NA | Low hemolytic | ||
| 31585860 | 2020 | KVPVILAGCK | LPR-KVP | Free | Free | Linear | L | None | 10 | Antimicrobial, LPS-neutralizing, angiogenic | 1.87 % Hemolysis at 500 μM | Sheep | Rice Protein Uncharacterized Protein | NA | Low hemolytic | ||
| 31585860 | 2020 | RPPKPDAPRIY | LPR-RPP | Free | Free | Linear | L | None | 11 | Antimicrobial, LPS-neutralizing, angiogenic | 2.53 % Hemolysis at 500 μM | Sheep | Rice Protein 1,4-A-Glucan-Branching Enzyme,Chloroplastic/Amyloplastic,(Ec 2.4.1.1) | NA | Low hemolytic | ||
| 31585860 | 2020 | KRKARKKGRFSKK | LPR-KRK | Free | Free | Linear | L | None | 13 | Antimicrobial, LPS-neutralizing, angiogenic | 4.26 % Hemolysis at 500 μM | Sheep | Rice Protein Uncharacterized Protein | NA | Low hemolytic | ||
| 31954105 | 2020 | LRKVRRLLRRL{nt:Amid}{ct:Amid} | AMP 21 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 25 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical, SDS = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRKVWRWLRRL{nt:Amid}{ct:Amid} | AMP 22 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 25 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRKFRRLLRRL{nt:Amid}{ct:Amid} | AMP 23 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 25 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRRLRRLLRRL{nt:Amid}{ct:Amid} | AMP 24 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 25 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRKVRRLLRRL{nt:Amid}{ct:Amid} | AMP 21 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 50 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical, SDS = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRKVWRWLRRL{nt:Amid}{ct:Amid} | AMP 22 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >10 % Hemolysis at 50 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | NA | ||
| 31954105 | 2020 | LRKFRRLLRRL{nt:Amid}{ct:Amid} | AMP 23 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >5 % Hemolysis at 50 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Low hemolytic | ||
| 31954105 | 2020 | LRRLRRLLRRL{nt:Amid}{ct:Amid} | AMP 24 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >5 % Hemolysis at 50 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Low hemolytic | ||
| 31954105 | 2020 | LRKVRRLLRRL{nt:Amid}{ct:Amid} | AMP 21 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 100 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical, SDS = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRKVWRWLRRL{nt:Amid}{ct:Amid} | AMP 22 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >10 % Hemolysis at 100 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | NA | ||
| 31954105 | 2020 | LRKFRRLLRRL{nt:Amid}{ct:Amid} | AMP 23 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >5 % Hemolysis at 100 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Low hemolytic | ||
| 31954105 | 2020 | LRRLRRLLRRL{nt:Amid}{ct:Amid} | AMP 24 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >5 % Hemolysis at 100 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Low hemolytic | ||
| 32206496 | 2020 | RKGSRMGKKCECP | Tn CRT2 | Free | Free | Linear | L | None | 13 | Antimicrobial | 50.38 % Hemolysis at 40 μM | Human | Toadfish Thalassophryne Nattereri | α-Helix, aqueous bufer = Random coil | NA | ||
| 32206496 | 2020 | RKGSQMGKKCECP | Tn CRT3 | Free | Free | Linear | L | None | 13 | Antimicrobial | 34.49 % Hemolysis at 40 μM | Human | Toadfish Thalassophryne Nattereri | β-Sheet, aqueous bufer = Random coil | NA | ||
| 32003561 | 2020 | KWCFRVCYRGICYRRCRX | TPI (Tachyplesin I) | Free | Free | Linear | L | None | 18 | Antimicrobial | ≤10 % Hemolysis at 0.25 μg/mL | Human | Asian Horseshoe Crabs Tachypleus Tridentatus | β-Hairpin | NA | ||
| 32169940 | 2020 | MEKLMVLNEEKLSYVIGGGNPKVAHCASQIGRSTAWGAVSGAATGTAVGQAVGALGGALFGGSMGVIKGSAACVSYLTRHRHH | acidocin 4356 ACD | Free | Free | Linear | L | None | 83 | Antivirulence, Antimicrobial | 50 % Hemolysis at >400 μg/mL | Human | Lactobacillus Acidophilus | Helical | Low hemolytic | ||
| 32397600 | 2020 | SLWGKLKEMAAAAGKAALNAVNGLVNQ{ct:Amid} | DRP-AC4 | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 26.25 μM | Horse | Frog Skin Agalychnis Callidryas(Dermaseptin) | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32397600 | 2020 | SLWGKLKEMLAKAGKAVANAVNGLANQ{ct:Amid} | DRP-AC4a | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 14.49 μM | Horse | Analogue Of Drp-Ac4 | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32397600 | 2020 | SLWGKLKEMLAAAGKAVANAVNGLANQ{ct:Amid} | DRP-AC4b | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 21.53 μM | Horse | Analogue Of Drp-Ac4 | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32347293 | 2020 | FLGALFKVASKLVPAAICSISKKC | Brevinin-1GHd | Free | Free | Linear | L | None | 24 | Antimicrobial, Anticancer, Antibiotic, Antibiofilm | 13 % Hemolysis at 32 μM | Horse | Frog Skin, Hylarana Guenther | aqueous(10 mM NH4AC buffer) = Random coil, membrane-mimetic environment (50% TFE in 10 mM NH4AC)membrane-mimetic environment (50% TFE in 10 mM NH4AC) = α-Helix | NA | ||
| 32582642 | 2020 | ALWKDMLKGIGKLAGKAALGAVKTLV{ct:Amid} | Dermaseptin-PP | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antitumor | <20 % Hemolysis at 16 μM | Horse | Frog Phyllomedusa Palliata | 50% TFE-10 mmol/L NH4Ac solution (MME) = α-Helical | NA | ||
| 32582642 | 2020 | ALWKDMLKGIGKLAGKAALGAVKTLV{ct:Amid} | Dermaseptin-PP | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antitumor | 50 % Hemolysis at 38.77 μM | Horse | Frog Phyllomedusa Palliata | 50% TFE-10 mmol/L NH4Ac solution (MME) = α-Helical | NA | ||
| 32630734 | 2020 | FIQHLIPLIPHAIQGIKDIF{ct:Amid} | Kassiniatuerin-3 | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Antibiofilm, Antiproliferation | ~2 % Hemolysis at 160 μM | Horse | Frog Kassina Senegalensis | aqueous = Random coil, 50% TFE = Helical | Low hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 50 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 50 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 100 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 100 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 250 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 250 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 500 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 500 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32752241 | 2020 | HHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2 [T2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 10 % Hemolysis at 1.4 μM | Human | Phylum Placozo Trichoplax Adhaerens | Helical | NA | ||
| 32752241 | 2020 | RHHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2A [T2R1] | Amidation | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 10 % Hemolysis at 3 μM | Human | Analog Of Trichoplaxin-2 | Helical | NA | ||
| 32752241 | 2020 | GIKKAVGKALKGLKGLLKALGES{ct:Amid} | Adepantin-1A [A1A] | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Anticancer | 10 % Hemolysis at 25 μM | Human | Adepantin-1 Analog | Helical | NA | ||
| 32752241 | 2020 | GIGKFLKKAKKFGKAFVLILKK{ct:Amid} | Pexiganan-L18 [PEXA] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 10 % Hemolysis at 1.6 μM | Human | Pexiganan Analog | Helical | NA | ||
| 32752241 | 2020 | GIKKWVKGVAKGVAKDLAKKIL{ct:Amid} | Flexampin [FLEX] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 10 % Hemolysis at 6 μM | Human | Template From Ranatuerin-2Csa | Helical | NA | ||
| 32752241 | 2020 | GIGREIIKKIIKKIGKKIGRII{ct:Amid} | Zyk-1 [ZYK1] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 10 % Hemolysis at 3 μM | Human | Zyk Strain Of Bacillus Oryziterrae Peptide | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKVALKAL{ct:Amid} | DiPGLa-H [PG2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 10 % Hemolysis at 3 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKGALKAL{ct:Amid} | Kiadin-1 [KIA1] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 10 % Hemolysis at 3 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIGKKILKALKGALKELA{ct:Amid} | Mapegin [MAPA] | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Anticancer | 10 % Hemolysis at 1.7 μM | Human | Syntheitc Cell-Penetrating Peptide | Helical | NA | ||
| 32752241 | 2020 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP1 [MP1] | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 10 % Hemolysis at 20 μM | Human | Synthetic Amps | Helical | NA | ||
| 32752241 | 2020 | HHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2 [T2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 20 % Hemolysis at 3 μM | Human | Phylum Placozo Trichoplax Adhaerens | Helical | NA | ||
| 32752241 | 2020 | RHHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2A [T2R1] | Amidation | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 20 % Hemolysis at 25 μM | Human | Analog Of Trichoplaxin-2 | Helical | NA | ||
| 32752241 | 2020 | GIKKAVGKALKGLKGLLKALGES{ct:Amid} | Adepantin-1A [A1A] | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Anticancer | 20 % Hemolysis at 80 μM | Human | Adepantin-1 Analog | Helical | NA | ||
| 32752241 | 2020 | GIGKFLKKAKKFGKAFVLILKK{ct:Amid} | Pexiganan-L18 [PEXA] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 20 % Hemolysis at 7 μM | Human | Pexiganan Analog | Helical | NA | ||
| 32752241 | 2020 | GIKKWVKGVAKGVAKDLAKKIL{ct:Amid} | Flexampin [FLEX] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 20 % Hemolysis at 25 μM | Human | Template From Ranatuerin-2Csa | Helical | NA | ||
| 32752241 | 2020 | GIGREIIKKIIKKIGKKIGRII{ct:Amid} | Zyk-1 [ZYK1] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 20 % Hemolysis at 8 μM | Human | Zyk Strain Of Bacillus Oryziterrae Peptide | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKVALKAL{ct:Amid} | DiPGLa-H [PG2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 20 % Hemolysis at 14 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKGALKAL{ct:Amid} | Kiadin-1 [KIA1] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 20 % Hemolysis at 6 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIGKKILKALKGALKELA{ct:Amid} | Mapegin [MAPA] | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Anticancer | 20 % Hemolysis at 3 μM | Human | Syntheitc Cell-Penetrating Peptide | Helical | NA | ||
| 32752241 | 2020 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP1 [MP1] | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 20 % Hemolysis at 37 μM | Human | Synthetic Amps | Helical | NA | ||
| 32752241 | 2020 | HHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2 [T2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 50 % Hemolysis at 28 μM | Human | Phylum Placozo Trichoplax Adhaerens | Helical | NA | ||
| 32752241 | 2020 | RHHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2A [T2R1] | Amidation | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 50 % Hemolysis at 7000 μM | Human | Analog Of Trichoplaxin-2 | Helical | Low hemolytic | ||
| 32752241 | 2020 | GIKKAVGKALKGLKGLLKALGES{ct:Amid} | Adepantin-1A [A1A] | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Anticancer | 50 % Hemolysis at 125 μM | Human | Adepantin-1 Analog | Helical | NA | ||
| 32752241 | 2020 | GIGKFLKKAKKFGKAFVLILKK{ct:Amid} | Pexiganan-L18 [PEXA] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 50 % Hemolysis at 520 μM | Human | Pexiganan Analog | Helical | NA | ||
| 32752241 | 2020 | GIKKWVKGVAKGVAKDLAKKIL{ct:Amid} | Flexampin [FLEX] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 50 % Hemolysis at 1600 μM | Human | Template From Ranatuerin-2Csa | Helical | Low hemolytic | ||
| 32752241 | 2020 | GIGREIIKKIIKKIGKKIGRII{ct:Amid} | Zyk-1 [ZYK1] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 50 % Hemolysis at 29 μM | Human | Zyk Strain Of Bacillus Oryziterrae Peptide | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKVALKAL{ct:Amid} | DiPGLa-H [PG2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 50 % Hemolysis at 18 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKGALKAL{ct:Amid} | Kiadin-1 [KIA1] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 50 % Hemolysis at 20 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIGKKILKALKGALKELA{ct:Amid} | Mapegin [MAPA] | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Anticancer | 50 % Hemolysis at 20 μM | Human | Syntheitc Cell-Penetrating Peptide | Helical | NA | ||
| 32752241 | 2020 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP1 [MP1] | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 50 % Hemolysis at 170 μM | Human | Synthetic Amps | Helical | NA | ||
| 32872343 | 2020 | SALRGCWTKSYPPKPCL{ct:Amid} | SL-BBI | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at 512 μM | Horse | Broad-Folded Frog (Sylvirana Latouchii) | NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet and Random coil | Non-hemolytic | ||
| 32872343 | 2020 | AALRGCWTKSIPPKPCK{ct:Amid} | K-SL | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at 512 μM | Horse | Sl-Bbi Analogues | NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet, Random coil and Helix | Non-hemolytic | ||
| 32872343 | 2020 | SALRGCWTFSIPPKPCL{ct:Amid} | F-SL | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Anticancer | ≥10 % Hemolysis at 512 μM | Horse | Sl-Bbi Analogues | NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet and Random coil | Low hemolytic | ||
| 32512236 | 2020 | GIGKFLKKAKKFGKAFVKILKK{nt:H}{ct:OH} | MSI-78 | OH | H | Linear | L | None | 22 | Antimicrobial | >50 % Hemolysis at 200 μg/mL | Sheep | Synthesized Peptide Prepared By Mimotopes | α-Helical | NA | ||
| 32512236 | 2020 | GSGIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP | OTD-244 | Free | Free | Linear | L | None | 43 | Antimicrobial | 0 % Hemolysis at 512 μg/mL | Sheep | Modified Human Β-Defensin-2 | antiparallel β-Sheets and one α-Helix | Non-hemolytic | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | HC1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 33 % Hemolysis at 50 μM | Mouse | Snake Hydrophis Cyanocinctus | water = Random coil, 60 mM SDS solution = α-helica | NA | ||
| 32786271 | 2020 | K{d}FFK{d}R{d}LLK{d}SVR{d}R{d}AVK{d}K{d}FR{d}K{d}{ct:Amid} | HC1-D1 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 28 % Hemolysis at 50 μM | Mouse | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = Random coil | NA | ||
| 32786271 | 2020 | K{d}ffK{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid} | HC1-D2 | Amidation | Free | Linear | D | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 31 % Hemolysis at 50 μM | Mouse | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = α-Helix | NA | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | Mix | None | 30 | Antimicrobial, Anti-inflammatory, Antibiofilm | 37 % Hemolysis at 50 μM | Mouse | Hc-Cath Derivatives | amphipathic α-Helical | NA | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | HC1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 13 % Hemolysis at 50 μM | Human | Snake Hydrophis Cyanocinctus | water = Random coil, 60 mM SDS solution = α-helica | NA | ||
| 32786271 | 2020 | K{d}FFK{d}R{d}LLK{d}SVR{d}R{d}AVK{d}K{d}FR{d}K{d}{ct:Amid} | HC1-D1 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 9 % Hemolysis at 50 μM | Human | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = Random coil | NA | ||
| 32786271 | 2020 | K{d}ffK{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid} | HC1-D2 | Amidation | Free | Linear | D | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 12 % Hemolysis at 50 μM | Human | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = α-Helix | NA | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | Mix | None | 30 | Antimicrobial, Anti-inflammatory, Antibiofilm | 16 % Hemolysis at 50 μM | Human | Hc-Cath Derivatives | amphipathic α-Helical | NA | ||
| 33063186 | 2020 | FKLVWKLLKKLALKL | Aper1 | Free | Free | Linear | L | None | 15 | Anticancer, Antimicrobial | 10 % Hemolysis at 5.96 μM | Human | Derived From The Thermophilic Bacteria Aeropyrum Pernix. | NA | NA | ||
| 33194795 | 2020 | RFRLPFRRPPIRIHPPPFYPPFRRFL{ct:Amid} | ChBac3.4-NH2(caprine proline-rich bactenecin) | Amidation | Free | Linear | L | None | 26 | Antitumor, Antimicrobial, Antibiofilm | 25 ± 2 % Hemolysis at 64 μM | Human | Domestic Goat Capra Hircus | NA | NA | ||
| 33193152 | 2020 | FLSLIPKIAGGIAALVKNL{ct:Amid} | Phylloseptin-PV1 (PPV1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Antiproliferative, Antibiofilm | ≥50 % Hemolysis at 32 μM | Horse | White-Lined Leaf Frog Phyllomedusa Vaillantii | aqueous = Random coil, 50% TFE = α-Helix | NA | ||
| 33193152 | 2020 | FLSLIPKIAGGIAALVKNL{ct:Amid} | Phylloseptin-PV1 (PPV1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Antiproliferative, Antibiofilm | ≥95 % Hemolysis at 64 μM | Horse | White-Lined Leaf Frog Phyllomedusa Vaillantii | aqueous = Random coil, 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAKGLPTLISWIKNR{ct:Amid} | AR‐23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 101.3 % Hemolysis at 10 μM (pH 7.4) | Human | Frog Skin‐Derived Amp From Rana Tagoi | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIKNR{ct:Amid} | aAR1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 79.9 % Hemolysis at 10 μM (pH 7.4) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENR{ct:Amid} | aAR2 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 14.6 % Hemolysis at 10 μM (pH 7.4) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENE{ct:Amid} | aAR3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 0.1 % Hemolysis at 10 μM (pH 7.4) | Human | Ar-23 Analogs | 50% TFE = α-Helix | Non-hemolytic | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENE{ct:Amid} | aAR3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 3.8 % Hemolysis at 40 μM (pH 7.4) | Human | Ar-23 Analogs | 50% TFE = α-Helix | Non-hemolytic | ||
| 32776410 | 2020 | AIGSILGALAKGLPTLISWIKNR{ct:Amid} | AR‐23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 42.7 % Hemolysis at 20 μM (pH 5.2) | Human | Frog Skin‐Derived Amp From Rana Tagoi | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIKNR{ct:Amid} | aAR1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 79.7 % Hemolysis at 20 μM (pH 5.2) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENR{ct:Amid} | aAR2 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 61.4 % Hemolysis at 20 μM (pH 5.2) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENE{ct:Amid} | aAR3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 56 % Hemolysis at 20 μM (pH 5.2) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENE{ct:Amid} | aAR3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 80.3 % Hemolysis at 40 μM (pH 7.4) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 34352320 | 2021 | MKLLFPIFASLMLQYQVNTEYFGLGRCVMGLGRCKDHCAVNEKEIDKCKKKKCCIGPKGIQLIKSYLQNEMIRTLEEVAKKNITKNSKVVTPSKYRPLSHLPEIKSTNPFASINTTIIPNGTTVNSTTTNSTTSRRSTHPATSTKSDTKKRRDSPTESPPADSSPIDPADSMT | pBD129 | Free | Free | Linear | L | None | 173 | Antimicrobial, cytotoxicity | 0 % Hemolysis at 256 μg/mL | Pig | Sus Scrofa (Pig) | Alpha Helix fragment and four β-Pleated Sheet fragments | Non-hemolytic | ||
| 33469079 | 2021 | RK{d}RW{d}WV{d}VK{d}RK{d}WW{d}V{ct:Amid} | AS01 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 7.24 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | NA | ||
| 33469079 | 2021 | RK{d}RW{d}LW{d}LK{d}RK{d}WL{d}W{ct:Amid} | AS02 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | Non-hemolytic | ||
| 33469079 | 2021 | KK{d}KW{d}WV{d}KK{d}KW{d}WV{d}V{ct:Amid} | AS03 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | Non-hemolytic | ||
| 33469079 | 2021 | WW{d}KK{d}KV{d}WV{d}KK{d}KW{d}W{ct:Amid} | AS04 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 0.25 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | Non-hemolytic | ||
| 33469079 | 2021 | KK{d}KV{d}VV{d}KK{d}KV{d}VW{d}K{ct:Amid} | AS06 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | Non-hemolytic | ||
| 33469079 | 2021 | WL{d}WL{d}WL{d}WV{d}KK{d}AK{d}AK{d}K{ct:Amid} | AS08 | Amidation | Free | Linear | Mix | None | 15 | Antimicrobial | 1.46 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | NA | ||
| 33582221 | 2021 | ALWKDLLKNVGIAAGKAALNKVTDMVNQ{ct:Amid} | DRS-TO | Amidation | Free | Linear | L | None | 28 | Anticancer, Antimicrobial | 50 % Hemolysis at 436.7 µM | Horse | Leaf Frog Phyllomedusa Tomopterna | Helical | Low hemolytic | ||
| 33582221 | 2021 | ALWKTLLKNVGKAAGKAVLNAVTDMVNQ{ct:Amid} | DRS-PS2 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 210.7 µM | Horse | Waxy Monkey Tree Frog Phyllomedusa Sauvagii | Helical | Low hemolytic | ||
| 33244888 | 2021 | INWLKLGKAIIDAL{ct:Amid} | agelaia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antinociceptive | 50 % Hemolysis at 11.5 ± 1.1 µM | Human | Wasp Parachartergus Fraternus | α-Helical | NA | ||
| 33244888 | 2021 | IFWLFRGKADVAL{ct:Amid} | neuroVAL | Amidation | Free | Linear | L | None | 13 | Anticancer, Antimicrobial | 50 % Hemolysis at >64 µM | Human | Agelaia-Mpi Analogues | 30% TFE = α-Helical | Low hemolytic | ||
| 33244888 | 2021 | ILGTILGLLKGL{ct:Amid} | protonectin | Amidation | Free | Linear | L | None | 12 | Anticancer, Antimicrobial | 50 % Hemolysis at >64 µM | Human | Wasp Parachartergus Fraternus | 30% TFE = α-Helical | Low hemolytic | ||
| 33244888 | 2021 | IFGTILGFLKGL{ct:Amid} | protonectin-F | Amidation | Free | Linear | L | None | 12 | Anticancer, Antimicrobial | 50 % Hemolysis at >64 µM | Human | Protonectin Analogues | 30% TFE = α-Helical | Low hemolytic | ||
| 34069651 | 2021 | LKLLKKLL{nt:α-(4-pentenyl)-Ala}{ct:Amid} | Feleucin-K65 | Amidation | α-(4-pentenyl)-Ala | Linear | L | α-(4-pentenyl)-Ala | 9 | Antimicrobial, Antibiofilm | 9.08 % Hemolysis at 64 μg/ml | Mouse | Feleucin-K3 Analogs (Frog Bombina Orientalis) | 50% TFE = α-Helical | NA | ||
| 34069651 | 2021 | LKLLKKLL{nt:α-(4-pentenyl)-Ala}{ct:Amid} | Feleucin-K65 | Amidation | α-(4-pentenyl)-Ala | Linear | L | α-(4-pentenyl)-Ala | 9 | Antimicrobial, Antibiofilm | 31.6 % Hemolysis at 128 μg/ml | Mouse | Feleucin-K3 Analogs (Frog Bombina Orientalis) | 50% TFE = α-Helical | NA | ||
| 34069651 | 2021 | FLKLLKKL{nnr:α-(4-pentenyl)-Ala}{ct:Amid} | Feleucin-K70 | Amidation | Free | Linear | L | α-(4-pentenyl)-Ala | 9 | Antimicrobial, Antibiofilm | 1 % Hemolysis at 128 μg/ml | Mouse | Feleucin-K3 Analogs (Frog Bombina Orientalis) | 50% TFE = α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0.1 % Hemolysis at 1.7 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 1.1 % Hemolysis at 3.4 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 1.2 % Hemolysis at 6.9 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 2.8 % Hemolysis at 13.7 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 6.3 % Hemolysis at 27.5 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 9.7 % Hemolysis at 55.1 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 21.8 % Hemolysis at 110.3 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 55.2 % Hemolysis at 220.6 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0 % Hemolysis at 0.8 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0 % Hemolysis at 1.7 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0 % Hemolysis at 3.4 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0 % Hemolysis at 6.9 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0 % Hemolysis at 13.8 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0.1 % Hemolysis at 27.7 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0.7 % Hemolysis at 55.5 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 4.3 % Hemolysis at 111 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Low hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 11.6 % Hemolysis at 222 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Low hemolytic | ||
| 33878564 | 2021 | PFKLSLHL | jelleine-1 | Free | Free | Linear | L | None | 8 | Antimicrobial | 1 % Hemolysis at 256 μM | Human | Royal Jelly Of Honeybees | NA | Non-hemolytic | ||
| 33878564 | 2021 | PFRLRLRL | 7 | Free | Free | Linear | L | None | 8 | Antimicrobial | 1 % Hemolysis at 256 μM | Human | Jelleine-1Analog | NA | Non-hemolytic | ||
| 33878564 | 2021 | PWRLRLRL | 15 | Free | Free | Linear | L | None | 8 | Antimicrobial | 1 % Hemolysis at 256 μM | Human | Jelleine-1Analog | NA | Non-hemolytic | ||
| 34436290 | 2021 | CAGSLRLTC{ct:OH} | A0 | OH | Free | Linear | L | None | 9 | Antimicrobial | 1 % Hemolysis at 100 µg/ml | Human | American Oyster Defensin (Aod) Analog | Extended Strand Random coil | Non-hemolytic | ||
| 34436290 | 2021 | CAGWRRLRC{nt:Acet}{ct:Amid} | A1 | Amidation | Acetylation | Linear | L | None | 9 | Antimicrobial | 1 % Hemolysis at 100 µg/ml | Human | American Oyster Defensin (Aod) Analog | Extended Strand Random coil | Non-hemolytic | ||
| 34436290 | 2021 | CRWRLRLRC{ct:OH} | A2 | OH | Free | Linear | L | None | 9 | Antimicrobial | 1 % Hemolysis at 100 µg/ml | Human | American Oyster Defensin (Aod) Analog | Extended Strand Random coil | Non-hemolytic | ||
| 34436290 | 2021 | CRRWRRRRC{ct:OH} | A3 | OH | Free | Linear | L | None | 9 | Antimicrobial | 1 % Hemolysis at 100 µg/ml | Human | American Oyster Defensin (Aod) Analog | Extended Strand Random coil | Non-hemolytic | ||
| 34436290 | 2021 | CRRWGWRRC{ct:Amid} | A4 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 1 % Hemolysis at 100 µg/ml | Human | American Oyster Defensin (Aod) Analog | Extended Strand Random coil | Non-hemolytic | ||
| 34342438 | 2021 | RPFTRAQWFAIQHISPRTIAMRAINNYRWR | hECP30 | Free | Free | Linear | L | None | 30 | Antimicrobial, Antibiofilm | 44 ± 4 % Hemolysis at 250 μM | Horse | Human Rnase 3 Eosinophil Cationic Protein (Ecp) Fragment | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | NA | ||
| 34282895 | 2021 | KYEITTIHNLFRKLTHRLFRRNFGYTLR | KYE28 | Free | Free | Linear | L | None | 28 | Anti-inflammatory, Antimicrobial | ~20 % Hemolysis at 25 μM | Human | Heparin Cofactor Ii (Hcii)-Derived Peptide | α-Helical | NA | ||
| 34033840 | 2021 | KLQVVPAIHLVWLQK{ct:Amid} | Psacotheasin-2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antiseptic, Anti-inflammatory | 0 % Hemolysis at 100 μg/ml | Mouse | Transcriptome Of Beetle Psacothea Hilaris | NA | Non-hemolytic | ||
| 34302796 | 2021 | FLGALLKIGAKLLPSVVGLFKKKQQ | M-PONTX–Na1b | Free | Free | Linear | L | None | 25 | Antimicrobial, anthelmintic, Insecticidal | 50 % Hemolysis at 39.9–61.5 μM | Human | Ant Neoponera Apicalis | aqueous = Disordered, 20% TFE or 20 mM SOS = α-Helical | NA | ||
| 34302796 | 2021 | FWGAAAKMLGKALPGLISMFQKN | M-PONTX–Nc1a | Free | Free | Linear | L | None | 23 | Antimicrobial, anthelmintic, Insecticidal | 50 % Hemolysis at 28.6–48.2 μM | Human | Ant Neoponera Commutata | aqueous = Disordered, 20% TFE or 20 mM SOS = α-Helical | NA | ||
| 34302796 | 2021 | FVKELWDKVKKMGSAAWSAAKGAFA | M-PONTX–Nc2a | Free | Free | Linear | L | None | 25 | Antimicrobial, anthelmintic, Insecticidal | 50 % Hemolysis at >250 μM | Human | Ant Neoponera Commutata | aqueous = Disordered, 20% TFE or 20 mM SOS = α-Helical | Low hemolytic | ||
| 34302796 | 2021 | GWKDWLNKAKDFIKEKGPEILRAAANAAIN | M-PONTX–Nc3a | Free | Free | Linear | L | None | 30 | Antimicrobial, anthelmintic, Insecticidal | 50 % Hemolysis at >100 μM | Human | Ant Neoponera Commutata | aqueous = Disordered, 20% TFE or 20 mM SOS = α-Helical | NA | ||
| 34302796 | 2021 | AGTKEWLNKAKDFIKEKGLGMLSAAANAALN | M-PONTX–Nc3b | Free | Free | Linear | L | None | 31 | Antimicrobial, anthelmintic, Insecticidal | 50 % Hemolysis at >300 μM | Human | Ant Neoponera Commutata | aqueous = Disordered, 20% TFE or 20 mM SOS = α-Helical | Low hemolytic | ||
| 34738013 | 2021 | FIPLVSGLFSKLL{ct:Amid} | Temporin-FL | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 157.4 μM | Horse | Frog Pelophylax Nigromaculatus | 50%TFE/NH4Ac = Helix | NA | ||
| 34738013 | 2021 | FIPLVSGLFKLL{ct:Amid} | Temporin-FLa | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 74.02 μM | Horse | Temporin-Fl Truncated Analogues | 50%TFE/NH4Ac = Helix | NA | ||
| 34738013 | 2021 | FIPVSGLFKLL{ct:Amid} | Temporin-FLb | Amidation | Free | Linear | L | None | 11 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 356 μM | Horse | Temporin-Fl Truncated Analogues | 50%TFE/NH4Ac = Helix | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 3.2 ± 1.0 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 13.0 ± 1.7 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 19.0 ± 3.3 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 64.3 ± 5.4 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 28.4 ± 1.9 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 35.1 ± 8.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 19.2 ± 3.1 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 79.0 ± 0.6 % Hemolysis at 150 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 1.7 ± 0.2 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 0.5 % Hemolysis at 150 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 0.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 0.8 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 1.3 % Hemolysis at 150 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 4.9 % Hemolysis at 150 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 4.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 35.2 ± 1.1 % Hemolysis at 150 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 95.1 ± 5.0 % Hemolysis at 150 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 3.1 ± 1.0 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 8.3 ± 0.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 62.2 ± 4.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 92.1 ± 5.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 7.2 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 35.6 ± 4.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 2.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 7.6 ± 0.8 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | KQFRIRVRV{ct:Amid} | 1029 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 2.3 ± 0.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 6.5 ± 0.6 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | KRFRIRVRV{ct:Amid} | 1037 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 2.4 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 3.7 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 6.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA-OH{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 9.8 ± 3.7 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 14.0 ± 1.8 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 30.8 ± 4.2 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 85.0 ± 5.7 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 43.9 ± 3.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 64.4 ± 9.4 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 29.6 ± 2.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 96.1 ± 1.8 % Hemolysis at 250 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 1.8 ± 0.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 3.9 % Hemolysis at 250 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 0.8 ± 1.1 % Hemolysis at 250 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 0.7 ± 0.4 % Hemolysis at 250 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 4.1 % Hemolysis at 250 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 2.1 % Hemolysis at 250 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 10.5 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 54.5 ± 3.7 % Hemolysis at 250 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 4.4 % Hemolysis at 250 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 3.8 ± 0.8 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 20.4 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 73.6 ± 1.1 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 96.6 ± 3.1 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 12.5 ± 0.6 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 43.0 ± 0.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 4.5 ± 1.9 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10.8 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | KQFRIRVRV{ct:Amid} | 1029 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 3.5 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 11.0 ± 1.6 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRV{ct:Amid} | 1037 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 3.3 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 4.4 ± 0.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 8.0 ± 1.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 17.8 ± 0.3 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 17.9 ± 0.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 37.3 ± 4.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 100.0 ± 5.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 72.4 ± 8.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 71.0 ± 7.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 50.2 ± 5.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 100.0 ± 1.7 % Hemolysis at 375 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 2.3 ± 0.7 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 0.7 % Hemolysis at 375 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 1.3 ± 0.2 % Hemolysis at 375 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 1.5 ± 0.3 % Hemolysis at 375 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 4.4 % Hemolysis at 375 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 2.9 % Hemolysis at 375 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 3.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 71.1 ± 6.0 % Hemolysis at 375 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.7 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 2.5 % Hemolysis at 375 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 10.0 ± 5.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 46.8 ± 3.3 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 2.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 99.1 ± 8.0 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 39.0 ± 1.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 45.9 ± 4.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 4.0 ± 0.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 14.5 ± 5.5 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KQFRIRVRV{ct:Amid} | 1029 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 3.4 ± 0.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 17.3 ± 1.3 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRV{ct:Amid} | 1037 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 4.9 ± 0.2 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 9.5 ± 1.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 9.7 ± 0.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34508563 | 2021 | FLGALFKVASKLVPAAICSISKKC | Brevinin-1HL | Free | Free | Linear | L | None | 24 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 11.5 ± 0.2 μM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | NA | ||
| 34508563 | 2021 | FFPLIFGALSSILPKIL | Temporin-HLa | Free | Free | Linear | L | None | 17 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 31.4 ± 0.7 μM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | NA | ||
| 34508563 | 2021 | FLQHIIGALSHIF | Temporin-HLb | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 18.6 ± 10.0 mM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | Low hemolytic | ||
| 34796903 | 2021 | FLGWLFKVASK{ct:Amid} | A4W-GGN5 | Amidation | Free | Linear | L | None | 11 | Antimicrobial, Anticancer | 23 % Hemolysis at 150 μM | Sheep | Na | NA | NA | ||
| 36044968 | 2022 | MQLESAITHTLFK | rtVWF | Free | Free | Linear | L | None | 13 | Antimicrobial | ~1.5 % Hemolysis at 45.4 μM | Fish | Rainbow Trout (Oncorhynchus Mykiss) | NA | Non-hemolytic | ||
| 36044968 | 2022 | MQLESAITHTLFK | rtVWF | Free | Free | Linear | L | None | 13 | Antimicrobial | ~1.5 % Hemolysis at 11.3 μM | Fish | Rainbow Trout (Oncorhynchus Mykiss) | NA | Non-hemolytic | ||
| 36044968 | 2022 | MQLESAITHTLFK | rtVWF | Free | Free | Linear | L | None | 13 | Antimicrobial | ~1.5 % Hemolysis at 2.8 μM | Fish | Rainbow Trout (Oncorhynchus Mykiss) | NA | Non-hemolytic | ||
| 36336133 | 2022 | GLFDIIKKIAESF | Aurein 1.2 | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer | >20 % Hemolysis at 500 μg/mL | Human | Skin Of Australian Bell Frogs, Ranoidea Aurea (Formerly Litoria Aurea) And R. Raniformis (Formerly L. Raniformis) | α-Helix | NA | ||
| 36336133 | 2022 | GLFDIIKKIAESF | Aurein 1.2 | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer | <35 % Hemolysis at 1000 μg/mL | Human | Skin Of Australian Bell Frogs, Ranoidea Aurea (Formerly Litoria Aurea) And R. Raniformis (Formerly L. Raniformis) | α-Helix | NA | ||
| 36555393 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:(FITC)-Ahx = Fluorescein isothiocyanate} | FITC-melittin | Free | (FITC)-Ahx = Fluorescein isothiocyanate | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 40 μM | Mouse | Honeybee Venom | NA | NA | ||
| 35987005 | 2023 | MCNDCGA | MOp3 | Free | Free | Linear | L | None | 7 | Antimicrobial agent against S. aureus | 0 % Hemolysis at 4 mg/mL | Rabbit | Moringa Oleifera Seeds | β-Sheet | Non-hemolytic | ||
| 37251186 | 2023 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anti-inflammatory | 15.2 ± 1.1 % Hemolysis at 100 µM | Pig | Derived From Magainin | LPC and LPS = α-Helical | NA | ||
| 35282007 | 2022 | SMATPHAGAAALILSKHPTWTNAQVRDRLESTATYLGNSFYYGK | Natto peptide | Free | Free | Linear | L | None | 45 | Cytotoxicity, Antimicrobial, Antibiofilm | <1.8 % Hemolysis at 200 μg/ml | Rabbit | Soybeans | NA | Non-hemolytic | ||
| 35529682 | 2022 | KPQSILVLLVL AVLALHCKENEAASFPWTCASLSGVCRQGVCLPSE LYFGSLGCGKGFLCCVSHFG | gcDefb1 | Free | Free | Linear | L | None | 68 | Antimicrobial | 0 % Hemolysis at 50 µg/mL | Mouse | Grass Carp | NA | Non-hemolytic | ||
| 35529682 | 2022 | KPQSILVLLVL AVLALHCKENEAASFPWTCASLSGVCRQGVCLPSE LYFGSLGCGKGFLCCVSHFG | gcDefb2 | Free | Free | Linear | L | None | 68 | Antimicrobial | <0.2 % Hemolysis at 100 µg/mL | Mouse | Grass Carp | NA | Non-hemolytic | ||
| 35529682 | 2022 | KPQSILVLLVL AVLALHCKENEAASFPWTCASLSGVCRQGVCLPSE LYFGSLGCGKGFLCCVSHFG | gcDefb3 | Free | Free | Linear | L | None | 68 | Antimicrobial | <0.4 % Hemolysis at 200 µg/mL | Mouse | Grass Carp | NA | Non-hemolytic | ||
| 35529682 | 2022 | KPQSILVLLVL AVLALHCKENEAASFPWTCASLSGVCRQGVCLPSE LYFGSLGCGKGFLCCVSHFG | gcDefb4 | Free | Free | Linear | L | None | 68 | Antimicrobial | <0.8 % Hemolysis at 300 µg/mL | Mouse | Grass Carp | NA | Non-hemolytic | ||
| 35529682 | 2022 | KPQSILVLLVL AVLALHCKENEAASFPWTCASLSGVCRQGVCLPSE LYFGSLGCGKGFLCCVSHFG | gcDefb5 | Free | Free | Linear | L | None | 68 | Antimicrobial | 1 % Hemolysis at 350 µg/mL | Mouse | Grass Carp | NA | Non-hemolytic | ||
| 35529682 | 2022 | KPQSILVLLVL AVLALHCKENEAASFPWTCASLSGVCRQGVCLPSE LYFGSLGCGKGFLCCVSHFG | gcDefb6 | Free | Free | Linear | L | None | 68 | Antimicrobial | 1.2 % Hemolysis at 450 µg/mL | Mouse | Grass Carp | NA | Non-hemolytic | ||
| 35529682 | 2022 | KPQSILVLLVL AVLALHCKENEAASFPWTCASLSGVCRQGVCLPSE LYFGSLGCGKGFLCCVSHFG | gcDefb7 | Free | Free | Linear | L | None | 68 | Antimicrobial | 1.26 % Hemolysis at 500 µg/mL | Mouse | Grass Carp | NA | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLCGVSGLC | Nigrocin-PN | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 10 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLCGVSGLC | Nigrocin-PN | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | <5 % Hemolysis at 100 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLLGVSGLL | Nigrocin-M1 | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 10 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLLGVSGLL | Nigrocin-M1 | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | <20 % Hemolysis at 100 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVL | Nigrocin-M2 | Free | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 0 % Hemolysis at 10 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVL | Nigrocin-M2 | Free | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 0 % Hemolysis at 100 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35740884 | 2022 | FLPLIIGALSSLLPKIF{ct:Amid} | Temporin-PKE | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 6.58 µM | Horse | Pelophylax Kl. Esculentus | Random coils | NA | ||
| 35740884 | 2022 | FLPLIIGKLSSLLPKIF{ct:Amid} | Temporin-PKE-2K | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 19.87 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | NA | ||
| 35740884 | 2022 | FLPLIIGALSSKLPKIF{ct:Amid} | Temporin-PKE-K12 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 122.7 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740884 | 2022 | FLPKIIGKLSSLLPKIF{ct:Amid} | Temporin-PKE-3K | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 87.47 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740884 | 2022 | FLPKIIGKLSSKLPKIF{ct:Amid} | Temporin-PKE-4K | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 1671 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Non-hemolytic | ||
| 35740884 | 2022 | FLPLIIGALSSLLPKI{d}F{ct:Amid} | Temporin-PKE-i | Amidation | Free | Linear | Mix | i = D-Isoleucine | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 68.37 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740884 | 2022 | FLPLI{d}I{d}GALSSLLPKI{d}F{ct:Amid} | Temporin-PKE-3i | Amidation | Free | Linear | Mix | i = D-Isoleucine | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 64 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740895 | 2022 | FLSGIVGMLGKLF | Temporin SHa | Free | Free | Linear | L | None | 13 | Antimicrobial, Antiproliferative | 50 % Hemolysis at 266.20 ± 41.27 µM | Human | Pelophylax Saharicus | α-Helix | Low hemolytic | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a] SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antimicrobial, Antiproliferative | 50 % Hemolysis at 43.66 ± 1.01 µM | Human | Analog Of Temporin-Sha | α-Helix | NA | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLFK-FLSGIVGMLDAKLF{ct:Amid} | [G10a]2 SHa | Amidation | Free | Linear | Mix | a = D-alanine, Linked b/w Phe26 and Lys40 and Lys41 and Phe39 | 27 | Antimicrobial, Antiproliferative | 50 % Hemolysis at 11.55 ± 0.38 µM | Human | Dendrimeric Analog Of Temporin-Sha | α-Helix | NA | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLFKK-FLSGIVGMLDAKLF-FLSGIVGMLDAKLF{ct:Amid} | [G10a]3 SHa | Amidation | Free | Branched | Mix | a = D-alanine, Linked b/w Lys27 and Phe27 | 41 | Antimicrobial, Antiproliferative | 50 % Hemolysis at 10.46 ± 0.36 µM | Human | Dendrimeric Analog Of Temporin-Sha | α-Helix | NA | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLF-FLSGIVGMLDAKLF{ct:Amid} | Jeff-[G10a2 SHa conjugate | Amidation | Free | Linear | Mix | Jeffamine linker b/w Phe13 and Phe26 | 26 | Antimicrobial, Antiproliferative | 50 % Hemolysis at 1926 ± 242 µM | Human | Dendrimeric Analog Of Temporin-Sha | Triple Helical | Non-hemolytic | ||
| 35740895 | 2022 | FLSGIVGMLGKLF | Temporin SHa | Free | Free | Linear | L | None | 13 | Antimicrobial, Antiproliferative | 24.54 ± 1.88 % Hemolysis at 100 µM | Human | Pelophylax Saharicus | α-Helix | Low hemolytic | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a] SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antimicrobial, Antiproliferative | 102.03 ± 6.18 % Hemolysis at 100 µM | Human | Analog Of Temporin-Sha | α-Helix | NA | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLFK-FLSGIVGMLDAKLF{ct:Amid} | [G10a]2 SHa | Amidation | Free | Linear | Mix | a = D-alanine, Linked b/w Phe26 and Lys40 and Lys41 and Phe39 | 27 | Antimicrobial, Antiproliferative | 100 % Hemolysis at 100 µM | Human | Dendrimeric Analog Of Temporin-Sha | α-Helix | NA | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLFKK-FLSGIVGMLDAKLF-FLSGIVGMLDAKLF{ct:Amid} | [G10a]3 SHa | Amidation | Free | Branched | Mix | a = D-alanine, Linked b/w Lys27 and Phe27 | 41 | Antimicrobial, Antiproliferative | 100 % Hemolysis at 100 µM | Human | Dendrimeric Analog Of Temporin-Sha | α-Helix | NA | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLF-FLSGIVGMLDAKLF{ct:Amid} | Jeff-[G10a2 SHa conjugate | Amidation | Free | Linear | Mix | a = D-alanine, Jeffamine linker b/w Phe13 and Phe26 | 26 | Antimicrobial, Antiproliferative | 24.01 ± 5.06 % Hemolysis at 100 µM | Human | Dendrimeric Analog Of Temporin-Sha | Triple Helical | Non-hemolytic | ||
| 35878166 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 3.03 ± 0.02 µg/mL | Rabbit | Apis Mellifera | α-Helix | NA | ||
| 35878166 | 2022 | GIGAVLKVLTTGLPALIS({nnr:DapAMCA})IKRKRQQ | MELFL | Free | Free | Linear | L | DapAMCA = noncanonical fluorescent amino acid, MELFL = labeled melittin | 25 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 40.30 ± 0.04 µg/mL | Rabbit | Analog Of Melittin | α-Helix | Low hemolytic | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 6 % Hemolysis at 0.156 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 0 % Hemolysis at 0.039 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 0 % Hemolysis at 0.019 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 0 % Hemolysis at 0.009 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 0 % Hemolysis at 0.004 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 1.48 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 91.6 % Hemolysis at 5 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 80.5 % Hemolysis at 45327 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA-OH{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5 ± 0.2 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE-OH{ct:OH} | Pep13 | OH | Free | Linear | L | None | 13 | Antimicrobial | 0 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTH{ct:Amid} | PIP1 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 4 ± 0.8 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 2 ± 1 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4 ± 0.5 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid}{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 3 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK({nnr:COC3H7})KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 4 ± 0.9 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK({nnr:COC3H7})L{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 0 ± 0 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 4 ± 1 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 2 ± 0.1 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 0 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 48 ± 4.1 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.9 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 5 ± 0.4 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 3 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 7 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 1 ± 1.0 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKRINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 4 ± 1.9 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 86 ± 13.2 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 4.0 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 8.3 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 9.4 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 6.1 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 80 ± 11.2 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 62 ± 8.2 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 2 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 1 ± 0.4 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 9 ± 1.0 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:OH} | BP100-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 5 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 5 ± 0.5 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 5 ± 1.9 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 9 ± 2.3 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKVWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 0 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 4 ± 0.4 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 9 ± 1.0 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 7 ± 0.8 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH{ct:Amid} | KSLW-PIP1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 8 ± 1.3 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 13 ± 2 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE{ct:OH} | Pep13 | OH | Free | Linear | L | None | 13 | Antimicrobial | 0 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTH{ct:Amid} | PIP1 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 0.5 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 1 ± 0.6 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4 ± 0.5 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 7 ± 2 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK({nnr:COC3H7})KYL{ct:Acet} | BP387 | Acetylation | Free | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 4 ± 0.6 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{nnr:COC3H7}L{ct:Acet}{ct:Acet} | BP475 | Acetylation | Free | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 11 ± 5 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 3 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.1 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 52 ± 4.3 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.8 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 15 ± 1.6 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 5 ± 0.9 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 28 ± 2.3 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 0 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 1 ± 0.4 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-RINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 7 ± 3.4 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 86 ± 1.6 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 2.3 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 5.9 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 5.5 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 3.7 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 3.6 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 90 ± 7.3 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 65 ± 5.9 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 3 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 1 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 25 ± 2.4 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:Amid} | BP100-Pep13 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 12 ± 1.1 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 8 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 9 ± 0.4 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 31 ± 3.7 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-VWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 2 ± 1.0 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 11 ± 0.5 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 18 ± 1.4 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 7 ± 1.1 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH{ct:Amid} | KSLW-PIP1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3 ± 2.1 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 27 ± 3 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE{nt:OH}{ct:OH} | Pep13 | OH | OH | Linear | L | None | 13 | Antimicrobial | 2 ± 0.1 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTH{ct:Amid} | PIP1 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 0 ± 2 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 1 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 6 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 6 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 14 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 0 ± 0 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 6 ± 1 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 4 ± 0.9 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 0 ± 0.6 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA-KKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 63 ± 2.4 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 3 ± 0.0 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 26 ± 3.5 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 7 ± 0.2 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 43 ± 2.7 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 1 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 1 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKRINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 8 ± 0.9 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 87 ± 1.2 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 8.5 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 99 ± 7.1 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 98 ± 3.3 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 3.2 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 7.1 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 100 ± 8.4 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 77 ± 12.9 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 4 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 1 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 45 ± 9.0 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:OH} | BP100-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 20 ± 2.4 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 10 ± 0.6 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 16 ± 1.9 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE-KKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 48 ± 3.8 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-VWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 3 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 18 ± 0.1 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 26 ± 2.8 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 6 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH{ct:Amid} | KSLW-PIP1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3 ± 1.2 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 42 ± 3 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE{ct:OH} | Pep13 | OH | Free | Linear | L | None | 13 | Antimicrobial | 0 ± 0.1 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTH{ct:Amid} | PIP1 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 1 ± 0.1 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3 ± 3 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 11 ± 0.9 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 7 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 18 ± 1 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 0 ± 0 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 20 ± 2 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 5 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.5 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 66 ± 9.2 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 6 ± 1.6 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 39 ± 2.1 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 9 ± 2.5 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 46 ± 3.6 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 1 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA-KKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-RINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 8 ± 2.7 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 93 ± 2.3 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 2.1 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 4.8 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 99 ± 3.7 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 10.6 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 7.0 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 99 ± 8.4 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 82 ± 10.4 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 4 ± 0.2 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 2 ± 0.4 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 49 ± 9.2 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:OH} | BP100-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 30 ± 3.2 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 17 ± 0.4 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 29 ± 0.9 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 60 ± 1.5 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKVWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 5 ± 1.0 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 24 ± 0.5 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 39 ± 2.0 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 6 ± 0.4 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH | KSLW-PIP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 5 ± 4.9 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35311294 | 2022 | IRIRCRRRFCRIRI | C(RI)2 | Free | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | IRIRRRRFRIRI | F(RI)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | RIRIRRRFIRIR | F(IR)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | FRFRRRRFRFRF | F(RF)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | WRWRRRRFRWRW | F(RW)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at 237 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | VRVRRRRFRVRV | F(RV)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | ARARRRRFRARA | F(RA)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | WKWKRRRFKWKW | F(KW)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | IKIKRRRFKIKI | F(KI)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | LKLKRRRFKLKL | F(KL)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | RIRIRRRRFRIRIR | F(RI)2R | Free | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | IRIRIRRRRFRIRIRI | F(RI)3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 56 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | KWKWKRRRFKWKWK | F(KW)2K | Free | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | WKWKWKRRRFKWKWKW | F(KW)3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | RFRFRRRRFRFRFR | F(RF)2R | Free | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | FRFRFRRRRFRFRFRF | F(RF)3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | RGGRLCYCRRRFCVCVGR | PG-1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 20 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35367840 | 2022 | RAGLQFPVGRLLRRLLRRLLR | α-pep | Free | Free | Linear | L | None | 21 | Antimicrobial | 100 % Hemolysis at 50 µM | Mouse | Synthetic | α-Helix | NA | ||
| 35500455 | 2022 | KPIINIIKNIIKNKIK | KK16 | Free | Free | Linear | L | None | 16 | Antimicrobial, Antifungal | 50 % Hemolysis at 2250 µM | Fish | Synthetic | α-Helix | Non-hemolytic | ||
| 35283164 | 2022 | IFKRIKAMWRGAKQAWKDYK | Ss-piscidins1 | Free | Free | Linear | L | None | 20 | Antimicrobial | No Hemolysis | Fish | Sebastes Schlegelii | α-Helix | Non-hemolytic | ||
| 35283164 | 2022 | FWASLGHAAGHFAKGFLGDRKMD | Ss-piscidins3 | Free | Free | Linear | L | None | 23 | Antimicrobial | No Hemolysis | Fish | Sebastes Schlegelii | α-Helix | Non-hemolytic | ||
| 35283164 | 2022 | FIHHIFGAIKRIFGDKQRD | Ss-piscidins2 | Free | Free | Linear | L | None | 19 | Antimicrobial | 16.4 % Hemolysis at 30 µM | Fish | Sebastes Schlegelii | α-Helix | NA | ||
| 35283164 | 2022 | FIHHIFGAIKRIFGDKQRD | Ss-piscidins2 | Free | Free | Linear | L | None | 19 | Antimicrobial | 93.2 % Hemolysis at 60 µM | Fish | Sebastes Schlegelii | α-Helix | NA | ||
| 35720462 | 2022 | MHHHHHHGVIPGECIALKGVCRDKICSTLDDTIGICNEGKKCORRWWILEPYPIPVPKGKSP | human β-defensin 130 (hBD130) | Free | Free | Linear | L | None | 63 | Antimicrobial | 1.2 % Hemolysis at 400 µg/mL | Murine | Human | NA | Low hemolytic | ||
| 35720462 | 2022 | MHHHHHHGVIPGECIALKGVCRDKICSTLDDTIGICNEGKKCORRWWILEPYPIPVPKGKSP | human β-defensin 130 (hBD130) | Free | Free | Linear | L | None | 63 | Antimicrobial | 1.1 % Hemolysis at 400 µg/mL | Pig | Human | NA | Low hemolytic | ||
| 35806412 | 2022 | KTMMOSGGTFGTMAIGMGIR | AMPR-11 | Free | Free | Linear | L | None | 20 | Antimicrobial | low hemolytic | mouse | Synthetic | NA | Low hemolytic | ||
| 35806412 | 2022 | KKMMKKGGKFTFMAIGGIR | AMPR-22 | Free | Free | Linear | L | None | 19 | Antimicrobial | low hemolytic | mouse | Synthetic | NA | Low hemolytic | ||
| 35889198 | 2022 | GIFSSRKCKTPSKTFKGICTRDSNCDTSCRYEGYPAGDCKGIRRRCMCSKPC | Defensin-d2 | Free | Free | Linear | L | None | 52 | Antimicrobial | 2.89 % Hemolysis at 985 µg/mL | Mouse | Spinacia Oleracea | NA | Low hemolytic | ||
| 35889198 | 2022 | GFGCNLITSNPYQCSNHCKSVGYRGGYCKLRTVCTCY | Actifensin | Free | Free | Linear | L | None | 37 | Antimicrobial | 1.25 % Hemolysis at 2895 µg/mL | Mouse | Actinomyces Ruminicola | NA | Low hemolytic | ||
| 35847280 | 2022 | QR{d}W{d}GL{d}SL{d}APYK{d}NFR{d}R{d}L{d}S | ASU2056 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <1 % Hemolysis at 32 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35847280 | 2022 | QR{d}W{d}GL{d}SL{d}APYK{d}NFR{d}R{d}L{d}S | ASU2056 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <1 % Hemolysis at 64 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35847280 | 2022 | QR{d}W{d}GL{d}SL{d}APYK{d}NFR{d}R{d}L{d}S | ASU2056 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <1 % Hemolysis at 128 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35847280 | 2022 | VGR{d}W{d}SAR{d}YNFR{d}W{d}R{d}K{d}SGL{d} | ASU2060 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <0.1 % Hemolysis at 8 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35847280 | 2022 | VGR{d}W{d}SAR{d}YNFR{d}W{d}R{d}K{d}SGL{d} | ASU2060 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <0.1 % Hemolysis at 16 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35847280 | 2022 | VGR{d}W{d}SAR{d}YNFR{d}W{d}R{d}K{d}SGL{d} | ASU2060 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <0.1 % Hemolysis at 32 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35834028 | 2022 | GLLSVFKGVLKTAGKNVAKNVAGSLLDQLKCKISGGC | B2CE | Free | Free | Linear | L | None | 37 | Antimicrobial | 50 % Hemolysis at 56.92 µM | Human | Chinese Forest Frog Rana Chensinensis | α-Helix | Low hemolytic | ||
| 35834028 | 2022 | GLLSVFKGVLKTAGKNVAKNVAGSLLDQLKCKISGGC | B2CE-nonDS | Free | Free | Linear | L | None | 37 | Antimicrobial | 50 % Hemolysis at 130.27 µM | Human | B2Ce Analogs | α-Helix | Low hemolytic | ||
| 35834028 | 2022 | GLLSVFKGVLKTAGKNVAKNVAGSLLDQLKSKISGGS | B2CE-C31,37 S | Free | Free | Linear | L | None | 37 | Antimicrobial | 50 % Hemolysis at 25 µM | Human | B2Ce Analogs | α-Helix | NA | ||
| 35834028 | 2022 | GLLSVFKGVLKTAGKNVAKNVAGSLL | B2CE-N26 | Free | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | B2Ce Analogs | α-Helix | Low hemolytic | ||
| 35834028 | 2022 | GLLSKFKGVLKTAGKNVAKNVAGSLL | B2CE-N26-V5K | Free | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | B2Ce Analogs | α-Helix | Low hemolytic | ||
| 35834028 | 2022 | GLLSVFKGVLKTAGKWVKKNVAKSLL | B2CE-N26- N16WA18KG23K | Free | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 30.68 µM | Human | B2Ce Analogs | α-Helix | NA | ||
| 35834028 | 2022 | GLLSVFKGVLKTAGK | B2-N15 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | B2Ce Analogs | α-Helix | Low hemolytic | ||
| 35834028 | 2022 | GLLSVFKKVLKTAGK | B2-N15-G8K | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | B2Ce Analogs | α-Helix | Low hemolytic | ||
| 35835842 | 2022 | RFGRFLRKIRRFRPK | N-15 Cath-2 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 97.76 μg/mL | Murine | N-Terminal Fragment Of Chicken Cathelicidin-2 | α-Helix | NA | ||
| 35835842 | 2022 | RFGRFLRKILRFLKK | DP1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 216 μg/mL | Murine | Synthetic; N-15 Cath-2 Analogs | α-Helix | NA | ||
| 35835842 | 2022 | RFGRFLRKILRFLRK | DP2 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 145 μg/mL | Murine | Synthetic; N-15 Cath-2 Analogs | α-Helix | NA | ||
| 35835842 | 2022 | RFGRFLRKILRFLLK | DP3 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 24.62 μg/mL | Murine | Synthetic | α-Helix | NA | ||
| 35576531 | 2022 | HVLDTPLL | MOp2 | Free | Free | Linear | L | None | 8 | Antimicrobial | 3.715 % Hemolysis at 4.408 mM | Rabbit | Moringa Oleifera | β-Sheet | Non-hemolytic | ||
| 35576531 | 2022 | HVLDTPLL | MOp2 | Free | Free | Linear | L | None | 8 | Antimicrobial | 3.578 % Hemolysis at 2.204 mM | Rabbit | Moringa Oleifera | β-Sheet | Non-hemolytic | ||
| 35576531 | 2022 | HVLDTPLL | MOp2 | Free | Free | Linear | L | None | 8 | Antimicrobial | 2.331 % Hemolysis at 1.102 mM | Rabbit | Moringa Oleifera | β-Sheet | Non-hemolytic | ||
| 35576531 | 2022 | HVLDTPLL | MOp2 | Free | Free | Linear | L | None | 8 | Antimicrobial | 0.15 % Hemolysis at 0.551 mM | Rabbit | Moringa Oleifera | β-Sheet | Non-hemolytic | ||
| 35910608 | 2022 | RVKRVWPLVIRTVIAGYNLYRAIKKK | CATH-1 | Free | Free | Linear | L | None | 26 | Antimicrobial | <20 % Hemolysis | mouse | Synthetic | NA | Low hemolytic | ||
| 35910608 | 2022 | RVKRFWPLVPVAINTVAAGINLYKAIRRK | CATH-3 | Free | Free | Linear | L | None | 29 | Antimicrobial | <20 % Hemolysis | mouse | Synthetic | NA | Low hemolytic | ||
| 35910608 | 2022 | GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG | PMAP-36 | Free | Free | Linear | L | None | 36 | Antimicrobial | <20 % Hemolysis | mouse | Synthetic | NA | Low hemolytic | ||
| 35887325 | 2022 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 76 µg/mL | Sheep | Scorpio Maurus Palmatus | α-Helix | NA | ||
| 35887325 | 2022 | IASFLIKAATKLLPSLFGGGKKDS | Smp24 W2A | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >512 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWFFLIKAATKLLPSLFGGGKKDS | Smp24 S3F | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 52 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWKFLIKAATKLLPSLFGGGKKDS | Smp24 S3K | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 11 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWKFLIKAATKLLPKLFGGGKKDS | Smp24 S3K/S15K | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 23 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSALIKAATKLLPSLFGGGKKDS | Smp24 F4A | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 423 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSFLISAATKLLPSLFGGGKKDS | Smp24 K7S | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 36 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSFLIFAATKLLPSLFGGGKKDS | Smp24 K7F | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 442 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSFLIKAATKLLPKLFGGGKKDS | Smp24 S15K | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 26 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSFLIKAATKLLPSLFGGGKKFS | Smp24 D23F | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 33 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSFLIKAATKLLPSLFGGGKKDK | Smp24 S24K | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 15 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | WDNDTGODDADGD | Daptomycin | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >512 µg/mL | Sheep | Synthetic | α-Helix | NA | ||
| 36015076 | 2022 | WRVCKQSEKVILNPFWKKKKKKKFRV | Octoprohibitin | Free | Free | Linear | L | None | 26 | Antimicrobial | 26.89 % Hemolysis at 600 µg/mL | Mouse | Synthetic | α-Helix | NA | ||
| 36015076 | 2022 | WRVCKQSEKVILNPFWKKKKKKKFRV | Octoprohibitin | Free | Free | Linear | L | None | 26 | Antimicrobial | 92.35 % Hemolysis at 800 µg/mL | Mouse | Synthetic | α-Helix | NA | ||
| 35561952 | 2022 | IFGAILPLALGALKNLIK{ct:Amid} | Hylin a1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 94 % Hemolysis at 50 μM | Sheep | Hypsiboas Albopunctatus | α-Helix | NA | ||
| 35561952 | 2022 | IAGAILPLALGALKNLIK{ct:Amid} | Hylin a1-2A | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3 % Hemolysis at 50 μM | Sheep | Synthetic; Hylin A1 Analog | α-Helix | NA | ||
| 35561952 | 2022 | IAKAILPLALGALKNLIK{ct:Amid} | Hylin a1-3K | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 15 % Hemolysis at 50 μM | Sheep | Synthetic; Hylin A1 Analog | α-Helix | NA | ||
| 35561952 | 2022 | IAKAILPLALKALKNLIK{ct:Amid} | Hylin a1-11K | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 30 % Hemolysis at 50 μM | Sheep | Synthetic; Hylin A1 Analog | α-Helix | NA | ||
| 35561952 | 2022 | IAKAILPLALKALKKLIK{ct:Amid} | Hylin a1-15K | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 28 % Hemolysis at 50 μM | Sheep | Synthetic; Hylin A1 Analog | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIRCKVAGGC | GL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 10 % Hemolysis at 5.86 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIRCKVAGGC | GL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 50 % Hemolysis at 32 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIR{ct:Amid} | GL-22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 87.304 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIR{ct:Amid} | GL-22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | ∼6 % Hemolysis at 32 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIA{ct:Amid} | GL-9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | LFVNVLDKIR{ct:Amid} | LF-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | FVNVLDKIR{ct:Amid} | FV-9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10 % Hemolysis at 504.21 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | VNVLDKIR{ct:Amid} | VN-8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | FVNVLDKI{ct:Amid} | FV-8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIRCKVAGGC | GL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 100 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIR{ct:Amid} | GL-22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | >80 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIA{ct:Amid} | GL-9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | <5 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | LFVNVLDKIR{ct:Amid} | LF-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | ∼10 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | FVNVLDKIR{ct:Amid} | FV-9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | <5 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | VNVLDKIR{ct:Amid} | VN-8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | FVNVLDKI{ct:Amid} | FV-8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 10 % Hemolysis at 504.21 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid} | BP214 | Amidation | Free | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 41 % Hemolysis at 150 μM | Human | Synthetic | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C4)}{ct:Amid} | 1 | Amidation | lipidated (C4) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp214 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C6)}{ct:Amid} | 2 | Amidation | lipidated (C6) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp215 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C8)}{ct:Amid} | 3 | Amidation | lipidated (C8) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp216 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C10)}{ct:Amid} | 4 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp217 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C12)}{ct:Amid} | 5 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp218 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C14)}{ct:Amid} | 6 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp219 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid} | 7 | Amidation | Free | Linear | D | Lower-case letters signify D-amino acids | 11 | Antimicrobial | 3 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp220 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid} | 8 | Amidation | Free | Linear | D | Lower-case letters signify D-amino acids | 11 | Antimicrobial | 3 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp221 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid} | 9 | Amidation | Free | Linear | D | Lower-case letters signify D-amino acids | 11 | Antimicrobial | 3 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp222 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid} | 10 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 81 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp223 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid} | 11 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 96 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp224 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid} | 12 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 95 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp225 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid} | 13 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 36 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp226 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid} | 14 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 98 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp227 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid} | 15 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 83 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp228 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid} | 16 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 59 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp229 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid} | 17 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp230 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid} | 18 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 94 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp231 | NA | NA | ||
| 36140173 | 2022 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 50 % Hemolysis at >256 μg/mL | Human | Synthetic | β-Sheets | Low hemolytic | ||
| 36140173 | 2022 | KLKLKLKL{ct:Amid} | KL8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 50 % Hemolysis at >256 μg/mL | Human | Synthetic | β-Sheets | Low hemolytic | ||
| 36140173 | 2022 | KLKLKLKLK{ct:Amid} | KL9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 50 % Hemolysis at >256 μg/mL | Human | Synthetic | β-Sheets | Low hemolytic | ||
| 36140173 | 2022 | LKLKLKLKL{ct:Amid} | LK9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 50 % Hemolysis at 145 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at 47 μg/mL | Human | Synthetic | β-Sheets | Non-hemolytic | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | Non-hemolytic | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at >256 μg/mL | Human | Synthetic | β-Sheets | Non-hemolytic | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at 3 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 9 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at <1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at <1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at <1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at <1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at <1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 0 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKL{ct:Amid} | KL8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 0 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLK{ct:Amid} | KL9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 2 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKL{ct:Amid} | LK9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 11 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 9 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 9 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 47 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 29 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 37 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 33 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 56 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 58 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 57 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 52 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 1 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKL{ct:Amid} | KL8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 0 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLK{ct:Amid} | KL9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 5 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKL{ct:Amid} | LK9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 6 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 12 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 8 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 19 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 22 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 86 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 55 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 59 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 80 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 77 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 87 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 94 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 71 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 1 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKL{ct:Amid} | KL8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 0 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLK{ct:Amid} | KL9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 7 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKL{ct:Amid} | LK9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 8 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 16 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 10 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 31 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 33 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 96 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 74 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 59 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 95 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 80 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 87 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 94 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 72 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 3 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKL{ct:Amid} | KL8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 0 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLK{ct:Amid} | KL9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 9 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKL{ct:Amid} | LK9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 9 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 20 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 9 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 48 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 46 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 96 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 86 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 69 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 95 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 76 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 77 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 92 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 72 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 2 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKL{ct:Amid} | KL8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLK{ct:Amid} | KL9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 9 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKL{ct:Amid} | LK9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 9 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 28 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 12 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 72 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 64 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 95 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 93 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 68 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 59 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 53 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 81 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 2 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKL{ct:Amid} | KL8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLK{ct:Amid} | KL9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKL{ct:Amid} | LK9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 11 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 40 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 15 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 86 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 81 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 94 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 94 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 51 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 82 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 37 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 49 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 81 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 47 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 4 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKL{ct:Amid} | KL8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLK{ct:Amid} | KL9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 12 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKL{ct:Amid} | LK9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 14 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 59 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 20 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 94 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 90 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 94 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 97 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 41 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 79 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 30 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 49 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 82 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 47 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 6 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKL{ct:Amid} | KL8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLK{ct:Amid} | KL9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 16 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKL{ct:Amid} | LK9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 18 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 81 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 29 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 98 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 93 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 91 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 97 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 35 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 78 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 29 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 84 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 42 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 7 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKL{ct:Amid} | KL8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLK{ct:Amid} | KL9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 21 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKL{ct:Amid} | LK9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 20 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 94 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 43 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 100 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 100 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 89 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 99 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 32 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 78 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 31 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 48 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 87 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 39 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 35779173 | 2022 | GIGAVLKVLTTGLPALIKRKRQQ{ct:Amid} | MDP1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 30 µg/mL | Human | Synthetic | α-Helix | NA | ||
| 35779173 | 2022 | GIGAVLKVLTTGLPALIKRKRQQ{ct:Amid} | MDP2 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 24 µg/mL | Human | Synthetic | α-Helix | NA | ||
| 35779173 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:H}{ct:Amid} | melittin | Amidation | H | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 0.47 µg/mL | Human | Snake | α-Helix | NA | ||
| 35852614 | 2022 | FLGAVLKVAGKLVPAAICKISKKC | BR-1GHa | Free | Free | Linear | L | None | 24 | Antimicrobial | 16 % Hemolysis at 1 μM | Human | Hylarana Guentheri | α-Helix | NA | ||
| 35852614 | 2022 | FLGAVLKVAGKLVPAAICKISKKC | BR-1GHa | Free | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 8 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35852614 | 2022 | FLGAVLKVAGKLV | BR-1GHa-1 | Free | Free | Linear | L | None | 11 | Antimicrobial | 12 % Hemolysis at 128 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | Non-hemolytic | ||
| 35852614 | 2022 | FLGAVLKVLGKLV{ct:Amid} | BR-1GHa-2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 20.7 % Hemolysis at 16 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35852614 | 2022 | FLGLVLKVLGKLV{ct:Amid} | BR-1GHa-3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 48.2 % Hemolysis at 16 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35852614 | 2022 | FLPLVLKVLGKLV{ct:Amid} | BR-1GHa-4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 13.4 % Hemolysis at 64 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35852614 | 2022 | FLPLVLKVLGKLV{ct:Amid} | BR-1GHa-4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 69.4 % Hemolysis at 128 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35852614 | 2022 | FLPLVLKVLGKLL{ct:Amid} | BR-1GHa-5 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 32 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35861280 | 2022 | KLLPSVVGLFKKKKQ{ct:Amid} | At1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 4 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KLLKKVVKLFKKKKK{ct:Amid} | At2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 4 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KLLKKVVKLFKKLLK{ct:Amid} | At3 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KLLKKLLKLLKKLLK{ct:Amid} | At4 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 0.4 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KIIKKIIKIIKKIIK{ct:Amid} | At5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32.3 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KVVKKVVKVVKKVVK{ct:Amid} | At6 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 4 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KIIKKIKKKIKKIIK{ct:Amid} | At7 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KLLKKLKKKLKKLLK{ct:Amid} | At8 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 129 μM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35861280 | 2022 | KVVKKVKKKVKKVVK{ct:Amid} | At9 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 4 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | IKKIIKIIKKIIKKI{ct:Amid} | At10 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | ~30 % Hemolysis at 200 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | IKKIIKIIKKIIKKI{ct:Amid} | At10 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32.3 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | IIIKKIKKKIKKIII{ct:Amid} | At11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32.3 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KIIIKIKKKIKIIIK{ct:Amid} | At12 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35640793 | 2022 | GVFKDALKQLGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-1 | OH | H | Linear | L | None | 25 | Antimicrobial | 8.8 % Hemolysis at 198.37 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-2 | OH | H | Linear | L | None | 25 | Antimicrobial | 4.5 % Hemolysis at 195.79 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDQAANALKPK{nt:H}{ct:OH} | Picturin-3 | OH | H | Linear | L | None | 25 | Antimicrobial | 88.1 % Hemolysis at 195.91 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 61.6 % Hemolysis at 218.54 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGGIALNVLT{nt:H}{ct:Amid} | Pictuseptin-2 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 33 % Hemolysis at 228.20 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGKVALDVAKNVLT{nt:H}{ct:Amid} | Pictuseptin-3 | Amidation | H | Linear | L | None | 26 | Antimicrobial | 22.3 % Hemolysis at 188.64 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQLGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-1 | OH | H | Linear | L | None | 25 | Antimicrobial | 3.88 % Hemolysis at 99.19 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-2 | OH | H | Linear | L | None | 25 | Antimicrobial | 2.8 % Hemolysis at 97.89 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDQAANALKPK{nt:H}{ct:OH} | Picturin-3 | OH | H | Linear | L | None | 25 | Antimicrobial | 28.3 % Hemolysis at 97.85 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 54.9 % Hemolysis at 209.27 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGGIALNVLT{nt:H}{ct:Amid} | Pictuseptin-2 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 15 % Hemolysis at 114.1 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGKVALDVAKNVLT{nt:H}{ct:Amid} | Pictuseptin-3 | Amidation | H | Linear | L | None | 26 | Antimicrobial | 8.3 % Hemolysis at 94.32 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQLGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-1 | OH | H | Linear | L | None | 25 | Antimicrobial | 0.67 % Hemolysis at 49.59 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-2 | OH | H | Linear | L | None | 25 | Antimicrobial | 1.4 % Hemolysis at 48.95 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDQAANALKPK{nt:H}{ct:OH} | Picturin-3 | OH | H | Linear | L | None | 25 | Antimicrobial | 0 % Hemolysis at 48.98 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 29.2 % Hemolysis at 54.64 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGGIALNVLT{nt:H}{ct:Amid} | Pictuseptin-2 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 8 % Hemolysis at 57.05 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGKVALDVAKNVLT{nt:H}{ct:Amid} | Pictuseptin-3 | Amidation | H | Linear | L | None | 26 | Antimicrobial | 4.1 % Hemolysis at 47.16 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 12 % Hemolysis at 27.32 (64) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGGIALNVLT{nt:H}{ct:Amid} | Pictuseptin-2 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 3 % Hemolysis at 28.52 (64) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGKVALDVAKNVLT{nt:H}{ct:Amid} | Pictuseptin-3 | Amidation | H | Linear | L | None | 26 | Antimicrobial | 1.2 % Hemolysis at 23.58 (64) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 5.3 % Hemolysis at 13.66 (32) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGGIALNVLT{nt:H}{ct:Amid} | Pictuseptin-2 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 1 % Hemolysis at 14.26 (32) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGKVALDVAKNVLT{nt:H}{ct:Amid} | Pictuseptin-3 | Amidation | H | Linear | L | None | 26 | Antimicrobial | 0.1 % Hemolysis at 11.79 (32) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 1.7 % Hemolysis at 6.83 (16) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35924350 | 2022 | {nnr:X}VAFLRIVGQLGAKAASWAWANKGKILGWIRDGLAIDWIINKINDMVN | Thuricin A5 | Free | Free | Linear | L | X = fM(formylmethionine) | 47 | Antimicrobial | 1.64 % Hemolysis at 64 μM | Sheep | Bacillus Thuringiensis | NA | Non-hemolytic | ||
| 36142214 | 2022 | MNSNLFFIFATSLVCVNAEVYGPSDYAEDYSISGQSSRRHPRDVTWDKQMGGGKVFGTLGQNDDGLFGKAGYNREIFNDDRGKLTGQAYGTRVLGPGGDSTNYGGRLDWA NKNAQATIDLNRQIGGRSGITASGSGVWDLDKNTHFSAGGMVSKEFGHKRPDVGLQAEIRHDW | BMGlv2 | Free | Free | Linear | L | None | 170 | Antimicrobial | <5 % Hemolysis at 21.87 μg/mL | Rabbit | Bombyx Mandarina | NA | Non-hemolytic | ||
| 36142214 | 2022 | MNSNLFFIFATSLVCVNAEVYGPSDYAEDYSISGQSSRRHPRDVTWDKQMGGGKVFGTLGQNDDGLFGKAGYNREIFNDDRGKLTGQAYGTRVLGPGGDSTNYGGRLDWA NKNAQATIDLNRQIGGRSGITASGSGVWDLDKNTHFSAGGMVSKEFGHKRPDVGLQAEIRHDW | BMGlv2 | Free | Free | Linear | L | None | 170 | Antimicrobial | ∼10 % Hemolysis at 43.75 μg/mL | Rabbit | Bombyx Mandarina | NA | Non-hemolytic | ||
| 36142214 | 2022 | MNSNLFFIFATSLVCVNAEVYGPSDYAEDYSISGQSSRRHPRDVTWDKQMGGGKVFGTLGQNDDGLFGKAGYNREIFNDDRGKLTGQAYGTRVLGPGGDSTNYGGRLDWA NKNAQATIDLNRQIGGRSGITASGSGVWDLDKNTHFSAGGMVSKEFGHKRPDVGLQAEIRHDW | BMGlv2 | Free | Free | Linear | L | None | 170 | Antimicrobial | ∼15 % Hemolysis at 87.5 μg/mL | Rabbit | Bombyx Mandarina | NA | Non-hemolytic | ||
| 36144584 | 2022 | FRIMRILRVLKL | pept_1 | Free | Free | Linear | L | None | 12 | Antimicrobial | 30 % Hemolysis at 50 μM | Human | Synthetic | NA | NA | ||
| 36144584 | 2022 | FRIMRILRVLK | pept_2 | Free | Free | Linear | L | None | 11 | Antimicrobial | <10 % Hemolysis at 50 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | RWRLVCFLCRRKKV | pept_3 | Free | Free | Linear | L | None | 14 | Antimicrobial | 22 % Hemolysis at 50 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | KFKKVIWKSFL | pept_4 | Free | Free | Linear | L | None | 11 | Antimicrobial | ∼5 % Hemolysis at 50 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | RPILIRVRRIRVI | pept_5 | Free | Free | Linear | L | None | 13 | Antimicrobial | ∼15 % Hemolysis at 50 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | FRIMRILRVLKL | pept_1 | Free | Free | Linear | L | None | 12 | Antimicrobial | 80 % Hemolysis at 100 μM | Human | Synthetic | NA | NA | ||
| 36144584 | 2022 | FRIMRILRVLK | pept_2 | Free | Free | Linear | L | None | 11 | Antimicrobial | ∼15 % Hemolysis at 100 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | RWRLVCFLCRRKKV | pept_3 | Free | Free | Linear | L | None | 14 | Antimicrobial | ∼30 % Hemolysis at 100 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | KFKKVIWKSFL | pept_4 | Free | Free | Linear | L | None | 11 | Antimicrobial | ∼15 % Hemolysis at 100 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | RPILIRVRRIRVI | pept_5 | Free | Free | Linear | L | None | 13 | Antimicrobial | ∼35 % Hemolysis at 100 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36109567 | 2022 | LLKELWTKMKGAGKAVLGKIKGLL | Bm-ponericin-L1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.2 % Hemolysis | Bovine | Bombyx Mori | α-Helix | Non-hemolytic | ||
| 36297519 | 2022 | K{d}K{d}I{d}R{d}V{d}R{d}L{d}S{d}A{d} | M33D | Free | Free | Linear | D | None | 9 | Antimicrobial | NA | Human | Synthetic | NA | Non-hemolytic | ||
| 36297519 | 2022 | K{d}K{d}L{d}R{d}V{d}R{d}L{d}S{d}A{d} | M33i/l | Free | Free | Linear | D | None | 9 | Antimicrobial | NA | Human | Synthetic | NA | Non-hemolytic | ||
| 36299717 | 2022 | GWGAKRWGKRGWKWKRHW{ct:Amid} | GW18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | No Hemolysis at 1.32–169.01 μM | Human | Synthetic | NA | Non-hemolytic | ||
| 36287965 | 2022 | IKGIMSIVKAFLGNLR | Ca-MAP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 91.09 % Hemolysis at 72.7 μM | Human | Synthetic | NA | NA | ||
| 36287965 | 2022 | IKGIMSIVKAFLGNLR | Ca-MAP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 71.95 % Hemolysis at 36.3 μM | Human | Synthetic | NA | NA | ||
| 36287965 | 2022 | IKGIMSIVKAFLGNLR | Ca-MAP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 32.25 % Hemolysis at 18.1 μM | Human | Synthetic | NA | NA | ||
| 36287965 | 2022 | IKGIMSIVKAFLGNLR | Ca-MAP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 5 % Hemolysis at 9.1 μM | Human | Synthetic | NA | NA | ||
| 36287965 | 2022 | IKGIMSIVKAFLGNLR | Ca-MAP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 4.5 μM | Human | Synthetic | NA | NA | ||
| 36094301 | 2022 | KNLLRRIRRKLRNKFSRSDVIKTPKIVEVN | P30 | Free | Free | Linear | L | None | 30 | Antimicrobial | 5.7 ± 0.4 % Hemolysis at 50 μM | Sheep | Clostridium Intestinale | NA | NA | ||
| 36094301 | 2022 | KNLLRRIRRKLRNKFSRSDVIKTPKIVEVN | P30 | Free | Free | Linear | L | None | 30 | Antimicrobial | <2.2 % Hemolysis at ≤25 μM | Sheep | Clostridium Intestinale | NA | NA | ||
| 35972429 | 2022 | RRRLCFVRP{d}KFVVCVRRP{d} | PLP-3 | Free | Free | Linear | Mix | None | 18 | Antimicrobial | 50 % Hemolysis at 48.5 mg/L | Human | Protegrin-1 (Pg-1) Analog | β-Hairpin | Non-hemolytic | ||
| 35543330 | 2022 | IWLTALKFLGKNGKHLAKQQLAKL{ct:Amid} | LyeTxI | Amidation | Free | Linear | L | None | 24 | Antimicrobial | ~97.39 ± 7.40 % Hemolysis at 160 μM | Rabbit | Lycosa Erythrognatha | α-Helix | NA | ||
| 26335363 | 2015 | MTFLILTILATVTPSLYSHVVQRELRVNFEPLAGQRDSWPVARAAMVTFDARSEKAREFSECRMINSMHELSRELMDSPEHTVKRASKEEMDDLVQRCSGSAEGRSWFIWPDTKWCGPGTDAKNESDLGPLEADKCCRTHDHCDYIGAGETKYGLTNKSFFTKLNCKCEAAFDQCLKESIDRAEGSAKSSMEGLHSFYFNTYSPECYEVKCSRKRDAECTNGIAIWKDSYKS | Phospholipase A2 hemilipin (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A(2)) [Cleaved into: Phospholipase A2 large subunit; Phospholipase A2 small subunit] | Free | Free | Linear | L | None | 232 | Antimicrobial | Hemolytic | NA | Hemiscorpius Lepturus (Scorpion) | NA | NA | ||
| 28335389 | 2017 | MAHCYYNSKRGCNRVMKTVALVVLISTVMVEESRGDSQEDKKRPIWNIGHMVNAVKQIEEFLDLGANALEADVTFDDNGNPKWTYHGTPCDCFRDCLRWEYVDEYLKRIRELTSPGSSKFRKGFILLMLDLKISKLSDNAKSKAGKEIADMIIKRLWSGSGEKAQLYIVLSFPYVNDIEFVRAFRERVKSKGFASEAEKRIGWDISGNEDLGKIRDAYQKLGITDNVWQSDGITNCLTRSHDRLAEAVCKRDSDKEWPSLKKVYYWTVDKQSSMKEALKVGVDGMITNDPDDLVAVLNEFSGTHRLANINDSPWQKIPRPKSNC | Dermonecrotic toxin Hl-PLD1 (EC 4.6.1.-) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D) | Free | Free | Linear | L | None | 324 | Antimicrobial | Hemolytic | NA | Hemiscorpius Lepturus (Scorpion) | NA | NA | ||
| 29900074 | 2018 | MNVFFMFSLVFLAAFGSCADDTRPLGECFREADYEEFLEIARNGLKKTSNPKHVVVVGAGMSGLSAAYVLAKAGHKVTLLEASEGVGGRVKTYRNKQEGWYINLGPMRLPERHRIVREYIRKFHLPLSEFVQENENTWYYIKNIRKRVSEVKKNPDLFEYPVNPSEKGKSASQLYQESLEKVIDELKRTNCNHILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSSFYLSFIESLKSDDIFSYEKRFDEIVGGFDQLPISMYQAIAEMVHLNAQVIKIQHNAKKVIVTYQTPAKTLPSVTADYVIVCSTSRAARHIRFQPPLPTNKARALRSIHYRSAIKIFLTCTKRFWEADGIHGGKSTTDLPSRFIYYFNQNFTNGIGVIMAYVLADDAKFFQPHDLKTNADIVINDLSLIHQLPKEEIQALCRPSWIQKWSLDKYAMGSITSFTPYQFLDYFEIAAAPVGRIHFAGEYTAKHHGWIDSTIKSGLRAARDVNRA | L-amino acid oxidase (LAO) (MipLAAO1) (EC 1.4.3.2) | Free | Free | Linear | L | None | 501 | Antibiotic;Antimicrobial | Hemolytic | NA | Micrurus Mipartitus (Red-Tailed Coral Snake) | NA | NA | ||
| 23326415 | 2013 | MERRTLLVVLLVCSCVVAAAAEASPSRWPSPGRPRPFPGRPKPIFRPRPCNCYAPPCPCDRWRH | Arasin 1 (Ara-1) (Proline-rich antimicrobial peptide) (PR-AMP) (Pro-rich AMP) | Free | Free | Linear | L | None | 64 | Antibiotic;Antimicrobial | Hemolytic at 100µM | Human | Hyas Araneus (Atlantic Lyre Crab) (Great Spider Crab) | NA | Non-hemolytic | ||
| 19393676 | 2009 | MNVFSIFSLVFLAAFGSCADDRRSALEECFREADYEEFLEIARNGLKKTSNPKHVVVVGAGMAGLSAAYVLAGAGHRVTLLEASDRVGGRVNTYRDEKEGWYVNMGPMRLPERHRIVRTYIAKFGLKLNEFFQENENAWYFIRNIRKRVWEVKKDPGVFKYPVKPSEEGKSASQLYRESLKKVIEELKRTNCSYILDKYDTYSTKEYLIKEGNLSRGAVDMIGDLLNEDSSYYLSFIESLKNDDLFSYEKRFDEISDGFDQLPKSMHQAIAEMVHLNAQVIKIQRDAEKVRVAYQTPAKTLSYVTADYVIVCATSRAVRRISFEPPLPPKKAHALRSIHYKSATKIFLTCTRKFWEADGIHGGKSTTDLPSRFIYYPNHNFTSGVGVIVAYVLADDSDFFQALDIKTSADIVINDLSLIHQLPKNEIQALCYPSLIKKWSLDKYTMGALTSFTPYQFQDYIETVAAPVGRIYFAGEYTATVHGWLDSTIKSGLTAARNVNRASQKPSRIHLINDNQL | L-amino-acid oxidase (Bf-LAAO) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 517 | Antibiotic;Antimicrobial | Hemolytic | NA | Bungarus Fasciatus (Banded Krait) (Pseudoboa Fasciata) | NA | NA | ||
| 22480909 | 2012 | MNVFFMFSLLFLAALGSCADDGNPLEECFRETDYEEFLEIAKNGLSATSNPKHVVIVGAGMSGLSAAYVLANAGHQVTVLEASKRAGGRVRTYRNDKEGWYANLGPMRLPEKHRIVREYIRKFGLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEVGKSAGQLYEESLQKAVEELRRTNCSYMLNKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDKLPTSMYQAIQEKVRLNVRVIKIQQDVKEVTVTYQTSAKETLSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFPSGVGVIIAYGIGDDANFFQALDFKDCGDIVINDLSLIHQLPKEEIQAFCRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLTAARDVNRASE | L-amino-acid oxidase (Bp-LAAO) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 503 | Antibiotic;Antimicrobial | High Hemolytic | NA | Bothrops Pauloensis (Neuwied'S Lancehead) (Bothrops Neuwiedi Pauloensis) | NA | NA | ||
| 26273287 | 2015 | MNVFFMFSLLFLAALGSCAHDRNPLEECFRETDYEEFLEIARNGLTVTSNPKHVVIVGAGMAGLSAAYVLAGAGHQVTVLEASERVGGRVRTYRKKDWYANLGPMRLPTKHRIVREYIRKFGLQLNEFFQENENAWYFIKNIRKRVREVKNNPGILEYPVKPSEEGKSAAQLYVESLRKVVKELKRTNCKYILDKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFGYEKRFDEIVGGMDQLPTSMYEAIKEKVQVHFNARVIEIQQNDRETKVTYQTSANEMSSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCKRKFWEDDGIRGGKSTTDLPSRFIYYPNHNFTSGVGVIIAYGIGDDANFFQALDFKDCADIVINDLSLIHQLPKEDIQTFCRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPFKRIYFAGEYTAQFHGWIDSTIKSGLTAARDVNRASENPSGIHLSNDNEF | L-amino acid oxidase bordonein-L (LAAO) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 516 | Antibiotic;Antimicrobial | Hemolytic | NA | Crotalus Durissus Terrificus (South American Rattlesnake) | NA | NA | ||
| 22100226 | 2011 | VNWKKILGKIIKVVK{nt:H}{ct:Amid} | Lasioglossin-3 (LL-III) | Amidation | H | Linear | L | None | 15 | Antimicrobial | 50 % Hemolytic at >200µM | Rat | Lasioglossum Laticeps (Bee) | Alphα-Helix | Low hemolytic | ||
| 21692149 | 2011 | MYVHLALILGCWTVVLQGAETDVGERADNRRPIWNLAHMVNAVKQIPTFLDLGANALEADVTFKGSVPTYTYHGTPCDFGRDCIRWEYFNVFLKTLREYTTPGNAKYRDGFILFVLDLKTGSLSNDQVRPAGENVAKELLQNYWNNGNNGGRAYVVLSLPDIGHYEFVRGFKEVLKKEGHEDLLEKVGYDFSGPYLPSLPTLDATHEAYKKAGVDGHIWLSDGLTNFSPLGDMARLKEAIKSRDSANGFINKIYYWSVDKYSTTRTALDVGVDGIMTNYPNVLIDVLNEDGYKDNYRLATYDDNPWETYKK | Dermonecrotic toxin (EC 4.6.1.-) (Phospholipase D isoform 1) (LlPLD1) (PLD1) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D) | Free | Free | Linear | L | None | 311 | Antimicrobial | Hemolytic | Human | Loxosceles Laeta (South American Recluse Spider) (Scytodes Laeta) | NA | NA | ||
| 21933345 | 2011 | MKISQVFIFVFLLMISVAWANEAYEEESNYLSERFDADVEEITPEFRGIRCPKSWKCKAFKQRVLKRLLAMLRQHAF | Oxyopinin-4a (Oxt-4a) | Free | Free | Linear | L | None | 77 | Antimicrobial | EC50 % Hemolytic at 7µM | Human | Oxyopes Takobius (Lynx Spider) (Oxyopes Foliiformis) | NA | NA | ||
| 23967105 | 2013 | FLSLIPHIVSGVASIAKHF{ct:Amid} | Phylloseptin-S1 (PLS-S1) (Phylloseptin-1) (PSN-1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 % Hemolytic at 39µM | Human | Phyllomedusa Sauvagei (Sauvage'S Leaf Frog) | NA | NA | ||
| 23967105 | 2013 | FLSLIPHIVSGVASLAKHF{ct:Amid} | Phylloseptin-S2 (PLS-S2) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 % Hemolytic at 25µM | Human | Phyllomedusa Sauvagei (Sauvage'S Leaf Frog) | NA | NA | ||
| 23967105 | 2013 | FLSMIPHIVSGVAALAKHL{ct:Amid} | Phylloseptin-S4 (PLS-S4) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 % Hemolytic at 33µM | Human | Phyllomedusa Sauvagei (Sauvage'S Leaf Frog) | NA | NA | ||
| 21624426 | 2011 | FIKELLPHLSGIIDSVANAIK{ct:Amid} | Kasstasin | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 12.8 % Hemolytic at 128µM | Horse | Phlyctimantis Maculatus (Red-Legged Running Frog) (Hylambates Maculatus) | NA | Low hemolytic | ||
| 21816202 | 2012 | DSMGAVKLAKLLIDKMKCEVTKAC | Jindongenin-1a (Jindongenin-1) | Free | Free | Linear | L | None | 24 | Antimicrobial | IC50 % Hemolytic at 150µM | Rabbit | Amolops Jingdongensis (Chinese Torrent Frog) | NA | Low hemolytic | ||
| 21816202 | 2012 | GFMDTAKNVAKNVAVTLIDKLRCKVTGGC | Palustrin-2AJ1 | Free | Free | Linear | L | None | 29 | Antimicrobial | IC50 % Hemolytic at 135µM | Rabbit | Amolops Jingdongensis (Chinese Torrent Frog) | NA | Low hemolytic | ||
| 21816202 | 2012 | DSMGAVKLAKLLIDKMKCEVTKAC | Jindongenin-1a (Jindongenin-1) | Free | Free | Linear | L | None | 24 | Antimicrobial | IC50 % Hemolytic at 150µM | Human | Amolops Jingdongensis (Chinese Torrent Frog) | NA | Low hemolytic | ||
| 21816202 | 2012 | GFMDTAKNVAKNVAVTLIDKLRCKVTGGC | Palustrin-2AJ1 | Free | Free | Linear | L | None | 29 | Antimicrobial | IC50 % Hemolytic at 135µM | Human | Amolops Jingdongensis (Chinese Torrent Frog) | NA | Low hemolytic | ||
| 22917879 | 2012 | GLLDTFKNLALNAAKSAGVSVLNSLSCKLSKTC{ct:OH} | Brevinin-2JD | OH | Free | Linear | L | None | 33 | Antimicrobial | 11.7 ± 3.2 % Hemolytic at 128µg/ml | Rabbit | Odorrana Jingdongensis (Jingdong Frog) (Rana Jingdongensis) | α-Helical | Low hemolytic | ||
| 22917879 | 2012 | GIFGKILGAGKKVLCGLSGLC{ct:OH} | Nigrocin-2JDa | OH | Free | Linear | L | None | 21 | Antimicrobial | 80.3 ± 5.5 % Hemolytic at 128µg/ml | Rabbit | Odorrana Jingdongensis (Jingdong Frog) (Rana Jingdongensis) | α-Helical | NA | ||
| 22917879 | 2012 | GIFGKILGVGKKVLCGLSGMC{ct:OH} | Nigrocin-2JDb | OH | Free | Linear | L | None | 21 | Antimicrobial | 88.4 ± 4.2 % Hemolytic at 128µg/ml | Rabbit | Odorrana Jingdongensis (Jingdong Frog) (Rana Jingdongensis) | α-Helical | NA | ||
| 30214940 | 2018 | GLGRLIGKIAKKGAKIAAEAAANAAAEKAAEAL{ct:Amid} | U-myrmeciitoxin(01)-Mg1a (MIITX(01)-Mg1a) (U-MIITX(01)-Mg1a) | Amidation | Free | Linear | L | None | 33 | Antimicrobial | HC(50) % Hemolytic at >10.2µM | Human | Myrmecia Gulosa (Red Bulldog Ant) | NA | Non-hemolytic | ||
| 28513074 | 2017 | LIGLVSKGTCVLVKTVCKKVLKQ | M-myrmeciitoxin-Mp2b (M-MIITX-Mp2b) (DELTA-myrtoxin-Mp1a B chain) (Mp1a B chain) (Pilosin-3 subunit b) (Pilosulin-3b) | Free | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolytic at 2.18µM | Human | Myrmecia Pilosula (Jack Jumper Ant) (Australian Jumper Ant) | β-Turn | NA | ||
| 19101583 | 2008 | ADDKNPLEECFRETDYEEFLEIARNGLKATSNPKRVV | L-amino-acid oxidase (BjarLAAO-I) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 37 | Antimicrobial | Hemolytic | Horse | Bothrops Jararaca (Jararaca) (Bothrops Jajaraca) | NA | NA | ||
| 29885399 | 2018 | NLYQFKNMVQCVGTQLCVAYVKYGCYCGPG | Non-toxic phospholipase A2 (WaPLA2) (svPLA2) (Phosphatidylcholine 2-acylhydrolase) (EC 3.1.1.4) | Free | Free | Linear | L | None | 30 | Antimicrobial | 100 % Hemolytic at 3ug | Human | Walterinnesia Aegyptia (Desert Black Snake) | NA | NA | ||
| 15142536 | 2004 | MRAVVVLLLVAVASAKVYDRCELARALKASGMDGYAGNSLPNWVCLSKWESSYNTQATNRNTDGSTDYGIFQINSRYWCDDGRTPGAKNVCGIRCSQLLTADLTVAIRCAKRVVLDPNGIGAWVAWRLHCQNQDLRSYVAGCGV | Lysozyme C II (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase C) (Lysozyme type II) | Free | Free | Linear | L | None | 144 | Antimicrobial | Hemolytic at 100U/ml | Fish | Oncorhynchus Mykiss (Rainbow Trout) (Salmo Gairdneri) | NA | Non-hemolytic | ||
| 18098329 | 2007 | IWLTALKFLGKHAAKHLAKQQLSKL{ct:Amid} | M-lycotoxin-Hc1a (M-LCTX-Hc1a) (Lycotoxin I) (Lycotoxin-1) | Amidation | Free | Linear | L | None | 25 | Antimicrobial | Hemolytic at 20µM | Sheep | Hogna Carolinensis (Carolina Wolf Spider) (Lycosa Carolinensis) | α-Helix | NA | ||
| 18098329 | 2007 | IWLTALKFLGKHAAKHLAKQQLSKL{ct:Amid} | M-lycotoxin-Hc1a (M-LCTX-Hc1a) (Lycotoxin I) (Lycotoxin-1) | Amidation | Free | Linear | L | None | 25 | Antimicrobial | Hemolytic at 20µM | Rabbit | Hogna Carolinensis (Carolina Wolf Spider) (Lycosa Carolinensis) | α-Helix | NA | ||
| 16828829 | 2006 | ADDKNPLEECFREDDYEEFLEIAKNGLEGWYANLGPMRYPVKPSEEGKHDDIFAYEKFDEIVGGMDKKFWEDDGIHGGKETFCYSPMIQKPYQFQHFSEALTAPVGR | L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 107 | Antimicrobial | Hemolytic | NA | Macrovipera Lebetinus (Levantine Viper) (Vipera Lebetina) | NA | NA | ||
| 11085990 | 2001 | MRIHYLLFALLFLFLVPVPGHGGIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK | Beta-defensin 103 (Beta-defensin 3) (BD-3) (DEFB-3) (HBD3) (hBD-3) (Defensin, beta 103) (Defensin-like protein) | Free | Free | Linear | L | None | 67 | Antimicrobial | <0.5 % Hemolytic at 500ug/ml | Human | Homo Sapiens (Human) | NA | Non-hemolytic | ||
| 18215128 | 2008 | MKYFVVALALVAAFACIAESKPAESEHELAEVEEENELADLEDAVWLEHLADLSDLEEARGFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYLLKYYGKKALQKASEKL{ct:Amid} | M-zodatoxin-Lt8a (M-ZDTX-Lt8a) (Cytoinsectotoxin-1a) (CIT-1a) | Amidation | Free | Linear | L | None | 129 | Antimicrobial | EC50 % Hemolytic at 6µM | Human | Lachesana Tarabaevi (Spider) | NA | NA | ||
| 15639237 | 2005 | MKLSCLLLTLTIIFVLTIVHAPNVEAKDLADPESEAVGFADAFGEADAVGEADPNAGLGSVFGRLARILGRVIPKVAKKLGPKVAKVLPKVMKEAIPMAVEMAKSQEEQQPQ | M-myrmeciitoxin-Mp1 (M-MIITX-Mp1) (Allergen Myr p I) (Major allergen Myr p 1) (Pilosulin-1) (allergen Myr p 1) [Cleaved into: M-myrmeciitoxin-Mp1a (M-MIITX-Mp1a) (M-myrmeciitoxin-Mp1b) (M-MIITX-Mp1b) (Pilosulin-1 57->112) (Myr p 1 57->112) (Myr p 1 57->112 (Ile5)) ([Ile-5]pilosulin-1); M-myrmeciitoxin-Mp1c (M-MIITX-Mp1c) (Pilosulin-1 65->112) (Myr p 1 65->112); M-myrmeciitoxin-Mp1d (M-MIITX-Mp1d) (Pilosulin-1 68->112) (Myr p 1 68->112); M-myrmeciitoxin-Mp1e (M-MIITX-Mp1e) (Pilosulin-1 71->112) (Myr p 1 71->112); U1-myrmeciitoxin-Mp1f (U1-MIITX-Mp1f) (Pilosulin-1 86->112) (Myr p 1 86->112)] | Free | Free | Linear | L | None | 112 | Antimicrobial | 50 % Hemolytic at 0.1µM | Human | Myrmecia Pilosula (Jack Jumper Ant) (Australian Jumper Ant) | NA | NA | ||
| 21980286 | 2011 | MTIKEELGQPQSHSIELDEVSKEAASTRAALTSNLSGRFDQYPTKKGDFAIDGYLLDYSSPKQGCWVDGITVYGDIYIGKQNWGTYTRPVFAYLQYVETISIPQNVTTTLSYQLTKGHTRSFETSVNAKYSVGANIDIVNVGSEISTGFTRSESWSTTQSFTDTTEMKGPGTFVIYQVVLVYAHNATSAGRQNANAFAYSKTQAVGSRVDLYYLSAITQRKRVIVPSSNAVTPLDWDTVQRNVLMENYNPGSNSGHFSFDWSAYNDPHRRY | Monalysin (beta-barrel pore-forming toxin) (beta-PFT) | Free | Free | Linear | L | None | 271 | Antimicrobial | Hemolytic | Human | Pseudomonas Entomophila (Strain L48) | NA | NA | ||
| 21590705 | 2011 | MQLFIILCLAGSAVQLEGTELDGVERADNRRPIWNIAHMVNDKGLIDEYLDDGANSVESDVSFDSNGKPEKMLHGSPCDCGRSCKRQMSFADYLDYMRQLTTPGDPKFRENLILVMLDLKLKKLSSEQAYSAGQEVASQMLDKYWKRGESGARAYIVLSIPTITRVTFVNGFYDKLHSEGFDQYREKVGVDFSGNEDLEDTGKILKSRDILDHIWQSDGITNCLFRIMKRLKAAIRKRDSNGYMVKVYTWSVDKYTTMRKALRAGADGMITNFPKRLVSVLNEREFSGKFRLATYNDNPWERYTG | Dermonecrotic toxin LiSicTox-betaID1 (EC 4.6.1.-) (Dermonecrotic toxin 5) (DT5) (LiRecDT5) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D 5) (SMD 5) (SMase D 5) (Sphingomyelinase D 5) | Free | Free | Linear | L | None | 305 | Antimicrobial | <25 % Hemolytic at 25µM | Human | Loxosceles Intermedia (Brown Spider) | NA | Non-hemolytic | ||
| 21590705 | 2011 | MLLHIALILGCWSVFSEGAETDVAERADGRRPIWNMGHMVNGIWQIDQFVDLGVNSIEFDINFDKNGKPVYTYHGVPCDCFRSCLNWEYFGEFLTALRHRTTPGDKLYKEKLILFVFDMKTNSLYDNQAYQAGVNMATDIFKYYWNNGQNGGRAYFILSIPNLNHYDLIKGFRETITKKGHPELMEKVGYDFSANDNIPDVEKAYGKVGVTDHVWQSDGITNCIARGLSRVKEAVKERDSGGVINKVYIWTIDKFSSTRDALDAGVDGIMTNYPYVLNDVLKEGAYKNKFRMATYEDNPWVTFKA | Dermonecrotic toxin LiSicTox-alphaII1 (EC 4.6.1.-) (Dermonecrotic toxin 4) (DT4) (LiRecDT4) (Phospholipase D) (Sphingomyelin phosphodiesterase D 4) (SMD 4) (SMase D 4) (Sphingomyelinase D 4) | Free | Free | Linear | L | None | 305 | Antimicrobial | <75 % Hemolytic at 25µM | Human | Loxosceles Intermedia (Brown Spider) | NA | Non-hemolytic | ||
| 9643471 | 1997 | MKTFLILAMAVALAKAQSTDEITNLVQFGKLVMCLGNIGYTEGLEYDGYGCFCGKGGKGTPVDATDRCCEVHDNCYGQAVEEGKCWSVETYGTTYWYDQSTSGSCSIRCWEEGDYNSLVPRKACKAAICECDRKAAQCFADNRPTFNRKYLNYAKDTC | Phospholipase A2 AP-PLA2-II (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2) | Free | Free | Linear | L | None | 158 | Antimicrobial | Low hemolytic | Sheep | Acanthaster Planci (Crown-Of-Thorns Starfish) | NA | Low hemolytic | ||
| 9643471 | 1998 | MNFLVVIVTTVSLAGAASAGEIQNLYQFGKMVMCLGNLNVLEGLEYNGYGCYCGRGGKGTPLDDTDRCCKQHDECYERATDEMGCWSIETYATTYDYTKSKVSGKCTIKCKLESDYSRFTIRKKCKAFICECDRIGAQCFADKRSTFNRSLISYTKDKC | Phospholipase A2 AP-PLA2-I (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2) | Free | Free | Linear | L | None | 159 | Antimicrobial | Low hemolytic | Sheep | Acanthaster Planci (Crown-Of-Thorns Starfish) | NA | Low hemolytic | ||
| 27792198 | 2016 | MAFLKKSLFLVLFLGLVNLSICEEEKREEENKEEEDENEALSEVKRGFLEKLKTGAKDFASAFVNSIKGT{ct:Amid} | Frenatin 4.1 [Cleaved into: Frenatin 4.2] | Amidation | Free | Linear | L | None | 70 | Antimicrobial | <5 % Hemolytic at 512ug/ml | Horse | Nyctimystes Infrafrenatus (White-Lipped Tree Frog) (Litoria Infrafrenata) | NA | Non-hemolytic | ||
| 12054688 | 2002 | MKTQFAILLVALVLFQMFAQSDAILGKIWEGIKSLFGKRGLSDLDGLDELFDGEISKADRDFLRELMR{ct:Amid} | Cytotoxic linear peptide IsCT (Non-disulfide-bridged peptide 4.1) (NDBP-4.1) (Non-disulfide-bridged peptide 5.2) (NDBP-5.2) [Cleaved into: Cytotoxic linear peptide IsCTf] | Amidation | Free | Linear | L | None | 68 | Antimicrobial | 30 % Hemolytic at 200µM | Sheep | Opisthacanthus Madagascariensis (Scorpion) | NA | Non-hemolytic | ||
| 12054688 | 2002 | MKTQFAILLVALVLFQMFAQSEAIFGAIWNGIKSLFGRRALNNDLDLDGLDELFDGEISQADVDFLKELMR{ct:Amid} | Cytotoxic linear peptide IsCT2 (Non-disulfide-bridged peptide 4.2) (NDBP-4.2) (Non-disulfide-bridged peptide 5.3) (NDBP-5.3) [Cleaved into: Cytotoxic linear peptide IsCT2f] | Amidation | Free | Linear | L | None | 71 | Antimicrobial | 20 % Hemolytic at 200µM | Sheep | Opisthacanthus Madagascariensis (Scorpion) | NA | Non-hemolytic | ||
| 28469603 | 2017 | MAFLKKSLFLVFFLGFVSLSICEEEKRETDEKENEQEDDREERSEEKRLLGMIPVAITAISALSKLG{ct:Amid} | Medusin-PT | Amidation | Free | Linear | L | None | 67 | Antimicrobial | 50 % Hemolytic at 1.814 × 10^6ug/ml | Horse | Phyllomedusa Tarsius (Brownbelly Leaf Frog) (Phyllomedusa Tarsia) | NA | Low hemolytic | ||
| 29649486 | 2017 | MNRLIIVCLVAAMIYSTIALPMKEDISNDERPISVNEEPVKKNAAVAGAVIQGATLTFQVLDRILTVLGDISRKIAIGVDNESGRKWTAKNAYFFSGTSDVVLPYSVPNGKAFLYDGKKTRGPVATGAVGVLAYSMSDGNTLGILFSVPYDYNWYENWWNIKVYSGSKRANKWMYENLYYNASPHKGDNGWHEKSLGYGLKSRGYMASSGQTKLEIRVTRA | Deep sea actinoporin Cjtox II (DELTA-actitoxin-Cja1b) (DELTA-AITX-Cja1b) | Free | Free | Linear | L | None | 221 | Antimicrobial | Hemolytic | Horse | Cribrinopsis Japonica (Deep-Sea Anemone) | NA | NA | ||
| 30036605 | 2018 | MKNRLVIIVFMVVTMLCASLALPLEEKEDEKDEKRSLEVAGAVMEGANLGMSVLQTILQAIGDVSRKIAVGVDNESGRSWTAQNAYFRSGTSDVILPHTVPSGKALLYDGQKNRGPVATGVVGVITYTMGDGNTLAVMFSVPYDYNWYSNWWNVKIYHGKVRASQKMYEDLYYYRSPFKGDNGWHERNLGYGLKSKGFMNSSGAALLQIKVMKA | Nigrelysin (Ng) (Actinoporin) (DELTA-actitoxin-Ani1a) (DELTA-AITX-Ani1a) (Pore-forming toxine) (PFT) | Free | Free | Linear | L | None | 214 | Antimicrobial | 50 % Hemolytic at 0.09nM | Human | Anthopleura Nigrescens (Sea Anemone) (Tealiopsis Nigrescens) | NA | NA | ||
| 31671555 | 2019 | ASWKVFLKNIGKAAGKAVLNSVTDMVNQ{ct:Amid} | Dermaseptin-SP2 (DRS-SP2) | Amidation | Free | Linear | L | None | 28 | Antimicrobial | >20 % Hemolytic at 512mg/L | Human | Agalychnis Spurrelli (Gliding Leaf Frog) (Agalychnis Litodryas) | α-Helix | Non-hemolytic | ||
| 17046111 | 2006 | MSAEALADPKADPLAGPNPDADPEAINLKAIAALAKKLLG{ct:Amid} | Mastoparan-like peptide 12c | Amidation | Free | Linear | L | None | 40 | Antimicrobial | Low hemolytic | Human | Vespa Magnifica (Hornet) | NA | Low hemolytic | ||
| 17023116 | 2006 | MSSDLVMPALGRPFTLGMLYDTRREKLIPGFSLFGDETLQQYQSSNTQRSSEFKIVASDSTESKSSAMDIEASLGVSFLGGLVEVGGSAKYLNNTKKYQNQSRVTLKYKATTIYKQFTAPPGTVKVQETVITQRGLATHVVTGILYGANAFFVFDSDKVEDTNLQDIQGKMEAVIKKIPTISIEGSASVQLTDEEKSLASNLSCKFHGDFLLESLPTTFEDAVTTYQTLPTLLGEDGASAVPMKVWLVPLKKFFSKAKLLTQEITVSKVRRIHTTLEELYKLKRRANEAMDDKLVQQIPLIHDKISNFHQIFQDYMLTVQKKIAEKLPLVRAGTESEQSLQKIIDDRAKSPFSNENVSTWLEVIEREIAVLKSCAGMVEGTQAKFVSNQTELDREVLAEDVKHALCFVFTSVERNDPYLKVLSDYLESPDSKDGKEAVPSTEDKWCFSTRVVLKMKQRAQTFCDHVNDFEKSRNVGFFVTALENGKFQGASIYHYKDGSLATQDFTFPRMPFVQGYKKRSDLLWYACDLTFDRNTINIWVSLSDNDTFAASEHGKRQNYPKHPERFLCYNQVLCNEGLTGKHYWEVEWNGYVDVGVAYISISRKEDNWVSAIGHNTCSWVFSSIPRAGYVERYNQRQYYVTVPTPGFKQLGVFLNWPDGSLSFYAVSSDEVHHLHTFKTKFTEPVYPAFCLGYRFDHGTVRLL | Neoverrucotoxin subunit alpha (NeoVTX subunit alpha) | Free | Free | Linear | L | None | 703 | Antimicrobial | 50 % Hemolytic | Rabbit | Synanceia Verrucosa (Reef Stonefish) | NA | NA | ||
| 17023116 | 2006 | MPSDILVVAALGRPFTLGMLYDARNDKLIPGFTLWEDEVIEESTVESSQPSSAFEIIASDSIDDKSSLMDIEASLKASFLGGLVEVGGSAKYLNNQKKFKNQSRVTLQYKATTNFKQLMTNLGTKHVEYSELFENIQATHVVIGILYGANAFFVFDSNKVDSTNVQEIQGQMEAVIKKIPSVEISGKASVQLTSEETDITNSFSCEFHGDFFLTSNPTTFEDAVKTYQQLPQMMGKDNAVPMTVWLVPMVNFYSEAPQLMADSSTPILRKVRNTLEAIVQVQMRCNDALDDPTVNLFTEVQKKLSDFQIICDDHMSKLQATIAKKLFAIRSGDEDESALVNLFEENLQSPFNIESLNMWMEFEEREINVLKSCMDILTKAKPKVIFNQGVLFKELYDSKVKHGLCYVFTNVTKNDDFLTVLNDFLDSPQSRPKKLRPSPKDYWYSYDDIPEMMREKAHLFRNLAKEMNNRCVHFFVTAINNPKQEGAGIHYYRESIQIIHEFTKPHMPGVETIKDRRELQWYDCELTLDTETAHQVLTLSEGNKKAVSGSTKSPADHFEKFSHFQQVMCTKGLSGRHYWELEWSGHVSAGVTYKGISRKTSTPDSSLGKNQKSWVFEYTKKSGYQQIHNGKNARVTVSSIGFKQLGVYLDWPAGTLSFYMVNKAWVTHLHTFHTKFYEAVYPAFLIGDAQQKVNGQIKLL | Neoverrucotoxin subunit beta (NeoVTX subunit beta) | Free | Free | Linear | L | None | 700 | Antimicrobial | 50 % Hemolytic | Rabbit | Synanceia Verrucosa (Reef Stonefish) | NA | NA | ||
| 22232283 | 2011 | MRTLTLLTALLLLALQVQTQSLEETADQVPAQDQPGAEAQDITISFAGDERSAREASKSLIGTASCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR | Alpha-defensin 1 | Free | Free | Linear | L | None | 98 | Antimicrobial | <3 % Hemolytic at 100µg/ml | Sheep | Equus Caballus (Horse) | NA | Non-hemolytic | ||
| 22232283 | 2011 | MRTLTLLTALLLLALQVQTQSLEETADQVPAQDQPGAEAQDITISFAGDERSAREASKSLIGTASCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR | Alpha-defensin 1 | Free | Free | Linear | L | None | 98 | Antimicrobial | <3 % Hemolytic at 100µg/ml | Horse | Equus Caballus (Horse) | NA | Non-hemolytic | ||
| 22542795 | 2012 | MAKLIAFALVASLCLSMVLCNPLPEEVQEEGLVRQKRVTCDVLSFEAKGIAVNHSACALHCIALRKKGGSCQNGVCVCRN | Defensin coprisin | Free | Free | Linear | L | None | 80 | Antimicrobial | 0 % Hemolytic at 100µM | Human | Copris Tripartitus (Dung Beetle) | NA | Non-hemolytic | ||
| 18584916 | 2008 | FLSGIVGMLGKLF{ct:Amid} | Temporin-SHa (Temporin-1Sa) (Temp-1Sa) | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LC50 % Hemolytic at 25µM | Human | Pelophylax Saharicus (Sahara Frog) (Rana Saharica) | NA | NA | ||
| 18584916 | 2008 | FLSHIAGFLSNLF{ct:Amid} | Temporin-SHc (Temporin-1Sc) (Temp-1Sc) | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LC50 % Hemolytic at >80µM | Human | Pelophylax Saharicus (Sahara Frog) (Rana Saharica) | NA | Non-hemolytic | ||
| 18620012 | 2008 | MEGFFWKTLLVVGALAIGGTSSLPHKPLTYEEAVDLAVSIYNSKSGEDSLYRLLEAVPPPEWDPLSESNQELNFTIKETVCLVAEERSLEECDFQEDGAIMGCTGYYFFGESPPVLVLTCKPVGEEEEQKQEEGNEEEKEVEKEEKEEDEKDQPRRVKRFKKFFKKLKNSVKKRAKKFFKKPRVIGVSIPF | Cathelicidin-related peptide Oh-Cath (Cathelicidin-related antimicrobial peptide) (Oh_CRAMP) (Vipericidin) | Free | Free | Linear | L | None | 191 | Antimicrobial | 0 % Hemolytic at 200µg/ml | Human | Ophiophagus Hannah (King Cobra) (Naja Hannah) | NA | Non-hemolytic | ||
| 24523715 | 2014 | VRDICKKEAERQDLSSCENYITQRRGY | Trypsin inhibitor 1 (JcTI-I) | Free | Free | Linear | L | None | 27 | Antimicrobial | 0 % Hemolytic at 25µM | Human | Jatropha Curcas (Barbados Nut) | NA | Non-hemolytic | ||
| 19591185 | 2009 | VNWKKVLGKIIKVAK{ct:Amid} | Lasioglossin-1 (LL-I) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | >200 % Hemolytic at 50µM | Rat | Lasioglossum Laticeps (Bee) | Alpha Helix | Non-hemolytic | ||
| 19591185 | 2009 | VNWKKILGKIIKVAK{ct:Amid} | Lasioglossin-2 (LL-II) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | >200 % Hemolytic at 50µM | Rat | Lasioglossum Laticeps (Bee) | Alpha Helix | Non-hemolytic | ||
| 21536670 | 2011 | MKVLVILFGAMLVLMEFQKASAATLLEDFDDDDDLLDDGGDFDLEANSDASSGNGNDSNDAVPEKRRACADLRGKTFCRLFKSYCDKKGIRGRLMRDKCSYSCGCRG{ct:Amid} | Antimicrobial peptide damicornin | Amidation | Free | Linear | L | None | 107 | Antimicrobial | 0 % Hemolytic at 80µM | Sheep | Pocillopora Damicornis (Cauliflower Coral) (Millepora Damicornis) | NA | Non-hemolytic | ||
| 22586077 | 2012 | MQFTKLATILLVSLMGSAAIAAPATNNAAVDAAADATPAVEKRGFGCPFNENECHAHCLSIGRKFGFCAGPLRATCTCGKQ | Fungal defensin micasin (Fungal defensin-like peptide) (DLP) (fDLP) | Free | Free | Linear | L | None | 81 | Antimicrobial | 20 % Hemolytic at 50µM | Mouse | Arthroderma Otae (Microsporum Canis) | ribbon | Non-hemolytic | ||
| 25017240 | 2014 | MKNYSKNATYLITVLLFSFVTMLLIIPSKCEAVSNDMQPLEARTADLVQQPRYIIDVPPRCPPGSKFVHKRCRVIVP{ct:Amid} | Secapin-2 | Amidation | Free | Linear | L | None | 77 | Antimicrobial | Hemolytic | Rat | Apis Mellifera (Honeybee) | Helical,Strand and unordered | Non-hemolytic | ||
| 23093408 | 2012 | GFGCPGDAYQCSEHCRALGGGRTGGYCAGPWYLGHPTCTCSF | Fungal defensin eurocin | Free | Free | Linear | L | None | 42 | Antimicrobial | 0.5– 4 % Hemolytic at 1024ug/ml | Human | Aspergillus Amstelodami | Alpha Beta fold | Non-hemolytic | ||
| 23182832 | 2013 | MKNQFVLLLLAIVFLQMIFQSDAILSAIWSGIKSLFGKRGLENMDKFDELFDGDLSEADLDFLKELMR{ct:Amid} | Antimicrobial peptide UyCT3 (CT3) (Non-disulfide-bridged peptide 4.17) (NDBP-4.17) (Non-disulfide-bridged peptide 5.15) (NDBP-5.15) | Amidation | Free | Linear | L | None | 68 | Antimicrobial | 95 % Hemolytic at 50µM | Human | Urodacus Yaschenkoi (Inland Robust Scorpion) | NA | NA | ||
| 15222751 | 2004 | MAFLKKSLFLVLFLALVPLSICEAEKREEENEEKQEDDDESEKKRGVVTDLLNTAGGLLGNLVGSLSGGER{ct:Amid} | Plasticin-DA1 (PTC-DA1) (Dermaseptin PD-3-6) (DRP-PD3-6) (PD36) | Amidation | Free | Linear | L | None | 71 | Antimicrobial | 65 % Hemolytic at 100µM | Rat | Agalychnis Dacnicolor (Giant Mexican Leaf Frog) (Pachymedusa Dacnicolor) | Helix | NA | ||
| 3615669 | 1987 | NLYQFKNMIHCTVPSRPWWHFADYGCYCGRGGKGTAVDDLDRCCQVHDNCYGEAEKLGCWPYLTLYKYECSQGKLTCSGGNNKCEAAVCNCDLVAANCFAGAPYIDANYNVNLKERCQ | Acidic phospholipase A2 CM-I (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 118 | Antimicrobial | Indirect hemolysis | Guinea-pig | Naja Mossambica (Mozambique Spitting Cobra) | NA | NA | ||
| 3615669 | 1987 | NLYQFKNMIHCTVPSRPWWHFADYGCYCGRGGKGTPVDDLDRCCQVHDNCYEKAGKMGCWPYFTLYKYKCSQGKLTCSGGNSKCGAAVCNCDLVAANCFAGARYIDANYNINFKKRCQ | Basic phospholipase A2 CM-III (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 118 | Antimicrobial | Direct hemolysis | Guinea-pig | Naja Mossambica (Mozambique Spitting Cobra) | NA | NA | ||
| 10728833 | 2000 | HLLQFGDLIDKIAGRSGFWYYGFYGCYCGLGGRGRPQDATDRCCFVHDCC | Acidic phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (LM-PLA2-I) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 50 | Antimicrobial | Hemolytic | Rabbit | Lachesis Muta Muta (Bushmaster) | NA | NA | ||
| 21699995 | 2011 | SLWQFGKMINYVMGESGVLQYLSYGCYCGLGGQGQPTDATDRCCFVHDCCYGKVTGCDPK | Acidic phospholipase A2 (svPLA2) (EC 3.1.1.4) (Bl-PLA2) (Phosphatidylcholine 2-acylhydrolase 1B) | Free | Free | Linear | L | None | 60 | Antimicrobial | Hemolytic at 35.47± 1.05mm | mouse | Bothrops Leucurus (Whitetail Lancehead) | NA | NA | ||
| 22091349 | 2011 | NLFQFARMINGKLGAFSV | Acidic phospholipase A2 Drs-PLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 18 | Antimicrobial | Hemolytic | Human | Daboia Siamensis (Eastern Russel'S Viper) (Daboia Russelii Siamensis) | NA | NA | ||
| 27128943 | 2016 | MKTIVLLFVLALVFCTLEMGIVEAGFGCPFNQGQCHKHCQSIRRRGGYCDGFLKQRCVCYRK{ct:Amid} | Defensin BmKDfsin4 (4 kDa defensin) | Amidation | Free | Linear | L | None | 62 | Antimicrobial | 50 % Hemolytic at 66.85µM | Human | Mesobuthus Martensii (Manchurian Scorpion) (Buthus Martensii) | NA | Non-hemolytic | ||
| 14572904 | 2003 | GITPDCTFNEKDIELHVYSRDKRNGIILKKEILKNYDLFKES | Phospholipase A1 (PLA1) (EC 3.1.1.32) (allergen Pol g 1) | Free | Free | Linear | L | None | 42 | Antimicrobial | Hemolytic | Human | Polistes Gallicus (Paper Wasp) | Loop | Low hemolytic | ||
| 19253295 | 2008 | YDLSKNCRLRGGICYIGKCPRRFFRSGSCSRGNVCCLRFG | Beta-defensin 1 (TBD-1) | Free | Free | Linear | L | None | 40 | Antimicrobial | 0 % Hemolytic at 25µmol/L | Human | Emys Orbicularis (European Pond Turtle) | NA | Non-hemolytic | ||
| 20331996 | 2010 | NLVQFKTLIMKIAGRSVVYKYFYGCYCGWGGIGQPRDATDRCCFVHDCCYGKVTNCNPKTATYSYTEENGALVCGGDDPCKKQVCECDRVAAMCFRDNKDTYDNKYWFLPPKNCQEDSEPC | Acidic phospholipase A2 SpII RP4 (Ba SpII RP4) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 121 | Antimicrobial | Hemolytic | Sheep | Bothrops Alternatus (Urutu) (Rhinocerophis Alternatus) | NA | Non-hemolytic | ||
| 16401077 | 2005 | GLRSKIWLWVLLMIWQESNKFKKM | Atypical cationic antimicrobial peptide (Dermaseptin-S9) (DRS-S9) | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolytic at 175µM | Rat | Phyllomedusa Sauvagei (Sauvage'S Leaf Frog) | Alphα-Helical | NA | ||
| 33387653 | 2021 | MNQVMTIFLVLGVIVYSVESSSTPDGTWVKCRHDCFTKYKSCQMSDSCHDEQSCHQCHVKHTDCVNTGCP | U-actitoxin-Aeq5a (U-AITX-Aeq5a) (Acrorhagin I) (Acrorhagin-1) | Free | Free | Linear | L | None | 70 | Antimicrobial | 0 % Hemolytic | Human | Actinia Equina (Beadlet Anemone) | two antiparallel α‑helices | NA | ||
| 16872274 | 2006 | GIPCGESCVWIPCISSAIGCSCKSKVCYRN{cyc:N-C} | Cycloviolacin-O2 | Free | Free | Cyclic | L | None | 30 | Antimicrobial | HD50 % Hemolytic at 36µM | Human | Viola Odorata (Sweet Violet) | NA | NA | ||
| 16872274 | 2006 | GIPCGESCVWIPCISAAIGCSCKSKVCYRN{cyc:N-C} | Cycloviolacin-O13 (Cyclotide c3) | Free | Free | Cyclic | L | None | 30 | Antimicrobial | HD50 % Hemolytic at 11µM | Human | Viola Odorata (Sweet Violet) | NA | NA | ||
| 15197474 | 2004 | ACQFWSCNSSCISRGYRQGYCWGIQYKYCQCQ | Defensin-1 (Cll-dlp) | Free | Free | Linear | L | None | 32 | Antimicrobial | Hemolytic | Human | Centruroides Limpidus (Mexican Scorpion) | NA | NA | ||
| 12220717 | 2002 | MRTLWIMAVLLVGVEGHLWQFREMIKEATGKEPLTTYLFYACYCGWGGRGEPKDATDRCCFVHDCCYGKLTACSPKLDIYSYSQKNEDIVCGGGTECEKQICECDKAAAICFLDNLGTYNKEYNNYSKSRCIEESPKC | Acidic phospholipase A2 jerdoxin (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 138 | Antimicrobial | 97 % Hemolytic at 2μg/mL | Rabbit | Protobothrops Jerdonii (Jerdon'S Pitviper) (Trimeresurus Jerdonii) | NA | NA | ||
| 11751887 | 2001 | MSKFWLLLLLVAAFQFAHSYPAAEYELDETTNDEVRQFIGDGYFEDEGDDGDEERFKIKPGKVLDKFGKIVGKVLKQLKKVSAVAKVAMKKGAALLKKMGVKISPLKCEEKTCKSCVIFKIPTENSFCLTIRFMKTNIATYLVVAGEINRKSKFEEKLKLGNMPRCVNVEGFIGKVCMKGIEGHAKSSSGQANVNFCLGLVAEKFGVGAKLCGIYANKKVRVKISPQLFPGATSLDGDIVKLDDNGEDATTLDVDEVEID | Trialysin (Triatoma infestans cytolysin) | Free | Free | Linear | L | None | 260 | Antimicrobial | Hemolytic | Human | Triatoma Infestans (Assassin Bug) | NA | NA | ||
| 12372834 | 2002 | MNFYKYLVVLVVLVLCLSATQTEARGFRKHFNKLVKKVKHTISETAHVAKDTAVIAGSGAAVVAATG{ct:Amid} | Stomoxyn | Amidation | Free | Linear | L | None | 67 | Antimicrobial | <4 % Hemolytic at 10µM | Bovine | Stomoxys Calcitrans (Stable Fly) (Conops Calcitrans) | Helix | NA | ||
| 22014884 | 2011 | KIAKVALKAL | PYLa/PGLa A [Cleaved into: PYLa; PGLa; PGLa-H] | Free | Free | Linear | L | None | 10 | Antimicrobial | 7.95 % Hemolytic at 200μg/mL | Rabbit | Xenopus Laevis (African Clawed Frog) | NA | Low hemolytic | ||
| 10964708 | 2000 | MSRGYSLHLVLFLVLSTAFPSQARLSRYRRSAADAVSTDIDGIIGQLNDLGTDTKRLKEALQGVQEAVKKEPATTIAKVSTIVGSVGGSLSKFKSGDPFDVASGCLDIIASVATTFGGPYGIAIGAVASLISSILSLFSGNSMGSAIKQVIDDAFKKYRDQELEDNVKGAKRTFNAVITFVNSVSKTENLTEVHLDSVRDAVRVDAFTNMLGVLESRINRGSVSTDNNEAMRTINFIFLYLQLSVMRETLLTQVILLYKRAGGAYDELALSLSLTSDQNKEATRETVTFLHQMETKYSLCGSYYYPIDHSKAAIGILKLTKFFGVPDPARYTFDGLYYRMQNRAWNRYSICKESYAGNHMFRGCKDSSYHGIRIKKLENGYHTITLRSKAMYVTKHAQGWGWGTADEDPGEQGYFTFIPLTNGFYMVSTKKWPDYFVYMESSAHGYIRSWHYNPDPQGQWKIL | Toxin CaTX-A (Toxin-A) (CAT-1) (Toxin CaTX-B) (Toxin-B) | Free | Free | Linear | L | None | 463 | Antimicrobial | 50 % Hemolytic at 70-80ng/ml | Sheep | Carybdea Alata (Hawaiian Box Jellyfish) | NA | Low hemolytic | ||
| 10964707 | 2000 | MILKHLPWLFIVLAITSAKHGKRSDVNSLLTKVETALKEASGSNEAALEALEGLKGEIQTKPDRVGQATKILGSVGSALGKLNSGDATKIISGCLDIVAGIATTFGGPVGMGIGAVASFVSSILSLFTGSSAKNSVAAVIDRALSKHRDEAIQRHAAGAKRDFAESSAFIQVMKQQSNLTDSDLSIIAANVPVYKFSNFIGQLESRISQGAATTSLSDAKRAVDFILLYCQLVVMRETLLVDLAILYRKGNAEHVASAVENANRVNKELAADTLDFLHKLIPEQALIGAVYHPISASETSKAILNYTKYFGVPDVPRPIGNRRYKFTNSYWNTYSICSEAYMGNYMFRGCSNVRNPNIRVSKMSDGFYTMENSDRRKLYITKHDQGWGWGTLDEDPGDQGHMRFIPLRHGKYMVSSKRWPNWFMYMESSASGYIRSWENNPGPQGHWSIT | Toxin CrTX-A (CRT-1) (CrTX-B) (Toxin 1) (Toxin-A) (Toxin-B) | Free | Free | Linear | L | None | 450 | Antimicrobial | 50 % Hemolytic at 1.9-2.2ng/ml | Sheep | Carybdea Rastonii (Box Jellyfish) | NA | NA | ||
| 29467168 | 2018 | MQFTKLATVLIVSLMGSAAIAAPSVDNAPAVAAEEVAAAPAENLEKRGFGCPLNERECHSHCQSIGRKFGYCGGTLRLTCICGKE | Fungal defensin triintsin | Free | Free | Linear | L | None | 85 | Antimicrobial | HC(50) % Hemolytic at 325µmol/L | Human | Trichophyton Interdigitale (Strain Mr816) | NA | Low hemolytic | ||
| 29174563 | 2017 | MKFSNISIAALFTILASTAMAAPAADSPDSIVAREPAPVEETYEAPSGLEKRGFGCPGSEKKCHNHCKSVKGYKGGYCDGPYIPFVGRPRCKCY | Fungal defensin scedosporisin-2 (fDEF) | Free | Free | Linear | L | None | 94 | Antimicrobial | <30 % Hemolytic at 50µM | Rabbit | Pseudallescheria Apiosperma (Scedosporium Apiospermum) | NA | Low hemolytic | ||
| 23933196 | 2018 | MPSDILVVAALGRPFTLGALYDARKDKLYPGFTLWEHEVLEESTVESDQPSSTFEITASDSIDDKSSLMDIEASLKASFLGGLIEVGGSAKYLNDTKKFKNQSRVTLQYKATTSFKQLMTNLETKHVEYSEYFQNIEATHVVIGILYGANAFFVFDSDKVDSSNVQDIQGSMEAVIKKIPSVEISGQGSVQLTSEESDITNSFSCKFHGDFHLPSNPTTFEDAVKTYQQLPQMMGKETAVPMTVWLVPMTNFYSEAPQLMADSSTPILRKVRNTLEAMRQLDMRCNDSLERRHSEAGFHCLKKKLKTFQKHYERLHVNPFRKNHFPETFSPSGKGTKMKLQCLPTFRNKLRSPSNINSLNMWMDCAEREINVLRSCIDIIEEAKHKVVLSKSQMARELDDSEVKHAVCYVFTYVTDYDPFLNALSDFSKSIKPKKYSPSKKDYWYTSDDVPEMMREKAHHFYNLAKDMENRCVRFLVASIVNPKEEGAAIHYYREGIQIINDFSNPRIPPVETIQDQESYSGMTVSSPWKETAHPALHLSEGNKKAMSGKPQPSDNNPKRFDHYQQVLCNKGLSKRHYWEVEWCGYVRAGITYKGIQRKTFASECSLGHTDMSWVFDYYPKSGYHHIYNNKKVRVKVASPGFDRLGVYLDWPAGTLSFYMVTSTWVTHLHTFSIRFNEAVYPAFLIGHGQKNANGQIKLKGE | Cytolytic toxin-beta (Sp-CTx-beta) | Free | Free | Linear | L | None | 702 | Antimicrobial | 50 % Hemolytic at 25-56ng/mL | Rabbit | Scorpaena Plumieri (Spotted Scorpionfish) | NA | NA | ||
| 15638808 | 2005 | FIGAILPAIAGLVHGLINR{ct:Amid} | Hylin-b1 (Hy-b1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | Hemolytic | Human | Boana Lundii (Brazilian Tree Frog) (Hypsiboas Lundii) | NA | NA | ||
| 15638808 | 2005 | FIGAILPAIAGLVGGLINR{ct:Amid} | Hylin-b2 (Hy-b2) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | Hemolytic | Human | Boana Lundii (Brazilian Tree Frog) (Hypsiboas Lundii) | NA | NA |